Citrus Sinensis ID: 012297
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 466 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VYY5 | 565 | Receptor-like serine/thre | yes | no | 0.939 | 0.775 | 0.534 | 1e-133 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.512 | 0.313 | 0.507 | 1e-62 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.512 | 0.337 | 0.509 | 1e-59 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.521 | 0.338 | 0.476 | 1e-58 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.521 | 0.356 | 0.48 | 3e-58 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.517 | 0.369 | 0.476 | 5e-58 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.504 | 0.330 | 0.479 | 6e-58 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.504 | 0.326 | 0.479 | 6e-57 | |
| Q9XI96 | 699 | Proline-rich receptor-lik | no | no | 0.495 | 0.330 | 0.5 | 9e-57 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.493 | 0.309 | 0.471 | 2e-56 |
| >sp|Q8VYY5|NCRK_ARATH Receptor-like serine/threonine-protein kinase NCRK OS=Arabidopsis thaliana GN=NCRK PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 474 bits (1221), Expect = e-133, Method: Compositional matrix adjust.
Identities = 247/462 (53%), Positives = 324/462 (70%), Gaps = 24/462 (5%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MK++V+ A L+ LI IQ+ G N+ CTC SS G++S+IL+ NCS SC+
Sbjct: 1 MKMRVETALAILLVLISIQQCY-------GGVSNYTCTCFSS--GNRSDILESNCSTSCN 51
Query: 61 CSPVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVVV 120
C P +W C+C A+G P +A +++CF SC C++G+ K +++S K+V+
Sbjct: 52 CRP----DRDQWVCLCPANGFPVIAIGGSNSSCFTSCNCSAGATKSSKK--QYLSRKLVI 105
Query: 121 IVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKESC-NSATNLISHRITSVPET 179
++LL C +L ++AFL ++CY+ RK KF ++ +SSD+ES +S+ NLI+ + +
Sbjct: 106 VILLFCGVLISLAFLASMICYICRKDKFSGQTPSVSSDRESSWHSSANLINRKSSVSQSK 165
Query: 180 RVEVVSPIDLATGCFLKTT--FCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGS 237
S GCF + FC SK TIHG I +FSY+ LE AT+KFS ++++G GGS
Sbjct: 166 ISISSS----VAGCFFQNASLFCVSKPETIHGAIFQFSYTELEQATNKFSSNSVIGHGGS 221
Query: 238 SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297
S VYRGQL DG+ A+KR T G + D++F TEV++LSRLHH HVVPL+GYCSEF GK
Sbjct: 222 SCVYRGQLKDGKTAAIKRLNTPKGDDTDTLFSTEVELLSRLHHYHVVPLIGYCSEFHGKH 281
Query: 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 357
A RLLVFE+M G+LRDCLDG L E M W+ R+++A+GAARGLEYLHEAAAPRILHRD+K
Sbjct: 282 AERLLVFEYMSYGSLRDCLDGELGEKMTWNIRISVALGAARGLEYLHEAAAPRILHRDVK 341
Query: 358 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYFAPEYAMVGRASLMS 416
S+NILLDEN +AKITDLGMAK L +DGL S SSSP +QGTFGYFAPEYA+ G AS MS
Sbjct: 342 STNILLDENWHAKITDLGMAKCLSSDGLQSGSSSPTTGLQGTFGYFAPEYAIAGCASQMS 401
Query: 417 DVFSFGVVLLELITGRQPIHR-SITKGEESLVLWVKSIITDA 457
DVFSFGVVLLELITGR+PI + S KGEESLV+W + D+
Sbjct: 402 DVFSFGVVLLELITGRKPIQKPSNNKGEESLVIWAVPRLQDS 443
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 241 bits (614), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 128/252 (50%), Positives = 169/252 (67%), Gaps = 13/252 (5%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
FSY L AT+ FS N++G+GG VY+G L D R+VAVK+ K GG D F EVD
Sbjct: 418 FSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGG-QGDREFKAEVD 476
Query: 274 MLSRLHHCHVVPLVGYC-SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 332
+SR+HH +++ +VGYC SE R RLL+++++PN NL L G++W TRV I
Sbjct: 477 TISRVHHRNLLSMVGYCISENR-----RLLIYDYVPNNNLYFHLHAAGTPGLDWATRVKI 531
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS- 391
A GAARGL YLHE PRI+HRDIKSSNILL+ N +A ++D G+AK L D C++
Sbjct: 532 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAK-LALD----CNTHI 586
Query: 392 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVK 451
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S G+ESLV W +
Sbjct: 587 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWAR 646
Query: 452 SIITDASICQSF 463
++++A+ + F
Sbjct: 647 PLLSNATETEEF 658
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 231 bits (589), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 128/251 (50%), Positives = 168/251 (66%), Gaps = 12/251 (4%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
FSY L AT+ FS N++G+GG VY+G L DGR+VAVK+ K GG D F EV+
Sbjct: 365 FSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGG-QGDREFKAEVE 423
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
LSR+HH H+V +VG+C G R RLL+++++ N +L L G ++W TRV IA
Sbjct: 424 TLSRIHHRHLVSIVGHC--ISGDR--RLLIYDYVSNNDLYFHLHGE-KSVLDWATRVKIA 478
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS-P 392
GAARGL YLHE PRI+HRDIKSSNILL++N +A+++D G+A RL D C++
Sbjct: 479 AGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLA-RLALD----CNTHIT 533
Query: 393 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKS 452
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S G+ESLV W +
Sbjct: 534 TRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARP 593
Query: 453 IITDASICQSF 463
+I+ A + F
Sbjct: 594 LISHAIETEEF 604
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 227 bits (579), Expect = 1e-58, Method: Compositional matrix adjust.
Identities = 120/252 (47%), Positives = 162/252 (64%), Gaps = 9/252 (3%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
F+Y L AT+ FS +N++GQGG YV++G L +G+ VAVK+ K +G + F EV
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLK-EGSSQGEREFQAEVG 400
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++SR+HH H+V LVGYC A RLLV+EF+PN L L G M W +R+ IA
Sbjct: 401 IISRVHHRHLVALVGYCI----ADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIA 456
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+G+A+GL YLHE P+I+HRDIK+SNIL+D AK+ D G+AK + +D S+
Sbjct: 457 VGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAK-IASDTNTHVST--- 512
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSI 453
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+PI + + SLV W + +
Sbjct: 513 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPL 572
Query: 454 ITDASICQSFLV 465
+ S +F V
Sbjct: 573 LNQVSELGNFEV 584
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 226 bits (575), Expect = 3e-58, Method: Compositional matrix adjust.
Identities = 120/250 (48%), Positives = 159/250 (63%), Gaps = 7/250 (2%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
FSY L T FS N++G+GG VY+G L+DGR VAVK+ K GG + F EV+
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKI-GGSQGEREFKAEVE 385
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++SR+HH H+V LVGYC RLLV++++PN L L M W+TRV +A
Sbjct: 386 IISRVHHRHLVTLVGYCI----SEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVA 441
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
GAARG+ YLHE PRI+HRDIKSSNILLD + A + D G+AK + L + S+
Sbjct: 442 AGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVST-- 499
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSI 453
R+ GTFGY APEYA G+ S +DV+S+GV+LLELITGR+P+ S G+ESLV W + +
Sbjct: 500 RVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPL 559
Query: 454 ITDASICQSF 463
+ A + F
Sbjct: 560 LGQAIENEEF 569
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 225 bits (574), Expect = 5e-58, Method: Compositional matrix adjust.
Identities = 119/250 (47%), Positives = 161/250 (64%), Gaps = 9/250 (3%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
F+Y L AT+ FS +N++GQGG YV++G L G+ VAVK+ K G + F EV+
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSG-QGEREFQAEVE 326
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++SR+HH H+V L+GYC RLLV+EF+PN NL L G M W TR+ IA
Sbjct: 327 IISRVHHRHLVSLIGYCM----AGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIA 382
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+G+A+GL YLHE P+I+HRDIK+SNIL+D AK+ D G+AK + +D S+
Sbjct: 383 LGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK-IASDTNTHVST--- 438
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSI 453
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ + ++SLV W + +
Sbjct: 439 RVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPL 498
Query: 454 ITDASICQSF 463
+ AS F
Sbjct: 499 LNRASEEGDF 508
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 225 bits (573), Expect = 6e-58, Method: Compositional matrix adjust.
Identities = 117/244 (47%), Positives = 158/244 (64%), Gaps = 9/244 (3%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
F+Y L T+ FS NI+G+GG VY+G+L DG++VAVK+ K G D F EV+
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSG-QGDREFKAEVE 399
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++SR+HH H+V LVGYC + RLL++E++PN L L G + W RV IA
Sbjct: 400 IISRVHHRHLVSLVGYCI----ADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIA 455
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
IG+A+GL YLHE P+I+HRDIKS+NILLD+ A++ D G+AK + + +
Sbjct: 456 IGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDS----TQTHVST 511
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSI 453
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ + GEESLV W + +
Sbjct: 512 RVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPL 571
Query: 454 ITDA 457
+ A
Sbjct: 572 LHKA 575
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 222 bits (565), Expect = 6e-57, Method: Compositional matrix adjust.
Identities = 117/244 (47%), Positives = 157/244 (64%), Gaps = 9/244 (3%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
FSY L T F+ NI+G+GG VY+G L DG++VAVK+ K G D F EV+
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSG-QGDREFKAEVE 417
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++SR+HH H+V LVGYC + RLL++E++ N L L G + + W RV IA
Sbjct: 418 IISRVHHRHLVSLVGYCISDQ----HRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIA 473
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
IG+A+GL YLHE P+I+HRDIKS+NILLD+ A++ D G+A RL S+
Sbjct: 474 IGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLA-RLNDTTQTHVST--- 529
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSI 453
R+ GTFGY APEYA G+ + SDVFSFGVVLLEL+TGR+P+ ++ GEESLV W + +
Sbjct: 530 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPL 589
Query: 454 ITDA 457
+ A
Sbjct: 590 LLKA 593
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XI96|PERK7_ARATH Proline-rich receptor-like protein kinase PERK7 OS=Arabidopsis thaliana GN=PERK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (563), Expect = 9e-57, Method: Compositional matrix adjust.
Identities = 120/240 (50%), Positives = 156/240 (65%), Gaps = 9/240 (3%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
F+Y L AT FS ++GQGG YV++G L +G+ +AVK K G + F EV+
Sbjct: 324 FTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSG-QGEREFQAEVE 382
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++SR+HH H+V LVGYCS G+R LLV+EF+PN L L G M+W TR+ IA
Sbjct: 383 IISRVHHRHLVSLVGYCSNAGGQR---LLVYEFLPNDTLEFHLHGKSGTVMDWPTRLKIA 439
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+G+A+GL YLHE P+I+HRDIK+SNILLD N AK+ D G+AK L D S+
Sbjct: 440 LGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAK-LSQDNNTHVST--- 495
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSI 453
R+ GTFGY APEYA G+ + SDVFSFGV+LLELITGR P+ S E+SLV W + +
Sbjct: 496 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGDM-EDSLVDWARPL 554
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 220 bits (561), Expect = 2e-56, Method: Compositional matrix adjust.
Identities = 115/244 (47%), Positives = 162/244 (66%), Gaps = 14/244 (5%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
F+ S LE ATD+FS ++G+GG VY+G + DG VAVK T+ N D F+ EV+
Sbjct: 337 FTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLL-TRDNQNRDREFIAEVE 395
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAI 332
MLSRLHH ++V L+G C E R R L++E + NG++ L EG ++WD R+ I
Sbjct: 396 MLSRLHHRNLVKLIGICIEGR----TRCLIYELVHNGSVESHLH----EGTLDWDARLKI 447
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 392
A+GAARGL YLHE + PR++HRD K+SN+LL+++ K++D G+A R +G S+
Sbjct: 448 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA-REATEGSQHIST-- 504
Query: 393 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKS 452
R+ GTFGY APEYAM G + SDV+S+GVVLLEL+TGR+P+ S GEE+LV W +
Sbjct: 505 -RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARP 563
Query: 453 IITD 456
++ +
Sbjct: 564 LLAN 567
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 466 | ||||||
| 297746278 | 635 | unnamed protein product [Vitis vinifera] | 0.980 | 0.719 | 0.704 | 0.0 | |
| 359478364 | 628 | PREDICTED: receptor-like serine/threonin | 0.965 | 0.716 | 0.698 | 0.0 | |
| 255578119 | 625 | kinase, putative [Ricinus communis] gi|2 | 0.961 | 0.716 | 0.671 | 1e-179 | |
| 224106790 | 563 | predicted protein [Populus trichocarpa] | 0.963 | 0.797 | 0.678 | 1e-174 | |
| 224132516 | 532 | predicted protein [Populus trichocarpa] | 0.907 | 0.795 | 0.699 | 1e-172 | |
| 351725463 | 610 | protein kinase family protein precursor | 0.972 | 0.742 | 0.629 | 1e-160 | |
| 356542635 | 612 | PREDICTED: receptor-like serine/threonin | 0.972 | 0.740 | 0.611 | 1e-160 | |
| 449456024 | 614 | PREDICTED: receptor-like serine/threonin | 0.959 | 0.728 | 0.610 | 1e-157 | |
| 351727637 | 612 | protein kinase family protein precursor | 0.972 | 0.740 | 0.600 | 1e-157 | |
| 449519593 | 610 | PREDICTED: receptor-like serine/threonin | 0.952 | 0.727 | 0.603 | 1e-154 |
| >gi|297746278|emb|CBI16334.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 655 bits (1689), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/461 (70%), Positives = 378/461 (81%), Gaps = 4/461 (0%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MKL V+V ACLI L+ IQ S+CD LS+ S W CTCSS+ QG Q+ IL NCS SCD
Sbjct: 1 MKLPVEVALACLISLLGIQLSLCDVLSDTSNINKWTCTCSSANQGSQNYILAGNCSTSCD 60
Query: 61 CSPVGGSSEG-KWTCICAADGLPKVAANSYDTTCFASCTCTSGSVS-GVKASGKHISSKV 118
CSP GG S G +WTCICAADG PKVA++S T+CF +C CTSGS + A KHISSKV
Sbjct: 61 CSPAGGGSTGDRWTCICAADGFPKVASDSGHTSCFTACNCTSGSPNEDAPARRKHISSKV 120
Query: 119 VVIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVP 177
VVI+LLLCV+LTT AFL VLCYVYRK K ++ V SSDKE SCNSATNLISH+I SVP
Sbjct: 121 VVIILLLCVVLTTFAFLASVLCYVYRKEKCPIQPPVFSSDKETSCNSATNLISHKINSVP 180
Query: 178 ETRVEVVSPIDLATGCFLK-TTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGG 236
E+RV++ SPI+ TGCF K ++ RSKT TIH TI++FSY LE+AT+KFS SN++G GG
Sbjct: 181 ESRVDIGSPINSLTGCFHKASSLFRSKTGTIHETIVQFSYYELENATNKFSNSNLIGVGG 240
Query: 237 SSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296
SSYVY GQL DG+ VAVKR KT+GGP+AD VFLTE+++LSRLHHCHVVPL+GYCSE +GK
Sbjct: 241 SSYVYCGQLKDGKTVAVKRLKTKGGPDADLVFLTEIELLSRLHHCHVVPLLGYCSESQGK 300
Query: 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356
A RLLVFE+M NGNLRDCLDG + M+W TRV+IA+GAARGLEYLHEAAAPRILHRD+
Sbjct: 301 HAQRLLVFEYMLNGNLRDCLDGDSGKNMDWATRVSIALGAARGLEYLHEAAAPRILHRDV 360
Query: 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMS 416
KS+NILLDEN AKITDLGMAKRL+ADGLPSCS+SPARMQGTFGYFAPEYA+VGRAS MS
Sbjct: 361 KSTNILLDENWRAKITDLGMAKRLRADGLPSCSNSPARMQGTFGYFAPEYAIVGRASPMS 420
Query: 417 DVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSIITDA 457
DVFSFGVVLLELI+GR+PIH+S KGEESLV+W + D+
Sbjct: 421 DVFSFGVVLLELISGRKPIHKSTNKGEESLVIWATPRLQDS 461
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478364|ref|XP_002282467.2| PREDICTED: receptor-like serine/threonine-protein kinase NCRK-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 644 bits (1662), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/461 (69%), Positives = 374/461 (81%), Gaps = 11/461 (2%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MKL V+V ACLI L+ IQ S+C G W CTCSS+ QG Q+ IL NCS SCD
Sbjct: 1 MKLPVEVALACLISLLGIQLSLC-------GLNKWTCTCSSANQGSQNYILAGNCSTSCD 53
Query: 61 CSPVGGSSEG-KWTCICAADGLPKVAANSYDTTCFASCTCTSGSVS-GVKASGKHISSKV 118
CSP GG S G +WTCICAADG PKVA++S T+CF +C CTSGS + A KHISSKV
Sbjct: 54 CSPAGGGSTGDRWTCICAADGFPKVASDSGHTSCFTACNCTSGSPNEDAPARRKHISSKV 113
Query: 119 VVIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVP 177
VVI+LLLCV+LTT AFL VLCYVYRK K ++ V SSDKE SCNSATNLISH+I SVP
Sbjct: 114 VVIILLLCVVLTTFAFLASVLCYVYRKEKCPIQPPVFSSDKETSCNSATNLISHKINSVP 173
Query: 178 ETRVEVVSPIDLATGCFLK-TTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGG 236
E+RV++ SPI+ TGCF K ++ RSKT TIH TI++FSY LE+AT+KFS SN++G GG
Sbjct: 174 ESRVDIGSPINSLTGCFHKASSLFRSKTGTIHETIVQFSYYELENATNKFSNSNLIGVGG 233
Query: 237 SSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296
SSYVY GQL DG+ VAVKR KT+GGP+AD VFLTE+++LSRLHHCHVVPL+GYCSE +GK
Sbjct: 234 SSYVYCGQLKDGKTVAVKRLKTKGGPDADLVFLTEIELLSRLHHCHVVPLLGYCSESQGK 293
Query: 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356
A RLLVFE+M NGNLRDCLDG + M+W TRV+IA+GAARGLEYLHEAAAPRILHRD+
Sbjct: 294 HAQRLLVFEYMLNGNLRDCLDGDSGKNMDWATRVSIALGAARGLEYLHEAAAPRILHRDV 353
Query: 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMS 416
KS+NILLDEN AKITDLGMAKRL+ADGLPSCS+SPARMQGTFGYFAPEYA+VGRAS MS
Sbjct: 354 KSTNILLDENWRAKITDLGMAKRLRADGLPSCSNSPARMQGTFGYFAPEYAIVGRASPMS 413
Query: 417 DVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSIITDA 457
DVFSFGVVLLELI+GR+PIH+S KGEESLV+W + D+
Sbjct: 414 DVFSFGVVLLELISGRKPIHKSTNKGEESLVIWATPRLQDS 454
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578119|ref|XP_002529929.1| kinase, putative [Ricinus communis] gi|223530559|gb|EEF32437.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 632 bits (1631), Expect = e-179, Method: Compositional matrix adjust.
Identities = 308/459 (67%), Positives = 364/459 (79%), Gaps = 11/459 (2%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MKLQV+V ACL+GLIWIQ+ +C G NW CTCS S QG+Q+ + K NCS SCD
Sbjct: 1 MKLQVEVALACLVGLIWIQQGLC-------GLNNWTCTCSLSSQGNQTYV-KSNCSTSCD 52
Query: 61 CSPV-GGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 119
C+PV GGS + W C CAADGLP++A+ S+D+TCF +C CTSGSV+ + KH S KVV
Sbjct: 53 CNPVAGGSKDSTWGCTCAADGLPRIASGSHDSTCFTACNCTSGSVAQAQEKRKHFSGKVV 112
Query: 120 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVPE 178
VI+LLLCVILTT+AFL + CYVYRK +S + SD+E S SATNLISH+ +S+ E
Sbjct: 113 VIILLLCVILTTLAFLASITCYVYRKDNCPFQSPIFISDRETSYTSATNLISHKASSLLE 172
Query: 179 TRVEVVSPIDLATGCFLKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSS 238
T V + + ++ GCF + F R + I+GTI+RFSYS LEHAT FS SN++G GGSS
Sbjct: 173 TGVSIDTHLNPMPGCF-RRAFYRGSSDIINGTIVRFSYSELEHATKNFSNSNLIGLGGSS 231
Query: 239 YVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298
YVYRGQL +G+ VA+KR QGGP+ADS+F EV++LSRLHHCHVVPL+G CSEF+GK +
Sbjct: 232 YVYRGQLRNGKTVAIKRLNAQGGPDADSLFSKEVEVLSRLHHCHVVPLLGCCSEFQGKHS 291
Query: 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 358
RLLVFE+MPNGNLRDCLDG+ E M W+TRVAIAIGAARGLEYLHEAAAPRILHRD+KS
Sbjct: 292 KRLLVFEYMPNGNLRDCLDGISGESMKWETRVAIAIGAARGLEYLHEAAAPRILHRDVKS 351
Query: 359 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 418
+NILLDEN AKITDLGMAKRLKADG+PS SSSPARMQGTFGYFAPEYAMVGRASLMSDV
Sbjct: 352 TNILLDENWGAKITDLGMAKRLKADGVPSSSSSPARMQGTFGYFAPEYAMVGRASLMSDV 411
Query: 419 FSFGVVLLELITGRQPIHRSITKGEESLVLWVKSIITDA 457
FSFGVVLLELI+GRQPIH+S KGEESLVLW + D+
Sbjct: 412 FSFGVVLLELISGRQPIHKSTNKGEESLVLWATPRLQDS 450
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106790|ref|XP_002314286.1| predicted protein [Populus trichocarpa] gi|222850694|gb|EEE88241.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 616 bits (1589), Expect = e-174, Method: Compositional matrix adjust.
Identities = 313/461 (67%), Positives = 369/461 (80%), Gaps = 12/461 (2%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MKLQ+KV A LIGLIWIQ++ +SG W CTCS+S QG+QS I K NCS SCD
Sbjct: 1 MKLQLKVALAFLIGLIWIQQA-------KSGINKWTCTCSASYQGNQSYI-KSNCSTSCD 52
Query: 61 CSPVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVVV 120
CSP G G WTC C++DGLPKVA DTTCF +C CTSG+ + + KH SSK+V+
Sbjct: 53 CSP--GMPGGMWTCTCSSDGLPKVATGIQDTTCFTACNCTSGTWFLWQYTRKHFSSKIVL 110
Query: 121 IVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVPET 179
++LLLCVILTT+AFL + CY+YRK K ++S V SD+E SCNSATNLISHR +SV ET
Sbjct: 111 VILLLCVILTTLAFLASITCYLYRKDKCLVQSPVFLSDRERSCNSATNLISHRASSVSET 170
Query: 180 RVEVVSPIDLATGCFLKTTF-CRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSS 238
++ V SPI+ +GCF K +F CRSKT I G +I F+YS LEHAT+KFS SN++G GGSS
Sbjct: 171 KIRVDSPINPISGCFRKASFLCRSKTEIIQGNLILFTYSELEHATNKFSHSNLIGLGGSS 230
Query: 239 YVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298
YVY GQL DGR VAVKR K QGGP+AD +F TEV++L++LHHCHVVPL+GYCS+F+GK +
Sbjct: 231 YVYHGQLKDGRTVAVKRLKAQGGPDADFLFSTEVELLAKLHHCHVVPLLGYCSKFQGKFS 290
Query: 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 358
RLLVFE+MPNGNLRDCLDGVL E MNW TRV IAIGAARGLEYLHE+AAPRILHRD+KS
Sbjct: 291 ERLLVFEYMPNGNLRDCLDGVLGEKMNWQTRVTIAIGAARGLEYLHESAAPRILHRDVKS 350
Query: 359 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 418
+NIL+DEN AKITDLGMAKRL+ DG+PS SSPARMQGTFGYFAPEYAM+GRAS MSDV
Sbjct: 351 TNILMDENWRAKITDLGMAKRLRGDGVPSSPSSPARMQGTFGYFAPEYAMIGRASPMSDV 410
Query: 419 FSFGVVLLELITGRQPIHRSITKGEESLVLWVKSIITDASI 459
FSFGVVLLELITGRQPIH+S KGEESLVLW ++ D+ +
Sbjct: 411 FSFGVVLLELITGRQPIHKSTNKGEESLVLWATPLLQDSGL 451
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224132516|ref|XP_002328308.1| predicted protein [Populus trichocarpa] gi|222837823|gb|EEE76188.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 610 bits (1573), Expect = e-172, Method: Compositional matrix adjust.
Identities = 300/429 (69%), Positives = 349/429 (81%), Gaps = 6/429 (1%)
Query: 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSPVGGSSEGKWTCICAADGLPKVAANSYD 90
G NW CTCS+S QG+QS K NCS SCDC+ G S G WTC C+ DGLPKVAA S D
Sbjct: 1 GINNWTCTCSASYQGNQS-YTKSNCSTSCDCT--GRQSRGTWTCTCSTDGLPKVAAGSQD 57
Query: 91 TTCFASCTCTSGSVSGVKASGKHISSKVVVIVLLLCVILTTIAFLMLVLCYVYRKGKFHL 150
TTCF +C CTSGS++ +A+ KHISSK+VV V+LLCVILTT+AFL Y+ RK K +
Sbjct: 58 TTCFTACNCTSGSLTDAQATRKHISSKIVV-VILLCVILTTLAFLASTTWYLCRKDKCPI 116
Query: 151 RSSVISSDKE-SCNSATNLISHRITSVPETRVEVVSPIDLATGCFLKTTF-CRSKTWTIH 208
+S SD+E SCNSATNLISHR +SV ET++ V SPI+ +GCF K +F CRSKT IH
Sbjct: 117 QSPTFLSDRETSCNSATNLISHRASSVSETKIRVDSPINPISGCFRKASFLCRSKTEIIH 176
Query: 209 GTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVF 268
GT+I F+YS LEHATDKFS SN++G GGSSYVYRGQL DG VAVKR K QGG +AD +F
Sbjct: 177 GTLICFAYSELEHATDKFSHSNLIGLGGSSYVYRGQLKDGTTVAVKRLKAQGGTDADLLF 236
Query: 269 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT 328
EV++L++LHHCHVVPL+GYCSEFRGK + RLLVFE+MPNGNLRDCLDG++ E MNW T
Sbjct: 237 SREVELLAKLHHCHVVPLLGYCSEFRGKLSERLLVFEYMPNGNLRDCLDGIMGENMNWQT 296
Query: 329 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388
RV IAIGAARGLEYLHEAAAPRILHRD+KS+NIL+DE AKITDLGMAKRL+ADG+PS
Sbjct: 297 RVTIAIGAARGLEYLHEAAAPRILHRDVKSTNILMDELWRAKITDLGMAKRLRADGVPSS 356
Query: 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 448
SSSPARMQGTFGYFAPEYAM+GRASLMSDVFSFGVVLLE+ITGRQPIH++ K EESLVL
Sbjct: 357 SSSPARMQGTFGYFAPEYAMIGRASLMSDVFSFGVVLLEVITGRQPIHKTTNKVEESLVL 416
Query: 449 WVKSIITDA 457
W ++ D+
Sbjct: 417 WATPLLQDS 425
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351725463|ref|NP_001237605.1| protein kinase family protein precursor [Glycine max] gi|223452292|gb|ACM89474.1| protein kinase family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1473), Expect = e-160, Method: Compositional matrix adjust.
Identities = 289/459 (62%), Positives = 347/459 (75%), Gaps = 6/459 (1%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MK Q+ V A +I L+ IQ S CD+ S+ +G WKC CSS LQG++ L NCS+SCD
Sbjct: 1 MKPQLNVAVALVISLLCIQHSFCDEPSD-TGLNKWKCRCSS-LQGNKIYSLA-NCSKSCD 57
Query: 61 CSPVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVVV 120
C P + WTC C +G PKV A+ ++ +CF +C CT G+V S K ISSK+VV
Sbjct: 58 CHPDAEENASIWTCECDPNGFPKVTADVHNLSCFNACNCTWGTVRKPLGSKKQISSKIVV 117
Query: 121 IVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVPET 179
I L +CVI TTIAFL V+C+VYR+ K ++S +ISSDKE S +S TNLISHR +SVPET
Sbjct: 118 IFLSICVICTTIAFLTSVVCHVYRRDKGPIQSPMISSDKETSYSSTTNLISHRTSSVPET 177
Query: 180 RVEVVSPIDLATGCFLKTTFC-RSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSS 238
+V + SPI TGCF K S+ T HG II+FS++ LE+AT+ FS SN++G GGSS
Sbjct: 178 KVAITSPISHITGCFQKAALLFGSQRETFHGNIIQFSFAELENATENFSTSNLIGLGGSS 237
Query: 239 YVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298
YVYRG+L DG VAVKR K Q GP ADS F TE+++LSRLHHCH+VPLVGYCSE +GK
Sbjct: 238 YVYRGRLKDGSNVAVKRIKDQRGPEADSEFFTEIELLSRLHHCHLVPLVGYCSELKGKNV 297
Query: 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 358
RLLVFE+M NGNLRD LDG+L + M+W TRV IA+GAARGLEYLHEAAAPRILHRD+KS
Sbjct: 298 QRLLVFEYMTNGNLRDRLDGILGQKMDWSTRVTIALGAARGLEYLHEAAAPRILHRDVKS 357
Query: 359 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 418
+NILLD+N AKITDLGMAK L+AD PSCS SPARMQGTFGYFAPEYA+VGRASL SDV
Sbjct: 358 TNILLDKNWQAKITDLGMAKNLRADDHPSCSDSPARMQGTFGYFAPEYAIVGRASLESDV 417
Query: 419 FSFGVVLLELITGRQPIHRSITKGEESLVLWVKSIITDA 457
FSFGVVLLELI+GRQPIH+S K EESLV+W S + D+
Sbjct: 418 FSFGVVLLELISGRQPIHKSAGK-EESLVIWATSRLQDS 455
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542635|ref|XP_003539772.1| PREDICTED: receptor-like serine/threonine-protein kinase NCRK-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 570 bits (1469), Expect = e-160, Method: Compositional matrix adjust.
Identities = 282/461 (61%), Positives = 346/461 (75%), Gaps = 8/461 (1%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MK Q+K+ A +I L+WIQ S CD+ SE S W+C CS QG+QS L NCS+SCD
Sbjct: 1 MKPQLKIALALVISLLWIQHSFCDENSETSSLNKWRCRCS--FQGNQSYSLA-NCSKSCD 57
Query: 61 CSPVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVVV 120
C S WTC+C ++G P+VAA+ + CF++C CT G+VS S KH+SSK+VV
Sbjct: 58 CHSDSEESASVWTCVCDSNGFPQVAADGRSSNCFSTCNCTWGTVSRPGGSKKHVSSKIVV 117
Query: 121 IVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHR--ITSVP 177
++LL+CVI TT+AFL+ ++C+VYRK + ++S + S+DKE S S TNLISHR +SVP
Sbjct: 118 VILLICVICTTMAFLVSLICHVYRKDRCTIQSPIFSTDKETSSGSTTNLISHRSGASSVP 177
Query: 178 ETRVEVVSPIDLATGCFLKTTFC-RSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGG 236
ET+ + SPI TGCF K +F S T HG I FS + LE+AT+ FS SN++G GG
Sbjct: 178 ETKYAINSPIYHITGCFQKASFLFGSPKETYHGNIFPFSLAELENATENFSSSNLIGVGG 237
Query: 237 SSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296
SSYVY G+L DG VAVKR K QGGP ADS F E+++L+RLHHCH+VPL+GYCSE +GK
Sbjct: 238 SSYVYLGRLKDGSNVAVKRLKDQGGPEADSAFFKEIELLARLHHCHLVPLLGYCSELKGK 297
Query: 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356
RLLVF++M NGNLRDCLDGV + ++W TRV IAIGAARGLEYLHEAAAPRILHRD+
Sbjct: 298 HVQRLLVFDYMANGNLRDCLDGVSGKHIDWATRVMIAIGAARGLEYLHEAAAPRILHRDV 357
Query: 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMS 416
KS+NILLDEN AKITDLGMAK L++D LPSCS+SPARMQGTFGYFAPEYA+VGRASL S
Sbjct: 358 KSTNILLDENWQAKITDLGMAKNLRSDDLPSCSNSPARMQGTFGYFAPEYAIVGRASLES 417
Query: 417 DVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSIITDA 457
DVFSFGVVLLELI+GR PIH+S K EESLV+W D+
Sbjct: 418 DVFSFGVVLLELISGRHPIHKSTGK-EESLVIWATPRFQDS 457
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449456024|ref|XP_004145750.1| PREDICTED: receptor-like serine/threonine-protein kinase NCRK-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 561 bits (1446), Expect = e-157, Method: Compositional matrix adjust.
Identities = 276/452 (61%), Positives = 343/452 (75%), Gaps = 5/452 (1%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
M+ QV TF L+G I +Q+ IC S+ S NW C C S Q +Q L NCS SC
Sbjct: 1 MRHQVAATFLSLVGFILLQQVICADTSDFSTSGNWTCRCFSPHQENQGLTLGPNCSTSCS 60
Query: 61 CSP-VGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 119
C+ V GS WTC+C+ DG PKV AN+ D+ CF SC CT G + + S +HISS VV
Sbjct: 61 CTQDVEGSR--LWTCMCSTDGFPKVVANNRDSNCFTSCNCTYGLLPELPYSKRHISSNVV 118
Query: 120 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVPE 178
VI+L LCVI+ T+AF +LV+CY+ ++ K +R+ +IS DK+ S NS TNLISHR +S P+
Sbjct: 119 VIILSLCVIIITVAFFILVVCYLCQRDKCRVRAPIISLDKQISYNSLTNLISHRSSSTPD 178
Query: 179 TRVEVVSPIDLATGCF-LKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGS 237
++V + SP++ GCF + R+K+ ++ G II+FSYS LE+AT+KFS S++VG+GGS
Sbjct: 179 SKVMMDSPVNNIKGCFFMNQCLLRTKSRSLCGIIIQFSYSELENATEKFSSSHLVGRGGS 238
Query: 238 SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297
S+VYRG+L DGR VAVKR QGGP+ D +FLTE+ +LSRL+HCHVVPL+GYC+E RGK
Sbjct: 239 SFVYRGELRDGRTVAVKRLNIQGGPDVDYLFLTEIQLLSRLNHCHVVPLLGYCTESRGKH 298
Query: 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 357
RLLV+E+MP GNLRDCLDG + M+W TRV IA+GAARGLEYLHEAAAPRILHRD+K
Sbjct: 299 TERLLVYEYMPKGNLRDCLDGASGKKMDWSTRVTIALGAARGLEYLHEAAAPRILHRDVK 358
Query: 358 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSD 417
S+NILLD++ AKITDLGMA RL+ D LPSCSSSPARMQGTFGYFAPEYA+VGRASL SD
Sbjct: 359 STNILLDKDWRAKITDLGMATRLRGDDLPSCSSSPARMQGTFGYFAPEYAIVGRASLKSD 418
Query: 418 VFSFGVVLLELITGRQPIHRSITKGEESLVLW 449
VFSFGVVLLELITG+ PIH+S KGEESL +W
Sbjct: 419 VFSFGVVLLELITGQHPIHKSAGKGEESLAIW 450
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727637|ref|NP_001235120.1| protein kinase family protein precursor [Glycine max] gi|223452424|gb|ACM89539.1| protein kinase family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 561 bits (1446), Expect = e-157, Method: Compositional matrix adjust.
Identities = 277/461 (60%), Positives = 344/461 (74%), Gaps = 8/461 (1%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MK Q+K+ A ++ L+WIQ+S CD+ S+ S W+C CS QG+QS L NCS+SCD
Sbjct: 1 MKPQLKIALALVVSLLWIQQSFCDETSDTSSLNKWRCRCS--FQGNQSYSLA-NCSKSCD 57
Query: 61 CSPVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVVV 120
C S WTC+C ++G P+VAA+ + + CF +C CT G+ S S KH+SSK+VV
Sbjct: 58 CFSDSEESASVWTCVCDSNGFPQVAADGHSSNCFNACNCTWGTFSRPGGSKKHVSSKIVV 117
Query: 121 IVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHR--ITSVP 177
++LL+CVI TT+AFL+ ++C+VYRK + + S + S DKE S S TNLISHR +SVP
Sbjct: 118 VILLICVICTTMAFLVSLICHVYRKDRCTIHSPIFSMDKETSSGSTTNLISHRSGTSSVP 177
Query: 178 ETRVEVVSPIDLATGCFLKTTFC-RSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGG 236
ET+ + SPI TGCF K +F + T HG I FS + LE+AT+ FS SN++G GG
Sbjct: 178 ETKYAMNSPIYHITGCFQKASFFFGNPKETYHGNIFPFSLAELENATENFSSSNLIGVGG 237
Query: 237 SSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296
SSYVY G+L DG VAVKR K QGG ADS F E+++L+RLHHCH+VPL+GYCSE +GK
Sbjct: 238 SSYVYLGRLKDGSNVAVKRLKDQGGSEADSAFFKEIELLARLHHCHLVPLLGYCSELKGK 297
Query: 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356
RLLVF++M NGNLRDCLDGV + ++W TRV IAIGAARGLEYLHEAAAPRILHRD+
Sbjct: 298 HVQRLLVFDYMANGNLRDCLDGVSGKHVDWATRVMIAIGAARGLEYLHEAAAPRILHRDV 357
Query: 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMS 416
KS+NILLDEN AKITDLGMAK L++D LPSCS+SPARMQGTFGYFAPEYA+VGRASL S
Sbjct: 358 KSTNILLDENWQAKITDLGMAKNLRSDDLPSCSNSPARMQGTFGYFAPEYAIVGRASLES 417
Query: 417 DVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSIITDA 457
DVFSFGVVLLELI+GR PIH+S K EESLV+W + D+
Sbjct: 418 DVFSFGVVLLELISGRHPIHKSTGK-EESLVIWATPRLQDS 457
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449519593|ref|XP_004166819.1| PREDICTED: receptor-like serine/threonine-protein kinase NCRK-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1418), Expect = e-154, Method: Compositional matrix adjust.
Identities = 272/451 (60%), Positives = 340/451 (75%), Gaps = 7/451 (1%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
M+ QV TF L+G I +Q+ IC S+ S NW C C S Q +Q L NCS SC
Sbjct: 1 MRHQVAATFLSLVGFILLQQVICADTSDFSTSGNWTCRCFSPHQENQGLTLGPNCSTSCS 60
Query: 61 CSP-VGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 119
C+ V GS WTC+C+ DG PKV AN+ D+ CF SC CT G + + S +HISS VV
Sbjct: 61 CTQDVEGSR--LWTCMCSTDGFPKVVANNRDSNCFTSCNCTYGLLPELPYSKRHISSNVV 118
Query: 120 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVPE 178
VI+L LCVI+ T+AF +LV+CY+ ++ K +R+ +IS DK+ S NS TNLISH+ +S P+
Sbjct: 119 VIILSLCVIIITVAFFILVVCYLCQRDKCRVRAPIISLDKQISYNSLTNLISHKSSSTPD 178
Query: 179 TRVEVVSPIDLATGCFLKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSS 238
++V + SP++ G + +K+ ++ G II+FSYS LE+AT+KFS S++VG+GGSS
Sbjct: 179 SKVMMDSPVNNIKGVLV---LLGTKSRSLCGIIIQFSYSELENATEKFSSSHLVGRGGSS 235
Query: 239 YVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298
+VYRG+L DGR VAVKR QGGP+ D +FLTE+ +LSRL+HCHVVPL+GYC+E RGK
Sbjct: 236 FVYRGELRDGRTVAVKRLNIQGGPDVDYLFLTEIQLLSRLNHCHVVPLLGYCTESRGKHT 295
Query: 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 358
RLLV+E+MP GNLRDCLDG + M+W TRV IA+GAARGLEYLHEAAAPRILHRD+KS
Sbjct: 296 ERLLVYEYMPKGNLRDCLDGASGKKMDWSTRVTIALGAARGLEYLHEAAAPRILHRDVKS 355
Query: 359 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 418
+NILLD++ AKITDLGMA RL+ D LPSCSSSPARMQGTFGYFAPEYA+VGRASL SDV
Sbjct: 356 TNILLDKDWRAKITDLGMATRLRGDDLPSCSSSPARMQGTFGYFAPEYAIVGRASLKSDV 415
Query: 419 FSFGVVLLELITGRQPIHRSITKGEESLVLW 449
FSFGVVLLELITG+ PIH+S KGEESL +W
Sbjct: 416 FSFGVVLLELITGQHPIHKSAGKGEESLAIW 446
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 466 | ||||||
| TAIR|locus:2062824 | 565 | NCRK [Arabidopsis thaliana (ta | 0.939 | 0.775 | 0.525 | 3.7e-119 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.577 | 0.371 | 0.465 | 2.5e-58 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.512 | 0.313 | 0.507 | 1.4e-57 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.512 | 0.337 | 0.509 | 1.6e-56 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.506 | 0.364 | 0.493 | 7.8e-55 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.506 | 0.361 | 0.485 | 1.6e-54 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.508 | 0.348 | 0.487 | 1.6e-54 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.504 | 0.330 | 0.491 | 5.5e-54 | |
| TAIR|locus:2010282 | 699 | PERK7 "proline-rich extensin-l | 0.495 | 0.330 | 0.5 | 1.1e-53 | |
| TAIR|locus:2038992 | 744 | ALE2 "Abnormal Leaf Shape 2" [ | 0.493 | 0.309 | 0.467 | 1.1e-53 |
| TAIR|locus:2062824 NCRK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1173 (418.0 bits), Expect = 3.7e-119, P = 3.7e-119
Identities = 243/462 (52%), Positives = 316/462 (68%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MK++V+ A L+ LI IQ+ C G N+ CTC SS G++S+IL+ NCS SC+
Sbjct: 1 MKMRVETALAILLVLISIQQ--C-----YGGVSNYTCTCFSS--GNRSDILESNCSTSCN 51
Query: 61 CSPVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTXXXXXXXXXXXXHISSKXXX 120
C P +W C+C A+G P +A +++CF SC C+ ++S K
Sbjct: 52 CRP----DRDQWVCLCPANGFPVIAIGGSNSSCFTSCNCSAGATKSSKKQ--YLSRKLVI 105
Query: 121 XXXXXXXXXXXXAFLMLVLCYVYRKGKFHLRSSVISSDKESC-NSATNLISHRITSVPET 179
AFL ++CY+ RK KF ++ +SSD+ES +S+ NLI+ + +SV ++
Sbjct: 106 VILLFCGVLISLAFLASMICYICRKDKFSGQTPSVSSDRESSWHSSANLINRK-SSVSQS 164
Query: 180 RVEVVSPIDLATGCFLKTT--FCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGS 237
++ + S + GCF + FC SK TIHG I +FSY+ LE AT+KFS ++++G GGS
Sbjct: 165 KISISSSV---AGCFFQNASLFCVSKPETIHGAIFQFSYTELEQATNKFSSNSVIGHGGS 221
Query: 238 SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297
S VYRGQL DG+ A+KR T G + D++F TEV++LSRLHH HVVPL+GYCSEF GK
Sbjct: 222 SCVYRGQLKDGKTAAIKRLNTPKGDDTDTLFSTEVELLSRLHHYHVVPLIGYCSEFHGKH 281
Query: 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 357
A RLLVFE+M G+LRDCLDG L E M W+ R+++A+GAARGLEYLHEAAAPRILHRD+K
Sbjct: 282 AERLLVFEYMSYGSLRDCLDGELGEKMTWNIRISVALGAARGLEYLHEAAAPRILHRDVK 341
Query: 358 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYFAPEYAMVGRASLMS 416
S+NILLDEN +AKITDLGMAK L +DGL S SSSP +QGTFGYFAPEYA+ G AS MS
Sbjct: 342 STNILLDENWHAKITDLGMAKCLSSDGLQSGSSSPTTGLQGTFGYFAPEYAIAGCASQMS 401
Query: 417 DVFSFGVVLLELITGRQPIHR-SITKGEESLVLWVKSIITDA 457
DVFSFGVVLLELITGR+PI + S KGEESLV+W + D+
Sbjct: 402 DVFSFGVVLLELITGRKPIQKPSNNKGEESLVIWAVPRLQDS 443
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 599 (215.9 bits), Expect = 2.5e-58, P = 2.5e-58
Identities = 135/290 (46%), Positives = 178/290 (61%)
Query: 172 RITSVPETRVEVVSPIDLATGCFLKTTFCRSKTWTIHGTIIRF-SYSALEHATDKFSGSN 230
R P+ E V P +L G F + H RF SY L+ AT F ++
Sbjct: 333 REEKAPDPHKEAVKPRNLDAGSFGGSL--------PHPASTRFLSYEELKEATSNFESAS 384
Query: 231 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
I+G+GG VYRG L DG VA+K+ T GGP D F E+DMLSRLHH ++V LVGY
Sbjct: 385 ILGEGGFGKVYRGILADGTAVAIKKL-TSGGPQGDKEFQVEIDMLSRLHHRNLVKLVGYY 443
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMN----WDTRVAIAIGAARGLEYLHEA 346
S R + LL +E +PNG+L L G L G+N WDTR+ IA+ AARGL YLHE
Sbjct: 444 SS-RDS-SQHLLCYELVPNGSLEAWLHGPL--GLNCPLDWDTRMKIALDAARGLAYLHED 499
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+ P ++HRD K+SNILL+ N NAK+ D G+AK+ +G + S+ R+ GTFGY APEY
Sbjct: 500 SQPSVIHRDFKASNILLENNFNAKVADFGLAKQAP-EGRGNHLST--RVMGTFGYVAPEY 556
Query: 407 AMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSIITD 456
AM G + SDV+S+GVVLLEL+TGR+P+ S G+E+LV W + ++ D
Sbjct: 557 AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWTRPVLRD 606
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 592 (213.5 bits), Expect = 1.4e-57, P = 1.4e-57
Identities = 128/252 (50%), Positives = 169/252 (67%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
FSY L AT+ FS N++G+GG VY+G L D R+VAVK+ K GG D F EVD
Sbjct: 418 FSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGG-QGDREFKAEVD 476
Query: 274 MLSRLHHCHVVPLVGYC-SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 332
+SR+HH +++ +VGYC SE R RLL+++++PN NL L G++W TRV I
Sbjct: 477 TISRVHHRNLLSMVGYCISENR-----RLLIYDYVPNNNLYFHLHAAGTPGLDWATRVKI 531
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS- 391
A GAARGL YLHE PRI+HRDIKSSNILL+ N +A ++D G+AK L D C++
Sbjct: 532 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAK-LALD----CNTHI 586
Query: 392 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVK 451
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S G+ESLV W +
Sbjct: 587 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWAR 646
Query: 452 SIITDASICQSF 463
++++A+ + F
Sbjct: 647 PLLSNATETEEF 658
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 582 (209.9 bits), Expect = 1.6e-56, P = 1.6e-56
Identities = 128/251 (50%), Positives = 168/251 (66%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
FSY L AT+ FS N++G+GG VY+G L DGR+VAVK+ K GG D F EV+
Sbjct: 365 FSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGG-QGDREFKAEVE 423
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
LSR+HH H+V +VG+C G R RLL+++++ N +L L G ++W TRV IA
Sbjct: 424 TLSRIHHRHLVSIVGHC--ISGDR--RLLIYDYVSNNDLYFHLHGEK-SVLDWATRVKIA 478
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS-P 392
GAARGL YLHE PRI+HRDIKSSNILL++N +A+++D G+A RL D C++
Sbjct: 479 AGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLA-RLALD----CNTHIT 533
Query: 393 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKS 452
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S G+ESLV W +
Sbjct: 534 TRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARP 593
Query: 453 IITDASICQSF 463
+I+ A + F
Sbjct: 594 LISHAIETEEF 604
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 566 (204.3 bits), Expect = 7.8e-55, P = 7.8e-55
Identities = 121/245 (49%), Positives = 162/245 (66%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
F+Y L AT+ FS +N++GQGG YV++G L G+ VAVK+ K G + F EV+
Sbjct: 263 FTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSG-QGEREFQAEVE 321
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++SR+HH H+V LVGYC G A RLLV+EF+PN NL L G M W TR+ IA
Sbjct: 322 IISRVHHRHLVSLVGYC--IAG--AKRLLVYEFVPNNNLELHLHGEGRPTMEWSTRLKIA 377
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+G+A+GL YLHE P+I+HRDIK+SNIL+D AK+ D G+AK + +D S+
Sbjct: 378 LGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK-IASDTNTHVST--- 433
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSI 453
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ + ++SLV W + +
Sbjct: 434 RVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPL 493
Query: 454 ITDAS 458
+ AS
Sbjct: 494 LNRAS 498
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 563 (203.2 bits), Expect = 1.6e-54, P = 1.6e-54
Identities = 119/245 (48%), Positives = 161/245 (65%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
F+Y L AT+ FS +N++GQGG YV++G L G+ VAVK+ K G + F EV+
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSG-QGEREFQAEVE 326
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++SR+HH H+V L+GYC G RLLV+EF+PN NL L G M W TR+ IA
Sbjct: 327 IISRVHHRHLVSLIGYC--MAG--VQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIA 382
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+G+A+GL YLHE P+I+HRDIK+SNIL+D AK+ D G+AK + +D S+
Sbjct: 383 LGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK-IASDTNTHVST--- 438
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSI 453
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ + ++SLV W + +
Sbjct: 439 RVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPL 498
Query: 454 ITDAS 458
+ AS
Sbjct: 499 LNRAS 503
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 563 (203.2 bits), Expect = 1.6e-54, P = 1.6e-54
Identities = 119/244 (48%), Positives = 157/244 (64%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
FSY L T FS N++G+GG VY+G L+DGR VAVK+ K GG + F EV+
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKI-GGSQGEREFKAEVE 385
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++SR+HH H+V LVGYC RLLV++++PN L L M W+TRV +A
Sbjct: 386 IISRVHHRHLVTLVGYCIS----EQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVA 441
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
GAARG+ YLHE PRI+HRDIKSSNILLD + A + D G+AK + L + S+
Sbjct: 442 AGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVST-- 499
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSI 453
R+ GTFGY APEYA G+ S +DV+S+GV+LLELITGR+P+ S G+ESLV W + +
Sbjct: 500 RVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPL 559
Query: 454 ITDA 457
+ A
Sbjct: 560 LGQA 563
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 5.5e-54, P = 5.5e-54
Identities = 120/244 (49%), Positives = 160/244 (65%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
F+Y L T+ FS NI+G+GG VY+G+L DG++VAVK+ K G D F EV+
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSG-QGDREFKAEVE 399
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++SR+HH H+V LVGYC + RLL++E++PN L L G + W RV IA
Sbjct: 400 IISRVHHRHLVSLVGYCIA----DSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIA 455
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
IG+A+GL YLHE P+I+HRDIKS+NILLD+ A++ D G+AK L D + S+
Sbjct: 456 IGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAK-LN-DSTQTHVST-- 511
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSI 453
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ + GEESLV W + +
Sbjct: 512 RVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPL 571
Query: 454 ITDA 457
+ A
Sbjct: 572 LHKA 575
|
|
| TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 555 (200.4 bits), Expect = 1.1e-53, P = 1.1e-53
Identities = 120/240 (50%), Positives = 156/240 (65%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
F+Y L AT FS ++GQGG YV++G L +G+ +AVK K G + F EV+
Sbjct: 324 FTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSG-QGEREFQAEVE 382
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++SR+HH H+V LVGYCS G+R LLV+EF+PN L L G M+W TR+ IA
Sbjct: 383 IISRVHHRHLVSLVGYCSNAGGQR---LLVYEFLPNDTLEFHLHGKSGTVMDWPTRLKIA 439
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+G+A+GL YLHE P+I+HRDIK+SNILLD N AK+ D G+AK L D S+
Sbjct: 440 LGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAK-LSQDNNTHVST--- 495
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSI 453
R+ GTFGY APEYA G+ + SDVFSFGV+LLELITGR P+ S E+SLV W + +
Sbjct: 496 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGDM-EDSLVDWARPL 554
|
|
| TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 555 (200.4 bits), Expect = 1.1e-53, P = 1.1e-53
Identities = 114/244 (46%), Positives = 162/244 (66%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
F+ S LE ATD+FS ++G+GG VY+G + DG VAVK T+ N D F+ EV+
Sbjct: 337 FTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLL-TRDNQNRDREFIAEVE 395
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAI 332
MLSRLHH ++V L+G C E R R L++E + NG++ L EG ++WD R+ I
Sbjct: 396 MLSRLHHRNLVKLIGICIEGR----TRCLIYELVHNGSVESHLH----EGTLDWDARLKI 447
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 392
A+GAARGL YLHE + PR++HRD K+SN+LL+++ K++D G+A+ +G S+
Sbjct: 448 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA-TEGSQHIST-- 504
Query: 393 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKS 452
R+ GTFGY APEYAM G + SDV+S+GVVLLEL+TGR+P+ S GEE+LV W +
Sbjct: 505 -RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARP 563
Query: 453 IITD 456
++ +
Sbjct: 564 LLAN 567
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8VYY5 | NCRK_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5346 | 0.9399 | 0.7752 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 466 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-40 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-20 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-16 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-47
Identities = 66/200 (33%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+GG VY + G+ VA+K K + + L E+++L +L+H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
+ LV E+ G+L+D L ++ D + I + GLEYLH
Sbjct: 61 EDENH----LYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHSN---G 112
Query: 351 ILHRDIKSSNILLDE-NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE-YAM 408
I+HRD+K NILLD N K+ D G++K L +D + + GT Y APE
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-----IVGTPAYMAPEVLLG 167
Query: 409 VGRASLMSDVFSFGVVLLEL 428
G S SD++S GV+L EL
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 78/210 (37%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 231 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+G G VY+ + G+IVAVK K + D E+ +L RL H ++V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHEA 346
F K + LV E+ G+L D L G ++ D IA+ RGLEYLH
Sbjct: 66 A---FEDKDHL-YLVMEYCEGGDLFD----YLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGYFAPE 405
I+HRD+K NILLDEN KI D G+AK SSS GT Y APE
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAK------KLLKSSSSLTTFVGTPWYMAPE 168
Query: 406 YAMVGR-ASLMSDVFSFGVVLLELITGRQP 434
+ G DV+S GV+L EL+TG+ P
Sbjct: 169 VLLGGNGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 6e-40
Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 230 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+G+G VY + G++VA+K K + L E+ +L +L H ++V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGA--ARGLEYLH 344
E K + V E+ G+L D L G L E A LEYLH
Sbjct: 65 VF-EDEDKLYL---VMEYCEGGDLFDLLKKRGRLSE------DEARFYLRQILSALEYLH 114
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 404
I+HRD+K NILLDE+ + K+ D G+A++L + GT Y AP
Sbjct: 115 SK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT------TFVGTPEYMAP 165
Query: 405 EYAMVGRASLMSDVFSFGVVLLELITGRQP 434
E + D++S GV+L EL+TG+ P
Sbjct: 166 EVLLGKGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 5e-39
Identities = 67/203 (33%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 240 VYRGQLTDG-----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 294
VY+G L VAVK K FL E ++ +L H ++V L+G C+E
Sbjct: 15 VYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-- 72
Query: 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHR 354
+ M +V E+MP G+L D L + ++ ++ A+ ARG+EYL +HR
Sbjct: 73 EEPLM--IVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHR 127
Query: 355 DIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQGTFGYFAPEYAMVGRA 412
D+ + N L+ ENL KI+D G+++ L D P R + APE G+
Sbjct: 128 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR------WMAPESLKEGKF 181
Query: 413 SLMSDVFSFGVVLLELIT-GRQP 434
+ SDV+SFGV+L E+ T G +P
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 4e-38
Identities = 67/206 (32%), Positives = 97/206 (47%), Gaps = 28/206 (13%)
Query: 240 VYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 294
VY+G+L VAVK K FL E ++ +L H +VV L+G C+E
Sbjct: 15 VYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTE-- 72
Query: 295 GKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
+V E+M G+L L L + ++ A+ ARG+EYL
Sbjct: 73 --EEPLYIVMEYMEGGDLLSYLRKNRPKL----SLSDLLSFALQIARGMEYLESK---NF 123
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQGTFGYFAPEYAMV 409
+HRD+ + N L+ ENL KI+D G+++ L D P R + APE
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR------WMAPESLKE 177
Query: 410 GRASLMSDVFSFGVVLLELIT-GRQP 434
G+ + SDV+SFGV+L E+ T G QP
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 2e-36
Identities = 69/238 (28%), Positives = 106/238 (44%), Gaps = 40/238 (16%)
Query: 230 NIVGQG--GSSYVYRGQLTDG----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+G+G G VY+G+L VAVK K FL E ++ +L H +V
Sbjct: 1 KKLGEGAFGE--VYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNV 58
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNL-------RDCLDGVLVEGMNWDTRVAIAIGA 336
V L+G C+E LV E+M G+L R ++ ++ AI
Sbjct: 59 VRLLGVCTE----EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PA 393
A+G+EYL + +HRD+ + N L+ E+L KI+D G+++ + D + P
Sbjct: 115 AKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI 171
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKG 442
R + APE G + SDV+SFGV+L E+ T G P + + KG
Sbjct: 172 R------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG 223
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 6e-36
Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 230 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFL-TEVDMLSRLHHCHVVPLV 287
++G+G VY D G ++AVK + G + L E+ +LS L H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 288 GYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRV-AIAIGAARGLEYL 343
G R + L +F E++ G+L L G L E + R I GL YL
Sbjct: 66 GSE---RDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQI--LEGLAYL 117
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
H I+HRDIK +NIL+D + K+ D G AKRL + S ++GT + A
Sbjct: 118 HSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS---VRGTPYWMA 171
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
PE +D++S G ++E+ TG+ P
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 70/218 (32%), Positives = 104/218 (47%), Gaps = 37/218 (16%)
Query: 233 GQG--GSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
G+G G VY+G L VAVK K FL E ++ +L H ++V
Sbjct: 8 GEGAFGE--VYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 342
L+G C++ G+ +V E+MP G+L D L L + +A+ A+G+EY
Sbjct: 66 LLGVCTQ--GEPLY--IVTEYMPGGDLLDFLRKHGEKL----TLKDLLQMALQIAKGMEY 117
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
L +HRD+ + N L+ ENL KI+D G+++ + D R +G G
Sbjct: 118 LESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY-------YRKRGG-GKL 166
Query: 403 -----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
APE G+ + SDV+SFGV+L E+ T G QP
Sbjct: 167 PIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 2e-29
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 232 VGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+GG VY+ G+ VA+K K + + + + E+ +L + H ++V Y
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI-INEIQILKKCKHPNIVKY--YG 64
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
S + +V EF G+L+D L + + + +GLEYLH
Sbjct: 65 SYLKKDELW--IVMEFCSGGSLKDLLKS-TNQTLTESQIAYVCKELLKGLEYLHSN---G 118
Query: 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQGTFGYFAPEYAM 408
I+HRDIK++NILL + K+ D G++ +L S + AR M GT + APE
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQL--------SDTKARNTMVGTPYWMAPEVIN 170
Query: 409 VGRASLMSDVFSFGVVLLELITGRQPIHRS 438
+D++S G+ +EL G+ P
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPPYSEL 200
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 225 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCH 282
+ +++G+G VY+G L G VA+K+ + + E+D+L L H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAA-RG 339
+V +G ++ ++ E+ NG+LR + G E + VA+ + +G
Sbjct: 61 IVKYIGS---IETSDSL-YIILEYAENGSLRQIIKKFGPFPE-----SLVAVYVYQVLQG 111
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L YLHE ++HRDIK++NIL ++ K+ D G+A +L S GT
Sbjct: 112 LAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-----VGTP 163
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
+ APE + AS SD++S G ++EL+TG P +
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYY 200
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 229 SNIVGQG--GSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+G+G G + R G VAVK G S F E+++L L H ++
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
V G E G R++RL + E++P+G+LRD L + +N + + +G++YL
Sbjct: 69 VKYKG-VCEKPGGRSLRL-IMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYL 125
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG----LPSCSSSPARMQGTF 399
R +HRD+ + NIL++ KI+D G+AK L D + SP
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF----- 177
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430
++APE + S SDV+SFGV L EL T
Sbjct: 178 -WYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 71/226 (31%), Positives = 105/226 (46%), Gaps = 18/226 (7%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRL-HHCHVVPLVG 288
+G+G VY + D ++VA+K + + V FL E+ +L+ L H ++V L
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHEAA 347
+ + LV E++ G+L D L + +G ++ + I LEYLH
Sbjct: 66 FFQDEGSL----YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK- 120
Query: 348 APRILHRDIKSSNILLDENLN-AKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGYFAPE 405
I+HRDIK NILLD + K+ D G+AK L G S + GT GY APE
Sbjct: 121 --GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 406 YAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 448
+ + AS SD++S G+ L EL+TG P S L
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 65/226 (28%), Positives = 106/226 (46%), Gaps = 37/226 (16%)
Query: 232 VGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
+G+G V+ G+ D +VAVK K +A F E ++L+ H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTR-------VAIA 333
G C+E G + +VFE+M +G+L L D ++ + + IA
Sbjct: 73 FYGVCTE--GDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+ A G+ YL A+ +HRD+ + N L+ +L KI D GM++ + ++
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY-------TTDYY 178
Query: 394 RMQGT----FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
R+ G + PE M + + SDV+SFGVVL E+ T G+QP
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 68/208 (32%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 233 GQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG-YC 290
GQG S VY+ + G+I A+K+ G L E+ L +VV G +
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVA-IAIGAARGLEYLHEAA 347
E G+ + +V E+M G+L D L G + E + +A IA +GL+YLH
Sbjct: 70 KE--GEIS---IVLEYMDGGSLADLLKKVGKIPEPV-----LAYIARQILKGLDYLHTKR 119
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 407
I+HRDIK SN+L++ KI D G++K L + L C++ GT Y +PE
Sbjct: 120 --HIIHRDIKPSNLLINSKGEVKIADFGISKVL-ENTLDQCNTF----VGTVTYMSPE-R 171
Query: 408 MVGRA-SLMSDVFSFGVVLLELITGRQP 434
+ G + S +D++S G+ LLE G+ P
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 72/208 (34%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 233 GQGGSSYVYRGQLTDGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
G G V+ G VAVK K G P A FL E ++ +L H +V L C
Sbjct: 15 GAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEA---FLQEAQIMKKLRHDKLVQLYAVC 70
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCL-DGVLVEG--MNWDTRVAIAIGAARGLEYLHEAA 347
SE +V E+M G+L D L G EG + V +A A G+ YL
Sbjct: 71 SE----EEPIYIVTEYMSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLESR- 122
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 407
+HRD+ + NIL+ ENL KI D G+A+ ++ D + + ++ T APE A
Sbjct: 123 --NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAA 176
Query: 408 MVGRASLMSDVFSFGVVLLELIT-GRQP 434
GR ++ SDV+SFG++L E++T GR P
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 68/227 (29%), Positives = 112/227 (49%), Gaps = 37/227 (16%)
Query: 232 VGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
+G+G VY+G+LT VA+K K P F E +++S L H ++V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWDTRVA 331
L+G C+ K ++FE++ +G+L + L D + ++ +
Sbjct: 73 LLGVCT----KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL-KAD--GLPSC 388
IAI A G+EYL ++ +HRD+ + N L+ E L KI+D G+++ + AD + S
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
S P R + PE + G+ + SD++SFGVVL E+ + G QP
Sbjct: 186 SLLPVR------WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 66/214 (30%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH 279
E ++F+ +G G V+ G + VA+K K+ F EV L RL
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD-FQKEVQALKRLR 60
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--A 337
H H++ L CS ++ E M G+L L EG I + A
Sbjct: 61 HKHLISLFAVCSVGEPV----YIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVA 114
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD-GLPSCSSSPARMQ 396
G+ YL E +HRD+ + NIL+ E+L K+ D G+A+ +K D L S P +
Sbjct: 115 EGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK-- 169
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430
+ APE A G S SDV+SFG++L E+ T
Sbjct: 170 ----WTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 9e-24
Identities = 67/222 (30%), Positives = 96/222 (43%), Gaps = 31/222 (13%)
Query: 229 SNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPL 286
N +G G VY L G ++AVK + Q P E+ +L L H ++V
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV-- 62
Query: 287 VGYCSEFRGKRAMR--LLVF-EFMPNGNLRDCLDGVLVEGMNWDTRV--AIAIGAARGLE 341
++ G R + +F E+ G L + +L G D V + GL
Sbjct: 63 -----KYYGVEVHREKVYIFMEYCSGGTLEE----LLEHGRILDEHVIRVYTLQLLEGLA 113
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
YLH I+HRDIK +NI LD N K+ D G A +LK + + GT Y
Sbjct: 114 YLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT-MGEEVQSLAGTPAY 169
Query: 402 FAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437
APE GRA +D++S G V+LE+ TG++P
Sbjct: 170 MAPEVITGGKGKGHGRA---ADIWSLGCVVLEMATGKRPWSE 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 62/224 (27%), Positives = 98/224 (43%), Gaps = 45/224 (20%)
Query: 230 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHCHVVPLV 287
+G+G VY+ + G +VA+K+ + + + + E+ +L +L H ++V L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 288 G-YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR-------- 338
S+ +G M VFE+M + D L G+L V +
Sbjct: 65 EIVTSKGKGSIYM---VFEYMDH----D-LTGLLDS-----PEVKFTESQIKCYMKQLLE 111
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
GL+YLH ILHRDIK SNIL++ + K+ D G+A+ ++ R+ T
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN---RVI-T 164
Query: 399 FGYFAPE-------YAMVGRASLMSDVFSFGVVLLELITGRQPI 435
Y PE Y G D++S G +L EL G+ PI
Sbjct: 165 LWYRPPELLLGATRY---GPE---VDMWSVGCILAELFLGK-PI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G+G V G G+ VAVK K A + FL E +++ L H ++V L+G
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTA-AQA-FLAEASVMTTLRHPNLVQLLGVV- 69
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
+G +V E+M G+L D L + ++ A+ G+EYL E
Sbjct: 70 -LQGNPLY--IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAK--RLKADG--LPSCSSSPARMQGTFGYFAPEYA 407
+HRD+ + N+L+ E+L AK++D G+AK D LP + APE
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP------------VKWTAPEAL 171
Query: 408 MVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437
+ S SDV+SFG++L E+ + GR P R
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 5e-23
Identities = 68/208 (32%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 248 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307
G +VAVK K + G S + E+++L L+H ++V G CSE GK L+ E++
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL--QLIMEYV 90
Query: 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 367
P G+LRD L +N + A G+ YLH + +HRD+ + N+LLD +
Sbjct: 91 PLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDR 144
Query: 368 NAKITDLGMAK---------RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 418
KI D G+AK R++ DG SP ++A E + S SDV
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDG-----DSPVF------WYAVECLKENKFSYASDV 193
Query: 419 FSFGVVLLELITGRQPIHRSITKGEESL 446
+SFGV L EL+T K EE +
Sbjct: 194 WSFGVTLYELLTHCDSKQSPPKKFEEMI 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 9e-23
Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 16/212 (7%)
Query: 226 FSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHV 283
F N +G+G V++ + D R+ A+K+ + + E +L++L ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
+ Y F K + + V E+ NG+L L + D I GL +L
Sbjct: 62 IR---YYESFLDKGKLNI-VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL 117
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYF 402
H + +ILHRDIKS N+ LD N KI DLG+AK L S +++ A + GT Y
Sbjct: 118 H---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL------SDNTNFANTIVGTPYYL 168
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+PE + SDV++ GVVL E TG+ P
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-22
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G+G VY+G L VAVK ++ P+ FL E ++L + H ++V L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
+ + +V E +P G+L L + + +++ AA G+EYL +
Sbjct: 63 Q----KQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLE---SKNC 114
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR 411
+HRD+ + N L+ EN KI+D GM+ R + G+ + S Q + APE GR
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS-REEEGGIYTVSD--GLKQIPIKWTAPEALNYGR 171
Query: 412 ASLMSDVFSFGVVLLELITG 431
+ SDV+S+G++L E +
Sbjct: 172 YTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 5e-22
Identities = 62/183 (33%), Positives = 93/183 (50%), Gaps = 9/183 (4%)
Query: 248 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307
G +VAVK+ + F E+++L L H ++V G C G+R +RL V E++
Sbjct: 33 GEVVAVKKLQ-HSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLRL-VMEYL 89
Query: 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 367
P G+LRD L E ++ + A +G+EYL + R +HRD+ + NIL++
Sbjct: 90 PYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESEN 145
Query: 368 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 427
KI D G+ K L D P + ++APE + S+ SDV+SFGVVL E
Sbjct: 146 RVKIGDFGLTKVLPQDKEYYKVREPG--ESPIFWYAPESLTESKFSVASDVWSFGVVLYE 203
Query: 428 LIT 430
L T
Sbjct: 204 LFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G G V+ G + VAVK K G FL E ++ +L H ++ L C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKP--GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
+V E M G+L + L G + + +A A G+ YL A
Sbjct: 72 ----LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNY 124
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 409
+HRD+ + N+L+ EN K+ D G+A+ +K D AR F + APE A+
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKED------IYEAREGAKFPIKWTAPEAALY 178
Query: 410 GRASLMSDVFSFGVVLLELIT-GRQP 434
R S+ SDV+SFG++L E++T GR P
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-21
Identities = 70/206 (33%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+GQG V+ G VA+K K G + FL E ++ +L H +V L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
E +V E+M G+L D L G + + + V +A A G+ Y+
Sbjct: 72 E-----EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 123
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 409
+HRD++++NIL+ ENL K+ D G+A RL D + AR F + APE A+
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLA-RLIED-----NEYTARQGAKFPIKWTAPEAALY 177
Query: 410 GRASLMSDVFSFGVVLLELIT-GRQP 434
GR ++ SDV+SFG++L EL T GR P
Sbjct: 178 GRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 71/206 (34%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+GQG V+ G VA+K K G FL E ++ +L H +VPL S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKP--GTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
E +V EFM G+L D L + + V +A A G+ Y+
Sbjct: 72 E-----EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NY 123
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 409
+HRD++++NIL+ +NL KI D G+A RL D + AR F + APE A+
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLA-RLIED-----NEYTARQGAKFPIKWTAPEAALY 177
Query: 410 GRASLMSDVFSFGVVLLELIT-GRQP 434
GR ++ SDV+SFG++L EL+T GR P
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 5e-21
Identities = 69/206 (33%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G G V+ G VAVK K G + FL E ++ +L H +V L S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP--GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
E +V E+M G+L D L + V +A A G+ Y+
Sbjct: 72 E-----EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NY 123
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 409
+HRD++S+NIL+ + L KI D G+A RL D + AR F + APE A+
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLA-RLIED-----NEYTARQGAKFPIKWTAPEAALY 177
Query: 410 GRASLMSDVFSFGVVLLELIT-GRQP 434
GR ++ SDV+SFG++L EL+T GR P
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 8e-21
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 40/219 (18%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVF-LTEVDMLSRLHHCHVVPLVGY 289
+G+G VY + +DG++ +K + L EV +L +L+H +++ Y
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII---KY 64
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--------MNWDTRVAIAIGAARGLE 341
F K + +V E+ G+L + EG ++W ++ +A L+
Sbjct: 65 YESFEEKGKL-CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA------LK 117
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
YLH +ILHRDIK NI L N K+ D G++K L + + + + GT Y
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST-VDLAKT----VVGTPYY 169
Query: 402 FAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 434
+PE Y + SD++S G VL EL T + P
Sbjct: 170 LSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 9e-21
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
+ + +G+G S VY+ G+ VA+K+ + + + + E+ ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK--QNKELIINEILIMKDCKHP 75
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA-RGL 340
++V +V E+M G+L D + V MN + ++A +GL
Sbjct: 76 NIVDYYD-SYLVGD---ELWVVMEYMDGGSLTDIITQNFVR-MN-EPQIAYVCREVLQGL 129
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
EYLH + ++HRDIKS NILL ++ + K+ D G A +L + S + GT
Sbjct: 130 EYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-----SKRNSVVGTPY 181
Query: 401 YFAPEYAMVGRASLMS---DVFSFGVVLLELITGRQP 434
+ APE V + D++S G++ +E+ G P
Sbjct: 182 WMAPE---VIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 59/172 (34%), Positives = 79/172 (45%), Gaps = 23/172 (13%)
Query: 269 LTEVDMLSRLHHCHVVP-LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMN 325
L E +L L+H P LV F+ + M LV + + G+LR L E
Sbjct: 48 LNERRILQELNH----PFLVNLWYSFQDEENM-YLVVDLLLGGDLRYHLSQKVKFSEEQ- 101
Query: 326 WDTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384
+ I I A LEYLH I+HRDIK NILLDE + ITD +A ++ D
Sbjct: 102 --VKFWICEIVLA--LEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154
Query: 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
L + +S GT GY APE S+ D +S GV E + G++P
Sbjct: 155 LTTSTS------GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKT-QGGPNADSVFLTEVDMLSRLHHC 281
+K+ +VG+G V + + G IVA+K+FK + + L EV +L +L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 282 HVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 340
++V L +R RL LVFE++ L + L+ G+ D + + +
Sbjct: 61 NIVNLKEAF-----RRKGRLYLVFEYVER-TLLELLE-ASPGGLPPDAVRSYIWQLLQAI 113
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
Y H + I+HRDIK NIL+ E+ K+ D G A+ L+A + A T
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA----TRW 166
Query: 401 YFAPE----YAMVGRASLMSDVFSFGVVLLELITGR 432
Y APE G+ DV++ G ++ EL+ G
Sbjct: 167 YRAPELLVGDTNYGKP---VDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 28/216 (12%)
Query: 230 NIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
++G G V RG+L VA+K K FLTE ++ + H +++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG---MNWDTRVAIAIGAARGLEY 342
L G + + + M ++ E+M NG LD L E V + G A G++Y
Sbjct: 70 LEGVVT--KSRPVM--IITEYMENG----SLDKFLRENDGKFTVGQLVGMLRGIASGMKY 121
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-ADGLPSCSS--SPARMQGTF 399
L E +HRD+ + NIL++ NL K++D G+++RL+ ++ + P R
Sbjct: 122 LSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR----- 173
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ APE + + SDV+SFG+V+ E+++ G +P
Sbjct: 174 -WTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 22/218 (10%)
Query: 232 VGQGGSSYVYRGQLTD-GRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
+G+GG V Q+ G++ A K R K + G + + L E +L ++ +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG---EQMALNEKKILEKVSSRFIVS 57
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
L Y E + LV M G+L+ + V G + A GLE+LH+
Sbjct: 58 L-AYAFETKDDLC---LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ 113
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 405
RI++RD+K N+LLD++ N +I+DLG+A LK GT GY APE
Sbjct: 114 R---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------GKKIKGRAGTPGYMAPE 164
Query: 406 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
D F+ G L E+I GR P + K E
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 61/215 (28%), Positives = 91/215 (42%), Gaps = 15/215 (6%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+K + +G+G V + +L G I A+K T P+ L E+++ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAIGAARGL 340
+V G + + + E+ G+L V G +V IA +GL
Sbjct: 61 IVKYYGAFLD--ESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
YLH +I+HRDIK SNILL K+ D G++ L +S GT
Sbjct: 119 SYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-------VNSLAGTFTGTSF 168
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435
Y APE S+ SDV+S G+ LLE+ R P
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 5e-20
Identities = 75/210 (35%), Positives = 107/210 (50%), Gaps = 23/210 (10%)
Query: 236 GSSYVYRGQLTDGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293
G ++ + + T G I A+K K N LTE D+LS+ +VV L Y S F
Sbjct: 7 GRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL--YYS-F 62
Query: 294 RGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIA-IGAARGLEYLHEAAAPR 350
+GK+ + LV E++P G+L L+ G L E + R+ IA I A LEYLH
Sbjct: 63 QGKKNL-YLVMEYLPGGDLASLLENVGSLDEDV---ARIYIAEIVLA--LEYLHSNG--- 113
Query: 351 ILHRDIKSSNILLDENLNAKITDLGMAK---RLKADGLPSCSSSPARMQGTFGYFAPEYA 407
I+HRD+K NIL+D N + K+TD G++K + L R+ GT Y APE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE-V 172
Query: 408 MVGRA-SLMSDVFSFGVVLLELITGRQPIH 436
++G+ S D +S G +L E + G P H
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 6e-20
Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 46/237 (19%)
Query: 231 IVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
++G G VY+G +G VA+K + + P A+ L E +++ + H HVV
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNL-------RDCLDGVLVEGMNWDTRVAIAIGAAR 338
L+G C + L+ + MP G L +D + + +NW ++A +
Sbjct: 74 LLGICL---SSQVQ--LITQLMPLGCLLDYVRNHKDNIGSQYL--LNWCVQIA------K 120
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG---LPSCSSSPARM 395
G+ YL E R++HRD+ + N+L+ + KITD G+AK L D P +
Sbjct: 121 GMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK- 176
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGE 443
+ A E + + SDV+S+GV + EL+T G +P I + KGE
Sbjct: 177 -----WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 7e-20
Identities = 64/230 (27%), Positives = 112/230 (48%), Gaps = 39/230 (16%)
Query: 232 VGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+ +Y+G L ++VA+K K P F E +++ LHH ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---------------DGVLVEGMNWDTRVA 331
+G ++ ++FE++ G+L + L DG + ++ +
Sbjct: 73 LGVVTQ----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 391
IAI A G+EYL ++ +H+D+ + NIL+ E L+ KI+DLG+++ + S+
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY-------SAD 178
Query: 392 PARMQGT----FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIH 436
R+Q + PE M G+ S SD++SFGVVL E+ + G QP +
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 63/189 (33%), Positives = 92/189 (48%), Gaps = 28/189 (14%)
Query: 269 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNW 326
LTE ++LSR++H +V L + + F+ + + LV E+ P G L L G E
Sbjct: 41 LTERNILSRINHPFIVKL--HYA-FQTEEKL-YLVLEYAPGGELFSHLSKEGRFSEE--- 93
Query: 327 DTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385
R A I A LEYLH I++RD+K NILLD + + K+TD G+AK L ++G
Sbjct: 94 RARFYAAEIVLA--LEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG- 147
Query: 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHR 437
++ GT Y APE + D +S GV+L E++TG+ P I+
Sbjct: 148 SRTNT----FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE 203
Query: 438 SITKGEESL 446
I K
Sbjct: 204 KILKDPLRF 212
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 66/205 (32%), Positives = 109/205 (53%), Gaps = 21/205 (10%)
Query: 231 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
I+G+G V +G+ T G+ VAVK K A FL E ++++LHH ++V L+G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
G +V E M GNL + L ++ + ++ A G+EYL + +
Sbjct: 69 LH-NGLY----IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKK 120
Query: 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG 410
++HRD+ + NIL+ E+ AK++D G+A R+ + G+ + S P + + APE
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLA-RVGSMGVDN-SKLPVK------WTAPEALKHK 172
Query: 411 RASLMSDVFSFGVVLLELIT-GRQP 434
+ S SDV+S+GV+L E+ + GR P
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-19
Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 25/209 (11%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G G V+ G + R VA+K + G ++ F+ E ++ +L H +V L G C+
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE--GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
E R+ LVFEFM +G L D L G + +T + + + G+ YL +
Sbjct: 70 E----RSPICLVFEFMEHGCLSDYLRAQRGKFSQ----ETLLGMCLDVCEGMAYLESSN- 120
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGYFAPEY 406
++HRD+ + N L+ EN K++D GM + + D S + + P + + +PE
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK------WSSPEV 172
Query: 407 AMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ S SDV+SFGV++ E+ + G+ P
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 7e-19
Identities = 67/212 (31%), Positives = 101/212 (47%), Gaps = 31/212 (14%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
G G S V + G+I+AVK + + L E+D+L H C+ +VG+
Sbjct: 10 GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDIL---HKCNSPYIVGFYG 66
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNW-DTRV--AIAIGAARGLEYLHEAAA 348
F + + + E+M G LD +L E R+ IA+ +GL YLHE
Sbjct: 67 AFYNNGDISICM-EYMDGG----SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH- 120
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRL---KADGLPSCSS--SPARMQGTFGYFA 403
+I+HRD+K SNIL++ K+ D G++ +L A SS +P R+QG Y
Sbjct: 121 -KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGN-DY-- 176
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435
S+ SD++S G+ L+EL TGR P
Sbjct: 177 ---------SVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 8e-19
Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 235 GGSSY--VYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
GG Y VY G VAVK K + FL E ++ + H ++V L+G C+
Sbjct: 15 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
+ ++ EFM GNL D L + +N + +A + +EYL
Sbjct: 73 ----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 125
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR 411
+HRD+ + N L+ EN K+ D G+++ + D ++ A + + APE +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYNK 181
Query: 412 ASLMSDVFSFGVVLLELIT 430
S+ SDV++FGV+L E+ T
Sbjct: 182 FSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G G V+ G VA+K K G + FL E +++ +L H +V L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ--GSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
+ ++ E+M NG+L D L + + + +A A G+ ++
Sbjct: 72 -----QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NY 123
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 409
+HRD++++NIL+ E L KI D G+A+ ++ + AR F + APE
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDN------EYTAREGAKFPIKWTAPEAINY 177
Query: 410 GRASLMSDVFSFGVVLLELIT-GRQP 434
G ++ SDV+SFG++L E++T GR P
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 34/214 (15%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHCHVVPLVG 288
G+G VY+ + L+D + A+K D+V E+ +L+ ++H +++
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV--NEIRILASVNHPNII---S 63
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNL------RDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
Y F + +V E+ P G+L R ++ E W I I RGL+
Sbjct: 64 YKEAFLDGNKL-CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGLQA 118
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGY 401
LHE +ILHRD+KS+NILL N KI DLG++K LK + A+ Q GT Y
Sbjct: 119 LHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK--------KNMAKTQIGTPHY 167
Query: 402 FAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQP 434
APE GR S SD++S G +L E+ T P
Sbjct: 168 MAPE-VWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 231 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
++G+G V++G L D VAVK K FL+E +L + H ++V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 291 SEFRGKRAMRLLVFEFMPNGN----LRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
++ R +V E +P G+ LR D + + + V A+ AA G+ YL
Sbjct: 62 TQ----RQPIYIVMELVPGGDFLSFLRKKKDELKTKQL-----VKFALDAAAGMAYLE-- 110
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+ +HRD+ + N L+ EN KI+D GM+ R + DG+ SS Q + APE
Sbjct: 111 -SKNCIHRDLAARNCLVGENNVLKISDFGMS-RQEDDGI---YSSSGLKQIPIKWTAPEA 165
Query: 407 AMVGRASLMSDVFSFGVVLLE 427
GR S SDV+S+G++L E
Sbjct: 166 LNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 58/191 (30%), Positives = 85/191 (44%), Gaps = 25/191 (13%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 310
VAVK K + FL E ++++L H +V L+G C K +LV E P G
Sbjct: 26 VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-----KGEPLMLVMELAPLG 80
Query: 311 NLRDCLDG----VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366
L L + + +VA G+ YL +HRD+ + N+LL
Sbjct: 81 PLLKYLKKRREIPVSDLKELAHQVA------MGMAYLESK---HFVHRDLAARNVLLVNR 131
Query: 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMVGRASLMSDVFSFGVV 424
AKI+D GM++ L A A G + ++APE G+ S SDV+S+GV
Sbjct: 132 HQAKISDFGMSRALGAGS----DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVT 187
Query: 425 LLELIT-GRQP 434
L E + G +P
Sbjct: 188 LWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 38/230 (16%)
Query: 231 IVGQGGSSYVYRGQL-TDGRIVAVK----RFKTQGGPNADSVFLTEVDMLSRL-HHCHVV 284
I+G+G S V + + A+K R + V E ++L+RL H ++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK-KVKYVK-IEKEVLTRLNGHPGII 65
Query: 285 PLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLE 341
L Y + F+ + L V E+ PNG L L + G + D + A LE
Sbjct: 66 KL--YYT-FQDEE--NLYFVLEYAPNGEL---LQYIRKYG-SLDEKCTRFYAAEILLALE 116
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS--------CSSSPA 393
YLH I+HRD+K NILLD++++ KITD G AK L + P S
Sbjct: 117 YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 394 RMQGTFGYF-------APEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
+ + F F +PE A SD+++ G ++ +++TG+ P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 63/212 (29%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 232 VGQGGSSYVYRGQLTD--GRI--VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 287
+G G V RG+ + G++ VAVK K+ + FL E ++ L H +++ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAIGAARGLEYL 343
G M +V E P G+L D L G + D V IA G+ YL
Sbjct: 63 GVV---LTHPLM--MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGMRYL 113
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
R +HRD+ + NILL + KI D G+ + L + ++ F + A
Sbjct: 114 ESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--DHYVMEEHLKVPFAWCA 168
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
PE S SDV+ FGV L E+ T G +P
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 5e-18
Identities = 54/183 (29%), Positives = 98/183 (53%), Gaps = 8/183 (4%)
Query: 248 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307
G VAVK K + G N + E+++L L+H ++V G C+E G ++L + EF+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE-DGGNGIKL-IMEFL 90
Query: 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 367
P+G+L++ L +N ++ A+ +G++YL + + +HRD+ + N+L++
Sbjct: 91 PSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEH 146
Query: 368 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 427
KI D G+ K ++ D + + ++APE + + + SDV+SFGV L E
Sbjct: 147 QVKIGDFGLTKAIETD--KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYE 204
Query: 428 LIT 430
L+T
Sbjct: 205 LLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 5e-18
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 25/218 (11%)
Query: 230 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFK-TQGGPNADSVFLTEVDMLSRLHHCHVVPLV 287
++G G ++ VY L + VA+KR + + D + EV +S+ +H +VV
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDEL-RKEVQAMSQCNHPNVVKY- 64
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTRVAIAIGAARGLEY 342
Y S F + LV ++ G+L D + G L E + +GLEY
Sbjct: 65 -YTS-FVVGDEL-WLVMPYLSGGSLLDIMKSSYPRGGLDE----AIIATVLKEVLKGLEY 117
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQGTFG 400
LH +HRDIK+ NILL E+ + KI D G++ L G + R GT
Sbjct: 118 LHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGG---DRTRKVRKTFVGTPC 171
Query: 401 YFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHR 437
+ APE +D++SFG+ +EL TG P +
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK 209
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 66/235 (28%), Positives = 95/235 (40%), Gaps = 59/235 (25%)
Query: 232 VGQGGSSYVYRGQL-------TDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCH 282
+GQG VY G + R VA+K + FL E ++ + H
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETR-VAIK--TVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----------DGV----LVEGMNWDT 328
VV L+G S G+ + +V E M G+L+ L G+ L + +
Sbjct: 71 VVRLLGVVS--TGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM-- 124
Query: 329 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RL 380
A A G+ YL + +HRD+ + N ++ E+L KI D GM + R
Sbjct: 125 ----AAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
GL P R + APE G + SDV+SFGVVL E+ T QP
Sbjct: 178 GGKGL-----LPVR------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 72/245 (29%), Positives = 115/245 (46%), Gaps = 47/245 (19%)
Query: 232 VGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
+G+G V+ + D +VAVK K + +A F E ++L+ L H H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTVLQHQHIVR 71
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEG--------MNWDTRVAI 332
G C+E R L+VFE+M +G+L L D ++ G + +AI
Sbjct: 72 FYGVCTEGR----PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 392
A A G+ YL A+ +HRD+ + N L+ + L KI D GM++ + S+
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-------STDY 177
Query: 393 ARMQG----TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR--------SI 439
R+ G + PE + + + SD++SFGVVL E+ T G+QP ++ I
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237
Query: 440 TKGEE 444
T+G E
Sbjct: 238 TQGRE 242
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 16/199 (8%)
Query: 232 VGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+G V+ G+L D VAVK + P+ + FL E +L + H ++V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI--GAARGLEYLHEAAA 348
++ K+ + +V E + G D L + EG + I + AA G+EYL +
Sbjct: 63 TQ---KQPI-YIVMELVQGG---DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---S 112
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408
+HRD+ + N L+ E KI+D GM+ R + DG+ +S+ Q + APE
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMS-REEEDGV--YASTGGMKQIPVKWTAPEALN 169
Query: 409 VGRASLMSDVFSFGVVLLE 427
GR S SDV+SFG++L E
Sbjct: 170 YGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 69/207 (33%), Positives = 100/207 (48%), Gaps = 31/207 (14%)
Query: 247 DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306
D +VAVK K NA F E ++L+ L H H+V G C E G ++VFE+
Sbjct: 34 DKILVAVKTLK-DASDNARKDFHREAELLTNLQHEHIVKFYGVCVE--GDPL--IMVFEY 88
Query: 307 MPNGNLRDCL-----DGVLVEGMNWDTRVA------IAIGAARGLEYLHEAAAPRILHRD 355
M +G+L L D VL+ N + IA A G+ YL A+ +HRD
Sbjct: 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRD 145
Query: 356 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEYAMVGR 411
+ + N L+ ENL KI D GM++ + S+ R+ G + PE M +
Sbjct: 146 LATRNCLVGENLLVKIGDFGMSRDVY-------STDYYRVGGHTMLPIRWMPPESIMYRK 198
Query: 412 ASLMSDVFSFGVVLLELIT-GRQPIHR 437
+ SDV+S GVVL E+ T G+QP ++
Sbjct: 199 FTTESDVWSLGVVLWEIFTYGKQPWYQ 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 67/231 (29%), Positives = 102/231 (44%), Gaps = 44/231 (19%)
Query: 230 NIVGQGGSSYVYRGQLTD------GRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
N +G G VY G TD G I VAVK + FL E ++S +H +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVE-----GMNWDTRVAIAIGAA 337
+V L+G C + ++ E M G+L L VE + + I + A
Sbjct: 61 IVKLLGVCLL----NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNA-----KITDLGMAK--------RLKADG 384
+G YL + +HRD+ + N L+ E KI D G+A+ R + +G
Sbjct: 117 KGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
L P R + APE + G+ + SDV+SFGV++ E++T G+QP
Sbjct: 174 L-----LPVR------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 2e-17
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 231 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLT---EVDMLSRLHHCHVVPL 286
+G+G VY+ + G IVA+K+ + + + T E+ +L L H ++V L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
+ +R + LVFE+ +L+ LD ++ + +I RGL Y H
Sbjct: 64 LDVI---HTERKL-YLVFEYCDM-DLKKYLD-KRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE- 405
RILHRD+K NIL++ + K+ D G+A +A G+P + + + T Y APE
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLA---RAFGIPLRTYTHEVV--TLWYRAPEI 169
Query: 406 ------YAMVGRASLMSDVFSFGVVLLELITGR 432
Y S D++S G + E+ITG+
Sbjct: 170 LLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 72/217 (33%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 232 VGQGGSSYVYRG-QLTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G G VY G L DG AVK Q G A E+ +LS+L H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 287 VGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGM--NWDTRVAIAIGAARGLE 341
+G E L +F E +P G+L L G E + + TR + GLE
Sbjct: 68 LGTERE-----EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLY-TRQILL-----GLE 116
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA-DGLPSCSSSPARMQGTFG 400
YLH +HRDIK +NIL+D N K+ D GMAK++ S SP M
Sbjct: 117 YLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWM----- 168
Query: 401 YFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIH 436
APE G L +D++S G +LE+ TG+ P
Sbjct: 169 --APEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS 203
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 65/221 (29%), Positives = 114/221 (51%), Gaps = 33/221 (14%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADS---------VFLTEVDMLSRLHH 280
++G G VY G + G ++AVK+ + +A S E+ +L L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPS-VSASSKDRKRSMLDALAREIALLKELQH 65
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGM--NWDTRVAIAIG 335
++V +G + A L +F E++P G++ L+ G E + N+ ++
Sbjct: 66 ENIVQYLGSSLD-----ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL---- 116
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR- 394
+GL YLH I+HRDIK +NIL+D KI+D G++K+L+A+ L S ++ AR
Sbjct: 117 --KGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL-STKTNGARP 170
Query: 395 -MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+QG+ + APE + +D++S G +++E++TG+ P
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G G V+ G+ VA+K + +G + D F+ E ++ +L H ++V L G C+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDD-FIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
+ R +V E+M NG L + L G L G W + + +EYL
Sbjct: 70 KQRPIF----IVTEYMANGCLLNYLRERKGKL--GTEWLLDMCSDV--CEAMEYLESNG- 120
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT---FGYFAPE 405
+HRD+ + N L+ E+ K++D G+A R D + S QGT + PE
Sbjct: 121 --FIHRDLAARNCLVGEDNVVKVSDFGLA-RYVLDDQYTSS------QGTKFPVKWAPPE 171
Query: 406 YAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437
R S SDV+SFGV++ E+ + G+ P R
Sbjct: 172 VFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 66/217 (30%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 231 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV------FLTEVDMLSRLHHCHV 283
++GQG VY D GR +AVK+ P++ E+ +L L H +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPF--DPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 284 VPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGL 340
V G C L +F E+MP G+++D L G L E + I G+
Sbjct: 67 VQYYG-CLRDDET----LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGV 117
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
EYLH I+HRDIK +NIL D N K+ D G +KRL+ + GT
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--VTGTPY 172
Query: 401 YFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQP 434
+ +PE GR +DV+S G ++E++T + P
Sbjct: 173 WMSPEVISGEGYGRK---ADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 7e-17
Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 27/226 (11%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDG-----RIVAVKRFKTQGGPNADSVFLTEVDMLSRL 278
D+ + S+++ +G ++ G L D V VK K ++ L E +L L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 279 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNL----RDCLDGVLVEGMNWDTR--VAI 332
H +++P++ C E +++ +M GNL + C G T+ V +
Sbjct: 66 SHQNILPILHVCIEDGEPP---FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM 122
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL---KADGLPSCS 389
AI A G+ YLH+ ++H+DI + N ++DE L KITD +++ L L
Sbjct: 123 AIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179
Query: 390 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ P + + A E + S SDV+SFGV+L EL+T G+ P
Sbjct: 180 NRPVK------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 9e-17
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV------FLTEVDMLSRLHHCHV 283
++G+G VY G G+++AVK+ + N + EVD+L L H ++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTS-NVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLE 341
V +G C + + EF+P G++ L+ G L E + I G A
Sbjct: 65 VQYLGTCLD----DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA---- 116
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFG 400
YLH ++HRDIK +N++L N K+ D G A+RL GL S+ + M GT
Sbjct: 117 YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435
+ APE SD++S G + E+ TG+ P+
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 9e-17
Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 38/209 (18%)
Query: 247 DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304
D +VAVK K P A F E ++L+ L H H+V G C G ++VF
Sbjct: 34 DKMLVAVKALKD---PTLAARKDFQREAELLTNLQHEHIVKFYGVC----GDGDPLIMVF 86
Query: 305 EFMPNGNLRDCLDG------VLVEG--------MNWDTRVAIAIGAARGLEYLHEAAAPR 350
E+M +G+L L +LV+G + + IA A G+ YL A+
Sbjct: 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQH 143
Query: 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEY 406
+HRD+ + N L+ NL KI D GM++ + S+ R+ G + PE
Sbjct: 144 FVHRDLATRNCLVGANLLVKIGDFGMSRDVY-------STDYYRVGGHTMLPIRWMPPES 196
Query: 407 AMVGRASLMSDVFSFGVVLLELIT-GRQP 434
M + + SDV+SFGV+L E+ T G+QP
Sbjct: 197 IMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 230 NIVGQGGSSYVYRGQLTDG----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
++G+G VY G L D AVK FL E ++ H +V+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG--AARGLEYL 343
L+G C G L+V +M +G+LR+ + E N + I G A+G+EYL
Sbjct: 61 LLGICLPSEG---SPLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYL 114
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT---FG 400
A+ + +HRD+ + N +LDE+ K+ D G+A+ D S G
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR----DIYDKEYYSVHNHTGAKLPVK 167
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439
+ A E + + SDV+SFGV+L EL+T P + +
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 28/195 (14%)
Query: 250 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
+VAVK + A + FL E+ ++SRL + +++ L+G C ++ E+M N
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV----SDDPLCMITEYMEN 101
Query: 310 GNLRDCLDGVLVEG----------MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359
G+L L +E ++ + +A+ A G++YL A+ +HRD+ +
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATR 158
Query: 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEYAMVGRASLM 415
N L+ + KI D GM++ L S R+QG + A E ++G+ +
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLY-------SGDYYRIQGRAVLPIRWMAWESILLGKFTTA 211
Query: 416 SDVFSFGVVLLELIT 430
SDV++FGV L E+ T
Sbjct: 212 SDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 5e-16
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 232 VGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNA----DSVFLTEVDMLSRLHHCHVVPL 286
+G+G + VY+ GRIVA+K+ K A + L E+ +L L H +++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
+ F K + L VFEFM +L + + D + + + RGLEYLH
Sbjct: 68 L---DVFGHKSNINL-VFEFME-TDLEKVIKDKSIVLTPADIK-SYMLMTLRGLEYLHSN 121
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG---TFGYFA 403
ILHRD+K +N+L+ + K+ D G+A+ S S +M T Y A
Sbjct: 122 W---ILHRDLKPNNLLIASDGVLKLADFGLAR--------SFGSPNRKMTHQVVTRWYRA 170
Query: 404 PEYAMVGRA-SLMSDVFSFGVVLLELITGR 432
PE R + D++S G + EL+
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 5e-16
Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 231 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADS-----VFLTEVDMLSRLHHCHVV 284
+G G S Y+ + + G ++AVK+ +++ E+ +++RL+H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLEY 342
++G E + L E+M G++ L G E + + RGL Y
Sbjct: 67 RMLGATCE----DSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI----INYTEQLLRGLSY 118
Query: 343 LHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
LHE +I+HRD+K +N+L+D +I D G A RL A ++ GT +
Sbjct: 119 LHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK-GTGAGEFQGQLLGTIAF 174
Query: 402 FAPEY---AMVGRASLMSDVFSFGVVLLELITGRQP 434
APE GR+ DV+S G V++E+ T + P
Sbjct: 175 MAPEVLRGEQYGRS---CDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 35/201 (17%)
Query: 250 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
+VAVK + NA + FL EV +LSRL +++ L+G C + ++ E+M N
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD----EDPLCMITEYMEN 103
Query: 310 GNLRDCLDG-VLVEG----------------MNWDTRVAIAIGAARGLEYLHEAAAPRIL 352
G+L L L + +++ + + +A+ A G++YL ++ +
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFV 160
Query: 353 HRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEYAM 408
HRD+ + N L+ ENL KI D GM++ L A R+QG + A E +
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYA-------GDYYRIQGRAVLPIRWMAWECIL 213
Query: 409 VGRASLMSDVFSFGVVLLELI 429
+G+ + SDV++FGV L E++
Sbjct: 214 MGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 7e-16
Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 54/234 (23%)
Query: 231 IVGQGGSSYVYRGQLT--DGRI--VAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVVP 285
I+G+G V GQL+ DG VAVK K ++ FL+E + H +V+
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 286 LVGYC--SEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAIGAARG 339
L+G C + K +++ FM +G+L L G L E + T + + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
+EYL + +HRD+ + N +L E++ + D G++K++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI------------------- 163
Query: 400 GYFAPEYAMVGRASLM------------------SDVFSFGVVLLELIT-GRQP 434
++ +Y GR + M SDV++FGV + E+ T G+ P
Sbjct: 164 --YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 7e-16
Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 32/217 (14%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIV----AVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
++G G VY+G + +G V A+K GP A+ F+ E +++ + H H+V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNL-------RDCLDGVLVEGMNWDTRVAIAIGAAR 338
L+G C LV + MP+G L +D + L+ +NW ++A +
Sbjct: 74 LLGVCLS-----PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLL--LNWCVQIA------K 120
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
G+ YL E R++HRD+ + N+L+ + KITD G+A+ L+ D ++ +M
Sbjct: 121 GMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE-KEYNADGGKM--P 174
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ A E + + SDV+S+GV + EL+T G +P
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 63/225 (28%), Positives = 109/225 (48%), Gaps = 23/225 (10%)
Query: 229 SNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVF-LTEVDMLSRL---HHCHV 283
+G+G VY+ + L GR VA+K+ + + L E+ +L +L H ++
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 284 VPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
V L+ C R R ++L LVFE + + +L L G+ +T + RG+++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD-GLPSCSSSPARMQGTFGY 401
LH + RI+HRD+K NIL+ + KI D G+A+ + L S T Y
Sbjct: 123 LH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-------TLWY 172
Query: 402 FAPEYAMVGRASLMS--DVFSFGVVLLELITGRQPIHRSITKGEE 444
APE + ++S + D++S G + EL R+P+ R ++ ++
Sbjct: 173 RAPEVLL--QSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQ 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 9e-16
Identities = 63/212 (29%), Positives = 109/212 (51%), Gaps = 21/212 (9%)
Query: 231 IVGQGGSSYVYRGQL-TDGR---IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
++G G V+RG L GR VA+K K FL+E ++ + H +++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 343
G ++F K AM ++ E+M NG L L DG V + G A G++YL
Sbjct: 72 EGVVTKF--KPAM--IITEYMENGALDKYLRDHDGEFSSYQ----LVGMLRGIAAGMKYL 123
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
+ +HRD+ + NIL++ NL K++D G+++ L+ D + ++S ++ + A
Sbjct: 124 SDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTA 178
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
PE + + SDV+SFG+V+ E+++ G +P
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 233 GQGGS-SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
G GGS S V + G ++A K + L E+ ++ H C +V +
Sbjct: 16 GNGGSVSKVKH--IPTGTVMAKKVVHIGAKSSVRKQILRELQIM---HECRSPYIVSFYG 70
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHEAAAP 349
F + + + EFM G+L D + +G + + IA+ GL YL+
Sbjct: 71 AFLNENNI-CMCMEFMDCGSL----DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH-- 123
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 409
RI+HRDIK SNIL++ K+ D G++ L +S GT Y +PE
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-------INSIADTFVGTSTYMSPERIQG 176
Query: 410 GRASLMSDVFSFGVVLLELITGRQP 434
G+ ++ SDV+S G+ ++EL G+ P
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLH---HCHVVPL 286
+G G VY+ + G VA+K + Q + + + EV +L RL H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 287 VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
+ C+ R R ++ LVFE + + +LR LD V G+ +T + RGL++LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH- 125
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 405
A I+HRD+K NIL+ K+ D G+A+ + SC + + T Y APE
Sbjct: 126 --ANCIVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMALTPVVVTLWYRAPE 177
Query: 406 YAMVGRASLMSDVFSFGVVLLELITGRQPI 435
+ + D++S G + E+ R+P+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 65/233 (27%), Positives = 109/233 (46%), Gaps = 33/233 (14%)
Query: 216 YSALEHATDKFSGSNIVGQGGSSYVYRGQL-TDG-RI-VAVKRFKTQGGPNADSVFLTEV 272
Y LE KF +++G+G V + ++ DG R+ A+KR K + F E+
Sbjct: 1 YPVLEWNDIKFQ--DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 58
Query: 273 DMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV---------- 321
++L +L HH +++ L+G C R L E+ P+GNL D L V
Sbjct: 59 EVLCKLGHHPNIINLLGACEH----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 114
Query: 322 ----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377
++ + A ARG++YL + + +HRD+ + NIL+ EN AKI D G++
Sbjct: 115 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 171
Query: 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430
+ + + P R + A E + SDV+S+GV+L E+++
Sbjct: 172 RGQEVYVKKTMGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 76/253 (30%), Positives = 111/253 (43%), Gaps = 37/253 (14%)
Query: 232 VGQGGSSYVYRGQL-TDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
+G+GG V Q+ G++ A K R K + G V E +L+++H +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV---EKRILAKVHSRFIVS 57
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA--RGLEYL 343
L F+ K + LV M G+LR + V E + A A GLE+L
Sbjct: 58 LA---YAFQTKTDL-CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
H+ RI++RD+K N+LLD + N +I+DLG+A LK DG S GT G+ A
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK-DG----QSKTKGYAGTPGFMA 165
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSIITDA------ 457
PE D F+ GV L E+I R P K E + + I+ D+
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQRILNDSVTYPDK 223
Query: 458 ------SICQSFL 464
S C++ L
Sbjct: 224 FSPASKSFCEALL 236
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 34/228 (14%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+G + VY+G+ T G IVA+K S + E+ ++ L H ++V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL---- 63
Query: 291 SEFRGKRAMRLLVFEFMPN---------GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
+ +LVFE+M G R LD V+ + +G+
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQL--------LKGIA 114
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
+ HE R+LHRD+K N+L+++ K+ D G+A +A G+P + S + T Y
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLA---RAFGIPVNTFSNEVV--TLWY 166
Query: 402 FAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIHRSITKGEESLVL 448
AP+ + R S D++S G ++ E+ITGR P+ T E+ L+
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR-PLFPG-TNNEDQLLK 212
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLT----EVDM 274
E+ D+ ++G+G VY + L+ +A+K P DS ++ E+ +
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI-----PERDSRYVQPLHEEIAL 58
Query: 275 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLVEGMNWDTRVA 331
S L H ++V +G SE + E +P G+L L G L + N T +
Sbjct: 59 HSYLKHRNIVQYLGSDSE----NGFFKIFMEQVPGGSLSALLRSKWGPLKD--NEQTIIF 112
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPSCSS 390
GL+YLH+ +I+HRDIK N+L++ KI+D G +KRL G+ C+
Sbjct: 113 YTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTE 167
Query: 391 SPARMQGTFGYFAPEYAMVGRASL--MSDVFSFGVVLLELITGRQPIH 436
+ GT Y APE G +D++S G ++E+ TG+ P
Sbjct: 168 T---FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI 212
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 28/222 (12%)
Query: 230 NIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
I+G G VY+ L RI+AVK ++E+++L + C ++G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEIL---YKCDSPYIIG 63
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNL---RDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
+ F + + + EFM G+L R + VL R+A+A+ +GL YL
Sbjct: 64 FYGAFFVENRISICT-EFMDGGSLDVYRKIPEHVL-------GRIAVAV--VKGLTYLW- 112
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 405
+ +ILHRD+K SN+L++ K+ D G++ +L +S GT Y APE
Sbjct: 113 --SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-------VNSIAKTYVGTNAYMAPE 163
Query: 406 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447
+ + SDV+S G+ +EL GR P + I K + SL+
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGRFP-YPQIQKNQGSLM 204
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 231 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNAD------SVFLTEVDMLSRLHHCHV 283
++GQG VY D GR +A K + Q P + S E+ +L L H +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAK--QVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLE 341
V G C R ++ + + + E+MP G+++D L G L E + I G+
Sbjct: 67 VQYYG-CLRDRAEKTLTIFM-EYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMS 120
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-----ADGLPSCSSSPARMQ 396
YLH + I+HRDIK +NIL D N K+ D G +KRL+ G+ S + +P M
Sbjct: 121 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM- 176
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+PE +DV+S G ++E++T + P
Sbjct: 177 ------SPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKT--QGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+G+G S VY+ L DGR+VA+K+ + A L E+D+L +L H +V+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIK--- 66
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTRVAIAIGAARGLEY 342
Y + F + +V E G+L + ++ E W V + LE+
Sbjct: 67 YLASFI-ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEH 121
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
+H RI+HRDIK +N+ + K+ DLG+ + + + S + GT Y
Sbjct: 122 MHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-----LVGTPYYM 173
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+PE + SD++S G +L E+ + P
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIVAVKRF---KTQGGPNAD------SVFLTEVDMLSRLHH 280
++G+G VY +T G ++AVK+ T G + +E++ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTRVAIAI 334
++V +G F + E++P G++ CL + LV
Sbjct: 68 LNIVQYLG----FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV------ 117
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
GL YLH ILHRD+K+ N+L+D + KI+D G++K K+D + +
Sbjct: 118 --LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK--KSDDIYD-NDQNMS 169
Query: 395 MQGTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP 434
MQG+ + APE S D++S G V+LE+ GR+P
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 37/221 (16%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHC 281
+K+ +VG+G V + + + G+IVA+K+F +++ + + E+ ML +L H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 282 HVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDC------LDGVLVEGMNWDTRVAIAI 334
++V L+ +R RL LVFEF+ + L D LD V +
Sbjct: 61 NLVNLIEVF-----RRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQI------ 109
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
RG+E+ H + I+HRDIK NIL+ ++ K+ D G A+ L A G + A
Sbjct: 110 --LRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVA- 162
Query: 395 MQGTFGYFAPEYAM----VGRASLMSDVFSFGVVLLELITG 431
T Y APE + GRA D+++ G ++ E++TG
Sbjct: 163 ---TRWYRAPELLVGDTKYGRA---VDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 6e-15
Identities = 58/191 (30%), Positives = 92/191 (48%), Gaps = 18/191 (9%)
Query: 248 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307
G VAVK K A FL E ++++L H ++V L+G E +G +V E+M
Sbjct: 29 GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGL---YIVTEYM 82
Query: 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 367
G+L D L + D + ++ +EYL A +HRD+ + N+L+ E+
Sbjct: 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDN 139
Query: 368 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 427
AK++D G+ K +A P + + APE + S SDV+SFG++L E
Sbjct: 140 VAKVSDFGLTK--EASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWE 191
Query: 428 LIT-GRQPIHR 437
+ + GR P R
Sbjct: 192 IYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIV-AVKRFKTQGGPNADSVFLTEVDMLSRL 278
E D F + +G G V + Q ++ A K + P + + E L L
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRE---LQVL 57
Query: 279 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV--AIAIGA 336
H C+ +VG+ F + + + E M G+L D VL E + ++I
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL----DQVLKEAKRIPEEILGKVSIAV 112
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
RGL YL E +I+HRD+K SNIL++ K+ D G++ +L + S ++S
Sbjct: 113 LRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANS---FV 163
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435
GT Y +PE S+ SD++S G+ L+EL GR PI
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVGY 289
+G G V+ G + VAVK K P SV FL E +++ L H +V L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK----PGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 349
+ K ++ E+M G+L D L + + + A G+ Y+
Sbjct: 70 VT----KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK--- 122
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYA 407
+HRD++++N+L+ E+L KI D G+A+ ++ + AR F + APE
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN------EYTAREGAKFPIKWTAPEAI 176
Query: 408 MVGRASLMSDVFSFGVVLLELIT-GRQP 434
G ++ SDV+SFG++L E++T G+ P
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 37/209 (17%)
Query: 250 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
+VAVK K + + + F E +++ H ++V L+G C+ + M LL FE+M
Sbjct: 37 MVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV---GKPMCLL-FEYMAY 92
Query: 310 GNL----RDCLDGVLVEGMNWDTR----------------VAIAIGAARGLEYLHEAAAP 349
G+L R + + + IA A G+ YL E
Sbjct: 93 GDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER--- 149
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PARMQGTFGYFAPEY 406
+ +HRD+ + N L+ EN+ KI D G+++ + + S + P R + PE
Sbjct: 150 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR------WMPPES 203
Query: 407 AMVGRASLMSDVFSFGVVLLELIT-GRQP 434
R + SDV+++GVVL E+ + G QP
Sbjct: 204 IFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 64/237 (27%), Positives = 97/237 (40%), Gaps = 42/237 (17%)
Query: 231 IVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNA--DSVFLTEVDMLSRLHHCHVVP 285
++G+GG VY D R VA+K+ + N FL E + + L H +VP
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 286 LVGYCSEFRGKRAMRLLVFEFMP--NG--------NLRDC--LDGVLVEGMNWDTRVAIA 333
+ CS+ V+ MP G ++ L L E + ++I
Sbjct: 67 VYSICSDGD-------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR----------LKAD 383
+EY+H +LHRD+K NILL I D G A + D
Sbjct: 120 HKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 384 GLPSCSSS---PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437
C SS P ++ GT Y APE + AS +D+++ GV+L +++T P R
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233
|
Length = 932 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G VY+ + G IVA+K+ K ++G P L E+ +L L+H +++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA---LREIKLLKELNHPNIIKL 63
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
+ FR K + LVFEFM + +L + G+ + +GL + H
Sbjct: 64 L---DVFRHKGDL-YLVFEFM-DTDLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ----GTFGYF 402
ILHRD+K N+L++ K+ D G+A+ SP R T Y
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSF---------GSPVRPYTHYVVTRWYR 165
Query: 403 APE--YAMVGRASLMSDVFSFGVVLLELITGR 432
APE G ++ + D++S G + EL++ R
Sbjct: 166 APELLLGDKGYSTPV-DIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 63/250 (25%), Positives = 116/250 (46%), Gaps = 38/250 (15%)
Query: 230 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
N++ +G Y+G+ + +G VK + +S+ +E+ + +L H ++V L+G
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEIN-----DVNSIPSSEIADMGKLQHPNIVKLIG 750
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
C +G L+ E++ NL + L ++W+ R IAIG A+ L +LH +
Sbjct: 751 LCRSEKGA----YLIHEYIEGKNLSEVL-----RNLSWERRRKIAIGIAKALRFLHCRCS 801
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408
P ++ ++ I++D + L + L D SS+ Y APE
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA---------YVAPETRE 851
Query: 409 VGRASLMSDVFSFGVVLLELITGRQP------IHRSITK------GEESLVLWVKSIIT- 455
+ SD++ FG++L+EL+TG+ P +H SI + + L +W+ I
Sbjct: 852 TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911
Query: 456 DASICQSFLV 465
D S+ Q+ +V
Sbjct: 912 DVSVNQNEIV 921
|
Length = 968 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 29/203 (14%)
Query: 241 YRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300
+RGQ VA+K K G ++ F+ E ++ +L H +V L G C+ K+
Sbjct: 25 WRGQYD----VAIKMIKE--GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT----KQRPI 74
Query: 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI---AIGAARGLEYLHEAAAPRILHRDIK 357
+V E+M NG CL L E + G+ YL + + +HRD+
Sbjct: 75 YIVTEYMSNG----CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLA 127
Query: 358 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGYFAPEYAMVGRASLM 415
+ N L+D+ K++D G+++ + D S S P R + PE + + S
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLLYSKFSSK 181
Query: 416 SDVFSFGVVLLELIT-GRQPIHR 437
SDV++FGV++ E+ + G+ P R
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 31/219 (14%)
Query: 230 NIVGQGGSSYVYRGQLT-DGRIV--AVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 285
+++G+G V + ++ DG + A+KR K + F E+++L +L HH +++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVA 331
L+G C R L E+ P+GNL D L V ++ +
Sbjct: 61 LLGACE----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 391
A ARG++YL + + +HRD+ + NIL+ EN AKI D G+++ + +
Sbjct: 117 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173
Query: 392 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430
P R + A E + SDV+S+GV+L E+++
Sbjct: 174 PVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 42/227 (18%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHC 281
+K+ + +G+G V++ + + G+IVA+K+F +++ P + L E+ ML +L H
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFM-----------PNGNLRDCLDGVLVEGMNWDTRV 330
++V L+ FR KR + L VFE+ P G + L++ + W T
Sbjct: 61 NLVNLI---EVFRRKRKLHL-VFEYCDHTVLNELEKNPRG-----VPEHLIKKIIWQT-- 109
Query: 331 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 390
+ + + H +HRD+K NIL+ + K+ D G A+ L G
Sbjct: 110 ------LQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160
Query: 391 SPARMQGTFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGRQPI 435
R Y APE +VG DV++ G V EL+TG QP+
Sbjct: 161 VATRW-----YRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG-QPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 41/219 (18%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G VY+ + G IVA+K+ + +G P S + E+ +L L+H ++V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVP---STAIREISLLKELNHPNIVRL 63
Query: 287 --VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
V + +L LVFEF+ + +L+ +D + G++ + +G+ Y
Sbjct: 64 LDVVHSEN-------KLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG------ 397
H + R+LHRD+K N+L+D K+ D G+A +A G+P ++
Sbjct: 116 H---SHRVLHRDLKPQNLLIDREGALKLADFGLA---RAFGVP--------VRTYTHEVV 161
Query: 398 TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPI 435
T Y APE + R S D++S G + E++ R+P+
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 69/222 (31%), Positives = 107/222 (48%), Gaps = 22/222 (9%)
Query: 226 FSGSNIVGQGGSSYVYRGQL-TDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLH 279
F ++G+GG V Q+ G++ A K R K + G +S+ L E +L +++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG---ESMALNEKQILEKVN 58
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339
VV L Y E K A+ LV M G+L+ + + G V A G
Sbjct: 59 SRFVVSL-AYAYE--TKDAL-CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
LE LH+ RI++RD+K NILLD++ + +I+DLG+A +P + R+ GT
Sbjct: 115 LEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVH-----VPEGQTIKGRV-GTV 165
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 441
GY APE R + D ++ G +L E+I G+ P + K
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 27/220 (12%)
Query: 230 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLT-EVDMLSRLHHCHVVPLV 287
+G+G V + + +DG+I+ K + L EV++L L H ++V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV--- 62
Query: 288 GYCSEFRGKRAMRL-LVFEFMPNGNL----RDC--LDGVLVEGMNWD--TRVAIAIGAAR 338
Y + L +V E+ G+L + C + E W T++ +A
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA----- 117
Query: 339 GLEYLH--EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
L H +LHRD+K +NI LD N N K+ D G+AK L D SS
Sbjct: 118 -LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-----SSFAKTYV 171
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
GT Y +PE SD++S G ++ EL P
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 230 NIVGQGGSSYVYRGQLT-DGRIV--AVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 285
+++G+G V R + DG + A+K K N F E+++L +L HH +++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVA 331
L+G C R + E+ P GNL D L V + +
Sbjct: 68 LLGACE----NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 391
A A G++YL E + +HRD+ + N+L+ ENL +KI D G+++ + +
Sbjct: 124 FASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180
Query: 392 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430
P R + A E + SDV+SFGV+L E+++
Sbjct: 181 PVR------WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 35/233 (15%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDM 274
+ DKF +G+G VY+ + D G +VA+K+ + N F + E+ +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD---NEKEGFPITAIREIKI 59
Query: 275 LSRLHHCHVVPLVGYCS------EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGM---N 325
L +L+H ++V L + +F+ + LVFE+M + L G+L G+ +
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFS 114
Query: 326 WDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385
D + GL Y H+ LHRDIK SNILL+ K+ D G+A+ ++
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSE-- 169
Query: 386 PSCSSSPARMQG-TFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPI 435
S P + T Y PE ++G R DV+S G +L EL T ++PI
Sbjct: 170 ---ESRPYTNKVITLWYRPPEL-LLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYR-GQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 278
E D F + +G G V++ G I+A K + P + + E L L
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRE---LQVL 57
Query: 279 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGA 336
H C+ +VG+ F + + + E M G+L L G + E + +V+IA+
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQIL--GKVSIAV-- 112
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
+GL YL E +I+HRD+K SNIL++ K+ D G++ +L + S ++S
Sbjct: 113 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANS---FV 163
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435
GT Y +PE S+ SD++S G+ L+E+ GR PI
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 51/238 (21%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQL-----TDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSR 277
D+ + +G+G V + + + VAVK K S ++E++M+
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 278 L-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVE 322
+ H +++ L+G C++ G +V E+ +GNLRD L E
Sbjct: 72 IGKHKNIINLLGVCTQ-EGPL---YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 323 GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK---- 378
+ V+ A ARG+E+L A+ + +HRD+ + N+L+ E+ KI D G+A+
Sbjct: 128 TLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
Query: 379 ----RLKADG-LPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELIT 430
R +G LP + APE A+ R + SDV+SFGV+L E+ T
Sbjct: 185 IDYYRKTTNGRLP------------VKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+ F+ +G+G VY+ ++VA+K + + E+ LS+ +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 283 VVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAI---GAA 337
+ G S +G +L ++ E+ G+ D L G L E IA
Sbjct: 61 ITKYYG--SFLKG---SKLWIIMEYCGGGSCLDLLKPGKLDET-------YIAFILREVL 108
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ- 396
GLEYLHE +HRDIK++NILL E + K+ D G++ +L +S+ ++
Sbjct: 109 LGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQL--------TSTMSKRNT 157
Query: 397 --GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
GT + APE +D++S G+ +EL G P
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 7e-14
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 232 VGQGGSSYVYRGQL-TDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
+G+GG V Q+ G++ A K R K + G + + L E ++L +++ +V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSG---EKMALLEKEILEKVNSPFIVN 57
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
L Y E + LV M G+L+ + V G+ + + + G+ +LH
Sbjct: 58 L-AYAFE---SKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 405
I++RD+K N+LLD+ N +++DLG+A LK DG + GT GY APE
Sbjct: 114 M---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKTITQRA-----GTNGYMAPE 164
Query: 406 YAMVGRASLMSDVFSFGVVLLELITGRQP 434
S D F+ G + E++ GR P
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 7e-14
Identities = 56/207 (27%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G VY+ + G +VA+K+ + T+G P S + E+ +L L+H ++V L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHPNIVKL 64
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
+ + LVFEF+ + +L+ +D + G+ + +GL + H
Sbjct: 65 L----DVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH-- 117
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+ R+LHRD+K N+L++ K+ D G+A +A G+P + + + T Y APE
Sbjct: 118 -SHRVLHRDLKPQNLLINTEGAIKLADFGLA---RAFGVPVRTYTHEVV--TLWYRAPEI 171
Query: 407 AMVGR-ASLMSDVFSFGVVLLELITGR 432
+ + S D++S G + E++T R
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-14
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 225 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
K++ +GQG S VY + G+ VA+K+ Q P + + + E+ ++ H ++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKE-LIINEILVMRENKHPNI 78
Query: 284 VPLVG---YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARG 339
V + E +V E++ G+L D V+ E M+ A+ +
Sbjct: 79 VNYLDSYLVGDEL-------WVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQA 127
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
LE+LH + +++HRDIKS NILL + + K+TD G ++ + S + M GT
Sbjct: 128 LEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTP 179
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+ APE D++S G++ +E++ G P
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 9e-14
Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 31/218 (14%)
Query: 225 KFSGSNIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
K++ +GQG S V+ D G+ VA+K+ Q P + + + E+ ++ L +
Sbjct: 20 KYTRYEKIGQGASGTVFTA--IDVATGQEVAIKQINLQKQPKKE-LIINEILVMKELKNP 76
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD-----CLDGVLVEGMNWDTRVAIAIGA 336
++V + S G +V E++ G+L D C+D + A+
Sbjct: 77 NIVNFLD--SFLVGDEL--FVVMEYLAGGSLTDVVTETCMDEAQI--------AAVCREC 124
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
+ LE+LH A +++HRDIKS N+LL + + K+TD G ++ + S + M
Sbjct: 125 LQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-----QSKRSTMV 176
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
GT + APE D++S G++ +E++ G P
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 9e-14
Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 31/212 (14%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+G+G VY+ G++VA+K + + E+ +L + ++V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYG- 65
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWD-TRVAIAI---GAARGLEYLHE 345
S F K +V E+ G++ D +++ N T IA +GLEYLH
Sbjct: 66 -SYF--KNTDLWIVMEYCGAGSVSD-----IMKITNKTLTEEEIAAILYQTLKGLEYLH- 116
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ---GTFGYF 402
+ + +HRDIK+ NILL+E AK+ D G++ +L + + A+ GT +
Sbjct: 117 --SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL--------TDTMAKRNTVIGTPFWM 166
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
APE + +D++S G+ +E+ G+ P
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 9e-14
Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 36/204 (17%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 310
VAVK K + L+E ++L +++H HV+ L G CS+ LL+ E+ G
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ----DGPLLLIVEYAKYG 88
Query: 311 NLR----------------------DCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
+LR LD + ++ A +RG++YL E
Sbjct: 89 SLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-- 146
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEY 406
+++HRD+ + N+L+ E KI+D G+++ + + S R +G + A E
Sbjct: 147 -KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE-----DSYVKRSKGRIPVKWMAIES 200
Query: 407 AMVGRASLMSDVFSFGVVLLELIT 430
+ SDV+SFGV+L E++T
Sbjct: 201 LFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 232 VGQGGSSYVYRGQ--LTDGRIVAVKRFKTQ----GGPNADSVFLTEVDMLSRLH---HCH 282
+G+G V++ + GR VA+KR + Q G P + + EV +L L H +
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST---IREVAVLRHLETFEHPN 65
Query: 283 VVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
VV L C+ R R +L LVFE + + +L LD V G+ +T + RGL+
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
+LH + R++HRD+K NIL+ + K+ D G+A+ + S + + T Y
Sbjct: 125 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR------IYSFQMALTSVVVTLWY 175
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437
APE + + D++S G + E+ R+P+ R
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFR 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 66/241 (27%), Positives = 107/241 (44%), Gaps = 35/241 (14%)
Query: 206 TIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNA 264
TI G + LE+ + +G G VY+ + G ++AVK+ + G
Sbjct: 4 TIDGQKYPADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE 56
Query: 265 DSVFLTEVDMLSRLHHC-HVVPLVGY-CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV- 321
+ L ++D++ + H C ++V GY ++ M L+ CLD +L
Sbjct: 57 NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM----------STCLDKLLKR 106
Query: 322 --EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379
+ D + + + L YL E ++HRD+K SNILLD + N K+ D G++ R
Sbjct: 107 IQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGR 164
Query: 380 LKADGLPSCSSSPARMQGTFGYFAPEY----AMVGRASLMSDVFSFGVVLLELITGRQPI 435
L D S + R G Y APE + + +DV+S G+ L+EL TG+ P
Sbjct: 165 L-VD-----SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY 218
Query: 436 H 436
Sbjct: 219 K 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 71/225 (31%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 231 IVGQGGSSYVYRGQLTD-GRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLH--HCH 282
I+G+GG VY + D G++ A+K R K + G +++ L E MLS + C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---ETLALNERIMLSLVSTGDCP 57
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGL 340
+ + Y K + + + M G+L L GV E + R A GL
Sbjct: 58 FIVCMSYAFHTPDKLS---FILDLMNGGDLHYHLSQHGVFSEA---EMRF-YAAEIILGL 110
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PARMQG 397
E++H +++RD+K +NILLDE+ + +I+DLG+A C S P G
Sbjct: 111 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA----------CDFSKKKPHASVG 157
Query: 398 TFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIHRSITK 441
T GY APE G A S D FS G +L +L+ G P + TK
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 72/255 (28%), Positives = 116/255 (45%), Gaps = 32/255 (12%)
Query: 226 FSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLHHCH 282
F ++G+GG V Q+ G++ A KR + + +S+ L E +L +++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
VV L Y E K A+ LV M G+L+ + + G + + A GLE
Sbjct: 62 VVNL-AYAYE--TKDAL-CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLED 117
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
LH ++RD+K NILLD+ + +I+DLG+A + +P S R+ GT GY
Sbjct: 118 LHREN---TVYRDLKPENILLDDYGHIRISDLGLAVK-----IPEGESIRGRV-GTVGYM 168
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQP------------IHRSITKGEESLVLWV 450
APE R +L D + G ++ E+I G+ P + R + + EE +
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV---YS 225
Query: 451 KSIITDA-SICQSFL 464
+A SIC+ L
Sbjct: 226 AKFSEEAKSICKMLL 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 37/219 (16%)
Query: 240 VYRGQL---TDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293
VY+G L G + VA+K K + F E M SRL H ++V L+G +
Sbjct: 21 VYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-- 78
Query: 294 RGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWDTRVAIAIGAARG 339
K ++F + + +L + L D + + V I A G
Sbjct: 79 --KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAG 136
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG---LPSCSSSPARMQ 396
+E+L ++ ++H+D+ + N+L+ + LN KI+DLG+ + + A L S P R
Sbjct: 137 MEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR-- 191
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ +PE M G+ S+ SD++S+GVVL E+ + G QP
Sbjct: 192 ----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 65/220 (29%), Positives = 98/220 (44%), Gaps = 30/220 (13%)
Query: 232 VGQGGSSYVYRGQLTDGRIVA---VKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+G G V G+ G A VK + P+ +FL EV L+H +V+ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGM-NWDTRVAIAIGAARGLEYLHE 345
C E LLV EF P G+L++ L + +V M D +A A GL +LH+
Sbjct: 63 QCIE----SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMA-KRLKADGLPS--CSSSPARMQGTFGYF 402
A +H D+ N L +L+ KI D G+A ++ D + C + P R +
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WL 169
Query: 403 APEYAMVGRASLM-------SDVFSFGVVLLELIT-GRQP 434
APE + L+ S+++S GV + EL T QP
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 53/194 (27%), Positives = 95/194 (48%), Gaps = 27/194 (13%)
Query: 250 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
+VAVK + NA + FL E+ ++SRL +++ L+ C ++ E+M N
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT----SDPLCMITEYMEN 103
Query: 310 GNLRDCLDGVLVEG---------MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 360
G+L L + +++ T + +A A G++YL ++ +HRD+ + N
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRN 160
Query: 361 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEYAMVGRASLMS 416
L+ +N KI D GM++ L S R+QG + + E ++G+ + S
Sbjct: 161 CLVGKNYTIKIADFGMSRNLY-------SGDYYRIQGRAVLPIRWMSWESILLGKFTTAS 213
Query: 417 DVFSFGVVLLELIT 430
DV++FGV L E++T
Sbjct: 214 DVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 53/165 (32%), Positives = 84/165 (50%), Gaps = 20/165 (12%)
Query: 275 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG----MNWDTRV 330
L LH C+ +VG+ F + + + E M G+L D VL + N ++
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL----DQVLKKAGRIPENILGKI 104
Query: 331 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 390
+IA+ RGL YL E I+HRD+K SNIL++ K+ D G++ +L + S ++
Sbjct: 105 SIAV--LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMAN 156
Query: 391 SPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435
S GT Y +PE ++ SD++S G+ L+E+ GR PI
Sbjct: 157 S---FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 43/140 (30%), Positives = 68/140 (48%), Gaps = 24/140 (17%)
Query: 302 LVFEFMPNGNLRDCLDGVLVEGM-----NWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356
LV E++ G DC L++ + +W + + G+E LH+ I+HRDI
Sbjct: 74 LVMEYLNGG---DC--ASLIKTLGGLPEDWAKQYIAEV--VLGVEDLHQRG---IIHRDI 123
Query: 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMS 416
K N+L+D+ + K+TD G+++ +GL + GT Y APE + MS
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSR----NGL-----ENKKFVGTPDYLAPETILGVGDDKMS 174
Query: 417 DVFSFGVVLLELITGRQPIH 436
D +S G V+ E + G P H
Sbjct: 175 DWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 235 GGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
G +Y VY+ + + G +VA+K K + G + + + E+ ML H ++V G S
Sbjct: 12 GSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEII-QQEISMLKECRHPNIVAYFG--S 68
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
R + +V E+ G+L+D V ++ + +GL YLHE
Sbjct: 69 YLRRDKLW--IVMEYCGGGSLQDIYQ-VTRGPLSELQIAYVCRETLKGLAYLHET---GK 122
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ---GTFGYFAPEYAM 408
+HRDIK +NILL E+ + K+ D G++ +L A + A+ + GT + APE A
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTA--------TIAKRKSFIGTPYWMAPEVAA 174
Query: 409 V---GRASLMSDVFSFGVVLLELITGRQP 434
V G D+++ G+ +EL + P
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 68/220 (30%), Positives = 100/220 (45%), Gaps = 50/220 (22%)
Query: 233 GQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV---FLTEVDMLSRLHHCHVVPLVGY 289
G GG+ Y + T GR+ A+K G + D+V E+++L ++H +VV
Sbjct: 85 GAGGTVYKVIHRPT-GRLYALKVIY---GNHEDTVRRQICREIEILRDVNHPNVVK---- 136
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA-------IAIGAARGLEY 342
C + ++ EFM G+L EG T +A +A G+ Y
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSL---------EG----THIADEQFLADVARQILSGIAY 183
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
LH I+HRDIK SN+L++ N KI D G++ R+ A + C+SS GT Y
Sbjct: 184 LHRR---HIVHRDIKPSNLLINSAKNVKIADFGVS-RILAQTMDPCNSS----VGTIAYM 235
Query: 403 APEY--------AMVGRASLMSDVFSFGVVLLELITGRQP 434
+PE A G A D++S GV +LE GR P
Sbjct: 236 SPERINTDLNHGAYDGYA---GDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 63/216 (29%), Positives = 110/216 (50%), Gaps = 27/216 (12%)
Query: 231 IVGQGGSSYVYRGQLT-DGR---IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
++G G V RG+L G+ VA+K K+ FL+E ++ + H +++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR-VAIAIGAARGLEYLHE 345
G ++ R +++ EFM NG L L +G + V + G A G++YL E
Sbjct: 71 EGVVTKSRPV----MIITEFMENGALDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL-PSCSSS-----PARMQGTF 399
+HRD+ + NIL++ NL K++D G+++ L+ D P+ +SS P R
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR----- 176
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ APE + + SDV+S+G+V+ E+++ G +P
Sbjct: 177 -WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 34/224 (15%)
Query: 225 KFSGSNIVGQGGSSYVYRG-QLTDG---RI-VAVKRFKTQGGPNADSVFLTEVDMLSRLH 279
+F ++G G VY+G + +G +I VA+K + P A+ L E +++ +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGM-NWDTRVAIAI 334
+ HV L+G C + L+ + MP G L D + D + + + NW ++A
Sbjct: 68 NPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA--- 119
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
+G+ YL E R++HRD+ + N+L+ + KITD G+AK L AD
Sbjct: 120 ---KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD------EKEYH 167
Query: 395 MQG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+G + A E + + SDV+S+GV + EL+T G +P
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 29/197 (14%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
VAVK K+ S ++E++M+ + H +++ L+G C++ ++ E+
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ----DGPLYVIVEYASK 108
Query: 310 GNLRDCL--------------DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 355
GNLR+ L V E +++ V+ A ARG+EYL A+ + +HRD
Sbjct: 109 GNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRD 165
Query: 356 IKSSNILLDENLNAKITDLGMAKRL-KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-S 413
+ + N+L+ E+ KI D G+A+ + D ++ ++ + APE A+ R +
Sbjct: 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK----WMAPE-ALFDRIYT 220
Query: 414 LMSDVFSFGVVLLELIT 430
SDV+SFGV+L E+ T
Sbjct: 221 HQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 231 IVGQGGSSYVYRGQL-TDGRIVAVKRF--KTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 287
++G+GG V Q+ G++ A K+ K +++ L E +L +++ VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 65
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
Y E K A+ LV M G+L+ + + G + + V A GLE LH
Sbjct: 66 AYAYE--TKDAL-CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE- 121
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGYFAPEY 406
RI++RD+K NILLD+ + +I+DLG+A + R + GT GY APE
Sbjct: 122 --RIVYRDLKPENILLDDYGHIRISDLGLAVEIP-------EGETIRGRVGTVGYMAPEV 172
Query: 407 AMVGRASLMSDVFSFGVVLLELITGRQP 434
R + D + G ++ E+I G+ P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 60/222 (27%), Positives = 92/222 (41%), Gaps = 45/222 (20%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
G+G V + + + G I+AVKR + L ++D+ R C Y
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP------YTV 63
Query: 292 EFRGKRAMRLLVFEFMPNGNLRD-CLD----GVLVEGMNWDTRV--AIAIGAARGLEYLH 344
F G V+ M + D LD V +G+ + IA+ + LEYLH
Sbjct: 64 TFYGALFREGDVWICM---EVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLG--------MAKRLKADGLPSCSSSPARMQ 396
++HRD+K SN+L++ N K+ D G +AK + A P
Sbjct: 121 SKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP---------- 168
Query: 397 GTFGYFAPEY---AMVGRA-SLMSDVFSFGVVLLELITGRQP 434
Y APE + + + SDV+S G+ ++EL TGR P
Sbjct: 169 ----YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 30/207 (14%)
Query: 243 GQLTDGRI---------VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293
G++ GR+ VA+K K FL+E ++ + H +++ L G +
Sbjct: 18 GEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-- 75
Query: 294 RGKRAMRLLVFEFMPNGNLRDCL---DG--VLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
+ K M +V E+M NG+L L DG +++ V + G A G++YL +
Sbjct: 76 KSKPVM--IVTEYMENGSLDAFLRKHDGQFTVIQ------LVGMLRGIASGMKYLSDMGY 127
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408
+HRD+ + NIL++ NL K++D G+++ L+ D P + + + + APE
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDD--PEAAYTTRGGKIPIRWTAPEAIA 182
Query: 409 VGRASLMSDVFSFGVVLLELIT-GRQP 434
+ + SDV+S+G+V+ E+++ G +P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 231 IVGQG--GSSYVYRGQLTDGRIVAVKRFK-TQGGPNADSVFLTEVDMLSRLHHCHVVPLV 287
++G+G G + +YR + D +V K T+ L E+ +LS L H +++
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNII--- 62
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLH 344
Y + F + L+ E+ G L D + G L E + + + Y+H
Sbjct: 63 AYYNHFMDDNTL-LIEMEYANGGTLYDKIVRQKGQLFEE---EMVLWYLFQIVSAVSYIH 118
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 404
+A ILHRDIK+ NI L + K+ D G++K L ++ S + GT Y +P
Sbjct: 119 KAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE-----YSMAETVVGTPYYMSP 170
Query: 405 EYAMVGRASLMSDVFSFGVVLLELIT 430
E + + SD+++ G VL EL+T
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 23/195 (11%)
Query: 250 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
+V VK + N S F E+DM +L H +VV L+G C E ++ E+
Sbjct: 37 LVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE----AEPHYMILEYTDL 92
Query: 310 GNLRDCL-------DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNIL 362
G+L+ L + + ++ +VA+ A G+++L A R +HRD+ + N L
Sbjct: 93 GDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCL 149
Query: 363 LDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGYFAPEYAMVGRASLMSDVFS 420
+ K++ L ++K + ++ P R + APE S SDV+S
Sbjct: 150 VSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR------WLAPEAVQEDDFSTKSDVWS 203
Query: 421 FGVVLLELIT-GRQP 434
FGV++ E+ T G P
Sbjct: 204 FGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 56/211 (26%), Positives = 85/211 (40%), Gaps = 30/211 (14%)
Query: 232 VGQGGSSYVYR-GQLTDGRIVAVKRF----KTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G V++ G VA+K+ G PN L E+ L H +VV L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPN---QALREIKALQACQHPYVVKL 64
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR----GLEY 342
+ F +LV E+MP+ L VL + A R G+ Y
Sbjct: 65 L---DVFPHGSGF-VLVMEYMPSD-----LSEVLRDEERPLPE-AQVKSYMRMLLKGVAY 114
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
+H I+HRD+K +N+L+ + KI D G+A+ + S A T Y
Sbjct: 115 MHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA----TRWYR 167
Query: 403 APEYAMVGRA-SLMSDVFSFGVVLLELITGR 432
APE R D+++ G + EL+ G
Sbjct: 168 APELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 232 VGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+G + V + GR VAVK+ + + +F EV ++ H ++V + Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-NEVVIMRDYQHPNIVEM--YS 83
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
S G +V EF+ G L D V MN + + + + L +LH A
Sbjct: 84 SYLVGDELW--VVMEFLEGGALTDI---VTHTRMNEEQIATVCLAVLKALSFLH---AQG 135
Query: 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQGTFGYFAPEYAM 408
++HRDIKS +ILL + K++D G ++ + P R + GT + APE +
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-------VPRRKSLVGTPYWMAPE--V 186
Query: 409 VGRASLMS--DVFSFGVVLLELITGRQP 434
+ R + D++S G++++E++ G P
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 230 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKT---QGGPNADSVFLTEVDMLSRLHHCHVVP 285
N +G+G VYR + T G IVA+K+ + + G S L E+ +L L H ++V
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--LREITLLLNLRHPNIVE 70
Query: 286 LVGYCSEFRGKRAMRL-LVFEFMPN--GNLRDCLDGVLVEGMNWDTRV-AIAIGAARGLE 341
L GK + LV E+ +L D + E ++V + + RGL+
Sbjct: 71 LKEVVV---GKHLDSIFLVMEYCEQDLASLLDNMPTPFSE-----SQVKCLMLQLLRGLQ 122
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
YLHE I+HRD+K SN+LL + KI D G+A+ GLP+ +P + T Y
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY---GLPAKPMTPKVV--TLWY 174
Query: 402 FAPEYAMVGRASLMS-DVFSFGVVLLELITGR 432
APE + + D+++ G +L EL+ +
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 68/234 (29%), Positives = 97/234 (41%), Gaps = 55/234 (23%)
Query: 233 GQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVF----LTEVDMLSRLHHCHVVPL- 286
G+G VY+ Q+ GR+VA+K+ N F L E+ +L +L H +VVPL
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILMH---NEKDGFPITALREIKILKKLKHPNVVPLI 73
Query: 287 ---VGYCSEFRGKRAMRLLVFEFM----------PNGNLRD----CLDGVLVEGMNWDTR 329
V + + KR +V +M P+ L + C L+EG+N
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN---- 129
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389
YLHE ILHRDIK++NIL+D KI D G+A R P+
Sbjct: 130 ------------YLHEN---HILHRDIKAANILIDNQGILKIADFGLA-RPYDGPPPNPK 173
Query: 390 SSPAR-------MQGTFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPI 435
+ T Y PE + R + D++ G V E+ T R PI
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 226 FSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHC 281
F+ +G G G+ Y R T +VA+K+ G + + + EV L +L H
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRT-NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 282 HVVPLVGYCSEFRG---KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 338
+ + E++G + LV E+ G+ D L+ V + + AI GA +
Sbjct: 76 NTI-------EYKGCYLREHTAWLVMEYCL-GSASDILE-VHKKPLQEVEIAAICHGALQ 126
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQG 397
GL YLH + +HRDIK+ NILL E K+ D G A + SPA G
Sbjct: 127 GLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLV----------SPANSFVG 173
Query: 398 TFGYFAPE--YAM-VGRASLMSDVFSFGVVLLELITGRQPI 435
T + APE AM G+ DV+S G+ +EL + P+
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G G V+ VAVK K G + FL E +++ L H +V L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351
+ ++ EFM G+L D L + + A G+ ++ +
Sbjct: 72 -----KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 123
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 409
+HRD++++NIL+ +L KI D G+A+ ++ + AR F + APE
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDN------EYTAREGAKFPIKWTAPEAINF 177
Query: 410 GRASLMSDVFSFGVVLLELIT-GRQP 434
G ++ SDV+SFG++L+E++T GR P
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 231 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNAD------SVFLTEVDMLSRLHHCHV 283
++GQG VY D GR +AVK + Q P + + E+ +L L H +
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVK--QVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 284 VPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGL 340
V G R L +F E MP G+++D L G L E + I G+
Sbjct: 67 VQYYGC---LRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGV 119
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-----ADGLPSCSSSPARM 395
YLH + I+HRDIK +NIL D N K+ D G +KRL+ G+ S + +P M
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+PE +D++S G ++E++T + P
Sbjct: 177 -------SPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 23/232 (9%)
Query: 226 FSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHH 280
F+ ++G+G V QL + VAVK K ++D FL E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 281 CHVVPLVGYC--SEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAI 334
+V+ L+G S +G+ + +++ FM +G+L L G + T V I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSS- 391
A G+EYL ++ +HRD+ + N +L+EN+ + D G++K++ + C+S
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 392 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
P + + A E + SDV++FGV + E++T Q + + E
Sbjct: 178 PVK------WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE 223
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 6e-13
Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 225 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
K++ +GQG S VY + G+ VA+++ Q P + + + E+ ++ + ++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPNI 79
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEY 342
V Y + + +V E++ G+L D V+ E M+ A+ + LE+
Sbjct: 80 V---NYLDSYLVGDEL-WVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEF 131
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
LH + +++HRDIKS NILL + + K+TD G ++ + S + M GT +
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTPYWM 183
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
APE D++S G++ +E+I G P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 8e-13
Identities = 52/159 (32%), Positives = 70/159 (44%), Gaps = 29/159 (18%)
Query: 302 LVFEFMPNGNLRDCL-DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 360
++ E+ G L L D L + + R IA EYLH I++RD+K N
Sbjct: 70 MLMEYCLGGELWTILRDRGLFD--EYTARFYIA-CVVLAFEYLHNRG---IIYRDLKPEN 123
Query: 361 ILLDENLNAKITDLGMAKRLKADGLPS---CSSSPARMQGTFGYFAPEYAMVGRASLMSD 417
+LLD N K+ D G AK+LK G + C GT Y APE + D
Sbjct: 124 LLLDSNGYVKLVDFGFAKKLK-SGQKTWTFC--------GTPEYVAPEIILNKGYDFSVD 174
Query: 418 VFSFGVVLLELITGRQP----------IHRSITKGEESL 446
+S G++L EL+TGR P I+ I KG L
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL 213
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 69/227 (30%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 231 IVGQGGSSYVYRGQLTD-GRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLH--HCH 282
I+G+GG VY + D G++ A+K R K + G +++ L E MLS + C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---ETLALNERIMLSLVSTGDCP 57
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGL 340
+ + Y K + + M G+L L GV E + R A GL
Sbjct: 58 FIVCMTYAFHTPDKLC---FILDLMNGGDLHYHLSQHGVFSEK---EMRF-YATEIILGL 110
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
E++H +++RD+K +NILLDE+ + +I+DLG+A P GT G
Sbjct: 111 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-------KKKPHASVGTHG 160
Query: 401 YFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIHRSITKGEESL 446
Y APE G A S D FS G +L +L+ G P + TK + +
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 26/201 (12%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 310
VA+K K + + + E +++ +L + ++V ++G C + +LV E G
Sbjct: 25 VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-----EAEALMLVMEMASGG 79
Query: 311 NLRDCL----DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366
L L D + V + V + + G++YL +HRD+ + N+LL
Sbjct: 80 PLNKFLSGKKDEITVSNV-----VELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQ 131
Query: 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMVGRASLMSDVFSFGVV 424
AKI+D G++K L AD S AR G + ++APE + S SDV+S+G+
Sbjct: 132 HYAKISDFGLSKALGADD----SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGIT 187
Query: 425 LLELIT-GRQPIHRSITKGEE 444
+ E + G++P + KG E
Sbjct: 188 MWEAFSYGQKPYKK--MKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 63/240 (26%), Positives = 98/240 (40%), Gaps = 47/240 (19%)
Query: 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDML 275
L T F ++G+G VY+ + G++VA+K D E ++L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNIL 56
Query: 276 SRL-HHCHVVPLVG--YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGM----NWDT 328
+ +H ++ G G LV E G++ D + G+ +G W
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-- 114
Query: 329 RVA-IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP- 386
+A I RGL YLHE +++HRDIK NILL +N K+ D G++ +L +
Sbjct: 115 -IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170
Query: 387 -SCSSSPARMQGTFGYFAPE-----------YAMVGRASLMSDVFSFGVVLLELITGRQP 434
+ +P M APE Y SDV+S G+ +EL G+ P
Sbjct: 171 NTFIGTPYWM-------APEVIACDEQPDASYDA------RSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG-Y 289
VG G VY+ + L G + AVK K + G + S+ E+ M+ HC++V G Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF-SLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA-IAIGAARGLEYLHEAAA 348
S R + E+ G+L+D V G + ++A + +GL YLH
Sbjct: 76 LS-----REKLWICMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408
+HRDIK +NILL +N + K+ D G+A ++ A + GT + APE A
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVAAKITA-----TIAKRKSFIGTPYWMAPEVAA 179
Query: 409 V---GRASLMSDVFSFGVVLLELITGRQPI 435
V G + + D+++ G+ +EL + P+
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 226 FSGSNIVGQGGSSYVYRGQL-TDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLH 279
F ++G+GG V Q+ G++ A K R K + G +++ L E +L +++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG---EAMALNEKRILEKVN 58
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339
VV L Y E K A+ LV M G+L+ + + G + + A G
Sbjct: 59 SRFVVSL-AYAYE--TKDAL-CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG 114
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
LE L RI++RD+K NILLD+ + +I+DLG+A + +P + R+ GT
Sbjct: 115 LEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQ-----IPEGETVRGRV-GTV 165
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437
GY APE + + D + G ++ E+I G+ P +
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
++G+G VYRG + GR+VA+K + S EV +LS+L + Y
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 290 C-SEFRGKRAMRLLVFEFMPNGNLRD-----CLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
S +G R ++ E+ G++R + + + + VA L+Y+
Sbjct: 68 YGSYLKGPRLW--IIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA--------LKYI 117
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
H+ ++HRDIK++NIL+ N K+ D G+A L SS + GT + A
Sbjct: 118 HKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN-----QNSSKRSTFVGTPYWMA 169
Query: 404 PEYAMVGRA-SLMSDVFSFGVVLLELITGRQP 434
PE G+ +D++S G+ + E+ TG P
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 55/212 (25%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 225 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
K++ +GQG S VY + G+ VA+K+ Q P + + + E+ ++ + ++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKE-LIINEILVMRENKNPNI 78
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEY 342
V Y + + +V E++ G+L D V+ E M+ A+ + L++
Sbjct: 79 V---NYLDSYLVGDEL-WVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALDF 130
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
LH + +++HRDIKS NILL + + K+TD G ++ + S + M GT +
Sbjct: 131 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTPYWM 182
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
APE D++S G++ +E++ G P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 231 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADS----VFLTEVDMLSRLHHCHVVP 285
++G+G VY D GR +AVK+ S E+ +L L H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 286 LVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLEY 342
G C R +L +F E+MP G+++D L G L E N R I +G+ Y
Sbjct: 69 YYG-C--LRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE--NVTRRYTRQI--LQGVSY 121
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-----ADGLPSCSSSPARMQG 397
LH + I+HRDIK +NIL D N K+ D G +KR++ G+ S + +P M
Sbjct: 122 LH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM-- 176
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+PE +DV+S ++E++T + P
Sbjct: 177 -----SPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 225 KFSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHC 281
K+ +VG+G G ++ R D ++V +K+ + + E +L L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
+++ Y F +A+ ++V E+ P G L + + ++ DT + + L
Sbjct: 60 NII---EYYENFLEDKAL-MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLN-AKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
++H ILHRD+K+ NILLD++ KI D G++K L S S + GT
Sbjct: 116 HVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL------SSKSKAYTVVGTPC 166
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELIT 430
Y +PE + SD+++ G VL EL +
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 20/106 (18%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+Y+H A ++HRD+K SN+L++E+ +I D GMA+ L SSSP +
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL--------SSSPTEHKY 166
Query: 398 -------TFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPI 435
T Y APE + + D++S G + E++ GR+ +
Sbjct: 167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 41/225 (18%)
Query: 230 NIVGQ-GGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
I+G+ G ++ VY+ Q G A K + + + F+ E+D+LS H ++V
Sbjct: 8 EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED-FMVEIDILSECKHPNIVG 66
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVE---GMNWDTRVAIAIGAARGLEY 342
L + K + + EF G LD +++E G+ + L +
Sbjct: 67 LYEAYF-YENKLWILI---EFCDGG----ALDSIMLELERGLTEPQIRYVCRQMLEALNF 118
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ------ 396
LH +++HRD+K+ NILL + + K+ D G++ + K+ +Q
Sbjct: 119 LHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-----------LQKRDTFI 164
Query: 397 GTFGYFAPEYAMVGRAS-----LMSDVFSFGVVLLELITGRQPIH 436
GT + APE +D++S G+ L+EL P H
Sbjct: 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 29/197 (14%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
VAVK K S ++E++M+ + H +++ L+G C++ ++ E+
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ----DGPLYVIVEYASK 105
Query: 310 GNLRDCLDG--------------VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 355
GNLR+ L V E M + V+ ARG+EYL A+ + +HRD
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRD 162
Query: 356 IKSSNILLDENLNAKITDLGMAKRL-KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-S 413
+ + N+L+ EN KI D G+A+ + D ++ ++ + APE A+ R +
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK----WMAPE-ALFDRVYT 217
Query: 414 LMSDVFSFGVVLLELIT 430
SDV+SFGV++ E+ T
Sbjct: 218 HQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 69/238 (28%), Positives = 99/238 (41%), Gaps = 41/238 (17%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQLTD---GRI---VAVKRFKTQGGPNADSVFLTEVD 273
E + +K + +GQG VY G D G VAVK FL E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR---- 329
++ HVV L+G S K L+V E M +G+L+ L + E N R
Sbjct: 62 VMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117
Query: 330 ----VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK------- 378
+ +A A G+ YL+ A + +HRD+ + N ++ + KI D GM +
Sbjct: 118 LQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174
Query: 379 -RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
R GL P R + APE G + SD++SFGVVL E+ + QP
Sbjct: 175 YRKGGKGL-----LPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 29/197 (14%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
VAVK K S ++E++M+ + H +++ L+G C++ + +LV E+
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLYVLV-EYASK 102
Query: 310 GNLRDCLDGVLVEGMNW--DT------------RVAIAIGAARGLEYLHEAAAPRILHRD 355
GNLR+ L GM++ DT V+ A ARG+EYL A+ + +HRD
Sbjct: 103 GNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRD 159
Query: 356 IKSSNILLDENLNAKITDLGMAKRL-KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-S 413
+ + N+L+ E+ KI D G+A+ + D ++ ++ + APE A+ R +
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK----WMAPE-ALFDRVYT 214
Query: 414 LMSDVFSFGVVLLELIT 430
SDV+SFGV+L E+ T
Sbjct: 215 HQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 231 IVGQGGSSYVYRG---QLTDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G VY+G + +I VAVK K P+ FL E ++ + H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
+G +E +V E P G LR L V ++ + + + + L YL
Sbjct: 73 IGVITE-----NPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLE-- 124
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+ R +HRDI + N+L+ K+ D G+++ L+ + S ++ + APE
Sbjct: 125 -SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK----WMAPES 179
Query: 407 AMVGRASLMSDVFSFGVVLLE-LITGRQPIH 436
R + SDV+ FGV + E L+ G +P
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 33/203 (16%)
Query: 249 RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308
+VAVK + NA FL EV +LSRL ++ L+G C+ ++ E+M
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDP----PLCMIMEYME 102
Query: 309 NGNL------RDCLDGVLVEGMN---WDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359
NG+L L + T + +A A G+ YL +HRD+ +
Sbjct: 103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159
Query: 360 NILLDENLNAKITDLGMAKRL------KADGLPSCSSSPARMQGTFGYFAPEYAMVGRAS 413
N L+ +N KI D GM++ L + G P R + A E ++G+ +
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPL---PIR------WMAWESVLLGKFT 210
Query: 414 LMSDVFSFGVVLLELIT--GRQP 434
SDV++FGV L E++T QP
Sbjct: 211 TKSDVWAFGVTLWEILTLCREQP 233
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 61/237 (25%), Positives = 95/237 (40%), Gaps = 48/237 (20%)
Query: 231 IVGQGGSSYVYRGQL----TDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVV 284
++G+G V L G++ A+K + + + E D+L+ +V
Sbjct: 8 VIGRGAFGEV---WLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIA-IGAARGLE 341
L Y S F+ + + LV E+MP G+L + L V E R IA + A L+
Sbjct: 65 KL--YYS-FQDEEHL-YLVMEYMPGGDLMNLLIRKDVFPEET---ARFYIAELVLA--LD 115
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG----------------- 384
+H+ +HRDIK NIL+D + + K+ D G+ K++
Sbjct: 116 SVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 385 -LPSCSSSPARMQ------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
L R GT Y APE L D +S GV+L E++ G P
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 68/239 (28%), Positives = 103/239 (43%), Gaps = 43/239 (17%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRI-------VAVKRFKTQGGPNADSVFLTEV 272
E A +K + S +GQG VY G + G + VA+K FL E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 273 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR--- 329
++ + HVV L+G S+ + L++ E M G+L+ L + E N +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPT----LVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116
Query: 330 -----VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK------ 378
+ +A A G+ YL+ A + +HRD+ + N ++ E+ KI D GM +
Sbjct: 117 SLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173
Query: 379 --RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
R GL P R + +PE G + SDV+SFGVVL E+ T QP
Sbjct: 174 YYRKGGKGL-----LPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 70/228 (30%), Positives = 100/228 (43%), Gaps = 33/228 (14%)
Query: 224 DKFSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLH 279
F ++VG+G G V R + T G I A+K K S F E D+LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLLAQETVSFFEEERDILSI-S 58
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMN--WDTRVAIAI 334
+ +P + Y F+ K + LV E+ P G+L L + E M + + +AI
Sbjct: 59 NSPWIPQLQYA--FQDKDNL-YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAI 115
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
+ + Y+H RDIK N+L+D + K+ D G A RL A+ + + S P
Sbjct: 116 HSVHQMGYVH---------RDIKPENVLIDRTGHIKLADFGSAARLTANKMVN-SKLPV- 164
Query: 395 MQGTFGYFAPEY--AMVGRASLMSDV----FSFGVVLLELITGRQPIH 436
GT Y APE M G V +S GV+ E+I GR P H
Sbjct: 165 --GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 8e-12
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G G V+ G+ VA+K G ++ F+ E ++ +L H +V L G C+
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE--GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
+ + +V EFM NG L + L G L + D +++ G+EYL +
Sbjct: 70 Q----QKPLYIVTEFMENGCLLNYLRQRQGKLSK----DMLLSMCQDVCEGMEYLERNS- 120
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408
+HRD+ + N L+ K++D GM + + D SSS A+ + PE
Sbjct: 121 --FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD--EYTSSSGAKF--PVKWSPPEVFN 174
Query: 409 VGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438
+ S SDV+SFGV++ E+ T G+ P +
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 64/241 (26%), Positives = 110/241 (45%), Gaps = 26/241 (10%)
Query: 232 VGQGGSSYV-YRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+G + V + G+ VAVK+ + + +F EV ++ HH +VV + Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHENVVDM--YN 86
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
S G +V EF+ G L D V MN + + + R L YLH
Sbjct: 87 SYLVGDELW--VVMEFLEGGALTDI---VTHTRMNEEQIATVCLSVLRALSYLHNQG--- 138
Query: 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQGTFGYFAPEYAM 408
++HRDIKS +ILL + K++D G ++ + P R + GT + APE
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE-------VPKRKSLVGTPYWMAPEVIS 191
Query: 409 VGRASLMSDVFSFGVVLLELITGR-----QPIHRSITKGEESLVLWVKSIITDASICQSF 463
D++S G++++E+I G +P +++ + ++L VK +S+ + F
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGF 251
Query: 464 L 464
L
Sbjct: 252 L 252
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 8e-12
Identities = 64/228 (28%), Positives = 93/228 (40%), Gaps = 41/228 (17%)
Query: 230 NIVGQGGSSYVYRGQLTDGRI------VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+G G VY G VAVK +S FL E ++S+ +H ++
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR---------VAIAI 334
V L+G E R R ++ E M G+L+ L E R + A
Sbjct: 72 VRLIGVSFE----RLPRFILLELMAGGDLKS----FLRENRPRPERPSSLTMKDLLFCAR 123
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAKRLKADGLPSCSSS 391
A+G +YL E +HRDI + N LL AKI D GMA+ + +S
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY-------RAS 173
Query: 392 PARMQGT----FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
R G + PE + G + +DV+SFGV+L E+ + G P
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 232 VGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+G + V + + G++VAVK+ + + +F EV ++ H +VV + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEM--YN 84
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
S G +V EF+ G L D V MN + A+ + + L LH A
Sbjct: 85 SYLVGDELW--VVMEFLEGGALTDI---VTHTRMNEEQIAAVCLAVLKALSVLH---AQG 136
Query: 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG 410
++HRDIKS +ILL + K++D G ++ + +P S + GT + APE ++
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKS----LVGTPYWMAPE--LIS 189
Query: 411 RASLMS--DVFSFGVVLLELITGRQP 434
R D++S G++++E++ G P
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 40/109 (36%), Positives = 56/109 (51%), Gaps = 15/109 (13%)
Query: 331 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 390
IA+ + L YL E +I+HRD+K SNILLD N N K+ D G++ +L
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV--------D 160
Query: 391 SPARMQ--GTFGYFAPEYAMVGRAS---LMSDVFSFGVVLLELITGRQP 434
S A+ + G Y APE + SDV+S G+ L E+ TG+ P
Sbjct: 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 67/238 (28%), Positives = 98/238 (41%), Gaps = 58/238 (24%)
Query: 232 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVD-------MLSRLHHCHV 283
+G G V + G+ A+K V L +V+ +L + H
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKA-----KIVKLKQVEHVLNEKRILQSIRH--- 60
Query: 284 VP-LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIA-IGAARG 339
P LV F+ + LV E++P G L L G E + R A + A
Sbjct: 61 -PFLVNLYGSFQDDSNL-YLVMEYVPGGELFSHLRKSGRFPEPV---ARFYAAQVVLA-- 113
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
LEYLH I++RD+K N+LLD + KITD G AKR+K C GT
Sbjct: 114 LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC--------GTP 162
Query: 400 GYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
Y APE Y G+A D ++ G+++ E++ G P I+ I +G+
Sbjct: 163 EYLAPEIILSKGY---GKA---VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 43/217 (19%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGY 289
+G G VY + G +VA+K+ K + + + L EV L +L H ++V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK-- 64
Query: 290 CSE-FRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR--------G 339
E FR L VFE+M GNL M + R G
Sbjct: 65 --EVFREND--ELYFVFEYM-EGNLYQL--------MKDRKGKPFSESVIRSIIYQILQG 111
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP-ARMQGT 398
L ++H+ HRD+K N+L+ KI D G+A+ ++ S P T
Sbjct: 112 LAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIR-------SRPPYTDYVST 161
Query: 399 FGYFAPEYAMVGRASLMS---DVFSFGVVLLELITGR 432
Y APE ++ R++ S D+++ G ++ EL T R
Sbjct: 162 RWYRAPE--ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 66/224 (29%), Positives = 111/224 (49%), Gaps = 26/224 (11%)
Query: 232 VGQGGSSYVYRG--QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+G+G + V++G +LT +VA+K + + A + EV +L L H ++V L
Sbjct: 13 LGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAI-GAARGLEYLHEA 346
+R + L VFE++ + +L+ LD G L+ N V I + RGL Y H+
Sbjct: 72 ---IHTERCLTL-VFEYLDS-DLKQYLDNCGNLMSMHN----VKIFMFQLLRGLSYCHKR 122
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+ILHRD+K N+L++E K+ D G+A +A +P+ + S + T Y P+
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLA---RAKSVPTKTYSNEVV--TLWYRPPD- 173
Query: 407 AMVGRASLMS--DVFSFGVVLLELITGRQPIHRSITKGEESLVL 448
++G + D++ G +L E+ TGR S K E L+
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 33/195 (16%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 310
VA+K + + G + + L H ++V L+G C A LV + P G
Sbjct: 39 VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-----ASLQLVTQLSPLG 93
Query: 311 NL-------RDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 363
+L RD LD + +NW ++A +G+ YL E R++HR++ + NILL
Sbjct: 94 SLLDHVRQHRDSLDPQRL--LNWCVQIA------KGMYYLEEH---RMVHRNLAARNILL 142
Query: 364 DENLNAKITDLGMAKRLKADG---LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFS 420
+ +I D G+A L D S +P + + A E + GR + SDV+S
Sbjct: 143 KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK------WMALESILFGRYTHQSDVWS 196
Query: 421 FGVVLLELIT-GRQP 434
+GV + E+++ G +P
Sbjct: 197 YGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 58/184 (31%), Positives = 90/184 (48%), Gaps = 20/184 (10%)
Query: 271 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV 330
E D+L+ ++H +V L Y + GK L+ +F+ G+L L E M + V
Sbjct: 48 ERDILAEVNHPFIVKL-HYAFQTEGKL---YLILDFLRGGDLFTRLSK---EVMFTEEDV 100
Query: 331 AIAIGA-ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389
+ A L++LH I++RD+K NILLDE + K+TD G++K D
Sbjct: 101 KFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAY 156
Query: 390 SSPARMQGTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447
S GT Y APE +V R + +D +SFGV++ E++TG P K +++
Sbjct: 157 S----FCGTVEYMAPE--VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
Query: 448 LWVK 451
L K
Sbjct: 211 LKAK 214
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 42/222 (18%)
Query: 231 IVGQGGSSYVYRG-QLTDG---RI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
++G G VY+G + DG +I VA+K + P A+ L E +++ + +V
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNL----RDCLDGVLVEGM-NWDTRVAIAIGAARGL 340
L+G C + LV + MP G L R+ D + + + NW ++A +G+
Sbjct: 74 LLGICLT-----STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIA------KGM 122
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-------ADGLPSCSSSPA 393
YL E R++HRD+ + N+L+ + KITD G+A+ L ADG P
Sbjct: 123 SYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG----GKVPI 175
Query: 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ + A E + R + SDV+S+GV + EL+T G +P
Sbjct: 176 K------WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G G VY+ + + G + A+K K + G + V E+ M+ H ++V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFA-VVQQEIIMMKDCKHSNIVAYFG-- 73
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA-IAIGAARGLEYLHEAAAP 349
S R R + EF G+L+D V G ++++A ++ +GL YLH
Sbjct: 74 SYLR--RDKLWICMEFCGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKGK- 127
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 409
+HRDIK +NILL +N + K+ D G++ ++ A + GT + APE A V
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITA-----TIAKRKSFIGTPYWMAPEVAAV 180
Query: 410 GRA---SLMSDVFSFGVVLLELITGRQPI 435
R + + D+++ G+ +EL + P+
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 46/142 (32%), Positives = 67/142 (47%), Gaps = 32/142 (22%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS---CSSSPARM 395
GL++LHE I++RD+K N+LLD + KI D GM K G+ + C
Sbjct: 108 GLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC------- 157
Query: 396 QGTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL------ 446
GT Y APE Y G A D ++ GV+L E++ G+ P E+ L
Sbjct: 158 -GTPDYIAPEILSYQPYGPA---VDWWALGVLLYEMLAGQSPFE---GDDEDELFQSILE 210
Query: 447 --VLWVKSIITDA-SICQSFLV 465
V + + + +A SI +SFL
Sbjct: 211 DEVRYPRWLSKEAKSILKSFLT 232
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 39/222 (17%)
Query: 223 TDKFSGSNIVGQGGSSYV--YRGQLTDGRIVAVKR----FKTQGGPNADSVFLTEVDMLS 276
T+++ VG G V R QLT G+ VA+K+ F T A + E+ +L
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPV--LAKRTY-RELKLLK 64
Query: 277 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAI 334
L H +++ L F V E + R L+ + +
Sbjct: 65 HLRHENIISL---SDIFISPLEDIYFVTELLGTDLHR------LLTSRPLEKQFIQYFLY 115
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
RGL+Y+H A ++HRD+K SNIL++EN + KI D G+A+ +
Sbjct: 116 QILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR-----------IQDPQ 161
Query: 395 MQG---TFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGR 432
M G T Y APE + + + D++S G + E++ G+
Sbjct: 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 27/196 (13%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
VAVK K + ++E++++ + H +++ L+G C++ ++ E+
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ----EGPLYVIVEYAAK 102
Query: 310 GNLRDCL------------DGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 355
GNLR+ L D V E +++ V+ A ARG+EYL + R +HRD
Sbjct: 103 GNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRD 159
Query: 356 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SL 414
+ + N+L+ E+ KI D G+A+ + +S R+ + APE A+ R +
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRL--PVKWMAPE-ALFDRVYTH 215
Query: 415 MSDVFSFGVVLLELIT 430
SDV+SFG+++ E+ T
Sbjct: 216 QSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 232 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G G VY+ + + G + A K +T+ + ++ E+++L+ +H ++V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YMVEIEILATCNHPYIVKLLG-A 77
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
+ GK ++ EF P G +D +++E T I + + LE L + +
Sbjct: 78 FYWDGKLW---IMIEFCPGG----AVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 351 ILHRDIKSSNILLDENLNAKITDLGM-AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 409
I+HRD+K+ N+LL + + K+ D G+ AK +K L S GT + APE M
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRRDS----FIGTPYWMAPEVVMC 184
Query: 410 GRAS-----LMSDVFSFGVVLLELITGRQPIH 436
+D++S G+ L+E+ P H
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 216
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 25/219 (11%)
Query: 232 VGQGGSSYVYRG--QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+G+G + VY+G +LTD +VA+K + + A + EV +L L H ++V L
Sbjct: 14 LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL--- 69
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
+ LVFE++ + +L+ LD G + N + + RGL Y H
Sbjct: 70 -HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLL---RGLNYCHRR- 123
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 407
++LHRD+K N+L++E K+ D G+A +A +P+ + S + T Y P+
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLA---RAKSIPTKTYSNEVV--TLWYRPPD-I 175
Query: 408 MVGRA--SLMSDVFSFGVVLLELITGRQPIHRSITKGEE 444
++G S D++ G + E+ TGR P+ T E+
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 3e-11
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 19/219 (8%)
Query: 226 FSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHV 283
F +VG G VY+G+ + G++ A+K G + + E++ML + HH ++
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNI 65
Query: 284 VPLVGYCSEFR--GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
G + G LV EF G++ D + + + I RGL
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
+LH+ +++HRDIK N+LL EN K+ D G++ +L GT +
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-----RTVGRRNTFIGTPYW 177
Query: 402 FAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPI 435
APE SD++S G+ +E+ G P+
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 46/140 (32%), Positives = 69/140 (49%), Gaps = 26/140 (18%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
A GL +LH I++RD+K N++LD + KI D GM K G + +
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-----FC 162
Query: 397 GTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEES 445
GT Y APE Y G++ D ++FGV+L E++ G+ P + +SI E
Sbjct: 163 GTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM---EH 216
Query: 446 LVLWVKSIITDA-SICQSFL 464
V + KS+ +A SIC+ L
Sbjct: 217 NVSYPKSLSKEAVSICKGLL 236
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 33/217 (15%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G VY+G+ G+IVA+K+ + +G P S + E+ +L L H ++V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVP---STAIREISLLKELQHPNIVCL 64
Query: 287 VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRV-AIAIGAARGLEYLH 344
+ RL L+FEF+ + +L+ LD + V + +G+ + H
Sbjct: 65 QDVLMQ-----ESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFG 400
+ R+LHRD+K N+L+D K+ D G+A +A G+ P R+ T
Sbjct: 119 ---SRRVLHRDLKPQNLLIDNKGVIKLADFGLA---RAFGI------PVRVYTHEVVTLW 166
Query: 401 YFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIH 436
Y APE + R S D++S G + E+ T + H
Sbjct: 167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 50/217 (23%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 231 IVGQGGSSYVYRGQLTDGRIVAVKRFK--TQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
++ + + +Y+G + + V ++ FK +G + E+ L R+ +++ + G
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AA 347
+ + L+ E+ G LR+ LD + +++ T++ +AI +GL L++
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYKYTN 143
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 407
P ++++ S + L+ EN KI G+ K L SS P + YF+ +
Sbjct: 144 KP---YKNLTSVSFLVTENYKLKIICHGLEKIL--------SSPPFKNVNFMVYFSYKML 192
Query: 408 --MVGRASLMSDVFSFGVVLLELITGRQPIHRSITKG 442
+ ++ D++S GVVL E+ TG+ P TK
Sbjct: 193 NDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE 229
|
Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 26/228 (11%)
Query: 221 HATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDML 275
K+ +GQG V++ + +IVA+K+ + N F L E+ +L
Sbjct: 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME---NEKEGFPITALREIKIL 65
Query: 276 SRLHHCHVVPLVGYC----SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 331
L H +VV L+ C + + + LVFEF + +L L V+
Sbjct: 66 QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVK-FTLSEIKK 123
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 391
+ GL Y+H +ILHRD+K++NIL+ ++ K+ D G+A+ S +S
Sbjct: 124 VMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSL----SKNSK 176
Query: 392 PARMQG---TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPI 435
P R T Y PE + R D++ G ++ E+ T R PI
Sbjct: 177 PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 226 FSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCH 282
F G + +G G VY +VAVK+ G + + EV L +L H +
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 283 VVPLVGYCSEFRG---KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339
+ E++G K LV E+ G+ D L+ V + + AI GA +G
Sbjct: 83 TI-------EYKGCYLKEHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIAAITHGALQG 133
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGT 398
L YLH ++HRDIK+ NILL E K+ D G A + SSPA GT
Sbjct: 134 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK----------SSPANSFVGT 180
Query: 399 FGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPI 435
+ APE + G+ DV+S G+ +EL + P+
Sbjct: 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 231 IVGQGGSSYVYRG--QLTDGR--IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
I+G G + RG +L R VA+ + FL E L + H ++V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 343
G + RG M +V E+M NG L L +G LV G + G A G++YL
Sbjct: 72 EGVIT--RGNTMM--IVTEYMSNGALDSFLRKHEGQLVAGQLMG----MLPGLASGMKYL 123
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS--SPARMQGTFGY 401
E +H+ + + +L++ +L KI+ + K++ + + S SP +
Sbjct: 124 SEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL------W 174
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
APE S SDV+SFG+V+ E+++ G +P
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 4e-11
Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 12/99 (12%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+YLH A ++HRD+K SNIL++ N + KI D G+A+ + D +
Sbjct: 114 RGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE-----DEKGFLTE 165
Query: 398 ---TFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGR 432
T Y APE + R + D++S G + EL+T +
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKT----QGGPNADSVFLTEVDMLSRL 278
D + +G+G VY+ + G++VA+K+ + +G P L E+ +L L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIP---PTALREISLLQML 57
Query: 279 HHC-HVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGV---LVEGMNWDTRVAI 332
++V L V + E GK LVFE++ + +L+ +D + T +
Sbjct: 58 SESIYIVRLLDVEHVEEKNGK-PSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPSCSSS 391
+G+ + H+ ++HRD+K N+L+D+ KI DLG+ +A +P S +
Sbjct: 116 MYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG---RAFSIPVKSYT 169
Query: 392 PARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPI 435
+ T Y APE + S D++S G + E+ +QP+
Sbjct: 170 HEIV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 226 FSGSNIVGQGGSSYVYRGQLTDGR---IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
F+ +G+G VY+G D R +VA+K + + E+ +LS+ +
Sbjct: 6 FTKLERIGKGSFGEVYKG--IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA-RGLE 341
+ G S +G + ++ E++ G+ D L +E +T +A + +GL+
Sbjct: 64 ITRYYG--SYLKGTKLW--IIMEYLGGGSALDLLKPGPLE----ETYIATILREILKGLD 115
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
YLH + R +HRDIK++N+LL E + K+ D G+A +L + + GT +
Sbjct: 116 YLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-----FVGTPFW 167
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
APE +D++S G+ +EL G P
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 233 GQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 292
G GS Y + T G +A+K + + + + + E+D+L H V P Y +
Sbjct: 12 GNYGSVYKVLHRPT-GVTMAMKEIRLELDESKFNQIIMELDIL---HKA-VSP---YIVD 63
Query: 293 FRGKRAMRLLVF---EFMPNGNLRDCLDG-VLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
F G + V+ E+M G+L G V EG+ D I +GL++L E
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH- 122
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGYFAPEYA 407
I+HRD+K +N+L++ N K+ D G++ L A S A+ G Y APE
Sbjct: 123 -NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--------SLAKTNIGCQSYMAPERI 173
Query: 408 MVGRA------SLMSDVFSFGVVLLELITGRQP 434
G ++ SDV+S G+ +LE+ GR P
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 29/216 (13%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G S VYR L DG VA+K+ + AD + E+D+L +L+H +V+
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI--KEIDLLKQLNHPNVIK- 66
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDG------VLVEGMNWDTRVAIAIGAARGL 340
Y + F + + V E G+L + ++ E W V + L
Sbjct: 67 --YYASFIEDNELNI-VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SAL 119
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
E++H + R++HRDIK +N+ + K+ DLG+ + S +++ + GT
Sbjct: 120 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-----SKTTAAHSLVGTPY 171
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
Y +PE + SD++S G +L E+ + P +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 25/231 (10%)
Query: 217 SALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDML 275
SAL F +VG G VY+G+ + G++ A+K + + E++ML
Sbjct: 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINML 66
Query: 276 SRL-HHCHVVPLVGYCSEFR--GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 332
+ HH ++ G + G LV EF G++ D + + D I
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI 126
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 392
RGL +LH A +++HRDIK N+LL EN K+ D G++ +L +
Sbjct: 127 CREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--------DRTV 175
Query: 393 ARMQ---GTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPI 435
R GT + APE SD++S G+ +E+ G P+
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 28/232 (12%)
Query: 218 ALEHATDKFSGSNIVGQGGSSYVYR-GQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLS 276
+L TD + +G+G VY+ DG + AVK + D E ++L
Sbjct: 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQ 73
Query: 277 RL-HHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--I 332
L +H +VV G + +L LV E G++ + + G+L+ G D + I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 392
GA GL++LH RI+HRD+K +NILL K+ D G++ +L + L +S
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV- 189
Query: 393 ARMQGTFGYFAPE---------YAMVGRASLMSDVFSFGVVLLELITGRQPI 435
GT + APE Y+ R DV+S G+ +EL G P+
Sbjct: 190 ----GTPFWMAPEVIACEQQYDYSYDARC----DVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 46/181 (25%), Positives = 87/181 (48%), Gaps = 11/181 (6%)
Query: 251 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309
VAVK K + ++E+ ++S L +H ++V L+G C+ L++ E+
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT----IGGPILVITEYCCY 123
Query: 310 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 369
G+L + L + + ++ + A+G+ +L A+ +HRD+ + N+LL
Sbjct: 124 GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIV 180
Query: 370 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 429
KI D G+A+ + D AR+ + APE + SDV+S+G++L E+
Sbjct: 181 KICDFGLARDIMNDS-NYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGILLWEIF 237
Query: 430 T 430
+
Sbjct: 238 S 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 232 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVG 288
VGQGG V+ + D G IVA+KR K + V LTE D+L+ +V L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAI-----AIGAARGLE 341
Y F+ + L E++P G+ R L+ GVL E R + A+ A
Sbjct: 68 Y--AFQDDEYL-YLAMEYVPGGDFRTLLNNLGVLSED---HARFYMAEMFEAVDA----- 116
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
LHE +HRD+K N L+D + + K+TD G++K G+ + ++S + G+ Y
Sbjct: 117 -LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANS---VVGSPDY 164
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
APE D +S G +L E + G P
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 36/98 (36%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
GL++LH I++RD+K NILLD + + KI D GM K +C+ GT
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-----FCGT 159
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
Y APE + + + D +SFGV+L E++ G+ P H
Sbjct: 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 9e-11
Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 24/170 (14%)
Query: 271 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNL----RDCLDGVLVEGM-- 324
E +L+++ H ++V + F + +V E+ G+L + + E
Sbjct: 48 EAVLLAKMKHPNIV---AFKESFEADGHL-YIVMEYCDGGDLMQKIKLQRGKLFPEDTIL 103
Query: 325 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384
W ++ + G++++HE R+LHRDIKS NI L +N K+ D G A+ L + G
Sbjct: 104 QWFVQMCL------GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154
Query: 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+C+ GT Y PE + SD++S G +L EL T + P
Sbjct: 155 AYACT-----YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 21/174 (12%)
Query: 268 FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL--VFEFMPNGNLRDCL--DGVLVEG 323
F E + +RL+H ++V L+ G+ LL VFE++P LR+ L DG L G
Sbjct: 25 FRRETALCARLYHPNIVALLD-----SGEAPPGLLFAVFEYVPGRTLREVLAADGALPAG 79
Query: 324 MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRL 380
+ + L H I+HRD+K NI++ +AK+ D G+ L
Sbjct: 80 ----ETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL 132
Query: 381 KA--DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
D + + + GT Y APE + SD++++G++ LE +TG+
Sbjct: 133 PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 26/183 (14%)
Query: 271 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLV---EGM 324
E +LS+L H ++V Y + G+ + +V F G+L L G L+ + +
Sbjct: 49 EAQLLSQLKHPNIV---AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVV 105
Query: 325 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384
W ++A+A L+YLHE ILHRD+K+ N+ L K+ DLG+A+ L+
Sbjct: 106 EWFVQIAMA------LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE--- 153
Query: 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 444
+ + + GT Y +PE + SDV++ G + E+ T + H K
Sbjct: 154 --NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK---HAFNAKDMN 208
Query: 445 SLV 447
SLV
Sbjct: 209 SLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 38/103 (36%), Positives = 53/103 (51%), Gaps = 26/103 (25%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+Y+H A I+HRD+K SNI ++E+ KI D G+A R D M G
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA-RHTDD----------EMTG 174
Query: 398 ---TFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGR 432
T Y APE M+ M D++S G ++ EL+TG+
Sbjct: 175 YVATRWYRAPE-IMLNW---MHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 2e-10
Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 32/220 (14%)
Query: 226 FSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHC 281
F+ +G G G+ Y R T+ +VA+K+ G + + + EV L R+ H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP 85
Query: 282 HVVPLVGYCSEFRG---KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 338
+ + E++G + LV E+ G+ D L+ V + + AI GA +
Sbjct: 86 NSI-------EYKGCYLREHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIAAITHGALQ 136
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
GL YLH + ++HRDIK+ NILL E K+ D G A S +S GT
Sbjct: 137 GLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSA---------SIASPANSFVGT 184
Query: 399 FGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPI 435
+ APE + G+ DV+S G+ +EL + P+
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 56/222 (25%), Positives = 107/222 (48%), Gaps = 33/222 (14%)
Query: 225 KFSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHC 281
++ +G+G G Y+ + + +D +K P + EV +L+++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLVEG---MNWDTRVAIAIG 335
++V + + F+ + +V E+ G+L ++ GVL ++W ++++
Sbjct: 60 NIV---TFFASFQENGRL-FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL--- 112
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLK--ADGLPSCSSSP 392
GL+++H+ +ILHRDIKS NI L +N + AK+ D G+A++L + +C +P
Sbjct: 113 ---GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTP 166
Query: 393 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
Y +PE + +D++S G VL EL T + P
Sbjct: 167 Y-------YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 226 FSGSNIVGQGGSSYVYRGQLTDGR---IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
F+ +G+G V++G D R +VA+K + + E+ +LS+ +
Sbjct: 6 FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
V G S +G + ++ E++ G+ D L + T + + +GL+Y
Sbjct: 64 VTKYYG--SYLKGTKLW--IIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDY 116
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
LH + + +HRDIK++N+LL E + K+ D G+A +L + + GT +
Sbjct: 117 LH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-----FVGTPFWM 168
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
APE +D++S G+ +EL G P
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 2e-10
Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 24/214 (11%)
Query: 226 FSGSNIVGQGGSSYVYRGQLTDGR---IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
F+ +G+G V++G D R +VA+K + + E+ +LS+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAIGAA-RGL 340
V G S + + ++ E++ G+ D L+ G L E T++A + +GL
Sbjct: 64 VTKYYG--SYLKDTKLW--IIMEYLGGGSALDLLEPGPLDE-----TQIATILREILKGL 114
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
+YLH + + +HRDIK++N+LL E+ K+ D G+A +L + GT
Sbjct: 115 DYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-----NTFVGTPF 166
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+ APE +D++S G+ +EL G P
Sbjct: 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 37/96 (38%), Positives = 51/96 (53%), Gaps = 8/96 (8%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+YLH A ILHRDIK N+L++ N KI D G+A+ + D S + +
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVV-- 166
Query: 398 TFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGR 432
T Y APE M R + D++S G + EL+ R
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 4e-10
Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
D + +G+G + VY+G+ +G++VA+K + Q + E +L L H +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
+V L + + LVFE++ + +L +D G++ + RGL Y
Sbjct: 65 IVLL----HDIIHTKETLTLVFEYV-HTDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSY 118
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
+H+ ILHRD+K N+L+ + K+ D G+A +A +PS + S + T Y
Sbjct: 119 IHQR---YILHRDLKPQNLLISDTGELKLADFGLA---RAKSVPSHTYSNEVV--TLWYR 170
Query: 403 APEYAMVGRA--SLMSDVFSFGVVLLELITG 431
P+ ++G S D++ G + +E+I G
Sbjct: 171 PPD-VLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 37/101 (36%), Positives = 56/101 (55%), Gaps = 14/101 (13%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK-RLKADGLPS--CSSSPARM 395
GL++LH+ I++RD+K N+LLD++ + KI D GM K + +G S C
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC------- 157
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
GT Y APE + + D +SFGV+L E++ G+ P H
Sbjct: 158 -GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 24/213 (11%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G G VY+ Q + ++A + ++ E+D+L+ H ++V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL---D 69
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE---YLHEAAA 348
F + + +L+ EF G +D V++E T I + + LE YLHE
Sbjct: 70 AFYYENNLWILI-EFCAGG----AVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN-- 122
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408
+I+HRD+K+ NIL + + K+ D G++ + + S GT + APE M
Sbjct: 123 -KIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDS----FIGTPYWMAPEVVM 176
Query: 409 VGRAS-----LMSDVFSFGVVLLELITGRQPIH 436
+ +DV+S G+ L+E+ P H
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPHH 209
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 61/240 (25%), Positives = 108/240 (45%), Gaps = 37/240 (15%)
Query: 231 IVGQG--GSSYVYRGQLTDGRIVAVKRF-KTQGGPNADSVFL-TEVDMLSRLHHCHVVPL 286
++G+G G + R + T ++ A+K K + +DS F E D+++ + VV L
Sbjct: 50 VIGRGAFGEVQLVRHKSTR-KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNW----DTRVAIAIGAARGLEY 342
F+ R + +V E+MP G+L + + V W V +A+ A + +
Sbjct: 109 F---YAFQDDRYL-YMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLALDAIHSMGF 163
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
+H RD+K N+LLD++ + K+ D G ++ +G+ C ++ GT Y
Sbjct: 164 IH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA----VGTPDYI 210
Query: 403 APEY-------AMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSIIT 455
+PE GR D +S GV L E++ G P + G S ++ K+ +T
Sbjct: 211 SPEVLKSQGGDGYYGRE---CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 267
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 5e-10
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 32/214 (14%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVG 288
+G G VY + + + +VA+K+ G + + + EV L +L H + +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI---- 78
Query: 289 YCSEFRG---KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
++RG + LV E+ G+ D L+ V + + A+ GA +GL YLH
Sbjct: 79 ---QYRGCYLREHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYFAP 404
++HRD+K+ NILL E K+ D G A + +PA GT + AP
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----------APANXFVGTPYWMAP 180
Query: 405 EYAMV---GRASLMSDVFSFGVVLLELITGRQPI 435
E + G+ DV+S G+ +EL + P+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 60/224 (26%), Positives = 109/224 (48%), Gaps = 26/224 (11%)
Query: 232 VGQGGSSYVYRG--QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+G+G + V++G +LT+ +VA+K + + A + EV +L L H ++V L
Sbjct: 14 LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL--- 69
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAI-GAARGLEYLHEA 346
+ LVFE++ + +L+ +D G ++ N V I + RGL Y H
Sbjct: 70 -HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHN----VKIFLYQILRGLAYCHRR 123
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
++LHRD+K N+L++E K+ D G+A +A +P+ + S + T Y P+
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLA---RAKSVPTKTYSNEVV--TLWYRPPD- 174
Query: 407 AMVGRA--SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 448
++G + S D++ G + E+ +GR S + E L+
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 29/219 (13%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ--LTDGRIVAVKRFK-TQGGPNADSVFLTEVDMLSRLHH 280
D++ +G+G VY+ + +T+ +A+K+ + Q S + E+ +L + H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 281 CHVVPL--VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRV--AIAIG 335
++V L V + + RL LVFE++ + +L+ +D + R+
Sbjct: 61 GNIVRLQDVVHSEK-------RLYLVFEYL-DLDLKKHMDSS--PDFAKNPRLIKTYLYQ 110
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPSCSSSPAR 394
RG+ Y H + R+LHRD+K N+L+D NA K+ D G+A +A G+P + +
Sbjct: 111 ILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLA---RAFGIPVRTFTHEV 164
Query: 395 MQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 432
+ T Y APE + R S D++S G + E++ +
Sbjct: 165 V--TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 37/120 (30%), Positives = 49/120 (40%), Gaps = 19/120 (15%)
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
EYLH I++RD+K N+LLD + K+TD G AK++ C GT
Sbjct: 132 EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC--------GTPE 180
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWVKS 452
Y APE D ++ GV+L E I G P I+ I G W
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240
|
Length = 329 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 6e-10
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 232 VGQGGSSYVYRGQLT-DGRI--VAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVVPLV 287
+G+G V GQL D I VAVK K ++ FL+E + H +V+ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 288 GYC---SEFRGKRAMRLLVFEFMPNGNLRDCLD----GVLVEGMNWDTRVAIAIGAARGL 340
G C E G + +++ FM +G+L L G + + V A G+
Sbjct: 67 GVCLQTVESEGYPS-PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
EYL ++ +HRD+ + N +L+EN+N + D G++K++ +G A+M
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAKM--PVK 179
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ A E + SDV+SFGV + E+ T G+ P
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 35/97 (36%), Positives = 48/97 (49%), Gaps = 9/97 (9%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L++LH+ I++RDIK NILLD + +TD G++K A+ S GT
Sbjct: 118 LDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS----FCGTI 170
Query: 400 GYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP 434
Y APE G D +S GV+ EL+TG P
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 61/218 (27%), Positives = 90/218 (41%), Gaps = 26/218 (11%)
Query: 232 VGQGGSSYVYRGQLTDGRI---VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+G G V G++ G V VK + FL E L H +++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV-EGMNWDTRV--AIAIGAARGLEYLHE 345
C+E LLV EF P G+L+ L E M D +A A GL +LH+
Sbjct: 63 QCTEV----TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAK-RLKADGLPSCSSSPARMQGTFGYFAP 404
+H D+ N LL +L KI D G++ + K D +P ++ + AP
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY----VTPDQLWVPLRWIAP 171
Query: 405 EYA-------MVGRASLMSDVFSFGVVLLELIT-GRQP 434
E +V + S+V+S GV + EL G QP
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 44/228 (19%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDGR-IVAVKRFK-TQGGPNADSVFLTEVDMLSRLHHC 281
+KF +VG+G V + + + + IVA+K+FK ++ L E+ ML L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEF-----------MPNGNLRDCLDGV---LVEGMNWD 327
++V L FR +R LVFE+ MPNG + + L++ ++W
Sbjct: 61 NIVELK---EAFR-RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW- 115
Query: 328 TRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 387
H+ I+HRDIK N+L+ N K+ D G A+ L
Sbjct: 116 ---------------CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE----G 153
Query: 388 CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435
+++ T Y +PE + D++S G +L EL G QP+
Sbjct: 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG-QPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
GL++LH I++RD+K N++LD + + KI D GM K G + + GT
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKE-NVFG----DNRASTFCGT 159
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
Y APE + + D +SFGV+L E++ G+ P H
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 232 VGQGGSSYVYRG---QLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLV 287
+G G V +G + VAVK K P L E +++ +L + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLVEGMNWDTRVAIAIGAARGLEYLH 344
G C + M LV E G L L V + + + + G++YL
Sbjct: 63 GIC---EAESWM--LVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLE 112
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYF 402
E +HRD+ + N+LL AKI+D G++K L AD + A+ G + ++
Sbjct: 113 ET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE----NYYKAKTHGKWPVKWY 165
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVL 448
APE + S SDV+SFGV++ E + G++P KG E +
Sbjct: 166 APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG--MKGNEVTQM 210
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 38/109 (34%), Positives = 55/109 (50%), Gaps = 30/109 (27%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+Y+H A +LHRD+K SN+LL+ N + KI D G+A+ + S M
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--------TTSEKGDFMTE 167
Query: 398 ---TFGYFAPEYAMVGRASLMS--------DVFSFGVVLLELITGRQPI 435
T Y APE L++ DV+S G + EL+ GR+P+
Sbjct: 168 YVVTRWYRAPEL-------LLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 50/215 (23%), Positives = 84/215 (39%), Gaps = 29/215 (13%)
Query: 233 GQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFL-TEVDMLSRLHHCHVVPLVGYCS 291
++ + + T +VAVK+ D L E+ +L H +++P Y +
Sbjct: 11 EDLMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP---YVT 66
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI---GAARGLEYLHEAAA 348
F + +V M G+ D L EG+ +AIA L+Y+H
Sbjct: 67 SFIVDSEL-YVVSPLMAYGSCEDLLKTHFPEGLP---ELAIAFILKDVLNALDYIHSKG- 121
Query: 349 PRILHRDIKSSNILLDENLNAKITDL----GMAKRLKADGLPSCSSSPARMQGTFGYFAP 404
+HR +K+S+ILL + ++ L M K K + P + +P
Sbjct: 122 --FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD--FPKSSVKNLPWLSP 177
Query: 405 EYAMVGRASLM-----SDVFSFGVVLLELITGRQP 434
E V + +L SD++S G+ EL G P
Sbjct: 178 E---VLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 64/237 (27%), Positives = 102/237 (43%), Gaps = 48/237 (20%)
Query: 232 VGQGGSSYVYRGQL---TDGRIVAVKRFKTQGGPNADSVFLT-----EVDMLSRLHHCHV 283
+G+G VY+ + DG+ A+K+FK G ++ E+ +L L H +V
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFK---GDKEQYTGISQSACREIALLRELKHENV 64
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR-VAIAIGAA----- 337
V LV E K L+F++ + D L + + + + ++I +
Sbjct: 65 VSLVEVFLEHADKSVY--LLFDYAEH-------D--LWQIIKFHRQAKRVSIPPSMVKSL 113
Query: 338 -----RGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLPSC 388
G+ YLH +LHRD+K +NIL+ E KI DLG+A+ A P
Sbjct: 114 LWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 389 SSSPARMQGTFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIHRSITKGEE 444
P + T Y APE + R + D+++ G + EL+T PI KG E
Sbjct: 171 DLDPVVV--TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE-PIF----KGRE 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 23/107 (21%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+Y+H A +LHRD+K SN+LL+ N + KI D G+A+ + P
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR----------IADPEHDHT 163
Query: 398 TF--------GYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPI 435
F Y APE + + + D++S G +L E+++ R P+
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 36/98 (36%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
LE+LH+ I++RDIK NILLD N + +TD G++K D + S GT
Sbjct: 117 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS----FCGT 169
Query: 399 FGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP 434
Y AP+ G D +S GV++ EL+TG P
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 67/303 (22%), Positives = 130/303 (42%), Gaps = 63/303 (20%)
Query: 150 LRSSVISSDKESCNSATNLISHRITSVPETRVEVVSPIDLATGC------FLKTTFCRSK 203
L+S+ SS+K++ S ++SH P + ++L C ++ T +CR
Sbjct: 75 LKSTARSSEKQALMSELKIMSHL---GPHLNI-----VNLLGACTKGGPIYIITEYCR-- 124
Query: 204 TWTIHGTII----RFSYSALEHATDK-------FSGSNIVGQGGSSYVYRGQLTDGRIVA 252
+G ++ R ++ L++ DK SG + S+V G +DG +
Sbjct: 125 ----YGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMD 180
Query: 253 VKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNL 312
+ + + + ++ DM + + + Y S + +++P+
Sbjct: 181 MSK-------DESADYVPMQDMKGTVKYADIES-SNYESPYD----------QYLPSAPE 222
Query: 313 RDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 370
R D ++ E +++ V + A G+E+L A+ +HRD+ + N+L+ E K
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVK 279
Query: 371 ITDLGMAKRLKADGLPSCSSSPARMQGTF---GYFAPEYAMVGRASLMSDVFSFGVVLLE 427
I D G+A+ + D S+ TF + APE + +SDV+SFG++L E
Sbjct: 280 ICDFGLARDIMRD------SNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333
Query: 428 LIT 430
+ T
Sbjct: 334 IFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 52/187 (27%), Positives = 87/187 (46%), Gaps = 16/187 (8%)
Query: 248 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307
GR VAVK + + +F EV ++ H +VV + Y S G+ L+ EF+
Sbjct: 46 GRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHQNVVEM--YKSYLVGEELWVLM--EFL 100
Query: 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 367
G L D + +N + + + L YLH + ++HRDIKS +ILL +
Sbjct: 101 QGGALTDIVSQTR---LNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDG 154
Query: 368 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 427
K++D G ++ D +P S + GT + APE D++S G++++E
Sbjct: 155 RVKLSDFGFCAQISKD-VPKRKS----LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIE 209
Query: 428 LITGRQP 434
++ G P
Sbjct: 210 MVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 46/163 (28%)
Query: 302 LVFEFMPNGNLRDCLDGVLVEGMNWD----------TRVAIAIGAARGLEYLHEAAAPRI 351
+V E+MP G+L + + N+D V +A+ A + ++H
Sbjct: 120 MVMEYMPGGDLVNLMS-------NYDIPEKWARFYTAEVVLALDAIHSMGFIH------- 165
Query: 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM--- 408
RD+K N+LLD++ + K+ D G ++ A+G+ C ++ GT Y +PE
Sbjct: 166 --RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA----VGTPDYISPEVLKSQG 219
Query: 409 ----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447
GR D +S GV L E++ G P + +SLV
Sbjct: 220 GDGYYGRE---CDWWSVGVFLYEMLVGDTPFY------ADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKT--QGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+G+G S VYR L D + VA+K+ + A + E+D+L +L+H +V+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK--- 66
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTRVAIAIGAARGLEY 342
Y F + + V E G+L + ++ E W V + +E+
Sbjct: 67 YLDSFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEH 121
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
+H + R++HRDIK +N+ + K+ DLG+ + + +++ + GT Y
Sbjct: 122 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-----TTAAHSLVGTPYYM 173
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
+PE + SD++S G +L E+ + P +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL-PSCSSSPARMQG 397
L YLHE I++RD+K N+LLD + K+TD GM K +GL P ++S G
Sbjct: 108 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTS--TFCG 158
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
T Y APE D ++ GV++ E++ GR P
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 42/137 (30%), Positives = 67/137 (48%), Gaps = 20/137 (14%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
+ GL +LH I++RD+K N++LD + KI D GM K DG+ + +
Sbjct: 111 SVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-----FC 162
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVL 448
GT Y APE D +++GV+L E++ G+ P + +SI E V
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM---EHNVS 219
Query: 449 WVKSIITDA-SICQSFL 464
+ KS+ +A SIC+ +
Sbjct: 220 YPKSLSKEAVSICKGLM 236
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGY 401
+H + ++HRDIKS+NILL N K+ D G +K A + S R GT Y
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA----TVSDDVGRTFCGTPYY 211
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
APE S +D+FS GV+L EL+T ++P
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 10/97 (10%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL-PSCSSSPARMQG 397
L +LHE I++RD+K N+LLD + + K+TD GM K +GL P ++S G
Sbjct: 108 ALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK----EGLGPGDTTST--FCG 158
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
T Y APE D ++ GV++ E++ GR P
Sbjct: 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 232 VGQGGSSYVYRGQLTD-GRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G V++ + + IVA+KR + +G P S L E+ +L L H ++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELKHKNIVRL 64
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
Y K+ LVFE+ + +L+ D + ++ + + +GL + H
Sbjct: 65 --YDVLHSDKKLT--LVFEYC-DQDLKKYFDSCNGD-IDPEIVKSFMFQLLKGLAFCHSH 118
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+LHRD+K N+L+++N K+ D G+A +A G+P S + T Y P+
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLA---RAFGIPVRCYSAEVV--TLWYRPPD- 169
Query: 407 AMVGRASLMS---DVFSFGVVLLELITGRQPI 435
+ G A L S D++S G + EL +P+
Sbjct: 170 VLFG-AKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 20/103 (19%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ--- 396
LEYLH + +++RDIK N++LD++ + KITD G+ K +DG A M+
Sbjct: 108 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------ATMKTFC 156
Query: 397 GTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIH 436
GT Y APE GRA D + GVV+ E++ GR P +
Sbjct: 157 GTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 57/218 (26%)
Query: 240 VYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDMLSRLHHCHVVPL----VG-- 288
VYR + G IVA+K+ K + F L E+++L +L H ++V + VG
Sbjct: 21 VYRARDKKTGEIVALKKLKME---KEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN 77
Query: 289 ----YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA----IAIGAARGL 340
Y +V E++ + +L+ L+E M + + + G+
Sbjct: 78 LDKIY------------MVMEYVEH-DLKS-----LMETMKQPFLQSEVKCLMLQLLSGV 119
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR----MQ 396
+LH+ ILHRD+K+SN+LL+ KI D G+A+ SP + +
Sbjct: 120 AHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY---------GSPLKPYTQLV 167
Query: 397 GTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQ 433
T Y APE + S D++S G + EL+T +
Sbjct: 168 VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 36/95 (37%), Positives = 53/95 (55%), Gaps = 8/95 (8%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-CSSSPARM 395
ARG+E+L A+ + +HRD+ + NILL EN KI D G+A+ + D P AR+
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD--PDYVRKGDARL 237
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430
+ APE + SDV+SFGV+L E+ +
Sbjct: 238 --PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L +LHE I++RD+K N+LLD + K+TD GM K G + + GT
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-----DTTSTFCGTP 160
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
Y APE D ++ GV++ E++ GR P
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 60/257 (23%), Positives = 98/257 (38%), Gaps = 44/257 (17%)
Query: 188 DLATGCFLKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVY----RG 243
L+ + C + + + +++R Y+ L T G V+ G
Sbjct: 66 SLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLT----------PGSEGEVFVCTKHG 115
Query: 244 QLTDGRIV--AVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301
+++ AV KT G E+D+L + H ++ L+ +R K
Sbjct: 116 DEQRKKVIVKAVTGGKTPG---------REIDILKTISHRAIINLI---HAYRWKS---- 159
Query: 302 LVFEFMP--NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359
V MP +L +D + + + I L YLH I+HRD+K+
Sbjct: 160 TVCMVMPKYKCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTE 214
Query: 360 NILLDENLNAKITDLGMAKRLKA-DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 418
NI LDE NA + D G A +L A P C GT +PE + +D+
Sbjct: 215 NIFLDEPENAVLGDFGAACKLDAHPDTPQCYG----WSGTLETNSPELLALDPYCAKTDI 270
Query: 419 FSFGVVLLELITGRQPI 435
+S G+VL E+ +
Sbjct: 271 WSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 31/196 (15%)
Query: 264 ADSVFL-TEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVE 322
+DS F E D+++ + VV L +C+ F+ + + +V E+MP G+L + + V
Sbjct: 85 SDSAFFWEERDIMAFANSPWVVQL--FCA-FQDDKYL-YMVMEYMPGGDLVNLMSNYDVP 140
Query: 323 ---GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379
+ V +A+ A +H ++HRD+K N+LLD++ + K+ D G +
Sbjct: 141 EKWAKFYTAEVVLALDA------IHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191
Query: 380 LKADGLPSCSSSPARMQGTFGYFAPEY-------AMVGRASLMSDVFSFGVVLLELITGR 432
+ G+ C ++ GT Y +PE GR D +S GV L E++ G
Sbjct: 192 MDETGMVRCDTA----VGTPDYISPEVLKSQGGDGYYGRE---CDWWSVGVFLFEMLVGD 244
Query: 433 QPIHRSITKGEESLVL 448
P + G S ++
Sbjct: 245 TPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 20/103 (19%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L YLH +++RD+K N++LD++ + KITD G+ K +DG ++ GT
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-----ATMKTFCGTP 159
Query: 400 GYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
Y APE Y GRA D + GVV+ E++ GR P +
Sbjct: 160 EYLAPEVLEDNDY---GRA---VDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 37/200 (18%)
Query: 271 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMN--W 326
E +L + H ++ L + +E +R + +L E++P G L L G +
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTE-HDQRFLYML-MEYVPGGELFSYLRNSGRFSNSTGLFY 106
Query: 327 DTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 386
+ + A+ EYLH + I++RD+K NILLD+ + K+TD G AK+L+
Sbjct: 107 ASEIVCAL------EYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT 157
Query: 387 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRS 438
C GT Y APE + D ++ G+++ E++ G P I+
Sbjct: 158 LC--------GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK 209
Query: 439 ITKG----EESLVLWVKSII 454
I G L L+ K +I
Sbjct: 210 ILAGKLEFPRHLDLYAKDLI 229
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 38/100 (38%), Positives = 55/100 (55%), Gaps = 9/100 (9%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-CSSSPARM 395
ARG+E+L A+ + +HRD+ + NILL EN KI D G+A+ + D P AR+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD--PDYVRKGSARL 238
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ APE + SDV+SFGV+L E+ + G P
Sbjct: 239 --PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
L+YLH + +++RD+K N++LD++ + KITD G+ K DG ++ GT
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-----ATMKTFCGT 159
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
Y APE D + GVV+ E++ GR P +
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 9/92 (9%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
GL YLH A RI+HRD+K+ NI +++ I DLG A+ P + + + G
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ------FPVVAPAFLGLAG 218
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 429
T APE + + +D++S G+VL E++
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 233 GQGGSSYVYRGQ--LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
G+G + VY+G+ LT ++VA+K + + A + E +L L H ++V L
Sbjct: 14 GEGSYATVYKGRSKLTG-QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTL---- 68
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
+ + LVFE++ + +L+ +D G++ RGL Y H+ R
Sbjct: 69 HDIIHTKKTLTLVFEYL-DTDLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQR---R 123
Query: 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG 410
+LHRD+K N+L+ E K+ D G+A +A +PS + S + T Y P+ +
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLA---RAKSVPSKTYSNEVV--TLWYRPPDVLLGS 178
Query: 411 RA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 446
S D++ G + E+ TGR P+ T E+ L
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGR-PLFPGSTDVEDQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 8/98 (8%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
L+YLH +I++RD+K N++LD++ + KITD G+ K D +++ GT
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-----AATMKTFCGT 158
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
Y APE D + GVV+ E++ GR P +
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 231 IVGQGGSSYVYRGQLTDG----RIVAVKRFKTQG-GPNADSVFLT--EVDMLSRLHHCHV 283
++G+GG V++ + G +I A+K K N T E ++L + H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLE 341
V L+ Y + GK L+ E++ G L L+ G+ +E DT + LE
Sbjct: 63 VDLI-YAFQTGGKL---YLILEYLSGGELFMHLEREGIFME----DTACFYLSEISLALE 114
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
+LH+ I++RD+K NILLD + K+TD G+ K +G + GT Y
Sbjct: 115 HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-----TVTHTFCGTIEY 166
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
APE M D +S G ++ +++TG P
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 45/140 (32%), Positives = 70/140 (50%), Gaps = 26/140 (18%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
A GL +LH I++RD+K N++LD + KI D GM K DG+ +
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-----TTKTFC 162
Query: 397 GTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEES 445
GT Y APE Y G++ D ++FGV+L E++ G+ P + +SI E
Sbjct: 163 GTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM---EH 216
Query: 446 LVLWVKSIITDA-SICQSFL 464
V + KS+ +A +IC+ +
Sbjct: 217 NVAYPKSMSKEAVAICKGLM 236
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 37/100 (37%), Positives = 56/100 (56%), Gaps = 9/100 (9%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-CSSSPARM 395
A+G+E+L A+ + +HRD+ + NILL EN KI D G+A+ + D P AR+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD--PDYVRKGDARL 243
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ APE ++ SDV+SFGV+L E+ + G P
Sbjct: 244 --PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 18/99 (18%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+Y+H A I+HRD+K SN+ ++E+ KI D G+A+ + M G
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH-----------TDDEMTG 176
Query: 398 ---TFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGR 432
T Y APE + + D++S G ++ EL+TGR
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 7e-08
Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 10/99 (10%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ- 396
+ L+Y+H ++HRD+K SNILL+ + K+ D G+A+ L L +P
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLTDY 172
Query: 397 -GTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGR 432
T Y APE ++G R + D++S G +L E++ G+
Sbjct: 173 VATRWYRAPE-ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 69/270 (25%), Positives = 104/270 (38%), Gaps = 58/270 (21%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 280
D F ++G+G V Q D G I A+K + + V E D+L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMN-WDTRVAIAIGA 336
VV + F+ KR + L+ EF+P G++ L D + E + +AI A
Sbjct: 61 AWVVKMF---YSFQDKRNL-YLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA 116
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-----------ADGL 385
L ++H RDIK N+LLD + K++D G+ LK
Sbjct: 117 IHQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNP 167
Query: 386 PSCSS-------------SPARMQ------GTFGYFAPEYAMVGRASLMSDVFSFGVVLL 426
PS S R Q GT Y APE M + + D +S GV++
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 427 ELITGRQPI--------HRSITKGEESLVL 448
E++ G P +R + +E+LV
Sbjct: 228 EMLIGYPPFCSETPQETYRKVMNWKETLVF 257
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 18/99 (18%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
+GL+Y+H A I+HRD+K N+ ++E+ KI D G+A++ + + M G
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-----------TDSEMTG 174
Query: 398 ---TFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGR 432
T Y APE + + D++S G ++ E++TG+
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 34/127 (26%), Positives = 62/127 (48%), Gaps = 12/127 (9%)
Query: 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366
+ +++ L EG+ ++ ARG+E+L A+ +HRD+ + N+LL +
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQG 273
Query: 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTF---GYFAPEYAMVGRASLMSDVFSFGV 423
KI D G+A+ + D S+ TF + APE + +SDV+S+G+
Sbjct: 274 KIVKICDFGLARDIMHD------SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 424 VLLELIT 430
+L E+ +
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 55/234 (23%), Positives = 90/234 (38%), Gaps = 48/234 (20%)
Query: 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADS-------------VFLTEVDML 275
+G+G V + T G+IVA+K+ K N + L E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 276 SRLHHCHVVPLVG-YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--- 331
+ + H +++ LV Y LV + M +L+ +D R+
Sbjct: 75 NEIKHENIMGLVDVYVEG-----DFINLVMDIM-ASDLKKVVDR--------KIRLTESQ 120
Query: 332 ---IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388
I + GL LH+ +HRD+ +NI ++ KI D G+A+R
Sbjct: 121 VKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 389 SSSPARMQG---------TFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGR 432
S MQ T Y APE M + D++S G + EL+TG+
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 39/103 (37%), Positives = 53/103 (51%), Gaps = 15/103 (14%)
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY--A 407
+HRDIK N+LLD+N + ++ D G RL ADG + S+ A GT Y +PE A
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVA--VGTPDYISPEILQA 177
Query: 408 M---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447
M GR D +S GV + E++ G P + ESLV
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFY------AESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 57/232 (24%), Positives = 98/232 (42%), Gaps = 40/232 (17%)
Query: 232 VGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+G + VY+G +G++VA+K + + E +L L H ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLL---- 68
Query: 291 SEFRGKRAMRLLVFEFMPN----------GNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 340
+ + VFE+M G L + R+ + RGL
Sbjct: 69 HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPY-----------NVRLFM-FQLLRGL 116
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
Y+H ILHRD+K N+L+ K+ D G+A +A +PS + S + T
Sbjct: 117 AYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLA---RAKSIPSQTYSSEVV--TLW 168
Query: 401 YFAPEYAMVGRASLMS--DVFSFGVVLLELITGRQPIHRSITKGEESLV-LW 449
Y P+ ++G S D++ G + +E++ G QP ++ E L +W
Sbjct: 169 YRPPD-VLLGATDYSSALDIWGAGCIFIEMLQG-QPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 37/107 (34%), Positives = 54/107 (50%), Gaps = 22/107 (20%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
GL+Y+H A +LHRD+K N+L++ + KI D G+A+ S +P G
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR--------GFSENPGENAG 164
Query: 398 -------TFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGRQPI 435
T Y APE M+ S DV+S G +L EL+ GR+P+
Sbjct: 165 FMTEYVATRWYRAPE-IMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 26/167 (15%)
Query: 271 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLV---EGM 324
EV +LS + H ++V Y F + +V ++ G+L ++ GVL + +
Sbjct: 49 EVAVLSNMKHPNIVQ---YQESFE-ENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQIL 104
Query: 325 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384
+W ++ +A L+++H+ +ILHRDIKS NI L ++ K+ D G+A+ L +
Sbjct: 105 DWFVQICLA------LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-- 153
Query: 385 LPSCSSSPARM-QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430
+ AR GT Y +PE + SD+++ G VL E+ T
Sbjct: 154 ----TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
L E + +++HRD+KS+NI L K+ D G +K+ +SS GT Y
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS---FCGTPYYL 238
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
APE R S +D++S GV+L EL+T +P
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 41/202 (20%)
Query: 266 SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNG----NLRDCLDGVL 320
S + EV+++ L H ++V Y F K +L ++ EF G N++ C +
Sbjct: 57 SQLVIEVNVMRELKHKNIVR---YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK--M 111
Query: 321 VEGMNWDTRVAIAIGAARGLEYLHEAA----APRILHRDIKSSNILLD------------ 364
+ V I L Y H R+LHRD+K NI L
Sbjct: 112 FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171
Query: 365 -ENLN----AKITDLGMAKRLKADGLP-SCSSSPARMQGTFGYFAPEYAMVGRASL--MS 416
NLN AKI D G++K + + + SC +P Y++PE + S S
Sbjct: 172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPY-------YWSPELLLHETKSYDDKS 224
Query: 417 DVFSFGVVLLELITGRQPIHRS 438
D+++ G ++ EL +G+ P H++
Sbjct: 225 DMWALGCIIYELCSGKTPFHKA 246
|
Length = 1021 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 51/208 (24%), Positives = 77/208 (37%), Gaps = 64/208 (30%)
Query: 271 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT-- 328
E D+L+ + VV L Y S F+ + + L+ E++P G++ L M DT
Sbjct: 51 ERDILAEADNPWVVKL--YYS-FQDENYL-YLIMEYLPGGDMMTLL-------MKKDTFT 99
Query: 329 ---------RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379
+AI + L Y+H RDIK N+LLD + K++D G+
Sbjct: 100 EEETRFYIAETILAIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTG 150
Query: 380 LKADG---------------LPSCSSSP------------ARMQ------GTFGYFAPEY 406
LK S P R GT Y APE
Sbjct: 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV 210
Query: 407 AMVGRASLMSDVFSFGVVLLELITGRQP 434
+ + D +S GV++ E++ G P
Sbjct: 211 FLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 26/226 (11%)
Query: 223 TDKFSGSNIVGQGGSSYVYR-GQLTDGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLH 279
+D + +G+G V++ +G AVK P + D E ++L L
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD----PIHDIDEEIEAEYNILKALS 72
Query: 280 -HCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIG 335
H +VV G + K +L LV E G++ D + G L G M I
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 395
A GL++LH + +HRD+K +NILL K+ D G++ +L + L +S
Sbjct: 133 ALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV---- 185
Query: 396 QGTFGYFAPEYAMVGRASLMS------DVFSFGVVLLELITGRQPI 435
GT + APE + L S DV+S G+ +EL G P+
Sbjct: 186 -GTPFWMAPE-VIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
R L+Y+H A + HRD+K NIL + + KI D G+A+ D + +
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD--YVA 168
Query: 398 TFGYFAPEY--AMVGRASLMSDVFSFGVVLLELITGR 432
T Y APE + + + D++S G + E++TG+
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 37/110 (33%), Positives = 54/110 (49%), Gaps = 15/110 (13%)
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
+H +HRDIK N+LLD N + ++ D G ++ DG + SS A GT Y
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVA--VGTPDYI 170
Query: 403 APEY--AM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447
+PE AM +G+ D +S GV + E++ G P + ESLV
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY------AESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 8/95 (8%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L +LH+ I++RD+K N+LLD + K+ D GM K +G + + GT
Sbjct: 109 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT-----STFCGTP 160
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
Y APE D ++ GV+L E++ G P
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
G+ Y+H+ RILHRD+K+ NI L NL KI D G+++ L + SC + GT
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL----MGSCDLATT-FTGT 168
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLEL 428
Y +PE SD++S G +L E+
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 34/97 (35%), Positives = 48/97 (49%), Gaps = 10/97 (10%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
LE+LH+ I++RDIK NILLD + +TD G++K L GT
Sbjct: 118 LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF----LSEEKERTYSFCGTI 170
Query: 400 GYFAPEY--AMVGRASLMSDVFSFGVVLLELITGRQP 434
Y APE G + D +S G+++ EL+TG P
Sbjct: 171 EYMAPEIIRGKGGHGKAV-DWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 52/233 (22%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
VG+G +VY+ + DG+ K G E+ +L L H +V+ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 292 EFRGKRAMRLLVFEF-----------------------MPNGNLRDCLDGVLVEGMNWDT 328
++ L+F++ +P G ++ L +L
Sbjct: 69 SHADRKVW--LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL-------- 118
Query: 329 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADG 384
G+ YLH A +LHRD+K +NIL+ E KI D+G A+ +
Sbjct: 119 ---------DGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIH 436
P P + TF Y APE + R + D+++ G + EL+T H
Sbjct: 167 KPLADLDPVVV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 26/103 (25%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
GL+Y+H A I+HRD+K N+ ++E+ KI D G+A+ + A M G
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----------HADAEMTG 173
Query: 398 ---TFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGR 432
T Y APE + + M D++S G ++ E++TG+
Sbjct: 174 YVVTRWYRAPEVIL----NWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 40/123 (32%), Positives = 56/123 (45%), Gaps = 24/123 (19%)
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389
+ IAI + L Y+H RDIK NIL+D N + ++ D G +L DG +
Sbjct: 111 MVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQ 159
Query: 390 SSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 444
SS A GT Y +PE G+ D +S GV + E++ G P + E
Sbjct: 160 SSVA--VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY------AE 211
Query: 445 SLV 447
SLV
Sbjct: 212 SLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 56/221 (25%), Positives = 86/221 (38%), Gaps = 29/221 (13%)
Query: 232 VGQGGSSYVYRGQLTDGRIVA---VKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+G G V ++ VA VK K + FL + D L H +++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT----RVAIAIGAARGLEYLH 344
C E LLVFE+ G+L+ L N R+A I A G+ ++H
Sbjct: 63 QCVE----AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA--GVTHMH 116
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMA-KRLKADGLPSCSSSPARMQGTFGYFA 403
+ LH D+ N L +L K+ D G+ R K D + + ++ + A
Sbjct: 117 KH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----WLA 169
Query: 404 PEYAMVGRASLM-------SDVFSFGVVLLELI-TGRQPIH 436
PE L+ S+V++ GV L EL QP
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 8e-07
Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 19/139 (13%)
Query: 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365
FM G+ L EGM+ I GA RGL YLH+ +HR+IK+S+IL+
Sbjct: 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY---IHRNIKASHILISG 136
Query: 366 NLNAKITDLGMAKRLKADG--------LPSCSSSPARMQGTFGYFAPEYAM--VGRASLM 415
+ ++ L L +G P S+S + +PE + ++
Sbjct: 137 DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTS------VLPWLSPELLRQDLYGYNVK 190
Query: 416 SDVFSFGVVLLELITGRQP 434
SD++S G+ EL TGR P
Sbjct: 191 SDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 8e-07
Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 10/103 (9%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
G+ YLH A +LHRD+K +NIL+ E KI D+G A+ + P P
Sbjct: 120 GIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 395 MQGTFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIH 436
+ TF Y APE + R + D+++ G + EL+T H
Sbjct: 177 V--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 8e-07
Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 8/99 (8%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L YLH+ RI+HRD+ +NI+L E+ ITD G+AK+ + + S + GT
Sbjct: 126 LRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE------SKLTSVVGTI 177
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438
Y PE +DV++FG +L ++ T + P + +
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 32/207 (15%)
Query: 251 VAVKRF---KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307
VA+KRF K D VF +E +L+ ++H V L G F+ + + LV EF+
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNLYG---SFKDESYL-YLVLEFV 113
Query: 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL--EYLHEAAAPRILHRDIKSSNILLDE 365
G L + V A L EYL I++RD+K N+LLD+
Sbjct: 114 IGGEFFT----FLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDK 166
Query: 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVV 424
+ K+TD G AK + C GT Y APE + VG +D ++ G+
Sbjct: 167 DGFIKMTDFGFAKVVDTRTYTLC--------GTPEYIAPEILLNVGHGK-AADWWTLGIF 217
Query: 425 LLELITGRQPIHRSITKGEESLVLWVK 451
+ E++ G P + E L+++ K
Sbjct: 218 IYEILVGCPPFY-----ANEPLLIYQK 239
|
Length = 340 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 15/101 (14%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK-RLKADGLPS--CSSSPARMQ 396
LE+LH+ I++RD+K NILLD + + D G++K L + + C
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-------- 157
Query: 397 GTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIH 436
GT Y APE + + + D +S GV++ E+ G P +
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 18/99 (18%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+Y+H A I+HRD+K SN+ ++E+ +I D G+A++ + M G
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-----------ADDEMTG 174
Query: 398 ---TFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGR 432
T Y APE + + D++S G ++ EL+ G+
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 51/218 (23%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 290
G+G S V + Q G+ A+K K L E+ L RL H +++ L+
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVL 67
Query: 291 SEFRGKRAMRL-LVFEFMPNGNL-------RDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
+ ++ RL LVFE M + NL + L V+ + + L++
Sbjct: 68 FD---RKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQL--------LKSLDH 115
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP-ARMQGTFGY 401
+H I HRDIK NIL+ +++ K+ D G + + S P T Y
Sbjct: 116 MHRNG---IFHRDIKPENILIKDDI-LKLADFGSCRGI-------YSKPPYTEYISTRWY 164
Query: 402 FAPE---------YAMVGRASLMSDVFSFGVVLLELIT 430
APE M D+++ G V E+++
Sbjct: 165 RAPECLLTDGYYGPKM--------DIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 66/268 (24%), Positives = 107/268 (39%), Gaps = 54/268 (20%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 280
+ F ++G+G V Q D G + A+K + + V E D+L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAAR 338
VV + F+ K + L+ EF+P G++ L L E +T+ IA
Sbjct: 61 LWVVKMF---YSFQDKLNL-YLIMEFLPGGDMMTLLMKKDTLTEE---ETQFYIA-ETVL 112
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA-----------DGLPS 387
++ +H+ +HRDIK N+LLD + K++D G+ LK LPS
Sbjct: 113 AIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 388 -------CSSSPA------RMQ------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLEL 428
S A R Q GT Y APE M + + D +S GV++ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 429 ITGRQPI--------HRSITKGEESLVL 448
+ G P ++ + +E+L+
Sbjct: 230 LIGYPPFCSETPQETYKKVMNWKETLIF 257
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L +LH +++RD+K NILLD + K+ D GM K +G+ + + GT
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT-----FCGTP 160
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
Y APE D ++ GV++ E++ G+ P
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 40/219 (18%)
Query: 230 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
NI+G G VY D VA+K K P + E+ ++ L+H +++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIK--KVLQDPQYKN---RELLIMKNLNHINIIFLKD 126
Query: 289 Y----CSEFRGKRAMRLLVFEFMPN---------GNLRDCLDGVLVEGMNWDTRVAIAIG 335
Y C + K +V EF+P L LV+ ++
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL------- 179
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPSCSSSPAR 394
R L Y+H + I HRD+K N+L+D N + K+ D G AK L A G S S +R
Sbjct: 180 -CRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA-GQRSVSYICSR 234
Query: 395 MQGTFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITG 431
Y APE M+G + + D++S G ++ E+I G
Sbjct: 235 F-----YRAPEL-MLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 11/99 (11%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
RGL+Y+H A +LHRD+K +N+ ++ E+L KI D G+A+ + P S +
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVD----PHYSHKGYLSE 177
Query: 397 G--TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 432
G T Y +P + + D+++ G + E++TG+
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 6e-06
Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 18/170 (10%)
Query: 269 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWD 327
L E +L++++ +VPL +F + +L LV F+ G L L EG
Sbjct: 41 LAERTVLAQVNCPFIVPL-----KFSFQSPEKLYLVLAFINGGELFHHLQR---EGRFDL 92
Query: 328 TRVAIAIGAAR-GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 386
+R LE LH+ +++RD+K NILLD + + D G+ K D
Sbjct: 93 SRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--- 146
Query: 387 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
GT Y APE + + D ++ GV+L E++TG P +
Sbjct: 147 --DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 48/227 (21%)
Query: 233 GQGGSSYVYRGQLTDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
G G+ Y+ R + T R A+K+ Q VF+ E D+L+ + VV + +
Sbjct: 12 GAYGAVYLVRHKETRQRF-AMKKINKQNLILRNQIQQVFV-ERDILTFAENPFVVSM--F 67
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR--------GLE 341
CS F KR + +V E++ G DC L++ + A+ + AR LE
Sbjct: 68 CS-FETKRHL-CMVMEYVEGG---DC--ATLLKNIG-----ALPVDMARMYFAETVLALE 115
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS----------- 390
YLH I+HRD+K N+L+ + K+TD G++K GL S ++
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI----GLMSLTTNLYEGHIEKDT 168
Query: 391 ---SPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
++ GT Y APE + D ++ G++L E + G P
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 33/100 (33%), Positives = 47/100 (47%), Gaps = 8/100 (8%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
A L YLH I++RD+K NILLD + +TD G+ K +G+ + S +
Sbjct: 106 ASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCK----EGI-AQSDTTTTFC 157
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
GT Y APE D + G VL E++ G P +
Sbjct: 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 33/99 (33%), Positives = 47/99 (47%), Gaps = 14/99 (14%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
GL+YLHE +I++RD+K N+LLD KI D G+ K G + GT
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-----DRTSTFCGT 164
Query: 399 FGYFAPEY---AMVGRASLMSDVFSFGVVLLELITGRQP 434
+ APE RA D + GV++ E++ G P
Sbjct: 165 PEFLAPEVLTETSYTRA---VDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 8e-06
Identities = 34/108 (31%), Positives = 45/108 (41%), Gaps = 35/108 (32%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLN-AKITDLGMAKRLKADGLPSCSSSPARMQG 397
L LH+ I+H DIK N+L D + + D G+ K + G PSC G
Sbjct: 121 ALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII---GTPSC------YDG 168
Query: 398 TFGYFAPE------YAMVGRASLMSDVFSF-----GVVLLELITGRQP 434
T YF+PE Y SF GV+ EL+TG+ P
Sbjct: 169 TLDYFSPEKIKGHNYD-----------VSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 34/107 (31%), Positives = 50/107 (46%), Gaps = 14/107 (13%)
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389
+A A+G YLH I++RD+K NILLD + +TD G+ K +G+ S
Sbjct: 105 IASALG------YLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEH-S 150
Query: 390 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
+ + GT Y APE D + G VL E++ G P +
Sbjct: 151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
A+G+ +L A+ +HRD+ + NILL KI D G+A+ ++ D AR+
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS-NYVVKGNARL- 278
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ APE + SDV+S+G++L E+ + G P
Sbjct: 279 -PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 14/126 (11%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
G+++LH A I+HRD+K SNI++ + KI D G+A+ S +P + T
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVV--T 181
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSIITDAS 458
Y APE + D++S G ++ E++ H+ + G + + W K I +
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-----HKILFPGRDYIDQWNKVIEQLGT 236
Query: 459 ICQSFL 464
C F+
Sbjct: 237 PCPEFM 242
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 31/99 (31%), Positives = 55/99 (55%), Gaps = 7/99 (7%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
A+G+++L A+ +HRD+ + N+LL + AKI D G+A+ + D AR+
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS-NYVVKGNARL- 276
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ APE ++ SDV+S+G++L E+ + G+ P
Sbjct: 277 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 34/203 (16%)
Query: 248 GRIVAVKRFKTQGGPNADSVFL-TEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306
G V V+R + N FL E+ + +H ++VP Y + F + +V F
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVP---YRATFIADNEL-WVVTSF 80
Query: 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-- 364
M G+ +D + ++GM+ I G + L+Y+H +HR +K+S+IL+
Sbjct: 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVD 137
Query: 365 -----ENLNAKITDLGMAKRLKA-DGLPSCSS------SPARMQGTF-GYFAPEYAMVGR 411
L + ++ + +RL+ P S SP +Q GY A
Sbjct: 138 GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK------- 190
Query: 412 ASLMSDVFSFGVVLLELITGRQP 434
SD++S G+ EL G P
Sbjct: 191 ----SDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 41/174 (23%), Positives = 67/174 (38%), Gaps = 47/174 (27%)
Query: 303 VFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 360
V +++P G++ L G+ E + R IA +E +H+ +HRDIK N
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDL---ARFYIA-ELTCAIESVHKMG---FIHRDIKPDN 131
Query: 361 ILLDENLNAKITDLGMAKRLK------------------------ADGLPSCSSSP---- 392
IL+D + + K+TD G+ + + C P
Sbjct: 132 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERR 191
Query: 393 -ARMQ---------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
R GT Y APE + + + D +S GV+L E++ G+ P
Sbjct: 192 RKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 14/126 (11%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
G+++LH A I+HRD+K SNI++ + KI D G+A+ S +P + T
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVV--T 188
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSIITDAS 458
Y APE + D++S G ++ E+I + G + + W K I +
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIK-----GGVLFPGTDHIDQWNKVIEQLGT 243
Query: 459 ICQSFL 464
C F+
Sbjct: 244 PCPEFM 249
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 33/101 (32%), Positives = 46/101 (45%), Gaps = 10/101 (9%)
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR-LKADGLPSCSSSPARM 395
A L YLH I++RD+K NILLD + +TD G+ K ++ +G S
Sbjct: 106 ASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST------F 156
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
GT Y APE D + G VL E++ G P +
Sbjct: 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
G+++LH A I+HRD+K SNI++ + KI D G+A R +P + T
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTSF---MMTPYVV--T 180
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
Y APE + D++S G ++ E+I G
Sbjct: 181 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 34/115 (29%), Positives = 57/115 (49%), Gaps = 14/115 (12%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
G+++LH A I+HRD+K SNI++ + KI D G+A+ + + +P + T
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM----MTPYVV--T 185
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSI 453
Y APE + D++S G ++ EL+ G I +G + + W K I
Sbjct: 186 RYYRAPEVILGMGYKENVDIWSVGCIMGELVKG-----SVIFQGTDHIDQWNKVI 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 37/108 (34%), Positives = 52/108 (48%), Gaps = 16/108 (14%)
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL-PSC 388
VA AIG YLH + I++RD+K NILLD + +TD G+ K +G+ P
Sbjct: 105 VASAIG------YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEE 151
Query: 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
++S GT Y APE D + G VL E++ G P +
Sbjct: 152 TTST--FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 50/200 (25%), Positives = 75/200 (37%), Gaps = 51/200 (25%)
Query: 269 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGM 324
LTE ++L+ L H + L Y S F+ + + LV ++ P G L L L E
Sbjct: 49 LTEQEILATLDHPFLPTL--YAS-FQTETYL-CLVMDYCPGGELFRLLQRQPGKCLSE-- 102
Query: 325 NWDTRVAIAIGAAR---GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD------LG 375
AA LEYLH I++RD+K NILL E+ + ++D
Sbjct: 103 -----EVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154
Query: 376 MAKRLKADGLPSCSSSPARMQ------------------GTFGYFAPEYAMVGRASLMS- 416
+ + L S + GT Y APE V
Sbjct: 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE---VISGDGHGS 211
Query: 417 --DVFSFGVVLLELITGRQP 434
D ++ G++L E++ G P
Sbjct: 212 AVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 30/137 (21%), Positives = 55/137 (40%), Gaps = 17/137 (12%)
Query: 231 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGY 289
++ G ++ VY D V +K ++ + EV +L L + VP V
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LKINPSR---EKGADREREVAILQLLARKGLPVPKVLA 60
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 349
E G L+ E+ ++G ++ ++ + + IA A L LH+
Sbjct: 61 SGESDGWSY---LLMEW---------IEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 350 RILHRDIKSSNILLDEN 366
+ H D+ NIL+D+
Sbjct: 109 VLCHGDLHPGNILVDDG 125
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 13/81 (16%)
Query: 302 LVFEFMPNGNLRDCLD--GVLVEGM--NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 357
LV E++ G+++ L G E M + + VA+A L+YLH I+HRD+K
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALA------LDYLHRHG---IIHRDLK 131
Query: 358 SSNILLDENLNAKITDLGMAK 378
N+L+ + K+TD G++K
Sbjct: 132 PDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 46/219 (21%)
Query: 233 GQGGSSYVYRGQL---TDGRIVA-------VKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
GQG + +Y+G L +D IV V + ++ + F T ++S+L H H
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFET-ASLMSQLSHKH 62
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAIGAAR 338
+V L G C R ++V E++ G L L + V ++W ++ +A A
Sbjct: 63 LVKLYGVCV-----RDENIMVEEYVKFGPLDVFLHREKNNV---SLHW--KLDVAKQLAS 112
Query: 339 GLEYLHEAAAPRILHRDIKSSNILL-DENLN------AKITDLGMAKRLKADGLPSCSSS 391
L YL + +++H ++ NIL+ LN K++D G+P S
Sbjct: 113 ALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD---------PGIPITVLS 160
Query: 392 PARMQGTFGYFAPEYAMVGRASLMS--DVFSFGVVLLEL 428
+ APE G+ASL D +SFG LLE+
Sbjct: 161 REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 7/103 (6%)
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389
+AI R ++YLHE RI+HRDIK+ NI ++ + + D G A + +
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA----CFPVDINA 237
Query: 390 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
+ GT APE D++S G+VL E+ T
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 25/82 (30%), Positives = 41/82 (50%), Gaps = 17/82 (20%)
Query: 302 LVFEFMPNGNLRDCLDGVLVEGMNWD------TRVAIAIGAARGLEYLHEAAAPRILHRD 355
L+ EF+P G+L L + +D TR +A +E +H+ +HRD
Sbjct: 78 LIMEFLPGGDLMTML-------IKYDTFSEDVTRFYMA-ECVLAIEAVHKLG---FIHRD 126
Query: 356 IKSSNILLDENLNAKITDLGMA 377
IK NIL+D + K++D G++
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 42/177 (23%), Positives = 67/177 (37%), Gaps = 51/177 (28%)
Query: 302 LVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359
V +++P G++ L G+ E + R IA +E +H+ +HRDIK
Sbjct: 78 FVMDYIPGGDMMSLLIRMGIFPEDL---ARFYIA-ELTCAVESVHKMG---FIHRDIKPD 130
Query: 360 NILLDENLNAKITDLGMAKRLK---------------------------------ADGLP 386
NIL+D + + K+TD G+ + D L
Sbjct: 131 NILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLK 190
Query: 387 SCSSSPARMQ---------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
AR GT Y APE + + + D +S GV+L E++ G+ P
Sbjct: 191 PLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 8e-04
Identities = 27/94 (28%), Positives = 43/94 (45%), Gaps = 13/94 (13%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP-ARMQGT 398
L+ LH I+ RD+ +NILLD+ + ++T ++ SC M
Sbjct: 98 LDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVE----DSCDGEAVENM--- 147
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
Y APE + + D +S G +L EL+TG+
Sbjct: 148 --YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 54/208 (25%), Positives = 85/208 (40%), Gaps = 55/208 (26%)
Query: 271 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDT 328
E D+L+ + VV L Y S F+ K + V +++P G++ L V E +
Sbjct: 51 ERDILAEADNEWVVKL--YYS-FQDKDNL-YFVMDYIPGGDMMSLLIRMEVFPEVL---A 103
Query: 329 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM------------ 376
R IA +E +H+ +HRDIK NIL+D + + K+TD G+
Sbjct: 104 RFYIA-ELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159
Query: 377 ---AKRLKADGL-PS----------CS------SSPARMQ----------GTFGYFAPEY 406
++ D + PS C A Q GT Y APE
Sbjct: 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV 219
Query: 407 AMVGRASLMSDVFSFGVVLLELITGRQP 434
+ + + D +S GV+L E++ G+ P
Sbjct: 220 LLRKGYTQLCDWWSVGVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 466 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.98 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.98 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.98 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.18 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.14 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.14 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.13 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.03 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.9 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.87 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.84 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.83 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.73 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.73 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.66 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.53 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.44 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.42 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.41 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.39 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.38 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.23 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.21 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.17 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.08 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.99 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.97 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.94 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.93 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.9 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.89 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.83 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.82 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.65 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.62 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.56 | |
| KOG1219 | 4289 | consensus Uncharacterized conserved protein, conta | 97.42 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.37 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.33 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.32 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.26 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.25 | |
| PLN02236 | 344 | choline kinase | 97.09 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.09 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.98 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.77 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.67 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.51 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.51 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.42 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.41 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.37 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.27 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.23 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.86 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 95.82 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.69 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.63 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.6 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.46 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-51 Score=409.47 Aligned_cols=239 Identities=54% Similarity=0.902 Sum_probs=212.1
Q ss_pred eeeeechHHHHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeee
Q 012297 210 TIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289 (466)
Q Consensus 210 ~~~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~ 289 (466)
....|++.++..||++|...++||+|+||.||+|.+++++.||||++....... ..+|.+|++++.+++|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 457899999999999999999999999999999999999999999988775543 5569999999999999999999999
Q ss_pred eeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 012297 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 369 (466)
Q Consensus 290 ~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~v 369 (466)
|.+... .++||||||++|+|.++|+......++|..|++||.++|+||+|||+...|+|+||||||+|||||+++++
T Consensus 140 C~e~~~---~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 140 CLEGGE---HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EecCCc---eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 998432 57999999999999999987543378999999999999999999999988899999999999999999999
Q ss_pred EEEecCCcccccc-CCCCCCCCCCCcc-ccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChhhHH
Q 012297 370 KITDLGMAKRLKA-DGLPSCSSSPARM-QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 447 (466)
Q Consensus 370 kL~DfGla~~~~~-~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~~~~~l~ 447 (466)
||+|||+++.... .. ..... .||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+......+.+++
T Consensus 217 KlsDFGLa~~~~~~~~------~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~ 290 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDT------SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV 290 (361)
T ss_pred EccCccCcccCCcccc------ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence 9999999965543 21 11111 7999999999999999999999999999999999999999876666677899
Q ss_pred HHHHHhhcchh
Q 012297 448 LWVKSIITDAS 458 (466)
Q Consensus 448 ~~~~~~~~d~~ 458 (466)
.|+++.+.+..
T Consensus 291 ~w~~~~~~~~~ 301 (361)
T KOG1187|consen 291 EWAKPLLEEGK 301 (361)
T ss_pred HHHHHHHHCcc
Confidence 99999888863
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=340.65 Aligned_cols=200 Identities=29% Similarity=0.472 Sum_probs=177.9
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.+|...+.||+|+|++||+|+++ ++..||||.+.... .++..+.+..|+++|+.++|||||++++++.. +...+
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~----~~~i~ 85 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED----DDFIY 85 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec----CCeEE
Confidence 45777788999999999999876 47899999998765 45556668899999999999999999999887 55889
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC------CcEEEEecC
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN------LNAKITDLG 375 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~------~~vkL~DfG 375 (466)
|||||+.+|+|.+|++.. ..+++.++..++.|+|.||++||+++ |+||||||.||||+.. -.+||+|||
T Consensus 86 lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 999999999999999875 46899999999999999999999999 9999999999999765 458999999
Q ss_pred CccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+|+.+.... .-...+|++-|||||++....|+.|+|+||+|++|||+++|+.||+..
T Consensus 161 fAR~L~~~~------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 161 FARFLQPGS------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hhhhCCchh------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 999886432 244578999999999999999999999999999999999999999843
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=342.82 Aligned_cols=203 Identities=34% Similarity=0.546 Sum_probs=175.0
Q ss_pred CcceecccCcEEEEEEEEcCCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEec
Q 012297 228 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 228 ~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey 306 (466)
..+.||+|+||+||+|.+.....||||++...... ...+.|.+|+.+|.+++|||||+++|+|.+... ...+||||
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---~~~iVtEy 121 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---SLCIVTEY 121 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC---ceEEEEEe
Confidence 34569999999999999976556999999876422 225679999999999999999999999987432 46899999
Q ss_pred CCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCccccccCCC
Q 012297 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRLKADGL 385 (466)
Q Consensus 307 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~-~vkL~DfGla~~~~~~~~ 385 (466)
|++|+|.++++......+++..++.++.|||+||+|||+.+. ||||||||+|||++.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999987545679999999999999999999999873 99999999999999997 99999999998765432
Q ss_pred CCCCCCCCccccCcccccchhcc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAM--VGRASLMSDVFSFGVVLLELITGRQPIHRSIT 440 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~ 440 (466)
.......||+.|||||++. ...++.|+|||||||+||||+||+.||.....
T Consensus 199 ----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 199 ----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred ----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 1223367999999999999 66899999999999999999999999986543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=359.04 Aligned_cols=208 Identities=30% Similarity=0.482 Sum_probs=180.6
Q ss_pred CCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
.+....+.||+|.||.||+|... +...||||.++.....+.+.+|.+|+++++.|+|||||+|+|+|.+ +
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~----~ 561 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE----G 561 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc----C
Confidence 33444578999999999999754 3568999999999888788999999999999999999999999998 5
Q ss_pred eeEEEEEecCCCCCHHHHhcccc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVL------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~ 365 (466)
...++|+|||..|||.+||.... ..+++..+.+.||.|||.||+||-++. +|||||.++|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence 56799999999999999995422 122888999999999999999999988 999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCC
Q 012297 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITK 441 (466)
Q Consensus 366 ~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~~~~ 441 (466)
+..|||+||||++.....++. +...+..-+.+|||||.+..++||++||||||||+|||+++ |++|+.....+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYY---k~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYY---KVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred ceEEEecccccchhhhhhhhh---cccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 999999999999987665543 22334456789999999999999999999999999999997 99999876543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=343.99 Aligned_cols=203 Identities=33% Similarity=0.479 Sum_probs=176.5
Q ss_pred CCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
.+...+.||+|.||.||.|.++....||+|.++... ...+.|.+|+.+|++|+|+|||+++|+|.. ....+|||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~----~~piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTK----QEPIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEec----CCceEEEE
Confidence 344567899999999999999888899999998763 233469999999999999999999999987 33679999
Q ss_pred ecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCC
Q 012297 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~ 384 (466)
|||+.|+|.+||+......++..+.+.++.|||+||+||.+++ +|||||.++||||+++..+||+|||||+....+.
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 9999999999998755667999999999999999999999998 9999999999999999999999999999665554
Q ss_pred CCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSIT 440 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~~~ 440 (466)
+.. .....-+..|.|||.+..+.++.|||||||||+||||+| |+.|+.....
T Consensus 358 Y~~----~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn 410 (468)
T KOG0197|consen 358 YTA----SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN 410 (468)
T ss_pred eee----cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH
Confidence 422 122223578999999999999999999999999999998 9999876543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=320.72 Aligned_cols=203 Identities=28% Similarity=0.392 Sum_probs=179.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
.++|++.++||+|+||.||.++.. .++.+|+|+++...- ....+....|..+|.+++||.||++...+.+ ...
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt----~~k 99 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT----EEK 99 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc----CCe
Confidence 356888999999999999999754 588999999987642 2345568899999999999999999987766 567
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.|||+||+.||.|.-+|++. ..+++..+.-.+..|+.||.|||+.+ |+||||||+|||||++|+++|+|||+++.
T Consensus 100 LylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred EEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchh
Confidence 89999999999999999865 55899999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
...++. ....++||+.|||||++.+..++..+|.||||+++|||++|.+||....
T Consensus 175 ~~~~~~-----~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 175 DLKDGD-----ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred cccCCC-----ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 655432 3455899999999999999999999999999999999999999998654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=331.47 Aligned_cols=202 Identities=29% Similarity=0.500 Sum_probs=181.6
Q ss_pred CCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
..|...++||+|+|+.+|+++. ..|+.||+|++.... .....+...+||++-++|+|||||+++++|.+ ....
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED----s~nV 93 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED----SNNV 93 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec----CCce
Confidence 4577889999999999999998 789999999997642 33445568899999999999999999999987 5678
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
|+|.|++++++|..++++. +.+++.++..+..||+.||.|||+.+ |+|||||..|+||+++.++||+|||||..+
T Consensus 94 YivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred EEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeee
Confidence 9999999999999999843 67999999999999999999999998 999999999999999999999999999998
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
..++ ......+||+-|+|||++.....+..+||||+||++|-|+.|++||+...
T Consensus 169 e~~~-----Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~ 222 (592)
T KOG0575|consen 169 EYDG-----ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT 222 (592)
T ss_pred cCcc-----cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch
Confidence 7653 23455799999999999999999999999999999999999999998653
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=316.01 Aligned_cols=194 Identities=34% Similarity=0.508 Sum_probs=162.6
Q ss_pred CCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHh--cCCCCccceeeeeeeccCcceeEEEEE
Q 012297 227 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR--LHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 227 ~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
+..+++|+|.||.||+|.+. ++.||||++.... .+.|.+|-++++. ++|+||++++++-......+..++||+
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCHHH----HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 33468999999999999995 5899999997653 3348888888875 479999999998665554566889999
Q ss_pred ecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA------APRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~------~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
+|.+.|+|.+||.. ..++|....+|+.-+++||+|||+.. .|+|+|||||++||||..|++..|+|||+|.
T Consensus 288 ~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999999986 45899999999999999999999753 3689999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCC------CchhHHHHHHHHHHHHHcC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA------SLMSDVFSFGVVLLELITG 431 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------s~~sDv~S~Gvll~elltG 431 (466)
++.+.... ......+||.+|||||++.+... -.+.||||+|.+||||++.
T Consensus 365 ~~~p~~~~---~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SR 420 (534)
T KOG3653|consen 365 RLEPGKPQ---GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASR 420 (534)
T ss_pred EecCCCCC---cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhh
Confidence 88754332 22334789999999999876432 3478999999999999984
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=312.24 Aligned_cols=196 Identities=31% Similarity=0.438 Sum_probs=176.6
Q ss_pred CcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEec
Q 012297 228 GSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 228 ~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey 306 (466)
..+.||+|..|+||+++++ +++.+|+|.+.....+...+++.+|++++++.+||+||+++|.|..... ...|+|||
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~---~isI~mEY 159 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE---EISICMEY 159 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc---eEEeehhh
Confidence 3578999999999999886 5889999999777777788889999999999999999999999987332 57999999
Q ss_pred CCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 307 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|.+|+|++++... +.+++...-.|+.+|++||.|||+ .+ |+||||||+|||++..|++||+|||.+..+...
T Consensus 160 MDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 9999999999865 568999999999999999999996 55 999999999999999999999999999887543
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.-..++||..|||||.+.+..|+.++||||||+.++|+.+|+.||...
T Consensus 233 -----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 233 -----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred -----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 234578999999999999999999999999999999999999999764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=309.41 Aligned_cols=208 Identities=25% Similarity=0.359 Sum_probs=176.5
Q ss_pred CCCCCcceecccCcEEEEEEE-EcCCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~-~~~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.+|++.++||+|.||.||++. +.+|..+|.|.++... +.+..+....|+.+|++|+|||||+.++.- ..++....+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~--f~~~~evln 96 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHS--FIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHh--hhccchhhH
Confidence 346677899999999999996 5689999999988553 344556689999999999999999999742 223344579
Q ss_pred EEEecCCCCCHHHHhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 302 LVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAA-PRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~~L~~LH~~~~-~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
|||||+..|+|.+.++... .+.+++..+++++.|+++||.++|+.-. ..|+||||||.||+|+.+|.|||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999996533 3459999999999999999999998431 139999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.+..+. ......+|||.||+||.+.+..|+.||||||+|+++|||..-++||...
T Consensus 177 ~l~s~~-----tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 177 FLSSKT-----TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred Hhcchh-----HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 876542 2345578999999999999999999999999999999999999999854
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=318.54 Aligned_cols=228 Identities=28% Similarity=0.418 Sum_probs=194.7
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
.+.+++...+.++||+|.||.|.++....+..||||+++.........+|.+|+++|.+++||||++|+|+|.. ++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~----De 608 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ----DD 608 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec----CC
Confidence 45566777888999999999999999988899999999999988888999999999999999999999999997 45
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++|+|||++|+|.+|+.+.......-...+.|+.|||.||+||.+.+ ++||||.++|+|+|.++++||+|||+++
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccc
Confidence 6799999999999999998765444455667789999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc--CCCCCCCCCCCChhhHHHHHHHhhcc
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT--GRQPIHRSITKGEESLVLWVKSIITD 456 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt--G~~Pf~~~~~~~~~~l~~~~~~~~~d 456 (466)
.+....+ .......+-+.+|||||.+..+.++.+||||+||+++||+++ .+.||..... +.+++=...++.+
T Consensus 686 ~lysg~y---y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~ 759 (807)
T KOG1094|consen 686 NLYSGDY---YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRD 759 (807)
T ss_pred ccccCCc---eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCC
Confidence 7765543 233445667889999999999999999999999999999886 8899976533 3455555555555
Q ss_pred hhh
Q 012297 457 ASI 459 (466)
Q Consensus 457 ~~~ 459 (466)
...
T Consensus 760 ~~~ 762 (807)
T KOG1094|consen 760 QGR 762 (807)
T ss_pred CCc
Confidence 443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=336.24 Aligned_cols=204 Identities=25% Similarity=0.417 Sum_probs=179.9
Q ss_pred CCcceecccCcEEEEEEEEcC----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 227 SGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 227 ~~~~~LG~G~fG~Vy~a~~~~----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.+.++||.|.||.|++|+++- ...||||.++.....+.+.+|+.|..+|.+++||||++|-|+... ....+|
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk----s~PvMI 707 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK----SKPVMI 707 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec----CceeEE
Confidence 467899999999999998863 468999999999888888899999999999999999999999886 456699
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
|+|||+||+|+.||+.+..+ |++.+.+.++++||.||.||-+.+ +|||||.++|||++.+...|++|||++|.+++
T Consensus 708 iTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999999987644 999999999999999999999999 99999999999999999999999999998866
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSIT 440 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~~~ 440 (466)
+... ........-+.+|.|||.+..+.++.+||||||||++||.++ |+.||.....
T Consensus 784 d~~~--~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 784 DPEA--AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred CCCc--cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence 5421 122222334678999999999999999999999999999886 9999986544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=313.24 Aligned_cols=203 Identities=27% Similarity=0.370 Sum_probs=170.6
Q ss_pred HhCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCC------hhHHHHHHHHHHHhcCCCCccceeeeeeecc
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPN------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 294 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~------~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~ 294 (466)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||+++...... ......+|+++|++|+|||||++++++..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-- 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-- 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--
Confidence 456677889999999999999975 469999999997653211 12235799999999999999999999987
Q ss_pred CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEE
Q 012297 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKI 371 (466)
Q Consensus 295 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~---~~vkL 371 (466)
....|+||||++||+|.+++-+. ..+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||
T Consensus 248 --~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 248 --PDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred --CCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEe
Confidence 44559999999999999999654 44677777899999999999999999 9999999999999655 78999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCcccccchhcccCC---CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 372 ~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
+|||+|+..... .....++||+.|.|||++.... +..+.|+||+||+||-+++|.+||....
T Consensus 321 tDFGlAK~~g~~------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 321 TDFGLAKVSGEG------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred cccchhhccccc------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 999999987543 3356689999999999997544 2458899999999999999999997543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=294.28 Aligned_cols=199 Identities=28% Similarity=0.366 Sum_probs=176.9
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|+..+.||.|+||.|.+++.+ +|..+|+|++....- .+..+...+|..+|+.+.||.++++.+.+.+ ....
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d----~~~l 119 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD----NSNL 119 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc----CCeE
Confidence 45677889999999999999876 588999999987642 2233447789999999999999999998877 5578
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||++||.|..+|++. +.+++..+.-+|.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||.|+++
T Consensus 120 ymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 9999999999999999875 56999999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.. ..-..+||+.|+|||.+....++..+|.|||||++|||+.|.+||....
T Consensus 195 ~~--------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 195 SG--------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred cC--------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 43 2345799999999999999999999999999999999999999997654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=309.37 Aligned_cols=206 Identities=28% Similarity=0.403 Sum_probs=175.0
Q ss_pred CCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
+.|+..++||+|.||.||+|+. .+|+.||+|++..+... ..-.-..+||.+|++|+||||++|.+...+. .....|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~--~~~siY 194 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK--LSGSIY 194 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec--CCceEE
Confidence 3455567899999999999975 56999999999877532 3333467999999999999999999998874 235789
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
||+|||+. +|..++... .-.|+..++..++.|++.||+|+|+.+ |+|||||.+|||||.+|.+||+|||||+.+.
T Consensus 195 lVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 99999955 888888753 245999999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSIT 440 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~~~ 440 (466)
.+.. ......+.|.+|.|||++.+. .|+...|+||.||||.||++|++.|+...+
T Consensus 270 ~~~~----~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE 325 (560)
T KOG0600|consen 270 PSGS----APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE 325 (560)
T ss_pred CCCC----cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence 5532 224556789999999998864 589999999999999999999999987643
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=302.54 Aligned_cols=209 Identities=25% Similarity=0.407 Sum_probs=185.5
Q ss_pred hCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.+.|.....||.|..++||+|+. +.++.||||++..+......+.+.+|+..|+.++||||++....|.. +...|
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv----~~~LW 100 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV----DSELW 100 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe----cceeE
Confidence 45677889999999999999975 45799999999988777777789999999999999999999998887 55789
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||+||.+|++.+.++.....++++..+..|++++++||.|||.+| .||||||+.||||+++|.|||+|||.+..+.
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 9999999999999998887888999999999999999999999999 9999999999999999999999999988777
Q ss_pred cCCCCCCCCCCCccccCcccccchhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
..+.....+ ...++||+.|||||++.. ..|+.|+||||||++..||.+|..||+...
T Consensus 178 ~~G~R~~~r-f~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 178 DSGDRQVTR-FNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred ccCceeeEe-eccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 666322222 266799999999999653 568999999999999999999999998654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=311.65 Aligned_cols=209 Identities=29% Similarity=0.406 Sum_probs=177.8
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCc
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~ 296 (466)
+-.++|..++.||+|+|++|++|+.. .++.+|||++....- ....+-...|-++|.+| .||.|++|+-.|.+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD---- 145 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD---- 145 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec----
Confidence 34567888999999999999999765 588999999876532 12222366788999999 79999999988877
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGl 376 (466)
....|+|+||+++|+|.++|.+. ..|++.....++.+|+.||+|||+.| ||||||||+|||||+|+++||+|||.
T Consensus 146 ~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 146 EESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred ccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccc
Confidence 55779999999999999999876 56899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCC----CC---CCC-CCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 377 AKRLKADGLP----SC---SSS-PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 377 a~~~~~~~~~----~~---~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|+.+.+.... .. ... ...++||..|.+||++.....++.+|+|+|||+||+|+.|++||...
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~ 290 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA 290 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc
Confidence 9987653321 11 111 14589999999999999999999999999999999999999999753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=338.55 Aligned_cols=206 Identities=30% Similarity=0.489 Sum_probs=177.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcC--Cc----EEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD--GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~--~~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
.+.+..+.||+|.||.||.|...+ +. .||||.++.....+...+|++|..+|++++|||||+++|+|.+ .
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~----~ 767 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD----S 767 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC----C
Confidence 344556789999999999998754 33 4999999988888888899999999999999999999999998 4
Q ss_pred eeEEEEEecCCCCCHHHHhcccc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVL-----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 372 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~ 372 (466)
..++|++|||++|+|..||+..+ ...++..+.+.++.|||+|+.||++++ +|||||.++|+||++...|||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEc
Confidence 46699999999999999998752 234889999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 012297 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 439 (466)
Q Consensus 373 DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~~ 439 (466)
|||||+.+....+.. ......-+.+|||||.+..+.++.|+|||||||+|||++| |..||....
T Consensus 845 DFGlArDiy~~~yyr---~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~ 909 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYR---KHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS 909 (1025)
T ss_pred ccchhHhhhhchhee---ccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc
Confidence 999999654433321 1122345679999999999999999999999999999998 999997543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=313.96 Aligned_cols=196 Identities=31% Similarity=0.511 Sum_probs=172.6
Q ss_pred HHHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 218 ~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
.|+...+..+.++.||.|+.|.||+|++. ++.||||+++... ..+|+.|++|+|+||+.+.|+|.. .
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtq----s 184 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQ----S 184 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecC----C
Confidence 34444445556789999999999999995 6889999887542 367999999999999999999987 5
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
..++|||||++.|.|.+.|+.. +.++....+.+..+||.||.|||.+. |||||||+-||||..+..+||+|||.+
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred ceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccch
Confidence 5779999999999999999865 66899999999999999999999988 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
+.+.... ..-.++||..|||||++...+.+.|.|||||||+||||+||..||..
T Consensus 260 ~e~~~~S------TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 260 KELSDKS------TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred Hhhhhhh------hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence 8775432 23347899999999999999999999999999999999999999964
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=306.34 Aligned_cols=208 Identities=27% Similarity=0.445 Sum_probs=171.9
Q ss_pred HhCCCCCcceecccCcEEEEEEEE------cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeecc
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 294 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~------~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~ 294 (466)
..++|.+.+.||+|+||.||+|.+ .+++.||||+++..........+.+|++++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 456788889999999999999974 235689999998654444556699999999999 899999999988642
Q ss_pred CcceeEEEEEecCCCCCHHHHhcccc------------------------------------------------------
Q 012297 295 GKRAMRLLVFEFMPNGNLRDCLDGVL------------------------------------------------------ 320 (466)
Q Consensus 295 ~~~~~~~lV~ey~~~gsL~~~l~~~~------------------------------------------------------ 320 (466)
....++||||+++|+|.+++....
T Consensus 84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 235689999999999999986421
Q ss_pred ------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCc
Q 012297 321 ------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394 (466)
Q Consensus 321 ------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~ 394 (466)
...+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++........ .....
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~---~~~~~ 235 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---VRKGS 235 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcch---hcccC
Confidence 124788899999999999999999998 999999999999999999999999999865432111 11222
Q ss_pred cccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 395 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 395 ~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
..++..|+|||.+....++.++||||||++||||++ |..||...
T Consensus 236 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~ 280 (338)
T cd05102 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280 (338)
T ss_pred CCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence 345678999999998899999999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=299.32 Aligned_cols=205 Identities=32% Similarity=0.502 Sum_probs=173.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.++...+.||+|+||+||++...+ |+..|||.+....... .+.+.+|+.+|++++|||||+.+|....... ..+.+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~--~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSREN--DEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccC--eeeEe
Confidence 345567899999999999998765 8999999988764333 4558899999999999999999997444222 46799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRLK 381 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~-~~~vkL~DfGla~~~~ 381 (466)
.|||+++|+|.+++.+... .+++..+..+.+|+++||+|||+++ |+|+||||+|||++. ++.+||+|||++....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999987654 7999999999999999999999998 999999999999999 7999999999998765
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
... ..........||+.|||||++..+ ...+++||||||++++||+||++||..
T Consensus 170 ~~~--~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 170 SKG--TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ccc--ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 411 112234457899999999999853 344699999999999999999999975
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=310.14 Aligned_cols=199 Identities=29% Similarity=0.479 Sum_probs=176.8
Q ss_pred hCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
...|.....||+|..|.||.|.. ..++.||||++....... .+.+++|+.+|+..+|+|||+++.-+.. ....|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-keLilnEi~Vm~~~~H~NiVnfl~Sylv----~deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-KELLLNEILVMRDLHHPNIVNFLDSYLV----GDELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-hhhhHHHHHHHHhccchHHHHHHHHhcc----cceeE
Confidence 45577778999999999999964 468899999998765433 3458899999999999999999987765 35779
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+|||||++|+|.+.+... .+++.++..|.+++++||+|||..+ |+|||||++|||++.++.+||+|||++..+.
T Consensus 347 VVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred EEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 999999999999998764 3899999999999999999999999 9999999999999999999999999998876
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
... ......+||+.|||||++....|.+|.||||||++++||+-|++||..
T Consensus 421 ~~~-----~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 421 EEQ-----SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred ccc-----CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 553 245667899999999999999999999999999999999999999985
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=306.22 Aligned_cols=214 Identities=29% Similarity=0.440 Sum_probs=181.6
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|.+.+.||+|.||.||||+-+ +.+.||+|.+..... .+..+.+.+|+++++.++||||+.+++++.. ..+.+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt----~~~~~ 77 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET----SAHLW 77 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc----cceEE
Confidence 46777789999999999999754 578999999876643 3345568999999999999999999988876 56779
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+|+||+.| +|..+|... ..+++..+..++.++..||.|||+.+ |+|||+||.|||++.++.+|++|||+|+...
T Consensus 78 vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMS 151 (808)
T ss_pred EEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcc
Confidence 99999966 999999764 56999999999999999999999998 9999999999999999999999999999875
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHHHHHhhcchh
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSIITDAS 458 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~~~~~l~~~~~~~~~d~~ 458 (466)
.. ......+.||+-|||||+..+++|+..+|+||+||+||||++|++||.. .++..-++..++|+-
T Consensus 152 ~~-----t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d~v 217 (808)
T KOG0597|consen 152 TN-----TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKDPV 217 (808)
T ss_pred cC-----ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcCCC
Confidence 43 2234457899999999999999999999999999999999999999963 344444444444443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=301.84 Aligned_cols=222 Identities=24% Similarity=0.360 Sum_probs=183.0
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
..++|+.+..||+|+||.||+++-+ .|..+|+|+++...- .......+.|-++|...+++.||+|+..|.+ ..
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD----~~ 214 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD----KE 214 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC----CC
Confidence 4567888999999999999999755 599999999987632 2233447889999999999999999988876 66
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..||||||+|||++..+|... ..+++..+...+.+++-|++-||..| +|||||||+|+|||..|++||+||||+.
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred eeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccc
Confidence 789999999999999999764 56899999999999999999999999 9999999999999999999999999986
Q ss_pred ccccCC------------------CCCCCC------CC------------------CccccCcccccchhcccCCCCchh
Q 012297 379 RLKADG------------------LPSCSS------SP------------------ARMQGTFGYFAPEYAMVGRASLMS 416 (466)
Q Consensus 379 ~~~~~~------------------~~~~~~------~~------------------~~~~gt~~y~aPE~~~~~~~s~~s 416 (466)
-+.... .+.... .. ..++|||.|+|||++.+..|+...
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 432100 000000 00 014699999999999999999999
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCCC-hhhHHHHHHH
Q 012297 417 DVFSFGVVLLELITGRQPIHRSITKG-EESLVLWVKS 452 (466)
Q Consensus 417 Dv~S~Gvll~elltG~~Pf~~~~~~~-~~~l~~~~~~ 452 (466)
|.||||+|+||||.|.+||......+ =..|+.|-.-
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~ 406 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET 406 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh
Confidence 99999999999999999998765443 3567777643
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=309.47 Aligned_cols=209 Identities=30% Similarity=0.460 Sum_probs=177.5
Q ss_pred echHHHHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeee
Q 012297 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 292 (466)
Q Consensus 214 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~ 292 (466)
.+.++|+...+++.+...||+|.||+||+|.+.. .||||+++... .++..+.|.+|+.++++-+|.||+-++|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3447788888888899999999999999999853 39999998774 33445679999999999999999999999986
Q ss_pred ccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 012297 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 372 (466)
Q Consensus 293 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~ 372 (466)
. .. .||+-|++|-+|..+|+... ..|+..+.+.||+|||+||.|||.++ |||||||+.||||.++++|||+
T Consensus 460 p----~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIg 530 (678)
T KOG0193|consen 460 P----PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIG 530 (678)
T ss_pred C----ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEe
Confidence 2 23 89999999999999998654 56999999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCcccccchhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 373 DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
|||++..-..-. .........|..-|||||++. ..+|+.++||||||+++|||++|..||.
T Consensus 531 DFGLatvk~~w~---g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 531 DFGLATVKTRWS---GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred cccceeeeeeec---cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 999987533221 111222334678899999986 3568999999999999999999999997
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=317.57 Aligned_cols=208 Identities=28% Similarity=0.417 Sum_probs=179.9
Q ss_pred CcceecccCcEEEEEEEE-cC----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 228 GSNIVGQGGSSYVYRGQL-TD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 228 ~~~~LG~G~fG~Vy~a~~-~~----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
..++||.|+||+||+|.+ ++ +-+||+|++......+...+|++|+.+|.+++|||+++|+|+|... ...|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s-----~~ql 774 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS-----TLQL 774 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc-----hHHH
Confidence 357899999999999975 33 3479999999888888888999999999999999999999999852 3689
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
|++|||.|+|.+|++..+ ..+..+..+.|..|||+||.|||++. ++||||.++|||+..-..+||.|||+++.+..
T Consensus 775 vtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999999998754 45888999999999999999999988 99999999999999999999999999999887
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCChhhHH
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLV 447 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~~~~~~~~l~ 447 (466)
++..- ......-++.|||-|.+....++.++|||||||++|||+| |..|++....++-.++.
T Consensus 851 d~~ey---~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll 913 (1177)
T KOG1025|consen 851 DEKEY---SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL 913 (1177)
T ss_pred ccccc---cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH
Confidence 76432 2222344678999999999999999999999999999998 99999876655444433
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=293.51 Aligned_cols=201 Identities=26% Similarity=0.426 Sum_probs=171.6
Q ss_pred CCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
|+..+.||+|+||.||++.. .+++.||+|.+..... ......+.+|+.++++++|+||+++++++.+ ....++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~----~~~~~l 77 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET----KDALCL 77 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc----CCeEEE
Confidence 56678999999999999986 4689999999875432 2233458899999999999999999998876 346799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.....
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 999999999998886544456899999999999999999999998 99999999999999999999999999976532
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 155 ~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 155 GE------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred CC------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 21 1223468999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=304.35 Aligned_cols=206 Identities=23% Similarity=0.366 Sum_probs=172.5
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|+..+.||+|+||+||++... +++.||+|++.... .......+.+|++++.+++|+||+++++.+.+ ....
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~----~~~~ 76 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD----KLNL 76 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec----CCeE
Confidence 36788899999999999999765 58899999987532 12233457889999999999999999998876 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 9999999999999999754 46899999999999999999999998 999999999999999999999999998764
Q ss_pred ccCCCCC------------------------------CCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc
Q 012297 381 KADGLPS------------------------------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430 (466)
Q Consensus 381 ~~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt 430 (466)
....... .........||+.|+|||.+.+..++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 231 (363)
T cd05628 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (363)
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence 3211000 0000123579999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 012297 431 GRQPIHRS 438 (466)
Q Consensus 431 G~~Pf~~~ 438 (466)
|+.||...
T Consensus 232 G~~Pf~~~ 239 (363)
T cd05628 232 GYPPFCSE 239 (363)
T ss_pred CCCCCCCC
Confidence 99999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=301.46 Aligned_cols=202 Identities=27% Similarity=0.391 Sum_probs=174.5
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC----CChhHHHHHHHHHHHhcC-CCCccceeeeeeeccC
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG----PNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRG 295 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~----~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~ 295 (466)
....|...+.||+|+||+|++|... +++.||+|++..... ......+.+|+.+++.++ ||||++++.++..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--- 91 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--- 91 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec---
Confidence 3467888899999999999999654 689999997766411 123445678999999998 9999999999876
Q ss_pred cceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEec
Q 012297 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDL 374 (466)
Q Consensus 296 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~-~~vkL~Df 374 (466)
....++||||+.+|+|.+++... ..+.+.++..+++|++.|++|+|+.+ |+||||||+|||+|.+ +++||+||
T Consensus 92 -~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 92 -PTKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred -CCeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence 34589999999999999999873 56888999999999999999999999 9999999999999999 99999999
Q ss_pred CCccccc-cCCCCCCCCCCCccccCcccccchhcccCC-C-CchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 375 GMAKRLK-ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-A-SLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 375 Gla~~~~-~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|++.... .+ ......+|++.|+|||++.+.. | ..++||||+||+||-|++|+.||+..
T Consensus 166 G~s~~~~~~~------~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~ 226 (370)
T KOG0583|consen 166 GLSAISPGED------GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS 226 (370)
T ss_pred ccccccCCCC------CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc
Confidence 9998763 22 3455678999999999999877 7 58899999999999999999999863
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=284.91 Aligned_cols=200 Identities=28% Similarity=0.408 Sum_probs=172.5
Q ss_pred CCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.|+...++|+|++|.||+++.++ |+.||||++..... +...+-.++|+++|++++|+|+|.|+.+|.. ....+|
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr----krklhL 78 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR----KRKLHL 78 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh----cceeEE
Confidence 46666789999999999999875 99999999876543 5555668999999999999999999999876 556799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
|+||+.. ++.+-|+.. ..+++......++.|+++|+.|+|+++ ++||||||+||||+.++.+||+|||+|+.+..
T Consensus 79 VFE~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 79 VFEYCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred Eeeecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 9999955 555556553 366899999999999999999999999 99999999999999999999999999998763
Q ss_pred CCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
. .......+.|-+|.|||++.+ ..|....||||.|+++.||++|.+-|...
T Consensus 154 p-----gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~ 205 (396)
T KOG0593|consen 154 P-----GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR 205 (396)
T ss_pred C-----cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc
Confidence 2 234566788999999999887 67999999999999999999999998654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=313.26 Aligned_cols=208 Identities=28% Similarity=0.396 Sum_probs=173.9
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcCC----cE-EEEEEccc--CCCCChhHHHHHHHHHHHhcCCCCccceeeeee
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDG----RI-VAVKRFKT--QGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~----~~-vaVK~l~~--~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~ 291 (466)
|+...++-...++||+|+||.||+|++..+ .. ||||..+. ........+|++|.++|++++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 444445555568999999999999987532 23 89999885 234555677999999999999999999999998
Q ss_pred eccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 012297 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 371 (466)
Q Consensus 292 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL 371 (466)
. ....+||||+++||+|.+||+... ..++..+++.++.++|+||+|||+.+ ++||||.++|+|++.++.+||
T Consensus 232 ~----~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 232 L----EEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred C----CCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEe
Confidence 7 556799999999999999998754 35999999999999999999999998 999999999999999999999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 012297 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 439 (466)
Q Consensus 372 ~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~~ 439 (466)
+|||+++....... ....-.-+.+|+|||.+....++.++|||||||++||+++ |..||....
T Consensus 304 SDFGLs~~~~~~~~-----~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 304 SDFGLSRAGSQYVM-----KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred CccccccCCcceee-----ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence 99999876541111 0111134678999999999999999999999999999998 888987653
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=308.13 Aligned_cols=202 Identities=24% Similarity=0.364 Sum_probs=173.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcce
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~ 298 (466)
.++|....+||+|+||+|+++.++ +++.+|||+++...- .+..+....|..++.-. +||.++.++.++.. ..
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT----~~ 442 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT----KE 442 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc----CC
Confidence 467888999999999999999876 478999999998753 22333467788887776 59999999998876 66
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
+.++||||..||++..+.+ ...+++..+.-++..|+.||+|||+++ ||+||||.+|||||.+|++||+||||++
T Consensus 443 ~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred eEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 7899999999999443333 356999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
...-. ......++||+.|+|||++.+..|+...|.|||||+|||||.|+.||....
T Consensus 517 e~m~~-----g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd 572 (694)
T KOG0694|consen 517 EGMGQ-----GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD 572 (694)
T ss_pred ccCCC-----CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 75432 234667899999999999999999999999999999999999999998543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=295.13 Aligned_cols=198 Identities=25% Similarity=0.368 Sum_probs=171.5
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++++++.+ ....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~ 76 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD----QRFL 76 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc----CCeE
Confidence 36788899999999999999875 58899999986542 22234458899999999999999999988765 4577
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 77 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~ 151 (291)
T cd05612 77 YMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL 151 (291)
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence 9999999999999999754 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 152 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 152 RDR--------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred cCC--------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 322 12346889999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=273.52 Aligned_cols=200 Identities=25% Similarity=0.367 Sum_probs=170.0
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCCh-hHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNA-DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+|...+.||+|.||.||+|++. .|+.||||+++.....+. ....++|++.|+.++|+||+.+++++.. ....-|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~----~~~l~l 78 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH----KSNLSL 78 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC----CCceEE
Confidence 4666788999999999999764 689999999987743322 3347899999999999999999999876 456789
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
|+||| ..+|+..++... ..++..++..++.++++|++|||++. |+||||||.|+|++++|.+||+|||+++.+..
T Consensus 79 VfEfm-~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 79 VFEFM-PTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred EEEec-cccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 99999 559999998643 56899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .....+-|-+|.|||++.+. .|+...|+||.||++.||+-|.+-|...
T Consensus 154 p~~-----~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~ 205 (318)
T KOG0659|consen 154 PNR-----IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD 205 (318)
T ss_pred CCc-----ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC
Confidence 432 12223678999999998864 5899999999999999999888777543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=282.83 Aligned_cols=203 Identities=26% Similarity=0.364 Sum_probs=173.6
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChh-HHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~-~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|+.++.|++|.||.||+|++. +++.||+|+++.+...... ---++||++|.+.+|||||.+-.+..-.. -...|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~--~d~iy 153 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN--MDKIY 153 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc--cceee
Confidence 45677889999999999999875 5889999999877533222 12689999999999999999988876433 33579
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||++. +|...++.- .++|...+..-+..|+++|++|||.+. |+|||||++|+|+...|.+||+|||+||.+.
T Consensus 154 ~VMe~~Eh-DLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeHHHHHh-hHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 99999954 999998764 367999999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. .......+.|.+|.|||++.+. .|++..|+||+|||+.||+++++-|...
T Consensus 229 sp-----~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 229 SP-----LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred CC-----cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence 54 2345667889999999998865 5899999999999999999999998754
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=300.14 Aligned_cols=198 Identities=26% Similarity=0.362 Sum_probs=171.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcC--CcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD--GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~--~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
++|+..+.||+|+||.||+|.+.+ +..||+|++.... .......+.+|+++++.++||||+++++++.+ ...
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----~~~ 105 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD----ESY 105 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe----CCE
Confidence 457788999999999999998643 3689999986432 22334568899999999999999999999876 456
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 79999999999999999754 45899999999999999999999998 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 181 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 181 VDTR--------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred cCCC--------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 5321 22356899999999999888999999999999999999999999754
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=304.71 Aligned_cols=206 Identities=23% Similarity=0.321 Sum_probs=171.1
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.|...+.||+|+||+||+|... +++.||||++.... .......+.+|++++++++|+||+++++++.+ ....+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~----~~~~~ 77 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD----KDNLY 77 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec----CCEEE
Confidence 5777889999999999999764 57899999987542 22334568899999999999999999999876 44679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~ 152 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFR 152 (381)
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence 999999999999999754 45889999999999999999999998 9999999999999999999999999976432
Q ss_pred cCCCCC------------------------------------------CCCCCCccccCcccccchhcccCCCCchhHHH
Q 012297 382 ADGLPS------------------------------------------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVF 419 (466)
Q Consensus 382 ~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~ 419 (466)
...... .........||+.|+|||.+....++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (381)
T cd05626 153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232 (381)
T ss_pred cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence 110000 00001235799999999999988899999999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 012297 420 SFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 420 S~Gvll~elltG~~Pf~~~~ 439 (466)
||||++|||++|+.||....
T Consensus 233 SlG~il~elltG~~Pf~~~~ 252 (381)
T cd05626 233 SVGVILFEMLVGQPPFLAPT 252 (381)
T ss_pred ehhhHHHHHHhCCCCCcCCC
Confidence 99999999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=299.26 Aligned_cols=198 Identities=29% Similarity=0.419 Sum_probs=172.6
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|++.+.||+|+||.||+|.+. +++.||||++.... .......+.+|++++..++|+||+++++++.+ ....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~----~~~~ 76 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD----DEYL 76 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc----CCEE
Confidence 36788899999999999999876 48899999987542 22334568899999999999999999998876 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~ 151 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGI 151 (333)
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence 9999999999999999754 45899999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 152 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 152 VT--------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred cc--------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence 33 123356899999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=302.42 Aligned_cols=206 Identities=24% Similarity=0.363 Sum_probs=172.5
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|+..+.||+|+||.||+++.. +++.||||++.... .......+.+|++++..++|+||+++++++.+ ....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~----~~~~ 76 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD----ENYL 76 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc----CCeE
Confidence 36888899999999999999875 58899999997542 12233457889999999999999999998876 4577
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++..+
T Consensus 77 ~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred EEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999999999754 45899999999999999999999998 999999999999999999999999998764
Q ss_pred ccCCCCCCC---------------------------------CCCCccccCcccccchhcccCCCCchhHHHHHHHHHHH
Q 012297 381 KADGLPSCS---------------------------------SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 427 (466)
Q Consensus 381 ~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~e 427 (466)
......... .......||+.|+|||++....++.++|||||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 231 (364)
T cd05599 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231 (364)
T ss_pred cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence 322110000 00112468999999999999899999999999999999
Q ss_pred HHcCCCCCCCC
Q 012297 428 LITGRQPIHRS 438 (466)
Q Consensus 428 lltG~~Pf~~~ 438 (466)
|++|..||...
T Consensus 232 l~~G~~Pf~~~ 242 (364)
T cd05599 232 MLVGYPPFCSD 242 (364)
T ss_pred hhcCCCCCCCC
Confidence 99999999753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=297.72 Aligned_cols=198 Identities=26% Similarity=0.368 Sum_probs=171.9
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+.+.||+|+||.||+|++. +++.||+|.+.... .......+.+|+.++++++||||+++++++.+ ....
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~ 93 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD----ENRV 93 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc----CCEE
Confidence 45777889999999999999875 58899999987542 22334568899999999999999999998876 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 9999999999999999754 45889999999999999999999998 999999999999999999999999999865
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .....|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 169 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 169 PDR--------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred CCC--------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 332 12346899999999999988999999999999999999999999643
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=296.34 Aligned_cols=195 Identities=26% Similarity=0.339 Sum_probs=167.4
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEec
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey 306 (466)
+.||+|+||.||++... +++.||+|+++... .......+.+|++++++++||||+++++++.. ....++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----~~~~~lv~e~ 76 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT----HDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc----CCEEEEEEeC
Confidence 36999999999999874 68899999987542 22333457889999999999999999998876 4467999999
Q ss_pred CCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCC
Q 012297 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 386 (466)
Q Consensus 307 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~ 386 (466)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-- 149 (323)
T cd05571 77 ANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-- 149 (323)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--
Confidence 9999999999754 46899999999999999999999998 9999999999999999999999999987542221
Q ss_pred CCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 387 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 387 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 150 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 150 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred ---CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 1233457899999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=303.74 Aligned_cols=206 Identities=24% Similarity=0.336 Sum_probs=170.9
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+.+.||+|+||.||++... +++.||||++.... .......+.+|++++++++||||+++++++.+ ....
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~----~~~~ 76 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD----AQYL 76 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CCee
Confidence 36788899999999999999764 68899999986432 22334558889999999999999999999876 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999999754 56889999999999999999999998 999999999999999999999999999643
Q ss_pred ccCCCC-----------CC-------------------------------CCCCCccccCcccccchhcccCCCCchhHH
Q 012297 381 KADGLP-----------SC-------------------------------SSSPARMQGTFGYFAPEYAMVGRASLMSDV 418 (466)
Q Consensus 381 ~~~~~~-----------~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv 418 (466)
...... .. ........||+.|+|||++....++.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 231 (377)
T cd05629 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence 211000 00 000012469999999999998899999999
Q ss_pred HHHHHHHHHHHcCCCCCCCC
Q 012297 419 FSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 419 ~S~Gvll~elltG~~Pf~~~ 438 (466)
|||||++|||++|+.||...
T Consensus 232 wSlGvil~elltG~~Pf~~~ 251 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCSE 251 (377)
T ss_pred EecchhhhhhhcCCCCCCCC
Confidence 99999999999999999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=273.34 Aligned_cols=202 Identities=26% Similarity=0.392 Sum_probs=178.9
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+.+.||+|-||.||.|+.+ ++..||+|++.... ......++.+|+++-++|+||||+++++++.+ ....
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd----~~ri 97 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD----SKRI 97 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec----ccee
Confidence 56788999999999999999865 57789999987552 22334458999999999999999999999998 5567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
||++||.++|.|...|+......+++.....+..|+|.|+.|+|..+ ++||||||+|+|++.++..||+|||.+-..
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999999777778999999999999999999999988 999999999999999999999999998654
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
. .......+||..|.+||...+...+...|+|++|++.||++.|.+||+...
T Consensus 175 p-------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 175 P-------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred C-------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 3 123455799999999999999999999999999999999999999998654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=284.62 Aligned_cols=199 Identities=30% Similarity=0.453 Sum_probs=166.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHh--cCCCCccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR--LHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
..+....+.||+|.||.||+|.++ |+.||||++.... +..+.+|.++++. |+|+||+.+++.-....+.-.+.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 344566688999999999999995 7889999997653 3347888888875 59999999998877777777899
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-----AAAPRILHRDIKSSNILLDENLNAKITDLG 375 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~-----~~~~~ivHrDLk~~NILld~~~~vkL~DfG 375 (466)
|||++|.+.|||.|||.. ..++....++++.-+|.||++||. ++.|.|.|||||+.|||+..++...|+|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 999999999999999976 568999999999999999999995 567899999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCccccCcccccchhcccCCC------CchhHHHHHHHHHHHHHc
Q 012297 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA------SLMSDVFSFGVVLLELIT 430 (466)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------s~~sDv~S~Gvll~ellt 430 (466)
||-....+.... ...+...+||.+|||||++.+... -..+||||||.++||+.-
T Consensus 362 LAv~h~~~t~~i-di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 362 LAVRHDSDTDTI-DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eeEEecccCCcc-cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 997765543222 223455689999999999865432 235899999999999875
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=286.89 Aligned_cols=202 Identities=26% Similarity=0.419 Sum_probs=169.5
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|...+.||+|+||.||+|... +++.||+|.++..........+.+|+.++++++|+||+++++++.. ....++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l 80 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT----ERCLTL 80 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC----CCeEEE
Confidence 45788899999999999999875 5789999998765444444568899999999999999999998765 346799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 81 VFEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred EEeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 999996 59999886532 45789999999999999999999998 99999999999999999999999999876432
Q ss_pred CCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.. .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 156 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 156 PT-----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred CC-----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 11223467889999998865 568999999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=293.12 Aligned_cols=195 Identities=26% Similarity=0.341 Sum_probs=166.7
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEec
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey 306 (466)
+.||+|+||.||++... +++.||+|++.... .......+.+|+++++.++||||+++++++.. ....++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~----~~~~~lv~E~ 76 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----HDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec----CCEEEEEEeC
Confidence 36999999999999864 68999999987542 22334457889999999999999999998876 4467999999
Q ss_pred CCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCC
Q 012297 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 386 (466)
Q Consensus 307 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~ 386 (466)
+++|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-- 149 (323)
T cd05595 77 ANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-- 149 (323)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--
Confidence 9999999988654 45899999999999999999999998 9999999999999999999999999987532221
Q ss_pred CCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 387 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 387 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 150 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 150 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred ---CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 1223356899999999999899999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=287.51 Aligned_cols=201 Identities=23% Similarity=0.364 Sum_probs=177.9
Q ss_pred hCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChh--HHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNAD--SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~--~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
..+|++.+.||+|.+|.|-+|.. ..|+.||||.++.+.-.... -.+.+||++|+.|+||||+.++.+|.. ...
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN----kdK 127 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN----KDK 127 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC----Cce
Confidence 34566778899999999999976 57999999999877543333 348899999999999999999998875 557
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
..|||||..+|.|.+|+... +.+++.++..+++||..|+-|+|.++ ++|||||.+|||||+|+++||+|||++..
T Consensus 128 IvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhh
Confidence 79999999999999999875 56999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+..+. ....++|++-|.+||++.+.+| .+..|-|||||+||-|+.|..||+..
T Consensus 203 y~~~k------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~ 256 (668)
T KOG0611|consen 203 YADKK------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR 256 (668)
T ss_pred hcccc------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc
Confidence 76543 3456899999999999999888 78999999999999999999999853
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=296.67 Aligned_cols=202 Identities=26% Similarity=0.375 Sum_probs=175.6
Q ss_pred hCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~~ 300 (466)
.++|...+.||.|.||.||+|+- .++..||||+++..-..-.+-.=++|+..|++|+ ||||++|..++.+.. ...
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~---~~L 85 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND---RIL 85 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC---ceE
Confidence 35677778999999999999975 4688999999987754444444678999999998 999999999887732 278
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||| ..+|.++++.+ .+.|++..+..|+.||++||+|+|.+| ++|||+||+|||+..+..+||+|||+||.+
T Consensus 86 ~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 9999999 67999999876 678999999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... ......+.|-+|.|||++. .+.|+.+.|||++|++++|+.+-++-|...
T Consensus 161 ~Sk------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~ 213 (538)
T KOG0661|consen 161 RSK------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA 213 (538)
T ss_pred ccC------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC
Confidence 653 2345577899999999875 567899999999999999999999988754
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=285.30 Aligned_cols=196 Identities=23% Similarity=0.406 Sum_probs=166.9
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEcccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEec
Q 012297 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey 306 (466)
...|++|++|.||+|.+ +|+.||||+++...... ..+.|.+|+++|++++||||++++|++.+........++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 35799999999999998 68899999997653222 1356889999999999999999999987643334467999999
Q ss_pred CCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 307 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~-~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
+++|+|.+++... +.+++...+.++.|++.||.|||+. + ++||||||+|||+++++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-- 176 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-- 176 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc--
Confidence 9999999999764 4689999999999999999999984 5 789999999999999999999999998765322
Q ss_pred CCCCCCCCccccCcccccchhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.....++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 177 ------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 177 ------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred ------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 122357889999999876 67899999999999999999999999754
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.76 Aligned_cols=205 Identities=23% Similarity=0.323 Sum_probs=170.0
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++|+||+++++.+.+ ....+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~----~~~~~ 77 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD----KDNLY 77 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe----CCEEE
Confidence 4778899999999999999874 57899999987532 12233458899999999999999999999876 45679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~ 152 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (382)
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence 999999999999999754 45788899999999999999999998 9999999999999999999999999975432
Q ss_pred cCCCC------------------------------------------CCCCCCCccccCcccccchhcccCCCCchhHHH
Q 012297 382 ADGLP------------------------------------------SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVF 419 (466)
Q Consensus 382 ~~~~~------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~ 419 (466)
..... ..........||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (382)
T cd05625 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence 10000 000011234689999999999998999999999
Q ss_pred HHHHHHHHHHcCCCCCCCC
Q 012297 420 SFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 420 S~Gvll~elltG~~Pf~~~ 438 (466)
||||++|||++|+.||...
T Consensus 233 SlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred echHHHHHHHhCCCCCCCC
Confidence 9999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=293.19 Aligned_cols=195 Identities=26% Similarity=0.344 Sum_probs=167.1
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEec
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey 306 (466)
+.||+|+||.||++... +++.||+|++.... .......+.+|+.+++.++||||+++++++.. ....++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~lv~Ey 76 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT----KDRLCFVMEY 76 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc----CCEEEEEEeC
Confidence 36899999999999865 58999999987542 22334568899999999999999999988875 4567999999
Q ss_pred CCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCC
Q 012297 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 386 (466)
Q Consensus 307 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~ 386 (466)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 77 ~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-- 149 (328)
T cd05593 77 VNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-- 149 (328)
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--
Confidence 9999999988653 45899999999999999999999998 9999999999999999999999999987532221
Q ss_pred CCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 387 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 387 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 150 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 150 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred ---cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence 1223356899999999999889999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=291.73 Aligned_cols=192 Identities=26% Similarity=0.340 Sum_probs=165.2
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCC
Q 012297 232 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (466)
Q Consensus 232 LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~ 308 (466)
||+|+||.||++... +++.||+|++.... .......+.+|++++++++||||+++++++.+ ....++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~ 76 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS----PEKLYLVLAFIN 76 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec----CCeEEEEEcCCC
Confidence 699999999999875 47899999987532 23334558899999999999999999998875 446799999999
Q ss_pred CCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCC
Q 012297 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388 (466)
Q Consensus 309 ~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~ 388 (466)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 147 (312)
T cd05585 77 GGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD---- 147 (312)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC----
Confidence 99999999753 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 389 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 148 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 148 -DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred -CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 122345689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=286.62 Aligned_cols=202 Identities=25% Similarity=0.423 Sum_probs=169.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+++++.++|+||+++++++.+ ....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~ 79 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT----KETLT 79 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec----CCeEE
Confidence 357888899999999999999876 6889999998765444444457899999999999999999999876 44679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 80 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 80 LVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred EEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 9999994 7888888653 245889999999999999999999998 9999999999999999999999999987543
Q ss_pred cCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 155 VPS-----HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CCC-----ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 221 11223457899999998865 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=290.23 Aligned_cols=201 Identities=28% Similarity=0.421 Sum_probs=173.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|+..+.||+|+||.||++... ++..+|+|.+...........+.+|++++++++|+||+++++++.. ....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 79 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS----DGEIS 79 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE----CCEEE
Confidence 367888899999999999999876 5788999998765444445669999999999999999999999876 44679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ .|+||||||+|||+++++.+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred EEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 999999999999999754 45899999999999999999999853 39999999999999999999999999987653
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 156 DS-------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred cc-------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 32 122346889999999999889999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.10 Aligned_cols=207 Identities=22% Similarity=0.353 Sum_probs=173.3
Q ss_pred HHHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeecc
Q 012297 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 294 (466)
Q Consensus 218 ~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~ 294 (466)
.+....++|+..+.||+|+||.||+++.. +++.+|+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-- 114 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-- 114 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--
Confidence 34445678999999999999999999876 47899999986432 22233458899999999999999999998875
Q ss_pred CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 012297 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 374 (466)
Q Consensus 295 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~Df 374 (466)
....++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 115 --~~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DF 186 (370)
T cd05621 115 --DKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADF 186 (370)
T ss_pred --CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEec
Confidence 4567999999999999999964 34788999999999999999999998 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCCccccCcccccchhcccC----CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG----RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|++........ .......||+.|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 187 G~a~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 187 GTCMKMDETGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred ccceecccCCc----eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 99987643221 112345689999999998653 3788999999999999999999999743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=300.71 Aligned_cols=207 Identities=23% Similarity=0.327 Sum_probs=170.8
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|++.+.||+|+||.||+++.. +++.||||++.... .......+.+|++++++++|+||+++++.+.+ ....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~----~~~~ 76 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD----KDNL 76 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc----CCEE
Confidence 36888899999999999999865 58899999986432 12233458899999999999999999998876 4577
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+
T Consensus 77 ~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 9999999999999999754 45788889999999999999999998 999999999999999999999999997533
Q ss_pred ccCCCC--------------------------------------CCCCCCCccccCcccccchhcccCCCCchhHHHHHH
Q 012297 381 KADGLP--------------------------------------SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFG 422 (466)
Q Consensus 381 ~~~~~~--------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~G 422 (466)
...... ..........||+.|+|||.+....++.++||||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 231 (376)
T cd05598 152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231 (376)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence 110000 000001234799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 012297 423 VVLLELITGRQPIHRSI 439 (466)
Q Consensus 423 vll~elltG~~Pf~~~~ 439 (466)
|++|||++|+.||....
T Consensus 232 vilyell~G~~Pf~~~~ 248 (376)
T cd05598 232 VILYEMLVGQPPFLADT 248 (376)
T ss_pred ceeeehhhCCCCCCCCC
Confidence 99999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=289.28 Aligned_cols=216 Identities=25% Similarity=0.396 Sum_probs=173.4
Q ss_pred echHHHHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-------------ChhHHHHHHHHHHHhcC
Q 012297 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-------------NADSVFLTEVDMLSRLH 279 (466)
Q Consensus 214 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-------------~~~~~f~~Ei~~l~~l~ 279 (466)
++-.+-....++|++...||+|.||.|-+|+.. +++.||||++...... ...+...+||.+|++++
T Consensus 87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~ 166 (576)
T KOG0585|consen 87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH 166 (576)
T ss_pred ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence 333344455678999999999999999999864 6899999998654211 11235789999999999
Q ss_pred CCCccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 012297 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 358 (466)
Q Consensus 280 H~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~-~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~ 358 (466)
|+|||+|+.+..+.. ....|||+||+..|.+...=. ... ++..++..+++++..||+|||.++ |+||||||
T Consensus 167 H~nVV~LiEvLDDP~--s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKP 238 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPE--SDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKP 238 (576)
T ss_pred CcCeeEEEEeecCcc--cCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccch
Confidence 999999999877654 347799999999888754322 233 899999999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCC----CCchhHHHHHHHHHHHHHcCCCC
Q 012297 359 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR----ASLMSDVFSFGVVLLELITGRQP 434 (466)
Q Consensus 359 ~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDv~S~Gvll~elltG~~P 434 (466)
+|+||+++|++||+|||.+..................+||+.|+|||...++. -+.+.||||+||+||.|+.|+.|
T Consensus 239 sNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P 318 (576)
T KOG0585|consen 239 SNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP 318 (576)
T ss_pred hheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence 99999999999999999998664332222222334478999999999887633 26789999999999999999999
Q ss_pred CCC
Q 012297 435 IHR 437 (466)
Q Consensus 435 f~~ 437 (466)
|..
T Consensus 319 F~~ 321 (576)
T KOG0585|consen 319 FFD 321 (576)
T ss_pred ccc
Confidence 963
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=290.98 Aligned_cols=195 Identities=27% Similarity=0.418 Sum_probs=165.5
Q ss_pred ceecccCcEEEEEEEE----cCCcEEEEEEcccCC---CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 230 NIVGQGGSSYVYRGQL----TDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~----~~~~~vaVK~l~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+.||+|+||.||+++. .+++.||||+++... .......+.+|+++++.++||||+++++++.. ....++
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~----~~~~~l 77 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT----GGKLYL 77 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec----CCeEEE
Confidence 5799999999999975 357899999987532 22233457889999999999999999998876 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++++|.+++... ..+.+..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 78 ILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred EEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 99999999999999754 45788889999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. .......|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 153 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~ 203 (323)
T cd05584 153 EG-----TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203 (323)
T ss_pred CC-----CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence 21 1123356899999999998888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=283.14 Aligned_cols=205 Identities=28% Similarity=0.435 Sum_probs=169.8
Q ss_pred CCCCCcceecccCcEEEEEEEEc--CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhc---CCCCccceeeeeeecc-Cc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT--DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFR-GK 296 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~--~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l---~H~nIv~llg~~~~~~-~~ 296 (466)
++|.+.+.||+|+||.||+|... +++.||+|+++..... .....+.+|+++++.+ +||||+++++++.... ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 4688999998755322 2233467788877766 6999999999886422 22
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGl 376 (466)
....++||||++ ++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 346799999995 69999997655566899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
++..... .......|++.|+|||.+....++.++||||||+++|||++|++||...
T Consensus 157 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 212 (290)
T cd07862 157 ARIYSFQ------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 212 (290)
T ss_pred eEeccCC------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence 9765432 1223456889999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=297.53 Aligned_cols=208 Identities=22% Similarity=0.341 Sum_probs=173.9
Q ss_pred HHHHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeec
Q 012297 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293 (466)
Q Consensus 217 ~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~ 293 (466)
.++....++|++.+.||+|+||.||++... +++.+|+|++.... .......+.+|+.+++.++||||+++++.+.+
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~- 114 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD- 114 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-
Confidence 345555688999999999999999999876 57899999986432 22233457889999999999999999998875
Q ss_pred cCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 012297 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 373 (466)
Q Consensus 294 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~D 373 (466)
....++||||+++|+|.+++.. ..++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 115 ---~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 115 ---DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred ---CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEe
Confidence 4567999999999999999865 34788889999999999999999998 99999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCCccccCcccccchhcccC----CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 374 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG----RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 374 fGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
||+++....... .......||+.|+|||++... .++.++||||||+++|||++|+.||...
T Consensus 186 fG~a~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 186 FGTCMKMNKEGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred CCceeEcCcCCc----ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 999987643321 112345689999999998653 3788999999999999999999999743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=286.59 Aligned_cols=205 Identities=29% Similarity=0.479 Sum_probs=169.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-----------------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-----------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-----------------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l 286 (466)
++|...+.||+|+||.||++.+.+ +..||+|.+...........|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467778899999999999997643 336999998866544455679999999999999999999
Q ss_pred eeeeeeccCcceeEEEEEecCCCCCHHHHhcccc-----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 012297 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL-----------------VEGMNWDTRVAIAIGAARGLEYLHEAAAP 349 (466)
Q Consensus 287 lg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~-----------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~ 349 (466)
++++.+ ....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+
T Consensus 85 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-- 158 (304)
T cd05096 85 LGVCVD----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158 (304)
T ss_pred EEEEec----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 999876 345699999999999999985421 123688899999999999999999998
Q ss_pred CeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHH
Q 012297 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 429 (466)
Q Consensus 350 ~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ell 429 (466)
|+||||||+|||+++++.+||+|||+++........ .......++..|+|||.+....++.++||||||+++|||+
T Consensus 159 -ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 159 -FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred -ccccCcchhheEEcCCccEEECCCccceecccCcee---EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence 999999999999999999999999999865332211 1122334578899999998888999999999999999998
Q ss_pred c--CCCCCCCC
Q 012297 430 T--GRQPIHRS 438 (466)
Q Consensus 430 t--G~~Pf~~~ 438 (466)
+ +..||...
T Consensus 235 ~~~~~~p~~~~ 245 (304)
T cd05096 235 MLCKEQPYGEL 245 (304)
T ss_pred HccCCCCCCcC
Confidence 6 66787653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=282.77 Aligned_cols=202 Identities=26% Similarity=0.359 Sum_probs=170.2
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|++.+.||+|+||.||+++.. +++.||+|++..... ......+.+|+++++.++|+||+++++++.. ....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 76 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR----RGKLY 76 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec----CCEEE
Confidence 36888899999999999999886 578999999876532 2334558899999999999999999998865 45679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||++++.+..+... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 77 LVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLS 151 (287)
T ss_pred EEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999998777655432 245899999999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 152 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 152 EGSN----ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred cccc----ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 3211 1122346889999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=295.37 Aligned_cols=206 Identities=26% Similarity=0.360 Sum_probs=174.9
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+.+.||+|+||.||+|... +++.||||++.... .......+.+|++++..++|+||+++++++.+ ....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~ 76 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD----EEHL 76 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec----CCeE
Confidence 36888899999999999999876 68999999987542 22344568899999999999999999988875 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 151 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKM 151 (350)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence 9999999999999999764 56899999999999999999999988 999999999999999999999999999865
Q ss_pred ccCCC------------------------CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 381 KADGL------------------------PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 381 ~~~~~------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
..... ...........||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence 44320 000012233568999999999999999999999999999999999999997
Q ss_pred CC
Q 012297 437 RS 438 (466)
Q Consensus 437 ~~ 438 (466)
..
T Consensus 232 ~~ 233 (350)
T cd05573 232 SD 233 (350)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=297.06 Aligned_cols=206 Identities=24% Similarity=0.375 Sum_probs=172.1
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|+..+.||+|+||.||++... +++.||+|++.... .......+.+|+.++..++|+||+++++.+.+ ....
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~----~~~~ 76 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD----KRNL 76 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCEE
Confidence 35778899999999999999875 58899999987432 22334558889999999999999999998875 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 77 ~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred EEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 9999999999999999754 45899999999999999999999998 999999999999999999999999998755
Q ss_pred ccCCCCC------------------------------CCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc
Q 012297 381 KADGLPS------------------------------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430 (466)
Q Consensus 381 ~~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt 430 (466)
....... .........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t 231 (360)
T cd05627 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (360)
T ss_pred ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence 3211000 0000113469999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 012297 431 GRQPIHRS 438 (466)
Q Consensus 431 G~~Pf~~~ 438 (466)
|+.||...
T Consensus 232 G~~Pf~~~ 239 (360)
T cd05627 232 GYPPFCSE 239 (360)
T ss_pred CCCCCCCC
Confidence 99999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=297.63 Aligned_cols=204 Identities=22% Similarity=0.349 Sum_probs=170.8
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
...++|+..+.||+|+||.||++... +++.||+|.+.... .......+.+|+++++.++||||+++++++.+ .
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~----~ 115 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD----D 115 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec----C
Confidence 34567888999999999999999875 58899999986432 12233447889999999999999999988775 4
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||+++|+|.+++.. ..++...+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccce
Confidence 567999999999999999865 34788888999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccC----CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG----RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
......... ......||+.|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 190 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 190 MKMDANGMV----RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred eeccCCCcc----cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 875433211 12235689999999988643 4788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=296.21 Aligned_cols=207 Identities=25% Similarity=0.405 Sum_probs=171.4
Q ss_pred HhCCCCCcceecccCcEEEEEEEE------cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeecc
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 294 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~------~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~ 294 (466)
..++|+..+.||+|+||.||+|+. ..+..||||+++..........+.+|+.++..+ +||||+++++++.+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-- 110 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV-- 110 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--
Confidence 345688889999999999999964 235689999998655444556689999999999 89999999999876
Q ss_pred CcceeEEEEEecCCCCCHHHHhcccc------------------------------------------------------
Q 012297 295 GKRAMRLLVFEFMPNGNLRDCLDGVL------------------------------------------------------ 320 (466)
Q Consensus 295 ~~~~~~~lV~ey~~~gsL~~~l~~~~------------------------------------------------------ 320 (466)
....++||||+++|+|.++++...
T Consensus 111 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 111 --GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred --CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 345699999999999999986422
Q ss_pred -------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 321 -------------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 321 -------------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
...+++..++.++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceecc
Confidence 114788899999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
..... .......++..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 266 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 266 NDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred Ccccc---cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 33211 11122335677999999999999999999999999999998 89998654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=289.04 Aligned_cols=200 Identities=26% Similarity=0.341 Sum_probs=168.1
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~ 300 (466)
+|...+.||+|+||.||+|... +++.||+|.+..... ......+..|..++..+ +|++|+++++++.+ ....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~~ 76 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT----MDRL 76 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec----CCEE
Confidence 4677889999999999999876 467999999875432 22333467788888877 58899999988765 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 77 ~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~ 151 (323)
T cd05616 77 YFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 151 (323)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceec
Confidence 9999999999999998654 45899999999999999999999998 999999999999999999999999998754
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... .......||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 152 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 204 (323)
T cd05616 152 MWDG-----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204 (323)
T ss_pred CCCC-----CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence 3221 1223456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=288.66 Aligned_cols=206 Identities=23% Similarity=0.336 Sum_probs=169.5
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC-cceeEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAMRL 301 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~-~~~~~~ 301 (466)
+|++.+.||+|+||.||+|... +++.||||++.... .......+.+|++++++++||||+++++++..... .....+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4677889999999999999865 58999999987532 22333458899999999999999999998764332 223579
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+ +++|.+++... ..+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999999 47999988754 45899999999999999999999998 9999999999999999999999999998653
Q ss_pred cCCCCCCCCCCCccccCcccccchhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... ........||..|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 155 NDTPT--AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred cccCc--cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 32211 112234568999999998865 67899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=279.54 Aligned_cols=203 Identities=24% Similarity=0.375 Sum_probs=170.8
Q ss_pred CCCCCcceecccCcEEEEEEEEc----CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~----~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
++|++.+.||+|+||.||+|.+. .+..||+|+++..........|.+|+..+++++||||++++|++.. ...
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~ 80 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR----GNT 80 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec----CCC
Confidence 45778899999999999999763 3568999999876555555679999999999999999999999875 346
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.++++|||.+..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccc
Confidence 799999999999999997532 45899999999999999999999998 99999999999999999999999998765
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
...... .......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 157 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 157 DKSEAI----YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred ccccch----hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 432211 11112334678999999999999999999999999999875 99999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=280.93 Aligned_cols=209 Identities=25% Similarity=0.314 Sum_probs=176.7
Q ss_pred CCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.|...+.||.|.-|+||++.+.+ +..+|+|++....- .+...+...|-++|+.++||.+..|++.+.. ....+
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet----~~~~c 153 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET----DKYSC 153 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec----cceeE
Confidence 35556789999999999999875 58899999987642 2333457789999999999999999998876 56779
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
|||||++||+|...++++..+.+++..+.-++..++-||+|||..| ||.|||||+||||.++|++.|+||.|+....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 9999999999999999988888999999999999999999999999 9999999999999999999999999976432
Q ss_pred cCCC-----------------------------CCCC----------------------CCCCccccCcccccchhcccC
Q 012297 382 ADGL-----------------------------PSCS----------------------SSPARMQGTFGYFAPEYAMVG 410 (466)
Q Consensus 382 ~~~~-----------------------------~~~~----------------------~~~~~~~gt~~y~aPE~~~~~ 410 (466)
.... .... .....++||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 1000 0000 011236799999999999999
Q ss_pred CCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 012297 411 RASLMSDVFSFGVVLLELITGRQPIHRSIT 440 (466)
Q Consensus 411 ~~s~~sDv~S~Gvll~elltG~~Pf~~~~~ 440 (466)
..+.+.|+|+|||+||||++|..||.....
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~ 340 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNN 340 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCc
Confidence 999999999999999999999999986543
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=281.94 Aligned_cols=201 Identities=28% Similarity=0.444 Sum_probs=171.4
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
+|+..++||+|+||.||++... +++.||||.+..... ......+.+|+.+++.++|+||+++++.+.+ ....+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 76 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET----KDALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC----CCeEE
Confidence 3677789999999999999875 588999999875432 2223457889999999999999999998865 34679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 9999999999999886544456899999999999999999999998 9999999999999999999999999987653
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... ......|+..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 154 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 154 EGE------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred CCC------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 221 112346889999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=287.95 Aligned_cols=194 Identities=26% Similarity=0.380 Sum_probs=165.8
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|+||.||++... +++.||+|+++... .......+.+|..++..+ +||||+++++++.+ ....++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~----~~~~~lv~e 76 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT----ESRLFFVIE 76 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc----CCEEEEEEe
Confidence 36999999999999875 57899999997642 223334578899999988 69999999998876 456799999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 150 (329)
T cd05588 77 FVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG- 150 (329)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-
Confidence 99999999988654 56899999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 151 ----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ----CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 122345789999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=289.03 Aligned_cols=201 Identities=24% Similarity=0.336 Sum_probs=168.0
Q ss_pred CCCCcceecccCcEEEEEEEE----cCCcEEEEEEcccCC---CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCc
Q 012297 225 KFSGSNIVGQGGSSYVYRGQL----TDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~----~~~~~vaVK~l~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~ 296 (466)
+|++.+.||+|+||.||+++. .+++.||+|++.... .......+..|+++++.+ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT---- 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec----
Confidence 477788999999999999975 357899999986432 222334578899999999 59999999988765
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGl 376 (466)
....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~ 151 (332)
T cd05614 77 EAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGL 151 (332)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcC
Confidence 44679999999999999999653 45899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
++....... .......||+.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 152 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 152 SKEFLSEEK----ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred CccccccCC----CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 986533221 112235689999999998765 4788999999999999999999999743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=287.61 Aligned_cols=201 Identities=27% Similarity=0.416 Sum_probs=173.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|+..+.||+|+||.||++.+. ++..+|+|.+...........+.+|++++++++|+||+++++++.+ ....+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 79 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS----DGEIS 79 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE----CCEEE
Confidence 467888999999999999999876 5788999988765444445568999999999999999999999887 44779
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ +++||||||+|||+++++.+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 999999999999999753 45889999999999999999999742 29999999999999999999999999987653
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 156 DSM-------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hhc-------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 221 12346889999999999888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=287.94 Aligned_cols=200 Identities=25% Similarity=0.340 Sum_probs=167.3
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCC-CccceeeeeeeccCcceeE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHC-HVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~-nIv~llg~~~~~~~~~~~~ 300 (466)
+|+..+.||+|+||.||+|... +++.||||++.... .......+..|++++..++|+ +|+++.+++.+ ....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~~ 76 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----MDRL 76 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc----CCEE
Confidence 4677889999999999999875 46789999987542 223345578899999999765 57788877765 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 77 ~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 77 YFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 9999999999999999754 45899999999999999999999998 999999999999999999999999998753
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 152 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 152 IFGG-----KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred CCCC-----CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 2211 1223456899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=290.76 Aligned_cols=195 Identities=27% Similarity=0.341 Sum_probs=165.7
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEec
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey 306 (466)
+.||+|+||.||++... +++.||+|++.... .......+.+|++++..++|+||+++.+++.. ....++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~----~~~~~lv~E~ 76 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT----HDRLCFVMEY 76 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc----CCEEEEEEeC
Confidence 36999999999999864 68899999987542 22334457889999999999999999988876 4567999999
Q ss_pred CCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 307 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
+++|+|..++... ..+++..+..++.|++.||.|||+ .+ |+||||||+|||+++++.+||+|||+++......
T Consensus 77 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~- 150 (325)
T cd05594 77 ANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG- 150 (325)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-
Confidence 9999999988654 458999999999999999999997 67 9999999999999999999999999987543221
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 151 ----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred ----cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 1122356899999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=296.55 Aligned_cols=209 Identities=25% Similarity=0.415 Sum_probs=171.8
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeee
Q 012297 220 EHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292 (466)
Q Consensus 220 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~ 292 (466)
....++|++.+.||+|+||.||+|... ++..||||+++..........+.+|+++++.+ +|+||+++++++..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 334457888899999999999998742 34579999998665444556688999999999 89999999999876
Q ss_pred ccCcceeEEEEEecCCCCCHHHHhcccc----------------------------------------------------
Q 012297 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVL---------------------------------------------------- 320 (466)
Q Consensus 293 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~---------------------------------------------------- 320 (466)
....++||||+++|+|.++++...
T Consensus 114 ----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 114 ----GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred ----CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 346799999999999999985421
Q ss_pred ----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCC
Q 012297 321 ----------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 321 ----------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~ 384 (466)
...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~ 266 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCc
Confidence 123788899999999999999999998 9999999999999999999999999997654321
Q ss_pred CCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
. ........++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 267 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 267 N---YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred c---eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence 1 111112235678999999988899999999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=286.36 Aligned_cols=203 Identities=29% Similarity=0.466 Sum_probs=170.0
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCc----EEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
.+|+..+.||+|+||.||+|.+. +++ .||+|+++.........+|.+|+.+++.++|+||++++|++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence 45788899999999999999864 333 48999997655555566799999999999999999999998752
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccc
Confidence 3579999999999999997643 45889999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
........ .......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 158 LLGADEKE---YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred cccCCCcc---eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 76543211 11112234678999999999999999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=287.64 Aligned_cols=195 Identities=26% Similarity=0.363 Sum_probs=165.8
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|+||.||++... +++.+|+|+++.... ......+.+|+.++.++ +|+||+++++++.+ ....++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e 76 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT----TSRLFLVIE 76 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe----CCEEEEEEe
Confidence 36999999999999875 578999999986532 23334578899999888 69999999998876 446799999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~- 150 (327)
T cd05617 77 YVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG- 150 (327)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-
Confidence 99999999988653 45899999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 151 ----DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred ----CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 1223456899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=288.02 Aligned_cols=198 Identities=25% Similarity=0.374 Sum_probs=165.9
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHH---HhcCCCCccceeeeeeeccCccee
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDML---SRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l---~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
|.+.+.||+|+||.||+|... +++.||||+++... .......+.+|++++ +.++||||+++++++.. ...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~----~~~ 76 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT----EDH 76 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc----CCE
Confidence 556789999999999999875 58899999987542 222334466676655 56679999999999876 456
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|..++.. ..+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 77 ~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred EEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 7999999999999988864 45899999999999999999999998 99999999999999999999999999875
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 151 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 151 GMGFG-----DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred CCCCC-----CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 32211 1223456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=287.08 Aligned_cols=195 Identities=27% Similarity=0.379 Sum_probs=165.6
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|+||.||+|... +++.||||++.... .......+..|.+++..+ +||||+++++++.. ....++|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~----~~~~~iv~E 76 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT----PDRLFFVME 76 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc----CCEEEEEEc
Confidence 36999999999999875 57899999987542 223345577888888876 69999999998876 446799999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++......
T Consensus 77 y~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~- 150 (320)
T cd05590 77 FVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG- 150 (320)
T ss_pred CCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-
Confidence 99999999998754 45899999999999999999999998 9999999999999999999999999987542221
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 151 ----KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred ----CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 1223456899999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=286.73 Aligned_cols=194 Identities=26% Similarity=0.380 Sum_probs=165.1
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|+||.||++... +++.+|+|+++... .......+.+|+.++.++ +||||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~----~~~~~lv~E 76 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----ESRLFFVIE 76 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe----CCEEEEEEe
Confidence 36999999999999875 57899999987642 223334577888888877 79999999998876 456799999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~- 150 (329)
T cd05618 77 YVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 150 (329)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-
Confidence 99999999988654 46899999999999999999999998 9999999999999999999999999987532221
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.......||..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 151 ----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ----CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 122345789999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=288.34 Aligned_cols=202 Identities=25% Similarity=0.363 Sum_probs=169.6
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|++.+.||+|+||.||+++.. +++.||+|++.... .......|.+|+.++..++|+||+++++++.+ ....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~ 76 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD----ENNL 76 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec----CCeE
Confidence 36788899999999999999875 58899999986421 22233458889999999999999999998876 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred EEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 9999999999999999653 245899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCcccccchhccc-----CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
...... ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 153 LADGTV----QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCCCCc----cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 433211 1122468999999999863 4578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=287.64 Aligned_cols=195 Identities=24% Similarity=0.356 Sum_probs=165.4
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
++||+|+||.||+|... +++.||+|++.... .......+..|.+++..+ +||||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~----~~~~~lv~E 76 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT----KDRLFFVME 76 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc----CCeEEEEEe
Confidence 36999999999999875 47899999987542 223334577888988876 79999999999876 446799999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 77 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~- 150 (321)
T cd05591 77 YVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG- 150 (321)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-
Confidence 99999999998754 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 151 ----VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred ----ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence 1223456899999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=275.78 Aligned_cols=205 Identities=26% Similarity=0.406 Sum_probs=171.6
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCC-ccceeeeeeecc--CcceeE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCH-VVPLVGYCSEFR--GKRAMR 300 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~n-Iv~llg~~~~~~--~~~~~~ 300 (466)
|...++||+|++|+||+|+.. +|+.||+|+++..... ..-....+|+.++++++|+| |++|.+++.... +.....
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 444567999999999999764 6899999999876442 22223689999999999999 999999998744 223367
Q ss_pred EEEEecCCCCCHHHHhccccc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
++|+||+ ..+|..+++.... ++++...+..+.+|+++||+|||+++ |+||||||.||||+++|.+||+|||+|+
T Consensus 93 ~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHH
Confidence 8999999 6799999987653 46788899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
...-. .......++|.+|.|||++.+. .|++..||||+|+|+.||+++++-|....
T Consensus 169 a~~ip-----~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s 225 (323)
T KOG0594|consen 169 AFSIP-----MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS 225 (323)
T ss_pred HhcCC-----cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence 65422 2234556789999999999876 68999999999999999999999887543
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=285.59 Aligned_cols=195 Identities=26% Similarity=0.391 Sum_probs=163.1
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|+||.||+|... +++.||+|.++... .......+..|.+++... +||||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----~~~~~lv~e 76 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT----KEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc----CCEEEEEEc
Confidence 36999999999999875 47889999987542 122333456677777654 89999999998765 446799999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~- 150 (316)
T cd05592 77 YLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE- 150 (316)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-
Confidence 99999999998754 45899999999999999999999998 9999999999999999999999999997543221
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 151 ----GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred ----CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 1223456899999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=286.28 Aligned_cols=199 Identities=25% Similarity=0.351 Sum_probs=167.1
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcceeEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~~~ 301 (466)
|...+.||+|+||.||+|... +++.||+|++.... .......+..|..++..+. |++|+++.+++.+ ....+
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~~~ 77 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT----VDRLY 77 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec----CCEEE
Confidence 566789999999999999865 58899999987542 2233345778889998886 5677788887765 34679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 78 lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 999999999999998754 45899999999999999999999998 9999999999999999999999999987543
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .......||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 153 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 153 VDG-----VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred CCC-----ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 221 1223356899999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=280.74 Aligned_cols=200 Identities=34% Similarity=0.574 Sum_probs=166.3
Q ss_pred cceecccCcEEEEEEEEc-----CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 229 SNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~-----~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
.+.||+|.||.||+|.+. .+..|+||+++..........|.+|++.+++++||||++++|++.. ....++|
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~----~~~~~lv 79 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE----NEPLFLV 79 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES----SSSEEEE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc----ccccccc
Confidence 468999999999999887 2578999999765555556779999999999999999999999984 3347999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++|+|.++|.......+++..++.|+.|+++||.|||+.+ ++|+||+++|||+++++.+||+|||++......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 99999999999998865567999999999999999999999998 999999999999999999999999999876322
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
... ...........|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 157 ~~~---~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 157 SKY---KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp SSE---EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred ccc---cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 111 11122345678999999999889999999999999999999 78998654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=293.87 Aligned_cols=209 Identities=26% Similarity=0.418 Sum_probs=173.2
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEcC------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeee
Q 012297 220 EHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSE 292 (466)
Q Consensus 220 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~~------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~ 292 (466)
+...++|.+.++||+|+||.||+|++.. +..||||++.........+.|.+|+++++++. ||||+++++++.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3445678888999999999999998632 34699999976655555567999999999996 9999999999876
Q ss_pred ccCcceeEEEEEecCCCCCHHHHhcccc----------------------------------------------------
Q 012297 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVL---------------------------------------------------- 320 (466)
Q Consensus 293 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~---------------------------------------------------- 320 (466)
....++||||+++|+|.+++....
T Consensus 113 ----~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 113 ----SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred ----CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 446799999999999999986421
Q ss_pred ------------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 012297 321 ------------------------------------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 358 (466)
Q Consensus 321 ------------------------------------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~ 358 (466)
...+++.+++.++.|+++||.|||+.+ ++||||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp 265 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAA 265 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCh
Confidence 124788889999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 359 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 359 ~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
+|||+++++.+||+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 266 ~Nill~~~~~~kL~DfGla~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 266 RNVLLAQGKIVKICDFGLARDIMHDSN---YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred HhEEEeCCCEEEEEeCCcceecccccc---ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 999999999999999999986543221 111223456788999999988889999999999999999997 9999875
Q ss_pred C
Q 012297 438 S 438 (466)
Q Consensus 438 ~ 438 (466)
.
T Consensus 343 ~ 343 (400)
T cd05105 343 M 343 (400)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=278.76 Aligned_cols=195 Identities=29% Similarity=0.420 Sum_probs=164.6
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEcccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCC
Q 012297 232 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (466)
Q Consensus 232 LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~ 308 (466)
||+|+||+||++... +++.+|+|.+...... .....+..|+++++.++|+||+++.+++.. ....++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT----KTDLCLVMTIMN 76 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC----CCeEEEEEeCCC
Confidence 689999999999865 6889999998654221 223457889999999999999999988765 446799999999
Q ss_pred CCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCC
Q 012297 309 NGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 386 (466)
Q Consensus 309 ~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~ 386 (466)
+|+|..++... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~- 152 (280)
T cd05608 77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS- 152 (280)
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-
Confidence 99999887432 2345899999999999999999999998 99999999999999999999999999976543221
Q ss_pred CCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 387 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 387 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 153 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 153 ----KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred ----cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 123356889999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=289.90 Aligned_cols=202 Identities=23% Similarity=0.341 Sum_probs=169.8
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+.+.||+|+||.||+++.. +++.||+|.+.... .......+.+|+.++..++|+||+++++++.+ ....
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~----~~~~ 76 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD----ENYL 76 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCEE
Confidence 46888899999999999999875 57889999986431 22233447889999999999999999998876 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 77 YLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred EEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999997532 45899999999999999999999998 999999999999999999999999999766
Q ss_pred ccCCCCCCCCCCCccccCcccccchhccc-----CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
..... .......|++.|+|||.+.. +.++.++||||||++||||++|+.||..
T Consensus 153 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 153 NQDGT----VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred cCCCc----eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 43321 11223468999999998865 4678899999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=286.73 Aligned_cols=195 Identities=26% Similarity=0.356 Sum_probs=162.9
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHH-HHHhcCCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~-~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|+||.||+|... +++.||+|++.... .......+..|.. +++.++||||+++++++.+ ....++|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~----~~~~~lv~e 76 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT----ADKLYFVLD 76 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe----CCEEEEEEc
Confidence 36999999999999875 68999999987542 1222334555555 5678999999999988865 456799999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 77 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-- 149 (323)
T cd05575 77 YVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-- 149 (323)
T ss_pred CCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--
Confidence 99999999999753 46899999999999999999999998 999999999999999999999999998753221
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 150 ---SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred ---CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 11233456899999999999989999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=298.88 Aligned_cols=201 Identities=30% Similarity=0.451 Sum_probs=173.7
Q ss_pred CcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc--CcceeEEEEE
Q 012297 228 GSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRAMRLLVF 304 (466)
Q Consensus 228 ~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~--~~~~~~~lV~ 304 (466)
..+.||+|+||.||+|+++ .|+.||||.++........+...+|+++|++++|+|||+++++-.+.. -.....++||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 3467999999999999965 699999999999888888888999999999999999999998744322 0023569999
Q ss_pred ecCCCCCHHHHhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCc--EEEEecCCccc
Q 012297 305 EFMPNGNLRDCLDGV-LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD--ENLN--AKITDLGMAKR 379 (466)
Q Consensus 305 ey~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld--~~~~--vkL~DfGla~~ 379 (466)
||+++|+|+..|++. +..++++.+.+.++.++..||.|||+++ |+||||||.||++- ++++ -||+|||.|+.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999753 3456999999999999999999999998 99999999999993 3343 79999999998
Q ss_pred cccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
+..+. ....++||..|++||.+.. +.|+...|.|||||++||..||..||..
T Consensus 174 l~d~s------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 174 LDDNS------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred CCCCC------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 86653 3556889999999999984 8889999999999999999999999963
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=288.94 Aligned_cols=195 Identities=27% Similarity=0.410 Sum_probs=162.3
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
+|+..+.||+|+||.||+|.+. +++.||||++...........+.+|+++++.++|+||+++++++.+ ....++|
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 150 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH----NGEIQVL 150 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc----CCeEEEE
Confidence 3455678999999999999875 5899999999765444455678999999999999999999998865 4467999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++|+|.+.. ..++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 151 ~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 151 LEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred EecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 9999999986532 3467778899999999999999998 999999999999999999999999999875432
Q ss_pred CCCCCCCCCCccccCcccccchhccc-----CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.. ......|+..|+|||.+.. ...+.++|||||||++|||++|+.||..
T Consensus 222 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 222 MD-----PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred cc-----cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 11 1223468999999998743 2345689999999999999999999974
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=288.76 Aligned_cols=203 Identities=23% Similarity=0.341 Sum_probs=169.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|++.+.||+|+||.||++.... ++.+|+|++.... .......|.+|+.++..++|+||+++++++.+ ....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~ 76 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD----ENNL 76 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec----CCEE
Confidence 367888999999999999998764 6789999986421 12233448889999999999999999998875 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred EEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheec
Confidence 99999999999999997532 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... .......||+.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 153 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 153 MEDGT----VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred ccCCc----ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 43321 1122356899999999886 345789999999999999999999999743
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=318.66 Aligned_cols=208 Identities=25% Similarity=0.500 Sum_probs=170.1
Q ss_pred hCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
...|...++||+|+||.||+|.. .++..||||++...... ...|++.+++++||||++++|+|.+ ....+
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~----~~~~~ 759 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRS----EKGAY 759 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEc----CCCCE
Confidence 34577788999999999999987 47899999998754321 2356889999999999999999976 34569
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++|+|.++++. ++|.++..++.|+|+||+|||....++|+||||||+||+++.++.+++. |+......
T Consensus 760 lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 99999999999999953 7999999999999999999997655669999999999999999988875 66544321
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHHHHHhhc
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSIIT 455 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~~~~~l~~~~~~~~~ 455 (466)
.+ ....+++.|+|||++....++.++|||||||++|||+||+.||+.... ....+++|++....
T Consensus 834 ~~---------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~ 897 (968)
T PLN00113 834 TD---------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYS 897 (968)
T ss_pred cC---------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcC
Confidence 11 122578899999999999999999999999999999999999964432 34567777765443
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=286.18 Aligned_cols=195 Identities=25% Similarity=0.341 Sum_probs=162.2
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHH-HHHhcCCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~-~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
++||+|+||.||+|+.. +++.||+|++.... .......+..|.. +++.++|+||+++++++.+ ....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~----~~~~~lv~e 76 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT----AEKLYFVLD 76 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc----CCEEEEEEc
Confidence 36999999999999875 57899999986542 1223334555554 5788999999999988865 446799999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 149 (321)
T cd05603 77 YVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-- 149 (321)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--
Confidence 99999999888653 45888999999999999999999998 999999999999999999999999998753221
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
........||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 150 ---EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred ---CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 11223456899999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=282.96 Aligned_cols=195 Identities=27% Similarity=0.412 Sum_probs=163.9
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|+||.||+|.+. +++.||||+++... .......+..|..++... +||||+++++++.+ ....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~----~~~~~lv~e 76 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT----KENLFFVME 76 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe----CCEEEEEEe
Confidence 36999999999999876 47899999987542 122334466778888764 89999999999876 446799999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++|+|.+++... ..+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 77 y~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 150 (316)
T cd05619 77 YLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD- 150 (316)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-
Confidence 99999999999753 45899999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......||..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 151 ----AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred ----CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 1223456899999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=290.41 Aligned_cols=203 Identities=29% Similarity=0.381 Sum_probs=171.5
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+.+.||+|+||.||++... +++.||+|+++.... ......+.+|+.+++.++|+||+++++++.+ ....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~----~~~~ 76 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD----KDNL 76 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec----CCeE
Confidence 36788899999999999999875 588999999875422 2344558899999999999999999998875 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred EEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 99999999999999997642 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcc------cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAM------VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 153 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 153 TANKMV----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred CCCCce----eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 443211 122346889999999886 456789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=279.71 Aligned_cols=209 Identities=27% Similarity=0.370 Sum_probs=170.0
Q ss_pred CCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc-ceeEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK-RAMRLLV 303 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~-~~~~~lV 303 (466)
|...+++|.|+||.||+|.+.+ ++.||||+...+.... -+|+.+|++++|||||+|+-++....+. ....-+|
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 3445799999999999998764 6899999987765432 3689999999999999999988876655 3455789
Q ss_pred EecCCCCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCcccc
Q 012297 304 FEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRL 380 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~-~~vkL~DfGla~~~ 380 (466)
|||||. +|.++++.. ..+.++...+.-+..|+.+||.|||+.+ |+||||||.|+|+|.+ +.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999965 999988742 2356888888999999999999999988 9999999999999977 89999999999987
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHHHH
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVK 451 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~~~~~l~~~~~ 451 (466)
..... .....-|-.|.|||++.+. .|+.+.||||.|+++.||+-|++-|..... ...|+..++
T Consensus 177 ~~~ep------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik 240 (364)
T KOG0658|consen 177 VKGEP------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIK 240 (364)
T ss_pred ccCCC------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHH
Confidence 65421 2334456779999998764 589999999999999999999999986433 344444443
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=277.22 Aligned_cols=205 Identities=29% Similarity=0.516 Sum_probs=171.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcC------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
++|+..+.||+|+||.||+|.... ...|++|.+...........|.+|+.++++++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~----~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK----E 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC----C
Confidence 357778899999999999998643 257999998766544455668999999999999999999999875 3
Q ss_pred eeEEEEEecCCCCCHHHHhccccc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 363 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl 363 (466)
...+++|||+++++|.+++..... ..+++.+++.++.|++.||.|||+.+ ++|+||||+||++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~ 157 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLV 157 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEE
Confidence 456999999999999999965321 34788999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 364 DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 364 d~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
++++.++|+|||+++........ .......+++.|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYY---RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred cCCCcEEECCCcceeeccccccc---cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999765332211 11223345788999999988899999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=283.18 Aligned_cols=195 Identities=26% Similarity=0.392 Sum_probs=164.1
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|+||.||+|.+. +++.||+|.++.... ......+..|..++... +|+||+++++++.+ ....++|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~~~lv~E 76 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT----KEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe----CCEEEEEEC
Confidence 36999999999999876 578999999875421 22334467788887754 89999999998876 457799999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++......
T Consensus 77 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 150 (316)
T cd05620 77 FLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD- 150 (316)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-
Confidence 99999999998753 45899999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 151 ----NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred ----CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 1223456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=293.51 Aligned_cols=197 Identities=27% Similarity=0.375 Sum_probs=173.1
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
|..++-||.|+.|.|-+|++. .|+.+|||++.... .......+.+|+-+|+-+.|||+++++++..+ ..+.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~----~~~lyl 89 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN----KQHLYL 89 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc----CceEEE
Confidence 556678999999999999864 69999999987652 22223348899999999999999999998876 667899
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
|.||+++|-|.++|-.. .++++.++.+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||||.....
T Consensus 90 vlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999999764 56899999999999999999999999 99999999999999999999999999986544
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
+. ....-+|.+.|.+||++.+..| ..++||||-|||||.|+||+.||+.
T Consensus 165 gk------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 165 GK------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred Cc------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 43 3445689999999999999988 7899999999999999999999984
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=277.15 Aligned_cols=205 Identities=29% Similarity=0.473 Sum_probs=172.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcC------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
++|.+.+.||+|+||.||+|...+ ++.||||.++.....+....|.+|++++++++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~ 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE----G 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec----C
Confidence 457777899999999999998643 478999999876554456679999999999999999999999876 3
Q ss_pred eeEEEEEecCCCCCHHHHhcccc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVL------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~ 365 (466)
...++||||+++++|.++++... ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~ 157 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGY 157 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcC
Confidence 46799999999999999996532 234789999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 366 ~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
++.++|+|||+++........ .......+++.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred CCeEEECCcccceecccCcce---ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999765332211 11223345678999999999999999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=287.01 Aligned_cols=208 Identities=29% Similarity=0.444 Sum_probs=171.4
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeecc
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 294 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~ 294 (466)
+.++|.+.+.||+|+||.||+|... .++.||+|+++..........+..|++++.++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 3457888899999999999999642 24789999997654444445688899999999 799999999988642
Q ss_pred CcceeEEEEEecCCCCCHHHHhcccc------------------------------------------------------
Q 012297 295 GKRAMRLLVFEFMPNGNLRDCLDGVL------------------------------------------------------ 320 (466)
Q Consensus 295 ~~~~~~~lV~ey~~~gsL~~~l~~~~------------------------------------------------------ 320 (466)
....+++|||+++++|.+++....
T Consensus 84 --~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 84 --GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred --CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 345689999999999999985421
Q ss_pred -----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCcc
Q 012297 321 -----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 395 (466)
Q Consensus 321 -----~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~ 395 (466)
...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||+++.+...... ......
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~---~~~~~~ 235 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---VRKGDA 235 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcch---hhccCC
Confidence 125799999999999999999999998 999999999999999999999999999876432211 112233
Q ss_pred ccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 396 ~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
.++..|+|||++.+..++.++||||||++||||++ |..||...
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~ 279 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279 (337)
T ss_pred CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence 45678999999999999999999999999999997 99999653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=286.07 Aligned_cols=200 Identities=24% Similarity=0.375 Sum_probs=178.6
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
.|+..++||+|.||.||+|.+. .++.||+|++..+......+++.+|+.++.+++++||.+.+|.+.. +...+++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~----g~~Lwii 89 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK----GTKLWII 89 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee----cccHHHH
Confidence 4566688999999999999764 5889999999998888888889999999999999999999998887 5577999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+.+|++.+.|+.. ..+++..+.-+.+++..|+.|||..+ .+|||||+.|||+.++|.+||+|||.+-.+...
T Consensus 90 Mey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999999999764 33588888889999999999999998 999999999999999999999999999877554
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
. .....++||+.|||||++....|+.|+||||||++.+||.+|.+|+...
T Consensus 165 ~-----~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~ 214 (467)
T KOG0201|consen 165 V-----KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL 214 (467)
T ss_pred h-----hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc
Confidence 2 2346689999999999999889999999999999999999999998643
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=307.10 Aligned_cols=208 Identities=28% Similarity=0.406 Sum_probs=172.8
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+.++||+|+||.||+|.+. .++.||+|++..... ....+.|.+|++++++++||||+++++++.+ ....
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d----~~~l 77 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD----GDPV 77 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee----CCEE
Confidence 46888899999999999999875 488999999875432 2234569999999999999999999999876 4467
Q ss_pred EEEEecCCCCCHHHHhcccc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 012297 301 LLVFEFMPNGNLRDCLDGVL---------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 371 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL 371 (466)
++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.++|
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKL 154 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVI 154 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEE
Confidence 99999999999999986421 123667888999999999999999998 999999999999999999999
Q ss_pred EecCCccccccCCC-------------CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 372 TDLGMAKRLKADGL-------------PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 372 ~DfGla~~~~~~~~-------------~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+|||+++....... ...........||+.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 99999986622110 00011223357999999999999999999999999999999999999999753
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=285.82 Aligned_cols=195 Identities=27% Similarity=0.349 Sum_probs=163.1
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHH-HHHhcCCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~-~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|+||.||+|... +++.+|+|++.... .......+..|.. +++.++||||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~----~~~~~lv~e 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT----TEKLYFVLD 76 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec----CCEEEEEEc
Confidence 36999999999999865 58899999986542 2223344556655 4677899999999988876 446799999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 77 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-- 149 (325)
T cd05604 77 FVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-- 149 (325)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--
Confidence 99999999988653 46899999999999999999999998 999999999999999999999999998753221
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
........|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 150 ---SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred ---CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 11233456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=287.30 Aligned_cols=195 Identities=27% Similarity=0.369 Sum_probs=166.3
Q ss_pred ceecccCcEEEEEEEE----cCCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEE
Q 012297 230 NIVGQGGSSYVYRGQL----TDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~----~~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
+.||+|+||.||++.. .+++.+|+|++..... ......+.+|++++++++|+||+++++++.+ ....++||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT----EGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc----CCEEEEEE
Confidence 5799999999999875 3578999999875432 2233457789999999999999999998876 44679999
Q ss_pred ecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCC
Q 012297 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~ 384 (466)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 78 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 78 DFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999999999653 45899999999999999999999998 9999999999999999999999999987653321
Q ss_pred CCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 153 -----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 153 -----KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred -----CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 1123356899999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=284.55 Aligned_cols=195 Identities=24% Similarity=0.336 Sum_probs=161.4
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHH-HHHhcCCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~-~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|+||.||++... +++.||+|++.... .......+..|.. +++.++|+||+++++++.+ ....++|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~----~~~~~lv~e 76 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----ADKLYFVLD 76 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc----CCeEEEEEe
Confidence 36999999999999875 56789999987532 1222233444444 5678899999999998876 446799999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~- 150 (325)
T cd05602 77 YINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN- 150 (325)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-
Confidence 99999999999753 45788888999999999999999998 9999999999999999999999999987542211
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 151 ----GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred ----CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence 1233456899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=274.19 Aligned_cols=194 Identities=27% Similarity=0.439 Sum_probs=164.9
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCC
Q 012297 232 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (466)
Q Consensus 232 LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~ 308 (466)
||+|+||.||++... +++.+|+|.+..... ......+..|++++++++||||+++.+++.. ....++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~----~~~~~lv~e~~~ 76 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES----KTHLCLVMSLMN 76 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec----CCeEEEEEecCC
Confidence 689999999999865 589999999865322 2223346679999999999999999988765 456799999999
Q ss_pred CCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCC
Q 012297 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388 (466)
Q Consensus 309 ~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~ 388 (466)
+++|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---- 149 (277)
T cd05607 77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---- 149 (277)
T ss_pred CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----
Confidence 999999886655556899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 389 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
......|+..|+|||++....++.++||||||+++|||++|+.||...
T Consensus 150 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 150 --TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred --eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 112345788999999998888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=289.01 Aligned_cols=194 Identities=23% Similarity=0.280 Sum_probs=165.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
...|++.+.||+|+||.||++.+. .++.||+|.... ..+.+|++++++++||||+++++++.. ....+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTY----NKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEE----CCeeE
Confidence 357999999999999999999875 578999996542 236899999999999999999999876 44679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+|+|++ .++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 160 lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred EEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 999999 57899888654 45899999999999999999999998 9999999999999999999999999997532
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
... ........||+.|+|||++....++.++||||||+++|||++|+.||..
T Consensus 234 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 234 DIN----ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccc----ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 211 1122335789999999999988999999999999999999999988753
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=292.30 Aligned_cols=208 Identities=28% Similarity=0.412 Sum_probs=182.1
Q ss_pred hHHHHHHhCCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc
Q 012297 216 YSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 294 (466)
Q Consensus 216 ~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~ 294 (466)
++.|+--..+....++||.|.+|.||.|.++. .-.||||.++.+. -..++|+.|..+|+.++|||+|+|+|+|..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~-- 334 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-- 334 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhcc--
Confidence 35666666777778899999999999999865 4579999998764 344569999999999999999999999986
Q ss_pred CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 012297 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 374 (466)
Q Consensus 295 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~Df 374 (466)
....|||+|||.+|+|.+||++.+....+.-..+.+|.||+.||+||...+ +|||||.++|+|+.++..+|++||
T Consensus 335 --EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADF 409 (1157)
T KOG4278|consen 335 --EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADF 409 (1157)
T ss_pred --CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeecc
Confidence 446699999999999999999988777888889999999999999999998 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 012297 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIH 436 (466)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~ 436 (466)
|+++....+-+.. .....=++.|.|||.+....++.|+|||+|||+|||+.| |-.||.
T Consensus 410 GLsRlMtgDTYTA----HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP 468 (1157)
T KOG4278|consen 410 GLSRLMTGDTYTA----HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP 468 (1157)
T ss_pred chhhhhcCCceec----ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC
Confidence 9999987765432 222233578999999999999999999999999999997 888875
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=277.13 Aligned_cols=208 Identities=28% Similarity=0.425 Sum_probs=171.0
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 294 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~ 294 (466)
..+++|+..+.||+|+||.||+|.+. .+..||||++...........|.+|+.+++.++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-- 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-- 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence 35677889999999999999999753 2567999998654433445568999999999999999999999865
Q ss_pred CcceeEEEEEecCCCCCHHHHhccccc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 012297 295 GKRAMRLLVFEFMPNGNLRDCLDGVLV--------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366 (466)
Q Consensus 295 ~~~~~~~lV~ey~~~gsL~~~l~~~~~--------~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~ 366 (466)
....++||||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 81 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 81 --GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 155 (277)
T ss_pred --CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCC
Confidence 4467999999999999999965321 23678899999999999999999988 9999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 367 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+.++|+|||+++......... ......++..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~ 225 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYR---KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225 (277)
T ss_pred CCEEECCCCCccccCCcceee---cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999987654322111 1112245678999999998889999999999999999999 78898643
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=278.65 Aligned_cols=202 Identities=24% Similarity=0.406 Sum_probs=168.9
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|...+.||+|+||.||+|+.. +++.||+|.++..........+.+|++++++++|+||+++++++.. ....++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 81 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT----DKSLTL 81 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee----CCeEEE
Confidence 45778889999999999999875 5788999998766544444568899999999999999999999876 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 82 VFEYLD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred EEeCCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 999996 48888886532 44789999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.. .......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||....
T Consensus 157 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 157 PT-----KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred Cc-----cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 11223457889999998765 568999999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=273.70 Aligned_cols=202 Identities=26% Similarity=0.434 Sum_probs=172.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.++|++.++||+|+||.||+|...++..|++|.+.... ...+.+.+|+++++.++|+||+++++++.+ ....++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTK----EEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC----CCCcEE
Confidence 35677889999999999999998888899999987542 234568999999999999999999988765 345699
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
+|||+++++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999999999997655566899999999999999999999988 99999999999999999999999999987543
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
.... ......++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 156 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 156 NEYT----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred Ccee----ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 2211 1122345678999999988889999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=274.91 Aligned_cols=200 Identities=29% Similarity=0.450 Sum_probs=170.6
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
|+..+.||+|+||.||++... +++.+|||.+...... .....+.+|+.++++++|+|++++++.+.+ ....++
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----~~~~~l 77 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET----KDALCL 77 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec----CCEEEE
Confidence 566789999999999999875 5889999998754322 223457889999999999999999998875 346799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++++|.+++.......+++..++.++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 999999999999996554456899999999999999999999998 99999999999999999999999999876432
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. ......|+..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 155 ~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 155 GQ------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred Cc------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 21 112346889999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=281.24 Aligned_cols=195 Identities=26% Similarity=0.383 Sum_probs=165.2
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|+||.||++... +++.||||+++... .......+..|++++..+ +|+||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~----~~~~~lv~e 76 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT----KDRLFFVME 76 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc----CCEEEEEEc
Confidence 36999999999999876 47899999987542 223344577888999888 69999999998875 446799999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 150 (318)
T cd05570 77 YVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG- 150 (318)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-
Confidence 99999999998754 46899999999999999999999998 9999999999999999999999999987532221
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 151 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 151 ----VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred ----CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 1123346899999999999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=270.92 Aligned_cols=201 Identities=26% Similarity=0.430 Sum_probs=170.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
++|+..+.||+|+||.||++.+.++..+|+|.+.... .....|.+|++++++++||||+++++++.+ ....++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ----QKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEcc----CCCEEEE
Confidence 3467778999999999999999888899999886442 234568999999999999999999999876 3457999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++|+|.++++... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 99999999999997533 35899999999999999999999998 999999999999999999999999998765332
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
... ......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 154 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~ 205 (256)
T cd05114 154 EYT----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205 (256)
T ss_pred cee----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 211 1122235568999999988889999999999999999999 99999654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=274.97 Aligned_cols=203 Identities=26% Similarity=0.413 Sum_probs=167.6
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCc----EEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
.+|...+.||+|+||.||+|.+. +++ .+++|.+..........++..|+..+++++|+||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-----~ 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-----A 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----C
Confidence 35667789999999999999864 343 4788887654444444567888889999999999999998743 2
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccce
Confidence 3578999999999999997532 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
........ .......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 158 LLYPDDKK---YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred eccCCCcc---cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 66433211 11223456778999999998899999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=274.78 Aligned_cols=200 Identities=29% Similarity=0.434 Sum_probs=170.3
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
|+..+.||+|+||+||++.+. +++.+|+|.+..... ......+.+|++++++++|+|++++.+++.. +...++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----~~~~~l 77 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET----KDALCL 77 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec----CCEEEE
Confidence 556688999999999999875 588999999875432 2223457889999999999999999988765 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 999999999999886544456999999999999999999999998 99999999999999999999999999876532
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 155 ~~------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 155 GE------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred CC------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 21 122346889999999998889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=271.42 Aligned_cols=204 Identities=29% Similarity=0.447 Sum_probs=173.2
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
..++|+..+.||+|++|.||+|.+.+++.||+|.++... .....|.+|++++++++|+||+++++++.. ....+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 77 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL----EEPIY 77 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEec----CCCee
Confidence 345688889999999999999998788899999987543 234568999999999999999999998775 34569
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++++|.+++.......+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999999999997655456899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
..... .......+..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 155 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 208 (261)
T cd05068 155 EDIYE----AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208 (261)
T ss_pred CCccc----ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 32211 1111223467999999988899999999999999999999 99999643
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=294.71 Aligned_cols=202 Identities=22% Similarity=0.268 Sum_probs=169.7
Q ss_pred CCCcceecccCcEEEEEEEEc-C-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-D-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
|...+.||+|+||.||+|... + ++.||+|.+.... ......+.+|+.+++.++||||+++++++.. ....+||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~----~~~~~lv 143 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKS----DDKLLLI 143 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE----CCEEEEE
Confidence 677789999999999999754 3 5778888765432 2333457889999999999999999999876 4577999
Q ss_pred EecCCCCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 304 FEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
|||+++|+|.+++... ...++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 9999999999988642 2245889999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... ........||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 221 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 221 DSVS---LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred Cccc---cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 3211 11233456899999999999999999999999999999999999999643
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=275.20 Aligned_cols=204 Identities=29% Similarity=0.489 Sum_probs=169.3
Q ss_pred CCCCCcceecccCcEEEEEEEE-----cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~-----~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
+.|+..+.||+|+||.||+|.+ .++..+++|.+...........|.+|++++++++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 80 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ----EQ 80 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec----CC
Confidence 3566778999999999999975 24678999999865444444568899999999999999999998765 34
Q ss_pred eEEEEEecCCCCCHHHHhcccc---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVL---------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 363 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~---------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl 363 (466)
..++||||+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili 157 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILI 157 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEE
Confidence 5699999999999999985321 124788999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 364 DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 364 d~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
++++.+||+|||+++........ .......++..|+|||.+....++.++||||||+++|||++ |..||..
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYY---RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred cCCCcEEeccccccccccCCcce---ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999876433211 11222345678999999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=300.70 Aligned_cols=214 Identities=23% Similarity=0.310 Sum_probs=174.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCC-cEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceee-eeeec-cCc-c
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDG-RIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVG-YCSEF-RGK-R 297 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~-~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg-~~~~~-~~~-~ 297 (466)
..++++.+.|.+|||+.||.|.+..+ ..+|+|++... +....+...+||++|++|+ |+|||.+++ ..... ... .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 34556678999999999999998776 99999998877 6667778999999999997 999999998 33222 122 3
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
.+.+|.||||++|.|-+++.......|++.++++|+.|+++|+.+||... |||||||||.+||||+.+++.||+|||.+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence 57799999999999999998766667999999999999999999999985 77999999999999999999999999998
Q ss_pred cccccCCCCCCCC----CCCccccCcccccchhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSS----SPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.-........... ......-|+.|.|||.+. +...++|+|||+|||+||-|++...||+..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 7432211000000 001123588999999764 567899999999999999999999999854
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.91 Aligned_cols=215 Identities=26% Similarity=0.294 Sum_probs=176.9
Q ss_pred HHHHHHhCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeecc
Q 012297 217 SALEHATDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 294 (466)
Q Consensus 217 ~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~ 294 (466)
.+.....++|.+.+.||+|+||+||+|+. .+++.||||++..... ......+.+|+..+..++|+|++++...+....
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 34455567899999999999999999975 4689999999876532 333455889999999999999999887665422
Q ss_pred C----cceeEEEEEecCCCCCHHHHhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 012297 295 G----KRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 368 (466)
Q Consensus 295 ~----~~~~~~lV~ey~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~ 368 (466)
. .....++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 1 1124689999999999999996432 345899999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 369 vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
+||+|||+++....... ........||+.|+|||.+....++.++||||||+++|||++|+.||..
T Consensus 182 vkL~DFGls~~~~~~~~---~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~ 247 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVS---DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247 (496)
T ss_pred EEEEecccCeecccccc---ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999986543211 1122345789999999999999999999999999999999999999964
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=272.27 Aligned_cols=207 Identities=27% Similarity=0.440 Sum_probs=173.1
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCc--
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK-- 296 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~-- 296 (466)
.+++.|+..+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.++.++ +|+||+++++++......
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 45677888899999999999999875 57889999987543 3345688999999998 699999999998764321
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGl 376 (466)
....++||||+++++|.+++.......+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 246799999999999999998654456899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCcccccchhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
+....... .......|+..|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 158 SAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred ceeccccc-----ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 87653321 1223356888999999885 34578899999999999999999999964
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=270.65 Aligned_cols=204 Identities=27% Similarity=0.446 Sum_probs=172.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcC----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
++|+..+.||+|+||.||+|.+.. ...|+||.++..........|.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 79 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK----SRP 79 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec----CCc
Confidence 467888999999999999998742 457999998766555556679999999999999999999998865 345
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||+++.
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 80 VMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhc
Confidence 799999999999999997643 36899999999999999999999988 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
....... .......++..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 156 ~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~ 212 (266)
T cd05033 156 LEDSEAT---YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred ccccccc---eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence 6421111 11112234678999999998899999999999999999998 99999643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=267.28 Aligned_cols=202 Identities=30% Similarity=0.381 Sum_probs=173.7
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+|+..+.||+|++|.||++... +++.|++|.+.... .......+.+|++++++++|+||+++++++.+ ....++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 76 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD----KGKLNI 76 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc----CCEEEE
Confidence 3667789999999999999875 58899999987542 33445668999999999999999999998876 456799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++++|.+++.......+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~ 153 (256)
T cd08529 77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153 (256)
T ss_pred EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence 999999999999998754567899999999999999999999988 99999999999999999999999999886643
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... ......|++.|+|||++....++.++|+||||+++|||++|+.||...
T Consensus 154 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 204 (256)
T cd08529 154 NTN-----FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN 204 (256)
T ss_pred ccc-----hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 321 122345788999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=271.61 Aligned_cols=205 Identities=30% Similarity=0.451 Sum_probs=175.9
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++..+|+..+.||+|+||.||+|...+++.+++|.+..... .....+.+|+.+++.++|+||+++++++.+ ....
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 77 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSV----GEPV 77 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEec----CCCe
Confidence 44567888899999999999999998899999999876532 234468899999999999999999998876 3467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhc
Confidence 99999999999999998755566899999999999999999999998 999999999999999999999999999776
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
..... ......++..|+|||.+....++.++||||||+++|+|++ |+.||...
T Consensus 155 ~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~ 208 (261)
T cd05148 155 KEDVY-----LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208 (261)
T ss_pred CCccc-----cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence 43221 1112335678999999988899999999999999999998 89999654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=271.66 Aligned_cols=208 Identities=26% Similarity=0.369 Sum_probs=175.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccC-CCCChhHHHHHHHHHHHhcCCCCccceeeeeee-ccCccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE-FRGKRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~-~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~-~~~~~~~ 299 (466)
...|...+.||+|++|.|..|... +|+.||||++... ......++-++|+.+|+.++|+||+.+++++.. ..+.-..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345555688999999999999875 5899999998733 344455668899999999999999999998876 3333456
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.|+|+|+| .-+|.+.++.. +.++..+...+..|+++||.|+|+.+ ++||||||+|+|++.+..+||+|||+|+.
T Consensus 101 vYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 79999999 77999999864 45899999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.... ......+..+.|-+|.|||++. ...|+...||||.|||+.||++|++-|....
T Consensus 175 ~~~~---~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d 232 (359)
T KOG0660|consen 175 LDKF---FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD 232 (359)
T ss_pred cccc---CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence 7543 1123345677899999999875 5679999999999999999999999997543
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=270.38 Aligned_cols=201 Identities=29% Similarity=0.442 Sum_probs=170.2
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.+|+..+.||+|++|.||+|... .++.|++|.+... ......+.+|+++++.++|+||+++++++.. ....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR----EPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcC----CCCcEE
Confidence 44667789999999999999865 4788999998754 2334568999999999999999999999876 345699
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 999999999999997655556899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 157 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 208 (263)
T cd05052 157 DTYT----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208 (263)
T ss_pred ceee----ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 3211 1122234567999999998899999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=271.80 Aligned_cols=202 Identities=31% Similarity=0.484 Sum_probs=170.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.++|.+.+.||+|+||.||+|.+.+...||+|++..... ....|.+|+++++.++|+||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-----~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCcEE
Confidence 356888899999999999999987777899999875432 33468999999999999999999987643 24589
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||.++....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 999999999999997654456899999999999999999999998 99999999999999999999999999976643
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
.... ......++..|+|||......++.++||||||+++|||+| |+.||...
T Consensus 155 ~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~ 207 (262)
T cd05071 155 NEYT----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207 (262)
T ss_pred cccc----cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 3211 1122345678999999988889999999999999999999 88898644
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=283.28 Aligned_cols=204 Identities=26% Similarity=0.313 Sum_probs=168.1
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc-ceeEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK-RAMRL 301 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~-~~~~~ 301 (466)
+|+..+.||+|+||.||++... +++.||||++.... .......+.+|+++++.++|+||+++++++...... ....+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4777899999999999999864 68999999986542 223345688999999999999999999998763311 12579
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999995 6888887643 46899999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 208 (372)
T cd07853 155 PDES----KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208 (372)
T ss_pred cCcc----ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence 3211 112234578899999998764 4799999999999999999999999754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=273.33 Aligned_cols=206 Identities=30% Similarity=0.434 Sum_probs=170.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcC------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~ 296 (466)
+++|.+.+.||+|++|.||+|.+.+ +..|++|.+...........|.+|+.++++++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE---- 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence 4668888999999999999998753 567999988765544455669999999999999999999998876
Q ss_pred ceeEEEEEecCCCCCHHHHhccccc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---c
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLV-----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---N 368 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~---~ 368 (466)
....++||||+++++|.++++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++ .
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcc
Confidence 3355899999999999999965432 24899999999999999999999998 99999999999998754 5
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 369 vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+||+|||+++......... .......+..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~ 225 (277)
T cd05036 158 AKIADFGMARDIYRASYYR---KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225 (277)
T ss_pred eEeccCccccccCCcccee---cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999998763322110 1112223567999999998899999999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=289.44 Aligned_cols=207 Identities=19% Similarity=0.240 Sum_probs=167.9
Q ss_pred echHHHHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCC------CCccce
Q 012297 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH------CHVVPL 286 (466)
Q Consensus 214 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H------~nIv~l 286 (466)
...+++...+++|.+.++||+|+||+||+|.+. .++.||||+++... .....+..|+.+++.++| .+++++
T Consensus 119 ~~~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i 196 (467)
T PTZ00284 119 VLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKI 196 (467)
T ss_pred ecCCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence 344556667889999999999999999999875 47889999986532 223346677777777754 457888
Q ss_pred eeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcC
Q 012297 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDE 365 (466)
Q Consensus 287 lg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivHrDLk~~NILld~ 365 (466)
++++... ....++|||++ +++|.+++... ..+++..+..++.|++.||+|||+ .+ |+||||||+|||++.
T Consensus 197 ~~~~~~~---~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~ 267 (467)
T PTZ00284 197 QRYFQNE---TGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMET 267 (467)
T ss_pred EEEEEcC---CceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEec
Confidence 8887642 34678999988 78899988654 468999999999999999999997 47 999999999999987
Q ss_pred CC----------------cEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHH
Q 012297 366 NL----------------NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 429 (466)
Q Consensus 366 ~~----------------~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ell 429 (466)
++ .+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell 339 (467)
T PTZ00284 268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339 (467)
T ss_pred CCcccccccccccCCCCceEEECCCCccccCcc--------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH
Confidence 65 499999998754321 123457899999999999999999999999999999999
Q ss_pred cCCCCCCCCC
Q 012297 430 TGRQPIHRSI 439 (466)
Q Consensus 430 tG~~Pf~~~~ 439 (466)
+|+.||....
T Consensus 340 tG~~pf~~~~ 349 (467)
T PTZ00284 340 TGKLLYDTHD 349 (467)
T ss_pred hCCCCCCCCC
Confidence 9999997543
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=269.14 Aligned_cols=203 Identities=27% Similarity=0.444 Sum_probs=173.0
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
..+.|++.++||+|+||.||+|...+++.+|+|.+..... ....|.+|++++++++|+||+++++++.. ...+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 76 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVTQ-----EPIY 76 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEcc-----CCcE
Confidence 4566888899999999999999998899999999875432 34568999999999999999999988642 3469
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
++|||+++++|.+++.......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 9999999999999997655556899999999999999999999998 9999999999999999999999999997664
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
..... ......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 154 ~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 154 DNEYT----AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred CCCcc----cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 32211 1122345678999999988889999999999999999999 99999643
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=271.47 Aligned_cols=203 Identities=28% Similarity=0.456 Sum_probs=169.4
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCc----EEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
++|+..+.||+|+||.||+|.+. +++ .||+|+++..........+.+|+.+++.++|+||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~ 81 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-----S 81 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----C
Confidence 45777889999999999999753 444 4899999876555556679999999999999999999999864 2
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCcee
Confidence 3578999999999999997532 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
........ .......++..|+|||......++.++||||||+++|||++ |..||...
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 158 LLDIDETE---YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred ecccccce---eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 76432211 01112234678999999988899999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=266.76 Aligned_cols=198 Identities=30% Similarity=0.463 Sum_probs=165.2
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCC
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~ 308 (466)
+.||+|+||.||+|.+. +++.+|+|.+...........|.+|++++++++|+||+++++++.. ....++||||++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ----KQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC----CCCeEEEEeecc
Confidence 36899999999999875 6889999988755444455669999999999999999999999876 345799999999
Q ss_pred CCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCC
Q 012297 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388 (466)
Q Consensus 309 ~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~ 388 (466)
+++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 77 ~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-- 150 (252)
T cd05084 77 GGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA-- 150 (252)
T ss_pred CCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc--
Confidence 99999999653 245899999999999999999999998 999999999999999999999999998764322111
Q ss_pred CCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 389 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
........+..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 151 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~ 200 (252)
T cd05084 151 -STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL 200 (252)
T ss_pred -ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 01111223467999999998889999999999999999997 99998643
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=267.47 Aligned_cols=196 Identities=26% Similarity=0.456 Sum_probs=163.7
Q ss_pred ecccCcEEEEEEEEc---CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCC
Q 012297 232 VGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (466)
Q Consensus 232 LG~G~fG~Vy~a~~~---~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~ 308 (466)
||+|+||.||+|.+. ++..||+|++.........+.|.+|+.++++++|+||+++++++.. ...++||||++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-----~~~~lv~e~~~ 77 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-----EALMLVMEMAS 77 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-----CCeEEEEEeCC
Confidence 899999999999764 3557999999776555555679999999999999999999998743 24689999999
Q ss_pred CCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCC
Q 012297 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388 (466)
Q Consensus 309 ~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~ 388 (466)
+++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....+...
T Consensus 78 ~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~-- 151 (257)
T cd05115 78 GGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-- 151 (257)
T ss_pred CCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccc--
Confidence 999999997532 45899999999999999999999998 999999999999999999999999999765433211
Q ss_pred CCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 389 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
........++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 202 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202 (257)
T ss_pred eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence 111112234578999999988889999999999999999996 99999754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=273.31 Aligned_cols=208 Identities=28% Similarity=0.428 Sum_probs=170.8
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEcC------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeec
Q 012297 220 EHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293 (466)
Q Consensus 220 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~~------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~ 293 (466)
+..+++|++.+.||+|+||.||+|...+ +..||+|.+...........+.+|+.+++.++|+||+++++++.+
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 80 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK- 80 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 3456788899999999999999997542 458999998765444445568899999999999999999998765
Q ss_pred cCcceeEEEEEecCCCCCHHHHhcccc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 012297 294 RGKRAMRLLVFEFMPNGNLRDCLDGVL--------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (466)
Q Consensus 294 ~~~~~~~~lV~ey~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~ 365 (466)
....++||||+++|+|.+++.... ....++..+..++.|++.||.|||+.+ ++||||||+|||+++
T Consensus 81 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~ 154 (288)
T cd05061 81 ---GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAH 154 (288)
T ss_pred ---CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcC
Confidence 335699999999999999996422 123567888999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 366 ~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
++.++|+|||+++........ .......++..|+|||.+....++.++||||||+++|||++ |..||..
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~ 224 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 224 (288)
T ss_pred CCcEEECcCCccccccccccc---cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999998865432211 11122235678999999998899999999999999999998 7889864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=284.01 Aligned_cols=198 Identities=23% Similarity=0.292 Sum_probs=167.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEc---CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~---~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
..+|.+.+.||+|+||.||++... .+..|++|.+.... .+.+|++++++++|+||+++++++.. ...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~----~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRW----KST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEee----CCE
Confidence 456888999999999999999753 35789999876532 25689999999999999999998875 446
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++|||++. ++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++.
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EEEEehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 799999994 7899988433 56899999999999999999999998 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
...... ........||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 235 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 235 LDAHPD---TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cCcccc---cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 543321 112234578999999999999999999999999999999999999997543
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=273.93 Aligned_cols=199 Identities=28% Similarity=0.404 Sum_probs=170.9
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|++.+.||+|+||.||++... ++..+++|.+...........+.+|++++++++||||+++++++.+ ....++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 76 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS----DGEISI 76 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----CCEEEE
Confidence 36788899999999999999865 5788999988765443444568899999999999999999999876 456799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
||||+++++|.++++.. ..+++..+..++.|+++||.|||+ .+ ++|+||||+|||+++++.++|+|||++....
T Consensus 77 v~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 77 CMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred EeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 99999999999999754 558999999999999999999997 46 9999999999999999999999999987553
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 152 ~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 152 DSM-------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred ccc-------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 221 22346788999999988888999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=267.94 Aligned_cols=200 Identities=26% Similarity=0.408 Sum_probs=168.2
Q ss_pred CCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
+|++.+.||+|+||.||++.+.++..+|+|.+..... ....|.+|++++++++|+||+++++++.+ ....++||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTK----QRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcC----CCceEEEE
Confidence 4667789999999999999988778899998864322 23458899999999999999999998765 34679999
Q ss_pred ecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCC
Q 012297 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~ 384 (466)
||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 79 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 79 EYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred ecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 9999999999997543 35899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
.. ......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 155 ~~----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 155 YT----SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred cc----ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 11 1111223467999999998899999999999999999999 89999653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=281.42 Aligned_cols=203 Identities=23% Similarity=0.292 Sum_probs=168.8
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--cc
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KR 297 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~--~~ 297 (466)
..++|+..+.||+|+||.||++... +++.||||++.... .......+.+|+.+++.++||||+++++++..... ..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3477888999999999999999874 58899999987542 23334568899999999999999999998864332 12
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||++ ++|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 34699999995 46766664 24788999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 171 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 171 RTACTNF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred cccccCc------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 7543221 123346789999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=266.88 Aligned_cols=202 Identities=25% Similarity=0.321 Sum_probs=173.8
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
+|++.+.||+|+||.||++... +++.+++|.++........+.+.+|+.+++.++|+||+++++.+.. ....++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA----DGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE----CCEEEEE
Confidence 4677789999999999999875 5889999998765444455668899999999999999999998865 4577999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++++|.+++.......+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++.....
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 99999999999987654456899999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. ......++..|+|||.+....++.++|+||||+++|+|++|+.||...
T Consensus 154 ~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 203 (255)
T cd08219 154 GA-----YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203 (255)
T ss_pred cc-----ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC
Confidence 21 122346788999999998888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=271.31 Aligned_cols=204 Identities=27% Similarity=0.428 Sum_probs=168.0
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCC-hhHHHHHHHHHHHhc---CCCCccceeeeeeeccC-cce
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFRG-KRA 298 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~-~~~~f~~Ei~~l~~l---~H~nIv~llg~~~~~~~-~~~ 298 (466)
+|+..+.||+|+||.||+|... +++.||+|.++...... ....+.+|+++++.+ +|+||+++++++..... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4677889999999999999876 58899999987543222 223466777777665 69999999998865332 234
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||++ ++|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 5799999996 58999987655556899999999999999999999998 9999999999999999999999999997
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... ......++..|+|||.+.+..++.++||||||+++|||++|++||...
T Consensus 157 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 157 IYSCQM------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cccCcc------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 654321 122346788999999998888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=271.49 Aligned_cols=202 Identities=30% Similarity=0.423 Sum_probs=168.3
Q ss_pred CCcceecccCcEEEEEEEE-----cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 227 SGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 227 ~~~~~LG~G~fG~Vy~a~~-----~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
+..+.||+|+||.||++.. .+++.||+|.+...........|.+|++++++++|+||+++++++.... ....+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~~~ 84 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG--GKGLQ 84 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--CceEE
Confidence 6778999999999988653 3577899999876544445566899999999999999999999886532 33568
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.++|+|||+++...
T Consensus 85 lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999999965 34899999999999999999999998 9999999999999999999999999998664
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... ........++..|+|||.+....++.++||||||+++|||++|..||...
T Consensus 159 ~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 159 EGHEY--YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred Ccchh--hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 32211 01112223566799999998888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=268.00 Aligned_cols=200 Identities=25% Similarity=0.414 Sum_probs=169.2
Q ss_pred CCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
+|...+.||+|+||.||+|...++..+|+|.+.... .....|.+|+.++++++||||+++++++.+ ....++||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~ 78 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK----QRPIYIVT 78 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc----CCCcEEEE
Confidence 466778899999999999998777789999987543 234568999999999999999999999865 33569999
Q ss_pred ecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCC
Q 012297 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~ 384 (466)
||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 79 e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 79 EYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 9999999999997543 35899999999999999999999998 9999999999999999999999999987654322
Q ss_pred CCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
. .......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 155 ~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 155 Y----TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred e----eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 1 11122335678999999988889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=268.41 Aligned_cols=202 Identities=31% Similarity=0.479 Sum_probs=171.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.++|++.+.||+|+||.||+|...++..+|+|.+..... ....|.+|++++++++|+|++++++++.+ ...++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-----~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVSE-----EPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEECC-----CCcEE
Confidence 356788899999999999999988888899999876533 23468999999999999999999988643 24589
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
+|||+++++|.+++.......+++.++..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999999999997654456899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
.... ......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 155 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 207 (260)
T cd05070 155 NEYT----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred cccc----cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 2211 1122335667999999988889999999999999999999 89999643
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=268.65 Aligned_cols=193 Identities=27% Similarity=0.404 Sum_probs=167.2
Q ss_pred CCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
+|+..++||+|+||.||+|.+ .+++.||+|.+...........|.+|++++++++||||+++++++.. ....++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 77 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV----ENRISIC 77 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE----CCEEEEE
Confidence 567778999999999999986 46889999998765444455668999999999999999999999886 3456899
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++++|..+. .+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++......
T Consensus 78 ~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 78 TEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred EecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 9999999997652 3688889999999999999999998 999999999999999999999999999765332
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 149 -------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 149 -------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred -------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 12234688899999999988999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=280.80 Aligned_cols=203 Identities=21% Similarity=0.276 Sum_probs=169.5
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeecc--Ccc
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKR 297 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~--~~~ 297 (466)
..++|...+.||+|+||.||++... .++.||||++.... .......+.+|+.+++.++|+||+++++++.... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3567888999999999999999865 57889999987543 2333456889999999999999999999875432 122
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||++ ++|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 35699999995 578777753 4788999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+...... ......+|..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 174 RTAGTSF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred cccCCCC------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 7653321 123346889999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=268.48 Aligned_cols=198 Identities=29% Similarity=0.415 Sum_probs=160.0
Q ss_pred eecccCcEEEEEEEEcC---CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecC
Q 012297 231 IVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307 (466)
Q Consensus 231 ~LG~G~fG~Vy~a~~~~---~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~ 307 (466)
.||+|+||.||+|...+ ...+++|.+...........|.+|++.++.++|+||+++++.+.. ....++||||+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~----~~~~~lv~e~~ 77 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE----SIPYLLVLEFC 77 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC----CCceEEEEEeC
Confidence 58999999999997543 357888887765444455668999999999999999999998875 34579999999
Q ss_pred CCCCHHHHhccccc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCC
Q 012297 308 PNGNLRDCLDGVLV---EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 308 ~~gsL~~~l~~~~~---~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~ 384 (466)
++|+|.+++..... ...++...+.++.|++.||+|||+.+ |+||||||+|||+++++++||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccch
Confidence 99999999965432 22467888999999999999999998 9999999999999999999999999987543322
Q ss_pred CCCCCCCCCccccCcccccchhccc-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYAMV-------GRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
.. .......++..|+|||++.. ..++.++||||||+++|||++ |..||...
T Consensus 155 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 155 YY---ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred he---eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 11 11122345678999998642 456889999999999999999 78888654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=263.75 Aligned_cols=197 Identities=31% Similarity=0.484 Sum_probs=166.9
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCCC
Q 012297 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~~ 309 (466)
++||+|+||.||+|...+++.+|+|.+...........|.+|++++++++|+||+++++++.. ....++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ----RQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec----CCccEEEEECCCC
Confidence 368999999999999888999999998766544445568999999999999999999999876 3456999999999
Q ss_pred CCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCC
Q 012297 310 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389 (466)
Q Consensus 310 gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~ 389 (466)
++|.+++.... ..+++..++.++.|++.+|.|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 77 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--- 149 (250)
T cd05085 77 GDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS--- 149 (250)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc---
Confidence 99999986543 45899999999999999999999998 999999999999999999999999998754322111
Q ss_pred CCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 390 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 390 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
......++..|+|||++....++.++||||||+++|||++ |..||...
T Consensus 150 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 150 -SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred -cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 1112234567999999988889999999999999999998 99999643
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=273.42 Aligned_cols=199 Identities=25% Similarity=0.354 Sum_probs=160.9
Q ss_pred cceecccCcEEEEEEEEc---CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEe
Q 012297 229 SNIVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~---~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
..+||+|+||.||+|... +++.+|+|.+.... ....+.+|++++++++||||+++++++.... ....++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHA--DRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCC--CcEEEEEEe
Confidence 358999999999999865 46789999986542 2234789999999999999999999876532 346799999
Q ss_pred cCCCCCHHHHhcccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEEec
Q 012297 306 FMPNGNLRDCLDGVL-------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDL 374 (466)
Q Consensus 306 y~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl----d~~~~vkL~Df 374 (466)
|++ ++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 984 58888875321 124889999999999999999999998 9999999999999 45678999999
Q ss_pred CCccccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|+++.......+ ........||+.|+|||.+.+ ..++.++||||||+++|||++|++||...
T Consensus 157 G~a~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 157 GFARLFNSPLKP--LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CceeccCCCCcc--ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 999876432211 112234568999999998876 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=268.63 Aligned_cols=198 Identities=28% Similarity=0.403 Sum_probs=162.0
Q ss_pred eecccCcEEEEEEEEcC---CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecC
Q 012297 231 IVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307 (466)
Q Consensus 231 ~LG~G~fG~Vy~a~~~~---~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~ 307 (466)
.||+|+||.||+|...+ +..+++|.++..........|.+|+.++++++|+||+++++++.+ ....++||||+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~ 77 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE----VTPYLLVMEFC 77 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC----CCCcEEEEECC
Confidence 58999999999998653 457999998876554555578999999999999999999998876 34569999999
Q ss_pred CCCCHHHHhccccc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCC
Q 012297 308 PNGNLRDCLDGVLV---EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 308 ~~gsL~~~l~~~~~---~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~ 384 (466)
++|+|.+++..... ...++..+..++.|++.||+|||+.+ ++||||||+||++++++++||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 99999999965321 23577888899999999999999998 9999999999999999999999999987543322
Q ss_pred CCCCCCCCCccccCcccccchhcccC-------CCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYAMVG-------RASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
. ........++..|+|||++... .++.++||||||+++|||++ |+.||...
T Consensus 155 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 155 Y---YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred e---eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1112234567889999987532 35789999999999999996 99999654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=287.18 Aligned_cols=202 Identities=24% Similarity=0.332 Sum_probs=163.5
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc----Cc
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR----GK 296 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~----~~ 296 (466)
...+|...+.||+|+||.||+|... .++.||||++..... ...+|+.+++.++|+||+++++++.... ..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3467889999999999999999875 578999998864321 2457999999999999999998764321 22
Q ss_pred ceeEEEEEecCCCCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEe
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITD 373 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~-~vkL~D 373 (466)
....++||||++ ++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence 234679999996 5787776432 2356899999999999999999999998 99999999999998665 699999
Q ss_pred cCCccccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 374 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 374 fGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
||+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|.+||...
T Consensus 215 FGla~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 215 FGSAKNLLAGQ------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred cccchhccCCC------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99998664321 1223467899999998865 46899999999999999999999999754
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=266.95 Aligned_cols=204 Identities=32% Similarity=0.485 Sum_probs=174.0
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
...++|.+.+.||+|+||.||+|.+.+++.++||.+..... ....+.+|++++++++|+||+++++++.. ....
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 76 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSE----EEPI 76 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeec----CCce
Confidence 34567888899999999999999988888999999875432 34568999999999999999999998765 3457
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++++|.+++.......+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceec
Confidence 99999999999999998755556899999999999999999999998 999999999999999999999999998766
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
...... .......+..|+|||.+.+..++.++|+||||+++|||++ |+.||..
T Consensus 154 ~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 207 (261)
T cd05034 154 EDDEYT----AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207 (261)
T ss_pred cchhhh----hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 432111 1112234567999999998889999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=260.45 Aligned_cols=215 Identities=26% Similarity=0.341 Sum_probs=175.7
Q ss_pred hCCCCCcceecccCcEEEEEEE-EcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC-cceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~-~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~-~~~~~ 300 (466)
.++|.+.+.||+|||..||+++ +.++..+|+|++.... .+..+..++|++..++++|||++++++++..... .....
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 3567778899999999999997 5678899999998765 4556668999999999999999999998775444 44567
Q ss_pred EEEEecCCCCCHHHHhcccccC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVE--GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~--~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
||+++|...|+|.+.++....+ .+++.+++.|+.++++||++||+.. |++.||||||.|||+.+++.++|.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999764433 4899999999999999999999986 579999999999999999999999999987
Q ss_pred ccccCCCC----CCCCCCCccccCcccccchhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 379 RLKADGLP----SCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 379 ~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
...-.-.. .....+....-|..|.|||++. ....++++||||||++||+|+.|..||+...
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~ 245 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY 245 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh
Confidence 64321100 0001122234578899999886 4456899999999999999999999998543
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=280.31 Aligned_cols=203 Identities=21% Similarity=0.270 Sum_probs=169.5
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--cc
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KR 297 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~--~~ 297 (466)
..++|...+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++|+||+++++++..... ..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578899999999999999999764 578999999876432 2334568899999999999999999998764321 22
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||++ ++|.+++.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCccc
Confidence 35699999995 577777653 4788999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 167 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 167 RTAGTSF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred ccCCCcc------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 7653321 123346889999999999889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=274.11 Aligned_cols=206 Identities=24% Similarity=0.381 Sum_probs=172.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccC
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRG 295 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~ 295 (466)
.++|...+.||+|+||.||++... .+..+|||+++..........+.+|+++++++ +|+||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--- 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec---
Confidence 346788899999999999999752 34579999988664444456689999999999 79999999999876
Q ss_pred cceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 012297 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (466)
Q Consensus 296 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfG 375 (466)
....++||||+++|+|.++++......+++.++..++.|++.||+|||+.+ ++|+||||+|||+++++.++|+|||
T Consensus 111 -~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 -GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred -CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence 345799999999999999997654444899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+++........ .......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 187 ~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 187 LARDIMNDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred ccccccCCCce---eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 99765432211 11122345678999999998899999999999999999998 99998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=283.69 Aligned_cols=202 Identities=30% Similarity=0.507 Sum_probs=177.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
+..+..++||+|.||.||+|...+ .-.||||..+.+..++..+.|+.|..+|++++||||++|+|+|.+ .
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-----~ 463 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-----Q 463 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-----c
Confidence 344556789999999999997643 236999999998888888889999999999999999999999986 3
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..|||||.++.|.|..||+.+. ..++......++.|++.+|.|||+.. +|||||.++|||+....-|||+|||+++
T Consensus 464 P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence 5699999999999999998743 55889999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
.+..+.+...+ ...-+..|||||.+..++++.+||||.|||.+||++. |..||+.-
T Consensus 540 ~~ed~~yYkaS----~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv 596 (974)
T KOG4257|consen 540 YLEDDAYYKAS----RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV 596 (974)
T ss_pred hccccchhhcc----ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc
Confidence 98776654322 3345688999999999999999999999999999986 99999853
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=266.00 Aligned_cols=199 Identities=28% Similarity=0.440 Sum_probs=168.6
Q ss_pred CCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.+|++.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.++++++|+||+++++++.. ....++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~----~~~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLS----REKLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEe----CCEEEE
Confidence 4688889999999999999986 4678999999875432 333457899999999999999999999876 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++++|.++++.. ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 84 CMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999999999998653 45899999999999999999999998 99999999999999999999999999986643
Q ss_pred CCCCCCCCCCCccccCcccccchhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.. .......++..|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 159 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~ 211 (267)
T cd06646 159 TI-----AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred cc-----cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 21 1122345788999999874 44578899999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=271.76 Aligned_cols=202 Identities=26% Similarity=0.420 Sum_probs=168.8
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|...+.||+|+||.||+|... +++.||+|.+...........+.+|+.++++++|+||+++++++.. ....++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----~~~~~l 81 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT----EKSLTL 81 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec----CCeEEE
Confidence 45777889999999999999875 5789999998765444444567899999999999999999999875 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||++ ++|.+++.... ..+++..+..++.|+++||+|||+.+ ++|+||||+|||+++++.++|+|||++.....
T Consensus 82 v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred EEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 999996 69999886542 45889999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.. .......+++.|+|||.+.+ ..++.++||||||+++|||++|++||....
T Consensus 157 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 157 PT-----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred CC-----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 11223356789999998765 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=272.17 Aligned_cols=207 Identities=26% Similarity=0.372 Sum_probs=174.0
Q ss_pred CCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
+|+..+.||+|++|.||++...+ ++.+|+|.+...... .....+.+|+++++.++|+||+++++.+.+ ....+
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~ 77 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT----ETYLC 77 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec----CCEEE
Confidence 57788899999999999998764 899999998765433 244568899999999999999999998865 45679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 9999999999999997655566899999999999999999999998 9999999999999999999999999987653
Q ss_pred cCCCCC------------------------CCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 382 ADGLPS------------------------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 382 ~~~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
...... .........|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 321100 00111234688899999999988899999999999999999999999964
Q ss_pred C
Q 012297 438 S 438 (466)
Q Consensus 438 ~ 438 (466)
.
T Consensus 235 ~ 235 (316)
T cd05574 235 S 235 (316)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=265.75 Aligned_cols=205 Identities=26% Similarity=0.391 Sum_probs=170.1
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC----CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG----PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
.+|+..+.||+|+||.||+|... +++.|++|.+..... ......+.+|+.++++++|+||+++++++.+.. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~ 79 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM--ER 79 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC--Cc
Confidence 46788899999999999999875 488999998864321 122345888999999999999999999876532 23
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++++|.+++... ..+++..++.++.|++.+|+|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 80 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 568999999999999999754 34788999999999999999999998 9999999999999999999999999988
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
........ ........++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 155 RLQTICLS--GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred cccccccc--ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 65432111 1112234578899999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=266.32 Aligned_cols=201 Identities=32% Similarity=0.485 Sum_probs=169.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
++|.+...||+|++|.||++.+.++..+++|.+.... .....|.+|++++++++|+|++++++++.. ...++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-----EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCcEEE
Confidence 4577778999999999999998877789999886543 234568999999999999999999988643 245899
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999999999997654456899999999999999999999998 999999999999999999999999999765432
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
... ......++..|+|||......++.++||||||+++|||++ |+.||...
T Consensus 156 ~~~----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 207 (260)
T cd05069 156 EYT----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred ccc----ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 211 1112335678999999988889999999999999999999 99999753
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=270.78 Aligned_cols=206 Identities=29% Similarity=0.424 Sum_probs=171.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcC------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~ 296 (466)
.++|.+.+.||+|+||.||+|...+ +..|++|.+...........+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---- 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST---- 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC----
Confidence 4567888999999999999998643 468999998765444445568899999999999999999999876
Q ss_pred ceeEEEEEecCCCCCHHHHhcccc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVL--------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 368 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~ 368 (466)
....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~ 157 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCC
Confidence 346799999999999999996432 123688999999999999999999988 999999999999999999
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 369 vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+||+|||+++........ .......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 225 (277)
T cd05032 158 VKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225 (277)
T ss_pred EEECCcccchhhccCccc---ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC
Confidence 999999999866443221 11222345778999999988889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=284.01 Aligned_cols=210 Identities=26% Similarity=0.412 Sum_probs=172.4
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeee
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCS 291 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~ 291 (466)
++...++|.+.+.||+|+||.||+|++. .++.||||+++..........+.+|++++.++. |+||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4444556778899999999999999864 246899999986644444456899999999997 999999999987
Q ss_pred eccCcceeEEEEEecCCCCCHHHHhccccc--------------------------------------------------
Q 012297 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLV-------------------------------------------------- 321 (466)
Q Consensus 292 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~-------------------------------------------------- 321 (466)
. ....++||||+++|+|.+++++...
T Consensus 112 ~----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 112 K----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred c----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 6 3457999999999999999964321
Q ss_pred ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 012297 322 ----------------------------------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 355 (466)
Q Consensus 322 ----------------------------------------------~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrD 355 (466)
..+++..++.++.|++.||+|||+.+ ++|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrd 264 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRD 264 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCccc
Confidence 23677888999999999999999987 99999
Q ss_pred CCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCC
Q 012297 356 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434 (466)
Q Consensus 356 Lk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~P 434 (466)
|||+|||+++++.+||+|||+++........ .......++..|+|||.+....++.++||||||+++|||++ |+.|
T Consensus 265 lkp~NiLl~~~~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P 341 (401)
T cd05107 265 LAARNVLICEGKLVKICDFGLARDIMRDSNY---ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341 (401)
T ss_pred CCcceEEEeCCCEEEEEecCcceeccccccc---ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999865332211 11222356788999999988889999999999999999998 8999
Q ss_pred CCCC
Q 012297 435 IHRS 438 (466)
Q Consensus 435 f~~~ 438 (466)
|...
T Consensus 342 ~~~~ 345 (401)
T cd05107 342 YPEL 345 (401)
T ss_pred CCCC
Confidence 8653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=270.22 Aligned_cols=207 Identities=29% Similarity=0.431 Sum_probs=173.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcC-----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~-----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
.++|+..+.||+|+||.||+|.+.+ +..|++|++...........+.+|+.++++++|+||+++++++... .
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---G 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---C
Confidence 4567788999999999999998765 7889999987665555566689999999999999999999987653 2
Q ss_pred eeEEEEEecCCCCCHHHHhccccc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLV------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 371 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~------~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL 371 (466)
...++++||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEE
Confidence 356899999999999999965322 35899999999999999999999998 999999999999999999999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 372 ~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+|||+++......... ......++..|+|||.+....++.++||||||+++||+++ |+.||...
T Consensus 159 ~d~g~~~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 159 TDNALSRDLFPMDYHC---LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223 (280)
T ss_pred CCCCCcccccCCceEE---eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence 9999998654332111 1112345678999999988889999999999999999999 99999653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=278.61 Aligned_cols=207 Identities=28% Similarity=0.451 Sum_probs=169.7
Q ss_pred hCCCCCcceecccCcEEEEEEEE------cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccC
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRG 295 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~------~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~ 295 (466)
.++|.+.+.||+|+||.||+|.. .+++.||||+++..........+.+|++++.++ +|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence 45788889999999999999974 347899999998655444455688999999999 689999999988652
Q ss_pred cceeEEEEEecCCCCCHHHHhcccc-------------------------------------------------------
Q 012297 296 KRAMRLLVFEFMPNGNLRDCLDGVL------------------------------------------------------- 320 (466)
Q Consensus 296 ~~~~~~lV~ey~~~gsL~~~l~~~~------------------------------------------------------- 320 (466)
....++||||+++|+|.+++....
T Consensus 84 -~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 84 -GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred -CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 235689999999999999986421
Q ss_pred ----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCC
Q 012297 321 ----------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 390 (466)
Q Consensus 321 ----------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~ 390 (466)
...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++........ ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~ 236 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD---YV 236 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcc---hh
Confidence 123678888999999999999999998 99999999999999999999999999976533211 01
Q ss_pred CCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 391 SPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 391 ~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
......++..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 1122335677999999988899999999999999999997 99998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=270.31 Aligned_cols=204 Identities=27% Similarity=0.422 Sum_probs=168.0
Q ss_pred CCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
+|++.+.||+|+||.||+|... ....+++|.+...........+.+|+.+++.++||||+++++.+.. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ----DG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec----CC
Confidence 3667789999999999999763 2357899988765544445568999999999999999999998875 34
Q ss_pred eEEEEEecCCCCCHHHHhcccc----------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVL----------------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDL 356 (466)
..++|+||+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~di 153 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDL 153 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhh
Confidence 5699999999999999986421 134789999999999999999999998 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCC
Q 012297 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPI 435 (466)
Q Consensus 357 k~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf 435 (466)
||+|||+++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 230 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSY---VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccch---hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999865432211 11122345678999999988889999999999999999998 99998
Q ss_pred CCC
Q 012297 436 HRS 438 (466)
Q Consensus 436 ~~~ 438 (466)
...
T Consensus 231 ~~~ 233 (290)
T cd05045 231 PGI 233 (290)
T ss_pred CCC
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=263.57 Aligned_cols=203 Identities=27% Similarity=0.414 Sum_probs=170.8
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC----ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~----~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
++|...+.||+|++|.||++... +++.+++|.+...... .....+.+|++++++++|+||+++++++.+ ..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~ 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD----DE 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc----CC
Confidence 46888899999999999999864 5889999998654221 123458889999999999999999999876 34
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~ 152 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 152 (263)
T ss_pred eEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccce
Confidence 779999999999999999754 45889999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
........ ........++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 153 RLQTICSS--GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred eccccccc--cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 65332110 1111234577889999999988899999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=265.73 Aligned_cols=205 Identities=26% Similarity=0.378 Sum_probs=165.7
Q ss_pred CCcceecccCcEEEEEEEEcCCc---EEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--cceeE
Q 012297 227 SGSNIVGQGGSSYVYRGQLTDGR---IVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAMR 300 (466)
Q Consensus 227 ~~~~~LG~G~fG~Vy~a~~~~~~---~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~--~~~~~ 300 (466)
.+.+.||+|+||.||+|.+.+.. .+|+|.++... .......|.+|+++++.++|+||+++++++..... .....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45678999999999999876532 58999887653 22334568899999999999999999998764332 12346
Q ss_pred EEEEecCCCCCHHHHhccc----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 012297 301 LLVFEFMPNGNLRDCLDGV----LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGl 376 (466)
+++|||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999987421 2234899999999999999999999988 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
++........ .......+++.|++||......++.++||||||+++|||++ |+.||..
T Consensus 159 ~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 217 (272)
T cd05075 159 SKKIYNGDYY---RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217 (272)
T ss_pred ccccCcccce---ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9876433211 11122345678999999999999999999999999999999 8999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=271.15 Aligned_cols=202 Identities=28% Similarity=0.471 Sum_probs=166.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-C--cEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-G--RIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-~--~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~ 299 (466)
++|++.+.||+|+||.||+|.+.+ + ..+++|.++..........|.+|++++.++ +||||+++++++.+ ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN----RGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc----CCc
Confidence 467888999999999999998754 3 357888887544444455689999999999 79999999998876 345
Q ss_pred EEEEEecCCCCCHHHHhcccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 012297 300 RLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~ 365 (466)
.++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+|||+++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~ 154 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGE 154 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECC
Confidence 799999999999999996532 124889999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 366 ~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
++.+||+|||++....... .......+..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 155 ~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~ 222 (297)
T cd05089 155 NLASKIADFGLSRGEEVYV------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM 222 (297)
T ss_pred CCeEEECCcCCCcccccee------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999986432110 0111123457999999988889999999999999999997 99999654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=273.72 Aligned_cols=205 Identities=28% Similarity=0.438 Sum_probs=168.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEc--------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeec
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~--------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~ 293 (466)
.++|.+.+.||+|+||.||++... +...+|+|.+...........+.+|+++++++ +|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 356888899999999999999753 23579999998654444455688999999999 79999999999876
Q ss_pred cCcceeEEEEEecCCCCCHHHHhccccc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 012297 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359 (466)
Q Consensus 294 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~ 359 (466)
....++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ ++||||||+
T Consensus 96 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~ 169 (307)
T cd05098 96 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 169 (307)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHH
Confidence 3467999999999999999975321 24889999999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 360 NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
|||+++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~ 245 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchh---hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 999999999999999998765432110 11111234568999999988889999999999999999998 8888864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=266.05 Aligned_cols=203 Identities=24% Similarity=0.349 Sum_probs=171.0
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|++.+.||+|+||.||+|+.. +++.||||.+.... .......|.+|+++++.++||||+++++++.+ ....
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 77 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE----DNEL 77 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE----CCeE
Confidence 46888899999999999999864 68899999876532 23334568899999999999999999998876 3466
Q ss_pred EEEEecCCCCCHHHHhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 301 LLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
++|+||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~ 154 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccce
Confidence 99999999999999885322 244788999999999999999999998 9999999999999999999999999988
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
....... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 155 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 155 FFSSKTT-----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred eccchhH-----HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 6543211 112345778899999998888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=266.84 Aligned_cols=206 Identities=28% Similarity=0.436 Sum_probs=168.3
Q ss_pred CCCCcceecccCcEEEEEEEEcC-C---cEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTD-G---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~-~---~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
.|.+.+.||+|+||.||+|.+.. + ..|+||.+...........|..|+.++++++||||+++++++.+ ....
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~ 80 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK----SRPV 80 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC----CCce
Confidence 35667899999999999998753 2 36999998765444455679999999999999999999998765 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 81 MIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccc
Confidence 99999999999999997542 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
.................+..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence 43221100011111112457999999998899999999999999999986 99999653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=266.58 Aligned_cols=198 Identities=26% Similarity=0.370 Sum_probs=173.0
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
+|+..+.||.|++|.||+|.+. +++.+++|.+...........+.+|+++++.++|+|++++++++.+ ....++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~v 77 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK----GSKLWII 77 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE----CCeEEEE
Confidence 5777789999999999999875 5889999998766544555668999999999999999999998876 3577999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
+||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.....
T Consensus 78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 78 MEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred EEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 9999999999999753 6899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
. .......++..|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus 152 ~-----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~ 200 (274)
T cd06609 152 M-----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200 (274)
T ss_pred c-----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 1 112234577889999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=272.95 Aligned_cols=210 Identities=28% Similarity=0.446 Sum_probs=172.7
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 291 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~ 291 (466)
++...++|+..+.||+|+||.||++... +...+|+|++...........+.+|++++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3344566788899999999999999864 23689999988654444445688999999999 7999999999987
Q ss_pred eccCcceeEEEEEecCCCCCHHHHhccc--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 012297 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGV--------------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 357 (466)
Q Consensus 292 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk 357 (466)
. ....+++|||+++|+|.++++.. ....+++..++.++.|++.||+|||+.+ |+|||||
T Consensus 87 ~----~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlk 159 (293)
T cd05053 87 Q----EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLA 159 (293)
T ss_pred C----CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccc
Confidence 5 34579999999999999999642 2345899999999999999999999988 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 012297 358 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIH 436 (466)
Q Consensus 358 ~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~ 436 (466)
|+|||+++++.+||+|||+++......... ......++..|+|||.+....++.++||||||+++|||++ |..||.
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 236 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYR---KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236 (293)
T ss_pred eeeEEEcCCCeEEeCcccccccccccccee---ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence 999999999999999999998764322111 1112234567999999988899999999999999999997 999986
Q ss_pred CC
Q 012297 437 RS 438 (466)
Q Consensus 437 ~~ 438 (466)
..
T Consensus 237 ~~ 238 (293)
T cd05053 237 GI 238 (293)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=271.36 Aligned_cols=206 Identities=28% Similarity=0.441 Sum_probs=169.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEc--------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeec
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~--------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~ 293 (466)
..+|.+.+.||+|+||.||+|+.. ++..||+|.+...........+.+|+.+++.+ +|+||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence 455777889999999999999742 24579999987654444556789999999999 79999999999876
Q ss_pred cCcceeEEEEEecCCCCCHHHHhcccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 012297 294 RGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359 (466)
Q Consensus 294 ~~~~~~~~lV~ey~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~ 359 (466)
....++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+
T Consensus 93 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 166 (304)
T cd05101 93 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR 166 (304)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence 346699999999999999996532 134788999999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 360 NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
|||+++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred eEEEcCCCcEEECCCccceeccccccc---ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999876433211 11122345678999999988889999999999999999998 88888643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=265.98 Aligned_cols=205 Identities=26% Similarity=0.420 Sum_probs=170.1
Q ss_pred CCCCCcceecccCcEEEEEEEEc----CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~----~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
.+|++.+.||+|+||.||+|.+. .+..+|+|.++..........|.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 79 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK----SKP 79 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----CCc
Confidence 45777889999999999999864 2347999998765444445679999999999999999999999865 345
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 699999999999999997543 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
....... ........++..|+|||.+....++.++|+||||+++||+++ |+.||...
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~ 213 (267)
T cd05066 156 LEDDPEA--AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213 (267)
T ss_pred cccccce--eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence 6433211 111122233567999999998889999999999999999886 99999754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=263.32 Aligned_cols=203 Identities=26% Similarity=0.382 Sum_probs=172.3
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|+..+.||+|++|.||+|... +++.|++|.++... .......+.+|++++++++|+|++++++++.+ ....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~----~~~~ 77 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE----NNEL 77 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec----CCeE
Confidence 56888899999999999999886 78999999886432 23334568999999999999999999999876 3466
Q ss_pred EEEEecCCCCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 301 LLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~ 154 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceee
Confidence 9999999999999998642 2244899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 155 FFSSKTT-----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred eccCCCc-----ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 6533211 122345778899999998888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=268.69 Aligned_cols=204 Identities=31% Similarity=0.463 Sum_probs=169.1
Q ss_pred CCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
++|.+.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVE----G 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec----C
Confidence 46778899999999999999752 34568999887543 2334568999999999999999999999875 3
Q ss_pred eeEEEEEecCCCCCHHHHhcccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVL-----------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~ 366 (466)
...++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 46799999999999999996432 124899999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 367 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+.++|+|||+++........ .......++..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred CcEEeccCCccccccCCcee---ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999865432211 11122345678999999998899999999999999999998 99998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=269.46 Aligned_cols=203 Identities=28% Similarity=0.406 Sum_probs=167.0
Q ss_pred CCCcceecccCcEEEEEEEEcC------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 226 FSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~~------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
|.+.+.||+|+||.||+|.+.+ +..||+|+++..........|.+|+.++..++|+||+++++++.. ...
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----~~~ 82 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK----EQP 82 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CCc
Confidence 4556789999999999998643 578999999865444444568899999999999999999999876 345
Q ss_pred EEEEEecCCCCCHHHHhcccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 012297 300 RLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~ 365 (466)
.++++||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecC
Confidence 689999999999999984211 134788899999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 366 ~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
++.+||+|||+++........ .......+++.|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred CCceEecccccccccccchhe---eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999998865432211 11122345678999999988889999999999999999998 88888643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=272.91 Aligned_cols=202 Identities=28% Similarity=0.486 Sum_probs=165.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-Cc--EEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-GR--IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-~~--~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~ 299 (466)
++|++.+.||+|+||.||+|.+.+ +. .+++|.++..........|.+|++++.++ +|+||+++++++.+ ...
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~----~~~ 82 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGY 82 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC----CCC
Confidence 467778899999999999998753 43 46788776544444555688999999999 89999999999865 346
Q ss_pred EEEEEecCCCCCHHHHhcccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 012297 300 RLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~ 365 (466)
.++||||+++++|.++++... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecC
Confidence 799999999999999996432 124789999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 366 ~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
++.+||+|||++...... .......++..|+|||.+....++.++||||||+++|||+| |..||...
T Consensus 160 ~~~~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 160 NYVAKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred CCcEEeCccccCcccchh------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 999999999998643211 01111224567999999988889999999999999999998 99999643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=265.24 Aligned_cols=205 Identities=27% Similarity=0.464 Sum_probs=169.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-C---cEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-G---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-~---~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
++|+..+.||+|+||.||+|.+.. + ..+++|.+...........+..|++++++++|+|++++++++.. ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 80 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK----FKP 80 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc----CCC
Confidence 467777899999999999998753 3 37999998765444445668999999999999999999999875 345
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcccee
Confidence 699999999999999997532 45899999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
........ ........+..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 157 LEDDPEGT--YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred cccccccc--eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 54322111 11111223457999999988889999999999999999997 99999643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=270.67 Aligned_cols=199 Identities=25% Similarity=0.352 Sum_probs=160.2
Q ss_pred cceecccCcEEEEEEEEcC---CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEe
Q 012297 229 SNIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~~---~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
..+||+|+||.||+|...+ +..||+|.+.... ....+.+|++++++++||||+++++++.... ....++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHS--DRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccC--CCeEEEEEe
Confidence 3579999999999998653 5789999886542 2234789999999999999999999886533 346799999
Q ss_pred cCCCCCHHHHhccc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEEec
Q 012297 306 FMPNGNLRDCLDGV-------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDL 374 (466)
Q Consensus 306 y~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl----d~~~~vkL~Df 374 (466)
|++ ++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+ ++++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 985 5888777421 1224789999999999999999999998 9999999999999 56678999999
Q ss_pred CCccccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|+++.......+ ........+|+.|+|||.+.+ ..++.++||||||+++|||+||++||...
T Consensus 157 G~a~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 157 GFARLFNSPLKP--LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cceeccCCCccc--ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 999876433211 112234568899999998876 45799999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=269.51 Aligned_cols=199 Identities=26% Similarity=0.437 Sum_probs=170.8
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.+|+..+.||+|++|.||+|... +++.+++|.+...... ....+.+|+.+++.++|+|++++++.+.. ....++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~----~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV----GDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEe----CCEEEE
Confidence 46777889999999999999864 6889999998765433 34558899999999999999999998876 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||++.....
T Consensus 95 v~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred eecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999999999864 34799999999999999999999998 99999999999999999999999999876533
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... ......+++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 169 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~ 219 (296)
T cd06654 169 EQS-----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (296)
T ss_pred ccc-----ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 211 122345788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=279.65 Aligned_cols=193 Identities=26% Similarity=0.325 Sum_probs=159.3
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhc---CCCCccceeeeeeeccCcceeEEEEEe
Q 012297 232 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 232 LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l---~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
||+|+||.||+|... +++.||||++.... .......+..|.+++... +||||+++++++.+ ....++|||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~----~~~~~lv~e 76 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT----DSDLYLVTD 76 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec----CCeEEEEEc
Confidence 699999999999875 58899999986432 112223355677777655 69999999988876 446799999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||+++......
T Consensus 77 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~- 150 (330)
T cd05586 77 YMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN- 150 (330)
T ss_pred CCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-
Confidence 99999999998753 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......||..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 151 ----KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred ----CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 122345689999999988754 4799999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=266.56 Aligned_cols=214 Identities=25% Similarity=0.333 Sum_probs=183.6
Q ss_pred hHHHHHHhCCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeee
Q 012297 216 YSALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289 (466)
Q Consensus 216 ~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~ 289 (466)
.+++.....+++...++-+|.||.||+|.+. +.+.|.||.++...++-....|+.|.-++..+.|||++++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4566666677888889999999999999654 3567899999988877777789999999999999999999999
Q ss_pred eeeccCcceeEEEEEecCCCCCHHHHhcc------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 012297 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDG------VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 363 (466)
Q Consensus 290 ~~~~~~~~~~~~lV~ey~~~gsL~~~l~~------~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl 363 (466)
+.+. ...++++|+++.-|+|..||.. ...+.++..+.+.++.|++.|++|||+.+ ++|.||.++|++|
T Consensus 356 ~ie~---~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvI 429 (563)
T KOG1024|consen 356 SIED---YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVI 429 (563)
T ss_pred Eeec---cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhccee
Confidence 9874 3467999999999999999973 22345788889999999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 364 DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 364 d~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
|+..++||+|=.++|.+.+.++..-.... ..+..||+||.+....|+..+|||||||+||||+| |+.|+-.-
T Consensus 430 dd~LqVkltDsaLSRDLFP~DYhcLGDnE---nRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI 502 (563)
T KOG1024|consen 430 DDQLQVKLTDSALSRDLFPGDYHCLGDNE---NRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI 502 (563)
T ss_pred hhheeEEeccchhccccCcccccccCCCC---CCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc
Confidence 99999999999999998776654333222 34688999999999999999999999999999998 99998543
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=267.39 Aligned_cols=200 Identities=26% Similarity=0.376 Sum_probs=172.5
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|+..+.||+|+||+||++... +++.+|+|++...........+.+|+++++.++|+||+++++++.. ...+++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~l 80 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN----ENNICM 80 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec----CCEEEE
Confidence 45667789999999999999865 5889999988766555556679999999999999999999999876 357799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
||||+++++|.+++... ..+++..+..++.+++.+|.|||+ .+ ++||||+|+||++++++.++|+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 81 CMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred EEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999999998753 458999999999999999999997 45 9999999999999999999999999987543
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
... .....|+..|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 156 ~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 156 NSI-------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred hhc-------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 221 123468899999999988889999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=263.01 Aligned_cols=204 Identities=28% Similarity=0.482 Sum_probs=171.5
Q ss_pred CCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCC-----ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~-----~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
+|+..+.||+|+||.||+|...+++.+|||.+...... .....+.+|++++++++|+||+++++++.+ ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD----DNT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec----CCe
Confidence 36778899999999999999888999999998754321 122448889999999999999999999876 356
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARR 151 (265)
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHh
Confidence 79999999999999999754 45789999999999999999999998 99999999999999999999999999886
Q ss_pred cccCCCCC-CCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 380 LKADGLPS-CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 380 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
........ .........++..|+|||.+....++.++||||||+++|||++|+.||..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 53221110 01112234688899999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=267.94 Aligned_cols=202 Identities=25% Similarity=0.433 Sum_probs=168.4
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|+..+.||+|++|.||+|... +++.||+|.+...........+.+|++++++++|+||+++++++.+ ....++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~l 80 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT----KKTLTL 80 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec----CCeEEE
Confidence 56778899999999999999876 6889999998765433334457889999999999999999999875 456799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 81 v~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 81 VFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred EEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 999997 59999987543 36899999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 156 ~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 156 PSK-----TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred CCc-----cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 111 1122345788999998865 457899999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=262.53 Aligned_cols=206 Identities=26% Similarity=0.401 Sum_probs=171.0
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC----ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~----~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
.+|+..+.||+|+||.||+|... .+..|++|++...... .....+.+|+.++++++|+||+++++++.+.. ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 79 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA--EK 79 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC--CC
Confidence 36888899999999999999875 5889999988654221 22345888999999999999999999876522 34
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++++||+++++|.+++... ..+++...+.++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||+++
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 668999999999999999754 35889999999999999999999988 9999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
........ ........++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 155 RLQTICMS--GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccccccc--CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 65432111 11122345788999999999888999999999999999999999999743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=270.19 Aligned_cols=206 Identities=26% Similarity=0.421 Sum_probs=169.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcC---------------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCcccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTD---------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 287 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~---------------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~ll 287 (466)
.++|.+.+.||+|+||.||++...+ ...||+|.+...........|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3568888999999999999987642 2358999988664444556699999999999999999999
Q ss_pred eeeeeccCcceeEEEEEecCCCCCHHHHhcccc----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 012297 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL----------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 357 (466)
Q Consensus 288 g~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~----------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk 357 (466)
+++.. ....++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|||||
T Consensus 84 ~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlk 156 (295)
T cd05097 84 GVCVS----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLA 156 (295)
T ss_pred EEEcC----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccC
Confidence 99865 346799999999999999985421 123688999999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc--CCCCC
Q 012297 358 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT--GRQPI 435 (466)
Q Consensus 358 ~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt--G~~Pf 435 (466)
|+||++++++.+||+|||++........ ........++..|+|||.+....++.++||||||+++|||++ |..||
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~ 233 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDY---YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcc---eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999976543221 111222345678999999988889999999999999999998 67788
Q ss_pred CCC
Q 012297 436 HRS 438 (466)
Q Consensus 436 ~~~ 438 (466)
...
T Consensus 234 ~~~ 236 (295)
T cd05097 234 SLL 236 (295)
T ss_pred ccc
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=275.34 Aligned_cols=202 Identities=23% Similarity=0.339 Sum_probs=169.0
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--c
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--K 296 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~--~ 296 (466)
...++|+..+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++|+||+++++++..... .
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45678999999999999999999864 578999999875422 2233457789999999999999999998764321 1
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGl 376 (466)
....++++|++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 23468999988 8899988764 45899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
++..... .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 165 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 165 ARQADDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred ceecCCC--------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9865322 223468899999999876 5689999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=272.45 Aligned_cols=208 Identities=26% Similarity=0.435 Sum_probs=169.8
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc--------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 291 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~--------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~ 291 (466)
....+|.+.+.||+|+||.||++... ....+|+|+++..........+.+|+++++++ +|+||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 33456778899999999999999752 24579999988654444455688999999999 6999999999987
Q ss_pred eccCcceeEEEEEecCCCCCHHHHhcccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 012297 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 357 (466)
Q Consensus 292 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk 357 (466)
+ ....++||||+++|+|.+++.... ...+++.+++.++.|++.||.|||+.+ ++|||||
T Consensus 89 ~----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlk 161 (314)
T cd05099 89 Q----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLA 161 (314)
T ss_pred c----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccc
Confidence 5 345799999999999999996532 134889999999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 012297 358 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIH 436 (466)
Q Consensus 358 ~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~ 436 (466)
|+|||+++++.+||+|||+++........ .......++..|+|||.+....++.++||||||+++|||++ |..||.
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 238 (314)
T cd05099 162 ARNVLVTEDNVMKIADFGLARGVHDIDYY---KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238 (314)
T ss_pred ceeEEEcCCCcEEEccccccccccccccc---cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999865432110 01111224467999999988889999999999999999999 899986
Q ss_pred CC
Q 012297 437 RS 438 (466)
Q Consensus 437 ~~ 438 (466)
..
T Consensus 239 ~~ 240 (314)
T cd05099 239 GI 240 (314)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=262.57 Aligned_cols=196 Identities=28% Similarity=0.445 Sum_probs=163.1
Q ss_pred eecccCcEEEEEEEEc---CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEec
Q 012297 231 IVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 231 ~LG~G~fG~Vy~a~~~---~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey 306 (466)
.||+|+||.||+|.+. ++..+|+|+++.... ....+.+.+|+.+++.++|+||+++++++.. ...++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-----ESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCcEEEEec
Confidence 5899999999999653 578899999875532 2344568999999999999999999998743 245899999
Q ss_pred CCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCC
Q 012297 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 386 (466)
Q Consensus 307 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~ 386 (466)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 77 AELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999999999753 45899999999999999999999998 999999999999999999999999999876433211
Q ss_pred CCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 387 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 387 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
. .......++..|+|||.+....++.++|+||||+++|||++ |+.||...
T Consensus 152 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 152 Y--KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred e--eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 11122234578999999988889999999999999999998 99999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=265.43 Aligned_cols=201 Identities=26% Similarity=0.417 Sum_probs=167.2
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+|+..+.||+|++|.||+|... +++.||+|.+..... ......+.+|+.+++.++|+||+++++++.+ ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~ 76 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ----ESRLYL 76 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee----CCeEEE
Confidence 4677789999999999999875 588999999875432 2233568899999999999999999999876 446799
Q ss_pred EEecCCCCCHHHHhccccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
||||++ ++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 999996 689998865432 45899999999999999999999998 9999999999999999999999999987543
Q ss_pred cCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus 153 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 153 IPV-----RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred CCc-----ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 221 11222356788999998765 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=267.19 Aligned_cols=198 Identities=28% Similarity=0.401 Sum_probs=171.5
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|+..+.||+|++|.||++... +++.+|+|.+.... .......+.+|++++++++|+||+++++++.+ ....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 76 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD----DSNL 76 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc----CCeE
Confidence 36778899999999999999875 58899999986542 22334568899999999999999999998876 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+|||+++++.+||+|||++...
T Consensus 77 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 77 YLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV 151 (290)
T ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence 9999999999999999764 56899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .....+++.|+|||.+.....+.++||||||+++|||++|+.||...
T Consensus 152 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 152 KGR--------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred CCC--------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 432 22345788999999998888899999999999999999999999643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=277.12 Aligned_cols=202 Identities=27% Similarity=0.345 Sum_probs=177.1
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCC--hhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcc
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~ 297 (466)
....|++.+.||+|.||.||+++... |+.+|+|.+....... ....+.+|+.+|+++. ||||+.+.+.+.+ .
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~----~ 108 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED----P 108 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc----C
Confidence 34567777899999999999998876 9999999997764332 3456899999999998 9999999999987 4
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----CcEEEEe
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN----LNAKITD 373 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~----~~vkL~D 373 (466)
...++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.+ ++||||||+|+|+... +.+|++|
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEee
Confidence 4779999999999999999765 3999999999999999999999998 9999999999999533 4799999
Q ss_pred cCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 374 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 374 fGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
||++...... ......+||+.|+|||.+....++...||||+||++|.|++|.+||....
T Consensus 183 FGla~~~~~~------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 183 FGLAKFIKPG------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred CCCceEccCC------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 9999887652 23455789999999999999999999999999999999999999998654
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=267.85 Aligned_cols=200 Identities=25% Similarity=0.418 Sum_probs=172.0
Q ss_pred hCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
..+|+..+.||+|++|.||++.. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++++.. ....+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLV----GDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEec----CCEEE
Confidence 36688889999999999999986 4689999999875433 334558899999999999999999999876 44679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++++|.+++.. ..+++..+..++.|++.+|.|||+.+ ++||||||+|||++.++.++|+|||++....
T Consensus 93 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred EeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999999999864 45789999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 167 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~ 218 (297)
T cd06656 167 PEQS-----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (297)
T ss_pred CCcc-----CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3221 122345788999999999888999999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=263.69 Aligned_cols=203 Identities=26% Similarity=0.427 Sum_probs=172.0
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
..+.|...+.||+|+||.||++.+.++..+++|.+.... .....|.+|++++++++|+||+++.+++.+ ...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 76 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-----EPIY 76 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-----CCeE
Confidence 346678889999999999999998888889999887542 234568999999999999999999988764 2468
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
++|||+++++|.+++.......+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 9999999999999997655556899999999999999999999988 9999999999999999999999999997654
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
.... .......++..|+|||.+....++.++|+||||+++|||++ |+.||...
T Consensus 154 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 154 DNEY----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred CCCc----ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 3221 11222345677999999988889999999999999999998 99999643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=261.48 Aligned_cols=197 Identities=29% Similarity=0.450 Sum_probs=167.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
.+|...+.||+|+||.||++... +..+++|.++... ..+.|.+|+.++++++|+|++++++++... ....++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC---CCceEEE
Confidence 45777889999999999999874 7789999886542 244689999999999999999999976542 3356999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999997655455899999999999999999999998 999999999999999999999999998764322
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
. ....++..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 156 ~--------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~ 203 (256)
T cd05082 156 Q--------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred C--------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1 12234567999999988889999999999999999997 99998643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=268.14 Aligned_cols=204 Identities=29% Similarity=0.459 Sum_probs=168.6
Q ss_pred CCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
.+|...+.||+|+||.||++... ++..+++|.+.... ......+.+|++++++++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGD----G 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc----C
Confidence 34666789999999999999743 34568899886543 2333568999999999999999999999875 3
Q ss_pred eeEEEEEecCCCCCHHHHhcccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 363 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl 363 (466)
...++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEE
Confidence 45799999999999999996532 123799999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 364 DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 364 d~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
++++.++|+|||++......... .......++..|+|||.+....++.++||||||+++|||+| |+.||...
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred ccCCcEEECCCCcccccCCCcee---ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999765432211 11223456788999999998999999999999999999999 99998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.13 Aligned_cols=212 Identities=23% Similarity=0.368 Sum_probs=172.2
Q ss_pred HHHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccC
Q 012297 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 295 (466)
Q Consensus 218 ~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~ 295 (466)
+.+....+|.+.+.||+|+||.||++... .+..+|+|.+..... ......|..|+.++++++||||+++++++....
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~- 85 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA- 85 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC-
Confidence 34455678999999999999999999875 467889998875432 233456899999999999999999999886533
Q ss_pred cceeEEEEEecCCCCCHHHHhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCCEEEcCC---
Q 012297 296 KRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAA----PRILHRDIKSSNILLDEN--- 366 (466)
Q Consensus 296 ~~~~~~lV~ey~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~~L~~LH~~~~----~~ivHrDLk~~NILld~~--- 366 (466)
....+|||||+++|+|.++|.... ...+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.+
T Consensus 86 -~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 86 -NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 346799999999999999996532 2458999999999999999999998542 349999999999999642
Q ss_pred --------------CcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhccc--CCCCchhHHHHHHHHHHHHHc
Q 012297 367 --------------LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELIT 430 (466)
Q Consensus 367 --------------~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~S~Gvll~ellt 430 (466)
..+||+|||++....... ......||+.|+|||++.. ..++.++|||||||+||||+|
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 348999999998654321 1233568999999998854 458999999999999999999
Q ss_pred CCCCCCC
Q 012297 431 GRQPIHR 437 (466)
Q Consensus 431 G~~Pf~~ 437 (466)
|+.||..
T Consensus 239 Gk~PF~~ 245 (1021)
T PTZ00266 239 GKTPFHK 245 (1021)
T ss_pred CCCCCCc
Confidence 9999974
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=263.26 Aligned_cols=206 Identities=27% Similarity=0.404 Sum_probs=167.9
Q ss_pred CCCcceecccCcEEEEEEEEcC----CcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--cce
Q 012297 226 FSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 298 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~~----~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~--~~~ 298 (466)
|.+.+.||+|+||.||+|.+.. +..||+|+++..... .....+.+|++.++.++|+||+++++++..... ...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998643 367999998865332 334568999999999999999999998865332 123
Q ss_pred eEEEEEecCCCCCHHHHhcccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVL----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 374 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~Df 374 (466)
..++||||+++|+|..++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 4699999999999999985422 235899999999999999999999998 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
|+++......... .......+..|+|||.+....++.++||||||+++|||++ |..||..
T Consensus 158 g~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~ 218 (273)
T cd05035 158 GLSKKIYSGDYYR---QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218 (273)
T ss_pred cceeecccccccc---ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 9998764432211 1112234678999999988889999999999999999999 8899864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=266.07 Aligned_cols=204 Identities=23% Similarity=0.364 Sum_probs=168.8
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++++|...+.||+|+||.||+|... +++.|++|++...........+.+|+++++.++|+||+++.+++.. ....
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~ 78 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT----KETL 78 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec----CCeE
Confidence 3567888899999999999999864 5889999998765444444457899999999999999999999865 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||+++..
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 79 TFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred EEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence 99999995 78877775432 45788889999999999999999998 999999999999999999999999998754
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 154 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 154 SIPS-----QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CCCC-----CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 3221 112223468899999988754 57889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=264.77 Aligned_cols=199 Identities=32% Similarity=0.517 Sum_probs=169.5
Q ss_pred CCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhH-HHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADS-VFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~-~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
|+..+.||+|+||+||++.... ++.+|+|.+.......... ...+|+.++++++|+||+++++++.+ ....++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD----DNYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE----SSEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc----ccccccc
Confidence 4566899999999999998865 5689999998774333322 24569999999999999999999887 4567899
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++++|.+++.. ...+++..+..++.|+++||.+||+.+ ++|+||||+||++++++.++|+|||.+......
T Consensus 77 ~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp EEEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST
T ss_pred ccccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 999999999999983 256899999999999999999999998 999999999999999999999999998754111
Q ss_pred CCCCCCCCCCccccCcccccchhcc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
........++..|+|||.+. ...++.++||||||+++|+|++|..||...
T Consensus 152 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 152 -----NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp -----TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred -----ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 12233456788999999998 788999999999999999999999999865
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=282.81 Aligned_cols=195 Identities=23% Similarity=0.273 Sum_probs=164.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
...|.+.+.||+|+||.||++.... ++.||||.... ..+.+|++++++++|+||+++++++.. ....+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~----~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVV----GGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEE----CCEEE
Confidence 3468888999999999999998764 78899995332 126789999999999999999998876 44679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+|||++ .++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 237 lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred EEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 999999 579999886532 46899999999999999999999998 9999999999999999999999999998653
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
.... ........||..|+|||++.+..++.++|||||||+||||++|..|+.
T Consensus 312 ~~~~---~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 312 GSWS---TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccc---cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 3211 111234568999999999999999999999999999999999887654
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=261.26 Aligned_cols=199 Identities=26% Similarity=0.401 Sum_probs=172.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|+..+.||+|++|.||+|...+ ++.+++|.+..... ...+.+|++++++++|+||+++++++.+ ....+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFK----NTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeec----CCcEE
Confidence 3578888999999999999998865 78999999875532 5579999999999999999999999876 35679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+++||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 75 l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLT 150 (256)
T ss_pred EEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcc
Confidence 9999999999999996532 56899999999999999999999998 9999999999999999999999999988654
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
... .......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 151 ~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~ 201 (256)
T cd06612 151 DTM-----AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201 (256)
T ss_pred cCc-----cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 321 112234477889999999888999999999999999999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=264.12 Aligned_cols=203 Identities=25% Similarity=0.354 Sum_probs=171.3
Q ss_pred CCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|++.+.||+|+||.||++.. .+++.++||.+..... .....++.+|+.+++.++|+||+++++++.+ ....
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~ 77 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE----DNEL 77 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe----CCeE
Confidence 3577778999999999999986 4789999998765322 2234568899999999999999999999876 4467
Q ss_pred EEEEecCCCCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 301 LLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
+++|||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~ 154 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhh
Confidence 9999999999999998642 2245899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
....... ......++..|+|||.+....++.++|+||||+++|||++|..||...
T Consensus 155 ~~~~~~~-----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 155 FFSSKTT-----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred ccccCCc-----ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 6543211 122345788999999998888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=266.98 Aligned_cols=204 Identities=27% Similarity=0.440 Sum_probs=170.6
Q ss_pred CCCCcceecccCcEEEEEEEEc-----CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-----~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
.|++.+.||+|+||.||++... ++..||+|.++..........+.+|+++++.++|+|++++++++.+.. ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG--GNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--CCc
Confidence 4677889999999999999742 478899999886655555567999999999999999999999887632 235
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 689999999999999996542 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
....... ........++..|+|||.+.+..++.++||||||+++|||++++.|+.
T Consensus 159 ~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 159 IETDKEY--YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred cccCccc--eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 6433211 111223456778999999988889999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=271.00 Aligned_cols=202 Identities=21% Similarity=0.334 Sum_probs=164.6
Q ss_pred cceeccc--CcEEEEEEEEc-CCcEEEEEEcccCCCCC-hhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEE
Q 012297 229 SNIVGQG--GSSYVYRGQLT-DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 229 ~~~LG~G--~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
.++||+| +|++||++... +++.||+|++....... ....+.+|+++++.++||||+++++++.. +...++||
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~lv~ 78 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----DNELWVVT 78 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE----CCEEEEEE
Confidence 4689999 78999999764 68999999997654322 33457789999999999999999999876 44679999
Q ss_pred ecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCC
Q 012297 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~ 384 (466)
||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++++||+........+
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999999997654456899999999999999999999998 9999999999999999999999998765432211
Q ss_pred CCC--CCCCCCccccCcccccchhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 385 LPS--CSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 385 ~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
... .........++..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 100 0011122346778999999875 4589999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=268.12 Aligned_cols=205 Identities=29% Similarity=0.466 Sum_probs=171.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcC-----------------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccc
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTD-----------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~-----------------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~ 285 (466)
.++|.+.+.||+|+||.||++.+.+ +..||+|++...........|.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4568888999999999999997643 24689999887655555667899999999999999999
Q ss_pred eeeeeeeccCcceeEEEEEecCCCCCHHHHhcccc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 012297 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL---------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356 (466)
Q Consensus 286 llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDL 356 (466)
+++++.. ....++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||
T Consensus 84 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dl 156 (296)
T cd05051 84 LLGVCTV----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDL 156 (296)
T ss_pred EEEEEec----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---cccccc
Confidence 9999876 346799999999999999996542 125899999999999999999999998 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc--CCCC
Q 012297 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT--GRQP 434 (466)
Q Consensus 357 k~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt--G~~P 434 (466)
||+||++++++.++|+|||+++........ .......++..|+|||.+....++.++||||||+++|||++ |..|
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred chhceeecCCCceEEccccceeecccCcce---eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 999999999999999999998765433211 11223345778999999988889999999999999999998 7788
Q ss_pred CCC
Q 012297 435 IHR 437 (466)
Q Consensus 435 f~~ 437 (466)
|..
T Consensus 234 ~~~ 236 (296)
T cd05051 234 YEH 236 (296)
T ss_pred CCC
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=265.16 Aligned_cols=203 Identities=29% Similarity=0.470 Sum_probs=169.6
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-Cc----EEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-~~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
.+|...+.||+|+||.||+|.+.+ ++ .+++|.+...........+.+|+.++++++|+||+++++++.. .
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 81 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-----S 81 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----C
Confidence 456777899999999999998643 32 6899988766554455678999999999999999999999875 3
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccc
Confidence 5689999999999999997643 34899999999999999999999988 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
......... ......++..|+|||.+....++.++|+||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 215 (279)
T cd05057 158 LLDVDEKEY---HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215 (279)
T ss_pred cccCcccce---ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 764322110 1111223567999999988889999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=260.38 Aligned_cols=197 Identities=31% Similarity=0.475 Sum_probs=170.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
++|+..+.||.|++|.||+|... ++.|++|.+..... ....+.+|+.++++++|+||+++++++.+ ....++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQ----GNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcC----CCCeEEE
Confidence 46777889999999999999875 78899999976643 45568999999999999999999999875 3467999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||.++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 99999999999997654446899999999999999999999998 999999999999999999999999999876322
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
.. ....+..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 156 ~~--------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 156 QD--------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred cc--------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 11 1234567999999988889999999999999999997 99998644
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=260.98 Aligned_cols=205 Identities=27% Similarity=0.458 Sum_probs=171.1
Q ss_pred CCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCC-----ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 225 KFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGP-----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~-----~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
+|+..+.||+|++|.||++.. .+++.+|+|.+...... .....+.+|++++++++|+||+++++++.+ ..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE----DS 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc----CC
Confidence 477788999999999999986 46889999998754321 123568899999999999999999999875 44
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMA 377 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~-~vkL~DfGla 377 (466)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||++
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~ 151 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAA 151 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccc
Confidence 679999999999999999754 46899999999999999999999998 99999999999998776 5999999998
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.......... ........++..|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 152 ~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 152 ARLAAKGTGA-GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred cccccccccC-CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 8765432111 111233467889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=264.89 Aligned_cols=205 Identities=30% Similarity=0.423 Sum_probs=167.7
Q ss_pred CCCCCcceecccCcEEEEEEEEc-----CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-----~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
++|++.+.||+|+||.||++... +++.|++|.+.... ......|.+|++++++++|+||+++++++.... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--RR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC--CC
Confidence 45777889999999999999753 57899999987543 333456899999999999999999999876432 33
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 5789999999999999997542 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
......... .......++..|+|||.+.+..++.++||||||+++|||++|..|+..
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 157 VLPQDKEYY--KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred cccCCCcce--eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 764332110 011112234569999999888899999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=261.02 Aligned_cols=205 Identities=27% Similarity=0.492 Sum_probs=170.7
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCC--------hhHHHHHHHHHHHhcCCCCccceeeeeeeccC
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 295 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~--------~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~ 295 (466)
+|.....||+|++|.||+|... +++.+++|.+....... ..+.+.+|++++++++|+||+++++++.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 3667789999999999999864 57899999886543221 12458889999999999999999999876
Q ss_pred cceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 012297 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (466)
Q Consensus 296 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfG 375 (466)
....++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||
T Consensus 78 -~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg 151 (267)
T cd06628 78 -ADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFG 151 (267)
T ss_pred -CCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccC
Confidence 34668999999999999999754 45889999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCCCC-CCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 376 MAKRLKADGLPSC-SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 376 la~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+++.......... ........|+..|+|||.+....++.++|+||||+++|||++|+.||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred CCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 9987653221111 11122345788999999998888999999999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=263.82 Aligned_cols=201 Identities=26% Similarity=0.400 Sum_probs=169.0
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|+..+.||+|++|.||+|.+. +++.||+|++..... ....+.+.+|++++++++|+|++++++++.. ....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~ 76 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR----KRKLH 76 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee----CCEEE
Confidence 35777889999999999999886 588999999875432 2334568899999999999999999999876 44679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++++|..++... ..+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 77 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 77 LVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILT 151 (286)
T ss_pred EEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecC
Confidence 999999999888877543 45899999999999999999999988 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 152 ~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 152 GPGD-----DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred CCcc-----cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 3221 1223346788999998865 55789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=267.01 Aligned_cols=197 Identities=25% Similarity=0.395 Sum_probs=168.9
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
|+..+.||+|+||.||+|.+. +++.||+|.+...........+.+|++++++++|+||+++++++.. ....++||
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~ 81 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK----GTKLWIIM 81 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc----CCceEEEE
Confidence 455678999999999999865 5788999998755444455678999999999999999999998875 44679999
Q ss_pred ecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCC
Q 012297 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~ 384 (466)
||+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 82 EYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999999999864 45899999999999999999999988 9999999999999999999999999987654321
Q ss_pred CCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
. ......++..|+|||.+....++.++||||||+++|||++|+.||..
T Consensus 156 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 156 I-----KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred h-----hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 1 11224578889999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=260.26 Aligned_cols=197 Identities=30% Similarity=0.437 Sum_probs=164.9
Q ss_pred ceecccCcEEEEEEEEcC----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|+||.||+|.+.. +..+|+|.+...........+.+|+.+++.++|+||+++++++.. ...++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-----EPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-----CceEEEEE
Confidence 369999999999997532 268999998876554455679999999999999999999998652 24699999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++++|.+++... ..+++..++.++.|++.+|+|||+.+ ++|+||||+|||++.++.+||+|||+++.......
T Consensus 76 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 76 LAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred eCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 99999999999764 36899999999999999999999998 99999999999999999999999999987644322
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
.. .......++..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 151 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 151 YY--RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred cc--ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 11 11112234567999999988889999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=261.23 Aligned_cols=198 Identities=30% Similarity=0.420 Sum_probs=167.4
Q ss_pred ceecccCcEEEEEEEEcC--C--cEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLTD--G--RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~--~--~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|++|.||+|.+.+ + ..||||.+.........+.|.+|+.++++++|+||+++++++.+ ...++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-----HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-----CeEEEEEE
Confidence 368999999999998743 2 36999999876544455679999999999999999999998765 35699999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999999997654346899999999999999999999998 99999999999999999999999999987644321
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
. ........++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 153 ~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 153 H--YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred c--eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 1 111123456788999999998899999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=265.86 Aligned_cols=200 Identities=27% Similarity=0.428 Sum_probs=168.2
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
+|+..+.||+|+||.||++... +++.+|+|.+...........+.+|++++++++|+||+++++.+.. ....++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~lv 77 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI----EGAVYMC 77 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec----CCeEEEE
Confidence 5777889999999999999876 6899999998765444444568999999999999999999998776 4567999
Q ss_pred EecCCCCCHHHHhcccc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 304 FEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qia~~L~~LH~~-~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
|||+++++|..+++... ...+++..+..++.|++.||.|||+. + ++||||||+||+++.++.++|+|||++....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999999999987532 23689999999999999999999974 6 9999999999999999999999999987653
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccC------CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVG------RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. ......++..|+|||.+... .++.++|+||||+++|||++|+.||...
T Consensus 155 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 155 AS-------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred CC-------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 22 11223477889999988543 3488999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=261.28 Aligned_cols=206 Identities=25% Similarity=0.378 Sum_probs=171.2
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC----CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG----GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~----~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
.+|.+.+.||+|+||.||+|.+. +++.+++|.+.... .......+.+|++++++++|+||+++++++.+.. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--~~ 79 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE--EK 79 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC--CC
Confidence 46788899999999999999875 58899999875431 2233456889999999999999999999876532 33
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++++||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 568999999999999998753 34789999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
........ ........++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 155 RIQTICMS--GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cccccccc--CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 65332110 11122345788999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=266.49 Aligned_cols=215 Identities=27% Similarity=0.404 Sum_probs=177.0
Q ss_pred echHHHHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012297 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 291 (466)
Q Consensus 214 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~ 291 (466)
+...++..++++|...+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +|+|++++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 445667778899999999999999999999874 58899999986542 2345578899999999 7999999999987
Q ss_pred eccC-cceeEEEEEecCCCCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 012297 292 EFRG-KRAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 368 (466)
Q Consensus 292 ~~~~-~~~~~~lV~ey~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~ 368 (466)
.... .....++||||+++++|.++++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 5432 234679999999999999988642 2345899999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccC-----CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-----RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 369 vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+||+|||++........ ......++..|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 167 ~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred EEEeecccchhcccccc-----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 99999999886543221 11224578889999987543 3688999999999999999999999754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=259.75 Aligned_cols=199 Identities=33% Similarity=0.519 Sum_probs=171.0
Q ss_pred ceecccCcEEEEEEEEcC----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|+||.||+|...+ +..+++|.+...........+.+|+++++.++|+|++++++++.. ....++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE----EEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC----CCceEEEEE
Confidence 368999999999998764 788999999876554445679999999999999999999998876 456799999
Q ss_pred cCCCCCHHHHhcccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 306 FMPNGNLRDCLDGVL-------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 306 y~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~ 153 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSR 153 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccc
Confidence 999999999997642 256899999999999999999999988 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
....... ........++..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 154 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 154 DVYDDDY---YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred ccccccc---cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 7654321 112233456788999999988889999999999999999999 69999754
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=266.65 Aligned_cols=204 Identities=30% Similarity=0.466 Sum_probs=167.7
Q ss_pred CCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
.+|...+.||+|+||.||++... ++..+++|.+.... ......|.+|+++++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTE----G 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEec----C
Confidence 35666789999999999999642 35678999877542 3344569999999999999999999998876 3
Q ss_pred eeEEEEEecCCCCCHHHHhccccc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLV-------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 364 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld 364 (466)
...+++|||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEc
Confidence 456999999999999999965321 24789999999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 365 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 365 ~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+++.+||+|||+++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |++||...
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 228 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYY---RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228 (280)
T ss_pred CCCCEEECCCCceeEcCCCcee---ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence 9999999999998765332111 11222345678999999998999999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=262.71 Aligned_cols=195 Identities=29% Similarity=0.504 Sum_probs=160.9
Q ss_pred ceecccCcEEEEEEEEcC-Cc--EEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLTD-GR--IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~-~~--~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|+||.||+|.+.+ +. .+++|.++..........+.+|++++.++ +||||+++++++.. ....++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec----CCCceEEEE
Confidence 368999999999998754 33 57888887554444556788999999999 79999999999876 345699999
Q ss_pred cCCCCCHHHHhcccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 012297 306 FMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 371 (466)
Q Consensus 306 y~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL 371 (466)
|+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl 153 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKI 153 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEE
Confidence 999999999996432 124789999999999999999999988 999999999999999999999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 372 ~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
+|||++....... .......+..|+|||++....++.++||||||+++|||++ |..||..
T Consensus 154 ~dfgl~~~~~~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 214 (270)
T cd05047 154 ADFGLSRGQEVYV------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214 (270)
T ss_pred CCCCCccccchhh------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 9999986322110 1111223567999999988889999999999999999997 9999964
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=259.50 Aligned_cols=201 Identities=24% Similarity=0.320 Sum_probs=172.8
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+|+..+.||+|+||.||.++.. +++.+++|.+.... .......+.+|++++++++|+||+++++++.+ ....++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD----DNTLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec----CCeEEE
Confidence 4777899999999999999764 58889999987543 33445568999999999999999999999876 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
+|||+++++|.+++.......+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~ 153 (256)
T cd08221 77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS 153 (256)
T ss_pred EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence 999999999999997654456899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 154 ~~~-----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08221 154 EYS-----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203 (256)
T ss_pred ccc-----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence 321 12334578999999999888889999999999999999999999965
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=263.36 Aligned_cols=199 Identities=27% Similarity=0.429 Sum_probs=168.4
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.+++.++||||+++++++.. ....++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~----~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLR----RDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEe----CCEEEE
Confidence 35666788999999999999864 588999999876532 233457889999999999999999998876 456799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++++|.+++... ..+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 84 CMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred EEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 99999999999998754 45899999999999999999999998 99999999999999999999999999876533
Q ss_pred CCCCCCCCCCCccccCcccccchhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.. .......|+..|+|||.+. ...++.++|+||||+++|||++|+.||..
T Consensus 159 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 159 TI-----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred cc-----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 21 1123346889999999874 45578899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=266.31 Aligned_cols=199 Identities=25% Similarity=0.435 Sum_probs=171.5
Q ss_pred CCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.+|+..+.||.|++|.||+|.. .+++.|++|.+..... .....+.+|+++++.++|+|++++++++.. ....++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLV----GDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEec----CceEEE
Confidence 4577788999999999999976 4688999999875533 334568899999999999999999999875 456799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
|+||+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 94 VMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999999999864 35899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... ......++..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 168 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~ 218 (296)
T cd06655 168 EQS-----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (296)
T ss_pred ccc-----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 321 112345788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=267.87 Aligned_cols=206 Identities=27% Similarity=0.434 Sum_probs=169.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-----------------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccc
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-----------------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-----------------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~ 285 (466)
.++|++.+.||+|+||.||++... ++..+|+|++...........|.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888899999999999998542 234689999886654445567999999999999999999
Q ss_pred eeeeeeeccCcceeEEEEEecCCCCCHHHHhccccc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 012297 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV---------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356 (466)
Q Consensus 286 llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~---------~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDL 356 (466)
+++++.. ....++||||+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++|+||
T Consensus 84 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl 156 (296)
T cd05095 84 LLAVCIT----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDL 156 (296)
T ss_pred EEEEEec----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccC
Confidence 9999876 3356999999999999999965321 23678899999999999999999998 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc--CCCC
Q 012297 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT--GRQP 434 (466)
Q Consensus 357 k~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt--G~~P 434 (466)
||+|||+++++.++|+|||+++........ .......++..|++||....+.++.++||||||+++|||++ |..|
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcce---eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999865432211 11122334678999999888889999999999999999998 7888
Q ss_pred CCCC
Q 012297 435 IHRS 438 (466)
Q Consensus 435 f~~~ 438 (466)
|...
T Consensus 234 ~~~~ 237 (296)
T cd05095 234 YSQL 237 (296)
T ss_pred cccc
Confidence 8643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=258.45 Aligned_cols=203 Identities=25% Similarity=0.352 Sum_probs=171.6
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.|++.+.||+|++|.||++... +++.+++|.+..... ....+.+.+|++++++++|+|++++++.+.. .....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG---EDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC---CCCEEEE
Confidence 3677889999999999999875 478899999875432 2334568899999999999999999987643 2335689
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++++|.+++.......+++.++..++.|++.|+++||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 999999999999997655556899999999999999999999998 99999999999999999999999999976643
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. .......+++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 155 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 155 QC-----DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred cC-----CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 22 1223345788999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=260.51 Aligned_cols=207 Identities=28% Similarity=0.421 Sum_probs=175.7
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|++.+.||.|+||.||+|... ++..+++|++...........+.+|++.++.++|+|++++++.+.. ....++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV----GDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee----CCEEEE
Confidence 36788899999999999999864 5788999998765444456679999999999999999999998866 456799
Q ss_pred EEecCCCCCHHHHhccccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
||||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 9999999999999976433 45899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... ........++..|+|||.+... .++.++|+||||+++|||++|+.||...
T Consensus 154 ~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 154 DGGDRT-RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred cCcccc-ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 443211 0122334688899999998776 7899999999999999999999999754
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=263.52 Aligned_cols=199 Identities=24% Similarity=0.374 Sum_probs=171.2
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
.|+..+.||.|+||.||+|.+. +++.||+|.+...........+.+|+.++++++|+||+++++++.+ ....++|
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 80 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK----GTKLWII 80 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----CCEEEEE
Confidence 4666788999999999999875 5889999998765444455678999999999999999999999876 4567999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++++|.+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 81 MEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999999999864 45889999999999999999999988 999999999999999999999999999765432
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. ......++..|+|||.+....++.++|+||||+++|||++|+.||...
T Consensus 155 ~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06640 155 QI-----KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204 (277)
T ss_pred cc-----ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 21 122245778899999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=265.14 Aligned_cols=214 Identities=26% Similarity=0.356 Sum_probs=175.8
Q ss_pred chHHHHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeee
Q 012297 215 SYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292 (466)
Q Consensus 215 ~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~ 292 (466)
.++.+..++++|++.+.||+|+||.||++... +++.+++|.+.... .....+.+|+.+++++ +|+||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 34567778899999999999999999999875 57899999876532 2335588899999999 69999999998764
Q ss_pred cc-CcceeEEEEEecCCCCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 012297 293 FR-GKRAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 369 (466)
Q Consensus 293 ~~-~~~~~~~lV~ey~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~v 369 (466)
.. ......++||||+++++|.+++... ....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 32 2345679999999999999988532 2245889999999999999999999998 9999999999999999999
Q ss_pred EEEecCCccccccCCCCCCCCCCCccccCcccccchhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 370 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 370 kL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+|+|||++........ ......|+..|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 164 kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred EEccCCceeecccCCC-----ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999876543221 122345889999999875 345788999999999999999999998754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=268.48 Aligned_cols=203 Identities=29% Similarity=0.488 Sum_probs=167.7
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCc----EEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
++|...+.||+|+||.||+|.+. ++. .+|+|.+...........+.+|+.+++.++|+||++++|++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----- 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----- 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence 45667789999999999999764 343 57999887665544455689999999999999999999988642
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++++||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccc
Confidence 3478999999999999987532 35889999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 158 LLEGDEKE---YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred cccCcccc---cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 66432211 11122345678999999998899999999999999999997 99999653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=270.84 Aligned_cols=193 Identities=23% Similarity=0.304 Sum_probs=162.5
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
...+|.+.+.||+|+||.||+|... +++.||+|..... ....|+.++++++|+||+++++++.+ ....
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVS----GAIT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEe----CCee
Confidence 3457999999999999999999875 4678999975432 14578999999999999999999876 3466
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+ .++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 133 CMVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EEEEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 8999999 57899988653 356899999999999999999999998 999999999999999999999999998753
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
... .......||..|+|||.+.+..++.++||||||+++|||+++..|+.
T Consensus 208 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 208 VVA------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ccC------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 221 11223568999999999999999999999999999999998655543
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=264.66 Aligned_cols=214 Identities=28% Similarity=0.439 Sum_probs=176.9
Q ss_pred chHHHHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeee
Q 012297 215 SYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292 (466)
Q Consensus 215 ~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~ 292 (466)
++.++..+...|+..+.||+|+||.||+|.+. +++.+|+|.+.... .....+..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 45666677888999999999999999999874 57899999886542 2334588899999998 69999999998864
Q ss_pred cc--CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 012297 293 FR--GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 370 (466)
Q Consensus 293 ~~--~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vk 370 (466)
.. +.....+++|||+++|+|.+++.......+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 32 22456799999999999999997655556889999999999999999999998 99999999999999999999
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCcccccchhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 371 L~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|+|||++....... .......|+..|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 162 l~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 162 LVDFGVSAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred EeeCcchhhhhccc-----cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 99999987653221 1223356788999999875 345788999999999999999999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=259.32 Aligned_cols=202 Identities=27% Similarity=0.415 Sum_probs=172.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|+..+.||+|+||.||+|... +++.+++|.+...... ....+.+|++++++++|+||+++++++.+ ....+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLR----RDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEe----CCEEE
Confidence 356888899999999999999875 4788999998765332 44568999999999999999999998876 44679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
++|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 77 l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhh
Confidence 9999999999999987542 45899999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccC---CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVG---RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .......++..|+|||.+... .++.++|+||||+++|||++|+.||...
T Consensus 153 ~~~-----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 153 ATI-----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred hhh-----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 321 112234578889999998766 7899999999999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=277.98 Aligned_cols=204 Identities=25% Similarity=0.336 Sum_probs=178.1
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|...+.+|+|+||.++..+.+ +...+++|.+..... ....+....|+.++++++|||||.+.+.+.+. +...+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~---~~~l~ 80 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED---GQLLC 80 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC---CceEE
Confidence 45777789999999999998764 567899999876643 33334588999999999999999999988762 22379
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
|||+|++||+|.+.+.......+++..+..++.|++.|+.|||+.. |+|||||+.|||++.+..+||+|||+|+.+.
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999999998877677999999999999999999999887 9999999999999999999999999999887
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.+. .......||+.|+.||.+.+.+|..|+||||||+++|||++=+.+|...
T Consensus 158 ~~~-----~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~ 209 (426)
T KOG0589|consen 158 PED-----SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS 209 (426)
T ss_pred Cch-----hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc
Confidence 653 1234578999999999999999999999999999999999999999754
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=266.73 Aligned_cols=205 Identities=27% Similarity=0.456 Sum_probs=170.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~ 296 (466)
.++|+..+.||+|+||.||++... ++..+|+|++...........|.+|+.++++++|+||+++++++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~---- 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV---- 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC----
Confidence 456888899999999999999864 4678999998765444455669999999999999999999998876
Q ss_pred ceeEEEEEecCCCCCHHHHhcccc--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVL--------------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~--------------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDL 356 (466)
....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl 156 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDL 156 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 345699999999999999996421 124788899999999999999999998 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCC
Q 012297 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPI 435 (466)
Q Consensus 357 k~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf 435 (466)
||+|||+++++.++|+|||++......... ........+..|+|||.+....++.++||||||+++|||++ |..||
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~ 233 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYY---KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccc---cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999998765332211 11112234567999999988899999999999999999997 88898
Q ss_pred CC
Q 012297 436 HR 437 (466)
Q Consensus 436 ~~ 437 (466)
..
T Consensus 234 ~~ 235 (288)
T cd05050 234 YG 235 (288)
T ss_pred CC
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=261.35 Aligned_cols=205 Identities=28% Similarity=0.421 Sum_probs=169.3
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
++.+++++.....||+|+||.||+|.+. ++..|++|.+.... ......+.+|+++++.++|+||+++++++.. .
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~ 77 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE----N 77 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc----C
Confidence 4556777777789999999999999865 57789999887543 2334568999999999999999999999876 4
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEec
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGM--NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDL 374 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~--~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~-~~~vkL~Df 374 (466)
...++|+||+++++|.+++.... ..+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.++|+||
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecc
Confidence 56799999999999999997532 234 78888999999999999999998 999999999999976 678999999
Q ss_pred CCccccccCCCCCCCCCCCccccCcccccchhcccCC--CCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
|++........ ......++..|+|||++.... ++.++||||||+++|||++|+.||..
T Consensus 154 g~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 154 GTSKRLAGINP-----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred hhheecccCCC-----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 99876533211 122235788999999986543 78899999999999999999999964
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=258.41 Aligned_cols=202 Identities=30% Similarity=0.436 Sum_probs=175.6
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|+..+.||+|++|.||+|...+ ++.++||++...........+.+|++.+.+++|+|++++++++.. ....++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~l 76 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK----EGEISI 76 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc----CCeEEE
Confidence 357788999999999999998864 899999998776544455679999999999999999999999876 356799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
||||+++++|.+++... ..+++..++.++.|++++|+|||+ .+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 77 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 77 VLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred EEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999999754 568999999999999999999999 88 9999999999999999999999999988664
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.... ......++..|+|||.+....++.++|+||||+++|||++|+.||....
T Consensus 152 ~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 152 NTLD-----QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred cCCC-----cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 3321 1123457788999999988889999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=259.98 Aligned_cols=200 Identities=28% Similarity=0.454 Sum_probs=160.9
Q ss_pred ceecccCcEEEEEEEEcC----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|+||.||+|.+.+ +..+|+|++...........+.+|+.+++.++||||+++++++.... ...++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE---GSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC---CCcEEEEe
Confidence 368999999999998642 45799998865444444556889999999999999999999876422 34589999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++|+|.+++.... ...++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 78 YMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999999997542 34678888999999999999999988 99999999999999999999999999976543221
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcC-CCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG-RQPIHR 437 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG-~~Pf~~ 437 (466)
.. ........++..|+|||.+....++.++||||||+++|||++| .+||..
T Consensus 154 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 154 YS-VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred ee-ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 10 0111223456789999999888899999999999999999995 556643
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=271.78 Aligned_cols=206 Identities=27% Similarity=0.426 Sum_probs=168.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEc--------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeec
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~--------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~ 293 (466)
..+|++.+.||+|+||.||++... ++..||+|.++..........+.+|+++++++ +|+||+++++++..
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 346788899999999999999742 12368999887654444456789999999999 79999999999876
Q ss_pred cCcceeEEEEEecCCCCCHHHHhcccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 012297 294 RGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359 (466)
Q Consensus 294 ~~~~~~~~lV~ey~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~ 359 (466)
....+++|||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+
T Consensus 90 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 163 (334)
T cd05100 90 ---DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR 163 (334)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence 345699999999999999996532 234789999999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 360 NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
|||+++++.+||+|||+++........ .......++..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred eEEEcCCCcEEECCcccceeccccccc---ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999999999765432111 11112234567999999999999999999999999999998 88998643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=264.06 Aligned_cols=200 Identities=24% Similarity=0.390 Sum_probs=167.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+.|++.+.||.|+||.||+|...+ ++.+++|.+.... ......+.+|++++++++|+|++++++++.. ....++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYW----DGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe----CCeEEE
Confidence 557788899999999999998754 7899999987542 3345568899999999999999999998875 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++++|..++.... ..+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 87 MIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 999999999998876532 45899999999999999999999988 99999999999999999999999999875432
Q ss_pred CCCCCCCCCCCccccCcccccchhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.. .......++..|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 163 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 163 TL-----QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred cc-----cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 21 1122345778899999874 34568899999999999999999999964
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=261.42 Aligned_cols=202 Identities=29% Similarity=0.383 Sum_probs=172.1
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
+|...+.||.|++|.||++.+. +++.+|+|.+...........+.+|++++++++|+||+++++++.+.. ....++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES--SSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC--CCeEEEE
Confidence 5667789999999999999885 578899999886654455667999999999999999999999986533 3357999
Q ss_pred EecCCCCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 304 FEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
|||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999999987542 2345889999999999999999999998 9999999999999999999999999987553
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .....++..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 157 ~~~-------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 157 NSL-------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccc-------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 221 12345678899999998889999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=264.70 Aligned_cols=202 Identities=25% Similarity=0.364 Sum_probs=170.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|++.+.||.|++|.||++.+. ++..+|+|.+.... ......|.+|++++++++|+||+++++++.. ....+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFY----ENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEec----CCeEE
Confidence 456788889999999999999875 58899999987542 2334568899999999999999999999876 44679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 79 lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred EEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999999999987532 45899999999999999999999998 9999999999999999999999999987653
Q ss_pred cCCCCCCCCCCCccccCcccccchhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .......++..|+|||.+. ...++.++|+||||+++|||++|+.||...
T Consensus 155 ~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 155 STL-----QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred ccc-----cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 321 1122345788999999874 345678999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=263.86 Aligned_cols=201 Identities=28% Similarity=0.438 Sum_probs=168.5
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|+..+.||+|+||.||+|.+. +++.+|+|++...... ...+.+.+|+++++.++|+||+++++++.. ....+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 76 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR----KKRLY 76 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc----CCeEE
Confidence 35777899999999999999886 4889999998754332 234568899999999999999999999865 45679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++++|.++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA 151 (286)
T ss_pred EEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence 999999999998877543 34899999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .......++..|+|||.+.+ ..++.++||||||+++|||++|++||...
T Consensus 152 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 152 APG-----EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred CCc-----cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 322 11223457888999998865 44788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=257.44 Aligned_cols=198 Identities=30% Similarity=0.490 Sum_probs=166.9
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCCC
Q 012297 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~~ 309 (466)
++||+|+||.||++.+.+++.|++|.+...........|.+|++++++++|+||+++++++.+ ....++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ----KQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec----CCCeEEEEEcCCC
Confidence 368999999999999877999999998766544455679999999999999999999998876 3467999999999
Q ss_pred CCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCC
Q 012297 310 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389 (466)
Q Consensus 310 gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~ 389 (466)
++|.+++.... ..+++..++.++.+++.+|.|||+.+ ++||||+|+|||++.++.++|+|||++.........
T Consensus 77 ~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~--- 149 (251)
T cd05041 77 GSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT--- 149 (251)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce---
Confidence 99999996542 35789999999999999999999998 999999999999999999999999999765422111
Q ss_pred CCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 390 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 390 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
........+..|+|||.+.++.++.++|+||||+++|||++ |..||...
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~ 199 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM 199 (251)
T ss_pred eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC
Confidence 11111233567999999988889999999999999999999 88998654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=260.59 Aligned_cols=197 Identities=24% Similarity=0.352 Sum_probs=157.3
Q ss_pred eecccCcEEEEEEEEcCC---cEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecC
Q 012297 231 IVGQGGSSYVYRGQLTDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307 (466)
Q Consensus 231 ~LG~G~fG~Vy~a~~~~~---~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~ 307 (466)
.||+|+||.||+|...++ ..+++|.+...........|.+|+++++.++||||+++++.+.+ ....++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----~~~~~lv~e~~ 77 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE----AIPYLLVFEYC 77 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC----CCccEEEEecC
Confidence 599999999999975443 34667776655444556679999999999999999999999876 34569999999
Q ss_pred CCCCHHHHhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 308 PNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 308 ~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
++|+|.+++.... ....++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 9999999997532 234667778899999999999999998 99999999999999999999999999764322111
Q ss_pred CCCCCCCCccccCcccccchhccc-------CCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMV-------GRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
........++..|+|||++.. ..++.++||||||+++|||++ |..||..
T Consensus 155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 155 ---IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred ---hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 111223457889999998743 345789999999999999997 5778754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=278.75 Aligned_cols=210 Identities=24% Similarity=0.309 Sum_probs=175.9
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC------CCCccceeeeeeeccCcc
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH------HCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~------H~nIv~llg~~~~~~~~~ 297 (466)
+|.+.++||+|.||.|.+|.+. .++.||||+++... ....+-..|+.+|..|+ --|+|++++++.. +
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f----r 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF----R 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc----c
Confidence 7888999999999999999765 48999999999763 33445678999999986 3589999999987 6
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC--CcEEEEecC
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN--LNAKITDLG 375 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~--~~vkL~DfG 375 (466)
.+.+||+|.+ ..||.++|+.+...+++...+..|+.||+.||.+||+.+ |||.||||+||||.+- ..+||+|||
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecc
Confidence 6789999999 679999999988889999999999999999999999998 9999999999999644 369999999
Q ss_pred CccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHHHHHhhc
Q 012297 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSIIT 455 (466)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~~~~~l~~~~~~~~~ 455 (466)
.++.....-+ ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.... +.+..+.+...+.
T Consensus 337 SSc~~~q~vy--------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n---e~DQl~~I~e~lG 405 (586)
T KOG0667|consen 337 SSCFESQRVY--------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN---EYDQLARIIEVLG 405 (586)
T ss_pred cccccCCcce--------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC---HHHHHHHHHHHhC
Confidence 9987644321 2233456999999999999999999999999999999988886543 3444445544443
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=261.02 Aligned_cols=202 Identities=26% Similarity=0.436 Sum_probs=168.6
Q ss_pred CCCCCcceecccCcEEEEEEEEcC----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
++|...+.||+|+||.||+|.+.+ ...|+||...........+.|.+|+.++++++|+||+++++++.+ ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 80 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-----NP 80 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----CC
Confidence 446777899999999999998644 246899988766544455679999999999999999999998764 23
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeee
Confidence 589999999999999997542 35899999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
....... ......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 157 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 212 (270)
T cd05056 157 LEDESYY----KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV 212 (270)
T ss_pred cccccce----ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 5433211 1112234567999999988889999999999999999986 99999654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=281.18 Aligned_cols=197 Identities=27% Similarity=0.440 Sum_probs=165.5
Q ss_pred ceecccCcEEEEEEEEcC-CcEEE---EEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLTD-GRIVA---VKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~-~~~va---VK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
.+||+|+|-+||+|.+.. |-.|| ||.-.....+...++|..|+.+|+.|+|+||++++.+..+... ....+|+|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n--~~in~iTE 123 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN--KTINFITE 123 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC--ceeeeeee
Confidence 469999999999998753 55554 2322233344555779999999999999999999998877543 46789999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCccccccCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLKADG 384 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~-~~vkL~DfGla~~~~~~~ 384 (466)
.|..|+|..|+.+. +.++.+.+..|++||++||.|||++. |||+|||||-+||||+.+ |.|||+|+|||......
T Consensus 124 L~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred cccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 99999999999876 55899999999999999999999985 789999999999999754 89999999999876543
Q ss_pred CCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
......|||.|||||.+. ..|+...||||||+.++||+|+..||....
T Consensus 200 ------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~ 247 (632)
T KOG0584|consen 200 ------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT 247 (632)
T ss_pred ------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC
Confidence 223378999999999776 889999999999999999999999997543
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=262.39 Aligned_cols=198 Identities=29% Similarity=0.482 Sum_probs=163.8
Q ss_pred ceecccCcEEEEEEEEcC-------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 230 NIVGQGGSSYVYRGQLTD-------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~-------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+.||+|+||.||+|+..+ +..+++|.+...........|.+|+++++.++|+||+++++++.. ....++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~ 76 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL----NEPQYI 76 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC----CCCeEE
Confidence 368999999999998643 257999988765444455679999999999999999999999865 335699
Q ss_pred EEecCCCCCHHHHhcccc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-----cEEEE
Q 012297 303 VFEFMPNGNLRDCLDGVL-----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-----NAKIT 372 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~-----~vkL~ 372 (466)
||||+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++ .++|+
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~ 153 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIG 153 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEEC
Confidence 999999999999996432 233789999999999999999999988 99999999999999877 89999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 373 DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
|||++......... .......++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 154 dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~ 216 (269)
T cd05044 154 DFGLARDIYKSDYY---RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216 (269)
T ss_pred Cccccccccccccc---ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc
Confidence 99999765432211 11122345678999999999999999999999999999998 9999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=262.36 Aligned_cols=199 Identities=24% Similarity=0.370 Sum_probs=166.1
Q ss_pred CCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
|++.+.||+|+||.||++.+.. +..+++|.+.... ......+.+|+++++.++|+|++++++++.. ....++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~----~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYY----ENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee----CCEEEEEE
Confidence 4566789999999999998764 6788888886442 3344568899999999999999999999876 44679999
Q ss_pred ecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCC
Q 012297 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~ 384 (466)
||+++++|..++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 82 EFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 999999999988643 246899999999999999999999998 9999999999999999999999999987653221
Q ss_pred CCCCCCCCCccccCcccccchhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......++..|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 158 -----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred -----cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 1122346788999999874 345788999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=256.08 Aligned_cols=199 Identities=30% Similarity=0.453 Sum_probs=169.8
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC----CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG----PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
+|+..+.||+|++|.||+|... +++.|++|.+..... ....+.+.+|+.+++.++|+||+++++++.+ ...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE----EDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec----CCe
Confidence 3666789999999999999876 789999999865432 2244568999999999999999999998875 346
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~ 151 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQ 151 (258)
T ss_pred EEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCcccee
Confidence 79999999999999999754 45889999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCC-CCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... ......++..|++||.+.... ++.++|+||||+++|||++|+.||...
T Consensus 152 ~~~~~------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 152 VVEFS------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred ccccc------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 54322 122345788899999987766 899999999999999999999999654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=260.86 Aligned_cols=207 Identities=28% Similarity=0.451 Sum_probs=173.4
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeecc--Cc
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR--GK 296 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~--~~ 296 (466)
.++++|++.+.||+|++|.||+|... +++.+++|++..... ....|.+|+++++++ +|+||+++++++.+.. ..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 45678999999999999999999875 578899999876532 345689999999999 6999999999987644 23
Q ss_pred ceeEEEEEecCCCCCHHHHhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 374 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~Df 374 (466)
....++||||+++++|.++++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCC
Confidence 456799999999999999986543 356899999999999999999999998 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCCccccCcccccchhccc-----CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
|++....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 158 GVSAQLDSTL-----GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred ccceecccch-----hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 9987653321 11223457889999998753 3467899999999999999999999964
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=260.23 Aligned_cols=199 Identities=27% Similarity=0.439 Sum_probs=169.8
Q ss_pred CCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC---CCCccceeeeeeeccCcceeE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~llg~~~~~~~~~~~~ 300 (466)
.|+..+.||+|+||.||+|.+ .+++.+++|.+...........+.+|++++++++ |+|++++++++.+ ....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~----~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK----GPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee----CCEE
Confidence 466778899999999999986 4688999999876554555566889999999996 9999999998875 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++++|.++++. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999999999865 36899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... .......|+..|+|||.+..+ .++.++|+||||+++|||++|+.||...
T Consensus 152 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 152 NQNS-----SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred CCCc-----cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 4432 112334578899999988654 4688999999999999999999999643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=258.14 Aligned_cols=195 Identities=31% Similarity=0.467 Sum_probs=165.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
++|++.+.||+|+||.||++.. +++.+|+|.+.... ....+.+|+.++++++|+|++++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILH-----NGLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----CCcEEE
Confidence 4577789999999999999975 67789999886542 33568999999999999999999998764 135899
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++++|.+++.......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 99999999999997655456899999999999999999999988 999999999999999999999999998754321
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
......+..|+|||.+....++.++|+||||+++|||++ |+.||...
T Consensus 154 --------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 154 --------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred --------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 111223567999999988899999999999999999997 99999644
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=256.59 Aligned_cols=201 Identities=29% Similarity=0.503 Sum_probs=169.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
.+|+..+.||+|+||.||++.+.+++.+++|.+..... ....|.+|++++++++|+|++++++++.. ....++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTE----RSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEcc----CCceEEE
Confidence 35667789999999999999887788999998875432 23468999999999999999999998765 3467999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++++|.+++.... ..+++..+..++.|++.+++|||+.+ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 99999999999997533 35789999999999999999999998 999999999999999999999999998765332
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
.. .......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 154 ~~----~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 205 (256)
T cd05112 154 QY----TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205 (256)
T ss_pred cc----cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 11 11122334678999999988889999999999999999998 99999743
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=265.48 Aligned_cols=194 Identities=26% Similarity=0.436 Sum_probs=165.8
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecC
Q 012297 229 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~ 307 (466)
...||+|+||.||++... ++..||||.+.... ....+.+.+|+.++++++|+||+++++.+.. ....++||||+
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~----~~~~~lv~e~~ 101 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLV----GDELWVVMEFL 101 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheec----CCeEEEEEeCC
Confidence 457999999999999874 58899999886543 3344568899999999999999999998775 44679999999
Q ss_pred CCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCC
Q 012297 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 387 (466)
Q Consensus 308 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~ 387 (466)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 102 ~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--- 172 (292)
T cd06658 102 EGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--- 172 (292)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc---
Confidence 99999998854 34899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 388 CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 388 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......++..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 173 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 221 (292)
T cd06658 173 --PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 221 (292)
T ss_pred --ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1122346788999999998888999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-32 Score=257.44 Aligned_cols=201 Identities=24% Similarity=0.322 Sum_probs=171.5
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+|+..+.||+|+||.+|++... +++.+++|.+.... .......+.+|++++++++|+||+++++++.+ ....++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE----NGNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC----CCeEEE
Confidence 4777889999999999999865 57899999987542 23334568999999999999999999998865 457799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++++|.+++.......+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 999999999999997654456899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
... ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus 154 ~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08218 154 TVE-----LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203 (256)
T ss_pred chh-----hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence 211 11224578889999999888899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-33 Score=269.50 Aligned_cols=205 Identities=28% Similarity=0.416 Sum_probs=176.7
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
+.|...++||+|+||.||-.... .|+.+|.|.+.... ....+...++|-.+|.+++.+.||.+--.+.. ....
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT----kd~L 260 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET----KDAL 260 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC----CCce
Confidence 55788899999999999998765 58899998886543 22344557899999999999999988655544 5567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
+||+..|.||+|.-+|......++++..++..+.+|+.||++||+.. ||.|||||+|||||+.|+++|+|+|+|..+
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999999997766678999999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 441 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~ 441 (466)
.... .....+||.+|||||++.+..|+...|.||||++||||+.|+.||.....+
T Consensus 338 ~~g~------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK 392 (591)
T KOG0986|consen 338 PEGK------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK 392 (591)
T ss_pred CCCC------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence 5532 223348999999999999999999999999999999999999999865444
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=265.14 Aligned_cols=194 Identities=25% Similarity=0.408 Sum_probs=166.4
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecC
Q 012297 229 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~ 307 (466)
...||+|+||.||++... +++.||+|.+..... .....+.+|+.+++.++|||++++++++.. ....++||||+
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----~~~~~iv~e~~ 100 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLV----GEELWVLMEFL 100 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheee----CCeEEEEEecC
Confidence 457999999999999875 688999999865433 334568899999999999999999998876 45679999999
Q ss_pred CCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCC
Q 012297 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 387 (466)
Q Consensus 308 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~ 387 (466)
++++|.+++.. ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 101 ~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--- 171 (297)
T cd06659 101 QGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--- 171 (297)
T ss_pred CCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc---
Confidence 99999998754 45899999999999999999999998 9999999999999999999999999987553321
Q ss_pred CCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 388 CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 388 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......++..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 220 (297)
T cd06659 172 --PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220 (297)
T ss_pred --ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1122356788999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=260.86 Aligned_cols=201 Identities=25% Similarity=0.428 Sum_probs=167.7
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+|+..+.||+|++|.||+|... +++.|+||++..... ......+.+|++++++++|+||+++++++.+ ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~~ 76 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT----ENKLYL 76 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc----CCcEEE
Confidence 4777889999999999999875 588999999875532 2233468899999999999999999999865 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||++ ++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 77 VFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152 (284)
T ss_pred Eeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999995 68999987655566899999999999999999999998 99999999999999999999999999876533
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCC-CCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. .......++..|+|||.+.+.. ++.++||||||+++|||+||+.||...
T Consensus 153 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 153 PV-----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred Cc-----cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 21 1122234678899999876644 588999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=258.64 Aligned_cols=199 Identities=30% Similarity=0.426 Sum_probs=173.0
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
+|+..+.||+|++|.||++.+. +++.+++|++...........+.+|++++++++|+||+++++.+.. ....+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~lv 77 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN----NGDISIC 77 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec----CCEEEEE
Confidence 4666788999999999999886 5889999998876555556679999999999999999999998876 3567999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
+||+++++|.+++.... ..+++..+..++.|++.+|.|||+ .+ ++|+||||+||++++++.++|+|||.+.....
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 78 MEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred EEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 99999999999997643 568999999999999999999999 77 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 154 ~~~-------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 154 SLA-------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred HHh-------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 211 1155778899999998889999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=258.31 Aligned_cols=191 Identities=24% Similarity=0.385 Sum_probs=156.8
Q ss_pred ceecccCcEEEEEEEEcC-------------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012297 230 NIVGQGGSSYVYRGQLTD-------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~-------------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~ 296 (466)
+.||+|+||.||+|.+.+ ...|++|.+.... ......|.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~---- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVR---- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec----
Confidence 368999999999997532 2358889876543 2334468899999999999999999999876
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-------E
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-------A 369 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~-------v 369 (466)
....++||||+++++|..++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++. +
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCcee
Confidence 335689999999999999886532 45899999999999999999999998 999999999999987664 8
Q ss_pred EEEecCCccccccCCCCCCCCCCCccccCcccccchhcc-cCCCCchhHHHHHHHHHHHHH-cCCCCCCCC
Q 012297 370 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELI-TGRQPIHRS 438 (466)
Q Consensus 370 kL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~S~Gvll~ell-tG~~Pf~~~ 438 (466)
+++|||++...... ....++..|+|||.+. ...++.++||||||+++|||+ +|..||...
T Consensus 152 ~l~d~g~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 152 KLSDPGIPITVLSR---------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred EeCCCCCCccccCc---------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999998654321 2234678899999886 566899999999999999998 588888643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=260.43 Aligned_cols=203 Identities=26% Similarity=0.417 Sum_probs=169.5
Q ss_pred CCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
++|+....||+|+||.||+|+.. +.+.+++|.+...........+.+|++++++++|+||+++++++.+ .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE----A 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC----C
Confidence 56778889999999999999864 3467999988765443345679999999999999999999998865 3
Q ss_pred eeEEEEEecCCCCCHHHHhccccc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLV-------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 370 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~-------~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vk 370 (466)
...++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEE
Confidence 456999999999999999975431 15899999999999999999999998 99999999999999999999
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 371 L~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
|+|||++........ .......++..|+|||.+....++.++||||||+++|||++ |..||..
T Consensus 158 l~~~~~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 158 VSLLSLSKDVYNSEY----YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred EcccccccccCcccc----cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 999999875432211 12223345678999999988889999999999999999998 8889854
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=256.57 Aligned_cols=189 Identities=25% Similarity=0.421 Sum_probs=158.6
Q ss_pred ceecccCcEEEEEEEEcCCc-----------EEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 230 NIVGQGGSSYVYRGQLTDGR-----------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~-----------~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
+.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.++++++|+||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-----D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-----C
Confidence 36899999999999886533 5788877655332 5668999999999999999999999875 2
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-------cEEE
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-------NAKI 371 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~-------~vkL 371 (466)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEe
Confidence 3489999999999999997643 26899999999999999999999988 99999999999999888 7999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCcccccchhcccC--CCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 372 ~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+|||++...... ....++..|+|||++... .++.++||||||+++|||++ |..||...
T Consensus 150 ~Dfg~a~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 150 SDPGIPITVLSR---------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred CCCCcccccccc---------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 999998865331 123456779999998776 78999999999999999999 67887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=263.05 Aligned_cols=206 Identities=23% Similarity=0.321 Sum_probs=169.6
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|+..+.||+|+||.||++... .++.|++|.+..... ......+.+|+++++.++|+||+++++.+.. ....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~ 76 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET----KRHL 76 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec----CCEE
Confidence 36778899999999999999875 478899998875532 2234468899999999999999999998865 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++..
T Consensus 77 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~ 151 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151 (305)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence 9999999999999999754 45899999999999999999999998 999999999999999999999999998642
Q ss_pred ccCCCCC----------CCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPS----------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
....... .........++..|+|||.+....++.++|+||||+++|||++|+.||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1110000 000111245788899999998888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=259.07 Aligned_cols=201 Identities=29% Similarity=0.376 Sum_probs=173.1
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
+|+..+.||.|+||.||++... +++.+++|.+..... ....+.+.+|++++++++||||+++++++.+ ....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 76 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD----EENMY 76 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC----CCeEE
Confidence 4777889999999999999876 488999999875432 2345679999999999999999999988765 45679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+|+||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~ 151 (258)
T cd05578 77 LVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVT 151 (258)
T ss_pred EEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence 999999999999999764 46899999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 440 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~ 440 (466)
... ......|+..|+|||.+....++.++|+||||+++|+|++|+.||.....
T Consensus 152 ~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 152 PDT------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred CCc------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 332 12234577889999999888899999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-33 Score=279.41 Aligned_cols=195 Identities=30% Similarity=0.431 Sum_probs=168.6
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
|+.++.||.|+||.||.|++. +.+.||||++....... .-.++++|+.+|++++|||++.+.|++.. ....||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr----e~TaWL 103 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR----EHTAWL 103 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec----cchHHH
Confidence 555678999999999999864 67899999998764322 23468999999999999999999999886 446699
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+ -|+-.+.+.-. .+++.+.++..|..+++.||+|||+.+ .||||||+.|||+++.|.|||+|||.+....+
T Consensus 104 VMEYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 104 VMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 99999 67888888643 367899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCCccccCcccccchhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
-..++||+.|||||++. .+.|+-++||||||++..||.-.++|+..+
T Consensus 179 ---------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM 228 (948)
T KOG0577|consen 179 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 228 (948)
T ss_pred ---------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc
Confidence 24578999999999874 678999999999999999999999998754
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=259.06 Aligned_cols=198 Identities=25% Similarity=0.395 Sum_probs=169.8
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
-|+..+.||+|+||.||+|... ++..+|+|.+...........+.+|++++++++|+||+++++++.+ ....++|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 80 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK----DTKLWII 80 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe----CCeEEEE
Confidence 3666788999999999999864 6789999988755444445678899999999999999999999876 4467999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++++|.+++.. ..+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 81 MEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred EEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 999999999999864 35899999999999999999999988 999999999999999999999999998765432
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.. ......++..|+|||.+....++.++|+||||+++|||++|..||..
T Consensus 155 ~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 155 QI-----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred hh-----hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 11 11224577889999999888889999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=254.74 Aligned_cols=201 Identities=32% Similarity=0.530 Sum_probs=170.6
Q ss_pred CCCcceecccCcEEEEEEEEcC-----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~~-----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
|++.+.||.|+||.||++...+ +..||+|++...........+..|++++..++|+||+++++++.+ ....
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 76 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE----EEPL 76 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC----CCee
Confidence 3456789999999999998764 488999999766544456679999999999999999999998876 3467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
+++|||+++++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++...
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceec
Confidence 99999999999999997654333899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
....... .....++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 154 ~~~~~~~----~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 154 YDDDYYK----KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred ccccccc----cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 5442211 112236788999999988889999999999999999998 8888864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=260.79 Aligned_cols=200 Identities=27% Similarity=0.389 Sum_probs=164.0
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHH-HHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDM-LSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~-l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|++.+.||+|+||.||++... +++.||+|+++..........+..|++. ++.++|+||+++++++.. ....+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~----~~~~~ 76 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR----EGDVW 76 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec----CCcEE
Confidence 36778899999999999999875 5899999998766444444556667765 566789999999999875 34579
Q ss_pred EEEecCCCCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 302 LVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~~-~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
+||||++ |+|.++++.. ....+++..++.++.|++.||+|||+. + ++||||||+|||+++++.+||+|||++.
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~ 152 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISG 152 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 9999995 7898888642 224589999999999999999999986 6 9999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhccc----CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV----GRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
...... ......++..|+|||.+.. ..++.++|+||||+++|||++|+.||..
T Consensus 153 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 153 YLVDSV------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cccccc------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 653221 1122457888999998764 4468899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=261.75 Aligned_cols=200 Identities=27% Similarity=0.395 Sum_probs=167.5
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC----ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~----~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
+|+..+.||+|++|.||+|... +++.|+||.+...... .....+..|++++++++|+||+++++++.+ ...
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH----KSN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec----CCE
Confidence 3667789999999999999875 5889999999765432 223457789999999999999999999876 446
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+ +++|.+++.... ..+++..++.++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~ 151 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS 151 (298)
T ss_pred EEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeee
Confidence 79999999 999999997643 36899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... ......++..|+|||.+.+ ..++.++||||||+++|||++|.+||...
T Consensus 152 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~ 206 (298)
T cd07841 152 FGSPNR-----KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD 206 (298)
T ss_pred ccCCCc-----cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC
Confidence 644321 1122345778999998854 45789999999999999999998887643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=262.24 Aligned_cols=199 Identities=24% Similarity=0.378 Sum_probs=164.6
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+|+..+.||+|+||.||+|... +|+.+++|++..... ......+.+|++++++++|+||+++++++.+ ....++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~----~~~~~l 76 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS----DKKLTL 76 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc----CCceEE
Confidence 3677789999999999999875 588999999875432 2223457889999999999999999998865 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
|+||++ ++|.+++.... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+++....
T Consensus 77 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 77 VFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred EEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 999996 68888876532 45899999999999999999999998 99999999999999999999999999876532
Q ss_pred CCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.. .......++..|+|||.+.+. .++.++||||||+++|||+||+.||..
T Consensus 152 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 152 PV-----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred CC-----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 21 112233567889999988764 468999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=259.09 Aligned_cols=202 Identities=26% Similarity=0.422 Sum_probs=168.9
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
+|+..+.||+|++|.||+|++. +++.||||.+...........+.+|++++++++|+||+++++++.+ ....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT----ENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee----CCcEEEE
Confidence 4777899999999999999985 5889999998866544445567899999999999999999999876 3456999
Q ss_pred EecCCCCCHHHHhcccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 304 FEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
|||++ ++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 77 FEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred EecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 99997 58998886533 235899999999999999999999998 99999999999999999999999999976533
Q ss_pred CCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.. .......++..|++||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 153 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 153 PV-----NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred Cc-----cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 11122346788999998765 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=254.77 Aligned_cols=201 Identities=25% Similarity=0.387 Sum_probs=170.7
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+|+..+.||+|++|.||++... +++.+++|++.... .......+.+|+++++.++|+|++++++.+.. ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~l 76 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE----DKALMI 76 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec----CCEEEE
Confidence 4677889999999999999764 57889999987543 23345568999999999999999999998764 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLK 381 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~-~~vkL~DfGla~~~~ 381 (466)
||||+++++|.+++.......+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++++ +.++|+|||++....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 999999999999998755556899999999999999999999998 9999999999999865 458999999998764
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... ......++..|+|||.+....++.++||||||+++|+|++|+.||...
T Consensus 154 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 154 SKS------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred CCc------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 321 122345788999999998888899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=258.17 Aligned_cols=194 Identities=30% Similarity=0.441 Sum_probs=164.9
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCC
Q 012297 232 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (466)
Q Consensus 232 LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~ 308 (466)
||+|+||+||++... +++.+++|.+.... .......+.+|+++++.++|||++++++++.. ....++||||++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET----KDDLCLVMTLMN 76 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec----CCeEEEEEecCC
Confidence 689999999999764 58899999986532 22234457889999999999999999988865 446799999999
Q ss_pred CCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCC
Q 012297 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388 (466)
Q Consensus 309 ~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~ 388 (466)
+++|.+++.......+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---- 149 (277)
T cd05577 77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---- 149 (277)
T ss_pred CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC----
Confidence 999999997654456899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 389 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 150 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 150 --KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred --ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 122335678899999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=260.49 Aligned_cols=210 Identities=20% Similarity=0.221 Sum_probs=158.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcC----CcEEEEEEcccCCCCChhH----------HHHHHHHHHHhcCCCCccceee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADS----------VFLTEVDMLSRLHHCHVVPLVG 288 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~----~~~vaVK~l~~~~~~~~~~----------~f~~Ei~~l~~l~H~nIv~llg 288 (466)
.++|.+.++||+|+||.||+|...+ +..+++|+..........+ ....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3578888999999999999998754 3456666543332211111 1122334455678999999999
Q ss_pred eeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 012297 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 368 (466)
Q Consensus 289 ~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~ 368 (466)
++..........++++|+. ..++.+.+... ...++..+..++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 7765444444567888887 44777766543 33578889999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccccCCCCCC--CCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 369 AKITDLGMAKRLKADGLPSC--SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 369 vkL~DfGla~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
++|+|||+++.......... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999987644321111 11122346899999999999999999999999999999999999999765
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=258.69 Aligned_cols=200 Identities=23% Similarity=0.329 Sum_probs=169.3
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+|++.+.||+|++|.||+|.+. +++.|++|++..... ......+.+|+.++++++|+||+++++++.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~~ 76 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH----GSGFVL 76 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec----CCeeEE
Confidence 4677889999999999999875 688999999876543 3334568999999999999999999999876 456799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+ +++|.+++.... ..+++.++..++.|++++|+|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 77 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 77 VMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSE 151 (286)
T ss_pred Eeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence 99999 999999987543 56899999999999999999999998 99999999999999999999999999886643
Q ss_pred CCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
... .......++..|+|||.+.+. .++.++||||||+++|||++|++||..
T Consensus 152 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 152 EEP----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred CCC----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 321 112234578899999988654 468999999999999999999888754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=260.35 Aligned_cols=190 Identities=25% Similarity=0.399 Sum_probs=155.3
Q ss_pred eecccCcEEEEEEEEcC-------------------------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccc
Q 012297 231 IVGQGGSSYVYRGQLTD-------------------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285 (466)
Q Consensus 231 ~LG~G~fG~Vy~a~~~~-------------------------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~ 285 (466)
.||+|+||.||+|.+.. ...|++|++.... ......|.+|+.+++.++|+||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 69999999999997521 1358899886543 233456889999999999999999
Q ss_pred eeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 012297 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (466)
Q Consensus 286 llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~ 365 (466)
+++++.+ ....++||||+++|+|..++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 81 ~~~~~~~----~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~ 152 (274)
T cd05076 81 VHGVCVR----GSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLAR 152 (274)
T ss_pred EEEEEEe----CCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEec
Confidence 9999986 346699999999999999986532 45899999999999999999999988 999999999999976
Q ss_pred CC-------cEEEEecCCccccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHH-cCCCCCC
Q 012297 366 NL-------NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELI-TGRQPIH 436 (466)
Q Consensus 366 ~~-------~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~ell-tG~~Pf~ 436 (466)
++ .+|++|||++...... ....++..|+|||.+.. ..++.++||||||+++|||+ +|+.||.
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~---------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 223 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR---------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK 223 (274)
T ss_pred cCcccCccceeeecCCccccccccc---------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcc
Confidence 43 3899999987643221 12246778999998865 56899999999999999995 7999997
Q ss_pred CC
Q 012297 437 RS 438 (466)
Q Consensus 437 ~~ 438 (466)
..
T Consensus 224 ~~ 225 (274)
T cd05076 224 ER 225 (274)
T ss_pred cc
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=255.39 Aligned_cols=204 Identities=29% Similarity=0.450 Sum_probs=172.0
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+|+..+.||+|+||.||+|... +++.+++|.++..... .....+.+|+++++.++|+||+++++++.. ....++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH----REKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec----CCEEEE
Confidence 4677889999999999999865 6889999998766432 345668999999999999999999998765 456799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 77 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 77 FMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred EEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 99999999999999754 34789999999999999999999998 99999999999999999999999999887654
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCC---CCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... ........++..|+|||++.... .+.++||||||+++|||++|+.||...
T Consensus 152 ~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 152 NTTTM-GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred CCCcc-cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 33221 11012345778999999988766 889999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-33 Score=252.79 Aligned_cols=202 Identities=32% Similarity=0.462 Sum_probs=171.8
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC----C---hhHHHHHHHHHHHhc-CCCCccceeeee
Q 012297 220 EHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP----N---ADSVFLTEVDMLSRL-HHCHVVPLVGYC 290 (466)
Q Consensus 220 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~----~---~~~~f~~Ei~~l~~l-~H~nIv~llg~~ 290 (466)
...-++|...+.||.|..+.|-+...+ .+...|+|++...... . ..+.-..|+.+|+++ .||||+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 445567778889999999999988654 5778899988654321 1 122345689999998 599999999987
Q ss_pred eeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 012297 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 370 (466)
Q Consensus 291 ~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vk 370 (466)
.. ....++|+|.|+.|.|.+||... -.++++....|.+|+..|++|||..+ |+||||||+|||+|++.++|
T Consensus 93 es----~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 93 ES----DAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred cC----cchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceE
Confidence 65 66789999999999999999765 45899999999999999999999998 99999999999999999999
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCcccccchhcc------cCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM------VGRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 371 L~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
|+|||.++.+.+. ......+||++|+|||.+. ...|+...|+|+.||++|.|+.|-+||.
T Consensus 164 isDFGFa~~l~~G------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 164 ISDFGFACQLEPG------EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred EeccceeeccCCc------hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 9999999988664 2355689999999999874 3558999999999999999999999996
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=266.32 Aligned_cols=206 Identities=24% Similarity=0.334 Sum_probs=170.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC-cceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~-~~~~~ 300 (466)
.++|++.+.||+|+||.||+|... +++.||+|.+...........+.+|+.++++++|+||+++++++..... .....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467888999999999999999764 6889999998754444455568899999999999999999998765321 22357
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++|+||++ ++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999995 588887754 45899999999999999999999998 999999999999999999999999998865
Q ss_pred ccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
...... ........|+..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 157 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 157 DPEHDH--TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred cccccc--cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 432211 112233567899999998654 5689999999999999999999999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-31 Score=257.37 Aligned_cols=193 Identities=28% Similarity=0.391 Sum_probs=157.2
Q ss_pred eecccCcEEEEEEEEc-CCcEEEEEEcccCCCC--ChhHHHHHHHHHHHh---cCCCCccceeeeeeeccCcceeEEEEE
Q 012297 231 IVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSR---LHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 231 ~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~---l~H~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
+||+|+||.||++... +++.+|+|.+...... .....+.+|..+++. .+|+|++.+++++.. ....++||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~ 76 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT----PDKLCFIL 76 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec----CCeEEEEE
Confidence 4899999999999875 5889999988754322 222334555544443 479999999988875 34679999
Q ss_pred ecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCC
Q 012297 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~ 384 (466)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||++.......
T Consensus 77 e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 77 DLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 999999999998754 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.....|+..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 152 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 152 -------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred -------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 122358899999998864 557999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=256.47 Aligned_cols=201 Identities=27% Similarity=0.459 Sum_probs=166.4
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC--C-------hhHHHHHHHHHHHhcCCCCccceeeeeeecc
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--N-------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 294 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~--~-------~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~ 294 (466)
+|...+.||+|+||.||+|... +++.+|+|.++..... . ..+.+..|+.+++.++|+|++++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 3566789999999999999764 6889999988643111 0 12347889999999999999999998875
Q ss_pred CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 012297 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 374 (466)
Q Consensus 295 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~Df 374 (466)
....++||||+++++|.++++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+||
T Consensus 80 --~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~ 152 (272)
T cd06629 80 --EEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDF 152 (272)
T ss_pred --CCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeec
Confidence 34679999999999999999765 46899999999999999999999998 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCCccccCcccccchhcccCC--CCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
|+++........ .......++..|+|||.+.... ++.++|+||||+++|||++|..||..
T Consensus 153 ~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 153 GISKKSDDIYDN---DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred cccccccccccc---cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 998764322111 1122345788999999887654 78999999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=260.42 Aligned_cols=199 Identities=26% Similarity=0.430 Sum_probs=170.3
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.+|...+.||+|+||.||++... ++..+++|.+.... ......+.+|+.++++++|||++++++++.. ....++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLV----GDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeee----CCcEEE
Confidence 56788899999999999999764 67889999986543 2334568899999999999999999999876 346799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
|+||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 94 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999999999865 34789999999999999999999998 99999999999999999999999998876543
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... ......+++.|++||.+....++.++|+||||+++|||++|+.||...
T Consensus 168 ~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 168 EQS-----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred ccc-----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 221 122345788899999998888999999999999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-31 Score=258.28 Aligned_cols=205 Identities=23% Similarity=0.326 Sum_probs=165.9
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcC-CCCccceeeeeeeccC-ccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRG-KRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~-~~~~ 299 (466)
++|+..+.||+|+||.||+|.+. +++.||+|.+...... .....+.+|+.+++.+. |+||+++++++..... ....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36788899999999999999875 5889999988655322 23345888999999995 6999999998876433 2234
Q ss_pred EEEEEecCCCCCHHHHhcccc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecC
Q 012297 300 RLLVFEFMPNGNLRDCLDGVL---VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLG 375 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~-~~~vkL~DfG 375 (466)
.++||||+++ +|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 6999999975 8998886432 235899999999999999999999998 999999999999998 8899999999
Q ss_pred CccccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
+++...... .......+++.|+|||.+.+ ..++.++||||||+++|||++|..||..
T Consensus 157 ~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 157 LGRAFSIPV-----KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred cceecCCCc-----cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 987653321 11122346788999998865 4579999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=253.08 Aligned_cols=208 Identities=24% Similarity=0.381 Sum_probs=173.1
Q ss_pred chHHHHHHhCCCCCcceecccCcEEEEEEE-EcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeee
Q 012297 215 SYSALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSE 292 (466)
Q Consensus 215 ~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~-~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~ 292 (466)
+++++.+.|++ +||+|+++.|-.+. +.++..+|||++.... ...+.+..+|++++.+.+ |+||+.|+.+|.+
T Consensus 74 ~F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 74 KFEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred hHHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 35677766654 89999999999885 5689999999998874 345566889999999985 9999999999887
Q ss_pred ccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cE
Q 012297 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---NA 369 (466)
Q Consensus 293 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~---~v 369 (466)
+...|||||-|.||+|..++++. ..|++.++.++..+|+.||.|||.++ |.||||||+|||-.... -+
T Consensus 148 ----d~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPv 218 (463)
T KOG0607|consen 148 ----DTRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPV 218 (463)
T ss_pred ----cceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCce
Confidence 56779999999999999999865 56999999999999999999999999 99999999999996554 38
Q ss_pred EEEecCCccccccCC--CCCCCCCCCccccCcccccchhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 370 KITDLGMAKRLKADG--LPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 370 kL~DfGla~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
||+||.+..-..... .+.........+|+..|||||+.. ...|+.+.|.|||||+||-|+.|.+||..
T Consensus 219 KiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 219 KICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred eeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 999999976543322 233233344468999999999763 24578999999999999999999999974
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=257.77 Aligned_cols=206 Identities=29% Similarity=0.427 Sum_probs=170.9
Q ss_pred CCCCcceecccCcEEEEEEEEc-----CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-----~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
.|+..+.||+|+||.||++.+. .+..+|||.+...........|.+|+++++.++|+||+++++++.... ...
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~--~~~ 82 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPG--GRS 82 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCC--CCc
Confidence 4566789999999999999864 367899999986644334567999999999999999999999886532 345
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 799999999999999997643 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
....... ........++..|++||......++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 159 LPEDKDY--YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cccCCcc--eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 6532211 01111123456799999998888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=287.27 Aligned_cols=224 Identities=26% Similarity=0.397 Sum_probs=183.9
Q ss_pred HHHHHhCCCCCcceecccCcEEEEEEEEc--------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceee
Q 012297 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVG 288 (466)
Q Consensus 218 ~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~--------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg 288 (466)
.++...++..+.+.||+|.||.|++|... ....||||+++........+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45666666677779999999999999753 14579999999887777778899999999999 5999999999
Q ss_pred eeeeccCcceeEEEEEecCCCCCHHHHhcccc------------c--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 012297 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL------------V--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHR 354 (466)
Q Consensus 289 ~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~------------~--~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHr 354 (466)
+|.. +...++|+||+..|+|.+||+..+ . ..++..+.+.++.|||.||+||++.. ++||
T Consensus 370 ~~t~----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHR 442 (609)
T KOG0200|consen 370 ACTQ----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHR 442 (609)
T ss_pred eecc----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccch
Confidence 9987 456799999999999999997654 0 12888999999999999999999987 9999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCC
Q 012297 355 DIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQ 433 (466)
Q Consensus 355 DLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~ 433 (466)
||.++|||+.++..+||+|||+++....+........ ... -+..|||||.+....|+.++|||||||+||||+| |..
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~-~~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~ 520 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSS-AGT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT 520 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEecCC-CCc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence 9999999999999999999999997655443221111 111 3567999999999999999999999999999998 999
Q ss_pred CCCCCCCCChhhHHHHHHH
Q 012297 434 PIHRSITKGEESLVLWVKS 452 (466)
Q Consensus 434 Pf~~~~~~~~~~l~~~~~~ 452 (466)
|+.... ...++.++++.
T Consensus 521 PYp~~~--~~~~l~~~l~~ 537 (609)
T KOG0200|consen 521 PYPGIP--PTEELLEFLKE 537 (609)
T ss_pred CCCCCC--cHHHHHHHHhc
Confidence 996522 13445555553
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=258.63 Aligned_cols=200 Identities=29% Similarity=0.392 Sum_probs=169.3
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+|+..+.||+|++|.||+|.+. +++.|++|.++.... ......+.+|++++++++|+||+++++++.. ....++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~i 77 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR----KGRLYL 77 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE----CCEEEE
Confidence 5778899999999999999876 478999999876432 3334568999999999999999999999876 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||++++.+..++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 78 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 78 VFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred EEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 99999987777665432 45899999999999999999999998 99999999999999999999999999887654
Q ss_pred CCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
... .......++..|+|||++... .++.++||||||+++|||++|+.||..
T Consensus 153 ~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 153 RPA----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred Ccc----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 321 112234577889999999887 789999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-33 Score=254.25 Aligned_cols=200 Identities=27% Similarity=0.375 Sum_probs=170.6
Q ss_pred hCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
+++|++.+.||+|.|+.||+... ..|+.+|+|.+.... .....+++.+|+.+-+.|+||||++|.....+ ....
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~----~~~~ 85 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----ESFH 85 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc----ccee
Confidence 45677788999999999999965 468889999887553 22345568899999999999999999976655 6688
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCCc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGMA 377 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~---~~~vkL~DfGla 377 (466)
++|+|+|.|++|..-+-.. ..+++..+-...+||+.+|.|.|.++ |+|||+||+|+|+.. .--+||+|||++
T Consensus 86 ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999999997655432 44788888899999999999999999 999999999999943 345999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
..+. + ......++||++|||||++...+|+..+|||+-||+||-|+.|.+||..
T Consensus 161 i~l~-~-----g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 161 IEVN-D-----GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred EEeC-C-----ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 9886 3 2356678899999999999999999999999999999999999999986
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=256.64 Aligned_cols=200 Identities=25% Similarity=0.425 Sum_probs=166.7
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
|+..+.||+|++|.||+|... ++..|++|++...... .....+.+|++++++++|+|++++++++.+ ....++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~----~~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS----ENKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc----CCeEEEE
Confidence 556789999999999999865 6899999998765322 233458899999999999999999999875 4567999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+ +++|.+++.......+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++......
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 77 FEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152 (283)
T ss_pred Eecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence 9999 579999997654446899999999999999999999988 999999999999999999999999998765322
Q ss_pred CCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
. .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 153 ~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 153 V-----RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred c-----cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 111223457889999987654 5689999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=278.28 Aligned_cols=201 Identities=28% Similarity=0.413 Sum_probs=171.3
Q ss_pred CcceecccCcEEEEEEEEcC--Cc--EEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 228 GSNIVGQGGSSYVYRGQLTD--GR--IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 228 ~~~~LG~G~fG~Vy~a~~~~--~~--~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
..++||+|.||.|++|.|.. |+ .||||.++.........+|++|+.+|.+|+|+|+++|+|+..+ ....+|
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-----qp~mMV 188 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-----QPAMMV 188 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-----chhhHH
Confidence 45789999999999998763 33 6899999988766677789999999999999999999999875 245899
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
||.++.|+|.+.|++.....|-....-.++.|||.||.||..++ +|||||.++|+||-....+||+||||.+.+...
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999998744455888888899999999999999888 999999999999999999999999999987653
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
... ........-++.|.|||.+....++.++|||+|||++|||+| |+.||-..
T Consensus 266 ed~--Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~ 319 (1039)
T KOG0199|consen 266 EDM--YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC 319 (1039)
T ss_pred Ccc--eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC
Confidence 221 111222334678999999999999999999999999999998 89998643
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=265.42 Aligned_cols=208 Identities=24% Similarity=0.330 Sum_probs=169.9
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccC-CCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcce
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~-~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~ 298 (466)
..++|+..+.||+|+||.||+|.+. +++.+|+|++... ........+.+|+.+++++ +|+||+++++++.... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~--~~ 82 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN--DK 82 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC--Cc
Confidence 4567888899999999999999875 5789999988543 2223334577899999999 9999999999886522 34
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||++ ++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 6799999996 6999988753 5789999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..................|+..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 7644322111122333568899999998754 55788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=253.20 Aligned_cols=193 Identities=28% Similarity=0.392 Sum_probs=166.3
Q ss_pred ecccCcEEEEEEEEcC-CcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCC
Q 012297 232 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (466)
Q Consensus 232 LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~ 308 (466)
||.|++|.||++++.. ++.+++|.+..... ......+.+|+.+++.++|+||+++++++.+ +...++||||++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD----KKYIYMLMEYCL 76 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc----CCccEEEEecCC
Confidence 6899999999998864 88999999875432 2344669999999999999999999998875 446799999999
Q ss_pred CCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCC
Q 012297 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388 (466)
Q Consensus 309 ~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~ 388 (466)
+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---- 147 (262)
T cd05572 77 GGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---- 147 (262)
T ss_pred CCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----
Confidence 99999999764 45899999999999999999999988 9999999999999999999999999998764321
Q ss_pred CCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 389 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
......++..|++||.+....++.++|+||||+++|||++|+.||....
T Consensus 148 --~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 148 --KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred --ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 1223457888999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=258.09 Aligned_cols=203 Identities=26% Similarity=0.431 Sum_probs=174.1
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
..++.|+..+.||+|++|.||++.+. ++..+++|++..... ....+.+|+++++.++|+|++++++++.. ...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLV----GDE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEE----CCE
Confidence 35566777889999999999999886 688999999876543 45568899999999999999999999876 356
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 165 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQ 165 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhh
Confidence 799999999999999998643 36899999999999999999999988 99999999999999999999999999865
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... ......++..|++||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 166 ~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~ 219 (286)
T cd06614 166 LTKEKS-----KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE 219 (286)
T ss_pred hccchh-----hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 533211 112234678899999998888999999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-33 Score=261.35 Aligned_cols=196 Identities=24% Similarity=0.383 Sum_probs=173.3
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
|.+..+||+|++|.||+|..+ .|+.+|||.+..+. ..+++.+|+.+|.+.+.+++|+.+|.+.. ....|+||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK----~sDLWIVM 107 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFK----HSDLWIVM 107 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhcc----CCceEeeh
Confidence 667788999999999999765 59999999987654 34568999999999999999999997765 45679999
Q ss_pred ecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCC
Q 012297 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~ 384 (466)
||+..|+..+.++.. .+++++.++..+++..++||+|||... -+|||||+.|||++.+|.+||+|||.+-.+....
T Consensus 108 EYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 108 EYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 999999999999864 477999999999999999999999987 8999999999999999999999999998765432
Q ss_pred CCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.....+.||+-|||||++..-.|+.++||||||++..||..|++||..
T Consensus 184 -----AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD 231 (502)
T KOG0574|consen 184 -----AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD 231 (502)
T ss_pred -----HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence 224457899999999999999999999999999999999999999863
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=257.04 Aligned_cols=202 Identities=23% Similarity=0.365 Sum_probs=165.4
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|+..+.||+|++|.||+|... +++.|++|.+..... ......+.+|++++++++|+||+++++++.+ ....+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 77 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS----EKRLY 77 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec----CCeEE
Confidence 46788889999999999999875 688999999865432 2233458899999999999999999999875 44679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCcccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRL 380 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~-~~~vkL~DfGla~~~ 380 (466)
+||||++ ++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||+|+||++++ ++.+||+|||++...
T Consensus 78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 9999995 68888886544444688888999999999999999998 999999999999985 567999999999765
Q ss_pred ccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... .......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus 154 ~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 154 GIPV-----RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred CCCc-----cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3321 11122356788999998865 45789999999999999999999999753
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=252.37 Aligned_cols=204 Identities=25% Similarity=0.323 Sum_probs=170.8
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+|++.+.||.|+||.||++... +++.+++|++..... ....+.+..|++++++++|+||+++++++.... ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRS--NQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCC--CCEEEE
Confidence 4677789999999999999764 578899999875432 333456889999999999999999999876532 345699
Q ss_pred EEecCCCCCHHHHhcccc--cCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 012297 303 VFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLH-----EAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~~L~~LH-----~~~~~~ivHrDLk~~NILld~~~~vkL~DfG 375 (466)
+|||+++++|.+++.... ...+++..++.++.|++.||.||| +.+ ++|+||+|+||++++++.+||+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccc
Confidence 999999999999996532 345899999999999999999999 665 9999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
++........ ......++..|+|||.+....++.++|+||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~-----~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 156 LAKILGHDSS-----FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred ccccccCCcc-----cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 9987644321 122345788999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=256.49 Aligned_cols=200 Identities=27% Similarity=0.372 Sum_probs=166.5
Q ss_pred CCCCcceecccCcEEEEEEEE----cCCcEEEEEEcccCC---CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCc
Q 012297 225 KFSGSNIVGQGGSSYVYRGQL----TDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~----~~~~~vaVK~l~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~ 296 (466)
+|++.+.||+|+||.||++.. .+|+.||+|++.... .....+.+.+|+.++.++ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---- 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence 367778999999999999986 368899999987542 223345578899999999 59999999988765
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGl 376 (466)
....++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||+++++.+||+|||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 151 (290)
T cd05613 77 DTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 151 (290)
T ss_pred CCeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcc
Confidence 34678999999999999999754 45889999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCcccccchhcccC--CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
+........ .......|+..|+|||.+... .++.++||||||+++|||++|+.||..
T Consensus 152 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 152 SKEFHEDEV----ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ceecccccc----cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 976543221 112234578899999988653 467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=254.81 Aligned_cols=207 Identities=27% Similarity=0.395 Sum_probs=166.4
Q ss_pred CCCcceecccCcEEEEEEEEc----CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc--e
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR--A 298 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~----~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~--~ 298 (466)
|.+.+.||+|+||.||+|.+. .++.||||++..... ....+.+.+|+++++.++||||+++++++....... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456688999999999999764 368899999876532 233456889999999999999999999876533221 2
Q ss_pred eEEEEEecCCCCCHHHHhcccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVL----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 374 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~Df 374 (466)
..++++||+++|+|.+++.... ...+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 4578999999999998874321 124788999999999999999999998 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
|+++........ .......++..|++||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 g~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~ 219 (273)
T cd05074 158 GLSKKIYSGDYY---RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219 (273)
T ss_pred cccccccCCcce---ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence 999865432210 11112335678999999988889999999999999999999 88998643
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=258.65 Aligned_cols=196 Identities=29% Similarity=0.427 Sum_probs=164.5
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
..|...+.||+|+||.||+|... +++.|++|.+...... .....+.+|+++++.++||||+++.+++.+ ....
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~----~~~~ 90 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR----EHTA 90 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe----CCeE
Confidence 45777889999999999999875 5889999988654322 233468899999999999999999999876 3456
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||++ |+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++...
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceec
Confidence 99999996 68877775432 45899999999999999999999998 999999999999999999999999998754
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
... ....++..|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 166 ~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 166 SPA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred CCC---------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 322 2235678899999874 45688999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=257.91 Aligned_cols=203 Identities=25% Similarity=0.364 Sum_probs=168.2
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|+..+.||+|+||.||+|... +++.+++|.++..... .....+.+|++++++++||||+++++++.... ....+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN--LDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC--CCcEE
Confidence 46777889999999999999876 5889999999755322 22334778999999999999999999887532 25779
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||++ ++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 83 lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 9999996 59999887543 35899999999999999999999998 9999999999999999999999999988664
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||...
T Consensus 158 ~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 158 SPLK-----PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred CCcc-----ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 4311 11223467889999988654 4689999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=257.54 Aligned_cols=209 Identities=24% Similarity=0.328 Sum_probs=168.3
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccC----cc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG----KR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~----~~ 297 (466)
++|+..+.||+|+||.||+|... +++.||||.+..... ......+.+|++++++++||||+++++++..... ..
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888899999999999999875 588999999865432 2223346789999999999999999998876432 13
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||++ ++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCc
Confidence 45699999995 58888886532 35899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 167 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 167 RAFSLSKNSK-PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred ccccCCcccC-CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 8664322111 1112234567889999987654 4688999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=264.26 Aligned_cols=209 Identities=22% Similarity=0.341 Sum_probs=172.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
..+|++.+.||+|++|.||+|... +++.|++|++..... ......+.+|+.++++++|+||+++++++..........
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888899999999999999865 589999999876432 233455788999999999999999999876544445577
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 6999998754 45899999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
....... ........++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 158 SSSPTEH-KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred cccCcCC-CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 4432211 111223467889999998765 55889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=255.51 Aligned_cols=196 Identities=24% Similarity=0.421 Sum_probs=167.1
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
|...+.||+|++|.||++... +++.+++|++.... ....+.+.+|+.+++.++|+|++++++++.. ....++|+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~----~~~~~~v~ 95 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV----GDELWVVM 95 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEc----CCeEEEEE
Confidence 444579999999999999864 68899999886543 2334558899999999999999999998875 34679999
Q ss_pred ecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCC
Q 012297 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~ 384 (466)
||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 96 EFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred eccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 99999999999876 45899999999999999999999998 9999999999999999999999999887553321
Q ss_pred CCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.......|+..|+|||.+....++.++||||||+++|||++|+.||..
T Consensus 170 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 170 -----PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred -----cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 112234578899999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=247.92 Aligned_cols=198 Identities=28% Similarity=0.471 Sum_probs=172.5
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+|++++++++.. ....++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~l~~ 76 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLK----KDELWIVM 76 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEec----CCeEEEEE
Confidence 667789999999999999886 688999999976643 345668999999999999999999998876 34679999
Q ss_pred ecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCC
Q 012297 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~ 384 (466)
||+++++|.+++.... ..+++..+..++.|++.+|.+||+.+ ++||||+|+||++++++.++|+|||.+.......
T Consensus 77 e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 77 EFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred ecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 9999999999987643 46899999999999999999999988 9999999999999999999999999987764432
Q ss_pred CCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
. .....++..|+|||.+.....+.++||||||+++|+|++|+.||...
T Consensus 153 ~------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 153 A------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred c------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 1 23356788999999998888999999999999999999999999754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=263.87 Aligned_cols=203 Identities=22% Similarity=0.291 Sum_probs=169.4
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--cc
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KR 297 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~--~~ 297 (466)
..++|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.+++.++|+||+++++++..... ..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4577888999999999999999865 68899999986542 23334457889999999999999999998764321 12
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||+. ++|.+++... ++...+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35699999995 5888887642 788999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+...... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 166 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 166 RTAGTSF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred eeCCCCC------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 8654321 122345788999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=250.72 Aligned_cols=198 Identities=21% Similarity=0.269 Sum_probs=162.5
Q ss_pred HHHHHHhCCCCCccee--cccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeee
Q 012297 217 SALEHATDKFSGSNIV--GQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292 (466)
Q Consensus 217 ~~l~~~t~~f~~~~~L--G~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~ 292 (466)
.+.....++|++.+.+ |+|+||.||++... ++..+|+|.+....... .|+.....+ +|+|++++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEec
Confidence 3444555677776766 99999999999864 57889999886542211 122222222 69999999999876
Q ss_pred ccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEE
Q 012297 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKI 371 (466)
Q Consensus 293 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~-~vkL 371 (466)
....++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|
T Consensus 81 ----~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l 151 (267)
T PHA03390 81 ----LKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYL 151 (267)
T ss_pred ----CCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEE
Confidence 34679999999999999999764 36899999999999999999999998 99999999999999998 9999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 372 ~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+|||++...... ....++..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 152 ~dfg~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 152 CDYGLCKIIGTP---------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred ecCccceecCCC---------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 999998765322 1235788999999999888999999999999999999999999854
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=252.19 Aligned_cols=199 Identities=24% Similarity=0.308 Sum_probs=163.3
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcceeEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
|+..+.||+|+||.||+|... +++.+|+|+++............+|+..+.++. |+|++++++++.+.. ....++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~--~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK--TGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC--CCcEEEE
Confidence 456688999999999999865 588999999876533333344568999999985 999999999987632 2467999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++. +.+||+|||+++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 79 FELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 99996 68888886532 45899999999999999999999998 999999999999999 99999999999866432
Q ss_pred CCCCCCCCCCccccCcccccchhcc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. .....++..|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 153 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~ 202 (282)
T cd07831 153 PP------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT 202 (282)
T ss_pred CC------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence 11 12235678899999764 455788999999999999999999999754
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=253.07 Aligned_cols=201 Identities=22% Similarity=0.382 Sum_probs=166.4
Q ss_pred CCCCcceecccCcEEEEEEEEcC--CcEEEEEEcccCC---------CCChhHHHHHHHHHHHh-cCCCCccceeeeeee
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTD--GRIVAVKRFKTQG---------GPNADSVFLTEVDMLSR-LHHCHVVPLVGYCSE 292 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~--~~~vaVK~l~~~~---------~~~~~~~f~~Ei~~l~~-l~H~nIv~llg~~~~ 292 (466)
+|++.+.||+|+||.||++.+.. ++.+|+|.+.... .......+..|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36777899999999999998865 6889999876431 12223447788888875 799999999999876
Q ss_pred ccCcceeEEEEEecCCCCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcE
Q 012297 293 FRGKRAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNA 369 (466)
Q Consensus 293 ~~~~~~~~~lV~ey~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivHrDLk~~NILld~~~~v 369 (466)
....++||||+++++|.+++... ....+++..++.++.|++.+|.|||+ .+ ++|+||+|+||+++.++.+
T Consensus 81 ----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~ 153 (269)
T cd08528 81 ----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKV 153 (269)
T ss_pred ----CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcE
Confidence 44679999999999999988542 23458999999999999999999996 55 9999999999999999999
Q ss_pred EEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 370 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 370 kL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+|+|||++....... ......++..|++||.+....++.++||||||+++|||++|+.||...
T Consensus 154 ~l~dfg~~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 154 TITDFGLAKQKQPES------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred EEecccceeeccccc------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 999999997654321 122345788999999999888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=252.13 Aligned_cols=201 Identities=25% Similarity=0.362 Sum_probs=169.6
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+|+..+.||+|+||.||++... ++..+|+|.+..... ....+.+.+|+++++.++|+||+++++.+.. ....++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~----~~~~~l 76 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE----NGRLFI 76 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc----CCeEEE
Confidence 4677889999999999999875 478899999865432 2334468899999999999999999998865 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRLK 381 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~-~vkL~DfGla~~~~ 381 (466)
|+||+++++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||||+||++++++ .++|+|||.+....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 999999999999997654445899999999999999999999998 99999999999998885 46999999987664
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.... ......|++.|+|||.+....++.++|+||||+++|||++|+.||..
T Consensus 154 ~~~~-----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 204 (257)
T cd08225 154 DSME-----LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204 (257)
T ss_pred CCcc-----cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3221 11223578899999999888899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=253.62 Aligned_cols=192 Identities=28% Similarity=0.407 Sum_probs=156.8
Q ss_pred eecccCcEEEEEEEEc-CCcEEEEEEcccCCCC--ChhHHHHHHHHH---HHhcCCCCccceeeeeeeccCcceeEEEEE
Q 012297 231 IVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDM---LSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 231 ~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~--~~~~~f~~Ei~~---l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
+||+|+||.||++... +++.||+|.+...... .....+..|..+ ++...|+||+++++++.+ ....++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----PDKLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec----CCEEEEEE
Confidence 4899999999999864 5889999998754322 222234455444 344579999999988775 44679999
Q ss_pred ecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCC
Q 012297 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~ 384 (466)
||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 77 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~- 150 (278)
T cd05606 77 DLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 150 (278)
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc-
Confidence 999999999998653 45899999999999999999999998 999999999999999999999999998755322
Q ss_pred CCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
......|+..|+|||.+..+ .++.++||||||+++|||++|+.||...
T Consensus 151 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 151 ------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred ------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 11234688999999998754 5889999999999999999999999755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=257.73 Aligned_cols=208 Identities=25% Similarity=0.331 Sum_probs=167.7
Q ss_pred CCCCcceecccCcEEEEEEEEcC---CcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~---~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
.|.+.+.||+|+||.||+|.... ++.||+|.+.... .......+.+|+.++++++||||+++++++.+.. ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA--DKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC--Cce
Confidence 36677899999999999998754 7899999988642 1223345788999999999999999999987632 246
Q ss_pred EEEEEecCCCCCHHHHhcccc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC----CCcEEEE
Q 012297 300 RLLVFEFMPNGNLRDCLDGVL---VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE----NLNAKIT 372 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~----~~~vkL~ 372 (466)
.++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++. ++.+||+
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 79 VYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred EEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEEC
Confidence 799999996 47777764322 125889999999999999999999998 999999999999999 8999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 012297 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSIT 440 (466)
Q Consensus 373 DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~ 440 (466)
|||++......... ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 155 Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 155 DLGLARLFNAPLKP--LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred CCccccccCCCccc--ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99999865433221 112233467889999998766 4578999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=268.83 Aligned_cols=203 Identities=29% Similarity=0.384 Sum_probs=175.9
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
.-...|.+...||+|.|+.|.+|+.. .+..||+|.+..... ......+.+|+++|..++|||||+++.+... ..
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t----~~ 128 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET----EA 128 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee----cc
Confidence 34566888899999999999999764 588999999877643 3333448899999999999999999998775 55
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..|+||||..+|.+.+||... ..+....+..++.|+.++++|||.+. |+|||||++||||+.+.++||+|||++.
T Consensus 129 ~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred eeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccce
Confidence 789999999999999999765 33566888899999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.+... ......+|++.|.|||++.+..+ .++.|+||+|++||-|+.|..||+..
T Consensus 204 ~~~~~------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 204 FFDYG------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred eeccc------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 87643 23455789999999999988776 88999999999999999999999853
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=277.64 Aligned_cols=203 Identities=19% Similarity=0.228 Sum_probs=157.2
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEcC--CcEEEEEEc--------------cc--CCCCChhHHHHHHHHHHHhcCCCC
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLTD--GRIVAVKRF--------------KT--QGGPNADSVFLTEVDMLSRLHHCH 282 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~~--~~~vaVK~l--------------~~--~~~~~~~~~f~~Ei~~l~~l~H~n 282 (466)
...++|.+.+.||+|+||+||++.++. +...++|.+ .. .........+.+|++++++++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999987542 222222211 00 011223345889999999999999
Q ss_pred ccceeeeeeeccCcceeEEEEEecCCCCCHHHHhccccc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 012297 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV---EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359 (466)
Q Consensus 283 Iv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~ 359 (466)
|+++++++.. ....++|+|++ .++|.+++..... .......+..++.|++.||+|||+.+ |+||||||+
T Consensus 225 Iv~l~~~~~~----~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~ 296 (501)
T PHA03210 225 ILKIEEILRS----EANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLE 296 (501)
T ss_pred cCcEeEEEEE----CCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 9999999876 34568999998 5688887754221 12345667889999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 012297 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435 (466)
Q Consensus 360 NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf 435 (466)
|||++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 297 NILl~~~~~vkL~DFGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 297 NIFLNCDGKIVLGDFGTAMPFEKERE----AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred HEEECCCCCEEEEeCCCceecCcccc----cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999987643221 1122356899999999999999999999999999999999987654
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=254.42 Aligned_cols=204 Identities=26% Similarity=0.314 Sum_probs=174.6
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|..+++||+|.||.|.+++-+ .++.+|+|+++.+--- .....-+.|-++|+..+||.+..|.-.+.. ....
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt----~drl 243 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT----QDRL 243 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc----CceE
Confidence 45677789999999999999765 5889999999877432 222335778999999999999988765544 5577
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||..||.|.-+|.+. +.+++.........|..||.|||+.+ |+.||||.+|+|+|.+|++||+|||+++..
T Consensus 244 CFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999999888754 56888888889999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 441 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~ 441 (466)
-..+ .....++||+.|+|||++....|....|.|-+||++|||+.|+.||...+.+
T Consensus 319 I~~g-----~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~ 374 (516)
T KOG0690|consen 319 IKYG-----DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE 374 (516)
T ss_pred cccc-----ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence 4443 3456789999999999999999999999999999999999999999865543
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=256.94 Aligned_cols=204 Identities=28% Similarity=0.397 Sum_probs=167.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
.++|+..+.||+|+||.||+|.+. +++.||+|.++..... .....+.+|+.++++++|+||+++++++.... ....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH--LDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC--CCeE
Confidence 356888899999999999999875 5899999998754322 22234678999999999999999999886522 2356
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999995 58998887533 56899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 159 GLPA-----KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred CCcc-----CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4321 11122335778999998865 55789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=289.48 Aligned_cols=208 Identities=25% Similarity=0.339 Sum_probs=178.4
Q ss_pred HHHHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeec
Q 012297 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293 (466)
Q Consensus 217 ~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~ 293 (466)
.++.--.++|.+.++||+|+||.|..++.+ .++.+|+|+++... ......-|.+|-++|..-+.+-|+.+.-.|.+
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD- 146 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD- 146 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC-
Confidence 445556688999999999999999999885 47899999997632 11223348889999999999999999877776
Q ss_pred cCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 012297 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 373 (466)
Q Consensus 294 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~D 373 (466)
..+.|+|||||+||+|..+|.... .+++.-+..++..|.-||.-||+.| +|||||||+|||||..|++||+|
T Consensus 147 ---~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 147 ---ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred ---ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeecc
Confidence 567899999999999999998764 5888888889999999999999999 99999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCCccccCcccccchhcc----c-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 374 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM----V-GRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 374 fGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
||.+-.+..+|.-. ....+|||.|++||++. + +.|++..|.||+||++|||+.|..||+.
T Consensus 219 FGsClkm~~dG~V~----s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVR----SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred chhHHhcCCCCcEE----eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 99998888776432 33468999999999884 3 6789999999999999999999999973
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=273.15 Aligned_cols=194 Identities=30% Similarity=0.463 Sum_probs=165.3
Q ss_pred ceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCC
Q 012297 230 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~ 308 (466)
-+||+|.+|+||-|++.+ ...+|||-+....+. ..+-+.+||.+-+.++|+|||+.+|.+.+ ++..-|.||-.|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~se----nGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSE----NGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCC----CCeEEEEeecCC
Confidence 369999999999998765 457899988655332 23347899999999999999999999877 457789999999
Q ss_pred CCCHHHHhcccccCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEEecCCccccccCCC
Q 012297 309 NGNLRDCLDGVLVEGM--NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 309 ~gsL~~~l~~~~~~~~--~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld-~~~~vkL~DfGla~~~~~~~~ 385 (466)
||+|.++|+..- .++ ++.++-...+||++||.|||++. |||||||-+|||++ -.|-+||+|||.++++..-
T Consensus 656 GGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-- 729 (1226)
T KOG4279|consen 656 GGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-- 729 (1226)
T ss_pred CCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--
Confidence 999999998653 345 77888889999999999999998 99999999999995 6789999999999886432
Q ss_pred CCCCCCCCccccCcccccchhcccC--CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
......+.||..|||||++..+ .|..++||||||+++.||.||++||..
T Consensus 730 ---nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 730 ---NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred ---CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence 2345668899999999999764 489999999999999999999999973
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=250.63 Aligned_cols=198 Identities=31% Similarity=0.434 Sum_probs=166.0
Q ss_pred ecccCcEEEEEEEEcC-CcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCC
Q 012297 232 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (466)
Q Consensus 232 LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~ 308 (466)
||.|+||.||++...+ ++.+++|.+..... ......+.+|++++++++|+||+++++.+.. ....++||||++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG----KKNLYLVMEYLP 76 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec----CcEEEEEEecCC
Confidence 6889999999999874 89999999875432 2344568899999999999999999988765 456799999999
Q ss_pred CCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCC--
Q 012297 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-- 386 (466)
Q Consensus 309 ~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~-- 386 (466)
+++|.+++.+. ..+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 77 ~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 77 GGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 99999999764 36899999999999999999999998 999999999999999999999999998765432110
Q ss_pred -CCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 387 -SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 387 -~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..........++..|++||.......+.++||||||+++|||++|+.||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 204 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE 204 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 0011223345778899999998888999999999999999999999999644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=260.57 Aligned_cols=208 Identities=25% Similarity=0.346 Sum_probs=172.4
Q ss_pred chHHHHHHhCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeee
Q 012297 215 SYSALEHATDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 292 (466)
Q Consensus 215 ~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~ 292 (466)
...++..++++|++.+.||+|+||.||++.. .+++.||+|++.... .......+.+|++++++++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456777889999999999999999999976 468899999987542 22234458889999999999999999998764
Q ss_pred ccC--cceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 012297 293 FRG--KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 370 (466)
Q Consensus 293 ~~~--~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vk 370 (466)
... .....+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 322 123467888887 8899988864 35899999999999999999999998 99999999999999999999
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 371 L~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
|+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 161 l~dfg~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 161 ILDFGLARHTDDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred Eeccccccccccc--------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999998764321 123457888999998766 5678899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=254.75 Aligned_cols=190 Identities=24% Similarity=0.386 Sum_probs=155.8
Q ss_pred ceecccCcEEEEEEEEcC--------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 230 NIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~--------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
+.||+|+||.||+|.... ...+++|.+.... ....+.|.+|+.+++.++|+|++++++++.. ....+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~----~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVC----GDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEe----CCCcE
Confidence 368999999999997642 2348888875432 3344568899999999999999999999876 33568
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--------EEEEe
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN--------AKITD 373 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~--------vkL~D 373 (466)
+||||+++|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. ++++|
T Consensus 76 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecc
Confidence 9999999999999997643 35899999999999999999999998 999999999999987765 69999
Q ss_pred cCCccccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCC-CCCCC
Q 012297 374 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGR-QPIHR 437 (466)
Q Consensus 374 fGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~-~Pf~~ 437 (466)
||++..... .....++..|+|||.+.. ..++.++||||||+++|||++|. .||..
T Consensus 152 ~g~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 152 PGISITVLP---------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred cccccccCC---------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 998865432 122456788999999876 45799999999999999999984 66543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=256.99 Aligned_cols=198 Identities=29% Similarity=0.403 Sum_probs=161.9
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcceeEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
|...+.||+|+||.||++... +++.+|+|.+...........+.+|+.++.++. |+||+++++++.. ....+++
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~----~~~~~~~ 81 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR----EGDCWIC 81 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec----CCcEEEE
Confidence 444578999999999999875 578999999876544445566899999999996 9999999998765 3456899
Q ss_pred EecCCCCCHHHHh---cccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 304 FEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 304 ~ey~~~gsL~~~l---~~~~~~~~~~~~~~~i~~qia~~L~~LH~~-~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
|||++ ++|.++. .......+++..+..++.|++.||+|||+. + ++||||||+||++++++.++|+|||+++.
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 99985 4655543 222235689999999999999999999975 6 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccC---CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVG---RASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
..... ......|+..|+|||.+... .++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 158 LVDSI------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred hccCC------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 54321 11223578889999998766 689999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=261.68 Aligned_cols=201 Identities=23% Similarity=0.360 Sum_probs=171.3
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCC-hhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
|...+.||+|.|..|-+|+.- .|..||||++....... ....+..|+..|+-++|||||+|+.+... ....|||
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT----QTKlyLi 95 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT----QTKLYLI 95 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc----cceEEEE
Confidence 555678999999999999643 69999999997764322 23448899999999999999999987543 5678999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCcccccc
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRLKA 382 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~-~~~vkL~DfGla~~~~~ 382 (466)
.|.-.+|+|.+|+.+.. .++.+..+.+++.||..|+.|+|... +|||||||+||.+-+ -|-|||+|||++..+.+
T Consensus 96 LELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999997643 56899999999999999999999998 999999999998865 47899999999987765
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSIT 440 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~Pf~~~~~ 440 (466)
. ......+|++.|-|||++.+..| .++.||||||||||-|+.|++||+....
T Consensus 172 G------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND 224 (864)
T KOG4717|consen 172 G------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND 224 (864)
T ss_pred c------chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc
Confidence 4 23455789999999999999988 5689999999999999999999986543
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=257.33 Aligned_cols=202 Identities=20% Similarity=0.263 Sum_probs=163.6
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEcccC-CCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecC
Q 012297 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~-~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~ 307 (466)
.+.+|.|+++.||++.. +++.||||++... ........+.+|+++++.++|+||+++++++.+ ....+++|||+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~----~~~~~~~~e~~ 81 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV----DSELYVVSPLM 81 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec----CCeEEEEEecc
Confidence 34455666666666655 6889999998765 234445569999999999999999999998876 44679999999
Q ss_pred CCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCC-
Q 012297 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP- 386 (466)
Q Consensus 308 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~- 386 (466)
++++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+......+..
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 9999999998655556899999999999999999999998 999999999999999999999999998765432211
Q ss_pred -CCCCCCCccccCcccccchhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 387 -SCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 387 -~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..........++..|+|||.+.. ..++.++|+||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11112233456788999999865 35788999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=254.83 Aligned_cols=209 Identities=27% Similarity=0.400 Sum_probs=170.3
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeecc----
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR---- 294 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~---- 294 (466)
...++|++.+.||+|+||.||+|... +++.|++|+++.... ......+.+|+++++.++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678889999999999999999885 588999999876532 233345788999999999999999999887643
Q ss_pred --CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 012297 295 --GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 372 (466)
Q Consensus 295 --~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~ 372 (466)
......++|+||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 112367999999975 787777653 346899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 373 DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|||++........ .......++..|+|||.+.. ..++.++||||||+++|||++|++||...
T Consensus 159 dfg~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 159 DFGLARLYNSEES----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred cccccccccCCcc----cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999987644321 11122345678999998764 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=252.47 Aligned_cols=202 Identities=27% Similarity=0.401 Sum_probs=167.6
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
|++.+.||+|++|.||+|... +++.+++|++.... .......+.+|++++++++|+|++++++++.+.. ....++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG--KGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC--CCcEEEE
Confidence 456788999999999999876 47899999998664 2333456889999999999999999999987632 2567999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||++ ++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 79 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 79 FEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 99997 58998886542 46899999999999999999999998 999999999999999999999999999876443
Q ss_pred CCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 154 ~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~ 205 (287)
T cd07840 154 NS----ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS 205 (287)
T ss_pred Cc----ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 11222346788999997764 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=254.69 Aligned_cols=192 Identities=25% Similarity=0.437 Sum_probs=165.0
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCC
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~ 308 (466)
..||+|+||.||++... +++.||||.+.... ......+.+|+.+++.++|+|++++++++.. ....++||||++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~ 100 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLV----GDELWVVMEFLE 100 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEe----CCEEEEEEecCC
Confidence 57999999999999874 68899999886432 3345568999999999999999999999876 456799999999
Q ss_pred CCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCC
Q 012297 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388 (466)
Q Consensus 309 ~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~ 388 (466)
+++|.+++.. ..+++..+..++.|++.+|+|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 101 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~---- 170 (292)
T cd06657 101 GGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---- 170 (292)
T ss_pred CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc----
Confidence 9999998854 35799999999999999999999998 9999999999999999999999999987653321
Q ss_pred CCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 389 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.......++..|+|||.+....++.++|+||||+++|||++|+.||..
T Consensus 171 -~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~ 218 (292)
T cd06657 171 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218 (292)
T ss_pred -ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 112234578899999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=245.90 Aligned_cols=205 Identities=26% Similarity=0.398 Sum_probs=174.2
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+|+..+.||+|++|.||+|... +++.+++|++..... ....+.+.+|++++++++|+||+++++.+.+.. ....++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE--KNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC--CCeEEE
Confidence 3667789999999999999886 688999999876542 234566899999999999999999999887632 256799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
|+||+++++|.+++... ..+++..+..++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 79 FLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999999764 37899999999999999999999988 99999999999999999999999999887654
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.... .......++..|+|||.+.....+.++||||||+++|+|++|..||....
T Consensus 154 ~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 154 IETG---EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccc---ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3210 01223457889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=251.94 Aligned_cols=206 Identities=29% Similarity=0.447 Sum_probs=173.7
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~ 299 (466)
++|...+.||+|++|.||++... +++.+++|++.... .......+.+|++++++++ |+||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~----~~~ 76 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD----EEN 76 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC----Cce
Confidence 36788899999999999999875 68999999987532 2233456889999999998 9999999998765 446
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~ 151 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKV 151 (280)
T ss_pred EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccc
Confidence 79999999999999999764 46999999999999999999999998 99999999999999999999999999886
Q ss_pred cccCCCCCC---------------CCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSC---------------SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
......+.. ........++..|+|||......++.++|+||||++++||++|+.||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 644322100 01223356788999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=257.70 Aligned_cols=207 Identities=23% Similarity=0.302 Sum_probs=167.7
Q ss_pred CCCCcceecccCcEEEEEEEEcC---CcEEEEEEcccCC-CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccee
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQG-GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~---~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~ 299 (466)
+|...+.||+|+||.||++.... +..||+|++.... .......+.+|+++++++ +|+||+++++.+.........
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 36677899999999999998753 6789999987542 222345688999999999 599999999876544333445
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++++||+. ++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 689999985 6999998653 56899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
........ ........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus 155 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 155 FSENPGEN-AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred cccccccc-cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 64432211 111233568899999998765 46899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=252.09 Aligned_cols=199 Identities=27% Similarity=0.368 Sum_probs=167.3
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcceeEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
|++.+.||+|++|.||+|... +++.|+||++.............+|+..+++++ |+|++++++++.+ ....++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~----~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE----NDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc----CCcEEEE
Confidence 456788999999999999986 478899999876544333444677999999999 9999999999876 4567999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+ +|+|.+++.......+++..++.++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9999 889999997654456899999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCCCCCCCccccCcccccchhcc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
. ......++..|+|||.+. ...++.++|+||||+++|||++|+.||...
T Consensus 153 ~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 153 P------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred C------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 1 112245678899999875 455789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=253.95 Aligned_cols=199 Identities=28% Similarity=0.479 Sum_probs=164.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|+..+.||+|++|.||+|...+ ++.||||+++..........+..|++++.+.. |+||+++++++.+ ....+
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~ 90 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT----DSDVF 90 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec----CCeEE
Confidence 557778899999999999999875 88999999976544444556778888777775 9999999999876 44679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
+||||++ ++|.+++.... ..+++..+..++.|+++||.|||+ .+ ++||||+|+||++++++.+||+|||++...
T Consensus 91 ~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 91 ICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 9999984 57877775532 468999999999999999999997 46 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCC----CCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGR----ASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
..... .....++..|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 166 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 166 VDSKA------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred cCCCc------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 33211 12234678899999986553 78899999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=254.95 Aligned_cols=211 Identities=27% Similarity=0.394 Sum_probs=168.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCC-hhHHHHHHHHHHHhcCCCCccceeeeeeeccC----c
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG----K 296 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~----~ 296 (466)
.++|++.+.||+|++|.||+|... +++.+++|++....... ....+.+|+++++.++|+||+++++++.+... .
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467888899999999999999875 57899999986543222 22347889999999999999999988765332 2
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGl 376 (466)
....++||||+. ++|.+.+... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 345799999995 5787777643 245999999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCC------CCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 377 AKRLKADGLPSC------SSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 377 a~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
++.......... ........+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 986543321110 111223456788999998765 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=245.44 Aligned_cols=202 Identities=27% Similarity=0.386 Sum_probs=173.1
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+|...+.||+|++|.||++... +++.+++|++..... ......+.+|+++++.++|+|++++++.+.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~----~~~~~l 76 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE----KGKLCI 76 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec----CCEEEE
Confidence 4677789999999999999875 588999999876543 2445568899999999999999999998776 357799
Q ss_pred EEecCCCCCHHHHhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 303 VFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
|+||+++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 153 (258)
T cd08215 77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL 153 (258)
T ss_pred EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeec
Confidence 999999999999997643 356899999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... .......|++.|+|||......++.++|+||||+++|+|++|+.||...
T Consensus 154 ~~~~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 154 SSTV-----DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred ccCc-----ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 4432 1122345788899999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=250.02 Aligned_cols=203 Identities=27% Similarity=0.405 Sum_probs=166.7
Q ss_pred CCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCC-ChhHHHHHHHHHHHhc---CCCCccceeeeeeeccC-ccee
Q 012297 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP-NADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFRG-KRAM 299 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l---~H~nIv~llg~~~~~~~-~~~~ 299 (466)
|++.+.||+|+||.||+|.... ++.+|+|++...... .....+.+|+++++++ +|+|++++++++..... ....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4567889999999999999864 899999999754322 2233466788877666 59999999999876432 2224
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.+++|||++ ++|.+++.......+++..++.++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 799999996 58999987654446899999999999999999999998 99999999999999999999999999877
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... .....++..|+|||.+....++.++|+||||+++|||++|++||...
T Consensus 157 ~~~~~~------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 157 YSFEMA------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred ccCCcc------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 643321 12234678899999999888999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=257.97 Aligned_cols=200 Identities=24% Similarity=0.359 Sum_probs=165.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--cce
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 298 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~--~~~ 298 (466)
..+|...+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++|+||+++++++..... ...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468888899999999999999864 68999999986542 22233458899999999999999999998865321 123
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++|+||+. .+|.+++. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 5689999995 47777653 35899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 166 HADAE--------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred CCCCC--------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 54221 123456788999998876 46889999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=283.05 Aligned_cols=207 Identities=29% Similarity=0.415 Sum_probs=165.6
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeee------
Q 012297 220 EHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE------ 292 (466)
Q Consensus 220 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~------ 292 (466)
.+...+|+..++||+||||.||+++++ ||+.+|||++...........+.+|+.++++|+|||||+++....+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 556677888899999999999999876 8999999999877655566668999999999999999998743222
Q ss_pred -------------------------------------------------c------------------------------
Q 012297 293 -------------------------------------------------F------------------------------ 293 (466)
Q Consensus 293 -------------------------------------------------~------------------------------ 293 (466)
.
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred -----------------------cC-------cceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHH
Q 012297 294 -----------------------RG-------KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343 (466)
Q Consensus 294 -----------------------~~-------~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~L 343 (466)
.. .....||-|||++.-+|+++++++... -.....++++++|+.||.|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHH
Confidence 00 013468889999998888888764321 14677889999999999999
Q ss_pred HhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc---c---------CCCCCCCC-CCCccccCcccccchhcccC
Q 012297 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK---A---------DGLPSCSS-SPARMQGTFGYFAPEYAMVG 410 (466)
Q Consensus 344 H~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~---~---------~~~~~~~~-~~~~~~gt~~y~aPE~~~~~ 410 (466)
|+++ ||||||||.||++|++..|||+|||++.... . ...+.... .....+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999998722 0 01111111 34457899999999998754
Q ss_pred ---CCCchhHHHHHHHHHHHHHc
Q 012297 411 ---RASLMSDVFSFGVVLLELIT 430 (466)
Q Consensus 411 ---~~s~~sDv~S~Gvll~ellt 430 (466)
.|+.|+|+|||||+|+||+.
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc
Confidence 49999999999999999985
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=247.73 Aligned_cols=191 Identities=26% Similarity=0.379 Sum_probs=158.1
Q ss_pred ceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHH-HhcCCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDML-SRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l-~~l~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|++|.||+|... +++.||+|++..... ......+..|..++ ...+|+|++++++++.. ....++|||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e 77 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS----KDYLYLVME 77 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc----CCeEEEEEe
Confidence 46899999999999874 588999999865421 11222344555444 45589999999999875 446799999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++++|.++++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++....
T Consensus 78 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 149 (260)
T cd05611 78 YLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--- 149 (260)
T ss_pred ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc---
Confidence 99999999999754 45899999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.....++..|+|||.+.+..++.++||||||+++|||++|..||...
T Consensus 150 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 150 ------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred ------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 12345778899999998888899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=243.99 Aligned_cols=200 Identities=29% Similarity=0.481 Sum_probs=171.8
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+|+..+.||+|++|.||++... +++.+++|.+...... .....+.+|++++++++|+|++++++++.+ ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET----SDSLYI 76 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe----CCEEEE
Confidence 4677789999999999999765 5789999998766432 344568999999999999999999998876 346799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++++|.+++... ..+++..+..++.|++.+|.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 77 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 77 ILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLND 151 (254)
T ss_pred EEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence 99999999999999764 56899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... ......++..|+|||.......+.++||||||+++|||++|+.||...
T Consensus 152 ~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~ 202 (254)
T cd06627 152 VSK-----DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL 202 (254)
T ss_pred Ccc-----cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence 321 123345788999999988877899999999999999999999999643
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=256.77 Aligned_cols=203 Identities=26% Similarity=0.343 Sum_probs=169.4
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChh--HHHHHHHHHHHhc-CCCCccceeeeeeeccCccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNAD--SVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~--~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~ 299 (466)
.+|....+||+|+||.|.+|.-+ ..+.+|||+++.+.--+.+ +--+.|-++|+-. +-|.++++..++.. ...
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT----mDR 424 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT----MDR 424 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh----hhh
Confidence 45677789999999999999654 3568999999876422221 1134566677666 46778888877765 446
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.|+||||+.||+|--++++. ..+.+..++-.|..||-||-|||+.+ |+.||||.+|||||.+|++||+|||+++.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 79999999999999988865 45888999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 440 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~ 440 (466)
.-.++ .....++||+.|+|||++..++|+...|.|||||+||||+.|++||+..++
T Consensus 500 ni~~~-----~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 500 NIFDG-----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred cccCC-----cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 54443 345668999999999999999999999999999999999999999987543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=257.23 Aligned_cols=205 Identities=24% Similarity=0.338 Sum_probs=169.6
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~ 296 (466)
+....++|+..+.||+|+||.||++... ++..||||++..... ......+.+|++++++++|+||+++++++......
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445678999999999999999999754 688999999865422 22334588999999999999999999988653321
Q ss_pred --ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 012297 297 --RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 374 (466)
Q Consensus 297 --~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~Df 374 (466)
....++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 13458999999 7899988864 45899999999999999999999998 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|++...... .....++..|+|||.+.. ..++.++|+||||+++|+|++|+.||...
T Consensus 163 g~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 163 GLARQTDSE--------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ccccccccC--------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 998765321 123356788999998875 45889999999999999999999999743
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=247.67 Aligned_cols=207 Identities=25% Similarity=0.342 Sum_probs=169.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-----CcEEEEEEcccCCCCCh-hHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNA-DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-----~~~vaVK~l~~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
..|+....||+|.+|.||+|.-.+ ...+|+|+++.+..... .....+|+.+++.++|+|++.|..++... +
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---d 100 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---D 100 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc---C
Confidence 457788899999999999995332 23799999987743322 33478999999999999999999988764 3
Q ss_pred eeEEEEEecCCCCCHHHHhccc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----CcEE
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGV---LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN----LNAK 370 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~----~~vk 370 (466)
...++++||.+. +|...++-. ..+.++......|+.||+.|+.|||++. |+||||||.|||+..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence 467999999965 888877432 2245888999999999999999999999 9999999999999877 8999
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 371 L~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
|+|||+++.+...-.|. .....++.|.+|.|||++.+. .||++.|||+.|||+.||+|-++-|....
T Consensus 177 IaDlGlaR~~~~plkpl--~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPL--ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred eecccHHHHhhcccccc--ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 99999999876543332 123446789999999998875 58999999999999999999999887543
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=253.30 Aligned_cols=195 Identities=29% Similarity=0.437 Sum_probs=163.1
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
|...+.||+|+||.||++... ++..+|+|.+...... .....+.+|++++++++|+|++++++++.+ ....++
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~l 102 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR----EHTAWL 102 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee----CCeEEE
Confidence 556688999999999999864 5889999998754322 233468899999999999999999999876 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 103 v~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 103 VMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred EEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 999996 5888777543 245899999999999999999999998 99999999999999999999999998865432
Q ss_pred CCCCCCCCCCCccccCcccccchhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.....++..|+|||.+. .+.++.++||||||+++|||++|+.||...
T Consensus 178 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 178 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred ---------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 12235778899999873 456889999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=256.27 Aligned_cols=201 Identities=25% Similarity=0.363 Sum_probs=162.2
Q ss_pred eeccc--CcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEec
Q 012297 231 IVGQG--GSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 231 ~LG~G--~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey 306 (466)
.||+| +||+||++.+. +++.||+|++...... ...+.+.+|+.+++.++|+||+++++++.. ....++||||
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----~~~~~~v~e~ 80 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT----GSWLWVISPF 80 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec----CCceEEEEec
Confidence 46666 99999999874 6899999998765322 233568889999999999999999999876 4467999999
Q ss_pred CCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCC
Q 012297 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 386 (466)
Q Consensus 307 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~ 386 (466)
+++++|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++++||+.+.........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999999998655556899999999999999999999998 999999999999999999999999865443222111
Q ss_pred C--CCCCCCccccCcccccchhcccC--CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 387 S--CSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 387 ~--~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
. .........++..|+|||++... .++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1 00111122356679999998763 4789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=245.47 Aligned_cols=200 Identities=30% Similarity=0.377 Sum_probs=170.2
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+|++.+.||+|++|.||++... +++.+++|.+.... .......+.+|++++++++|+||+++++++.+ ....++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD----GNKLCI 76 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc----CCEEEE
Confidence 4677789999999999999764 67899999987543 22334558899999999999999999988776 356799
Q ss_pred EEecCCCCCHHHHhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 303 VFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~ 153 (256)
T cd08530 77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL 153 (256)
T ss_pred EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhh
Confidence 999999999999986522 245899999999999999999999998 999999999999999999999999999776
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... .....++..|++||.+....++.++|+||||+++|||++|+.||...
T Consensus 154 ~~~~-------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 204 (256)
T cd08530 154 KKNM-------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204 (256)
T ss_pred ccCC-------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 4431 11234678899999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=251.16 Aligned_cols=200 Identities=26% Similarity=0.339 Sum_probs=165.5
Q ss_pred CCCCcceecccCcEEEEEEEE----cCCcEEEEEEcccCC---CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCc
Q 012297 225 KFSGSNIVGQGGSSYVYRGQL----TDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~----~~~~~vaVK~l~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~ 296 (466)
+|++.+.||+|++|.||++.. .+++.||||.++... .......+.+|+.++.++ +|+||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~---- 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT---- 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence 366778999999999999975 357889999987432 122334588999999999 59999999988765
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGl 376 (466)
....++||||+++++|.+++... ..+++..+..++.|++++|+|||+.+ ++||||+|+||++++++.++|+|||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~ 151 (288)
T cd05583 77 DTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGL 151 (288)
T ss_pred CCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcc
Confidence 44678999999999999998653 45889999999999999999999988 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCcccccchhcccCC--CCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
++....... .......|+..|+|||.+.+.. .+.++||||||+++|||++|..||..
T Consensus 152 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 152 SKEFLAEEE----ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccccc----cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 876543321 1122345788999999987655 78899999999999999999999953
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=256.47 Aligned_cols=205 Identities=25% Similarity=0.353 Sum_probs=168.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC-ccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~-~~~~ 299 (466)
..+|.+.+.||+|+||.||+|... +++.||||.+.... .......+.+|+.+++.++|+||+++++++..... ....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 356888899999999999999864 58899999987542 22334457889999999999999999998765322 1234
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 7899988753 45899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 158 TSEKG-----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred cCCCc-----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 54321 11223356788999998764 46889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=255.79 Aligned_cols=206 Identities=26% Similarity=0.349 Sum_probs=171.2
Q ss_pred CCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeecc-CcceeEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR-GKRAMRL 301 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~-~~~~~~~ 301 (466)
+|.+.+.||+|++|.||+|...+ ++.+++|++..... ....+.+.+|+++++.++|+||+++++++.... ......+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 46778899999999999998764 88999999876532 334456899999999999999999999887643 1223579
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||++ ++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 5899988754 36899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... ........++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...
T Consensus 155 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 155 PDEDE--KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred ccccc--cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 43210 0112234578889999999877 7899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=254.10 Aligned_cols=201 Identities=25% Similarity=0.359 Sum_probs=167.6
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 220 EHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 220 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
..++++|+..+.||+|+||.||++... +++.||+|++.... .......+.+|++++++++||||+++++++... .
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~ 82 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP---L 82 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC---C
Confidence 346788999999999999999999865 68899999876432 233345688999999999999999999987642 2
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++
T Consensus 83 ~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 83 EDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred CcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence 3568999998 6799988864 34788888999999999999999998 999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 156 RIQDPQ--------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred cccCCC--------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 754221 122356788999998765 56899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=253.88 Aligned_cols=205 Identities=25% Similarity=0.368 Sum_probs=164.4
Q ss_pred CCCC-CcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCC-------------hhHHHHHHHHHHHhcCCCCccceee
Q 012297 224 DKFS-GSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-------------ADSVFLTEVDMLSRLHHCHVVPLVG 288 (466)
Q Consensus 224 ~~f~-~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~-------------~~~~f~~Ei~~l~~l~H~nIv~llg 288 (466)
++|. ..+.||+|+||.||+|.+. +++.||||.+....... ....+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3444 3467999999999999865 58899999986543222 1124778999999999999999999
Q ss_pred eeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 012297 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 368 (466)
Q Consensus 289 ~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~ 368 (466)
++.. ....++||||++ |+|.+++... ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.
T Consensus 88 ~~~~----~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 88 VYVE----GDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGI 157 (335)
T ss_pred EEec----CCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCC
Confidence 9875 446799999996 6999998653 45899999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccccCCCC---------CCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 369 AKITDLGMAKRLKADGLP---------SCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 369 vkL~DfGla~~~~~~~~~---------~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
++|+|||++......... ..........++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999866421110 001111223467889999988764 4689999999999999999999999754
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=247.95 Aligned_cols=195 Identities=30% Similarity=0.454 Sum_probs=162.8
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
|...+.||+|+||.||+|+.. +++.|++|.+...... .....+.+|+++++.++|+|++++++++.+ ....++
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 98 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK----EHTAWL 98 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe----CCEEEE
Confidence 555678999999999999874 5889999998754332 233458899999999999999999999876 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||++ |+|.+++... ...+++.+++.++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 99 v~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 99 VMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173 (313)
T ss_pred EEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence 999995 6888877643 245899999999999999999999998 99999999999999999999999998864321
Q ss_pred CCCCCCCCCCCccccCcccccchhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.....|+..|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 174 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 174 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred ---------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 12346788999999874 456888999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=226.45 Aligned_cols=201 Identities=25% Similarity=0.398 Sum_probs=167.1
Q ss_pred CCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCCh-hHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNA-DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+|...++||+|.+|+||+|+..+ ++.||+|+++.+...+. -...++|+-+++.++|+|||+++++... +...-+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs----dkkltl 78 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----DKKLTL 78 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc----CceeEE
Confidence 34555789999999999998754 78999999987643322 2347899999999999999999988765 556789
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
|+||+ ..+|..|.+..+ ..++......++.|+++||.|.|+++ +.||||||.|+||+.+|++|++|||+++.+.-
T Consensus 79 vfe~c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 79 VFEFC-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred eHHHh-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 99999 679999998754 45899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCC-CCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELIT-GRQPIHRSI 439 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~S~Gvll~ellt-G~~Pf~~~~ 439 (466)
. .......+.|.+|.+|.++.+.. |++..|+||-|+++.|+.. |++.|...+
T Consensus 154 p-----vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 154 P-----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred c-----eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 2 12233346789999999988755 7999999999999999997 666665543
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=246.32 Aligned_cols=199 Identities=26% Similarity=0.387 Sum_probs=167.3
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
|+..+.||+|++|.||++... +++.+++|++...... .....+.+|++++++++|+||+++++++.. ....++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH----KGDLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc----CCCEEEE
Confidence 455678999999999999875 6889999998765432 344568899999999999999999998775 3567999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++ +|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 77 ~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 77 FEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred EeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 999964 8988887643 46899999999999999999999998 999999999999999999999999998776443
Q ss_pred CCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. ......++..|+|||.+... .++.++|+||||+++|+|++|+.||...
T Consensus 152 ~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 202 (283)
T cd05118 152 VR-----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK 202 (283)
T ss_pred cc-----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 11223467889999988776 7899999999999999999999999654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=258.66 Aligned_cols=201 Identities=24% Similarity=0.360 Sum_probs=167.5
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccC-CCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~-~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~~~ 301 (466)
..|++.+.||.||.+.||++...+.+.+|+|++... .+.+...-|.+|+++|.+|+ |.+|++|++|-.. +...|
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~----d~~lY 436 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT----DGYLY 436 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc----CceEE
Confidence 456778899999999999999988888998887654 34445556999999999995 9999999998665 56889
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||- ..+|..+|++.......| .+..+..|++.++.+.|.++ |||.||||.|+|+-. |.+||+|||.|..+.
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred EEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 999976 779999998765443445 67788999999999999999 999999999999964 689999999999887
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCC-----------CCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-----------ASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.+-.. ......+||+.||+||.+.... .++++||||+|||||+|+.|+.||..
T Consensus 511 ~DTTs---I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 511 PDTTS---IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred ccccc---eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 76432 2334468999999999885322 46789999999999999999999973
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=246.50 Aligned_cols=199 Identities=28% Similarity=0.414 Sum_probs=166.7
Q ss_pred CCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
|+..+.||+|++|.||+|+..+ ++.+++|.+.... .......+..|+++++.++|+|++++++++.+ ....++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT----ERKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc----CCceEEE
Confidence 4556789999999999998764 8999999988654 22334557889999999999999999998876 3567999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.++.....
T Consensus 77 ~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 77 FEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred ecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 99997 59999997643 45899999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. ......++..|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 152 ~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 152 LR-----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred cc-----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 21 11223356789999998766 7899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=267.06 Aligned_cols=198 Identities=22% Similarity=0.355 Sum_probs=165.4
Q ss_pred CCCcceecccCcEEEEEEEEcCCcE-EEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLTDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~~~~~-vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
|.+...||.|+||.||+|..++... .|-|++... .....++|+-||++|+..+||+||+|++.+.. ....|+..
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~----enkLwili 108 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYF----ENKLWILI 108 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc----cCceEEEE
Confidence 4445678999999999998876444 455666554 34555679999999999999999999986654 34679999
Q ss_pred ecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCC
Q 012297 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~ 384 (466)
||++||-.+..+-.. .+.++..++..+..|++.||.|||++. |||||||+.|||++-+|.++|+|||.+......
T Consensus 109 EFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t- 183 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST- 183 (1187)
T ss_pred eecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-
Confidence 999999998877543 367999999999999999999999998 999999999999999999999999998654332
Q ss_pred CCCCCCCCCccccCcccccchhc-----ccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYA-----MVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
......+.||+.|||||+. ...+|+.++||||||++|.||..+.+|.+.
T Consensus 184 ----~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 184 ----RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred ----HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 1234457899999999976 467899999999999999999999999764
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=254.51 Aligned_cols=205 Identities=22% Similarity=0.339 Sum_probs=164.9
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc------
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK------ 296 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~------ 296 (466)
.+|...+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|++++++++|+||+++++++......
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 57888899999999999999875 588999999876543 3445688999999999999999999876643221
Q ss_pred ----ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEE
Q 012297 297 ----RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKI 371 (466)
Q Consensus 297 ----~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld-~~~~vkL 371 (466)
....++||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++ +++.++|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 124689999996 599888864 35889999999999999999999998 99999999999997 4567899
Q ss_pred EecCCccccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 372 ~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+|||+++........ ........++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 157 ~dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 157 GDFGLARIVDPHYSH--KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred CCcccceecCCcccc--ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999765332111 111122356788999997654 56788999999999999999999999644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=239.39 Aligned_cols=193 Identities=32% Similarity=0.438 Sum_probs=165.4
Q ss_pred ecccCcEEEEEEEEc-CCcEEEEEEcccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCC
Q 012297 232 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (466)
Q Consensus 232 LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~ 308 (466)
||+|++|.||++... +++.+++|.+...... .....+.+|++++++++|+||+++++.+.. ....++||||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~v~e~~~ 76 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT----EEKLYLVLEYAP 76 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec----CCeeEEEEecCC
Confidence 689999999999876 4889999998765332 234468899999999999999999988765 456799999999
Q ss_pred CCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCC
Q 012297 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388 (466)
Q Consensus 309 ~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~ 388 (466)
+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---- 147 (250)
T cd05123 77 GGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---- 147 (250)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC----
Confidence 99999999754 35899999999999999999999988 9999999999999999999999999997764321
Q ss_pred CCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 389 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 389 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......++..|++||.......+.++|+||||+++|||++|+.||...
T Consensus 148 -~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 196 (250)
T cd05123 148 -SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196 (250)
T ss_pred -CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 1123345788899999998888899999999999999999999999643
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=249.27 Aligned_cols=196 Identities=29% Similarity=0.429 Sum_probs=162.9
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.|+..+.||+|+||.||+|... +++.+++|.+.... .......+.+|+++++.++|+|++++++++.. ....+
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 91 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----EHTAW 91 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc----CCeeE
Confidence 3566678999999999999875 57889999886532 22233458899999999999999999999876 34679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+. |+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++....
T Consensus 92 lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 9999996 68888775432 45899999999999999999999998 9999999999999999999999999987653
Q ss_pred cCCCCCCCCCCCccccCcccccchhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. ....++..|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 167 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 167 PA---------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred Cc---------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 22 2235778899999874 356788999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=235.40 Aligned_cols=199 Identities=28% Similarity=0.458 Sum_probs=166.4
Q ss_pred CcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcceeEEEEEe
Q 012297 228 GSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 228 ~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
....||.|..|+|++++... |...|||.+.........++++..++++.+-+ .|.||+.+|||.. +...++.||
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~----n~dV~IcMe 171 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT----NTDVFICME 171 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee----CchHHHHHH
Confidence 34679999999999998764 88999999998887777788888888877664 8999999999987 334478899
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
.| ..-++.+|.. ..+++++.-+-++...+.+||.||.+++ .|+|||+||+|||+|+.|++||+|||++-++..+
T Consensus 172 lM-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-- 245 (391)
T KOG0983|consen 172 LM-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-- 245 (391)
T ss_pred HH-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc--
Confidence 88 3455666554 3356888888899999999999998766 5999999999999999999999999999876543
Q ss_pred CCCCCCCCccccCcccccchhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSIT 440 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~ 440 (466)
.....-.|.+.|||||.+. ...|+.++||||||+.|+||.||+.||.....
T Consensus 246 ----kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t 299 (391)
T KOG0983|consen 246 ----KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT 299 (391)
T ss_pred ----cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc
Confidence 3445567889999999885 45689999999999999999999999987544
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=242.04 Aligned_cols=200 Identities=24% Similarity=0.305 Sum_probs=162.0
Q ss_pred CCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCC----CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG----GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~----~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
+|.+.+.||+|+||.||++.... +..+++|.++... .......+..|+.++++++||||+++++++.+ ...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE----RDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc----CCc
Confidence 46777899999999999998754 3445566554321 22333457789999999999999999998765 345
Q ss_pred EEEEEecCCCCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 300 RLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
.++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.++|+|||++
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~ 152 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVS 152 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCce
Confidence 79999999999999988642 2346899999999999999999999998 999999999999975 56999999998
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
....... .......++..|+|||.+....++.++|+||||+++|+|++|..||..
T Consensus 153 ~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 153 RLLMGSC-----DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred eecCCCc-----ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 7653321 112234578889999999888889999999999999999999999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-31 Score=252.98 Aligned_cols=209 Identities=31% Similarity=0.422 Sum_probs=171.5
Q ss_pred CCCCCcceecccCcEEEEEEE-EcCCcEEEEEEcccCCCCCh------hHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNA------DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~-~~~~~~vaVK~l~~~~~~~~------~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~ 296 (466)
++|-.+++||+|+|+.||+|. +.+++.||||+-........ .+...+|.++-+.|+||-||++++|+.-..
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt-- 540 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT-- 540 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc--
Confidence 456677899999999999995 45688999998655433222 223678899999999999999999987633
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEe
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITD 373 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~---~~~vkL~D 373 (466)
...+-|+||++|-+|+-||+.. +.+++.++..|+.||..||.||.+.. |||+|-||||.||||.. -|.+||+|
T Consensus 541 -dsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 -DSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred -ccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 3458899999999999999865 56999999999999999999999874 77999999999999954 47899999
Q ss_pred cCCccccccCCCCCC--CCCCCccccCcccccchhcccC----CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 374 LGMAKRLKADGLPSC--SSSPARMQGTFGYFAPEYAMVG----RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 374 fGla~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
||+++....+.+... ........||.+|++||.+..+ ..+.|.||||.|||+|..+.|+.||-..
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 999998876554321 1234557899999999988643 3688999999999999999999999654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=254.17 Aligned_cols=195 Identities=26% Similarity=0.356 Sum_probs=167.3
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEec
Q 012297 229 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey 306 (466)
.+.||.|.||+||-|+.+ +|+.||||++....- .+.+..+.+|+.+|.+++||.||.+---|.. .+..++|||-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET----~ervFVVMEK 644 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET----PERVFVVMEK 644 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC----CceEEEEehh
Confidence 378999999999999865 699999999977643 3344568999999999999999999877765 5567999999
Q ss_pred CCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEecCCccccccC
Q 012297 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKITDLGMAKRLKAD 383 (466)
Q Consensus 307 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~---~~vkL~DfGla~~~~~~ 383 (466)
+ +|++.+.+-......+++.....++.||+.||.|||.++ |+|.||||+|||+... -++||+|||.|+.+.+.
T Consensus 645 l-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 645 L-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred h-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 9 667777665444456888888899999999999999999 9999999999999644 46999999999998764
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
. .....+||+.|+|||++....|+..-|+||.|||+|--++|..||..
T Consensus 721 s------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 721 S------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred h------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 3 34567899999999999999999999999999999999999999963
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-31 Score=284.35 Aligned_cols=212 Identities=30% Similarity=0.388 Sum_probs=174.1
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~ 296 (466)
+...+-+++....||.|.||.||.|.. ++|.-.|+|-++.... ........+|+.++..++|||+|+.+|+-..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH---- 1305 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH---- 1305 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec----
Confidence 455667788889999999999999975 4688899998875532 3344558899999999999999999998665
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGl 376 (466)
+...+|.|||+++|+|.+.++... -.++.....+-.|++.|+.|||+.+ ||||||||.||||+.+|.+|++|||.
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccc
Confidence 445689999999999999997643 3556666677899999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCcccccchhcccC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 012297 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG---RASLMSDVFSFGVVLLELITGRQPIHRSIT 440 (466)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDv~S~Gvll~elltG~~Pf~~~~~ 440 (466)
|..+...... ....-....||+.|||||.+.+. ....++||||+||+++||+||+.||...+.
T Consensus 1381 a~ki~~~~~~-~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1381 AVKIKNNAQT-MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred eeEecCchhc-CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 9887654211 11233457899999999999653 356789999999999999999999975543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=240.53 Aligned_cols=202 Identities=26% Similarity=0.316 Sum_probs=171.1
Q ss_pred HhCCCCCc-ceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHh-cCCCCccceeeeeeeccCcce
Q 012297 222 ATDKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSR-LHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 222 ~t~~f~~~-~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~-l~H~nIv~llg~~~~~~~~~~ 298 (466)
.+++|++. ++||-|-.|.|-.+..+ .++.+|+|++... ++ ..+|+++--. -.|+|||.+++++........
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--~K----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--PK----ARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--HH----HHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 45666654 57999999999999764 5888999998754 22 4678876433 469999999999988777788
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEEecC
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLG 375 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld---~~~~vkL~DfG 375 (466)
..++|||.|+||.|.+.+++...+.+++.++..|..||+.|+.|||+.+ |.||||||+|+|.. .|-.+||+|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 8899999999999999999887788999999999999999999999999 99999999999995 45569999999
Q ss_pred CccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+|+.-...+ .....+-|+.|.|||++-...|+...|+||+||++|-|+.|.+||...
T Consensus 210 FAK~t~~~~------~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~ 266 (400)
T KOG0604|consen 210 FAKETQEPG------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_pred cccccCCCc------cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence 998754322 123345689999999999888999999999999999999999999754
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=255.64 Aligned_cols=219 Identities=22% Similarity=0.321 Sum_probs=174.1
Q ss_pred CCCCcceecccCcEEEEEEE-EcCCcEEEEEEcccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~-~~~~~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
-|...+.||-|+||.|.++. .+....+|.|.++...-.. .......|-++|..-+.+-||+|+-.|.+ +..+|
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD----kdnLY 705 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD----KDNLY 705 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc----CCceE
Confidence 35567789999999999995 4446678999887653211 12236678899999999999999987776 56789
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||+|++||++-.+|-+. .-|.+..+...+..+..|+++.|+.| +|||||||+|||||.+|++||+||||+.-+.
T Consensus 706 FVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccce
Confidence 999999999999998653 45788888888899999999999999 9999999999999999999999999986432
Q ss_pred c--------CCCCCCCC-----------------------------CCCccccCcccccchhcccCCCCchhHHHHHHHH
Q 012297 382 A--------DGLPSCSS-----------------------------SPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVV 424 (466)
Q Consensus 382 ~--------~~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvl 424 (466)
. .+...... .-...+||+.|+|||++....++.-.|.||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 1 01000000 0112469999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCC-ChhhHHHHHHH
Q 012297 425 LLELITGRQPIHRSITK-GEESLVLWVKS 452 (466)
Q Consensus 425 l~elltG~~Pf~~~~~~-~~~~l~~~~~~ 452 (466)
||||+.|++||...... .+..+..|..-
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~ 889 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRNF 889 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhhc
Confidence 99999999999875543 35667777654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=251.04 Aligned_cols=202 Identities=27% Similarity=0.382 Sum_probs=167.2
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--cc
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KR 297 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~--~~ 297 (466)
..++|+..+.||+|++|.||+|... +++.||||++.... .......+.+|+.++++++|+|++++++++..... ..
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4567888899999999999999875 57899999986542 22233457889999999999999999987654221 12
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 2479999998 6799999875 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 166 RHTDDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred cccccc--------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 765322 122356788999998765 46789999999999999999999999643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-31 Score=241.30 Aligned_cols=196 Identities=27% Similarity=0.380 Sum_probs=161.4
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeEEEEEec
Q 012297 229 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~~lV~ey 306 (466)
+..||.|+||+|+|-..+ .|+..|||+++.......+.+++.|.+...+- +-||||+++|.+.. ++..|+.||.
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~----EGdcWiCMEL 144 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS----EGDCWICMEL 144 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc----CCceeeeHHH
Confidence 457999999999999765 58999999999887777788899999875554 79999999998776 4466999999
Q ss_pred CCCCCHHHHh---cccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 307 MPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 307 ~~~gsL~~~l---~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
| ..+|+.+- .......+++.-.-.|..-...||.||-+.. .|+|||+||+|||||..|.+||+|||.+-.+..+
T Consensus 145 M-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 M-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred H-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 9 66776554 2233345788888888889999999998754 5999999999999999999999999998766432
Q ss_pred CCCCCCCCCCccccCcccccchhcc--cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAM--VGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.......|...|||||.+. ...|..+|||||||++|||+.||+.|+..
T Consensus 222 ------iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 222 ------IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred ------HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 2233456778899999885 33589999999999999999999999864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=264.95 Aligned_cols=146 Identities=26% Similarity=0.356 Sum_probs=127.8
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+.+.||+|+||.||+|.+. +++.||||+++.... ......+.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----~~~~ 79 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS----ANNV 79 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE----CCEE
Confidence 56788899999999999999876 588999999875432 2223558899999999999999999988765 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 80 ~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999999754 45889999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=234.99 Aligned_cols=180 Identities=21% Similarity=0.225 Sum_probs=151.4
Q ss_pred cCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCCCCCHH
Q 012297 235 GGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLR 313 (466)
Q Consensus 235 G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~ 313 (466)
|.+|.||++.+. +++.+|+|++.... .+.+|...+....||||+++++++.+ ....++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVS----EDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheec----CCeEEEEEecCCCCCHH
Confidence 899999999875 57899999987642 23455555666679999999998775 44679999999999999
Q ss_pred HHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCC
Q 012297 314 DCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393 (466)
Q Consensus 314 ~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~ 393 (466)
+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++++|||.+...... ..
T Consensus 74 ~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--------~~ 140 (237)
T cd05576 74 SHISKF--LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--------CD 140 (237)
T ss_pred HHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc--------cc
Confidence 998654 45899999999999999999999998 999999999999999999999999987655332 11
Q ss_pred ccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 394 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 394 ~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
...++..|+|||......++.++||||+|+++|||++|+.||..
T Consensus 141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 22346679999999888889999999999999999999988764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=224.56 Aligned_cols=208 Identities=26% Similarity=0.365 Sum_probs=168.8
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCc
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~ 296 (466)
++...+.......||+|++|.|-+-++ .+|...|||++...-..+..+..+.|+++..+- ..|.+|.++|...+
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r---- 116 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR---- 116 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc----
Confidence 444455555567899999999988876 479999999999887777777788999886655 68999999996654
Q ss_pred ceeEEEEEecCCCCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 374 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~Df 374 (466)
....++.||.| ..+|+.+-.+. ....+++..+-+||..+.+||.|||++- .++|||+||+||||+.+|++|++||
T Consensus 117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccc
Confidence 44569999999 67887776432 2245888889999999999999999976 5999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCCccccCcccccchhcc----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM----VGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
|.+-.+..+ .......|...|||||.+. ...|+-++||||||+++.||.+++.||..-.
T Consensus 194 GIsG~L~dS------iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 194 GISGYLVDS------IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ccceeehhh------hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 998766432 1222245778899999875 3468999999999999999999999997543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=254.63 Aligned_cols=207 Identities=23% Similarity=0.348 Sum_probs=154.4
Q ss_pred hCCCCCcceecccCcEEEEEEEE-----------------cCCcEEEEEEcccCCCCC-------------hhHHHHHHH
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL-----------------TDGRIVAVKRFKTQGGPN-------------ADSVFLTEV 272 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~-----------------~~~~~vaVK~l~~~~~~~-------------~~~~f~~Ei 272 (466)
.++|.+.++||+|+||.||+|.+ .+++.||||++....... ..+.+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999964 235689999987543211 111234577
Q ss_pred HHHHhcCCCCc-----cceeeeeeeccC----cceeEEEEEecCCCCCHHHHhccccc----------------------
Q 012297 273 DMLSRLHHCHV-----VPLVGYCSEFRG----KRAMRLLVFEFMPNGNLRDCLDGVLV---------------------- 321 (466)
Q Consensus 273 ~~l~~l~H~nI-----v~llg~~~~~~~----~~~~~~lV~ey~~~gsL~~~l~~~~~---------------------- 321 (466)
.++.+++|.++ ++++++|..... .....+|||||+++++|.++++....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77788876654 678888764321 13457999999999999999864211
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCccc
Q 012297 322 EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401 (466)
Q Consensus 322 ~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y 401 (466)
..+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++........ .......+++.|
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~----~~~~~g~~tp~Y 376 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN----FNPLYGMLDPRY 376 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc----cCccccCCCcce
Confidence 12467788999999999999999998 99999999999999999999999999976533211 111223347899
Q ss_pred ccchhcccCCC----------------------CchhHHHHHHHHHHHHHcCCC-CCC
Q 012297 402 FAPEYAMVGRA----------------------SLMSDVFSFGVVLLELITGRQ-PIH 436 (466)
Q Consensus 402 ~aPE~~~~~~~----------------------s~~sDv~S~Gvll~elltG~~-Pf~ 436 (466)
+|||.+..... ..+.||||+||++|||++|.. ||.
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 99998753221 234699999999999999886 664
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=233.28 Aligned_cols=202 Identities=24% Similarity=0.349 Sum_probs=171.5
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCC--ChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcc
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP--NADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~ 297 (466)
..++|....+||+|++..|..+++.. .+.+|+|+++.+--. +...=...|-.++.+- +||.+|-+..++.. .
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt----e 323 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT----E 323 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc----c
Confidence 45678889999999999999998764 678999998866321 1112245676677665 79999999887765 5
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++|.||.++|+|--+++++ +.+++.++......|.-||.|||+.+ |+.||||.+|||+|.+|++||+|||++
T Consensus 324 srlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmc 398 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMC 398 (593)
T ss_pred ceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchh
Confidence 5779999999999998777654 56999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
+..-.++ .....++||+.|+|||++.+..|....|.|+|||+++||+.|+.||+-
T Consensus 399 ke~l~~g-----d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 399 KEGLGPG-----DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred hcCCCCC-----cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 8654332 346678999999999999999999999999999999999999999973
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-28 Score=224.82 Aligned_cols=200 Identities=30% Similarity=0.418 Sum_probs=169.1
Q ss_pred CCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
|...+.||+|++|.||++...+ ++.+++|.+...........+.+|++.+++++|+|++++++++.. ....++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~----~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED----PEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec----CCceEEEE
Confidence 4556789999999999999875 889999998865433245678999999999999999999998765 34679999
Q ss_pred ecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCC
Q 012297 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~ 384 (466)
||+++++|.+++..... .+++.....++.+++.++.+||+.+ ++|+||+++||+++.++.++|+|||.+.......
T Consensus 77 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 77 EYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred eccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 99999999999976432 1799999999999999999999998 9999999999999999999999999988764432
Q ss_pred CCCCCCCCCccccCcccccchhc-ccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYA-MVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
. .......++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 153 ~----~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 A----ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred c----ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0 012234567889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=256.00 Aligned_cols=214 Identities=27% Similarity=0.425 Sum_probs=181.8
Q ss_pred chHHHHHHhCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeee
Q 012297 215 SYSALEHATDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292 (466)
Q Consensus 215 ~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~ 292 (466)
.++.+...++.|.+.+.||.|.+|.||+++. ++++.+|+|++......+ ++...|.++++.. +|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3455566677788889999999999999975 468899999988775443 4467888999888 69999999998764
Q ss_pred c-cCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 012297 293 F-RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 371 (466)
Q Consensus 293 ~-~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL 371 (466)
. ...+.+.|||||||.+|+..++++......+.|..+..|++.+++|+.+||+.. ++|||||-.|||++.++.|||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 2 344568999999999999999998877778999999999999999999999988 999999999999999999999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCcccccchhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 372 ~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.|||.+..+... ........||+.|||||++. ...|+..+|+||||++..||--|.+|+-.+
T Consensus 165 vDFGvSaQldsT-----~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 165 VDFGVSAQLDST-----VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred eeeeeeeeeecc-----cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 999999877543 22344568999999999885 345788999999999999999999998643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=245.44 Aligned_cols=198 Identities=22% Similarity=0.307 Sum_probs=167.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCCh----hH---HHHHHHHHHHhcC---CCCccceeeeeee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNA----DS---VFLTEVDMLSRLH---HCHVVPLVGYCSE 292 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~----~~---~f~~Ei~~l~~l~---H~nIv~llg~~~~ 292 (466)
..|+..+.+|+|+||.|++|.++. ...|+||++..+.-... ++ -.-.||.+|..++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 457888999999999999998865 56789999876531110 00 1456999999997 9999999999987
Q ss_pred ccCcceeEEEEEecC-CCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 012297 293 FRGKRAMRLLVFEFM-PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 371 (466)
Q Consensus 293 ~~~~~~~~~lV~ey~-~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL 371 (466)
...+||+||-. ++.+|.++++.. ..+++.++..|++|++.|+++||+++ |+|||||-+||.+|.+|-+||
T Consensus 641 ----dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 641 ----DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred ----CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEE
Confidence 56789999875 567999999865 56999999999999999999999999 999999999999999999999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCcccccchhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 372 ~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
+|||.+...... ....++||..|.|||++.+..| ...-|||++|++||.++..+.||..
T Consensus 712 idfgsaa~~ksg-------pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 712 IDFGSAAYTKSG-------PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eeccchhhhcCC-------CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999998765432 2345789999999999998887 6678999999999999999999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=255.35 Aligned_cols=203 Identities=22% Similarity=0.268 Sum_probs=141.8
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcC-----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeee-ec-c
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS-EF-R 294 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~~-----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~-~~-~ 294 (466)
..++|...+.||+|+||.||+|++.+ +..||||++..... .+.+..| .+....+.++..++..+. .. .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 45678899999999999999998754 68999998764321 1111211 122222333333222111 11 1
Q ss_pred CcceeEEEEEecCCCCCHHHHhcccccC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 012297 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVE------------------GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356 (466)
Q Consensus 295 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~------------------~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDL 356 (466)
......++||||+++++|.+++...... ......+..++.|++.||+|||+.+ |+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 2345679999999999999998643210 0123345679999999999999998 999999
Q ss_pred CCCCEEEcC-CCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccC----------------------CCC
Q 012297 357 KSSNILLDE-NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG----------------------RAS 413 (466)
Q Consensus 357 k~~NILld~-~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s 413 (466)
||+|||+++ ++.+||+|||+++....... .......+++.|+|||.+... .++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~----~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN----YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccc----cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 999999986 57999999999986543221 123346788999999965322 234
Q ss_pred chhHHHHHHHHHHHHHcCCCCCC
Q 012297 414 LMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 414 ~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
.++|||||||+||||+++..|+.
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCc
Confidence 46699999999999999877754
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-29 Score=246.81 Aligned_cols=201 Identities=22% Similarity=0.321 Sum_probs=172.6
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCc-EEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGR-IVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~-~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
.++.....||-|+||.|=+....... .+|+|.++... ....++....|-++|...+.+.||+++-.+.+ ....
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd----~kyv 495 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD----SKYV 495 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc----chhh
Confidence 34445567899999999999876544 48888887653 33344557889999999999999999977665 5567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
|+.||-+-||.|...|+.. ..|+..+...++..+.+|++|||..+ |+.|||||+|++||.+|-+||.|||+|+.+
T Consensus 496 YmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHh
Confidence 8999999999999999865 56899999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.... ..-.++||+.|.|||++.....+...|.||||+++|||++|.+||...+
T Consensus 571 ~~g~------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d 623 (732)
T KOG0614|consen 571 GSGR------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD 623 (732)
T ss_pred ccCC------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence 6542 3345899999999999999999999999999999999999999998643
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=221.50 Aligned_cols=187 Identities=33% Similarity=0.489 Sum_probs=162.7
Q ss_pred CcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCCCCCHHH
Q 012297 236 GSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD 314 (466)
Q Consensus 236 ~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~ 314 (466)
+||.||+|...+ ++.+++|++...........+.+|++.+++++|+|++++++++.. ....++++||+++++|.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED----EDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee----CCEEEEEEeCCCCCCHHH
Confidence 589999999864 899999999876544435679999999999999999999999876 356799999999999999
Q ss_pred HhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCc
Q 012297 315 CLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394 (466)
Q Consensus 315 ~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~ 394 (466)
++.... .+++..++.++.++++++.+||+.+ ++|+||+|+||++++++.++|+|||.+....... ....
T Consensus 77 ~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~------~~~~ 145 (244)
T smart00220 77 LLKKRG--RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG------LLTT 145 (244)
T ss_pred HHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc------cccc
Confidence 997642 3899999999999999999999998 9999999999999999999999999998765432 1223
Q ss_pred cccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 395 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 395 ~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
..++..|++||.+....++.++||||||+++|+|++|..||..
T Consensus 146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4567889999999888899999999999999999999999975
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-29 Score=229.36 Aligned_cols=209 Identities=24% Similarity=0.361 Sum_probs=167.6
Q ss_pred CCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCC-hhHHHHHHHHHHHhcCCCCccceeeeeeeccC----ccee
Q 012297 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG----KRAM 299 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~----~~~~ 299 (466)
|....+||+|.||.||+|+..+ ++.||+|++..+.... .-...++|+++|..++|+|++.++..|..... .+..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 3445689999999999998654 6778888765432221 12236899999999999999999988865332 3345
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||++++. +|...|... ...++..++..+..++..||.|+|... |+|||+||.|+||+.++.+||+|||+++.
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 7999999954 888888653 356999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSIT 440 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~ 440 (466)
+....... .....+.+.|.+|.+||.+.+ +.++++.|||.-|+++.||+|+.+-|+....
T Consensus 174 fs~~~n~~-kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte 234 (376)
T KOG0669|consen 174 FSTSKNVV-KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE 234 (376)
T ss_pred eecccccC-CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence 65443222 223455677999999998876 5589999999999999999999998876543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=235.14 Aligned_cols=203 Identities=23% Similarity=0.272 Sum_probs=170.3
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcC--CCC----ccceeeeee
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH--HCH----VVPLVGYCS 291 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~--H~n----Iv~llg~~~ 291 (466)
-...+++|.+..++|+|.||.|-+..+.. +..||||+++.. ....+..+-|++++.++. .|+ ++.+.+++.
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 34458899999999999999999997754 689999999866 334455778999999994 222 456656665
Q ss_pred eccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC------
Q 012297 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE------ 365 (466)
Q Consensus 292 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~------ 365 (466)
. +.+.++|+|.+ |-|+.++|..++-.+++..++..|+.|+++++.|||+.. ++|-||||+|||+.+
T Consensus 162 y----rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 162 Y----RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred c----cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEE
Confidence 4 56779999988 779999999887788999999999999999999999998 999999999999941
Q ss_pred --------------CCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcC
Q 012297 366 --------------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG 431 (466)
Q Consensus 366 --------------~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG 431 (466)
+..++|+|||.|+..... ...++.|..|.|||++.+-.++.++||||+|+||.||.||
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG 305 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG 305 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccC--------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence 335899999999865432 2446778899999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 012297 432 RQPIHRSI 439 (466)
Q Consensus 432 ~~Pf~~~~ 439 (466)
...|+...
T Consensus 306 ~~LFqtHe 313 (415)
T KOG0671|consen 306 ETLFQTHE 313 (415)
T ss_pred ceecccCC
Confidence 99998654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=242.54 Aligned_cols=197 Identities=23% Similarity=0.302 Sum_probs=163.1
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccee
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~ 299 (466)
+++.|.....+|.|+|+.|-.+... +++..+||++...... -.+|+.++... +|+||+++.+.+.+ ..+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-----~~~e~~~~~~~~~h~niv~~~~v~~~----~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-----NQDEIPISLLVRDHPNIVKSHDVYED----GKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc-----cccccchhhhhcCCCcceeecceecC----Cce
Confidence 4667777788999999999999754 5788999998766222 24567666655 79999999999887 567
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-cCCCcEEEEecCCcc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL-DENLNAKITDLGMAK 378 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl-d~~~~vkL~DfGla~ 378 (466)
.|+|||.+.++-|.+.+... +.+. ..+..|+.+|+.++.|||+++ ++||||||+|||+ ++.++++|+|||.++
T Consensus 391 ~~~v~e~l~g~ell~ri~~~--~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSK--PEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eeeeehhccccHHHHHHHhc--chhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhh
Confidence 79999999999888877653 2233 788889999999999999998 9999999999999 588999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 441 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~ 441 (466)
....+. ...+-|..|.|||+.....+++++|+||||++||+|++|+.||.....+
T Consensus 465 ~~~~~~--------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 465 ELERSC--------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred hCchhh--------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 876541 1123467899999999999999999999999999999999999865543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-29 Score=228.95 Aligned_cols=201 Identities=26% Similarity=0.345 Sum_probs=164.0
Q ss_pred CcceecccCcEEEEEEEEc-CCcEEEEEEcccC-CCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc-ceeEEEEE
Q 012297 228 GSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK-RAMRLLVF 304 (466)
Q Consensus 228 ~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~-~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~-~~~~~lV~ 304 (466)
..+.||-|+||.||..++. +|+.|+.|++... ......+.+.+|+++|..++|.|++..+++......+ -.+.|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 3468999999999999874 7999999987644 2333445689999999999999999988765432211 12357888
Q ss_pred ecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCC
Q 012297 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~ 384 (466)
|.| ..+|...+-. .+.++..++.-++.||++||.|||+.+ |.||||||.|+|++.|..+||+|||+++..+.+.
T Consensus 137 ELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 137 ELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 888 5577777753 367899999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.......+.|..|.|||++++. .|+...||||.|+++.||+..+..|+..
T Consensus 211 ----~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq 261 (449)
T KOG0664|consen 211 ----RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA 261 (449)
T ss_pred ----hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence 2334445678899999999875 5899999999999999999999988754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=241.18 Aligned_cols=199 Identities=31% Similarity=0.444 Sum_probs=159.2
Q ss_pred CcceecccCcEE-EEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeEEEEEe
Q 012297 228 GSNIVGQGGSSY-VYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 228 ~~~~LG~G~fG~-Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
..+++|.|+.|+ ||+|.. +++.||||++-.+. .....+|+..|+.- +||||+++++.-.+ +.+.||..|
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d----~qF~YIalE 583 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQD----RQFLYIALE 583 (903)
T ss_pred cHHHcccCCCCcEEEEEee-CCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccC----CceEEEEeh
Confidence 345788888865 789988 68899999987553 23367899999988 59999999865333 668899999
Q ss_pred cCCCCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---C--CcEEEEecCCcc
Q 012297 306 FMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---N--LNAKITDLGMAK 378 (466)
Q Consensus 306 y~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~---~--~~vkL~DfGla~ 378 (466)
.+ ..+|+++++.. ..........+.+..|++.||++||+.+ |+||||||.||||+- + ..++|+|||+++
T Consensus 584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 99 67999999863 1111222445778899999999999998 999999999999965 2 569999999999
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcC-CCCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG-RQPIHRSITK 441 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG-~~Pf~~~~~~ 441 (466)
++..+.. .........||.+|+|||.+.....+.+.||||||+++|+.++| ..||.....+
T Consensus 660 kl~~~~s--S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 660 KLAGGKS--SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred ccCCCcc--hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 8866532 22335667899999999999999989999999999999999985 9999765433
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-27 Score=213.57 Aligned_cols=211 Identities=19% Similarity=0.389 Sum_probs=164.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~ 300 (466)
.+.|.+.+.||+|.||.+-++..+. ++.+++|.+... .....+|.+|...--.| .|.||+.-+++..+. ...+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt---~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT---SDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhc---CceE
Confidence 4568888999999999999998864 677888988765 33455688888765555 599999888764432 2366
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-c-CCCcEEEEecCCcc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL-D-ENLNAKITDLGMAK 378 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl-d-~~~~vkL~DfGla~ 378 (466)
++++||+|.|+|.+-+.. .++.+.....++.|++.||+|+|+.+ +||||||.+|||| + +...+||+|||+.+
T Consensus 98 vF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred EEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccc
Confidence 899999999999987754 45788888999999999999999999 9999999999999 3 33479999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhccc---CC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHHHHHh
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV---GR--ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSI 453 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~--~s~~sDv~S~Gvll~elltG~~Pf~~~~~~~~~~l~~~~~~~ 453 (466)
..... -.....+..|-+||.... +. ..+.+|+|.||++++.++||..||+.... ......+|.+..
T Consensus 172 k~g~t--------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~w~ 242 (378)
T KOG1345|consen 172 KVGTT--------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQWL 242 (378)
T ss_pred ccCce--------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHHHh
Confidence 65332 111223456889997643 22 37789999999999999999999995443 456677776643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=207.56 Aligned_cols=208 Identities=20% Similarity=0.321 Sum_probs=169.0
Q ss_pred hCCCCCcceecccCcEEEEEEE-EcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~-~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~~ 300 (466)
.++|++.+++|+|-++.||.|. ..+++.++||+++.... +.+.+|+.+|.+|. ||||++|+++..+... ..+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk----kKIkREikIL~nL~gg~NIi~L~DiV~Dp~S--ktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK----KKIKREIKILQNLRGGPNIIKLLDIVKDPES--KTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH----HHHHHHHHHHHhccCCCCeeehhhhhcCccc--cCc
Confidence 3567888999999999999996 45788999999987643 34889999999997 9999999999887553 356
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKR 379 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~-~~vkL~DfGla~~ 379 (466)
.||+||+.+.+...+- +.++..++.....++++||.|+|+.| |.|||+||.|++||.. -.++|+|+|+|..
T Consensus 111 aLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence 8999999998877654 45788889999999999999999999 9999999999999865 4699999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHHHH
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVK 451 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~~~~~l~~~~~ 451 (466)
.-+.. .....+.+..|.-||++.. +.|+..-|+||||++|.+|+..+.||..-.+ .-..|++.++
T Consensus 183 YHp~~------eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIak 248 (338)
T KOG0668|consen 183 YHPGK------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAK 248 (338)
T ss_pred cCCCc------eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHH
Confidence 65432 1222344556788998754 5578889999999999999999999976544 3456666554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-24 Score=198.22 Aligned_cols=184 Identities=35% Similarity=0.542 Sum_probs=157.2
Q ss_pred ecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCCCC
Q 012297 232 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 310 (466)
Q Consensus 232 LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~~g 310 (466)
||+|.+|.||++...+ ++.+++|++...........+.+|+..++.++|++++++++++.. ....++++||++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED----ENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec----CCeEEEEEecCCCC
Confidence 6899999999998865 899999999876543244569999999999999999999998876 35679999999999
Q ss_pred CHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCccccccCCCCCCC
Q 012297 311 NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRLKADGLPSCS 389 (466)
Q Consensus 311 sL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~-~~~vkL~DfGla~~~~~~~~~~~~ 389 (466)
+|.+++.... ..+++..+..++.++++++.+||+.+ ++|+||+|+||+++. ++.++|+|||.+........
T Consensus 77 ~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---- 148 (215)
T cd00180 77 SLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---- 148 (215)
T ss_pred cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----
Confidence 9999997542 35899999999999999999999998 999999999999999 89999999999986543311
Q ss_pred CCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHH
Q 012297 390 SSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLEL 428 (466)
Q Consensus 390 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~el 428 (466)
......+...|++||..... ..+.++|+|++|+++++|
T Consensus 149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 12234567889999998877 788999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=207.58 Aligned_cols=208 Identities=25% Similarity=0.336 Sum_probs=166.0
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc--ceeE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK--RAMR 300 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~--~~~~ 300 (466)
+|.....++.|.. .|.-|.+. .+++||+|++.... .....+...+|..++..++|+||++++.++...... ....
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 3455567888887 55555432 57889999876542 233344578999999999999999999988643221 2345
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
|+|||+| ..+|.+.+. ..++-.++..|+.|++.|++|||+.+ |+||||||+||++..+..+||.|||+++..
T Consensus 97 y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 97 YLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhccc
Confidence 9999999 679988876 23677888999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHHHHH
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKS 452 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~~~~~l~~~~~~ 452 (466)
..+ -.....+.|-.|.|||++.+..+.+.+||||.||++.||++|+.-|. ++..+.+|.+.
T Consensus 169 ~~~------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~-----g~d~idQ~~ki 229 (369)
T KOG0665|consen 169 DTD------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP-----GKDHIDQWNKI 229 (369)
T ss_pred Ccc------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec-----CchHHHHHHHH
Confidence 543 12344667888999999998889999999999999999999999986 34566666653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-25 Score=212.75 Aligned_cols=210 Identities=27% Similarity=0.429 Sum_probs=170.6
Q ss_pred HHHHHHhCCCCCcceecccCcEEEEEEEEcC----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeee
Q 012297 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCS 291 (466)
Q Consensus 217 ~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~ 291 (466)
+.+....+.|...++||+|.|++||++.+.. .+.||+|.+.....+. ...+|+++|..+. +.||+++.+++.
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~---ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS---RILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch---HHHHHHHHHHHhccchhhhcchhhhc
Confidence 3455667788999999999999999997643 6789999998776554 3789999999995 999999999876
Q ss_pred eccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEE
Q 012297 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAK 370 (466)
Q Consensus 292 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~-~~vk 370 (466)
. .....+|+||++.....++... ++..++...++.+.+||.++|.+| |+||||||+|+|.+.. +.-.
T Consensus 106 n----nd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~ 173 (418)
T KOG1167|consen 106 N----NDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGV 173 (418)
T ss_pred c----CCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCce
Confidence 5 4567999999999999888754 678899999999999999999999 9999999999999754 5688
Q ss_pred EEecCCccccccCC-------------CC---------------------C-----CCCCCCccccCcccccchhccc-C
Q 012297 371 ITDLGMAKRLKADG-------------LP---------------------S-----CSSSPARMQGTFGYFAPEYAMV-G 410 (466)
Q Consensus 371 L~DfGla~~~~~~~-------------~~---------------------~-----~~~~~~~~~gt~~y~aPE~~~~-~ 410 (466)
|.|||+|....... .+ . .........||++|.|||++.. +
T Consensus 174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~ 253 (418)
T KOG1167|consen 174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP 253 (418)
T ss_pred EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence 99999987211100 00 0 0001122469999999998865 5
Q ss_pred CCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 012297 411 RASLMSDVFSFGVVLLELITGRQPIHRSITK 441 (466)
Q Consensus 411 ~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~ 441 (466)
..+++.||||-|||++.+++++.||.+...+
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd 284 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDD 284 (418)
T ss_pred CcCCccceeeccceeehhhccccccccCccc
Confidence 6799999999999999999999999887654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-24 Score=207.25 Aligned_cols=136 Identities=26% Similarity=0.335 Sum_probs=119.6
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC--------CCCccceeeeeeecc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH--------HCHVVPLVGYCSEFR 294 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~--------H~nIv~llg~~~~~~ 294 (466)
.+|.+.++||=|.|++||++.+. ..+.||+|+.+.. ....+..+.||++|++++ ..+||+|++.|.-.+
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 67888899999999999999764 5789999998864 334455789999999984 246999999999888
Q ss_pred CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 012297 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 364 (466)
Q Consensus 295 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld 364 (466)
..+.+.++|+|++ |-+|..++....-++++...+.+|++||+.||.|||... +|||-||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 8888999999999 889999998888889999999999999999999999876 599999999999994
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-23 Score=206.52 Aligned_cols=207 Identities=24% Similarity=0.315 Sum_probs=166.4
Q ss_pred CCCCcceecccCcEEEEEEEEcCC--cEEEEEEcccCCCCChhHHHHHHHHHHHhcCC----CCccceeeeeeeccCcce
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTDG--RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH----CHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~~--~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H----~nIv~llg~~~~~~~~~~ 298 (466)
+|.+.+.||+|+||.||++...+. ..+|+|........... .+..|..++..+.. +++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~---~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGR---STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEecc---CCCc
Confidence 688889999999999999987653 47888887765433332 57788999888863 57777776653 2244
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-----CcEEEEe
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-----LNAKITD 373 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~-----~~vkL~D 373 (466)
..++||+.. |.+|.++......+.++..+.+.|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEe
Confidence 669999987 899999886655577999999999999999999999999 9999999999999755 4699999
Q ss_pred cCCccccc--cCCCC--CCCCC-CCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 374 LGMAKRLK--ADGLP--SCSSS-PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 374 fGla~~~~--~~~~~--~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
||+++... ..... ..... ...+.||.+|.++..+.+...+++.|+||++.++.||+.|..||....
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 99999432 22211 11111 344679999999999999999999999999999999999999997644
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=207.63 Aligned_cols=170 Identities=22% Similarity=0.209 Sum_probs=129.0
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc--CCcEEEEEEcccCC----CCChhHHHHHHHHHHHhcCCCCccceeeeeeecc
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT--DGRIVAVKRFKTQG----GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 294 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~--~~~~vaVK~l~~~~----~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~ 294 (466)
....+|...+.||+|+||+||+|.+. +++.+|||++.... .......|.+|+++|++++|+|+++.+...
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34567888999999999999999875 57788999875331 122345589999999999999999644221
Q ss_pred CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCEEEcCCCcEEEEe
Q 012297 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI-KSSNILLDENLNAKITD 373 (466)
Q Consensus 295 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDL-k~~NILld~~~~vkL~D 373 (466)
...++||||+++++|.. +.. .. ...++.|++++|.|||+.+ |+|||| ||+|||++.++.+||+|
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 13599999999999973 211 11 1467889999999999998 999999 99999999999999999
Q ss_pred cCCccccccCCCCCCC---CCCCccccCcccccchhccc
Q 012297 374 LGMAKRLKADGLPSCS---SSPARMQGTFGYFAPEYAMV 409 (466)
Q Consensus 374 fGla~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~ 409 (466)
||+++.....+..... ..-....+++.|++||.+..
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999977554321111 11134678888999998753
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-24 Score=210.56 Aligned_cols=213 Identities=25% Similarity=0.276 Sum_probs=172.7
Q ss_pred eeechHHHHHHhCCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcC------CCCcc
Q 012297 212 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH------HCHVV 284 (466)
Q Consensus 212 ~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~------H~nIv 284 (466)
-.|.+.--+.....|.+....|+|-|++|.+|.+.. |+.||||++..... ..+.=+.|+++|++|+ ..|++
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 345555556677889988999999999999998754 78999999987632 2233568999999995 45788
Q ss_pred ceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 012297 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 363 (466)
Q Consensus 285 ~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl 363 (466)
+++-.|.. ..+.+||+|-+ ..+|.+.|.... .-++.......++.|+.-||..|-..+ |+|.||||+|||+
T Consensus 498 rl~r~F~h----knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 498 RLFRHFKH----KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILV 569 (752)
T ss_pred HHHHHhhh----cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEe
Confidence 88876655 55789999987 679999997643 235888899999999999999999999 9999999999999
Q ss_pred cCCC-cEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 012297 364 DENL-NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 441 (466)
Q Consensus 364 d~~~-~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~ 441 (466)
++.. .+||+|||.|........ ..+..+--|.|||++.+-+|+...|+||.||.||||.||+..|......
T Consensus 570 NE~k~iLKLCDfGSA~~~~enei-------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 570 NESKNILKLCDFGSASFASENEI-------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred ccCcceeeeccCccccccccccc-------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 8774 589999999987654322 1122334599999999999999999999999999999999999876543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=189.81 Aligned_cols=203 Identities=21% Similarity=0.280 Sum_probs=166.6
Q ss_pred CCCCCcceecccCcEEEEEEE-EcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~-~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~~~ 301 (466)
-+|.+.++||+|+||.++.|+ +-++++||||.-...+ ....+..|....+.|. -+.|..++-+-.+ +..-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqe----G~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQE----GKYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccc----cchhh
Confidence 357888999999999999996 4589999999654332 2234677888888885 5677777654433 33448
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-----cEEEEecCC
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-----NAKITDLGM 376 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~-----~vkL~DfGl 376 (466)
||+|.+ |-+|+|+++-. .+.|+..+.+.+|.|++.-++|+|++. +|.|||||+|+||...+ .+.|+|||+
T Consensus 101 LVidLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccc
Confidence 999998 88999988754 467999999999999999999999998 99999999999996443 488999999
Q ss_pred ccccccCCC--CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 377 AKRLKADGL--PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 377 a~~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|+.+..... ....+......||.+||+-....+...+.+.|+-|||-++++.+-|..||+.-
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 998765433 23344556688999999999999999999999999999999999999999854
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=184.11 Aligned_cols=206 Identities=22% Similarity=0.285 Sum_probs=167.9
Q ss_pred hCCCCCcceecccCcEEEEEEE-EcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCC-CccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC-HVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~-~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~-nIv~llg~~~~~~~~~~~~ 300 (466)
-.+|...++||.|+||.+|.|. ..+|+.||||+-...... ..+..|..+.+.|++- .|..+..|..+ +..-
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e----~~yn 86 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTE----KDYN 86 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhccc----cccc
Confidence 3567888999999999999996 567999999987655432 2378899999999864 45555555444 3344
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEecCCc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKITDLGMA 377 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~---~~vkL~DfGla 377 (466)
.+||+.+ |.+|++++.-.. +.++..+.+.++-|++.-++|+|..+ ++||||||+|+|..-+ ..+.++|||++
T Consensus 87 vlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccch
Confidence 8999998 889999886543 56999999999999999999999999 9999999999999644 46899999999
Q ss_pred cccccCC--CCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 012297 378 KRLKADG--LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 440 (466)
Q Consensus 378 ~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~ 440 (466)
+.+.+.. .....+......||.+|.+-..+.+...+...|+-|+|.+|.++.-|..||+....
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 9876533 23334455668899999999888888899999999999999999999999997543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-24 Score=217.29 Aligned_cols=200 Identities=27% Similarity=0.416 Sum_probs=169.3
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
..++|...+.+|.|.+|.|||+++. .++..|||+++.+.... ......|+-+++.-+|+||+.++|-+.. +...
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc~h~nivay~gsylr----~dkl 87 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDCRHPNIVAYFGSYLR----RDKL 87 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-ccccccceeeeecCCCcChHHHHhhhhh----hcCc
Confidence 3467788899999999999999864 58899999998775433 3346788999999999999999998776 4456
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
|+.|||+.+|+|++.-+.. .++++.++..+.+..++|+.|||+.+ -+|||||-.|||+++.+.+|++|||.+-.+
T Consensus 88 wicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred EEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhh
Confidence 9999999999999977654 56899999999999999999999998 899999999999999999999999998766
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
... ......+.||+.|||||+.. .+.|..++|||+.|+...|+---++|..
T Consensus 163 tat-----i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf 216 (829)
T KOG0576|consen 163 TAT-----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF 216 (829)
T ss_pred hhh-----hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc
Confidence 442 22344578999999999763 5678999999999999999987777754
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.5e-23 Score=226.17 Aligned_cols=155 Identities=19% Similarity=0.169 Sum_probs=114.3
Q ss_pred hcCC-CCccceeeeeeecc---CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 012297 277 RLHH-CHVVPLVGYCSEFR---GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRIL 352 (466)
Q Consensus 277 ~l~H-~nIv~llg~~~~~~---~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~iv 352 (466)
.++| .||.++++++.... ......++++||+ +++|.++|+.. ...+++.+++.++.||++||.|||+++ |+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 3445 57888888763322 1123457788988 67999999753 355899999999999999999999998 99
Q ss_pred ecCCCCCCEEEcCCCc-------------------EEEEecCCccccccCC------C--CC---CCCCCCccccCcccc
Q 012297 353 HRDIKSSNILLDENLN-------------------AKITDLGMAKRLKADG------L--PS---CSSSPARMQGTFGYF 402 (466)
Q Consensus 353 HrDLk~~NILld~~~~-------------------vkL~DfGla~~~~~~~------~--~~---~~~~~~~~~gt~~y~ 402 (466)
||||||+||||+..+. +|++|||+++...... . .. .........||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999965444 5555555554321100 0 00 000111245889999
Q ss_pred cchhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 403 aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
|||++.+..++.++|||||||+||||++|..|+.
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 9999999999999999999999999999999875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.8e-21 Score=184.83 Aligned_cols=205 Identities=33% Similarity=0.486 Sum_probs=169.4
Q ss_pred CCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCC--hhHHHHHHHHHHHhcCCC-CccceeeeeeeccCcceeEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHC-HVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~-nIv~llg~~~~~~~~~~~~~l 302 (466)
|...+.||.|+||.||++... ..+++|.+....... ....|.+|+.+++.+.|+ +++++.+.+.. ....++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD----EGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec----CCEEEE
Confidence 556678999999999999886 789999998776554 366799999999999988 79999998843 233699
Q ss_pred EEecCCCCCHHHHhccccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccc
Q 012297 303 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRL 380 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~-~vkL~DfGla~~~ 380 (466)
+++++.++++.+++..... ..+.......+..|++.+++|+|+.+ ++|||+||+||+++... .+++.|||.++..
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 9999999999977764321 15889999999999999999999998 99999999999999998 7999999999855
Q ss_pred ccCCCCCCC-CCCCccccCcccccchhccc---CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 381 KADGLPSCS-SSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 381 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
......... .......|+..|++||.+.. .......|+||+|++++++++|..||....
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 443221110 12355678999999999987 578999999999999999999999976544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-22 Score=184.58 Aligned_cols=224 Identities=23% Similarity=0.347 Sum_probs=167.8
Q ss_pred ccccccccCCcceecceeeeechHHHHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCC-CCChhHHHHHHH
Q 012297 194 FLKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEV 272 (466)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~-~~~~~~~f~~Ei 272 (466)
+..+.+.+.++...++++.+|+.-++.. .....+|.+...|..|+|+++ |..+++|+++... .....++|.+|.
T Consensus 164 fkdt~wkgtktr~rdatlsr~~gid~~~----lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneef 238 (448)
T KOG0195|consen 164 FKDTTWKGTKTRTRDATLSRYTGIDVSS----LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEF 238 (448)
T ss_pred ccccccccccccccccccccccCcchhh----hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhC
Confidence 3444445556666666666666544322 233457889999999999996 4557778876543 333445699999
Q ss_pred HHHHhcCCCCccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 012297 273 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRIL 352 (466)
Q Consensus 273 ~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~iv 352 (466)
-.|+.+.||||++++|.|.. .....++..|||.|+|...|++...-..+-.++++++.++|+|++|||+.. |-|.
T Consensus 239 p~lrifshpnilpvlgacns----ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ip 313 (448)
T KOG0195|consen 239 PALRIFSHPNILPVLGACNS----PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIP 313 (448)
T ss_pred cceeeecCCchhhhhhhccC----CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhh
Confidence 99999999999999999987 456689999999999999999876556788899999999999999999986 3345
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCC---CCchhHHHHHHHHHHHHH
Q 012297 353 HRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELI 429 (466)
Q Consensus 353 HrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDv~S~Gvll~ell 429 (466)
--.|.+..|+||++.+++|+--. ++.... .....-.+.|++||.+...+ .-...|+|||+++||||.
T Consensus 314 r~~lns~hvmidedltarismad-~kfsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~ 383 (448)
T KOG0195|consen 314 RFYLNSKHVMIDEDLTARISMAD-TKFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELN 383 (448)
T ss_pred hhhcccceEEecchhhhheeccc-ceeeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhh
Confidence 55799999999999998876211 111000 01112346799999887544 355799999999999999
Q ss_pred cCCCCCCC
Q 012297 430 TGRQPIHR 437 (466)
Q Consensus 430 tG~~Pf~~ 437 (466)
|.+.||..
T Consensus 384 trevpfad 391 (448)
T KOG0195|consen 384 TREVPFAD 391 (448)
T ss_pred cccccccc
Confidence 99999964
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-21 Score=174.41 Aligned_cols=140 Identities=16% Similarity=0.156 Sum_probs=107.9
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEcccCCCCC-h-------hHH-----------------HHHHHHHHHhcCCCCc
Q 012297 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN-A-------DSV-----------------FLTEVDMLSRLHHCHV 283 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~-~-------~~~-----------------f~~Ei~~l~~l~H~nI 283 (466)
...||+|+||.||+|...+|+.||||+++...... . ... ...|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999998889999999997652211 1 011 2348999999988877
Q ss_pred cceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCEE
Q 012297 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL-HEAAAPRILHRDIKSSNIL 362 (466)
Q Consensus 284 v~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~L-H~~~~~~ivHrDLk~~NIL 362 (466)
.....+.. ...+|||||++++++...+.. ...++......++.|++.+|.+| |+.+ |+||||||+|||
T Consensus 82 ~~p~~~~~------~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIl 150 (190)
T cd05147 82 PCPEPILL------KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLL 150 (190)
T ss_pred CCCcEEEe------cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEE
Confidence 43332211 122899999998877654322 24588999999999999999999 6888 999999999999
Q ss_pred EcCCCcEEEEecCCcccc
Q 012297 363 LDENLNAKITDLGMAKRL 380 (466)
Q Consensus 363 ld~~~~vkL~DfGla~~~ 380 (466)
++ ++.++|+|||++...
T Consensus 151 i~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EE-CCcEEEEEccccccC
Confidence 98 478999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5e-21 Score=178.09 Aligned_cols=178 Identities=12% Similarity=0.130 Sum_probs=135.9
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChh--HH------HHHHHHHHHhcCCCCccceeeeee
Q 012297 220 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD--SV------FLTEVDMLSRLHHCHVVPLVGYCS 291 (466)
Q Consensus 220 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~--~~------f~~Ei~~l~~l~H~nIv~llg~~~ 291 (466)
.....+|...++||.|+||.||++.. ++..+|||.+......... .. |.+|+..+.+++|++|..+..++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 44578899999999999999999766 5778999999765432221 11 578999999999999999988866
Q ss_pred eccCc----ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 012297 292 EFRGK----RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 367 (466)
Q Consensus 292 ~~~~~----~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~ 367 (466)
..... ....+|||||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||+||+||++++++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 43211 234689999999999988732 222 24569999999999999 99999999999999988
Q ss_pred cEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHH
Q 012297 368 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 429 (466)
Q Consensus 368 ~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ell 429 (466)
++|+|||.......+. ....+.....+..++|+||||+++..+.
T Consensus 173 -i~liDfg~~~~~~e~~-----------------a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRK-----------------AKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchh-----------------hHHHHHHHhHhcccccccceeEeehHHH
Confidence 9999999886542211 0011344555667899999999988654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.1e-20 Score=167.92 Aligned_cols=140 Identities=22% Similarity=0.226 Sum_probs=110.1
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEcccCCCCC---------------------h----hHHHHHHHHHHHhcCCCCc
Q 012297 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN---------------------A----DSVFLTEVDMLSRLHHCHV 283 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~---------------------~----~~~f~~Ei~~l~~l~H~nI 283 (466)
...||+|++|.||+|.+.+|+.||||+++...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 36799999999999998889999999988652110 0 1124578899999999987
Q ss_pred cceeeeeeeccCcceeEEEEEecCCCCCHHHH-hcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCE
Q 012297 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDC-LDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNI 361 (466)
Q Consensus 284 v~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~-l~~~~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivHrDLk~~NI 361 (466)
.....+... ..+|||||++++++... +.. ..++..+...++.|++.++.+||+ .+ |+||||||+||
T Consensus 82 ~~p~~~~~~------~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NI 149 (190)
T cd05145 82 PVPEPILLK------KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNI 149 (190)
T ss_pred CCceEEEec------CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhE
Confidence 544433222 23899999988865433 332 347788899999999999999999 88 99999999999
Q ss_pred EEcCCCcEEEEecCCccccc
Q 012297 362 LLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 362 Lld~~~~vkL~DfGla~~~~ 381 (466)
|++ ++.++|+|||++....
T Consensus 150 ll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 150 LYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEE-CCCEEEEEcccceecC
Confidence 999 7899999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.9e-20 Score=166.99 Aligned_cols=107 Identities=25% Similarity=0.259 Sum_probs=94.1
Q ss_pred CCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCC
Q 012297 310 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389 (466)
Q Consensus 310 gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~ 389 (466)
|+|.++++.. ...+++.+++.++.|+++||.|||+.+ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------
Confidence 7899999753 356999999999999999999999875 999999999999999 9998765332
Q ss_pred CCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 390 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 390 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...|++.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 63 ----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 63 ----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred ----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 125789999999999999999999999999999999999999654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=165.81 Aligned_cols=192 Identities=16% Similarity=0.073 Sum_probs=139.4
Q ss_pred CCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCC---hhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcceeEEE
Q 012297 227 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN---ADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 227 ~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~---~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.....|++|+||+||.+.. ++..++.+.+....... ....|.+|+++|++++ |+++.+++++. ..++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~--------~~~l 75 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD--------GRHL 75 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc--------CEEE
Confidence 3456899999999998766 67778888777654321 1225889999999995 58899998762 2489
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCEEEcCCCcEEEEecCCccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI-KSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDL-k~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+|||+.|.+|.+.+.. ....++.|++.+|+++|+.+ |+|||| ||.|||+++++.++|+|||++....
T Consensus 76 vmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 76 DRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred EEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 9999999998754321 11357789999999999999 999999 7999999999999999999998543
Q ss_pred cCCCCC---CCCC-----CCccccCcccccchhccc-CCCC-chhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 382 ADGLPS---CSSS-----PARMQGTFGYFAPEYAMV-GRAS-LMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 382 ~~~~~~---~~~~-----~~~~~gt~~y~aPE~~~~-~~~s-~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
..+.-. .... ......++.|++|+-..- ...+ ...+.++-|.-+|.++|++.|+....
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 221000 0000 001124667777774432 2233 56799999999999999999976543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-18 Score=160.49 Aligned_cols=140 Identities=19% Similarity=0.216 Sum_probs=107.2
Q ss_pred CCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-----CCCCccceeeeeeeccCcceeEE
Q 012297 227 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-----HHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 227 ~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-----~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
...++||+|+||.||. .++....+||++..... ...+.+.+|+.+++.+ .||||++++|++.+..+......
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3457899999999996 43333347898866432 2445689999999999 57999999999987554444455
Q ss_pred EEEec--CCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCCEEEcC----CCcEEEEec
Q 012297 302 LVFEF--MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL-EYLHEAAAPRILHRDIKSSNILLDE----NLNAKITDL 374 (466)
Q Consensus 302 lV~ey--~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L-~~LH~~~~~~ivHrDLk~~NILld~----~~~vkL~Df 374 (466)
+|+|| .++|+|.+++.+. .+++. ..++.|++.++ +|||+++ |+||||||+|||++. +..++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 89999 5579999999652 25554 35677888777 9999999 999999999999974 347999995
Q ss_pred CCc
Q 012297 375 GMA 377 (466)
Q Consensus 375 Gla 377 (466)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.1e-18 Score=155.31 Aligned_cols=145 Identities=20% Similarity=0.141 Sum_probs=112.2
Q ss_pred HHHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCC---------------------ChhHHHHHHHHHHH
Q 012297 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP---------------------NADSVFLTEVDMLS 276 (466)
Q Consensus 218 ~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~---------------------~~~~~f~~Ei~~l~ 276 (466)
++......|...+.||+|+||.||++...+|+.||||++...... .....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 444444457778999999999999999888999999987643210 01112567888999
Q ss_pred hcCCCC--ccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 012297 277 RLHHCH--VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHR 354 (466)
Q Consensus 277 ~l~H~n--Iv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHr 354 (466)
.+.|++ +.+.++. ...++||||+++++|.+.... .....++.+++.++.++|+.+ ++||
T Consensus 89 ~l~~~~i~v~~~~~~--------~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~ 149 (198)
T cd05144 89 ALYEEGFPVPKPIDW--------NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHG 149 (198)
T ss_pred HHHHcCCCCCceeec--------CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcC
Confidence 998874 4444432 133899999999999775431 234578899999999999988 9999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 355 DIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 355 DLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
||||+||++++++.++|+|||++....
T Consensus 150 Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 150 DLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3e-18 Score=185.54 Aligned_cols=200 Identities=22% Similarity=0.242 Sum_probs=155.2
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC---CCCccceeeeeeeccC
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRG 295 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~llg~~~~~~~ 295 (466)
.+.-...|.+.+.||+|++|+||+|...+|+.||+|+-+.....+ |.--..++.+|+ -+-|+.+.....-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~--- 765 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVF--- 765 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHcc---
Confidence 444456788889999999999999999889999999877765443 333344555555 2233333322222
Q ss_pred cceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-------CCCc
Q 012297 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-------ENLN 368 (466)
Q Consensus 296 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld-------~~~~ 368 (466)
...-+||+||.+.|+|.+++. ..+.++|.-.+.++.|+++.+++||..+ |||+||||+|+||. +..-
T Consensus 766 -~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 766 -QNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred -CCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccc
Confidence 112389999999999999998 3467999999999999999999999999 99999999999994 2345
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCC
Q 012297 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434 (466)
Q Consensus 369 vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~P 434 (466)
++|+|||.+-.+..-.. .......++|-.+--+|...++.++.+.|.|-|+-+++-|+.|+.-
T Consensus 840 l~lIDfG~siDm~lfp~---~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPD---GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eEEEecccceeeeEcCC---CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 89999999876533211 1233446788889999999999999999999999999999998753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=157.39 Aligned_cols=145 Identities=19% Similarity=0.164 Sum_probs=111.1
Q ss_pred hCCCCCcceecccCcEEEEEEE--EcCCcEEEEEEcccCCCC-------------------C----hhHHHHHHHHHHHh
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQ--LTDGRIVAVKRFKTQGGP-------------------N----ADSVFLTEVDMLSR 277 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~--~~~~~~vaVK~l~~~~~~-------------------~----~~~~f~~Ei~~l~~ 277 (466)
-.-|.+.+.||+|++|.||+|. ..+|+.||+|+++..... . ....+..|+..+.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3347788999999999999998 568999999998754210 0 11235689999999
Q ss_pred cCCCC--ccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 012297 278 LHHCH--VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 355 (466)
Q Consensus 278 l~H~n--Iv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrD 355 (466)
+.+.. +.+++++. ..++||||+++.+|..++... ..+...+...++.|++.++.+||+.+ +++|||
T Consensus 107 L~~~~i~~p~~~~~~--------~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~D 174 (237)
T smart00090 107 LYEAGVPVPKPIAWR--------RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGD 174 (237)
T ss_pred HHhcCCCCCeeeEec--------CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCC
Confidence 97533 33444321 238999999998887665322 23556667899999999999999886 599999
Q ss_pred CCCCCEEEcCCCcEEEEecCCcccc
Q 012297 356 IKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 356 Lk~~NILld~~~~vkL~DfGla~~~ 380 (466)
|||+||+++ ++.++|+|||.+...
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhcc
Confidence 999999999 889999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.1e-17 Score=152.64 Aligned_cols=135 Identities=20% Similarity=0.305 Sum_probs=110.5
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEcccCCCCC-------hhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN-------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~-------~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+.||+|++|.||+|.. ++..+++|+........ ....+.+|++++..++|+++.....++... ...++
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~----~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP----ENFII 76 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC----CCCEE
Confidence 5799999999999987 67789999866443211 123477899999999999987766665542 24589
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
||||+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 77 v~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999998642 22 78899999999999999998 99999999999999 78999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-18 Score=184.72 Aligned_cols=202 Identities=23% Similarity=0.294 Sum_probs=152.7
Q ss_pred CcceecccCcEEEEEEEEc-CCcEEEEEEcc----cC-CCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 228 GSNIVGQGGSSYVYRGQLT-DGRIVAVKRFK----TQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 228 ~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~----~~-~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
...++|.|.+|.|+..... .....+.|.+. .. ........+..|+-+-..++|+|++..+..+.+... ..
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~----~~ 397 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG----IL 397 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc----ch
Confidence 4578999999988777543 33334444332 11 111111124556666777899999888776665332 23
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
-+|||+++ +|..++... ..++..++-.++.|+..|+.|+|+.+ |.|||||++|++++.++.+||+|||.+....
T Consensus 398 ~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeec
Confidence 34999999 999999764 35888899999999999999999999 9999999999999999999999999987664
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASL-MSDVFSFGVVLLELITGRQPIHRSIT 440 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~-~sDv~S~Gvll~elltG~~Pf~~~~~ 440 (466)
..... .......+.|+..|+|||.+....|.+ ..||||.|+++..|.+|+.||.....
T Consensus 472 ~~~e~-~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~ 530 (601)
T KOG0590|consen 472 YPWEK-NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKK 530 (601)
T ss_pred cCcch-hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccc
Confidence 43221 123445678999999999999988854 68999999999999999999976543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.7e-17 Score=149.52 Aligned_cols=132 Identities=22% Similarity=0.320 Sum_probs=104.0
Q ss_pred eecccCcEEEEEEEEcCCcEEEEEEcccCCCCC-------hhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 231 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN-------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 231 ~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~-------~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
+||+|+||.||+|.+ ++..+++|......... ....+.+|++++..++|+++.....++.. ....++|
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~----~~~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD----PDNKTIV 75 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE----CCCCEEE
Confidence 489999999999986 57889999865432111 12347789999999998876544444333 2234899
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
|||+++++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++...
T Consensus 76 ~e~~~g~~l~~~~~~~~-----~----~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGN-----D----ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEEECCccHHHHHhhcH-----H----HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999999999875421 1 78999999999999998 99999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.3e-19 Score=179.36 Aligned_cols=186 Identities=27% Similarity=0.310 Sum_probs=150.6
Q ss_pred ecccCcEEEEEEE----EcCCcEEEEEEcccCCCCChhH-HHHHHHHHHHhcC-CCCccceeeeeeeccCcceeEEEEEe
Q 012297 232 VGQGGSSYVYRGQ----LTDGRIVAVKRFKTQGGPNADS-VFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 232 LG~G~fG~Vy~a~----~~~~~~vaVK~l~~~~~~~~~~-~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+|+|.+|.|++.+ .+.+..+|.|.++........+ ....|..++...+ |+.++++.-.+.. +...+++.+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt----~~kl~l~ld 77 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT----DGKLYLILD 77 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc----ccchhHhhh
Confidence 7899999999774 3357788888887654322211 3456777888887 9999998866654 445689999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|..+|.|...+... ..++..........++-+++++|+.+ ++|||+|++||+++.+|++++.|||+++..-....
T Consensus 78 ~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred hcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 99999998887654 34666666777888999999999999 99999999999999999999999999987644321
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.+||..|||||++. ......|.||||++.+||+||..||..
T Consensus 153 ---------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ---------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 17899999999888 666789999999999999999999986
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.5e-17 Score=173.47 Aligned_cols=143 Identities=19% Similarity=0.287 Sum_probs=111.2
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEE-cccCCCC------ChhHHHHHHHHHHHhcCCCCccceeeeee
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKR-FKTQGGP------NADSVFLTEVDMLSRLHHCHVVPLVGYCS 291 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~-l~~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~llg~~~ 291 (466)
.+.....|...+.||+|+||.||+|.+.+.. +++|+ +...... .....+.+|+++++.++|++++....++.
T Consensus 328 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 406 (535)
T PRK09605 328 EEEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV 406 (535)
T ss_pred ccccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence 3334455566789999999999999886544 44443 2221111 11245889999999999999988776665
Q ss_pred eccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 012297 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 371 (466)
Q Consensus 292 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL 371 (466)
. ....++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++|
T Consensus 407 ~----~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 407 D----PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred e----CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEE
Confidence 4 223589999999999999885 34678999999999999998 9999999999999 6779999
Q ss_pred EecCCcccc
Q 012297 372 TDLGMAKRL 380 (466)
Q Consensus 372 ~DfGla~~~ 380 (466)
+|||+++..
T Consensus 469 iDFGla~~~ 477 (535)
T PRK09605 469 IDFGLGKYS 477 (535)
T ss_pred EeCcccccC
Confidence 999999764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.7e-17 Score=156.01 Aligned_cols=201 Identities=23% Similarity=0.297 Sum_probs=129.2
Q ss_pred CcceecccCcEEEEEEEEcC-CcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCC-----------CCccceeeee---
Q 012297 228 GSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHH-----------CHVVPLVGYC--- 290 (466)
Q Consensus 228 ~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H-----------~nIv~llg~~--- 290 (466)
..+.||.|+++.||.+++.+ ++.+|||++..... ....+.+.+|.-....+.+ +-++++--.-
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 34689999999999999875 89999999765542 2334456666544444322 1222221111
Q ss_pred ----eeccC--cce---eEEEEEecCCCCCHHHHhcc---cccC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 012297 291 ----SEFRG--KRA---MRLLVFEFMPNGNLRDCLDG---VLVE--GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356 (466)
Q Consensus 291 ----~~~~~--~~~---~~~lV~ey~~~gsL~~~l~~---~~~~--~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDL 356 (466)
.+... ... ..+++|+-+ .++|.+++.. .... .+....++.+..|+.+.+++||+.+ ++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 01111 111 347788877 6799888642 1111 2345566777799999999999999 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhccc--------CCCCchhHHHHHHHHHHHH
Q 012297 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--------GRASLMSDVFSFGVVLLEL 428 (466)
Q Consensus 357 k~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDv~S~Gvll~el 428 (466)
+|+|+|++++|.+.|+||+........... ...+..|.+||.... -.++.+.|.|++|+++|.|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC--------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG--------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec--------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999987765432110 123467999997643 2468899999999999999
Q ss_pred HcCCCCCCCCCC
Q 012297 429 ITGRQPIHRSIT 440 (466)
Q Consensus 429 ltG~~Pf~~~~~ 440 (466)
.+|+.||.....
T Consensus 244 WC~~lPf~~~~~ 255 (288)
T PF14531_consen 244 WCGRLPFGLSSP 255 (288)
T ss_dssp HHSS-STCCCGG
T ss_pred HHccCCCCCCCc
Confidence 999999986543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2e-17 Score=159.48 Aligned_cols=207 Identities=24% Similarity=0.329 Sum_probs=147.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcC--------C----------------------------cEEEEEEcccCCCCChhHH
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD--------G----------------------------RIVAVKRFKTQGGPNADSV 267 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~--------~----------------------------~~vaVK~l~~~~~~~~~~~ 267 (466)
++|.+.+.||+|....||.|++.+ + -+.|+|++..-........
T Consensus 157 ddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~~ 236 (598)
T KOG4158|consen 157 DDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDAH 236 (598)
T ss_pred hhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchHH
Confidence 346778999999999999997542 0 1467887765433333322
Q ss_pred HHH----HH--------------HHHHhc--------CCCCccceeeeeee-----------------------ccCcce
Q 012297 268 FLT----EV--------------DMLSRL--------HHCHVVPLVGYCSE-----------------------FRGKRA 298 (466)
Q Consensus 268 f~~----Ei--------------~~l~~l--------~H~nIv~llg~~~~-----------------------~~~~~~ 298 (466)
+++ |. ...+.+ +|||||++.+.|.+ .-+...
T Consensus 237 iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~ 316 (598)
T KOG4158|consen 237 ILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPK 316 (598)
T ss_pred HHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCc
Confidence 332 21 111222 49999999887765 112234
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE--cCCC--cEEEEec
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL--DENL--NAKITDL 374 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl--d~~~--~vkL~Df 374 (466)
..|+||.-. ..+|.+|+.. +..+......++.|+++|+.|||.++ +.|||+|++|||+ |+|. .+.|+||
T Consensus 317 tlylvMkrY-~~tLr~yl~~---~~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 317 TLYLVMKRY-RQTLREYLWT---RHRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred eEEEehhcc-hhhHHHHHhc---CCCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEccc
Confidence 568898877 4599999975 34677788889999999999999999 9999999999999 4443 4789999
Q ss_pred CCccccccCCCCCCCCC-CCccccCcccccchhcccCC------CCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 375 GMAKRLKADGLPSCSSS-PARMQGTFGYFAPEYAMVGR------ASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 375 Gla~~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~------~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
|.+-.-...+......+ .....|...-||||+....+ .-.|+|.|+.|-+.||+++...||..
T Consensus 390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 98765444333322222 22345778899999875422 24589999999999999999999986
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.9e-18 Score=179.45 Aligned_cols=223 Identities=23% Similarity=0.188 Sum_probs=155.4
Q ss_pred CCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHH--HHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDM--LSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~--l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++...+.||.+.|=+|.+|++++|. |+||++-.....-..+.|.++++- ...++|||.+++.-+-.. ..-.|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t----~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT----DKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHh----hHHHHH
Confidence 5666788999999999999999888 899998766544444445555544 444589999988754322 334477
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc-c
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL-K 381 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~-~ 381 (466)
|-+|. .-+|.|.|.-+ .-+...+...|+.|++.||...|+.+ |+|||||.+||||+.-.-+.|+||..-+.. -
T Consensus 99 vRqyv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 99 VRQYV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHHH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 87887 44888887542 33677788899999999999999999 999999999999999999999999754321 1
Q ss_pred cCCCCCCCCCCCc-cccCcccccchhccc-----------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCC----CCChh
Q 012297 382 ADGLPSCSSSPAR-MQGTFGYFAPEYAMV-----------GRASLMSDVFSFGVVLLELIT-GRQPIHRSI----TKGEE 444 (466)
Q Consensus 382 ~~~~~~~~~~~~~-~~gt~~y~aPE~~~~-----------~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~~----~~~~~ 444 (466)
+.+.|......-. -..-.-|+|||.+.. ...+++.||||+||++.||++ |++||+-.. ..+..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~ 252 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNA 252 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCc
Confidence 1112211110000 012245999997743 125889999999999999997 899997321 11224
Q ss_pred hHHHHHHHhhcchh
Q 012297 445 SLVLWVKSIITDAS 458 (466)
Q Consensus 445 ~l~~~~~~~~~d~~ 458 (466)
...+...+.+.|.+
T Consensus 253 ~~~e~~Le~Ied~~ 266 (1431)
T KOG1240|consen 253 DDPEQLLEKIEDVS 266 (1431)
T ss_pred cCHHHHHHhCcCcc
Confidence 44444445555543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=6e-16 Score=141.15 Aligned_cols=136 Identities=24% Similarity=0.263 Sum_probs=97.6
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEcccCCCCCh-hHH----------------------HHHHHHHHHhcCCCC--c
Q 012297 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA-DSV----------------------FLTEVDMLSRLHHCH--V 283 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~-~~~----------------------f~~Ei~~l~~l~H~n--I 283 (466)
.+.||+|+||+||+|.+.+++.||||++........ ... ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999988899999999875422111 111 134566666664432 3
Q ss_pred cceeeeeeeccCcceeEEEEEecCCCCCHHH-HhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCE
Q 012297 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD-CLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNI 361 (466)
Q Consensus 284 v~llg~~~~~~~~~~~~~lV~ey~~~gsL~~-~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivHrDLk~~NI 361 (466)
.+.+++. ..++||||++++.+.. .+.... .. .....++.+++.++.++|. .+ ++|+||||+||
T Consensus 82 ~~~~~~~--------~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Ni 146 (187)
T cd05119 82 PKPIDLN--------RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNI 146 (187)
T ss_pred CceEecC--------CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhE
Confidence 4444321 2489999999854422 111110 11 5677899999999999999 77 99999999999
Q ss_pred EEcCCCcEEEEecCCcccc
Q 012297 362 LLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 362 Lld~~~~vkL~DfGla~~~ 380 (466)
+++ ++.++|+|||.+...
T Consensus 147 li~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EEE-CCcEEEEECcccccc
Confidence 999 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.5e-15 Score=130.86 Aligned_cols=134 Identities=21% Similarity=0.194 Sum_probs=110.7
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCC--CCccceeeeeeeccCcceeEEEEEec
Q 012297 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~llg~~~~~~~~~~~~~lV~ey 306 (466)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++.+++++... ....+++|||
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~----~~~~~~v~e~ 74 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGES----DGWSYLLMEW 74 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC----CCccEEEEEe
Confidence 4679999999999999855 7899998866533 4458999999999976 588888876654 2456999999
Q ss_pred CCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 307 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
++++.+..+ +......++.++++++.+||....++++|+|++|+||++++++.++++|||.+..
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 988777653 5567778899999999999986545699999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.4e-15 Score=140.92 Aligned_cols=139 Identities=17% Similarity=0.197 Sum_probs=106.4
Q ss_pred ceec-ccCcEEEEEEEEcCCcEEEEEEcccCC------------CCChhHHHHHHHHHHHhcCCCCc--cceeeeeeecc
Q 012297 230 NIVG-QGGSSYVYRGQLTDGRIVAVKRFKTQG------------GPNADSVFLTEVDMLSRLHHCHV--VPLVGYCSEFR 294 (466)
Q Consensus 230 ~~LG-~G~fG~Vy~a~~~~~~~vaVK~l~~~~------------~~~~~~~f~~Ei~~l~~l~H~nI--v~llg~~~~~~ 294 (466)
..|| .|+.|+||++... +..++||++.... .......+.+|++++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8999999999885 6778999885421 01223457889999999998875 66777644322
Q ss_pred CcceeEEEEEecCCC-CCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 012297 295 GKRAMRLLVFEFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 373 (466)
Q Consensus 295 ~~~~~~~lV~ey~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~D 373 (466)
......++||||+++ .+|.+++... .++.. .+.+++.+|.+||+.+ |+||||||.|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEE
Confidence 222234699999997 6999988642 34443 3578999999999999 99999999999999999999999
Q ss_pred cCCccc
Q 012297 374 LGMAKR 379 (466)
Q Consensus 374 fGla~~ 379 (466)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998865
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.6e-16 Score=159.16 Aligned_cols=167 Identities=23% Similarity=0.398 Sum_probs=130.6
Q ss_pred HHhcCCCCccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 012297 275 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHR 354 (466)
Q Consensus 275 l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHr 354 (466)
|+.+.|.|+.+++|.+.+. ...++|.+|++.|+|.+.+... ...++|.....+.++++.||+|||+.. -..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~----~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG----PEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecC----CceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeee
Confidence 3568899999999999984 5679999999999999999763 356999999999999999999999764 23999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccC-------CCCchhHHHHHHHHHHH
Q 012297 355 DIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-------RASLMSDVFSFGVVLLE 427 (466)
Q Consensus 355 DLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~sDv~S~Gvll~e 427 (466)
.|+++|+++|..+.+||+|||+.........+ .......-..-|.|||.+... ..+.+.||||||++++|
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~---~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEP---EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccc---cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 99999999999999999999998776431100 111112234569999988653 14778999999999999
Q ss_pred HHcCCCCCCCCCCCCh-hhHHHHHH
Q 012297 428 LITGRQPIHRSITKGE-ESLVLWVK 451 (466)
Q Consensus 428 lltG~~Pf~~~~~~~~-~~l~~~~~ 451 (466)
+++.+.||........ ..++.+++
T Consensus 151 i~~r~~~~~~~~~~~~~~eii~~~~ 175 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDPDEIILRVK 175 (484)
T ss_pred HHhccCccccccccCChHHHHHHHH
Confidence 9999999987543332 34444433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-16 Score=159.20 Aligned_cols=132 Identities=24% Similarity=0.347 Sum_probs=110.2
Q ss_pred eEEEEEecCCCCCHHHHhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 299 MRLLVFEFMPNGNLRDCLDG-VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
..++.|+++.-.+|.+||.+ ......++...+.++.|++.+++| ++ .+|+|+||.||+...+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 46899999999999999964 334557899999999999999999 56 899999999999999999999999999
Q ss_pred cccccCCCCCCC-CCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 012297 378 KRLKADGLPSCS-SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIH 436 (466)
Q Consensus 378 ~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~ 436 (466)
..........+. .......||..||+||.+.+..|+.|+||||||+||+||+. -..+|+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e 464 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE 464 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH
Confidence 876655422111 12344679999999999999999999999999999999998 444443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1e-15 Score=163.42 Aligned_cols=170 Identities=24% Similarity=0.388 Sum_probs=120.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
..+|...++|..|++|.||..++++ .+.+|+| ++.+.. + + +||+.+-+ ..+
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l------i------l-----Rnilt~a~----------npf 133 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL------I------L-----RNILTFAG----------NPF 133 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch------h------h-----hccccccC----------Ccc
Confidence 3567778899999999999998764 4556664 222211 1 1 12333221 223
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+| |+-...+..- ..++. +++.+++|||+.+ |+|||+||+|.+|..-|++|++|||+.+..-
T Consensus 134 vv------gDc~tllk~~--g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 134 VV------GDCATLLKNI--GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred ee------chhhhhcccC--CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhh
Confidence 33 4444444332 22222 2277899999998 9999999999999999999999999987532
Q ss_pred cCC--------CCC--CCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 382 ADG--------LPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 382 ~~~--------~~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
... ... .......++||+.|.|||++....|....|+|++|+|+||.+.|..||....
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt 262 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 262 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC
Confidence 211 111 0112334689999999999999999999999999999999999999998763
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-13 Score=142.34 Aligned_cols=148 Identities=23% Similarity=0.242 Sum_probs=104.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCCh--------------------------------------
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA-------------------------------------- 264 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~-------------------------------------- 264 (466)
...|. .+.||.|++|.||+|++.+|+.||||+.+.......
T Consensus 117 F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~ 195 (437)
T TIGR01982 117 FAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR 195 (437)
T ss_pred HhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence 34444 368999999999999999999999999865421100
Q ss_pred -hHHHHHHHHHHHhc----CCCCccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHH-
Q 012297 265 -DSVFLTEVDMLSRL----HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR- 338 (466)
Q Consensus 265 -~~~f~~Ei~~l~~l----~H~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~- 338 (466)
+-+|.+|...+.++ +|.+-+.+-.++.+.. ...+|||||++|++|.++..... ...+ +..++.+++.
T Consensus 196 ~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~---~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~ 268 (437)
T TIGR01982 196 RELDLRREAANASELGENFKNDPGVYVPEVYWDRT---SERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARS 268 (437)
T ss_pred HHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhc---CCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHH
Confidence 00244555555554 2444444444443321 23599999999999988765321 1222 3456666666
Q ss_pred HHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 339 ~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
.+..+|..+ ++|+|+||.||+++++++++++|||++..+.
T Consensus 269 ~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 269 FLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 478889888 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.5e-14 Score=153.52 Aligned_cols=217 Identities=27% Similarity=0.329 Sum_probs=163.3
Q ss_pred CCCCcceecccCcEEEEEEEEcC--CcEEEEEEcccCC-CCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcceeE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTD--GRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~--~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~~ 300 (466)
.|...+.||+|.|+.|-...... ...+|+|.+.... ..........|..+-..+. |+|++.+++...+ ....
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~----~~~~ 96 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS----PRSY 96 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC----Cccc
Confidence 34555679999999999887643 4456666665543 2222223344677777776 9999999987655 4566
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH-EAAAPRILHRDIKSSNILLDENL-NAKITDLGMAK 378 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH-~~~~~~ivHrDLk~~NILld~~~-~vkL~DfGla~ 378 (466)
+++++|..++++.+-+.......++....-..+.|+..++.|+| +.+ +.|+||||+|.+++..+ ..+++|||+|.
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence 99999999999988873222224667777889999999999999 888 99999999999999999 99999999998
Q ss_pred cccc-CCCCCCCCCCCcccc-CcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHHHHH
Q 012297 379 RLKA-DGLPSCSSSPARMQG-TFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKS 452 (466)
Q Consensus 379 ~~~~-~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~~~~~l~~~~~~ 452 (466)
.... .+. ........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...... .....|...
T Consensus 174 ~~~~~~g~---~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~ 246 (601)
T KOG0590|consen 174 AYRNKNGA---ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSN 246 (601)
T ss_pred cccccCCc---ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeeccc
Confidence 8766 332 223334567 9999999988874 55778999999999999999999998765443 344444443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=5e-12 Score=113.17 Aligned_cols=130 Identities=18% Similarity=0.107 Sum_probs=96.1
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccc-eeeeeeeccCcceeEEEEEecCC
Q 012297 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP-LVGYCSEFRGKRAMRLLVFEFMP 308 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~-llg~~~~~~~~~~~~~lV~ey~~ 308 (466)
+.|+.|.++.||+++.. +..+++|........ ...+.+|+++++.+.+.++++ ++.+.. ...++||||++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~~~------~~~~lv~e~i~ 74 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYFDP------ETGVLITEFIE 74 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEEeC------CCCeEEEEecC
Confidence 46888999999999875 778999987654321 223678999999987666554 444321 12379999999
Q ss_pred CCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA--APRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 309 ~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~--~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
+.++.+.. . ....++.+++++|..||..+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 75 G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 98876430 1 11235678999999999886 22469999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.1e-12 Score=131.97 Aligned_cols=153 Identities=18% Similarity=0.207 Sum_probs=98.7
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCC---------------------------------Ch
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP---------------------------------NA 264 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~---------------------------------~~ 264 (466)
++.....|+. +.||.|++|+||+|++.+ |+.||||+.+..... +.
T Consensus 115 ~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~ 193 (537)
T PRK04750 115 VEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF 193 (537)
T ss_pred HHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence 3444556776 789999999999999987 999999999754210 00
Q ss_pred h------HHHHHHHHHHHhcC----CCCccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHH
Q 012297 265 D------SVFLTEVDMLSRLH----HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 334 (466)
Q Consensus 265 ~------~~f~~Ei~~l~~l~----H~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~ 334 (466)
. -+|.+|...+.+++ +.+.+.+-.++.+. ....+|||||++|+.+.++-.- ...+.+... ++.
T Consensus 194 ~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~---st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~---la~ 266 (537)
T PRK04750 194 EKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY---CSETVMVMERMYGIPVSDVAAL-RAAGTDMKL---LAE 266 (537)
T ss_pred HHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc---CCCceEEEeeecCccHHhHHHH-HhcCCCHHH---HHH
Confidence 0 11445555554442 44445444444432 2245899999999999874211 112222222 222
Q ss_pred HHH-HHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEEecCCcccccc
Q 012297 335 GAA-RGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKITDLGMAKRLKA 382 (466)
Q Consensus 335 qia-~~L~~LH~~~~~~ivHrDLk~~NILld~~~----~vkL~DfGla~~~~~ 382 (466)
..+ .-+..+...+ ++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 267 ~~v~~~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 267 RGVEVFFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 111 1233344567 99999999999999988 999999999887643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=9.6e-11 Score=106.92 Aligned_cols=136 Identities=18% Similarity=0.210 Sum_probs=97.6
Q ss_pred ceecccCcEEEEEEEEcC-------CcEEEEEEcccCCC---------------------CChhHHHH----HHHHHHHh
Q 012297 230 NIVGQGGSSYVYRGQLTD-------GRIVAVKRFKTQGG---------------------PNADSVFL----TEVDMLSR 277 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~-------~~~vaVK~l~~~~~---------------------~~~~~~f~----~Ei~~l~~ 277 (466)
..||.|--+.||.|...+ +..+|||+++.... ......+. +|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 47899998875311 11122333 78999999
Q ss_pred cCC--CCccceeeeeeeccCcceeEEEEEecCCCCCHHH-HhcccccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEe
Q 012297 278 LHH--CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD-CLDGVLVEGMNWDTRVAIAIGAARGLEYL-HEAAAPRILH 353 (466)
Q Consensus 278 l~H--~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~-~l~~~~~~~~~~~~~~~i~~qia~~L~~L-H~~~~~~ivH 353 (466)
+.. -++.+++++. ..+|||||+.+..+.. .+.. ..++..+...+..+++.+|..| |+.+ ++|
T Consensus 83 l~~~Gv~vP~pi~~~--------~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVH 148 (197)
T cd05146 83 MQKAGIPCPEVVVLK--------KHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVH 148 (197)
T ss_pred HHHcCCCCCeEEEec--------CCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 864 4556666541 2389999997654422 2221 1244556677889999999998 8888 999
Q ss_pred cCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 354 RDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 354 rDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
+||++.|||+++ +.+.|+|||.+-..
T Consensus 149 GDLs~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 149 ADLSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCCCHHHEEEEC-CcEEEEECCCceeC
Confidence 999999999974 67999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.2e-10 Score=108.61 Aligned_cols=146 Identities=21% Similarity=0.232 Sum_probs=109.9
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCC--CccceeeeeeeccCcceeEEEEEecC
Q 012297 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--HVVPLVGYCSEFRGKRAMRLLVFEFM 307 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~llg~~~~~~~~~~~~~lV~ey~ 307 (466)
+.|+.|.++.+|++...+|+.+++|.............+..|.++++.+.+. ++.+++.+..... .....++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~-~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS-VLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC-ccCCceEEEEEe
Confidence 4689999999999998777889999976553322334588999999999764 4566777654321 112458999999
Q ss_pred CCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 012297 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA---------------------------------------- 347 (466)
Q Consensus 308 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~---------------------------------------- 347 (466)
++.++.+.+.. ..++......++.++++.|..||+..
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99988775532 34677778888888999888888531
Q ss_pred -------------CCCeEecCCCCCCEEEcC--CCcEEEEecCCccc
Q 012297 348 -------------APRILHRDIKSSNILLDE--NLNAKITDLGMAKR 379 (466)
Q Consensus 348 -------------~~~ivHrDLk~~NILld~--~~~vkL~DfGla~~ 379 (466)
...++|+|+++.||++++ ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 135799999999999998 66789999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=5.1e-10 Score=98.76 Aligned_cols=145 Identities=19% Similarity=0.268 Sum_probs=102.4
Q ss_pred CcceecccCcEEEEEEEEcCCcEEEEEEcccC-CC-CC-----hhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 228 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQ-GG-PN-----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 228 ~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~-~~-~~-----~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
...++-+|+-+.|+++.+ .|+..+||.-... .. +. ...+..+|++.+.++.--.|.--.-++.+... -
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~----~ 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG----G 85 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----C
Confidence 346889999999999998 4677777643222 11 11 12336789999998865444422223334322 2
Q ss_pred EEEEecCCC-CCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEEecCC
Q 012297 301 LLVFEFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---NAKITDLGM 376 (466)
Q Consensus 301 ~lV~ey~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~---~vkL~DfGl 376 (466)
.|+|||+++ -++.+++...............++..+-+.+.-||..+ |+|+||..+||+|..++ .+.++|||+
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecc
Confidence 799999966 48888887655444344444788999999999999999 99999999999996554 358999999
Q ss_pred cccc
Q 012297 377 AKRL 380 (466)
Q Consensus 377 a~~~ 380 (466)
+...
T Consensus 163 s~~s 166 (229)
T KOG3087|consen 163 SSVS 166 (229)
T ss_pred hhcc
Confidence 8653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5e-10 Score=115.89 Aligned_cols=166 Identities=18% Similarity=0.253 Sum_probs=121.3
Q ss_pred EcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCC
Q 012297 245 LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGM 324 (466)
Q Consensus 245 ~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~ 324 (466)
..++.+|.|..++.... .......+.++.|+.++||||++++..... ....|||+|-+ ..|..++...
T Consensus 34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~----~~~~ylvTErV--~Pl~~~lk~l----- 101 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEE----EGTLYLVTERV--RPLETVLKEL----- 101 (690)
T ss_pred eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcc----cCceEEEeecc--ccHHHHHHHh-----
Confidence 34677888888776644 334446778899999999999999987665 44779999976 4677777543
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccc
Q 012297 325 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 404 (466)
Q Consensus 325 ~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aP 404 (466)
........+.||+.||.|||+.+ .++|++|.-..|++++.|+.||++|.++........+. ....---.|..|
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~-----~~~~~~~s~~~P 174 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA-----KSLYLIESFDDP 174 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc-----ccchhhhcccCh
Confidence 24445566789999999998655 49999999999999999999999999887643322110 001111236666
Q ss_pred hhcccCCCCchhHHHHHHHHHHHHHcC
Q 012297 405 EYAMVGRASLMSDVFSFGVVLLELITG 431 (466)
Q Consensus 405 E~~~~~~~s~~sDv~S~Gvll~elltG 431 (466)
+.+....+ ..|.|-||+++||++.|
T Consensus 175 ~~~~~s~~--s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 175 EEIDPSEW--SIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhcCcccc--chhhhhHHHHHHHHhCc
Confidence 64433332 36999999999999999
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.1e-09 Score=105.21 Aligned_cols=146 Identities=18% Similarity=0.139 Sum_probs=103.7
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChh----------HHHHHHHHHHHhcCCCCc--cceeeeeeeccCc-
Q 012297 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD----------SVFLTEVDMLSRLHHCHV--VPLVGYCSEFRGK- 296 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~----------~~f~~Ei~~l~~l~H~nI--v~llg~~~~~~~~- 296 (466)
+.+-+-....|++..+ +|+.+.||+.......... ..+.+|...+.++...+| .+++++.......
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444555778766 6788999987543311111 137789999988854443 4556665432111
Q ss_pred ceeEEEEEecCCCC-CHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-------CCc
Q 012297 297 RAMRLLVFEFMPNG-NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-------NLN 368 (466)
Q Consensus 297 ~~~~~lV~ey~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~-------~~~ 368 (466)
...-+||||++++- +|.+++........+......++.+++..+.-||..+ |+|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 23458999999876 8999985432234566777889999999999999999 999999999999975 468
Q ss_pred EEEEecCCccc
Q 012297 369 AKITDLGMAKR 379 (466)
Q Consensus 369 vkL~DfGla~~ 379 (466)
+.|+||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998853
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7e-11 Score=112.29 Aligned_cols=159 Identities=19% Similarity=0.298 Sum_probs=116.9
Q ss_pred HHHhcCCCCccceeeeeeeccC-cceeEEEEEecCCCCCHHHHhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 012297 274 MLSRLHHCHVVPLVGYCSEFRG-KRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350 (466)
Q Consensus 274 ~l~~l~H~nIv~llg~~~~~~~-~~~~~~lV~ey~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ 350 (466)
-|-++.|.||+++..|..+... +.....++.|||+-|+|..+|++.. ...+......+|.-||..||.|||+.. |+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 3445579999999998876554 4456688999999999999997633 234677778899999999999999985 77
Q ss_pred eEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc
Q 012297 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430 (466)
Q Consensus 351 ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt 430 (466)
|+|+++.-+.|++..++-+|+.---- ......-............+-++|.+||+=.....+..+|||+||...+||.-
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999998888752110 00000000000011112235678999998777777889999999999999988
Q ss_pred CCCC
Q 012297 431 GRQP 434 (466)
Q Consensus 431 G~~P 434 (466)
+..-
T Consensus 278 lEiq 281 (458)
T KOG1266|consen 278 LEIQ 281 (458)
T ss_pred heec
Confidence 7664
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.4e-09 Score=96.48 Aligned_cols=132 Identities=24% Similarity=0.362 Sum_probs=93.3
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEcc-cCCC-CChh-----HHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFK-TQGG-PNAD-----SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~~vaVK~l~-~~~~-~~~~-----~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.++++|+-+.+|.+.+. |.++++|.=. ..-. +..+ ..-.+|..++.+++-..|.--.=+..+ .....|
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD----~~~~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD----PDNGLI 76 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc----CCCCEE
Confidence 35789999999999774 3446666432 2211 2222 225678889988864444322222223 224489
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
+|||++|-.|.+++... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 77 ~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999999898753 2456677777888899999 99999999999998765 99999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.2e-10 Score=119.22 Aligned_cols=202 Identities=23% Similarity=0.278 Sum_probs=150.9
Q ss_pred CCCCCcceecc--cCcEEEEEEEE---cCCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCc
Q 012297 224 DKFSGSNIVGQ--GGSSYVYRGQL---TDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 224 ~~f~~~~~LG~--G~fG~Vy~a~~---~~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~ 296 (466)
..|.....+|. |.+|.+|.+.. .++..+|+|+-+.... +.....=.+|+...++++ |+|.++.......
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~---- 189 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG---- 189 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc----
Confidence 34556678999 99999999987 3577899987443322 222222346666666674 9999985544433
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEE
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR----GLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKI 371 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~----~L~~LH~~~~~~ivHrDLk~~NILld~~-~~vkL 371 (466)
....++-+|++ +.+|.++.+... .-++....+....+... |+.++|+.. ++|-|+||.||++..+ ...++
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred CCcceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeec
Confidence 44557888877 688988887543 33677777788888888 999999988 9999999999999999 88999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 012297 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435 (466)
Q Consensus 372 ~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf 435 (466)
+|||+...+.............+..|...|++|| +..+.++..+|+|++|.+.+|-.++-.++
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke-~~~~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKE-LLNGLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChh-hhccccchHhhhcchhhhhHhhHhhcccc
Confidence 9999999887665443333333446778899999 45667888999999999999988866554
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.2e-09 Score=97.53 Aligned_cols=126 Identities=26% Similarity=0.294 Sum_probs=81.1
Q ss_pred EEEEEEEcCCcEEEEEEcccCCCC------------C--------h-----hHHHHHHHHHHHhcCCC--Cccceeeeee
Q 012297 239 YVYRGQLTDGRIVAVKRFKTQGGP------------N--------A-----DSVFLTEVDMLSRLHHC--HVVPLVGYCS 291 (466)
Q Consensus 239 ~Vy~a~~~~~~~vaVK~l~~~~~~------------~--------~-----~~~f~~Ei~~l~~l~H~--nIv~llg~~~ 291 (466)
.||.|...++..+|||+.+..... . . .....+|.+.|.++... ++.+++++-.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 489999999999999998753110 0 0 11256799999999866 4556664421
Q ss_pred eccCcceeEEEEEecCC--CCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCCEEEcCCCc
Q 012297 292 EFRGKRAMRLLVFEFMP--NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY-LHEAAAPRILHRDIKSSNILLDENLN 368 (466)
Q Consensus 292 ~~~~~~~~~~lV~ey~~--~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~-LH~~~~~~ivHrDLk~~NILld~~~~ 368 (466)
..|||||++ +..+..+.... ++......++.+++..+.. +|+.+ |+|+||.+.|||++++ .
T Consensus 81 --------~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 81 --------NVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp --------TEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-C
T ss_pred --------CEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-e
Confidence 289999998 54554433221 1133445677777775555 57888 9999999999999988 9
Q ss_pred EEEEecCCcccc
Q 012297 369 AKITDLGMAKRL 380 (466)
Q Consensus 369 vkL~DfGla~~~ 380 (466)
+.|+|||.+...
T Consensus 145 ~~iIDf~qav~~ 156 (188)
T PF01163_consen 145 VYIIDFGQAVDS 156 (188)
T ss_dssp EEE--GTTEEET
T ss_pred EEEEecCcceec
Confidence 999999988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=6.7e-08 Score=88.63 Aligned_cols=144 Identities=21% Similarity=0.132 Sum_probs=107.3
Q ss_pred ecccCcEEEEEEEEcCCcEEEEEEcccCC-----CCChhHHHHHHHHHHHhcCC--CCccceeeeeeeccCcceeEEEEE
Q 012297 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQG-----GPNADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 232 LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~-----~~~~~~~f~~Ei~~l~~l~H--~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
-++||-+.|++..+. |..+-+|+-.... .+.....|.+|+..+.++.. -++.+++.......+.....+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 356888999998774 4478889865221 13455669999999999953 334455532222233345568999
Q ss_pred ecCCC-CCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--EEEEecCCccc
Q 012297 305 EFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN--AKITDLGMAKR 379 (466)
Q Consensus 305 ey~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~--vkL~DfGla~~ 379 (466)
|-+++ -+|.+++......+.+...+..+..++++.+.-||+.+ +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97753 58999986644445677888899999999999999999 999999999999986666 99999987664
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.6e-08 Score=91.52 Aligned_cols=109 Identities=28% Similarity=0.314 Sum_probs=86.5
Q ss_pred HHHHHHHHHHHhcCCC--CccceeeeeeeccCcceeEEEEEecCCCC-CHHHHhcccccCCCCHHHHHHHHHHHHHHHHH
Q 012297 266 SVFLTEVDMLSRLHHC--HVVPLVGYCSEFRGKRAMRLLVFEFMPNG-NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342 (466)
Q Consensus 266 ~~f~~Ei~~l~~l~H~--nIv~llg~~~~~~~~~~~~~lV~ey~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~ 342 (466)
..+.+|...+..+... ...+.+++...........+||+|++++. +|.+++..... .+......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 3478888888888533 45577777665433334568999999874 89999876322 5666778899999999999
Q ss_pred HHhCCCCCeEecCCCCCCEEEcCCC---cEEEEecCCccc
Q 012297 343 LHEAAAPRILHRDIKSSNILLDENL---NAKITDLGMAKR 379 (466)
Q Consensus 343 LH~~~~~~ivHrDLk~~NILld~~~---~vkL~DfGla~~ 379 (466)
||+.+ |+|+|+++.|||++.+. .+.++||+.++.
T Consensus 134 lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 99999999999998887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.7e-09 Score=110.93 Aligned_cols=199 Identities=23% Similarity=0.235 Sum_probs=145.8
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEE--cCCcEEEEEEcccCCCCChhHH-HHHHHHHHHhc-CCCCccceeeeeeecc
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQL--TDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRL-HHCHVVPLVGYCSEFR 294 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~--~~~~~vaVK~l~~~~~~~~~~~-f~~Ei~~l~~l-~H~nIv~llg~~~~~~ 294 (466)
....+.+|..+..||.|.|+.|+.... .++..+++|.+.........+. -+.|+-+...+ .|.++++........+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 445567888899999999999999854 3577899998876644333322 34566666655 4888887655444422
Q ss_pred CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEe
Q 012297 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITD 373 (466)
Q Consensus 295 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~-~~vkL~D 373 (466)
..++--||++++++...+ .....++...++.+..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|
T Consensus 340 ----~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~ 410 (524)
T KOG0601|consen 340 ----QGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGD 410 (524)
T ss_pred ----cccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccc
Confidence 346888999999887665 22345788888999999999999999888 9999999999999876 7889999
Q ss_pred cCCccccccCCCCCCCCCCCccccCcccc--cchhcccCCCCchhHHHHHHHHHHHHHcCCCC
Q 012297 374 LGMAKRLKADGLPSCSSSPARMQGTFGYF--APEYAMVGRASLMSDVFSFGVVLLELITGRQP 434 (466)
Q Consensus 374 fGla~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~sDv~S~Gvll~elltG~~P 434 (466)
||....+... .....+.-+++ +|+......+..+.|++|||.-+.|.+++..-
T Consensus 411 ~~~~t~~~~~--------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 411 FGCWTRLAFS--------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred ccccccccee--------cccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 9988653221 11112223344 45555667789999999999999999987764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.83 E-value=6.9e-08 Score=97.44 Aligned_cols=172 Identities=19% Similarity=0.266 Sum_probs=129.3
Q ss_pred CcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCCC-CCHH
Q 012297 236 GSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN-GNLR 313 (466)
Q Consensus 236 ~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~~-gsL~ 313 (466)
...+.|++.- .||..|++|++......... ....-++.++++.|.|+|++..++......+...++||+|.|+ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN-KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc-cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 4577899864 58999999999443222111 1234578999999999999998887444445678999999985 5776
Q ss_pred HHhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 314 DCLDGV-------------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 314 ~~l~~~-------------~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++-... .....++..++.++.|+..||.++|+.| +.-+-|.+++||++.+..++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeee
Confidence 654221 1123678899999999999999999999 888999999999999999999999988776
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQ 433 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~ 433 (466)
..+..+ | +. --.+-|.=.||.+++-|.||..
T Consensus 444 ~~d~~~-----------------~--le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 444 QEDPTE-----------------P--LE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cCCCCc-----------------c--hh---HHhhhhHHHHHHHHHHHhhccc
Confidence 554310 0 10 1225699999999999999954
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.7e-08 Score=91.27 Aligned_cols=135 Identities=21% Similarity=0.184 Sum_probs=96.0
Q ss_pred CCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCC-----------------C----ChhHHHHHHHHHHHhcCCC--C
Q 012297 226 FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-----------------P----NADSVFLTEVDMLSRLHHC--H 282 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~-----------------~----~~~~~f~~Ei~~l~~l~H~--n 282 (466)
..+.+.||.|--+.||.|..++|.++|||.-+.... . .......+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345688999999999999999999999996543210 0 1112366899999999755 6
Q ss_pred ccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 012297 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNIL 362 (466)
Q Consensus 283 Iv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NIL 362 (466)
+.+.+++- ...+||||+++-.|...- ++....-.++..|+.-+..+-+.| ++|+|+.+-||+
T Consensus 173 VP~P~~~n--------RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIl 234 (304)
T COG0478 173 VPKPIAWN--------RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNIL 234 (304)
T ss_pred CCCccccc--------cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEE
Confidence 77766542 338999999886665421 122233334444555555555667 999999999999
Q ss_pred EcCCCcEEEEecCCcc
Q 012297 363 LDENLNAKITDLGMAK 378 (466)
Q Consensus 363 ld~~~~vkL~DfGla~ 378 (466)
+++||.+.++||-.+.
T Consensus 235 V~~dg~~~vIDwPQ~v 250 (304)
T COG0478 235 VTEDGDIVVIDWPQAV 250 (304)
T ss_pred EecCCCEEEEeCcccc
Confidence 9999999999997654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.2e-09 Score=114.55 Aligned_cols=138 Identities=26% Similarity=0.368 Sum_probs=105.4
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGl 376 (466)
....+||++|..+++|...|+... ..+..........+..+++|||... +.|+|++|.|+|+..+++.+++|||+
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccc
Confidence 456699999999999999887643 2343333444556778899999876 89999999999999999999999985
Q ss_pred ccccccC----CC------------------CC----CCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc
Q 012297 377 AKRLKAD----GL------------------PS----CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430 (466)
Q Consensus 377 a~~~~~~----~~------------------~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt 430 (466)
......- +. +. .........||+.|.+||...+......+|+|++|+.++|.++
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence 4322110 00 00 0011223568999999999999999999999999999999999
Q ss_pred CCCCCCCCC
Q 012297 431 GRQPIHRSI 439 (466)
Q Consensus 431 G~~Pf~~~~ 439 (466)
|.+||....
T Consensus 1031 g~pp~na~t 1039 (1205)
T KOG0606|consen 1031 GIPPFNAET 1039 (1205)
T ss_pred CCCCCCCcc
Confidence 999998654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=7e-08 Score=100.50 Aligned_cols=152 Identities=21% Similarity=0.225 Sum_probs=100.5
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChh----------------------------------
Q 012297 220 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD---------------------------------- 265 (466)
Q Consensus 220 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~---------------------------------- 265 (466)
+....+|.. +.|+.++-|.||+|++.+|+.||||+.+..-.....
T Consensus 122 ee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 122 EELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred HHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 334444542 689999999999999999999999988764221110
Q ss_pred -----HHHHHHHHHHHhc----CCCCccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHH
Q 012297 266 -----SVFLTEVDMLSRL----HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA 336 (466)
Q Consensus 266 -----~~f~~Ei~~l~~l----~H~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi 336 (466)
-++.+|...+.++ +...-+++-.++++.. ....|+|||++|..+.+...-.. .+++...+ +..+
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t---~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i---a~~~ 273 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYT---TRRVLTMEWIDGIKISDIAALKS-AGIDRKEL---AELL 273 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhcc---CCcEEEEEeeCCEecccHHHHHh-cCCCHHHH---HHHH
Confidence 0144555555544 3333444445554422 24599999999999988743222 44564443 3333
Q ss_pred HHH-HHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 337 ARG-LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 337 a~~-L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
+++ +..+=..+ ++|.|.+|.||+++.++.+.+.|||+...+.+
T Consensus 274 ~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 274 VRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 332 23333356 99999999999999999999999999876543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.9e-07 Score=89.97 Aligned_cols=194 Identities=16% Similarity=0.179 Sum_probs=126.4
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee---eccCcceeEEEEE
Q 012297 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS---EFRGKRAMRLLVF 304 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~---~~~~~~~~~~lV~ 304 (466)
...||+|+.+.+|-.- +-...+-|++....-.. . ...++.|.+. .||-+..-+.+=. .........-+.|
T Consensus 16 gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~-~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 16 GRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAA-Q---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CccccCCccceeeecc--hhhchhheeecCCCchH-H---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4679999999999542 11223557776553221 1 2234455555 4654433111100 0111122256777
Q ss_pred ecCCCCC-HHHHhc----ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 305 EFMPNGN-LRDCLD----GVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 305 ey~~~gs-L~~~l~----~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
+.+++.. +..+.. +..-...+|.-.+++++.+|.+.+-||+.| .+-+|+.++|+|+.++..+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 8776542 223321 112234789999999999999999999999 89999999999999999999998432211
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcc-----cCCCCchhHHHHHHHHHHHHHcC-CCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITG-RQPIHR 437 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG-~~Pf~~ 437 (466)
- . ........+|...|.+||... +-..+...|.|-|||++++|+.| +.||..
T Consensus 167 ~-~-----ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 167 N-A-----NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred c-c-----CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 1 1 122334457889999999765 33457789999999999999985 999974
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.9e-06 Score=80.40 Aligned_cols=152 Identities=22% Similarity=0.290 Sum_probs=101.7
Q ss_pred echHHHHHHhCCCCCcceec---ccCcEEEEEEEEcCCcEEEEEEcccCCCCChh--------HH---------------
Q 012297 214 FSYSALEHATDKFSGSNIVG---QGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD--------SV--------------- 267 (466)
Q Consensus 214 ~~~~~l~~~t~~f~~~~~LG---~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~--------~~--------------- 267 (466)
.+++.+....+...+....| +|--..||+|...++..+|||+++........ ..
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 45566777777766666544 67778899999888999999999865321110 01
Q ss_pred HHHHHHHHHhcC--CCCccceeeeeeeccCcceeEEEEEecCCCCCH-HHHhcccccCCCCHHHHHHHHHHHHHHHHHHH
Q 012297 268 FLTEVDMLSRLH--HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNL-RDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH 344 (466)
Q Consensus 268 f~~Ei~~l~~l~--H~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL-~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH 344 (466)
..+|...|.++. +-.+.+-+++.. -.|||||+....+ .-.|.. -++...+...+..++++.+.-|-
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~--------nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~ 183 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFRN--------NVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLY 183 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeecC--------CeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHH
Confidence 234666666664 334444454432 2899999965311 111111 11233356777888888888887
Q ss_pred h-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 345 E-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 345 ~-~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
. .+ +||+||..-|||+. ++.+.|+|||.+-..
T Consensus 184 ~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 184 KEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred HhcC---cccccchhhheEEE-CCeEEEEECcccccc
Confidence 6 66 99999999999999 889999999987643
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.1e-06 Score=91.46 Aligned_cols=149 Identities=17% Similarity=0.205 Sum_probs=95.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCCh------------------------------------hH
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA------------------------------------DS 266 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~------------------------------------~~ 266 (466)
...|+ .+.||.-+.|.||+|++++|+.||||+-+..-.... +-
T Consensus 161 f~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~EL 239 (538)
T KOG1235|consen 161 FSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQEL 239 (538)
T ss_pred HHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhc
Confidence 33443 357999999999999999999999998765422110 00
Q ss_pred HHHHHHHHHHh----cCCCCc---cceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHH
Q 012297 267 VFLTEVDMLSR----LHHCHV---VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339 (466)
Q Consensus 267 ~f~~Ei~~l~~----l~H~nI---v~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~ 339 (466)
+|.+|.+-..+ +.|-++ |.+-.++++. ...+.|+||||+|..+.+.-. -...+++...+..-+.++..-
T Consensus 240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~---st~RVLtME~~~G~~i~Dl~~-i~~~gi~~~~i~~~l~~~~~~ 315 (538)
T KOG1235|consen 240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL---STKRVLTMEYVDGIKINDLDA-IDKRGISPHDILNKLVEAYLE 315 (538)
T ss_pred chHHHHHhHHHHHHHHHhcccccceeCCeehhhc---CcceEEEEEecCCccCCCHHH-HHHcCCCHHHHHHHHHHHHHH
Confidence 25555544333 346662 2233333332 235699999999987765432 122456766555544444332
Q ss_pred HHHHHhCCCCCeEecCCCCCCEEEcC----CCcEEEEecCCccccc
Q 012297 340 LEYLHEAAAPRILHRDIKSSNILLDE----NLNAKITDLGMAKRLK 381 (466)
Q Consensus 340 L~~LH~~~~~~ivHrDLk~~NILld~----~~~vkL~DfGla~~~~ 381 (466)
+-+ ..| ++|.|=+|.||+++. ++.+.+-|||+...+.
T Consensus 316 qIf--~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 316 QIF--KTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHH--hcC---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 222 235 999999999999984 6789999999987653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.9e-06 Score=80.66 Aligned_cols=144 Identities=22% Similarity=0.254 Sum_probs=85.3
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCC--ccceeeeeeeccCcceeEEEEEecC
Q 012297 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSEFRGKRAMRLLVFEFM 307 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~llg~~~~~~~~~~~~~lV~ey~ 307 (466)
+.|+.|..+.||+....+ ..+++|..... .....+.+|.++++.+.... +.+++.+... .......+++|+++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~-~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTS-DEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEE-TEETSEEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeeccc-ccccccceEEEEEe
Confidence 568999999999999877 68999986544 34455788999998886443 4566664433 22233469999999
Q ss_pred CCCCHHH----------------Hh---cccc--cCCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 012297 308 PNGNLRD----------------CL---DGVL--VEGMNWDT---------RVAI------------AIGAAR-GLEYLH 344 (466)
Q Consensus 308 ~~gsL~~----------------~l---~~~~--~~~~~~~~---------~~~i------------~~qia~-~L~~LH 344 (466)
++..+.. .+ +... ...+.+.. .... ...+.. .++.++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 11 1111 01111111 0000 112222 334443
Q ss_pred h----CCCCCeEecCCCCCCEEEc-CCCcEEEEecCCcc
Q 012297 345 E----AAAPRILHRDIKSSNILLD-ENLNAKITDLGMAK 378 (466)
Q Consensus 345 ~----~~~~~ivHrDLk~~NILld-~~~~vkL~DfGla~ 378 (466)
+ .....++|+|+.+.|||++ +++.+-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 1344699999999999999 56666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.3e-06 Score=79.75 Aligned_cols=103 Identities=22% Similarity=0.265 Sum_probs=83.4
Q ss_pred HHHHHHHHhcCC-CCccceeeeeeeccCcceeEEEEEecCCCCCHHHH---hcccccCCCCHHHHHHHHHHHHHHHHHHH
Q 012297 269 LTEVDMLSRLHH-CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDC---LDGVLVEGMNWDTRVAIAIGAARGLEYLH 344 (466)
Q Consensus 269 ~~Ei~~l~~l~H-~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~---l~~~~~~~~~~~~~~~i~~qia~~L~~LH 344 (466)
.+|.-+++.+++ +++.+++|+|.. ++|.||.+.+++... +... ...+|..+.+||.++++.+++|+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~--------~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR--------FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC--------EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHh
Confidence 457888888876 699999999975 789999987765421 1111 22589999999999999999999
Q ss_pred hCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 345 ~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+.....+...|++++|+-+++++++|++|...+....
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred cCCCCcEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8655568889999999999999999999998876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.39 E-value=7.2e-06 Score=75.68 Aligned_cols=144 Identities=15% Similarity=0.203 Sum_probs=93.2
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHH---------HHHHHHHhcCC---CCcccee
Q 012297 220 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFL---------TEVDMLSRLHH---CHVVPLV 287 (466)
Q Consensus 220 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~---------~Ei~~l~~l~H---~nIv~ll 287 (466)
.....+|...+++-......|.+-.. ++..+++|..+..... .++.|. +.+..+.+++. .....++
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 34557788778888887778887776 5788999988765322 222222 33333344422 2233322
Q ss_pred eeeeecc-CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 012297 288 GYCSEFR-GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366 (466)
Q Consensus 288 g~~~~~~-~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~ 366 (466)
.+...-. .-....+++|||++|..|.++.. ++. .++..+..++.-||+.| ++|+|.+|.|++++++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC
Confidence 2222111 11234478999999988876542 222 24566778899999999 9999999999999865
Q ss_pred CcEEEEecCCccc
Q 012297 367 LNAKITDLGMAKR 379 (466)
Q Consensus 367 ~~vkL~DfGla~~ 379 (466)
.++++||+..+.
T Consensus 172 -~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 -GIRIIDTQGKRM 183 (229)
T ss_pred -cEEEEECccccc
Confidence 499999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.38 E-value=7.7e-06 Score=76.99 Aligned_cols=138 Identities=13% Similarity=0.180 Sum_probs=81.2
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCc--cceeeeeeeccCcceeEEEEEecC
Q 012297 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV--VPLVGYCSEFRGKRAMRLLVFEFM 307 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~llg~~~~~~~~~~~~~lV~ey~ 307 (466)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-.+ .+.+++... .....+|||++
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~----~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVED----GGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEec----CCeeeeeeeec
Confidence 46899999999984 24467888876533 22336889999999864444 566666543 22347899999
Q ss_pred CCCC-HHHHh---------------------cccccCCCCHHHHHH-HHH----------HHHH-HHHHHHhC-CCCCeE
Q 012297 308 PNGN-LRDCL---------------------DGVLVEGMNWDTRVA-IAI----------GAAR-GLEYLHEA-AAPRIL 352 (466)
Q Consensus 308 ~~gs-L~~~l---------------------~~~~~~~~~~~~~~~-i~~----------qia~-~L~~LH~~-~~~~iv 352 (466)
+|.+ +...+ +.............. +.. .+.. ..++|... ..+.++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 8863 21111 111111111111110 000 0111 12222211 224579
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 353 HRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 353 HrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
|+|+.|.||++++++ +.|+||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.4e-05 Score=87.46 Aligned_cols=150 Identities=16% Similarity=0.224 Sum_probs=92.3
Q ss_pred cceecccCcEEEEEEEEcCC---cEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCc--cceeeeeeeccCcceeEEE
Q 012297 229 SNIVGQGGSSYVYRGQLTDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHV--VPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~~~---~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nI--v~llg~~~~~~~~~~~~~l 302 (466)
.+.++.|.++.+|+....++ ..+++|+............+.+|.++++.+. |.++ .+++++|.+... ....++
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v-~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV-IGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc-CCCceE
Confidence 35688899999999887654 4678887654433333346889999999995 6665 677887765322 234589
Q ss_pred EEecCCCCCHHH--------------------H---hcccccC---------CCCH--HHHHHHH---------------
Q 012297 303 VFEFMPNGNLRD--------------------C---LDGVLVE---------GMNW--DTRVAIA--------------- 333 (466)
Q Consensus 303 V~ey~~~gsL~~--------------------~---l~~~~~~---------~~~~--~~~~~i~--------------- 333 (466)
||||+++..+.+ . |+..... +..+ .++..+.
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 999998764321 1 1111100 0011 1111111
Q ss_pred HHHHHHHHHHHhCCC--------CCeEecCCCCCCEEEcCC-Cc-EEEEecCCccc
Q 012297 334 IGAARGLEYLHEAAA--------PRILHRDIKSSNILLDEN-LN-AKITDLGMAKR 379 (466)
Q Consensus 334 ~qia~~L~~LH~~~~--------~~ivHrDLk~~NILld~~-~~-vkL~DfGla~~ 379 (466)
..+...+++|..+-+ +.++|+|+++.|||++.+ .. .-|.||.++..
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 123344566744322 249999999999999853 33 57999998764
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.3e-05 Score=74.51 Aligned_cols=138 Identities=22% Similarity=0.170 Sum_probs=82.0
Q ss_pred ecccCc-EEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcceeEEEEEecCCC
Q 012297 232 VGQGGS-SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 309 (466)
Q Consensus 232 LG~G~f-G~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~~~lV~ey~~~ 309 (466)
|..|.. ..||+.... +..++||+..... ...+.+|+++++.+. +--+.+++++.... ...++|||+++|
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~----~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDD----GRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecC----CccEEEEEeeCC
Confidence 444555 789999764 4778889876543 223678999988884 43344666655431 245899999999
Q ss_pred CCHHHHh-------------------cccccC--CCC--HHHHHHHHH--------------------HHHHHHHHHHh-
Q 012297 310 GNLRDCL-------------------DGVLVE--GMN--WDTRVAIAI--------------------GAARGLEYLHE- 345 (466)
Q Consensus 310 gsL~~~l-------------------~~~~~~--~~~--~~~~~~i~~--------------------qia~~L~~LH~- 345 (466)
.+|.... +..... ++. ....+.... .+...++.|-.
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 8776432 111000 111 001110000 01111222211
Q ss_pred ---CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 346 ---AAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 346 ---~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
...+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 123469999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.9e-07 Score=95.19 Aligned_cols=99 Identities=26% Similarity=0.493 Sum_probs=75.6
Q ss_pred HHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc-CCCCCCCC---CCCccccCcccccchhccc
Q 012297 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA-DGLPSCSS---SPARMQGTFGYFAPEYAMV 409 (466)
Q Consensus 334 ~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~-~~~~~~~~---~~~~~~gt~~y~aPE~~~~ 409 (466)
.+++.|+.|+|... .+||++|.|++|.++.++.+||..|+.+-.... ..+|.... .+.-..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 44559999999765 699999999999999999999999998754432 11221111 1112334567999999999
Q ss_pred CCCCchhHHHHHHHHHHHHHcCCCC
Q 012297 410 GRASLMSDVFSFGVVLLELITGRQP 434 (466)
Q Consensus 410 ~~~s~~sDv~S~Gvll~elltG~~P 434 (466)
...+.++|+||+|+++|.+..|..+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcc
Confidence 8889999999999999999855554
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.08 E-value=0.00012 Score=71.94 Aligned_cols=80 Identities=11% Similarity=0.057 Sum_probs=56.7
Q ss_pred CcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCC---CCccceeeeeeeccCcceeEEEEE
Q 012297 228 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH---CHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 228 ~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H---~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
..+.||+|..+.||+....+++ +++|..+... ....|..|.+.++.+.. -.+.++++++..... ....+|||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~-~g~~~LVm 92 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS-PGPDVLLL 92 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc-CCCeEEEE
Confidence 3457999999999999876664 6777744311 12358999999999853 357788887754222 23469999
Q ss_pred ecCCCCCH
Q 012297 305 EFMPNGNL 312 (466)
Q Consensus 305 ey~~~gsL 312 (466)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=6.6e-05 Score=66.56 Aligned_cols=128 Identities=20% Similarity=0.220 Sum_probs=87.9
Q ss_pred CcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccc-eeeeeeeccCcceeEEEEEec
Q 012297 228 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP-LVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 228 ~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~-llg~~~~~~~~~~~~~lV~ey 306 (466)
..+.|++|.+|.||++.+. |..+|+|+-+.++ ....+..|.+++..++-.++.+ ++.|-.+ ++.|||
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~yg~~--------~i~me~ 93 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFYGED--------FIRMEY 93 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEechh--------hhhhhh
Confidence 3467999999999999985 4578888766543 2345889999999998887764 4444322 566999
Q ss_pred CCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC-CCCEEEcCCCcEEEEecCCccc
Q 012297 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK-SSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 307 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk-~~NILld~~~~vkL~DfGla~~ 379 (466)
+.|..|.+.-... +..+...+ +..---|-..| |-|+.|. |...+|..+..+.|+||.-|+.
T Consensus 94 i~G~~L~~~~~~~-----~rk~l~~v----lE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIGG-----DRKHLLRV----LEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhcc-----cHHHHHHH----HHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9888888765431 33343333 33333344456 8888875 4444454555999999998874
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00047 Score=70.06 Aligned_cols=76 Identities=21% Similarity=0.179 Sum_probs=52.7
Q ss_pred ceecccCcEEEEEEEEcCC-cEEEEEEcccCC------CCChhHHHHHHHHHHHhcC---CCCccceeeeeeeccCccee
Q 012297 230 NIVGQGGSSYVYRGQLTDG-RIVAVKRFKTQG------GPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~-~~vaVK~l~~~~------~~~~~~~f~~Ei~~l~~l~---H~nIv~llg~~~~~~~~~~~ 299 (466)
+.||.|.+..||++.+.+| +.++||.-.... .+-...++..|.+.|..+. ..++.+++.+.. ..
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~------~~ 105 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE------EL 105 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC------CC
Confidence 4689999999999999887 489999843221 1223345777888888763 345666776632 24
Q ss_pred EEEEEecCCCCC
Q 012297 300 RLLVFEFMPNGN 311 (466)
Q Consensus 300 ~~lV~ey~~~gs 311 (466)
.++||||+++..
T Consensus 106 ~~lVME~L~~~~ 117 (401)
T PRK09550 106 AVTVMEDLSDHK 117 (401)
T ss_pred CEEEEecCCCcc
Confidence 589999998743
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.0001 Score=69.79 Aligned_cols=76 Identities=17% Similarity=0.168 Sum_probs=44.7
Q ss_pred ceecccCcE-EEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCC---CccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSS-YVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC---HVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG-~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.|+.|+.. .||+. +..+++|..... .....+.+|.+++..+... .+.++++.... .+.....+++|+
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~---~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~-~~~~~~~~~l~~ 74 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA---GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEP-GEGYPWPWSVYR 74 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc---chHHHHHHHHHHHHHHhccCCCCCCceeecCCC-ccCCCcceEEEE
Confidence 356666655 58975 234777865432 1234588999999888632 23344433221 111124588999
Q ss_pred cCCCCCHH
Q 012297 306 FMPNGNLR 313 (466)
Q Consensus 306 y~~~gsL~ 313 (466)
+++|.++.
T Consensus 75 ~i~G~~l~ 82 (235)
T cd05155 75 WLEGETAT 82 (235)
T ss_pred eecCCCCC
Confidence 99987763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.0002 Score=67.54 Aligned_cols=73 Identities=15% Similarity=0.145 Sum_probs=48.7
Q ss_pred ceecccCcEEEEEEEEcC--CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCcc-ceeeeeeeccCcceeEEEEEec
Q 012297 230 NIVGQGGSSYVYRGQLTD--GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~--~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~llg~~~~~~~~~~~~~lV~ey 306 (466)
+.|..|-...+|+....+ +..+++|+........ ....+|+.+++.+....++ ++++... ..++|||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~--~d~~~E~~~~~~l~~~gl~P~v~~~~~--------~~~l~e~ 73 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI--IDRERELRIHKLLSKHGLAPKLYATFQ--------NGLIYEF 73 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce--ecHHHHHHHHHHHHhCCCCCeEEEEeC--------CcEEEEe
Confidence 457778889999998764 6789999776442221 1235788889888654454 4443221 1479999
Q ss_pred CCCCCH
Q 012297 307 MPNGNL 312 (466)
Q Consensus 307 ~~~gsL 312 (466)
++|.++
T Consensus 74 i~G~~l 79 (235)
T cd05157 74 IPGRTL 79 (235)
T ss_pred eCCCcC
Confidence 998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00049 Score=63.21 Aligned_cols=130 Identities=21% Similarity=0.300 Sum_probs=88.4
Q ss_pred CcceecccCcEEEEEEEEcCCcEEEEEEcccCC---------------CCChhHHHHHHHHHHHhcC------CCCccce
Q 012297 228 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG---------------GPNADSVFLTEVDMLSRLH------HCHVVPL 286 (466)
Q Consensus 228 ~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~---------------~~~~~~~f~~Ei~~l~~l~------H~nIv~l 286 (466)
....||+|+.-.||.- ++.....||+..... ......++.+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3468999999999974 455668889887665 1123445777877666665 8899999
Q ss_pred eeeeeeccCcceeEEEEEecCCC------CCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 012297 287 VGYCSEFRGKRAMRLLVFEFMPN------GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 360 (466)
Q Consensus 287 lg~~~~~~~~~~~~~lV~ey~~~------gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~N 360 (466)
+|+.....+. -+|+|.+.+ -+|.+++.. ..++. ... ..+-.-.+||-+.+ |+.+||+|.|
T Consensus 83 ~G~veT~~G~----Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~---~~L~~f~~~l~~~~---Iv~~dl~~~N 148 (199)
T PF10707_consen 83 YGFVETNLGL----GLVVELIRDADGNISPTLEDYLKE---GGLTE-ELR---QALDEFKRYLLDHH---IVIRDLNPHN 148 (199)
T ss_pred eEEEecCCce----EEEEEEEECCCCCcCccHHHHHHc---CCccH-HHH---HHHHHHHHHHHHcC---CeecCCCccc
Confidence 9998775443 566666532 367888854 33554 333 33334456777777 9999999999
Q ss_pred EEEcCC---C-cEEEEe
Q 012297 361 ILLDEN---L-NAKITD 373 (466)
Q Consensus 361 ILld~~---~-~vkL~D 373 (466)
|++..+ . .+.|+|
T Consensus 149 Iv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 149 IVVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEEecCCCceEEEEEe
Confidence 999533 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00019 Score=65.54 Aligned_cols=130 Identities=26% Similarity=0.402 Sum_probs=91.4
Q ss_pred CCCCCcceecccCc-EEEEEEEEcCCcEEEEEEccc---CCC-------C----------ChhHHHHHHHHHHHhcC---
Q 012297 224 DKFSGSNIVGQGGS-SYVYRGQLTDGRIVAVKRFKT---QGG-------P----------NADSVFLTEVDMLSRLH--- 279 (466)
Q Consensus 224 ~~f~~~~~LG~G~f-G~Vy~a~~~~~~~vaVK~l~~---~~~-------~----------~~~~~f~~Ei~~l~~l~--- 279 (466)
.+++..+.||.|.. |.||+++. +|+.+|+|+++. ... . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 56777889999999 99999999 577999999321 100 0 11123788888888775
Q ss_pred CCCc--cceeeeeeecc--------------CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHH
Q 012297 280 HCHV--VPLVGYCSEFR--------------GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343 (466)
Q Consensus 280 H~nI--v~llg~~~~~~--------------~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~L 343 (466)
+.++ ++.+||..-.. .....+.||.||++... .+.. .-+.+|.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHHH
Confidence 4566 89999875431 11223467888875533 1222 2355677778889
Q ss_pred HhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 344 H~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
|..+ |+=+|+++.|.. .-+|.|||.+
T Consensus 181 ~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9999 999999999996 4689999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00012 Score=70.08 Aligned_cols=137 Identities=14% Similarity=0.068 Sum_probs=79.4
Q ss_pred ecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCcc-ceeeeeeeccCcceeEEEEEecCCCC
Q 012297 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVFEFMPNG 310 (466)
Q Consensus 232 LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~llg~~~~~~~~~~~~~lV~ey~~~g 310 (466)
+..|-.+.+|+... +++.+++|+.......- .....+|.++++.+....+. ++++... .++||||++|.
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~~--------~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVNE--------HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEeC--------CEEEEEeccCc
Confidence 45688889999874 56678888765432211 11257889999988654444 4444321 16899999987
Q ss_pred CHHHH-----------------hccccc--CCCCHHHHH-HHH---------HHHHHHHHHHHhCC-----CCCeEecCC
Q 012297 311 NLRDC-----------------LDGVLV--EGMNWDTRV-AIA---------IGAARGLEYLHEAA-----APRILHRDI 356 (466)
Q Consensus 311 sL~~~-----------------l~~~~~--~~~~~~~~~-~i~---------~qia~~L~~LH~~~-----~~~ivHrDL 356 (466)
.+... |+.... .+++....+ ... ..+.+.+..+-... .+.++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 65321 121111 112222111 111 11112222222221 235899999
Q ss_pred CCCCEEEcCCCcEEEEecCCccc
Q 012297 357 KSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 357 k~~NILld~~~~vkL~DfGla~~ 379 (466)
.|.||++++++ +.|+||..+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.82 E-value=2.1e-06 Score=88.90 Aligned_cols=184 Identities=17% Similarity=0.171 Sum_probs=126.4
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCC
Q 012297 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~ 308 (466)
.+-+++++.++++|.+....+....+.+... ....-++++|.+++||| ..+.+..+. +.+...++++++..
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~--~~v~~~~d~-~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPN--PVVRYLEDY-DGEDYLWIPMRICS 317 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCC--CcccccccC-Ccccccchhhhhhc
Confidence 3457889999999987654444445554433 22456789999999999 223232232 22456689999987
Q ss_pred CC-CHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCC
Q 012297 309 NG-NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 387 (466)
Q Consensus 309 ~g-sL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~ 387 (466)
.+ +-..-... ....+...+...+.+.-++++++||+.- =+|+| ||+..+ ...+..||+....+....
T Consensus 318 ~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--- 385 (829)
T KOG0576|consen 318 TGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--- 385 (829)
T ss_pred CCccccccCCh-hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---
Confidence 76 22111110 0011334445566777888999999864 48888 777765 678999999887765432
Q ss_pred CCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 388 CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 388 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
.+....+++.|+|||......+....|+|++|+=..++--|.+|-.
T Consensus 386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3445678999999999999999999999999987777777777644
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0004 Score=68.25 Aligned_cols=140 Identities=22% Similarity=0.259 Sum_probs=84.0
Q ss_pred ceecccCcEEEEEEEEcC-------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCcc-ceeeeeeeccCcceeEE
Q 012297 230 NIVGQGGSSYVYRGQLTD-------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~-------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~llg~~~~~~~~~~~~~ 301 (466)
+.+..|-...+|+....+ ++.+++|+....... .....+|.+++..+....+. ++++++.. .
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~r~~E~~~~~~l~~~g~~P~~~~~~~~--------~ 73 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL--LIDRERELVVFARLSERNLGPKLYGIFPN--------G 73 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc--eechHHHHHHHHHHHhCCCCCceEEEeCC--------C
Confidence 345667788999998765 578999987654321 22357888888888644444 45554421 3
Q ss_pred EEEecCCCCCHHHH-----------------hcccccC-------CCC--HHHHHH------------------------
Q 012297 302 LVFEFMPNGNLRDC-----------------LDGVLVE-------GMN--WDTRVA------------------------ 331 (466)
Q Consensus 302 lV~ey~~~gsL~~~-----------------l~~~~~~-------~~~--~~~~~~------------------------ 331 (466)
+|+||++|..+... ++..... ..+ |.....
T Consensus 74 ~v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (302)
T cd05156 74 RIEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVEL 153 (302)
T ss_pred chhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhH
Confidence 58999988766431 1111111 000 111100
Q ss_pred --HHHHHHHHHHHHHh------CCCCCeEecCCCCCCEEEcCC----CcEEEEecCCccc
Q 012297 332 --IAIGAARGLEYLHE------AAAPRILHRDIKSSNILLDEN----LNAKITDLGMAKR 379 (466)
Q Consensus 332 --i~~qia~~L~~LH~------~~~~~ivHrDLk~~NILld~~----~~vkL~DfGla~~ 379 (466)
+...+...++.|-. .....++|+|+.+.|||++++ +.+.++||..+..
T Consensus 154 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 154 SLFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 11222333444432 133468999999999999985 8899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00036 Score=68.27 Aligned_cols=146 Identities=14% Similarity=0.117 Sum_probs=84.1
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCC--ccceeeeeee--ccCcceeEEEEE
Q 012297 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSE--FRGKRAMRLLVF 304 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~llg~~~~--~~~~~~~~~lV~ 304 (466)
.+.+..|....+|+....+ ..+++|+.... .......|++++..+.+.. +.+++..... ........++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCC----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 3567778888999987654 46888987641 1234667888888885433 3444431100 000123458999
Q ss_pred ecCCCCCHHH----H----------hccc----cc-----CCCCHHHHH----------HHHHHHHHHHHHHHh----CC
Q 012297 305 EFMPNGNLRD----C----------LDGV----LV-----EGMNWDTRV----------AIAIGAARGLEYLHE----AA 347 (466)
Q Consensus 305 ey~~~gsL~~----~----------l~~~----~~-----~~~~~~~~~----------~i~~qia~~L~~LH~----~~ 347 (466)
+|++|..+.. . ++.. .. ....|.... .....+..++.++.+ ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998876522 0 1110 00 011222211 011223344555543 12
Q ss_pred CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 348 APRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 348 ~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
+..++|+|+.|.|||++++....|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 23599999999999999987778999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0016 Score=64.54 Aligned_cols=158 Identities=15% Similarity=0.151 Sum_probs=81.5
Q ss_pred HHHHHHhCCCCC-----cceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCC--ccceeee
Q 012297 217 SALEHATDKFSG-----SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGY 289 (466)
Q Consensus 217 ~~l~~~t~~f~~-----~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~llg~ 289 (466)
+++......|.. .+.++.|....+|+....+| .+++|++. ... ......|+.++..|.... +.+.+..
T Consensus 10 ~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~ 84 (319)
T PRK05231 10 DELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-RLT---AEDLPFFLGLMQHLAARGVPVPAPVAR 84 (319)
T ss_pred HHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-cCC---hHHhHHHHHHHHHHHHCCCCCCcceeC
Confidence 444444444533 24566777789999987666 58889875 211 122344566666664222 3333321
Q ss_pred eee--ccCcceeEEEEEecCCCCCHH-----------HHh---cccc---------cCCCCH-HHHHH------------
Q 012297 290 CSE--FRGKRAMRLLVFEFMPNGNLR-----------DCL---DGVL---------VEGMNW-DTRVA------------ 331 (466)
Q Consensus 290 ~~~--~~~~~~~~~lV~ey~~~gsL~-----------~~l---~~~~---------~~~~~~-~~~~~------------ 331 (466)
... ........++++||++|..+. +.| +... ...+.| .....
T Consensus 85 ~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (319)
T PRK05231 85 RDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAA 164 (319)
T ss_pred CCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHH
Confidence 000 001123468999999887431 111 1110 001112 11111
Q ss_pred HH-HHHHHHHHHHHhC----CCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 332 IA-IGAARGLEYLHEA----AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 332 i~-~qia~~L~~LH~~----~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.. ..+...++.+... -+..++|+|+++.||+++++....|+||+.+..
T Consensus 165 ~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 165 LLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 11 1111222333211 234699999999999999765568999998764
|
|
| >KOG1219 consensus Uncharacterized conserved protein, contains laminin, cadherin and EGF domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00029 Score=81.13 Aligned_cols=53 Identities=25% Similarity=0.525 Sum_probs=38.4
Q ss_pred cCcccceEEeccCCCCCchhhcccCCcccccccCCCC--CCCCeeeeeecCCCCCcc
Q 012297 30 SGQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSPVGG--SSEGKWTCICAADGLPKV 84 (466)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~~--~~~~~~~c~~~~~g~~~~ 84 (466)
++..+|.|.|.+-|-||--=+--.+| .+.-|+-++. -..+++.|.| .+|+-|.
T Consensus 3881 ~~~ggy~CkCpsqysG~~CEi~~epC-~snPC~~GgtCip~~n~f~CnC-~~gyTG~ 3935 (4289)
T KOG1219|consen 3881 QPKGGYKCKCPSQYSGNHCEIDLEPC-ASNPCLTGGTCIPFYNGFLCNC-PNGYTGK 3935 (4289)
T ss_pred CCCCceEEeCcccccCcccccccccc-cCCCCCCCCEEEecCCCeeEeC-CCCccCc
Confidence 34579999999999997645533678 4666766553 3678899999 7777663
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0056 Score=60.30 Aligned_cols=145 Identities=13% Similarity=0.140 Sum_probs=81.5
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCC--ccceeeeeee--ccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSE--FRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~llg~~~~--~~~~~~~~~lV~e 305 (466)
+.++.|....+|+....++ .+++|+...... ......|++++..|.... +.+++..... .....+..++++|
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 4567777789999876555 577887654321 223456777777774322 3444431110 0011235689999
Q ss_pred cCCCCCHH-----------HH---hccccc----C------CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 012297 306 FMPNGNLR-----------DC---LDGVLV----E------GMNWDTRV------------AIAIGAARGLEYLHE---- 345 (466)
Q Consensus 306 y~~~gsL~-----------~~---l~~~~~----~------~~~~~~~~------------~i~~qia~~L~~LH~---- 345 (466)
|++|..+. .. ++.... . .-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885431 11 111000 0 01121110 111223445555543
Q ss_pred CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 346 ~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++.++|+|+++.||++++++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223569999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00035 Score=67.68 Aligned_cols=146 Identities=17% Similarity=0.168 Sum_probs=98.1
Q ss_pred echHHHHHHhCC---CCCcceecccCcEEEEEEEEcCCcEEEEEEcccCC-----------------CCCh----hHHHH
Q 012297 214 FSYSALEHATDK---FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-----------------GPNA----DSVFL 269 (466)
Q Consensus 214 ~~~~~l~~~t~~---f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~-----------------~~~~----~~~f~ 269 (466)
++|-.|...+++ ++..+.||-|--+.||.+...+|++.++|.-+... ...+ +-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 445555444433 56778999999999999999999999988543211 0001 11245
Q ss_pred HHHHHHHhcC-C-CCccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 012297 270 TEVDMLSRLH-H-CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347 (466)
Q Consensus 270 ~Ei~~l~~l~-H-~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~ 347 (466)
+|...|+.|. | -.+.+.++++ ..++|||++.+-.|.+.-+- .+..+ +...+..-+--|.+.|
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~~--------RH~Vvmelv~g~Pl~~v~~v-----~d~~~---ly~~lm~~Iv~la~~G 222 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDHN--------RHCVVMELVDGYPLRQVRHV-----EDPPT---LYDDLMGLIVRLANHG 222 (465)
T ss_pred HHHHHHHHHHHcCCCCCCccccc--------ceeeHHHhhcccceeeeeec-----CChHH---HHHHHHHHHHHHHHcC
Confidence 7888888885 3 3444555443 34899999988887654322 22233 2233334445566778
Q ss_pred CCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 348 APRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 348 ~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
+||+|..-=||+++++..++++||-..-
T Consensus 223 ---lIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 223 ---LIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred ---ceecccchheeEEecCCCEEEeechHhh
Confidence 9999999999999999999999997643
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0034 Score=61.69 Aligned_cols=148 Identities=18% Similarity=0.221 Sum_probs=83.8
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCC--CCccceeeeeeeccCcceeEEEEEecC
Q 012297 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAMRLLVFEFM 307 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~llg~~~~~~~~~~~~~lV~ey~ 307 (466)
+.+..|..-.+|..... ++.+++++-.............+|..+|+.+.- -...+.+++|.+.. ...++.||+|.
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~--~g~pf~v~~~v 107 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY--LGTPFYVMEWV 107 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC--CCCceEEEEEe
Confidence 33434444555555544 777888822112222333346678888888753 34456677777644 34669999999
Q ss_pred CCCCHHHHhcc---------------------ccc--------------CC-CCHHHHHH--------HHHHHHHHHHHH
Q 012297 308 PNGNLRDCLDG---------------------VLV--------------EG-MNWDTRVA--------IAIGAARGLEYL 343 (466)
Q Consensus 308 ~~gsL~~~l~~---------------------~~~--------------~~-~~~~~~~~--------i~~qia~~L~~L 343 (466)
+|..+.+.+.. ... .+ ..|..... ..-....-..+|
T Consensus 108 eGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl 187 (321)
T COG3173 108 EGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL 187 (321)
T ss_pred cceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence 88433221110 000 00 01111110 001122334455
Q ss_pred HhCC-----CCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 344 HEAA-----APRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 344 H~~~-----~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
+... .+.++|+|+++.|++++++..+-|.||+++..-
T Consensus 188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 4332 257999999999999999988999999998754
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.019 Score=58.32 Aligned_cols=73 Identities=18% Similarity=0.189 Sum_probs=48.6
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEcccCCC------CChhHHHHHHHHHHHhcC---CCCccceeeeeeeccCcceeE
Q 012297 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG------PNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~------~~~~~~f~~Ei~~l~~l~---H~nIv~llg~~~~~~~~~~~~ 300 (466)
+.||.|....||+.... +..++||+-..... +....+-..|.+.|+.+. ..++.+++.++.+ ..
T Consensus 38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded------~~ 110 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT------MA 110 (418)
T ss_pred EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC------CC
Confidence 56899999999998874 45688997552211 112222344566666553 3577788888764 34
Q ss_pred EEEEecCCC
Q 012297 301 LLVFEFMPN 309 (466)
Q Consensus 301 ~lV~ey~~~ 309 (466)
+++|||+++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 889999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.012 Score=58.83 Aligned_cols=74 Identities=22% Similarity=0.171 Sum_probs=47.4
Q ss_pred eecccCcEEEEEEEEcCC-cEEEEEEccc------CCCCChhHHHHHHHHHHHhcC--CC-CccceeeeeeeccCcceeE
Q 012297 231 IVGQGGSSYVYRGQLTDG-RIVAVKRFKT------QGGPNADSVFLTEVDMLSRLH--HC-HVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 231 ~LG~G~fG~Vy~a~~~~~-~~vaVK~l~~------~~~~~~~~~f~~Ei~~l~~l~--H~-nIv~llg~~~~~~~~~~~~ 300 (466)
.||.|....||++.++++ +.|+||.-.. ...+-...+..-|.+.|+... -| .+.+++.+- +...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D------~e~~ 75 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD------TEMA 75 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc------cccc
Confidence 479999999999998765 5799987321 122333334556777776663 34 344555442 3355
Q ss_pred EEEEecCCCC
Q 012297 301 LLVFEFMPNG 310 (466)
Q Consensus 301 ~lV~ey~~~g 310 (466)
.+|||+++..
T Consensus 76 ~~vMEdL~~~ 85 (370)
T TIGR01767 76 VTVMEDLSHH 85 (370)
T ss_pred eehHhhCccc
Confidence 8999999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0044 Score=62.20 Aligned_cols=139 Identities=17% Similarity=0.152 Sum_probs=81.5
Q ss_pred eecccCcEEEEEEEEcC-----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCcc-ceeeeeeeccCcceeEEEEE
Q 012297 231 IVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 231 ~LG~G~fG~Vy~a~~~~-----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~llg~~~~~~~~~~~~~lV~ 304 (466)
.|..|-...+|+....+ ++.+++|+...... .. -.-.+|..+++.+...++. ++++.+.. ..|+
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~--------g~v~ 112 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LF-FDRDDEIRTFECMSRHGQGPRLLGRFPN--------GRVE 112 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-ee-echHHHHHHHHHHHHcCCCCceEEEECC--------ceEE
Confidence 45558888999987543 36789998765432 11 1236789999988765555 55555422 2478
Q ss_pred ecCCCCCHHHH-----------------hcccccC----CCCHHHHHHHHHH-----------------HHHHHHHH---
Q 012297 305 EFMPNGNLRDC-----------------LDGVLVE----GMNWDTRVAIAIG-----------------AARGLEYL--- 343 (466)
Q Consensus 305 ey~~~gsL~~~-----------------l~~~~~~----~~~~~~~~~i~~q-----------------ia~~L~~L--- 343 (466)
+|+++.+|... ++..... ...|.++..+..+ +...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99987666321 1111100 1112222222211 11112222
Q ss_pred -Hh-CCCCCeEecCCCCCCEEEcC-CCcEEEEecCCccc
Q 012297 344 -HE-AAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKR 379 (466)
Q Consensus 344 -H~-~~~~~ivHrDLk~~NILld~-~~~vkL~DfGla~~ 379 (466)
.. .....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 21 12235899999999999986 46899999998764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0068 Score=58.81 Aligned_cols=31 Identities=29% Similarity=0.478 Sum_probs=25.9
Q ss_pred CCeEecCCCCCCEEEcCCCc-EEEEecCCccc
Q 012297 349 PRILHRDIKSSNILLDENLN-AKITDLGMAKR 379 (466)
Q Consensus 349 ~~ivHrDLk~~NILld~~~~-vkL~DfGla~~ 379 (466)
+.++|+|+++.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.004 Score=60.66 Aligned_cols=73 Identities=25% Similarity=0.271 Sum_probs=44.5
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC---CCCccceeeeeeeccCcceeEEEEEe
Q 012297 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
.+.++.|....+|+.. .+++.+.||.-... ....|..|.+-|+.|. --.+.+++++.... ...+||+|
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~----~~~fLlle 92 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD----DDAFLLLE 92 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S----SCCEEEEE
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec----CCceEEEE
Confidence 3568889999999988 67888999976622 2235889999998884 33455777765442 22389999
Q ss_pred cCCCC
Q 012297 306 FMPNG 310 (466)
Q Consensus 306 y~~~g 310 (466)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 99876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0018 Score=72.10 Aligned_cols=157 Identities=21% Similarity=0.187 Sum_probs=111.2
Q ss_pred HHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 012297 268 FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347 (466)
Q Consensus 268 f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~ 347 (466)
-..|.+.+.++.|+|++.+++|..+.....-...+..++++..++...++.. ...+......+..++..|+.|+|+..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 4456777888899999999998776433221223456788888888888754 44788888889999999999999985
Q ss_pred CCCeEecCCCCC---CEEEcCCCcEEEE--ecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCc--hhHHHH
Q 012297 348 APRILHRDIKSS---NILLDENLNAKIT--DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASL--MSDVFS 420 (466)
Q Consensus 348 ~~~ivHrDLk~~---NILld~~~~vkL~--DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--~sDv~S 420 (466)
..|.-|..+ +...+.++.+.++ ||+.......... .....-+..|.+||......+.. ..|+|.
T Consensus 307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~------~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK------SFSDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred ---cceeEEecccccccccCccceeecchhhhcccccCCCccc------chhhcCccccccccccccccchhhhhhHHHH
Confidence 666655555 5555666677777 8888776543221 11122345578888777666544 479999
Q ss_pred HHHHHHHHHcCCCCC
Q 012297 421 FGVVLLELITGRQPI 435 (466)
Q Consensus 421 ~Gvll~elltG~~Pf 435 (466)
+|.++..+..|..+-
T Consensus 378 lgll~~~~~~~~~i~ 392 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDIS 392 (1351)
T ss_pred HHHHHhhhhhcCccc
Confidence 999999999877653
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.01 Score=58.78 Aligned_cols=138 Identities=20% Similarity=0.237 Sum_probs=90.8
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEcccCCC---------------------CChhHH----HHHHHHHHHhcCCCCcc
Q 012297 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG---------------------PNADSV----FLTEVDMLSRLHHCHVV 284 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~---------------------~~~~~~----f~~Ei~~l~~l~H~nIv 284 (466)
-.|..|--..||.|.-.+|..+|||+++..-. ...++. ...|+.-|.+|+...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 35778999999999999999999999875310 011111 33577777777655543
Q ss_pred ceeeeeeeccCcceeEEEEEecCCCCCH-HHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 012297 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNL-RDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 363 (466)
Q Consensus 285 ~llg~~~~~~~~~~~~~lV~ey~~~gsL-~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl 363 (466)
----+.. . ...|||+|+..-.- .-.|+ .-.++...+...-.|++.-|.-|-... ++||.||.--|+|+
T Consensus 230 ~PePIlL-----k-~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 230 CPEPILL-----K-NHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY 298 (520)
T ss_pred CCCceee-----e-cceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence 1111111 1 23899999842111 11111 123677777788888888888885544 49999999999998
Q ss_pred cCCCcEEEEecCCccc
Q 012297 364 DENLNAKITDLGMAKR 379 (466)
Q Consensus 364 d~~~~vkL~DfGla~~ 379 (466)
- +|.+.|+|.+.+-.
T Consensus 299 h-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 299 H-DGKLYIIDVSQSVE 313 (520)
T ss_pred E-CCEEEEEEcccccc
Confidence 5 45899999886643
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.017 Score=57.53 Aligned_cols=140 Identities=16% Similarity=0.169 Sum_probs=80.3
Q ss_pred ceecccCcEEEEEEEEcC----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCcc-ceeeeeeeccCcceeEEEEE
Q 012297 230 NIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~llg~~~~~~~~~~~~~lV~ 304 (466)
+.|..|-...+|+....+ +..|++|+....... .-.-.+|..+++.+...++. ++++++.. .+|.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~--~IdR~~E~~il~~l~~~gl~P~~l~~~~~--------G~i~ 89 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY--VIDRERELQAIKYLSAAGFGAKLLGVFGN--------GMIQ 89 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe--EechHHHHHHHHHHHhcCCCCceeEEeCC--------cEee
Confidence 345558888899987643 237889987654321 12246788899988766665 55555421 2488
Q ss_pred ecCCCCCHHH-------H----------hcccccC---CC-CHHHHHHHHHHH----------------------HHHHH
Q 012297 305 EFMPNGNLRD-------C----------LDGVLVE---GM-NWDTRVAIAIGA----------------------ARGLE 341 (466)
Q Consensus 305 ey~~~gsL~~-------~----------l~~~~~~---~~-~~~~~~~i~~qi----------------------a~~L~ 341 (466)
+|+++..|.. . ++..... .. -|..+..+..++ ..-+.
T Consensus 90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 169 (330)
T PLN02421 90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV 169 (330)
T ss_pred hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence 9997765521 0 1111100 01 122222222111 11122
Q ss_pred HHH----hCC-CCCeEecCCCCCCEEEcC-CCcEEEEecCCccc
Q 012297 342 YLH----EAA-APRILHRDIKSSNILLDE-NLNAKITDLGMAKR 379 (466)
Q Consensus 342 ~LH----~~~-~~~ivHrDLk~~NILld~-~~~vkL~DfGla~~ 379 (466)
.+. ..+ +.-++|+|+.+.|||+++ ++.++++||..+..
T Consensus 170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 221 111 234899999999999975 57899999998764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.072 Score=54.00 Aligned_cols=74 Identities=20% Similarity=0.143 Sum_probs=48.5
Q ss_pred ceecccCcEEEEEEEEcC-CcEEEEEEcccC-----CCCChhHHHHHHHHHHHhcC--CC-CccceeeeeeeccCcceeE
Q 012297 230 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQ-----GGPNADSVFLTEVDMLSRLH--HC-HVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~-----~~~~~~~~f~~Ei~~l~~l~--H~-nIv~llg~~~~~~~~~~~~ 300 (466)
+.||.|.-..||++.+.+ ++.|+||.-... ..+-...+..-|.+.|+... -| ++.+++.+- +...
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D------~e~~ 108 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD------SVMN 108 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC------cHHh
Confidence 578999999999999853 567999863211 12333344666778777663 34 444566542 3355
Q ss_pred EEEEecCCC
Q 012297 301 LLVFEFMPN 309 (466)
Q Consensus 301 ~lV~ey~~~ 309 (466)
.+|||+++.
T Consensus 109 ~~vMEdL~~ 117 (409)
T PRK12396 109 CCVMEDLSD 117 (409)
T ss_pred hHHHHhCcc
Confidence 899999965
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.038 Score=54.84 Aligned_cols=144 Identities=21% Similarity=0.311 Sum_probs=85.6
Q ss_pred eecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCC------ccceeeeeeeccCcceeEEEEE
Q 012297 231 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH------VVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 231 ~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~llg~~~~~~~~~~~~~lV~ 304 (466)
.|.+ .-..+|+....+|+. ++|+.... .. ..+...|++.+..+.-.. +..+-|-....-......+-++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~--~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG-WT--RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC-CC--HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 3444 567799998888876 88988776 22 234667788888774222 2222222111111113668899
Q ss_pred ecCCCCCHHH-H-----------h-------cccc------cCCCCHHH-------------HHHHHHHHHHHHHHHHhC
Q 012297 305 EFMPNGNLRD-C-----------L-------DGVL------VEGMNWDT-------------RVAIAIGAARGLEYLHEA 346 (466)
Q Consensus 305 ey~~~gsL~~-~-----------l-------~~~~------~~~~~~~~-------------~~~i~~qia~~L~~LH~~ 346 (466)
+|++|..+.. . | ++.. .....|.. ......++...+..+.+.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999887762 1 1 1111 00123331 012444555555655543
Q ss_pred CC-------CCeEecCCCCCCEEEcCCCc-EEEEecCCccc
Q 012297 347 AA-------PRILHRDIKSSNILLDENLN-AKITDLGMAKR 379 (466)
Q Consensus 347 ~~-------~~ivHrDLk~~NILld~~~~-vkL~DfGla~~ 379 (466)
-. ..+||+|+.|.||+++++.. ..++||+-+..
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 21 12899999999999999885 89999998763
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.059 Score=52.95 Aligned_cols=29 Identities=24% Similarity=0.360 Sum_probs=25.3
Q ss_pred CCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 349 PRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 349 ~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
+.++|+|+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.013 Score=57.89 Aligned_cols=74 Identities=16% Similarity=0.204 Sum_probs=58.5
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGl 376 (466)
....|++|++. |++|.- + .-..|.+.+.++.+.+..+.-|...- +.-|||+...||||+ +|++.|+||-+
T Consensus 298 ~~y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred ceEEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence 33557777775 555542 1 23578999999999998888887654 689999999999999 99999999999
Q ss_pred cccc
Q 012297 377 AKRL 380 (466)
Q Consensus 377 a~~~ 380 (466)
+|.-
T Consensus 368 sRl~ 371 (488)
T COG5072 368 SRLS 371 (488)
T ss_pred eecc
Confidence 9854
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.038 Score=56.17 Aligned_cols=74 Identities=16% Similarity=0.236 Sum_probs=46.2
Q ss_pred ceecccCcEEEEEEEEcCCc-------EEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCcc-ceeeeeeeccCcceeEE
Q 012297 230 NIVGQGGSSYVYRGQLTDGR-------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~-------~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~llg~~~~~~~~~~~~~ 301 (466)
+.|..|-...+|++...++. .|+++...... ...-+-.+|+++++.+...++. ++++.+.. .
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~--~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~--------g 125 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN--SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD--------F 125 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC--ceEeccHHHHHHHHHHHhCCCCCeEEEecCC--------E
Confidence 35555888999999765431 24444432221 1111235789999999776666 45554432 6
Q ss_pred EEEecCCCCCHH
Q 012297 302 LVFEFMPNGNLR 313 (466)
Q Consensus 302 lV~ey~~~gsL~ 313 (466)
+++||++|.+|.
T Consensus 126 ~l~efIeGr~l~ 137 (383)
T PTZ00384 126 TIQEWVEGNTMG 137 (383)
T ss_pred EEEEEeccccCC
Confidence 899999987763
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.0095 Score=55.22 Aligned_cols=30 Identities=27% Similarity=0.449 Sum_probs=21.5
Q ss_pred CeEecCCCCCCEEE-cCCCcEEEEecCCccc
Q 012297 350 RILHRDIKSSNILL-DENLNAKITDLGMAKR 379 (466)
Q Consensus 350 ~ivHrDLk~~NILl-d~~~~vkL~DfGla~~ 379 (466)
.++|+||.+.|||+ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8889999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.079 Score=60.74 Aligned_cols=145 Identities=20% Similarity=0.283 Sum_probs=78.3
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC--CCC--cccee----ee-ee--eccCcce
Q 012297 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH--HCH--VVPLV----GY-CS--EFRGKRA 298 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~--H~n--Iv~ll----g~-~~--~~~~~~~ 298 (466)
+.|+ |..-.+|+....++..+++|+.+..... .....|...|..|. ++. +.+++ |- .. .......
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~---~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~ 106 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR---VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEP 106 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccch---hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCce
Confidence 3454 5567889998888888999998865322 22334555665552 122 22222 11 01 1111122
Q ss_pred eEEEEEecCCCCCHHHH---------------------hcccc----cCCCCHHH-----------------HHHHHHHH
Q 012297 299 MRLLVFEFMPNGNLRDC---------------------LDGVL----VEGMNWDT-----------------RVAIAIGA 336 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~---------------------l~~~~----~~~~~~~~-----------------~~~i~~qi 336 (466)
..+-+++|++|..|.+. ++... .+.+.|.. ...++.++
T Consensus 107 ~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~ 186 (1013)
T PRK06148 107 RLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERF 186 (1013)
T ss_pred EEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHH
Confidence 45778999999777541 01110 01122321 11222222
Q ss_pred HHHHH-----HHHhCCCCCeEecCCCCCCEEEcCCC--cEE-EEecCCccc
Q 012297 337 ARGLE-----YLHEAAAPRILHRDIKSSNILLDENL--NAK-ITDLGMAKR 379 (466)
Q Consensus 337 a~~L~-----~LH~~~~~~ivHrDLk~~NILld~~~--~vk-L~DfGla~~ 379 (466)
...++ .|.+ -...+||+|+++.|||++.+. ++. |+|||-+..
T Consensus 187 ~~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 187 LARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 22221 1211 233599999999999999875 554 999998754
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.13 Score=51.20 Aligned_cols=72 Identities=24% Similarity=0.265 Sum_probs=44.8
Q ss_pred cCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCC--Ccccee---ee-eeeccCcceeEEEEEecCC
Q 012297 235 GGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--HVVPLV---GY-CSEFRGKRAMRLLVFEFMP 308 (466)
Q Consensus 235 G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~ll---g~-~~~~~~~~~~~~lV~ey~~ 308 (466)
+....||+....++..+++|+.+... ........|++.+..|... .++..+ |- .... +..++.++++++
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~---~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEH---QGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEE---CCEEEEEEeeeC
Confidence 55678999998888889999886442 2234467788888777422 222212 10 0111 235688999998
Q ss_pred CCC
Q 012297 309 NGN 311 (466)
Q Consensus 309 ~gs 311 (466)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 764
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.0053 Score=40.09 Aligned_cols=18 Identities=33% Similarity=0.466 Sum_probs=8.4
Q ss_pred HHHHHHHHHHHHHhhcCC
Q 012297 130 TTIAFLMLVLCYVYRKGK 147 (466)
Q Consensus 130 ~~l~~l~~~~~~~~rr~k 147 (466)
+++++++++++++|||+|
T Consensus 23 vI~~vl~~~l~~~~rR~k 40 (40)
T PF08693_consen 23 VIIIVLGAFLFFWYRRKK 40 (40)
T ss_pred HHHHHHHHHhheEEeccC
Confidence 333344444454566543
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.0028 Score=72.40 Aligned_cols=162 Identities=13% Similarity=-0.010 Sum_probs=106.2
Q ss_pred HHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCC--CCHHHHHHHHHHHHHHHHHHHh
Q 012297 268 FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHE 345 (466)
Q Consensus 268 f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~--~~~~~~~~i~~qia~~L~~LH~ 345 (466)
.+.|.+.++...|+++.....-... .....-+.+++|+..|++.+.+-+...+. ++..-....-.+......-.|.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~p--s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPP--SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCC--CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 4445556666788888765433222 12234488999999999999885432221 2222111111221333333333
Q ss_pred C--CCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHH
Q 012297 346 A--AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGV 423 (466)
Q Consensus 346 ~--~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gv 423 (466)
. +..--+|++||+-|.+|+.+.++++.++|+.+...+. ........+++.|+.|+....-.++.++|+|..+.
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-----~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-----LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCch-----HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence 2 2234699999999999999999999999999832221 11122345777899999888888898899999999
Q ss_pred HHHHHHcCCCCCC
Q 012297 424 VLLELITGRQPIH 436 (466)
Q Consensus 424 ll~elltG~~Pf~ 436 (466)
.+|++--|..||-
T Consensus 1429 ~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHhcccHHHH
Confidence 9999888887763
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.13 Score=50.75 Aligned_cols=30 Identities=20% Similarity=0.273 Sum_probs=27.3
Q ss_pred CeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 350 RILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 350 ~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++|+|+.++|||+++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 599999999999999999999999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.081 Score=50.50 Aligned_cols=132 Identities=20% Similarity=0.134 Sum_probs=82.0
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHH---HHHHhcCCCCccceeeeeeeccCcceeEEEEEec
Q 012297 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEV---DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei---~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey 306 (466)
..+..|..+.|+.++..+|+++++|+...... +..|. ..|+..+=...+++++.-.+ ...+.+|.
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~------~~~E~~g~~~L~~w~G~GaVrll~~d~~------~~AlLLEr 75 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE------AEHEARGEAALRWWNGRGAVRLLAADPE------RGALLLER 75 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCccc------chhhhhHHhHhheeCCCCceeeeccccc------cchhhhhh
Confidence 34667999999999999999999998875532 22333 55788887778999975322 33788899
Q ss_pred C-CCCCHHHHhc-------------------ccccCCC-----CHHHHH----------------HHHHHHHHHHHHH-H
Q 012297 307 M-PNGNLRDCLD-------------------GVLVEGM-----NWDTRV----------------AIAIGAARGLEYL-H 344 (466)
Q Consensus 307 ~-~~gsL~~~l~-------------------~~~~~~~-----~~~~~~----------------~i~~qia~~L~~L-H 344 (466)
+ ++.+|.+... .....+. +..+.. .++.+.+.....| .
T Consensus 76 l~~g~~L~~~~~~g~d~~a~~i~a~l~~~L~~~~~~~~p~~l~~l~~~~~~l~~~~~~~~~~~~~~l~~~a~~~~~~Ll~ 155 (253)
T PF04655_consen 76 LDPGRSLASLPREGDDDEATRIAAGLLRRLHRPAPEPLPSGLPPLADWFARLFARARERAGAPPRRLVDAAAALARELLA 155 (253)
T ss_pred ccCCCchhhcccccCchHHHHHHHHHHHHHhCCCCCCCCccchhHHHHHHHHHHHhHhhhccccHHHHHHHHHHHHHHhc
Confidence 8 5567765541 0111011 111110 1222222223333 3
Q ss_pred hCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 012297 345 EAAAPRILHRDIKSSNILLDENLNAKITD 373 (466)
Q Consensus 345 ~~~~~~ivHrDLk~~NILld~~~~vkL~D 373 (466)
+.....++|+||+..|||-......+.+|
T Consensus 156 ~~~~~~lLHGDLH~~NIL~~~~~~WlaID 184 (253)
T PF04655_consen 156 SPGEEVLLHGDLHHGNILAAGRRGWLAID 184 (253)
T ss_pred CCCcceeeccccchHhhhccCCCCceEeC
Confidence 33334689999999999998766677776
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.15 Score=49.81 Aligned_cols=30 Identities=23% Similarity=0.367 Sum_probs=25.1
Q ss_pred CeEecCCCCCCEEEcCC--C---cEEEEecCCccc
Q 012297 350 RILHRDIKSSNILLDEN--L---NAKITDLGMAKR 379 (466)
Q Consensus 350 ~ivHrDLk~~NILld~~--~---~vkL~DfGla~~ 379 (466)
-++|||+++.|||+..+ + .+++.||.+++.
T Consensus 216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred EEEcCccCHHhEeEccccccccccceeeccccccC
Confidence 58999999999999654 3 699999998753
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 466 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-45 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-44 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-38 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-30 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-30 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-29 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 329 bits (846), Expect = e-111
Identities = 100/252 (39%), Positives = 151/252 (59%), Gaps = 12/252 (4%)
Query: 209 GTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVF 268
G + RFS L+ A+D FS NI+G+GG VY+G+L DG +VAVKR K + + F
Sbjct: 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74
Query: 269 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNW 326
TEV+M+S H +++ L G+C RLLV+ +M NG++ CL ++W
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMT----PTERLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 327 DTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 386
R IA+G+ARGL YLH+ P+I+HRD+K++NILLDE A + D G+AK L
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDT 189
Query: 387 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES- 445
++ ++GT G+ APEY G++S +DVF +GV+LLELITG++ + ++
Sbjct: 190 HVTT---AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 446 -LVLWVKSIITD 456
L+ WVK ++ +
Sbjct: 247 MLLDWVKGLLKE 258
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 316 bits (811), Expect = e-105
Identities = 99/251 (39%), Positives = 138/251 (54%), Gaps = 13/251 (5%)
Query: 213 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEV 272
R LE AT+ F ++G G VY+G L DG VA+KR F TE+
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT-PESSQGIEEFETEI 86
Query: 273 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRV 330
+ LS H H+V L+G+C E R +L++++M NGNL+ L G M+W+ R+
Sbjct: 87 ETLSFCRHPHLVSLIGFCDE----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 331 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 390
I IGAARGL YLH A I+HRD+KS NILLDEN KITD G++K + + S
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK-KGTELDQTHLS 198
Query: 391 SPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWV 450
+ ++GT GY PEY + GR + SDV+SFGVVL E++ R I +S+ + +L W
Sbjct: 199 T--VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256
Query: 451 KSIITDASICQ 461
+ + Q
Sbjct: 257 VESHNNGQLEQ 267
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 5e-97
Identities = 86/254 (33%), Positives = 132/254 (51%), Gaps = 24/254 (9%)
Query: 213 RFSYSALEHATDKFS------GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA-- 264
FS+ L++ T+ F G N +G+GG VY+G + + VAVK+
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 265 -DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-DGVLVE 322
F E+ ++++ H ++V L+G+ S+ LV+ +MPNG+L D L
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSD----GDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 323 GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382
++W R IA GAA G+ +LHE +HRDIKS+NILLDE AKI+D G+A+ +
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKG 442
+S R+ GT Y APE + G + SD++SFGVVLLE+ITG + +
Sbjct: 186 FAQTVMTS---RIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH--RE 239
Query: 443 EESLVLWVKSIITD 456
+ L+ + I +
Sbjct: 240 PQLLLDIKEEIEDE 253
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-71
Identities = 67/257 (26%), Positives = 97/257 (37%), Gaps = 21/257 (8%)
Query: 208 HGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV 267
H + + L + + +G V++ QL VAVK F Q
Sbjct: 8 HSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD--KQSWQ 64
Query: 268 FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWD 327
EV L + H +++ +G L+ F G+L D L ++W+
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWN 121
Query: 328 TRVAIAIGAARGLEYLHEAAA-------PRILHRDIKSSNILLDENLNAKITDLGMAKRL 380
IA ARGL YLHE P I HRDIKS N+LL NL A I D G+A +
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-----RASLMSDVFSFGVVLLELITGRQPI 435
+A + GT Y APE A L D+++ G+VL EL +
Sbjct: 182 EAGKSAGDTHGQV---GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 436 HRSITKGEESLVLWVKS 452
+ + +
Sbjct: 239 DGPVDEYMLPFEEEIGQ 255
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 6e-58
Identities = 59/243 (24%), Positives = 93/243 (38%), Gaps = 27/243 (11%)
Query: 212 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTE 271
+ + S D ++G+G VY+G L D R VAVK F F+ E
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINE 55
Query: 272 VDM--LSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDT 328
++ + + H ++ + M LV E+ PNG+L L +W +
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVS 112
Query: 329 RVAIAIGAARGLEYLHEAAA------PRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382
+A RGL YLH P I HRD+ S N+L+ + I+D G++ RL
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 383 DGLPSCSSSPARM---QGTFGYFAPEYAM-------VGRASLMSDVFSFGVVLLELITGR 432
+ L GT Y APE A D+++ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 433 QPI 435
+
Sbjct: 233 TDL 235
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 4e-56
Identities = 71/209 (33%), Positives = 110/209 (52%), Gaps = 17/209 (8%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 287
+G G V+R + G VAVK Q +A+ V FL EV ++ RL H ++V +
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 288 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCL-DGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
G + + L +V E++ G+L L E ++ R+++A A+G+ YLH
Sbjct: 101 GAVT-----QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH- 154
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 405
P I+HR++KS N+L+D+ K+ D G++ RLKA S S+ GT + APE
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS-RLKASTFLSSKSAA----GTPEWMAPE 209
Query: 406 YAMVGRASLMSDVFSFGVVLLELITGRQP 434
++ SDV+SFGV+L EL T +QP
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 4e-53
Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 20/210 (9%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+ + S +++G+ G + VK K + F E L H +V+P++G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
C L+ +MP G+L + L ++ V A+ ARG+ +LH
Sbjct: 75 ACQSPPAPHPT--LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLE 131
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408
P I + S ++++DE++ A+I+ + ++ G + APE A+
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG----------RMYAPAWVAPE-AL 180
Query: 409 VGRASLM----SDVFSFGVVLLELITGRQP 434
+ +D++SF V+L EL+T P
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-52
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+VG+G V + + + VA+K+ +++ + F+ E+ LSR++H ++V L G
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGV-LVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
C LV E+ G+L + L G + ++ + ++G+ YLH
Sbjct: 70 CLN------PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 349 PRILHRDIKSSNILLDENLN-AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 407
++HRD+K N+LL KI D G A ++ + +G+ + APE
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--------THMTNNKGSAAWMAPEVF 175
Query: 408 MVGRASLMSDVFSFGVVLLELITGRQP 434
S DVFS+G++L E+IT R+P
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKP 202
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 7e-52
Identities = 72/216 (33%), Positives = 98/216 (45%), Gaps = 26/216 (12%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV---FLTEVDMLSRLHHCHVVPL 286
I+G GG VYR G VAVK + + E + + L H +++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
G C K LV EF G L L G + + D V A+ ARG+ YLH+
Sbjct: 72 RGVCL----KEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDE 124
Query: 347 AAPRILHRDIKSSNILLDE--------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
A I+HRD+KSSNIL+ + N KITD G+A R ++ G
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-REWHR------TTKMSAAGA 177
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+ + APE S SDV+S+GV+L EL+TG P
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-51
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 230 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV------FLTEVDMLSRLHHCH 282
+G+GG V++G+ + D +VA+K + F EV ++S L+H +
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
+V L G +V EF+P G+L L + W ++ + + A G+EY
Sbjct: 85 IVKLYGLMHN------PPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEY 137
Query: 343 LHEAAAPRILHRDIKSSNILLDE-----NLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
+ P I+HRD++S NI L + AK+ D G++ + + G
Sbjct: 138 MQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-QQSVHSVSGLL-------G 188
Query: 398 TFGYFAPEYAMVGRASL---MSDVFSFGVVLLELITGRQP 434
F + APE + +D +SF ++L ++TG P
Sbjct: 189 NFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-51
Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 22/218 (10%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDM--LSRLHHCHVVPLV 287
VG+G V+RG G VAVK F ++ + + E ++ L H +++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFI 68
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
R L+ + G+L D L + ++ + + I + A GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 348 A-----PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
P I HRD+KS NIL+ +N I DLG+A + + GT Y
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 403 APE------YAMVGRASLMSDVFSFGVVLLELITGRQP 434
APE + D+++FG+VL E+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-50
Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G G VY+G+ VAVK P F EV +L + H +++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
+ +V ++ +L L + IA ARG++YLH A
Sbjct: 90 TA-----PQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLH---AKS 140
Query: 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE---YA 407
I+HRD+KS+NI L E+ KI D G+A + G+ + APE
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS---GSILWMAPEVIRMQ 197
Query: 408 MVGRASLMSDVFSFGVVLLELITGRQP 434
S SDV++FG+VL EL+TG+ P
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-49
Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDM--LSRLHHCHVVPLV 287
+G+G V+RG+ G VAVK F ++ + + E ++ L H +++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFI 102
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
++ G LV ++ +G+L D L+ + + + +A+ A GL +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 348 A-----PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
P I HRD+KS NIL+ +N I DLG+A R + + R GT Y
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-VGTKRYM 218
Query: 403 APE------YAMVGRASLMSDVFSFGVVLLELITGRQP 434
APE + +D+++ G+V E+
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-49
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 22/218 (10%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDM--LSRLHHCHVVPLV 287
+G+G V+ G+ G VAVK F T ++ + E ++ + H +++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFI 97
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
+ G L+ ++ NG+L D L ++ + + +A + GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 348 A-----PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
P I HRD+KS NIL+ +N I DLG+A + +D R+ GT Y
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYM 213
Query: 403 APE------YAMVGRASLMSDVFSFGVVLLELITGRQP 434
PE ++ +M+D++SFG++L E+
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 8e-48
Identities = 55/218 (25%), Positives = 87/218 (39%), Gaps = 25/218 (11%)
Query: 230 NIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
++G+G + G ++ +K + FL EV ++ L H +V+ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT-FLKEVKVMRCLEHPNVLKFIG 74
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
+ KR + E++ G LR + D W RV+ A A G+ YLH
Sbjct: 75 VLY--KDKRLN--FITEYIKGGTLRGIIKSMDSQY----PWSQRVSFAKDIASGMAYLHS 126
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ--------- 396
I+HRD+ S N L+ EN N + D G+A+ + + +
Sbjct: 127 M---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
G + APE DVFSFG+VL E+I
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-47
Identities = 51/217 (23%), Positives = 78/217 (35%), Gaps = 25/217 (11%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 287
++G+G VY G+ G VA++ + N D + F EV + H +VV +
Sbjct: 39 ELIGKGRFGQVYHGRW-HGE-VAIRLIDIER-DNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 288 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
G C L ++ L + + ++ + IA +G+ YLH
Sbjct: 96 GACM-----SPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMGYLH-- 147
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
A ILH+D+KS N+ D ITD G+ G + APE
Sbjct: 148 -AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 407 AMVGRASLM---------SDVFSFGVVLLELITGRQP 434
SDVF+ G + EL P
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-37
Identities = 44/206 (21%), Positives = 81/206 (39%), Gaps = 21/206 (10%)
Query: 232 VGQGGSSYVYRG--QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+ GG ++Y + +GR V +K G A ++ + E L+ + H +V + +
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 290 CSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
+V E++ +L+ L +A + L YLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKL----PVAEAIAYLLEILPALSYLHSI-- 201
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408
+++ D+K NI+L E K+ DLG R+ + G + GT G+ APE
Sbjct: 202 -GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY---------LYGTPGFQAPEIVR 250
Query: 409 VGRASLMSDVFSFGVVLLELITGRQP 434
++ +D+++ G L L
Sbjct: 251 -TGPTVATDIYTVGRTLAALTLDLPT 275
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 22/211 (10%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVVPLVG 288
+G+G VY+G VA + + ++ F E +ML L H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGM--NWDTRVAIAIGAARGLEYLH 344
+ +LV E M +G L+ L V+ + +W ++ +GL++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI------LKGLQFLH 146
Query: 345 EAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
P I+HRD+K NI + + KI DLG+A +A + + GT + A
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-------VIGTPEFMA 198
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
PE DV++FG+ +LE+ T P
Sbjct: 199 PEMYEEK-YDESVDVYAFGMCMLEMATSEYP 228
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 62/215 (28%), Positives = 87/215 (40%), Gaps = 30/215 (13%)
Query: 233 GQG--GSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
G+G G V G +VAVK K GP S + E+D+L L+H H++
Sbjct: 40 GEGHFGK--VSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
G C + LV E++P G+LRD L + + A G+ YLH
Sbjct: 98 YKGCCEDAGAASLQ--LVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHA 152
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-----MQGTFG 400
+HRD+ + N+LLD + KI D G+AK +
Sbjct: 153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----- 204
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
APE + SDV+SFGV L EL+T
Sbjct: 205 --APECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 24/218 (11%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+GG SYV + L DG A+KR E DM +H +++ LV YC
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAIGAARGLEYLHEAAA 348
RG + L+ F G L + ++ + +G + +G RGLE +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ------GTFGYF 402
HRD+K +NILL + + DLG + S +Q T Y
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH--VEGSRQALTLQDWAAQRCTISYR 210
Query: 403 APE------YAMVGRASLMSDVFSFGVVLLELITGRQP 434
APE + ++ +DV+S G VL ++ G P
Sbjct: 211 APELFSVQSHCVIDER---TDVWSLGCVLYAMMFGEGP 245
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 34/221 (15%)
Query: 230 NIVGQG--GSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+G+G G V + G VAVK K + G N + E+++L L+H +
Sbjct: 27 RDLGEGHFGK--VELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARG 339
+V G C+E G L+ EF+P+G+L++ L + N ++ A+ +G
Sbjct: 85 IVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYLPKNKNKI----NLKQQLKYAVQICKG 138
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR----- 394
++YL + +HRD+ + N+L++ KI D G+ K ++ D
Sbjct: 139 MDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 395 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
APE M + + SDV+SFGV L EL+T
Sbjct: 196 Y-------APECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 240 VYRGQLTDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298
V+ G+L VAVK + P+ + FL E +L + H ++V L+G C+ ++
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT----QKQ 185
Query: 299 MRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 356
+V E + G+ L +G + T + + AA G+EYL +HRD+
Sbjct: 186 PIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDL 239
Query: 357 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF-----APEYAMVGR 411
+ N L+ E KI+D GM++ A G APE GR
Sbjct: 240 AARNCLVTEKNVLKISDFGMSREEADG-------VYAASGGL-RQVPVKWTAPEALNYGR 291
Query: 412 ASLMSDVFSFGVVLLELIT-GRQP 434
S SDV+SFG++L E + G P
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP 315
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 8e-34
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 25/218 (11%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
+ VG+G V+R + G AVK+ + + E+ + L
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------ELVACAGLSSP 110
Query: 282 HVVPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAA- 337
+VPL G + G + +F E + G+L + G L E R +G A
Sbjct: 111 RIVPLYG--AVREGPW---VNIFMELLEGGSLGQLIKQMGCLPE-----DRALYYLGQAL 160
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
GLEYLH RILH D+K+ N+LL + A + D G A L+ DGL + +
Sbjct: 161 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
GT + APE M D++S ++L ++ G P
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 65/218 (29%), Positives = 93/218 (42%), Gaps = 35/218 (16%)
Query: 233 GQG--GSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
G+G GS V + G +VAVK+ + GP+ F E+ +L LH +V
Sbjct: 32 GKGNFGS--VELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 342
G + LV E++P+G LRD L L + + + +G+EY
Sbjct: 89 YRGVSYGPGRQSLR--LVMEYLPSGCLRDFLQRHRARL----DASRLLLYSSQICKGMEY 142
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-----MQG 397
L R +HRD+ + NIL++ + KI D G+AK L D P +
Sbjct: 143 LGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-- 197
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
APE S SDV+SFGVVL EL T +
Sbjct: 198 -----APESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-33
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 14/208 (6%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVG 288
+G GG S V+ + L D R VAVK + + F E + L+H +V +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHEA 346
+ +V E++ LRD ++ M + + A + L + H+
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRD----IVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
I+HRD+K +NI++ K+ D G+A+ + G ++ + GT Y +PE
Sbjct: 136 ---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA--VIGTAQYLSPEQ 190
Query: 407 AMVGRASLMSDVFSFGVVLLELITGRQP 434
A SDV+S G VL E++TG P
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-33
Identities = 61/232 (26%), Positives = 94/232 (40%), Gaps = 34/232 (14%)
Query: 230 NIVGQG--GSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+G+G GS V + G +VAVK+ + F E+++L L H +
Sbjct: 47 QQLGKGNFGS--VEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDN 103
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARG 339
+V G C + L+ E++P G+LRD L + + + +G
Sbjct: 104 IVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERI----DHIKLLQYTSQICKG 157
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR----- 394
+EYL R +HRD+ + NIL++ KI D G+ K L D P
Sbjct: 158 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 214
Query: 395 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 446
APE + S+ SDV+SFGVVL EL T + + +
Sbjct: 215 Y-------APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-33
Identities = 60/227 (26%), Positives = 91/227 (40%), Gaps = 32/227 (14%)
Query: 233 GQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 287
G GS V + G +VAVK+ + F E+++L L H ++V
Sbjct: 21 GNFGS--VEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLH 344
G C + L+ E++P G+LRD L + + + +G+EYL
Sbjct: 78 GVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERI----DHIKLLQYTSQICKGMEYLG 131
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-----MQGTF 399
R +HRD+ + NIL++ KI D G+ K L D P
Sbjct: 132 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY---- 184
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 446
APE + S+ SDV+SFGVVL EL T + + +
Sbjct: 185 ---APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-33
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 233 GQGGSSYVYRGQLT--DGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
G G V +G +I VA+K K + E ++ +L + ++V L+G
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
C + M LV E G L L + + + G++YL E
Sbjct: 79 CQA---EALM--LVMEMAGGGPLHKFLVGKREEI----PVSNVAELLHQVSMGMKYLEEK 129
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+HRD+ + N+LL AKI+D G++K L AD + S + ++APE
Sbjct: 130 ---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW--PLKWYAPEC 184
Query: 407 AMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ S SDV+S+GV + E ++ G++P
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 31/219 (14%)
Query: 230 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
++G+G VY G L D AVK S FLTE ++ H +V+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 342
L+G C G L+V +M +G+LR+ + + + A+G++Y
Sbjct: 91 LLGICLRSEGS---PLVVLPYMKHGDLRNFIRNETHNPTVK----DLIGFGLQVAKGMKY 143
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
L A+ + +HRD+ + N +LDE K+ D G+A+ + + G
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-------DKEYYSVHNKTGAK 193
Query: 403 ------APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
A E + + SDV+SFGV+L EL+T G P
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 56/209 (26%), Positives = 80/209 (38%), Gaps = 22/209 (10%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL-- 286
VG+GG VY + RIVA+K + E RL HVVP+
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHE 345
G E G + + +L L +G + VAI L+ H
Sbjct: 102 FG---EIDG---QLYVDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHA 152
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 405
A HRD+K NIL+ + A + D G+A + L + GT Y APE
Sbjct: 153 A---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL----TQLGNTVGTLYYMAPE 205
Query: 406 YAMVGRASLMSDVFSFGVVLLELITGRQP 434
A+ +D+++ VL E +TG P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVG 288
+G GG S VY + VA+K +++ F EV S+L H ++V ++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHEAA 347
E LV E++ L + ++ G ++ DT + G+++ H+
Sbjct: 79 VDEE----DDCYYLVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDM- 130
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 407
RI+HRDIK NIL+D N KI D G+AK L L + + GT YF+PE A
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL----TQTNHVLGTVQYFSPEQA 184
Query: 408 MVGRASLMSDVFSFGVVLLELITGRQP 434
+D++S G+VL E++ G P
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 54/225 (24%), Positives = 88/225 (39%), Gaps = 35/225 (15%)
Query: 230 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHCHVV 284
I+G+G V G L VAVK K + FL+E + H +V+
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 285 PLVGYCSEFRGKRAMRLLV-FEFMPNGNL----RDCLDGVLVEGMNWDTRVAIAIGAARG 339
L+G C E + + +V FM G+L + + T + + A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSCSSS 391
+EYL + LHRD+ + N +L +++ + D G++K R
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK-----M 211
Query: 392 PAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
P + + A E + SDV++FGV + E+ T G P
Sbjct: 212 PVKWI-------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 230 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
++G+G VY G+ D A+K FL E ++ L+H +V+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR--VAIAIGAARGLEYL 343
L+G G + ++ +M +G+L + N + ++ + ARG+EYL
Sbjct: 87 LIGIMLPPEG---LPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYL 140
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF- 402
A + +HRD+ + N +LDE+ K+ D G+A+ + + Q
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR------EYYSVQQHRHARLP 191
Query: 403 ----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
A E R + SDV+SFGV+L EL+T G P
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 36/226 (15%)
Query: 230 NIVGQGGSSYVYRGQLTDG----RIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVV 284
++G+G V QL VAVK K ++D FL E + H HV
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 285 PLVGYCSEFRGKRAMR--LLVFEFMPNGN----LRDCLDGVLVEGMNWDTRVAIAIGAAR 338
LVG R K + +++ FM +G+ L G + T V + A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSCSS 390
G+EYL ++ +HRD+ + N +L E++ + D G+++ R
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK----- 200
Query: 391 SPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
P + + A E ++ SDV++FGV + E++T G+ P
Sbjct: 201 LPVKWL-------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-32
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 32/218 (14%)
Query: 231 IVGQGGSSYVYRGQLTDGRI-----VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
++G G VY+G L VA+K K FL E ++ + H +++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 342
L G S + K M ++ E+M NG L L DG + V + G A G++Y
Sbjct: 111 LEGVIS--KYKPMM--IITEYMENGALDKFLREKDGEF----SVLQLVGMLRGIAAGMKY 162
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS----PAR-MQG 397
L +HRD+ + NIL++ NL K++D G+++ L+ D + ++S P R
Sbjct: 163 LANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT-- 217
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
APE + + SDV+SFG+V+ E++T G +P
Sbjct: 218 -----APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 8e-32
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 230 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
++G+G VY G L D AVK S FLTE ++ H +V+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR--VAIAIGAARGLEYL 343
L+G C G L+V +M +G+LR+ + E N + + + A+G+++L
Sbjct: 155 LLGICLRSEGS---PLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF- 402
A+ + +HRD+ + N +LDE K+ D G+A+ + T
Sbjct: 209 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-----DKEFDSVH-NKTGAKLP 259
Query: 403 ----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
A E + + SDV+SFGV+L EL+T G P
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-32
Identities = 60/236 (25%), Positives = 98/236 (41%), Gaps = 42/236 (17%)
Query: 230 NIVGQGGSSYVYRGQLTDGR-----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 284
++G G VY+G VA+K + P A+ L E +++ + + HV
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLE 341
L+G C L+ + MP G L D + + + + A+G+
Sbjct: 81 RLLGICLT---STVQ--LITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGMN 131
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
YL + R++HRD+ + N+L+ + KITD G+AK L A+ G
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEG-GK 180
Query: 402 F-----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGE 443
A E + + SDV+S+GV + EL+T G +P I + KGE
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 31/218 (14%)
Query: 230 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
I+G G S V G+L VA+K K FL+E ++ + H +++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 342
L G + RG+ AM +V E+M NG+L L DG V + G G+ Y
Sbjct: 115 LEGVVT--RGRLAM--IVTEYMENGSLDTFLRTHDGQF----TIMQLVGMLRGVGAGMRY 166
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-----MQG 397
L + +HRD+ + N+L+D NL K++D G+++ L+ D + +++ +
Sbjct: 167 LSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-- 221
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
APE S SDV+SFGVV+ E++ G +P
Sbjct: 222 -----APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 230 NIVGQGGSSYVYRGQLTDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+ +G G VY G + VAVK K + + FL E ++ + H ++V L+G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 76
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
C+ R ++ EFM GNL D L + ++ + +A + +EYL
Sbjct: 77 VCT--REPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EK 129
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAPE 405
+HRD+ + N L+ EN K+ D G+++ + D + + + P + APE
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT-------APE 182
Query: 406 YAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ S+ SDV++FGV+L E+ T G P
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 27/228 (11%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
Y + E + +G G V G+ VA+K K G ++ F+ E
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAK 71
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRV 330
++ L H +V L G C+ K+ ++ E+M NG L + L +
Sbjct: 72 VMMNLSHEKLVQLYGVCT----KQRPIFIITEYMANGCLLNYLREMRHRF----QTQQLL 123
Query: 331 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 390
+ +EYL + + LHRD+ + N L+++ K++D G+++ + D S
Sbjct: 124 EMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180
Query: 391 S--PAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
S P R PE M + S SD+++FGV++ E+ + G+ P
Sbjct: 181 SKFPVRWS-------PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 5e-31
Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 233 GQGGSSYVYRGQLT--DGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
G GS V +G +I VA+K K + E ++ +L + ++V L+G
Sbjct: 347 GNFGS--VRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
C + M LV E G L L + + + G++YL E
Sbjct: 405 CQA---EALM--LVMEMAGGGPLHKFLVGKREEI----PVSNVAELLHQVSMGMKYLEEK 455
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+HR++ + N+LL AKI+D G++K L AD + S + ++APE
Sbjct: 456 ---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW--PLKWYAPEC 510
Query: 407 AMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ S SDV+S+GV + E ++ G++P
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 233 GQGGSSYVYRGQLTDGRI---VAVKRFKT-QGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
G G+ V +G ++ VAVK K P L E +++ +L + ++V ++G
Sbjct: 28 GNFGT--VKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
C + M LV E G L L + + + + G++YL E+
Sbjct: 86 ICE---AESWM--LVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES-- 136
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408
+HRD+ + N+LL AKI+D G++K L+AD + + + ++APE
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW--PVKWYAPECIN 193
Query: 409 VGRASLMSDVFSFGVVLLELIT-GRQP 434
+ S SDV+SFGV++ E + G++P
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-31
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+G G V+ G + VA+K + G ++ F+ E +++ +L H +V L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
C ++A LV EFM +G L D L G+ +T + + + G+ YL
Sbjct: 72 CL----EQAPICLVTEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYL--- 120
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFA 403
++HRD+ + N L+ EN K++D GM + + D S + + P + +
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA-------S 173
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
PE R S SDV+SFGV++ E+ + G+ P
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 36/220 (16%)
Query: 230 NIVGQG--GSSYVYRGQLTDGR-----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
++G G G+ V++G V +K + + G + + + L H H
Sbjct: 19 KVLGSGVFGT--VHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARG 339
+V L+G C LV +++P G+L D + G L + + A+G
Sbjct: 77 IVRLLGLCPG---SSLQ--LVTQYLPLGSLLDHVRQHRGAL----GPQLLLNWGVQIAKG 127
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PAR-M 395
+ YL E ++HR++ + N+LL ++ D G+A L D S P + M
Sbjct: 128 MYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
A E G+ + SDV+S+GV + EL+T G +P
Sbjct: 185 -------ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-31
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 27/211 (12%)
Query: 231 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G G V G+ VAVK K G ++ F E + +L H +V G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKE--GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
S K +V E++ NG L + L L + + G+ +L
Sbjct: 73 S----KEYPIYIVTEYISNGCLLNYLRSHGKGL----EPSQLLEMCYDVCEGMAFL---E 121
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAP 404
+ + +HRD+ + N L+D +L K++D GM + + D S + P + AP
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS-------AP 174
Query: 405 EYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
E + S SDV++FG+++ E+ + G+ P
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+ +G G V+ VAVK K G + FL E +++ L H +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKL 245
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
V L ++ + ++ EFM G+L D L + + A G+ ++
Sbjct: 246 VKLHAVVTK---EPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGY 401
+ +HRD++++NIL+ +L KI D G+A+ ++ + + + P + +
Sbjct: 301 EQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK------W 351
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
APE G ++ SDV+SFG++L+E++T GR P
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 230 NIVGQGGSSYVYRGQLTDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+ +G G VY G + VAVK K FL E ++ + H ++V L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
C+ ++ EFM GNL D L + ++ + +A + +EYL +
Sbjct: 284 VCTR--EPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-- 337
Query: 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF--APEY 406
+HR++ + N L+ EN K+ D G+++ + D + A F APE
Sbjct: 338 -NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFPIKWTAPES 390
Query: 407 AMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ S+ SDV++FGV+L E+ T G P
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 30/215 (13%)
Query: 231 IVGQGGSSYVYRGQLTDGRI----VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
I+G+G VY G T+ + VAVK K + F++E ++ L H H+V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 343
+G E ++ E P G L L L T V ++ + + YL
Sbjct: 79 IGIIEE-----EPTWIIMELYPYGELGHYLERNKNSL----KVLTLVLYSLQICKAMAYL 129
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFG 400
+HRDI NIL+ K+ D G+++ ++ + S + P + M
Sbjct: 130 ESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----- 181
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+PE R + SDV+ F V + E+++ G+QP
Sbjct: 182 --SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 67/224 (29%), Positives = 108/224 (48%), Gaps = 19/224 (8%)
Query: 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
+ A E + +GQG V+ G VA+K K G + FL E
Sbjct: 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQ 231
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
++ +L H +V L SE + +V E+M G+L D L G + + V +A
Sbjct: 232 VMKKLRHEKLVQLYAVVSE---EPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 286
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS-- 391
A G+ Y+ +HRD++++NIL+ ENL K+ D G+A+ ++ + + +
Sbjct: 287 AQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343
Query: 392 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
P + + APE A+ GR ++ SDV+SFG++L EL T GR P
Sbjct: 344 PIK------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+G G V+ G VAVK K G + FL E +++ +L H +V L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 349
+ + + ++ E+M NG+L D L + + + +A A G+ ++
Sbjct: 77 VT----QEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EER 128
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAPEY 406
+HRD++++NIL+ + L+ KI D G+A+ ++ + + + P + APE
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT-------APEA 181
Query: 407 AMVGRASLMSDVFSFGVVLLELIT-GRQP 434
G ++ SDV+SFG++L E++T GR P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 230 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 285
+VG G V G+L VA+K K FL E ++ + H +++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 342
L G + + K M +V E+M NG+L L D V + G A G++Y
Sbjct: 111 LEGVVT--KSKPVM--IVTEYMENGSLDSFLRKHDAQF----TVIQLVGMLRGIASGMKY 162
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS----PAR-MQG 397
L + +HRD+ + NIL++ NL K++D G+ + L+ D + ++ P R
Sbjct: 163 LSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-- 217
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+PE + + SDV+S+G+VL E+++ G +P
Sbjct: 218 -----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 19/225 (8%)
Query: 213 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEV 272
+ A E + +GQG V+ G VA+K K G + FL E
Sbjct: 256 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEA 313
Query: 273 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 332
++ +L H +V L SE + +V E+M G+L D L G + + V +
Sbjct: 314 QVMKKLRHEKLVQLYAVVSE---EPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 368
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS- 391
A A G+ Y+ +HRD++++NIL+ ENL K+ D G+A+ ++ + + +
Sbjct: 369 AAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 425
Query: 392 -PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
P + + APE A+ GR ++ SDV+SFG++L EL T GR P
Sbjct: 426 FPIK------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 54/215 (25%), Positives = 87/215 (40%), Gaps = 30/215 (13%)
Query: 231 IVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G V++G VA+K K + FL E + + H H+V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 343
+G +E ++ E G LR L L + + A + L YL
Sbjct: 82 IGVITE---NPVW--IIMELCTLGELRSFLQVRKYSLDLA----SLILYAYQLSTALAYL 132
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFG 400
R +HRDI + N+L+ N K+ D G+++ ++ S P + M
Sbjct: 133 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----- 184
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
APE R + SDV+ FGV + E++ G +P
Sbjct: 185 --APESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 63/231 (27%), Positives = 93/231 (40%), Gaps = 47/231 (20%)
Query: 230 NIVGQG--GSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
+GQG G VY G VA+K FL E ++ +
Sbjct: 31 RELGQGSFGM--VYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------DGVLVEGMNWDTRVAIA 333
HVV L+G S + L++ E M G+L+ L + ++ + + +A
Sbjct: 89 HVVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGL 385
A G+ YL A + +HRD+ + N ++ E+ KI D GM + R GL
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 386 PSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
P R M +PE G + SDV+SFGVVL E+ T QP
Sbjct: 202 -----LPVRWM-------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+G+G V G G VAVK K A FL E ++++L H ++V L+G
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGV 82
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 349
E +G +V E+M G+L D L + D + ++ +EYL
Sbjct: 83 IVEEKGGL---YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGN 136
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAPEY 406
+HRD+ + N+L+ E+ AK++D G+ K + + + P + APE
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT-------APEA 185
Query: 407 AMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ S SDV+SFG++L E+ + GR P
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 32/218 (14%)
Query: 230 NIVGQGGSSYVYRGQLTDGR-----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 284
++G G VY+G VA+K + P A+ L E +++ + + HV
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLE 341
L+G C + L+ + MP G L D + + + + A+G+
Sbjct: 81 RLLGICLT-----STVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGMN 131
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PAR-MQG 397
YL + R++HRD+ + N+L+ + KITD G+AK L A+ + P + M
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-- 186
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
A E + + SDV+S+GV + EL+T G +P
Sbjct: 187 -----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 60/214 (28%), Positives = 86/214 (40%), Gaps = 24/214 (11%)
Query: 231 IVGQGGSSYVYRGQLTDGRI----VAVKRFK--TQGGPNADSVFLTEVDMLSRLHHCHVV 284
+G G V RG+ VAVK K P A F+ EV+ + L H +++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLE 341
L G +V E P G+L D L G T A+ A G+
Sbjct: 85 RLYGVVLT---PPMK--MVTELAPLGSLLDRLRKHQGHF----LLGTLSRYAVQVAEGMG 135
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
YL R +HRD+ + N+LL KI D G+ + L + ++ F +
Sbjct: 136 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFAW 190
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
APE S SD + FGV L E+ T G++P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 25/199 (12%)
Query: 240 VYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299
V G G VAVK K A FL E ++++L H ++V L+G E +G
Sbjct: 209 VMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGL-- 262
Query: 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359
+V E+M G+L D L + D + ++ +EYL +HRD+ +
Sbjct: 263 -YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAAR 318
Query: 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAPEYAMVGRASLMS 416
N+L+ E+ AK++D G+ K + + + P + APE + S S
Sbjct: 319 NVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT-------APEALREKKFSTKS 367
Query: 417 DVFSFGVVLLELIT-GRQP 434
DV+SFG++L E+ + GR P
Sbjct: 368 DVWSFGILLWEIYSFGRVP 386
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 56/237 (23%), Positives = 95/237 (40%), Gaps = 40/237 (16%)
Query: 220 EHATDKFSGSN-----IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVD 273
H DK G + ++G GG V++ + DG+ +KR K N + EV
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEKA--EREVK 56
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRL------------LVFEFMPNGNLRDCLD---- 317
L++L H ++V G F + EF G L ++
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 318 GVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377
L + + + + +G++Y+H ++++RD+K SNI L + KI D G+
Sbjct: 117 EKLDKVLALE----LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLV 169
Query: 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
LK DG R +GT Y +PE D+++ G++L EL+
Sbjct: 170 TSLKNDGK------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 50/225 (22%)
Query: 240 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293
V+ + + +VAVK K A F E ++L+ L H H+V G C
Sbjct: 31 VFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-- 87
Query: 294 RGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTR---------VAIAIGAARG 339
++VFE+M +G+L L D +++ + IA A G
Sbjct: 88 --DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 145
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSCSSS 391
+ YL A+ +HRD+ + N L+ NL KI D GM++ R+ +
Sbjct: 146 MVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM-----L 197
Query: 392 PAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
P R M PE M + + SDV+SFGV+L E+ T G+QP
Sbjct: 198 PIRWM-------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 41/221 (18%)
Query: 240 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293
VY+G L VA+K K + F E + +RL H +VV L+G +
Sbjct: 25 VYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-- 82
Query: 294 RGKRAMRLLVFEFMPNGNLRDCL--------DGVLVEGMNWDTR------VAIAIGAARG 339
K ++F + +G+L + L G + + V + A G
Sbjct: 83 --KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAG 140
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
+EYL ++ ++H+D+ + N+L+ + LN KI+DLG+ + + ++ ++ G
Sbjct: 141 MEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY-------AADYYKLLGN- 189
Query: 400 GYF-----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
APE M G+ S+ SD++S+GVVL E+ + G QP
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 51/216 (23%), Positives = 85/216 (39%), Gaps = 20/216 (9%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG-- 288
+G+GG V+ + D A+KR + A + EV L++L H +V
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 289 -----YCSEFRGKRAMRL-LVFEFMPNGNLRDCLDG-VLVEGMNWDTRVAIAIGAARGLE 341
+ L + + NL+D ++G +E + I + A +E
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ----- 396
+LH ++HRD+K SNI + K+ D G+ + D +P
Sbjct: 133 FLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 397 --GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430
GT Y +PE S D+FS G++L EL+
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 67/231 (29%), Positives = 103/231 (44%), Gaps = 49/231 (21%)
Query: 233 GQGGSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
G+G V+ + + +VAVK K + +A F E ++L+ L H H+V
Sbjct: 50 GEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTMLQHQHIVRF 108
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTR--------VAIA 333
G C+ + L+VFE+M +G+L L D L+ G +A+A
Sbjct: 109 FGVCT----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGL 385
A G+ YL A +HRD+ + N L+ + L KI D GM++ R+ +
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 386 PSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
P R M PE + + + SDV+SFGVVL E+ T G+QP
Sbjct: 222 -----LPIRWM-------PPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-29
Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 44/230 (19%)
Query: 230 NIVGQGGSSYVYRGQLTDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 285
+++G+G V + ++ A+KR K + F E+++L +L HH +++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTR--------VA 331
L+G C R L E+ P+GNL D L + + T +
Sbjct: 91 LLGACE----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK-----RLKADGLP 386
A ARG++YL + + +HRD+ + NIL+ EN AKI D G+++ K G
Sbjct: 147 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR- 202
Query: 387 SCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
P R M A E + SDV+S+GV+L E+++ G P
Sbjct: 203 ----LPVRWM-------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-29
Identities = 58/229 (25%), Positives = 89/229 (38%), Gaps = 43/229 (18%)
Query: 230 NIVGQGGSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+G G VY GQ++ VAVK + FL E ++S+ +H ++
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTRVAIAIGAAR 338
V +G + R ++ E M G+L+ L + + +A A
Sbjct: 96 VRCIGVSL----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAK--------RLKADGLPS 387
G +YL +HRDI + N LL AKI D GMA+ R +
Sbjct: 152 GCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM-- 206
Query: 388 CSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
P + M PE M G + +D +SFGV+L E+ + G P
Sbjct: 207 ---LPVKWM-------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-28
Identities = 53/214 (24%), Positives = 87/214 (40%), Gaps = 28/214 (13%)
Query: 231 IVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 286
+G+G V++G VA+K K + FL E + + H H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 343
+G +E ++ E G LR L L + + A + L YL
Sbjct: 457 IGVITE---NPVW--IIMELCTLGELRSFLQVRKFSLDLA----SLILYAYQLSTALAYL 507
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGY 401
R +HRDI + N+L+ N K+ D G+++ ++ S P + +
Sbjct: 508 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------W 558
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
APE R + SDV+ FGV + E++ G +P
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 280
F +G+G S VYR L DG VA+K+ + +A + + E+D+L +L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTRVAIAI 334
+V+ Y + F + +V E G+L + ++ E W +
Sbjct: 92 PNVI---KYYASFIEDNEL-NIVLELADAGDLSRMIKHFKKQKRLIPERTVWK----YFV 143
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
LE++H R++HRDIK +N+ + K+ DLG+ + S ++ A
Sbjct: 144 QLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAH 194
Query: 395 -MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+ GT Y +PE + SD++S G +L E+ + P
Sbjct: 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 43/230 (18%)
Query: 233 GQG--GSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHV 283
G+G G V R VAVK K + ++E+ +L + HH +V
Sbjct: 36 GRGAFGQ--VIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWDTR 329
V L+G C++ G +++ EF GNL L + + + + +
Sbjct: 94 VNLLGACTKPGGPL---MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG---LP 386
+ + A+G+E+L A+ + +HRD+ + NILL E KI D G+A+ + D
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 387 SCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ P + M APE ++ SDV+SFGV+L E+ + G P
Sbjct: 208 GDARLPLKWM-------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 54/235 (22%), Positives = 93/235 (39%), Gaps = 23/235 (9%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFL-TEVDMLSRLHHC 281
+ + +G G + + +DG+I+ K A+ L +EV++L L H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 282 HVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--AR 338
++V Y + L +V E+ G+L + E D + +
Sbjct: 66 NIV---RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 339 GLEYLHE--AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
L+ H +LHRD+K +N+ LD N K+ D G+A+ L D + +
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-----FV 177
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
GT Y +PE + SD++S G +L EL P + I +G+
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 49/224 (21%), Positives = 88/224 (39%), Gaps = 23/224 (10%)
Query: 223 TDKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVFL-TEVDMLSRL 278
+ ++G+G V + G V V+R + N FL E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 279 HHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 337
+H ++VP + L +V FM G+ +D + ++GMN I G
Sbjct: 84 NHPNIVPY--RATFIADNE---LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARM 395
+ L+Y+H +HR +K+S+IL+ + ++ L + + G P
Sbjct: 139 KALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 396 QGTFGYFAPEYAMVGRASLM-----SDVFSFGVVLLELITGRQP 434
+ +PE V + +L SD++S G+ EL G P
Sbjct: 196 VKVLPWLSPE---VLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 30/270 (11%), Positives = 70/270 (25%), Gaps = 54/270 (20%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV---------------------- 267
++GQ G V P ++++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 268 -----FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM--PNGNLRDCLDGVL 320
F+ D++ ++ + E R ++ M + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRL--DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202
Query: 321 VEG--MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378
+ R+ + + R L LH ++H ++ +I+LD+ +T
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-----SLMSDVFSFGVVLLELITGRQ 433
R A + A G+ + D ++ G+ + +
Sbjct: 260 RDGASAVSPIGRGF----APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 434 PIHRSITKGEESLVL--------WVKSIIT 455
P G + V++++
Sbjct: 316 PNTDDAALGGSEWIFRSCKNIPQPVRALLE 345
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 48/233 (20%)
Query: 233 GQG--GSSYVYRGQLTDGR--------IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHC 281
G+G G V + VAVK K S ++E++M+ + H
Sbjct: 44 GEGAFGQ--VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWD 327
+++ L+G C+ + ++ E+ GNLR+ L + V E M +
Sbjct: 102 NIINLLGACT----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 328 TRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 387
V+ ARG+EYL A+ + +HRD+ + N+L+ EN KI D G+A+ +
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID--- 211
Query: 388 CSSSPARMQGTFGYF-----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ T G APE + SDV+SFGV++ E+ T G P
Sbjct: 212 -----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 54/233 (23%), Positives = 96/233 (41%), Gaps = 57/233 (24%)
Query: 240 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293
V++ + +VAVK K + + + F E +++ + ++V L+G C+
Sbjct: 63 VFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA-- 120
Query: 294 RGKRAMRLLVFEFMPNGNLRDCL--------DGVLVEGMNWDTR--------------VA 331
L+FE+M G+L + L + ++ R +
Sbjct: 121 --VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 178
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKAD 383
IA A G+ YL + + +HRD+ + N L+ EN+ KI D G+++ + +
Sbjct: 179 IARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGN 235
Query: 384 GLPSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
P R M PE R + SDV+++GVVL E+ + G QP
Sbjct: 236 DA-----IPIRWM-------PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 58/229 (25%), Positives = 90/229 (39%), Gaps = 43/229 (18%)
Query: 230 NIVGQGGSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+G G VY GQ++ VAVK + FL E ++S+ +H ++
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTR--VAIAIGAAR 338
V +G + R ++ E M G+L+ L + + + +A A
Sbjct: 137 VRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAK--------RLKADGLPS 387
G +YL +HRDI + N LL AKI D GMA+ R +
Sbjct: 193 GCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM-- 247
Query: 388 CSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
P + M PE M G + +D +SFGV+L E+ + G P
Sbjct: 248 ---LPVKWM-------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 53/218 (24%), Positives = 80/218 (36%), Gaps = 27/218 (12%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRL-HH 280
F + +G G V++ + DGR+ AVKR + D L EV ++ H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 281 CHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD---GVLVEGMNWDTRVAIAIGA 336
V L + G L L E +L+ + L E W
Sbjct: 117 PCCVRL--EQAWEEGGI---LYLQTELC-GPSLQQHCEAWGASLPEAQVWG----YLRDT 166
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
L +LH ++H D+K +NI L K+ D G+ L G +
Sbjct: 167 LLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV------QE 217
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
G Y APE + G +DVFS G+ +LE+ +
Sbjct: 218 GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 49/217 (22%), Positives = 91/217 (41%), Gaps = 22/217 (10%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVF-LTEVDMLSRLHHC 281
+K+ +G+G + DGR +K + + EV +L+ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAIGAA 337
++V Y F ++ +V ++ G+L + + E D +
Sbjct: 84 NIV---QYRESFEENGSL-YIVMDYCEGGDLFKRINAQKGVLFQEDQILD----WFVQIC 135
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
L+++H+ +ILHRDIKS NI L ++ ++ D G+A+ L + + + G
Sbjct: 136 LALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-----CIG 187
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
T Y +PE + SD+++ G VL EL T +
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 51/237 (21%)
Query: 233 GQG--GSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 284
G+G G V + + VAVK K P+ L+E ++L +++H HV+
Sbjct: 32 GEGEFGK--VVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----------------------DGVLVE 322
L G CS + LL+ E+ G+LR L D
Sbjct: 90 KLYGACS----QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 323 GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382
+ ++ A ++G++YL A +++HRD+ + NIL+ E KI+D G+++ +
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 383 DG---LPSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ S P + M A E + SDV+SFGV+L E++T G P
Sbjct: 203 EDSYVKRSQGRIPVKWM-------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-28
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
++G+G VY G L++ +A+K + + + E+ + L H ++V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL-HEEIALHKHLKHKNIVQYLGS 87
Query: 290 CSEFRGKRAMRLLVF-EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA-RGLEYLHEAA 347
SE + +F E +P G+L L + + + GL+YLH+
Sbjct: 88 FSE-----NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN- 141
Query: 348 APRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+I+HRDIK N+L++ + KI+D G +KRL G+ C+ + GT Y APE
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTET---FTGTLQYMAPEI 194
Query: 407 AMVGR--ASLMSDVFSFGVVLLELITGRQP 434
G +D++S G ++E+ TG+ P
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 52/224 (23%), Positives = 92/224 (41%), Gaps = 48/224 (21%)
Query: 240 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292
V VAVK K+ + ++E+ ++S L H ++V L+G C+
Sbjct: 62 VVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT- 120
Query: 293 FRGKRAMRLLVFEFMPNGNLRDCL----------DGVLVEGMNWDTR--VAIAIGAARGL 340
L++ E+ G+L + L + TR + + A+G+
Sbjct: 121 ---HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGM 177
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSCSSSP 392
+L A+ +HRD+ + N+LL AKI D G+A+ +K + P
Sbjct: 178 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR-----LP 229
Query: 393 AR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ M APE ++ SDV+S+G++L E+ + G P
Sbjct: 230 VKWM-------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 62/237 (26%), Positives = 101/237 (42%), Gaps = 56/237 (23%)
Query: 233 GQG--GSSYVYRGQLTDGR--------IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHC 281
G+G G V + VAVK K S ++E++M+ + H
Sbjct: 90 GEGCFGQ--VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWD 327
+++ L+G C+ + ++ E+ GNLR+ L + V E M +
Sbjct: 148 NIINLLGACT----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 328 TRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------R 379
V+ ARG+EYL A+ + +HRD+ + N+L+ EN KI D G+A+ +
Sbjct: 204 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 380 LKADGLPSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+G P + M APE + SDV+SFGV++ E+ T G P
Sbjct: 261 KTTNGR-----LPVKWM-------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 8e-28
Identities = 54/223 (24%), Positives = 90/223 (40%), Gaps = 42/223 (18%)
Query: 240 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292
V VAVK K ++E+ +LS L +H ++V L+G C+
Sbjct: 39 VVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT- 97
Query: 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR----------------VAIAIGA 336
L++ E+ G+L + L + T ++ +
Sbjct: 98 ---IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQV 154
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG---LPSCSSSPA 393
A+G+ +L A+ +HRD+ + NILL KI D G+A+ +K D + + P
Sbjct: 155 AKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211
Query: 394 R-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ M APE + SDV+S+G+ L EL + G P
Sbjct: 212 KWM-------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 56/237 (23%)
Query: 233 GQG--GSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHC 281
G+G G V + VAVK K+ S ++E++M+ + H
Sbjct: 78 GEGAFGQ--VVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR------------ 329
+++ L+G C+ + ++ E+ GNLR+ L G+ +
Sbjct: 136 NIINLLGACT----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 330 --VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------R 379
V+ A ARG+EYL A+ + +HRD+ + N+L+ E+ KI D G+A+ +
Sbjct: 192 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 380 LKADGLPSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+G P + M APE + SDV+SFGV+L E+ T G P
Sbjct: 249 KTTNGR-----LPVKWM-------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 46/224 (20%), Positives = 84/224 (37%), Gaps = 44/224 (19%)
Query: 233 GQGGSSYVYRGQLTDGRI--------VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 284
GQG + +++G + V +K + N F M+S+L H H+V
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-KAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLE 341
G C +LV EF+ G+L L + N ++ +A A +
Sbjct: 76 LNYGVCV----CGDENILVQEFVKFGSLDTYLKKNKNCI----NILWKLEVAKQLAAAMH 127
Query: 342 YLHEAAAPRILHRDIKSSNILLD--------ENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+L ++H ++ + NILL K++D G++ + +
Sbjct: 128 FL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI---LQERI 181
Query: 394 R-MQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELIT-GRQP 434
+ PE + +L +D +SFG L E+ + G +P
Sbjct: 182 PWV-------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 63/233 (27%), Positives = 97/233 (41%), Gaps = 41/233 (17%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+ S+I+GQG ++ V+RG+ G + A+K F V + E ++L +L+H +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT---RVAIAIGA--A 337
+V L + E ++L+ EF P G+L VL E N + +
Sbjct: 69 IVKL--FAIEEETTTRHKVLIMEFCPCGSLYT----VLEEPSNAYGLPESEFLIVLRDVV 122
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGL--PSCSSS 391
G+ +L E I+HR+IK NI+ D K+TD G A+ L+ D
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176
Query: 392 PARMQGTFGYFAPEYAMVGRASLMS----------DVFSFGVVLLELITGRQP 434
GT Y P+ M RA L D++S GV TG P
Sbjct: 177 -----GTEEYLHPD--MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 49/221 (22%), Positives = 86/221 (38%), Gaps = 32/221 (14%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRL--HHCHVVPL 286
+G GGSS V++ +I A+K + N + E+ L++L H ++ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLEYLH 344
Y + + +V E N +L L + + D + + +H
Sbjct: 94 YDY---EITDQYI-YMVMECG-NIDLNS----WLKKKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 404
+ I+H D+K +N L+ + K+ D G+A +++ D S GT Y P
Sbjct: 145 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV---GTVNYMPP 197
Query: 405 E-----------YAMVGRASLMSDVFSFGVVLLELITGRQP 434
E + S SDV+S G +L + G+ P
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 70/216 (32%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL--VGY 289
G GG YV R G VA+K+ + + P + E+ ++ +L+H +VV V
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTRVAIA-IGAARGLEYL 343
+ + LL E+ G+LR L L EG R ++ I +A L YL
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG---PIRTLLSDISSA--LRYL 137
Query: 344 HEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
HE RI+HRD+K NI+L + L KI DLG AK L L C+ GT
Sbjct: 138 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEF----VGTLQ 188
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
Y APE + ++ D +SFG + E ITG +P
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 63/233 (27%), Positives = 97/233 (41%), Gaps = 41/233 (17%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+ S+I+GQG ++ V+RG+ G + A+K F V + E ++L +L+H +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT---RVAIAIGA--A 337
+V L + E ++L+ EF P G+L VL E N + +
Sbjct: 69 IVKL--FAIEEETTTRHKVLIMEFCPCGSLYT----VLEEPSNAYGLPESEFLIVLRDVV 122
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGL--PSCSSS 391
G+ +L E I+HR+IK NI+ D K+TD G A+ L+ D
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176
Query: 392 PARMQGTFGYFAPEYAMVGRASLMS----------DVFSFGVVLLELITGRQP 434
GT Y P+ M RA L D++S GV TG P
Sbjct: 177 -----GTEEYLHPD--MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 48/221 (21%), Positives = 85/221 (38%), Gaps = 32/221 (14%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRL-HHC-HVVPL 286
+G GGSS V++ +I A+K + N + E+ L++L H ++ L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLEYLH 344
Y + + +V E N +L L + + D + + +H
Sbjct: 122 YDY---EITDQYI-YMVMEC-GNIDLNS----WLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 404
+ I+H D+K +N L+ + K+ D G+A +++ D S G Y P
Sbjct: 173 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV---GAVNYMPP 225
Query: 405 E-----------YAMVGRASLMSDVFSFGVVLLELITGRQP 434
E + S SDV+S G +L + G+ P
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 24/219 (10%)
Query: 225 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHV 283
F +++G G + + D R VAVKR + AD EV +L H +V
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR----EVQLLRESDEHPNV 80
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
+ +C+E R + + E L++ ++ + + + GL +L
Sbjct: 81 IRY--FCTEK--DRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHL 134
Query: 344 HEAAAPRILHRDIKSSNILLDE-----NLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
H I+HRD+K NIL+ + A I+D G+ K+L S GT
Sbjct: 135 HSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV--PGT 189
Query: 399 FGYFAPEY---AMVGRASLMSDVFSFGVVLLELITGRQP 434
G+ APE + D+FS G V +I+
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 49/221 (22%), Positives = 86/221 (38%), Gaps = 32/221 (14%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRL--HHCHVVPL 286
+G GGSS V++ +I A+K + N + E+ L++L H ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLEYLH 344
Y + + +V E N +L L + + D + + +H
Sbjct: 75 YDY---EITDQYI-YMVMEC-GNIDLNS----WLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 404
+ I+H D+K +N L+ + K+ D G+A +++ D S GT Y P
Sbjct: 126 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV---GTVNYMPP 178
Query: 405 E-----------YAMVGRASLMSDVFSFGVVLLELITGRQP 434
E + S SDV+S G +L + G+ P
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 56/232 (24%), Positives = 94/232 (40%), Gaps = 55/232 (23%)
Query: 240 VYRGQLTDGR------IVAVKRFKTQGGPNADSV----FLTEVDMLSRL-HHCHVVPLVG 288
V VAVK K ADS ++E+ M+++L H ++V L+G
Sbjct: 61 VMNATAYGISKTGVSIQVAVKMLK----EKADSSEREALMSELKMMTQLGSHENIVNLLG 116
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCL---------DGVLVEGMNWDTR---------- 329
C+ L+FE+ G+L + L D + E
Sbjct: 117 ACT----LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 330 --VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL-- 385
+ A A+G+E+L +HRD+ + N+L+ KI D G+A+ + +D
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 386 -PSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
+ P + M APE G ++ SDV+S+G++L E+ + G P
Sbjct: 230 VRGNARLPVKWM-------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-26
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 17/222 (7%)
Query: 224 DKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
D + ++G G ++ V VA+KR + + L E+ +S+ HH +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 283 VVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTR---VAIAI---G 335
+V Y S L LV + + G++ D + ++ +G + IA
Sbjct: 75 IVSY--YTSFVVKDE---LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 395
GLEYLH+ +HRD+K+ NILL E+ + +I D G++ L G + +
Sbjct: 130 VLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 396 QGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIH 436
GT + APE R +D++SFG+ +EL TG P H
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 1e-25
Identities = 28/235 (11%), Positives = 56/235 (23%), Gaps = 42/235 (17%)
Query: 231 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 287
+ G S V+ + A+K F + + +RL
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 288 GYCSEFRGKRAMRL----------------------LVFEFMP--NGNLRDCLDGVLVEG 323
A+ + L+ L LD V V
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 324 MNWDTRVAIAIGA--ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381
+ + A R L ++H N+ + + + D+ ++
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP 434
G S Y E+ A + + + G+ + + P
Sbjct: 246 TRGPASS--------VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 59/252 (23%), Positives = 92/252 (36%), Gaps = 42/252 (16%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
F ++GQG V + + D R A+K+ + S L+EV +L+ L+H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQ 62
Query: 282 HVVPLVG-YCSEFRGKRAMRL--------LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 332
+VV + + M + E+ NG L D ++ R
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD----LIHSENLNQQRDEY 118
Query: 333 A-----IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 387
I L Y+H I+HRD+K NI +DE+ N KI D G+AK +
Sbjct: 119 WRLFRQI--LEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 388 CSSSPARMQ---------GTFGYFAPE-YAMVGRASLMSDVFSFGVVLLELITG------ 431
S GT Y A E G + D++S G++ E+I
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 432 RQPIHRSITKGE 443
R I + +
Sbjct: 234 RVNILKKLRSVS 245
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 24/217 (11%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
+ F+ +G+G V++G ++VA+K + + E+ +LS+
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-DGVLVEGMNWDTRVAIAI---GAA 337
+V Y S + + ++ E++ G+ D L G L E IA
Sbjct: 81 YVTKY--YGSYLKDTKLW--IIMEYLGGGSALDLLEPGPLDETQ-------IATILREIL 129
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
+GL+YLH + +HRDIK++N+LL E+ K+ D G+A +L + + G
Sbjct: 130 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-----FVG 181
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
T + APE +D++S G+ +EL G P
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 51/221 (23%), Positives = 91/221 (41%), Gaps = 22/221 (9%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGY 289
+ +GG ++VY Q + GR A+KR + ++ + EV + +L H ++V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI-IQEVCFMKKLSGHPNIVQFCSA 94
Query: 290 CSEFR---GKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHE 345
S + L+ + G L + L + G ++ DT + I R ++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-------GT 398
P I+HRD+K N+LL K+ D G A + S S+ + T
Sbjct: 155 QKPP-IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 399 FGYFAPEYAMVGRASLM-----SDVFSFGVVLLELITGRQP 434
Y PE ++ S D+++ G +L L + P
Sbjct: 214 PMYRTPE--IIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 25/217 (11%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
K++ +GQG S VY + G+ VA+++ Q P + + E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-NEILVMRENKNP 77
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAI---GAA 337
++V + S G +V E++ G+L D + + EG IA
Sbjct: 78 NIVNYLD--SYLVGDELW--VVMEYLAGGSLTDVVTETCMDEGQ-------IAAVCRECL 126
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
+ LE+LH +++HRDIKS NILL + + K+TD G ++ + S + M G
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVG 178
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
T + APE D++S G++ +E+I G P
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 54/242 (22%), Positives = 84/242 (34%), Gaps = 51/242 (21%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRL-H 279
T +F +G G V++ DG I A+KR K + D L EV + L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCL------DGVLVEGMNWDTRVAI 332
H HVV + + +L+ E+ G+L D + E D +
Sbjct: 70 HSHVVRY--FSAWAEDDH---MLIQNEYCNGGSLADAISENYRIMSYFKEAELKD----L 120
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-------------------LNAKITD 373
+ RGL Y+H ++H DIK SNI + + KI D
Sbjct: 121 LLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 374 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 432
LG R+ SSP +G + A E +D+F+ + ++
Sbjct: 178 LGHVTRI---------SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
Query: 433 QP 434
Sbjct: 229 PL 230
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 35/276 (12%), Positives = 82/276 (29%), Gaps = 67/276 (24%)
Query: 231 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV---------------------- 267
++GQ G V P ++++
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 268 -----FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD----- 317
F+ D++ ++ + E R ++ M NL+ +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLD--ERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH 196
Query: 318 GVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377
+ + R+ + + R L LH ++H ++ +I+LD+ +T
Sbjct: 197 SSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 378 KRLKADGLPSCSSSPARMQGTFGYFAPEY--------AMVGRASLMS---DVFSFGVVLL 426
R + + G+ PE R +LM+ D ++ G+V+
Sbjct: 254 VRD---------GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 427 ELITGRQP--------IHRSITKGEESLVLWVKSII 454
+ P I + +++ V++++
Sbjct: 305 WIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALL 340
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 25/217 (11%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
+G+G + V + GR VAVK + + +F EV ++ H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHF 102
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAI---GAA 337
+VV + S G+ ++ EF+ G L D + L E IA
Sbjct: 103 NVVEMYK--SYLVGEELW--VLMEFLQGGALTDIVSQVRLNEEQ-------IATVCEAVL 151
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
+ L YLH A ++HRDIKS +ILL + K++D G ++ D + G
Sbjct: 152 QALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD-----VPKRKSLVG 203
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
T + APE + D++S G++++E++ G P
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 49/224 (21%), Positives = 92/224 (41%), Gaps = 32/224 (14%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
+ + +G G VY+ + G + A K +T+ + ++ E+++L+ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD---CLDGVLVEGMNWDTRVAIAI---G 335
++V L+G + + + ++ EF P G + LD L E I +
Sbjct: 77 YIVKLLG--AYYHDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQ-------IQVVCRQ 125
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 395
L +LH RI+HRD+K+ N+L+ + ++ D G++ + S
Sbjct: 126 MLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-----F 177
Query: 396 QGTFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGRQP 434
GT + APE M D++S G+ L+E+ P
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
+ F +G+G VY+ G+IVA+K+ + + E+ ++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL---QEIIKEISIMQQCDSP 84
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD---CLDGVLVEGMNWDTRVAIAI---G 335
HVV G S F+ +V E+ G++ D + L E IA
Sbjct: 85 HVVKYYG--SYFKNTDLW--IVMEYCGAGSVSDIIRLRNKTLTEDE-------IATILQS 133
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 395
+GLEYLH R +HRDIK+ NILL+ +AK+ D G+A +L + +
Sbjct: 134 TLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-----V 185
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
GT + APE + ++D++S G+ +E+ G+ P
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 60/229 (26%), Positives = 94/229 (41%), Gaps = 39/229 (17%)
Query: 233 GQGGSSYVYRGQLTD-GRIVAVK-RFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
G+GG + + D + A K K+ P+ E+ + L H HVV G+
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
F + +V E +L + L E + R G +YLH
Sbjct: 110 ---FEDNDFV-FVVLELCRRRSLLELHKRRKALTE---PEAR-YYLRQIVLGCQYLHRN- 160
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP---SCSSSPARMQGTFGYFAP 404
R++HRD+K N+ L+E+L KI D G+A +++ DG C GT Y AP
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--------GTPNYIAP 210
Query: 405 EYAMVGRA--SLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
E ++ + S DV+S G ++ L+ G+ P + I K E
Sbjct: 211 E--VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 257
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 64/241 (26%), Positives = 98/241 (40%), Gaps = 47/241 (19%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCH 282
+ I+G G S V GR VAVKR + + L E+ +L+ H +
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML----IDFCDIALMEIKLLTESDDHPN 70
Query: 283 VVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD--GVLVEGM-NWDTRVAIAI--GA 336
V+ YCSE L + E N NL+D ++ V E + I++
Sbjct: 71 VIRY--YCSE---TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLD-------------ENLNAKITDLGMAKRLKAD 383
A G+ +LH +I+HRD+K NIL+ ENL I+D G+ K+L +
Sbjct: 125 ASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 384 GLPSCSSSPARMQ---GTFGYFAPE-------YAMVGRASLMSDVFSFGVVLLELITGRQ 433
SS + GT G+ APE R + D+FS G V +++ +
Sbjct: 182 Q----SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 434 P 434
Sbjct: 238 H 238
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 232 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G G V++ G ++A K + P + + E+ +L + ++V Y
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF--YG 98
Query: 291 SEFRGKR---AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV--AIAIGAARGLEYLHE 345
+ + M E M G LD VL + ++ ++I +GL YL E
Sbjct: 99 AFYSDGEISICM-----EHMDGG----SLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYFAP 404
+I+HRD+K SNIL++ K+ D G++ +L S A GT Y +P
Sbjct: 150 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--------IDSMANSFVGTRSYMSP 199
Query: 405 EYAMVGRASLMSDVFSFGVVLLELITGRQPI 435
E S+ SD++S G+ L+E+ GR PI
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 40/248 (16%), Positives = 87/248 (35%), Gaps = 55/248 (22%)
Query: 233 GQGGSSYVYRGQLTDGRIVAVK--------RFKTQGGPNADSVFLT--------EVDMLS 276
QG + + + + A+K + + N D + + E+ +++
Sbjct: 40 NQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 277 RLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIA 333
+ + + + G + +++E+M N ++ + VL + + +
Sbjct: 99 DIKNEYCLTCEGI---ITNYD--EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 334 IGAAR----GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-SC 388
+ Y+H I HRD+K SNIL+D+N K++D G ++ + + S
Sbjct: 154 KCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR 211
Query: 389 SSSPARMQGTFGYFAPEYAMV----GRASLMSDVFSFGVVLLELITGRQP---------I 435
GT+ + PE D++S G+ L + P +
Sbjct: 212 --------GTYEFMPPE--FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261
Query: 436 HRSITKGE 443
+I
Sbjct: 262 FNNIRTKN 269
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-23
Identities = 32/208 (15%), Positives = 58/208 (27%), Gaps = 50/208 (24%)
Query: 232 VGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL 286
G ++ D R VA+ QG D + L+ LSR+ V +
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
+ RA L+V E++ G+L++ D + + A + H A
Sbjct: 97 LDVVHT----RAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRA 148
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
+ S + + + + +
Sbjct: 149 G---VALSIDHPSRVRVSIDGDVVL-------------------------AYPATMPD-- 178
Query: 407 AMVGRASLMSDVFSFGVVLLELITGRQP 434
A+ D+ G L L+ R P
Sbjct: 179 -----ANPQDDIRGIGASLYALLVNRWP 201
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 19/231 (8%)
Query: 213 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTE 271
SAL F +VG G VY+G+ + G++ A+K G + E
Sbjct: 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE--IKQE 70
Query: 272 VDMLSRL-HHCHVVPLVG-YCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDT 328
++ML + HH ++ G + + +L LV EF G++ D + + +
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW 130
Query: 329 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 388
I RGL +LH+ +++HRDIK N+LL EN K+ D G++ +L
Sbjct: 131 IAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 187
Query: 389 SSSPARMQGTFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGRQP 434
+ GT + APE + D++S G+ +E+ G P
Sbjct: 188 T-----FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-23
Identities = 60/229 (26%), Positives = 94/229 (41%), Gaps = 39/229 (17%)
Query: 233 GQGGSSYVYRGQLTD-GRIVAVK-RFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
G+GG + + D + A K K+ P+ E+ + L H HVV G+
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
F + +V E +L + L E + R G +YLH
Sbjct: 84 ---FEDNDFV-FVVLELCRRRSLLELHKRRKALTE---PEAR-YYLRQIVLGCQYLHRN- 134
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP---SCSSSPARMQGTFGYFAP 404
R++HRD+K N+ L+E+L KI D G+A +++ DG C GT Y AP
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--------GTPNYIAP 184
Query: 405 EYAMVGRA--SLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
E ++ + S DV+S G ++ L+ G+ P + I K E
Sbjct: 185 E--VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 231
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 8e-23
Identities = 65/232 (28%), Positives = 92/232 (39%), Gaps = 44/232 (18%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVK-RFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
G+G + VYR + + G VA+K K EV + +L H ++ L Y
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 290 CSEFRGKRAMRL-LVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIA-IGAARGLEYLH 344
F + LV E NG + L E + R + I G+ YLH
Sbjct: 80 ---FEDSN--YVYLVLEMCHNGEMNRYLKNRVKPFSE---NEARHFMHQI--ITGMLYLH 129
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP---SCSSSPARMQGTFGY 401
ILHRD+ SN+LL N+N KI D G+A +LK C GT Y
Sbjct: 130 SH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--------GTPNY 178
Query: 402 FAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
+PE + R+ L SDV+S G + L+ GR P + +
Sbjct: 179 ISPE--IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD 228
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 60/228 (26%), Positives = 86/228 (37%), Gaps = 44/228 (19%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFL--TEVDMLSRLH 279
FS +G G VY + + + +VA+K+ G + + EV L +L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD---CLDGVLVEGMNWDTRVAIAI-- 334
H + + G R A LV E+ G+ D L E IA
Sbjct: 113 HPNTIQYRG--CYLREHTAW--LVMEYCL-GSASDLLEVHKKPLQEVE-------IAAVT 160
Query: 335 -GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG----MAKRLKADGLPSCS 389
GA +GL YLH ++HRD+K+ NILL E K+ D G MA
Sbjct: 161 HGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---------- 207
Query: 390 SSPARMQGTFGYFAPEYAMVGRAS---LMSDVFSFGVVLLELITGRQP 434
GT + APE + DV+S G+ +EL + P
Sbjct: 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 62/237 (26%), Positives = 93/237 (39%), Gaps = 39/237 (16%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKR-FKTQ-GGPNADSVFLTEVDMLSRLHH 280
+ F +G+G VY + I+A+K FK Q + EV++ S L H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 281 CHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAA 337
+++ L GY F R+ L+ E+ P G + L E T I A
Sbjct: 69 PNILRLYGY---FHDAT--RVYLILEYAPLGTVYRELQKLSKFDE---QRTATYIT-ELA 119
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-SCSSSPARMQ 396
L Y H R++HRDIK N+LL KI D G + + C
Sbjct: 120 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-------- 168
Query: 397 GTFGYFAPEYAMVGRAS--LMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
GT Y PE M+ D++S GV+ E + G+ P ++ I++ E
Sbjct: 169 GTLDYLPPE--MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 223
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-22
Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 21/213 (9%)
Query: 232 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC-HVVPLVGY 289
+G+G V + + G+I+AVKR + L ++D+ R C V Y
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF--Y 72
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV--AIAIGAARGLEYLHEAA 347
+ FR + E M + +L V+ +G + IA+ + LE+LH
Sbjct: 73 GALFREGDVW--ICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE-- 405
++HRD+K SN+L++ K+ D G++ L + G Y APE
Sbjct: 130 --SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD------DVAKDIDAGCKPYMAPERI 181
Query: 406 --YAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
S+ SD++S G+ ++EL R P
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-22
Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC-HVVPLVGY 289
+G+G V + G+I+AVKR ++ L ++D++ R C ++V Y
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF--Y 87
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV-------AIAIGAARGLEY 342
+ FR + E M + D + V I + + L +
Sbjct: 88 GALFREGDCW--ICMELM-ST----SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
L E +I+HRDIK SNILLD + N K+ D G++ +L S + R G Y
Sbjct: 141 LKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD------SIAKTRDAGCRPYM 192
Query: 403 APEYAMVGRA----SLMSDVFSFGVVLLELITGRQPIH 436
APE + + SDV+S G+ L EL TGR P
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 21/210 (10%)
Query: 232 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC-HVVPLVGY 289
+G G V++ + G ++AVK+ + G + L ++D++ + H C ++V +
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQC--F 90
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 349
+ + E M G + L + + + + + L YL E
Sbjct: 91 GTFITNTDVF--IAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH-- 144
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 409
++HRD+K SNILLDE K+ D G++ RL + R G Y APE
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD------DKAKDRSAGCAAYMAPERIDP 198
Query: 410 GRA-----SLMSDVFSFGVVLLELITGRQP 434
+ +DV+S G+ L+EL TG+ P
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 65/257 (25%), Positives = 102/257 (39%), Gaps = 33/257 (12%)
Query: 202 SKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRF-KTQ 259
+ T F S H ++ + +G G V A+K KT
Sbjct: 15 YFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS 74
Query: 260 GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGV 319
+++S L EV +L L H +++ L + + KR L V E G L D
Sbjct: 75 VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED---KRNYYL-VMECYKGGELFD----E 126
Query: 320 LVEGMNWDTRVAIAI--GAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDL 374
++ M ++ A I G+ YLH+ I+HRD+K N+LL +++ KI D
Sbjct: 127 IIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDF 183
Query: 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
G++ + GT Y APE + + DV+S GV+L L+ G P
Sbjct: 184 GLSAVFENQ------KKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
Query: 435 --------IHRSITKGE 443
I R + KG+
Sbjct: 237 FGGQTDQEILRKVEKGK 253
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 222 ATDKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDM 274
AT ++ +G G +Y VY+ + G VA+K + G + EV +
Sbjct: 7 ATSRYEPVAEIGVG--AYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 275 LSRLH---HCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRV 330
L RL H +VV L+ C+ R R +++ LVFE + +LR LD G+ +T
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 331 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 390
+ RGL++LH I+HRD+K NIL+ K+ D G+A+ S
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY---------S 171
Query: 391 SPARMQG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
+ T Y APE + + D++S G + E+ +
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 60/239 (25%), Positives = 95/239 (39%), Gaps = 43/239 (17%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKR-FKTQ-GGPNADSVFLTEVDMLSRLHH 280
D F +G+G VY + + I+A+K FK+Q + E+++ S L H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 281 CHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGA- 336
+++ + Y F ++ R+ L+ EF P G L L G E + +
Sbjct: 74 PNILRMYNY---FHDRK--RIYLMLEFAPRGELYKELQKHGRFDE------QRSATFMEE 122
Query: 337 -ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-SCSSSPAR 394
A L Y HE +++HRDIK N+L+ KI D G + + C
Sbjct: 123 LADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC------ 173
Query: 395 MQGTFGYFAPEYAMVGRAS--LMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
GT Y PE M+ + D++ GV+ E + G P HR I +
Sbjct: 174 --GTLDYLPPE--MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD 228
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 3e-20
Identities = 39/164 (23%), Positives = 63/164 (38%), Gaps = 12/164 (7%)
Query: 276 SRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAI 334
R+ VG K + + + NL+D ++ +E + I I
Sbjct: 113 RRMDPFSTKNTVGQLQPSSPKVYL-YIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
A +E+LH ++HRD+K SNI + K+ D G+ + D +P
Sbjct: 172 QIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 395 MQ-------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG 431
GT Y +PE S D+FS G++L EL+
Sbjct: 229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 59/237 (24%), Positives = 99/237 (41%), Gaps = 34/237 (14%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLH 279
+D++ G ++G+G V G+ AVK + L EV +L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAIGAA 337
H +++ L + + + LV E G L D ++ + A I
Sbjct: 85 HPNIMKLYEFFED----KGYFYLVGEVYTGGELFD----EIISRKRFSEVDAARIIRQVL 136
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
G+ Y+H+ +I+HRD+K N+LL ++ N +I D G++ +A
Sbjct: 137 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS------KKMKD 187
Query: 395 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
GT Y APE + G DV+S GV+L L++G P I + + KG+
Sbjct: 188 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK 243
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 44/234 (18%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLT---EVDMLSRLH 279
K+ +GQG V++ + G+ VA+K+ + + +T E+ +L L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLK 74
Query: 280 HCHVVPL----VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 335
H +VV L S + + LVF+F + D L G+L + V +
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----D-LAGLL-------SNVLVKFT 122
Query: 336 AA----------RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385
+ GL Y+H +ILHRD+K++N+L+ + K+ D G+A+ L
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF---SL 176
Query: 386 PSCSSSPARMQG---TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPI 435
+S P R T Y PE + R D++ G ++ E+ T PI
Sbjct: 177 AK-NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PI 228
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 53/229 (23%), Positives = 92/229 (40%), Gaps = 47/229 (20%)
Query: 232 VGQGGSSYVYRGQ---LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
VG+G +VY+ + D + A+K+ + G + E+ +L L H +V+ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQK 85
Query: 289 YCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA---------- 337
F ++ L+F++ + +L + + + + +
Sbjct: 86 V---FLSHADRKVWLLFDYAEH-DLWHIIK---FHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNA----KITDLGMAKRLKADGLPSCSSSPA 393
G+ YLH +LHRD+K +NIL+ KI D+G A RL L +
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSPLKPLADLDP 194
Query: 394 RMQGTFGYFAPE-------YAMVGRASLMSDVFSFGVVLLELITGRQPI 435
+ TF Y APE Y + D+++ G + EL+T PI
Sbjct: 195 VVV-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE-PI 235
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 45/226 (19%)
Query: 224 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDMLS 276
+K+ +VG+G SY V + + GRIVA+K+F + D + + E+ +L
Sbjct: 25 EKYENLGLVGEG--SYGMVMKCRNKDTGRIVAIKKFLES---DDDKMVKKIAMREIKLLK 79
Query: 277 RLHHCHVVPLVGYCSE-FRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 334
+L H ++V L+ E + K+ R LVFEF+ + + D L+ + G+++
Sbjct: 80 QLRHENLVNLL----EVCKKKK--RWYLVFEFVDH-TILDDLE-LFPNGLDYQVVQKYLF 131
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
G+ + H I+HRDIK NIL+ ++ K+ D G A R A A
Sbjct: 132 QIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA-RTLAAPGEVYDDEVA- 186
Query: 395 MQGTFGYFAPE-------YAM-VGRASLMSDVFSFGVVLLELITGR 432
T Y APE Y V DV++ G ++ E+ G
Sbjct: 187 ---TRWYRAPELLVGDVKYGKAV-------DVWAIGCLVTEMFMGE 222
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 4e-19
Identities = 68/260 (26%), Positives = 112/260 (43%), Gaps = 35/260 (13%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF--LTEVDMLSRLHH 280
D F ++G+GG V+ Q+ G++ A K+ + + E +L+++H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 281 CHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--A 337
+V L Y F K L LV M G++R + V + + AI A
Sbjct: 245 RFIVSLA-YA--FETKT--DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
GLE+LH+ I++RD+K N+LLD++ N +I+DLG+A LKA + G
Sbjct: 300 SGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-----TKTKGYAG 351
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP------------IHRSITKGEES 445
T G+ APE + D F+ GV L E+I R P + + + +
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-- 409
Query: 446 LVLWVKSIITDA-SICQSFL 464
V + + C++ L
Sbjct: 410 -VTYPDKFSPASKDFCEALL 428
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 38/238 (15%), Positives = 76/238 (31%), Gaps = 35/238 (14%)
Query: 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEV 272
+ + +++G+G + VY D + +K K P + +
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGTQLM 118
Query: 273 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLVEGMNWDTR 329
+ L + F+ LV E G L + ++ + M
Sbjct: 119 ERLKPSMQHMFMKFY-SAHLFQNGSV---LVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL-----------DENLNAKITDLGMAK 378
++ A+ +E +H+ I+H DIK N +L D + + DLG +
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRAS--LMSDVFSFGVVLLELITGRQP 434
+K + ++ T G+ E M+ D F + ++ G
Sbjct: 232 DMKLFPKGTIFTAKC---ETSGFQCVE--MLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 54/235 (22%)
Query: 223 TDKFSGSNIVGQGGSSY--VYRGQLTDGRIVAVKRFKTQGGPNADSVF-LTEVDMLSRLH 279
++ ++G G S+ V++ +L + VA+K+ D F E+ ++ +
Sbjct: 39 EIAYTNCKVIGNG--SFGVVFQAKLVESDEVAIKKVL------QDKRFKNRELQIMRIVK 90
Query: 280 HCHVVPLVGY-CSEFRGKRAMRL-LVFEFMP---------NGNLRDCLDGVLVEGMNWDT 328
H +VV L + S K + L LV E++P L+ + +L++ +
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 329 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPS 387
R L Y+H I HRDIK N+LLD K+ D G AK L A G P+
Sbjct: 151 --------LRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA-GEPN 198
Query: 388 ----CSSSPARMQGTFGYFAPEYAMVGRASLMS---DVFSFGVVLLELITGRQPI 435
CS R Y APE + G A+ + D++S G V+ EL+ G QP+
Sbjct: 199 VSYICS----RY-----YRAPE-LIFG-ATNYTTNIDIWSTGCVMAELMQG-QPL 241
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 51/234 (21%)
Query: 223 TDKFSGSNIVGQGGSSY--VYRGQLTD-GRIVAVKRFKTQGGPNADSVF-LTEVDMLSRL 278
++ + ++G G S+ VY+ +L D G +VA+K+ D F E+ ++ +L
Sbjct: 53 EVSYTDTKVIGNG--SFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKL 104
Query: 279 HHCHVVPLVGY-CSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG- 335
HC++V L + S K + L LV +++P + + + +
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARH------YSRAKQTLPVIY 157
Query: 336 -------AARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPS 387
R L Y+H I HRDIK N+LLD + K+ D G AK+L P+
Sbjct: 158 VKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PN 213
Query: 388 ----CSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPI 435
CS R Y APE + G + DV+S G VL EL+ G QPI
Sbjct: 214 VSYICS----RY-----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-19
Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 224 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDMLS 276
+K+ +G+G SY V++ + G+IVA+K+F D V L E+ ML
Sbjct: 3 EKYEKIGKIGEG--SYGVVFKCRNRDTGQIVAIKKFLES---EDDPVIKKIALREIRMLK 57
Query: 277 RLHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 334
+L H ++V L V FR KR + LVFE+ + + LD G+ +I
Sbjct: 58 QLKHPNLVNLLEV-----FRRKRRL-HLVFEYCDH-TVLHELDRYQR-GVPEHLVKSITW 109
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
+ + + H+ +HRD+K NIL+ ++ K+ D G A RL A
Sbjct: 110 QTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFA-RLLTGPSDYYDDEVA- 164
Query: 395 MQGTFGYFAPE-------YAMVGRASLMSDVFSFGVVLLELITGR 432
T Y +PE Y DV++ G V EL++G
Sbjct: 165 ---TRWYRSPELLVGDTQY------GPPVDVWAIGCVFAELLSGV 200
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 9e-19
Identities = 52/176 (29%), Positives = 77/176 (43%), Gaps = 32/176 (18%)
Query: 269 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNW 326
E+ ++ L H +V L Y F+ + M +V + + G+LR L + E
Sbjct: 63 FKELQIMQGLEHPFLVNLW-YS--FQDEEDM-FMVVDLLLGGDLRYHLQQNVHFKEE--- 115
Query: 327 DTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385
++ I + A L+YL RI+HRD+K NILLDE+ + ITD +A L +
Sbjct: 116 TVKLFICELVMA--LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
Query: 386 PS--CSSSPARMQGTFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGRQP 434
+ GT Y APE M D +S GV EL+ GR+P
Sbjct: 171 ITTMA--------GTKPYMAPE--MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 67/224 (29%), Positives = 111/224 (49%), Gaps = 42/224 (18%)
Query: 224 DKFSGSNIVGQGGSSY--VYRGQLTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSR 277
+K+ VG+G +Y VY+ + + GRIVA+KR + +G P S + E+ +L
Sbjct: 21 EKYQKLEKVGEG--TYGVVYKAKDSQGRIVALKRIRLDAEDEGIP---STAIREISLLKE 75
Query: 278 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 337
LHH ++V L+ +R + LVFEFM +L+ LD + + +
Sbjct: 76 LHHPNIVSLI---DVIHSERCL-TLVFEFMEK-DLKKVLD---------ENKTGLQDSQI 121
Query: 338 --------RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389
RG+ + H+ RILHRD+K N+L++ + K+ D G+A +A G+P S
Sbjct: 122 KIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLA---RAFGIPVRS 175
Query: 390 SSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 432
+ + T Y AP+ M + S D++S G + E+ITG+
Sbjct: 176 YTHEVV--TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 31/222 (13%)
Query: 224 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLS 276
K+ +G+G +Y V++ + IVA+KR + +G P S L E+ +L
Sbjct: 2 QKYEKLEKIGEG--TYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLK 56
Query: 277 RLHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 334
L H ++V L V + + LVFEF +L+ D ++ + +
Sbjct: 57 ELKHKNIVRLHDV-----LHSDKKL-TLVFEFCDQ-DLKKYFDSCNG-DLDPEIVKSFLF 108
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
+GL + H +LHRD+K N+L++ N K+ + G+A +A G+P S
Sbjct: 109 QLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLA---RAFGIPVRCYSAEV 162
Query: 395 MQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPI 435
+ T Y P+ + S D++S G + EL +P+
Sbjct: 163 V--TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 66/240 (27%), Positives = 99/240 (41%), Gaps = 62/240 (25%)
Query: 233 GQGGSSYVYRG--QLTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
G+G + V LT GR VA+K KTQ P + EV ++ L+H ++V L +
Sbjct: 24 GKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAAR--------G 339
E L+ E+ G + D L G + E AR
Sbjct: 81 --EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE------------ARSKFRQIVSA 126
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQG 397
++Y H+ RI+HRD+K+ N+LLD ++N KI D G + G C + P
Sbjct: 127 VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP----- 178
Query: 398 TFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
Y APE Y G DV+S GV+L L++G P + + +G+
Sbjct: 179 ---YAAPELFQGKKYD--GPE---VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 224 DKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+ + + +G+G + VY+G +VA+K + + A + EV +L L H +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 283 VVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 340
+V L + ++++ LVFE++ +L+ LD +N RGL
Sbjct: 62 IVTLHDI-----IHTEKSL-TLVFEYLDK-DLKQYLDDCGN-IINMHNVKLFLFQLLRGL 113
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
Y H ++LHRD+K N+L++E K+ D G+A +A +P+ + + T
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA---RAKSIPTKTYDNEVV--TLW 165
Query: 401 YFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 432
Y P+ + S D++ G + E+ TGR
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 58/248 (23%), Positives = 89/248 (35%), Gaps = 46/248 (18%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV------------FL 269
+ + +G G V + A+K K
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 270 TEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDT 328
E+ +L L H +++ L + LV EF G L + ++ +D
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFED-----KKYFYLVTEFYEGGELFE----QIINRHKFDE 145
Query: 329 RVAIAIGA--ARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKAD 383
A I G+ YLH+ I+HRDIK NILL + LN KI D G++ D
Sbjct: 146 CDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202
Query: 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------I 435
GT Y APE + + + DV+S GV++ L+ G P I
Sbjct: 203 ------YKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI 255
Query: 436 HRSITKGE 443
+ + KG+
Sbjct: 256 IKKVEKGK 263
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 57/239 (23%), Positives = 98/239 (41%), Gaps = 40/239 (16%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
D + +G G V+R + GR+ K T + +V E+ ++++LHH
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV-KNEISIMNQLHHP 108
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR--- 338
++ L F K M +L+ EF+ G L D + E I R
Sbjct: 109 KLINLHDA---FEDKYEM-VLILEFLSGGEL---FDRIAAEDYKMSEAEVINY--MRQAC 159
Query: 339 -GLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSPARM 395
GL+++HE I+H DIK NI+ + + KI D G+A +L D +
Sbjct: 160 EGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV------T 210
Query: 396 QGTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
T + APE VG +D+++ GV+ L++G P +++ + +
Sbjct: 211 TATAEFAAPEIVDREPVGFY---TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD 266
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 61/264 (23%), Positives = 93/264 (35%), Gaps = 82/264 (31%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVK---------------RFKTQGGPNADSVFLTEVDMLS 276
G+G V D A+K R +G A + +
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 277 R----------LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-DGVLVEGMN 325
+ L H +VV L +VFE + G + + L E
Sbjct: 82 QVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED-- 137
Query: 326 WDTRVAIAIGAAR--------GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377
AR G+EYLH +I+HRDIK SN+L+ E+ + KI D G++
Sbjct: 138 ----------QARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 378 KRLK-ADGLPSCSS-SPARMQGTFGYFAPE--------YAMVGRASLMSDVFSFGVVLLE 427
K +D L S + +PA + APE ++ G+A DV++ GV L
Sbjct: 185 NEFKGSDALLSNTVGTPA-------FMAPESLSETRKIFS--GKA---LDVWAMGVTLYC 232
Query: 428 LITGRQP--------IHRSITKGE 443
+ G+ P +H I
Sbjct: 233 FVFGQCPFMDERIMCLHSKIKSQA 256
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 25/221 (11%)
Query: 221 HATDKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 277
++ +F +G G +Y VY+G T G VA+K K S + E+ ++
Sbjct: 2 SSSSQFKQLEKLGNG--TYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKE 59
Query: 278 LHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPN---GNLRDCLDGVLVEGMNWDTRVAI 332
L H ++V L V + + LVFEFM N + G G+ +
Sbjct: 60 LKHENIVRLYDV-----IHTENKL-TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 392
+GL + HE +ILHRD+K N+L+++ K+ D G+A +A G+P + S
Sbjct: 114 QWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA---RAFGIPVNTFSS 167
Query: 393 ARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 432
+ T Y AP+ M R S D++S G +L E+ITG+
Sbjct: 168 EVV--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 49/273 (17%), Positives = 74/273 (27%), Gaps = 57/273 (20%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV----FLTEVDMLSR 277
K+ +GQG V + I A+K + TEV ++ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 278 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD-------------------CLDG 318
LHH ++ L + LV E G+L D
Sbjct: 85 LHHPNIARLYEVYED----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 319 VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR----------------ILHRDIKSSNIL 362
E +I E I HRDIK N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 363 L--DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE--YAMVGRASLMSDV 418
+++ K+ D G++K GT + APE D
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLN-NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 419 FSFGVVLLELITGRQP--------IHRSITKGE 443
+S GV+L L+ G P + +
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKK 292
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 62/249 (24%), Positives = 96/249 (38%), Gaps = 51/249 (20%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLS 276
D + ++G+G S V R G+ AVK +F + G + + + E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICH 81
Query: 277 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT---RVAIA 333
L H H+V L+ S M +VFEFM +L ++ VA
Sbjct: 82 MLKHPHIVELLETYSS----DGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASH 134
Query: 334 IGAAR----GLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLP 386
R L Y H+ I+HRD+K +LL + + K+ G+A +L G
Sbjct: 135 Y--MRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-- 187
Query: 387 SCSSSPARMQ---GTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP------- 434
GT + APE +V R DV+ GV+L L++G P
Sbjct: 188 ------LVAGGRVGTPHFMAPE--VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER 239
Query: 435 IHRSITKGE 443
+ I KG+
Sbjct: 240 LFEGIIKGK 248
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 3e-18
Identities = 66/251 (26%), Positives = 107/251 (42%), Gaps = 34/251 (13%)
Query: 231 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF--LTEVDMLSRLHHCHVVPLV 287
++G+GG V Q+ G++ A K+ + + L E +L +++ VV L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 288 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
Y + K L LV M G+L+ + + G V A GLE LH
Sbjct: 251 -YA--YETKD--ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
RI++RD+K NILLD++ + +I+DLG+A + +G GT GY APE
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIKG-----RVGTVGYMAPEV 356
Query: 407 AMVGRASLMSDVFSFGVVLLELITGRQP------------IHRSITKGEESLVLWVKSII 454
R + D ++ G +L E+I G+ P + R + + + +
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP---EEYSERFS 413
Query: 455 TDA-SICQSFL 464
A S+C L
Sbjct: 414 PQARSLCSQLL 424
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 59/251 (23%), Positives = 104/251 (41%), Gaps = 33/251 (13%)
Query: 208 HGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD- 265
H + R + ++++ ++G+G V + + AVK N D
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 266 SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMN 325
S L EV++L +L H +++ L + + + V E G L D +++
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILED---SSSFYI-VGELYTGGELFD----EIIKRKR 117
Query: 326 WDTRVA--IAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRL 380
+ A I G+ Y+H+ I+HRD+K NILL +++ + KI D G++
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP------ 434
+ + GT Y APE + G DV+S GV+L L++G P
Sbjct: 175 QQNTKMK------DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 435 --IHRSITKGE 443
I + + G+
Sbjct: 228 YDILKRVETGK 238
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 33/224 (14%)
Query: 224 DKFSGSNIVGQGGSSY--VYRGQ--LTDGRIVAVKRFK----TQGGPNADSVFLTEVDML 275
++ +G+G +Y V++ + GR VA+KR + +G P + EV +L
Sbjct: 11 QQYECVAEIGEG--AYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVL 65
Query: 276 SRLH---HCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 331
L H +VV L C+ R R +L LVFE + +L LD V G+ +T
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 391
+ RGL++LH R++HRD+K NIL+ + K+ D G+A+ S
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---------SF 172
Query: 392 PARMQG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
+ T Y APE + + D++S G + E+ +
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 62/221 (28%), Positives = 91/221 (41%), Gaps = 41/221 (18%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL-- 286
G+G V AVK + K + PN ++ E+ +L RL H +V+ L
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR-------- 338
V Y E + +V E+ G +++ LD V + A
Sbjct: 74 VLYNEE----KQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQ--------AHGYFCQLID 120
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA---KRLKADGLPSCSSSPARM 395
GLEYLH + I+H+DIK N+LL KI+ LG+A AD C +S
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT--CRTS---- 171
Query: 396 QGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQP 434
QG+ + PE A + D++S GV L + TG P
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 61/251 (24%), Positives = 97/251 (38%), Gaps = 53/251 (21%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSV--FLTEVDM 274
D++ S +G G V + + VA++ +F AD TE+++
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 275 LSRLHHCHVVPLVGYCSE---FRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTR 329
L +L+H ++ + + + +V E M G L D + L E +
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYY--------IVLELMEGGELFDKVVGNKRLKEA---TCK 242
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLP 386
++YLHE I+HRD+K N+LL +E+ KITD G +K L L
Sbjct: 243 -LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 298
Query: 387 S--CSSSPARMQGTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------- 434
C GT Y APE + D +S GV+L ++G P
Sbjct: 299 RTLC--------GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 350
Query: 435 --IHRSITKGE 443
+ IT G+
Sbjct: 351 VSLKDQITSGK 361
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 66/250 (26%), Positives = 99/250 (39%), Gaps = 49/250 (19%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV--------FLTEVD 273
+ + I+G+G SS V R + AVK GG + + L EVD
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 274 MLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRV 330
+L ++ H +++ L LVF+ M G L D L E +TR
Sbjct: 76 ILRKVSGHPNIIQLKDTYET----NTFFFLVFDLMKKGELFDYLTEKVTLSEK---ETRK 128
Query: 331 AI-AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-- 387
+ A+ + LH+ I+HRD+K NILLD+++N K+TD G + +L
Sbjct: 129 IMRAL--LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 183
Query: 388 CSSSPARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP------- 434
C GT Y APE D++S GV++ L+ G P
Sbjct: 184 C--------GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 235
Query: 435 -IHRSITKGE 443
+ R I G
Sbjct: 236 LMLRMIMSGN 245
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 8e-18
Identities = 69/228 (30%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 231 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 287
I+G+G S V + R A+K + + + V E D++SRL H V L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 288 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIA-IGAARGLEYL 343
Y + F+ +L + NG L + G E TR A I +A LEYL
Sbjct: 96 -YFT-FQDDE--KLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAEIVSA--LEYL 146
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
H I+HRD+K NILL+E+++ +ITD G AK L + + ++S GT Y +
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS---FVGTAQYVS 200
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
PE A SD+++ G ++ +L+ G P I + I K E
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 9e-18
Identities = 62/238 (26%), Positives = 93/238 (39%), Gaps = 39/238 (16%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
F ++G G S V+ Q G++ A+K K S+ E+ +L ++ H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE-NEIAVLKKIKHE 66
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAARG 339
++V L + LV + + G L D GV E D + I
Sbjct: 67 NIVTLEDI---YESTTHY-YLVMQLVSGGELFDRILERGVYTEK---DASLVIQQ-VLSA 118
Query: 340 LEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
++YLHE I+HRD+K N+L +EN ITD G++K + M
Sbjct: 119 VKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----------NGIMS 165
Query: 397 ---GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
GT GY APE S D +S GV+ L+ G P + I +G
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY 223
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 47/242 (19%), Positives = 96/242 (39%), Gaps = 41/242 (16%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 278
+ +K+ + +G+G V+R + + + K K +G E+ +L+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIA 58
Query: 279 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 338
H +++ L F + +++FEF+ ++ + + + R ++
Sbjct: 59 RHRNILHLHES---FESMEEL-VMIFEFISGLDI---FERINTSAFELNEREIVSY--VH 109
Query: 339 ----GLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSP 392
L++LH I H DI+ NI+ + KI + G A++LK
Sbjct: 110 QVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---- 162
Query: 393 ARMQGTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITK 441
+ Y+APE + +V A +D++S G ++ L++G P I +I
Sbjct: 163 --LFTAPEYYAPEVHQHDVVSTA---TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217
Query: 442 GE 443
E
Sbjct: 218 AE 219
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 60/244 (24%), Positives = 99/244 (40%), Gaps = 59/244 (24%)
Query: 220 EHATDKFSGSNIVGQGGSSY--VYRGQLTD-GRIVAVKR-FKTQGGPNADSVF----LTE 271
D+F + GQG ++ V G+ G VA+K+ D F L
Sbjct: 19 RKEMDRFQVERMAGQG--TFGTVQLGKEKSTGMSVAIKKVI-------QDPRFRNRELQI 69
Query: 272 VDMLSRLHHCHVVPL--VGYCSEFRGKRAMRL-LVFEFMP---------NGNLRDCLDGV 319
+ L+ LHH ++V L Y R +R + L +V E++P + +
Sbjct: 70 MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI 129
Query: 320 LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAK 378
L++ + R + LH + + HRDIK N+L++ + K+ D G AK
Sbjct: 130 LIKVFLFQL--------IRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180
Query: 379 RLKADGLPS----CSSSPARMQGTFGYFAPEYAMVGRASLMS---DVFSFGVVLLELITG 431
+L P+ CS R Y APE + G + D++S G + E++ G
Sbjct: 181 KLSPSE-PNVAYICS----RY-----YRAPEL-IFG-NQHYTTAVDIWSVGCIFAEMMLG 228
Query: 432 RQPI 435
+PI
Sbjct: 229 -EPI 231
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 2e-17
Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 30/218 (13%)
Query: 224 DKFSGSNIVGQGGSSY--VYRGQLTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSR 277
+K+ G +G+G +Y VY+ Q G A+K+ + +G P S + E+ +L
Sbjct: 2 EKYHGLEKIGEG--TYGVVYKAQNNYGETFALKKIRLEKEDEGIP---STTIREISILKE 56
Query: 278 LHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 335
L H ++V L V K+ + +LVFE + +L+ LD V G+ T + +
Sbjct: 57 LKHSNIVKLYDV-----IHTKKRL-VLVFEHLDQ-DLKKLLD-VCEGGLESVTAKSFLLQ 108
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 395
G+ Y H+ R+LHRD+K N+L++ KI D G+A +A G+P + +
Sbjct: 109 LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLA---RAFGIPVRKYTHEIV 162
Query: 396 QGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 432
T Y AP+ M + S D++S G + E++ G
Sbjct: 163 --TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 2e-17
Identities = 69/235 (29%), Positives = 103/235 (43%), Gaps = 33/235 (14%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF--LTEVDMLSRLHH 280
+ FS I+G+GG VY + D G++ A+K + L E MLS +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 281 CH---VVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIA- 333
+V + Y K L + + M G+L L GV E D R A
Sbjct: 249 GDCPFIVCMS-YAFHTPDK----LSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAE 300
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-CSSSP 392
I GLE++H +++RD+K +NILLDE+ + +I+DLG+A +
Sbjct: 301 I--ILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---- 351
Query: 393 ARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 446
GT GY APE G A +D FS G +L +L+ G P + TK + +
Sbjct: 352 ----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 49/172 (28%), Positives = 84/172 (48%), Gaps = 38/172 (22%)
Query: 224 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNA-DSVFLT---EVDMLS 276
++ + +G+G + VY+ + +IVA+K+ K A D + T E+ +L
Sbjct: 10 KRYEKLDFLGEG--QFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 277 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA 336
L H +++ L+ F K + LVF+FM D L+ ++ + + + +
Sbjct: 68 ELSHPNIIGLLDA---FGHKSNI-SLVFDFME----TD-LEVII-KDNS------LVLTP 111
Query: 337 A----------RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378
+ +GLEYLH+ ILHRD+K +N+LLDEN K+ D G+AK
Sbjct: 112 SHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 54/240 (22%), Positives = 84/240 (35%), Gaps = 61/240 (25%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLT----EVDMLSRLHHCHVV 284
G G +V+ + V VK + K + L E+ +LSR+ H +++
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGN-LRDCLD--GVLVEGMNWDTRVAIAIGAAR--- 338
++ + + LV E +G L +D L E + A
Sbjct: 93 KVL----DIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL------------ASYIF 136
Query: 339 -----GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSS 391
+ YL I+HRDIK NI++ E+ K+ D G A L+ L C
Sbjct: 137 RQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--- 190
Query: 392 PARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPIH--RSITKGE 443
GT Y APE Y G +++S GV L L+ P +
Sbjct: 191 -----GTIEYCAPEVLMGNPYR--GPE---LEMWSLGVTLYTLVFEENPFCELEETVEAA 240
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 62/249 (24%), Positives = 99/249 (39%), Gaps = 48/249 (19%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-------RFKTQGGPNADSVFLTEVDM 274
K+ +++G+G SS V R G AVK R + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 275 LSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVA 331
L ++ H H++ L+ + LVF+ M G L D L E +TR
Sbjct: 153 LRQVAGHPHIITLIDSYES----SSFMFLVFDLMRKGELFDYLTEKVALSEK---ETRSI 205
Query: 332 I-AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS--C 388
+ ++ + +LH I+HRD+K NILLD+N+ +++D G + L+ C
Sbjct: 206 MRSL--LEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC 260
Query: 389 SSSPARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP-------- 434
GT GY APE D+++ GV+L L+ G P
Sbjct: 261 --------GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL 312
Query: 435 IHRSITKGE 443
+ R I +G+
Sbjct: 313 MLRMIMEGQ 321
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 9e-17
Identities = 60/221 (27%), Positives = 88/221 (39%), Gaps = 49/221 (22%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
G G V G+ G VAVK R K + + E+ L H H++ L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK-REIQNLKLFRHPHIIKL-- 76
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR-------- 338
Y + +V E++ G L D C G + E AR
Sbjct: 77 Y--QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM------------EARRLFQQILS 122
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQ 396
++Y H ++HRD+K N+LLD ++NAKI D G++ + SC SP
Sbjct: 123 AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPN--- 175
Query: 397 GTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQP 434
Y APE ++ A D++S GV+L L+ G P
Sbjct: 176 ----YAAPE--VISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 60/237 (25%), Positives = 93/237 (39%), Gaps = 55/237 (23%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKR------FKTQGGPNADSVFLTEVDMLSRLHHC--HV 283
G GG VY G ++D VA+K PN V + EV +L ++ V
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSGV 110
Query: 284 VPLVGYCSEFRGKRAMRLLVFEF-MPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAAR-- 338
+ L+ ++ + +L+ E P +L D + G L E + AR
Sbjct: 111 IRLL----DWFERPDSFVLILERPEPVQDLFDFITERGALQEEL------------ARSF 154
Query: 339 ------GLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLKADGL--PSCS 389
+ + H +LHRDIK NIL+D N K+ D G LK D +
Sbjct: 155 FWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD- 209
Query: 390 SSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIH--RSITKGE 443
GT Y PE+ R + V+S G++L +++ G P I +G+
Sbjct: 210 -------GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 259
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 51/247 (20%), Positives = 91/247 (36%), Gaps = 53/247 (21%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHH 280
T+++ +G+G S V R ++ G+ A T+ D E + L H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAI--GA 336
++V L SE L+F+ + G L + E A
Sbjct: 70 PNIVRLHDSISE----EGHHYLIFDLVTGGELFEDIVAREYYSE------ADASHCIQQI 119
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+ + H+ ++HR++K N+LL + K+ D G+A ++ +
Sbjct: 120 LEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--------Q 168
Query: 394 RMQ---GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IH 436
GT GY +PE Y G+ D+++ GV+L L+ G P ++
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPY---GKP---VDLWACGVILYILLVGYPPFWDEDQHRLY 222
Query: 437 RSITKGE 443
+ I G
Sbjct: 223 QQIKAGA 229
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 60/254 (23%), Positives = 107/254 (42%), Gaps = 39/254 (15%)
Query: 208 HGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD- 265
H + R + ++++ ++G+G V + + AVK N D
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 266 SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMN 325
S L EV++L +L H +++ L + + +V E G L D +++
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILED----SSSFYIVGELYTGGELFD----EIIKRKR 117
Query: 326 WDTRVA--IAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRL 380
+ A I G+ Y+H+ I+HRD+K NILL +++ + KI D G++
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 381 KADGLPSCSSSPARMQ---GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--- 434
+ + +M+ GT Y APE + G DV+S GV+L L++G P
Sbjct: 175 QQNT---------KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYG 224
Query: 435 -----IHRSITKGE 443
I + + G+
Sbjct: 225 KNEYDILKRVETGK 238
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 62/248 (25%), Positives = 92/248 (37%), Gaps = 59/248 (23%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
G+G V VAVK + +++ E+ + L+H +VV Y
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHENVVKF--Y- 71
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR--------GL 340
R + ++ L E+ G L D D + E A+ G+
Sbjct: 72 -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP------------DAQRFFHQLMAGV 118
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-----SCSSSPARM 395
YLH I HRDIK N+LLDE N KI+D G+A + + C
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------- 168
Query: 396 QGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIH---------RSITKGE 443
GT Y APE ++ R + DV+S G+VL ++ G P + +
Sbjct: 169 -GTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225
Query: 444 ESLVLWVK 451
L W K
Sbjct: 226 TYLNPWKK 233
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 59/237 (24%), Positives = 99/237 (41%), Gaps = 40/237 (16%)
Query: 225 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
S + I+G G V++ + G +A K KT+G + + V E+ ++++L H ++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV-KNEISVMNQLDHANL 148
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR----G 339
+ L F K + +LV E++ G L D ++ E N I + G
Sbjct: 149 IQLYDA---FESKNDI-VLVMEYVDGGEL---FDRIIDESYNLTELDTILF--MKQICEG 199
Query: 340 LEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
+ ++H+ ILH D+K NIL + KI D G+A+R K G
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV------NFG 250
Query: 398 TFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
T + APE Y V +D++S GV+ L++G P +I
Sbjct: 251 TPEFLAPEVVNYDFVSFP---TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACR 304
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 56/245 (22%), Positives = 93/245 (37%), Gaps = 46/245 (18%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 278
+H D + +G G V+R + G A K T + ++V E+ +S L
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV-RKEIQTMSVL 211
Query: 279 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 338
H +V L F M ++++EFM G L + V E A+ R
Sbjct: 212 RHPTLVNLHDA---FEDDNEM-VMIYEFMSGGEL---FEKVADEHNKMSEDEAVEY--MR 262
Query: 339 ----GLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSP 392
GL ++HE +H D+K NI+ + K+ D G+ L
Sbjct: 263 QVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-------- 311
Query: 393 ARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRS 438
++ T G + APE VG +D++S GV+ L++G P R+
Sbjct: 312 -SVKVTTGTAEFAAPEVAEGKPVGYY---TDMWSVGVLSYILLSGLSPFGGENDDETLRN 367
Query: 439 ITKGE 443
+ +
Sbjct: 368 VKSCD 372
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 59/222 (26%), Positives = 87/222 (39%), Gaps = 50/222 (22%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
G+G V VAVK + +++ E+ + L+H +VV Y
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHENVVKF--Y- 71
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR--------GL 340
R + ++ L E+ G L D D + E A+ G+
Sbjct: 72 -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP------------DAQRFFHQLMAGV 118
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-----SCSSSPARM 395
YLH I HRDIK N+LLDE N KI+D G+A + + C
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------- 168
Query: 396 QGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQP 434
GT Y APE ++ R + DV+S G+VL ++ G P
Sbjct: 169 -GTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 62/252 (24%), Positives = 99/252 (39%), Gaps = 55/252 (21%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSV--FLTEVDM 274
D++ S +G G V + + VA+K +F AD TE+++
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 275 LSRLHHCHVVPLVGYCSE---FRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTR 329
L +L+H ++ + + + +V E M G L D + L E +
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYY--------IVLELMEGGELFDKVVGNKRLKEA---TCK 117
Query: 330 VAI-AIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGL 385
+ + ++YLHE I+HRD+K N+LL +E+ KITD G +K L L
Sbjct: 118 LYFYQM--LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 386 --PSCSSSPARMQGTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------ 434
C GT Y APE + D +S GV+L ++G P
Sbjct: 173 MRTLC--------GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224
Query: 435 ---IHRSITKGE 443
+ IT G+
Sbjct: 225 QVSLKDQITSGK 236
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 59/258 (22%), Positives = 100/258 (38%), Gaps = 41/258 (15%)
Query: 231 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 287
++G+G V +L + ++ A+K F E D+L + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL- 139
Query: 288 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIA-IGAARGLEY 342
+ + F+ L LV ++ G+L L + L E M R +A + A ++
Sbjct: 140 -HYA-FQDDN--NLYLVMDYYVGGDLLTLLSKFEDRLPEEM---ARFYLAEMVIA--IDS 190
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
+H+ +HRDIK NIL+D N + ++ D G +L DG S GT Y
Sbjct: 191 VHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV----AVGTPDYI 243
Query: 403 APE-----YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVL- 448
+PE GR D +S GV + E++ G P + I +E
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303
Query: 449 -WVKSIITDA-SICQSFL 464
V + +A + + +
Sbjct: 304 TQVTDVSENAKDLIRRLI 321
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 52/251 (20%), Positives = 92/251 (36%), Gaps = 57/251 (22%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV-----FLTEVDMLS 276
D + +G G + V + + + G A K K + + EV +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 277 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAI 334
++ H +++ L + + + +L+ E + G L D L E A
Sbjct: 71 QVLHPNIITLHDV---YENRTDV-VLILELVSGGELFDFLAQKESLSE--------EEAT 118
Query: 335 GAAR----GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLP 386
+ G+ YLH +I H D+K NI+L + K+ D G+A ++
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-- 173
Query: 387 SCSSSPARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------ 434
+ FG + APE Y +G +D++S GV+ L++G P
Sbjct: 174 -------EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGVITYILLSGASPFLGDTK 223
Query: 435 --IHRSITKGE 443
+IT
Sbjct: 224 QETLANITAVS 234
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 67/241 (27%), Positives = 100/241 (41%), Gaps = 45/241 (18%)
Query: 222 ATDKFSGS---------NIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTE 271
+TD FSG +++G+G + V L + AVK + Q G VF E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF-RE 60
Query: 272 VDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDT 328
V+ML + H +V+ L+ + E LVFE M G++ E
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEE----EDRFYLVFEKMRGGSILSHIHKRRHFNE------ 110
Query: 329 RVAIAI--GAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKAD 383
A + A L++LH I HRD+K NIL ++ KI D + +K +
Sbjct: 111 LEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 384 GLPSCSSSPARMQ--GTFGYFAPEYAMVGRASLMS--------DVFSFGVVLLELITGRQ 433
G S S+P + G+ Y APE V A D++S GV+L L++G
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPE---VVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
Query: 434 P 434
P
Sbjct: 225 P 225
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 8e-16
Identities = 63/224 (28%), Positives = 91/224 (40%), Gaps = 55/224 (24%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
G G V G+ G VAVK R K + + E+ L H H++ L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR-REIQNLKLFRHPHIIKL-- 81
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR-------- 338
Y + + +V E++ G L D C +G L E +R
Sbjct: 82 Y--QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK------------ESRRLFQQILS 127
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQ 396
G++Y H ++HRD+K N+LLD ++NAKI D G++ + SC SP
Sbjct: 128 GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPN--- 180
Query: 397 GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 434
Y APE YA G D++S GV+L L+ G P
Sbjct: 181 ----YAAPEVISGRLYA--GPE---VDIWSSGVILYALLCGTLP 215
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 53/224 (23%), Positives = 93/224 (41%), Gaps = 37/224 (16%)
Query: 224 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLS 276
D++ +G+G +Y VY+ VA+KR + +G P + EV +L
Sbjct: 34 DRYRRITKLGEG--TYGEVYKAIDTVTNETVAIKRIRLEHEEEGVP---GTAIREVSLLK 88
Query: 277 RLHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 334
L H +++ L V + L+FE+ N +L+ +D ++ +
Sbjct: 89 ELQHRNIIELKSV-----IHHNHRL-HLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLY 139
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-----KITDLGMAKRLKADGLPSCS 389
G+ + H R LHRD+K N+LL + + KI D G+A +A G+P
Sbjct: 140 QLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA---RAFGIPIRQ 193
Query: 390 SSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 432
+ + T Y PE + R S D++S + E++
Sbjct: 194 FTHEII--TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 8e-16
Identities = 58/251 (23%), Positives = 95/251 (37%), Gaps = 57/251 (22%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLS 276
D + +G G + V + Q G+ A K R + + EV++L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 277 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAI 334
+ H +++ L F K + +L+ E + G L D L L E A
Sbjct: 64 EIRHPNIITLHDI---FENKTDV-VLILELVSGGELFDFLAEKESLTE--------DEAT 111
Query: 335 GAAR----GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLP 386
+ G+ YLH RI H D+K NI+L N K+ D G+A +++A
Sbjct: 112 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-- 166
Query: 387 SCSSSPARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------ 434
+ FG + APE Y +G +D++S GV+ L++G P
Sbjct: 167 -------EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGVITYILLSGASPFLGETK 216
Query: 435 --IHRSITKGE 443
+I+
Sbjct: 217 QETLTNISAVN 227
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 9e-16
Identities = 52/251 (20%), Positives = 92/251 (36%), Gaps = 57/251 (22%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLS 276
D + +G G + V + + + G A K + + + EV +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 277 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAI 334
++ H +V+ L + + + +L+ E + G L D L E A
Sbjct: 71 QVLHHNVITLHDV---YENRTDV-VLILELVSGGELFDFLAQKESLSE--------EEAT 118
Query: 335 GAAR----GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLP 386
+ G+ YLH +I H D+K NI+L + K+ D G+A ++
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-- 173
Query: 387 SCSSSPARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------ 434
+ FG + APE Y +G +D++S GV+ L++G P
Sbjct: 174 -------EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGVITYILLSGASPFLGDTK 223
Query: 435 --IHRSITKGE 443
+IT
Sbjct: 224 QETLANITSVS 234
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 53/253 (20%), Positives = 86/253 (33%), Gaps = 34/253 (13%)
Query: 208 HGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADS 266
H + R + D F +G G V+ + + G +K
Sbjct: 6 HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65
Query: 267 VFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNW 326
E+++L L H +++ + F M + V E G L + + G
Sbjct: 66 QIEAEIEVLKSLDHPNIIKIFEV---FEDYHNMYI-VMETCEGGELLERIVSAQARGKAL 121
Query: 327 DTRVAIAI--GAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLK 381
+ L Y H ++H+D+K NIL + KI D G+A+ K
Sbjct: 122 SEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178
Query: 382 ADGLPSCSSSPARMQ---GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP---- 434
+D GT Y APE + D++S GVV+ L+TG P
Sbjct: 179 SD---------EHSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228
Query: 435 ----IHRSITKGE 443
+ + T E
Sbjct: 229 SLEEVQQKATYKE 241
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 50/217 (23%), Positives = 81/217 (37%), Gaps = 31/217 (14%)
Query: 228 GSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 285
++G G + V G+ A+K EVD + H+V
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKARQEVDHHWQASGGPHIVC 86
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT-----RVAIAIGAARGL 340
++ + L++ E M G L + G T + IG A +
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGEL---FSRIQERGDQAFTEREAAEIMRDIGTA--I 141
Query: 341 EYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
++LH I HRD+K N+L +++ K+TD G AK + L +P
Sbjct: 142 QFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPC---Y 191
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
T Y APE + D++S GV++ L+ G P
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 58/246 (23%), Positives = 91/246 (36%), Gaps = 71/246 (28%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKR------FKTQGGPNADSVFLTEVDMLSRLH----HC 281
G+GG V+ G LTD VA+K ++ + L EV +L ++ H
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGHP 98
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-----GVLVEGMNWDTRVAIAIGA 336
V+ L+ ++ + +LV E +D D G L EG
Sbjct: 99 GVIRLL----DWFETQEGFMLVLERPLPA--QDLFDYITEKGPLGEGP------------ 140
Query: 337 AR--------GLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGL-- 385
+R +++ H ++HRDIK NIL+D AK+ D G L D
Sbjct: 141 SRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYT 196
Query: 386 PSCSSSPARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPIH--R 437
GT Y PE Y + V+S G++L +++ G P +
Sbjct: 197 DFD--------GTRVYSPPEWISRHQYH--ALP---ATVWSLGILLYDMVCGDIPFERDQ 243
Query: 438 SITKGE 443
I + E
Sbjct: 244 EILEAE 249
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 62/261 (23%), Positives = 100/261 (38%), Gaps = 45/261 (17%)
Query: 231 IVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL 286
++G+G V + + T G++ A+K V F E D+L + L
Sbjct: 68 VIGRGAFSEVAVVKMKQT-GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 287 VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIA-IGAARGLE 341
+ + F+ + L LV E+ G+L L + M R +A I A ++
Sbjct: 127 --HFA-FQDEN--YLYLVMEYYVGGDLLTLLSKFGERIPAEM---ARFYLAEIVMA--ID 176
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
+H +HRDIK NILLD + ++ D G +L+ADG GT Y
Sbjct: 177 SVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV----AVGTPDY 229
Query: 402 FAPE-------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESL 446
+PE G D ++ GV E+ G+ P + I +E L
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289
Query: 447 VLWV--KSIITDA-SICQSFL 464
L + + + +A Q L
Sbjct: 290 SLPLVDEGVPEEARDFIQRLL 310
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 49/239 (20%), Positives = 91/239 (38%), Gaps = 55/239 (23%)
Query: 233 GQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRL-HHCHVVPLVGY 289
G+G + V + + G+ A K K + + L E+ +L V+ L
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRD-CLD---GVLVEGMNWDTRVAIAIGAAR----GLE 341
+ + +L+ E+ G + CL ++ E I + G+
Sbjct: 98 ---YENTSEI-ILILEYAAGGEIFSLCLPELAEMVSE--------NDVIRLIKQILEGVY 145
Query: 342 YLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
YLH+ I+H D+K NILL + KI D GM++++ ++
Sbjct: 146 YLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---------ELREI 193
Query: 399 FG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
G Y APE Y + A +D+++ G++ L+T P + +I++
Sbjct: 194 MGTPEYLAPEILNYDPITTA---TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN 249
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 57/259 (22%), Positives = 91/259 (35%), Gaps = 50/259 (19%)
Query: 209 GTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-S 266
G F +A +D + +G+G S V R T G A K T+ D
Sbjct: 14 GRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ 73
Query: 267 VFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNW 326
E + +L H ++V L E + LVF+ + G L + +V +
Sbjct: 74 KLEREARICRKLQHPNIVRLHDSIQE----ESFHYLVFDLVTGGELFE----DIVAREFY 125
Query: 327 DTRVAIAIGA--ARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLK 381
A + Y H I+HR++K N+LL + K+ D G+A +
Sbjct: 126 SEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182
Query: 382 ADGLPSCSSSPARMQ---GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGR 432
GT GY +PE Y + D+++ GV+L L+ G
Sbjct: 183 DSE---------AWHGFAGTPGYLSPEVLKKDPY---SKP---VDIWACGVILYILLVGY 227
Query: 433 QP--------IHRSITKGE 443
P ++ I G
Sbjct: 228 PPFWDEDQHRLYAQIKAGA 246
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 63/237 (26%), Positives = 95/237 (40%), Gaps = 37/237 (15%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
+D F + +G+G +S VYR Q + A+K K + TE+ +L RL H
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT---VDKKIVRTEIGVLLRLSHP 108
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAI-AIGAAR 338
+++ L LV E + G L D G E D A+ I
Sbjct: 109 NIIKLKEIFET----PTEISLVLELVTGGELFDRIVEKGYYSER---DAADAVKQI--LE 159
Query: 339 GLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARM 395
+ YLHE I+HRD+K N+L + KI D G++K ++ L +
Sbjct: 160 AVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK------TV 210
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP---------IHRSITKGE 443
GT GY APE D++S G++ L+ G +P + R I E
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE 267
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 62/258 (24%), Positives = 109/258 (42%), Gaps = 45/258 (17%)
Query: 231 IVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL 286
++G+G G + R + T ++ A+K F E D+++ + VV L
Sbjct: 76 VIGRGAFGEVQLVRHKST-RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 287 VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIA-IGAARGLEYL 343
+ + F+ R L +V E+MP G+L + + + E R A + A L+ +
Sbjct: 135 --FYA-FQDDR--YLYMVMEYMPGGDLVNLMSNYDVPEKW---ARFYTAEVVLA--LDAI 184
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
H +HRD+K N+LLD++ + K+ D G ++ +G+ C + GT Y +
Sbjct: 185 HSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT----AVGTPDYIS 237
Query: 404 PE-------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVL 448
PE GR D +S GV L E++ G P + I + SL
Sbjct: 238 PEVLKSQGGDGYYGRE---CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF 294
Query: 449 WVKSIITDA--SICQSFL 464
+ I+ ++ +FL
Sbjct: 295 PDDNDISKEAKNLICAFL 312
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 5e-15
Identities = 56/246 (22%), Positives = 87/246 (35%), Gaps = 52/246 (21%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHH 280
+D + +G+G S V R T G A K T+ D E + +L H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAI-AIGAA 337
++V L E + LVF+ + G L + E D I I
Sbjct: 65 PNIVRLHDSIQE----ESFHYLVFDLVTGGELFEDIVAREFYSEA---DASHCIQQI--L 115
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
+ Y H I+HR++K N+LL + K+ D G+A +
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---------A 163
Query: 395 MQ---GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHR 437
GT GY +PE Y + D+++ GV+L L+ G P ++
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPY---SKP---VDIWACGVILYILLVGYPPFWDEDQHRLYA 217
Query: 438 SITKGE 443
I G
Sbjct: 218 QIKAGA 223
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 61/224 (27%), Positives = 86/224 (38%), Gaps = 56/224 (25%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
G+G V + VA+K R + V E+ L L H H++ L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-REISYLKLLRHPHIIKL-- 74
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR-------- 338
Y + ++V E+ G L D + E R
Sbjct: 75 Y--DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED------------EGRRFFQQIIC 119
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQ 396
+EY H +I+HRD+K N+LLD+NLN KI D G++ + SC SP
Sbjct: 120 AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-GSPN--- 172
Query: 397 GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 434
Y APE YA G DV+S G+VL ++ GR P
Sbjct: 173 ----YAAPEVINGKLYA--GPE---VDVWSCGIVLYVMLVGRLP 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 59/265 (22%), Positives = 98/265 (36%), Gaps = 62/265 (23%)
Query: 209 GTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGP 262
GT+ R E+ D + +G G + V + + + G A K R K+
Sbjct: 1 GTVFR-----QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRG 55
Query: 263 NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVL 320
+ EV +L + H +V+ L + K + +L+ E + G L D L L
Sbjct: 56 VSREDIEREVSILKEIQHPNVITLHEV---YENKTDV-ILILELVAGGELFDFLAEKESL 111
Query: 321 VEGMNWDTRVAIAIGAAR----GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKIT 372
E A + G+ YLH +I H D+K NI+L KI
Sbjct: 112 TE--------EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKII 160
Query: 373 DLGMAKRLKADGLPSCSSSPARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLL 426
D G+A ++ + FG + APE Y +G +D++S GV+
Sbjct: 161 DFGLAHKIDFGN---------EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGVITY 208
Query: 427 ELITGRQP--------IHRSITKGE 443
L++G P +++
Sbjct: 209 ILLSGASPFLGDTKQETLANVSAVN 233
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 53/221 (23%), Positives = 79/221 (35%), Gaps = 51/221 (23%)
Query: 233 GQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
G G + +VAVK + ++V E+ L H ++V
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQ-REIINHRSLRHPNIVRF--K- 82
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR--------GL 340
E ++ E+ G L + C G E AR G+
Sbjct: 83 -EVILTPTHLAIIMEYASGGELYERICNAGRFSED------------EARFFFQQLLSGV 129
Query: 341 EYLHEAAAPRILHRDIKSSNILLDEN--LNAKITDLGMAKRLKADGLP--SCSSSPARMQ 396
Y H + +I HRD+K N LLD + KI D G +K P +
Sbjct: 130 SYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-------- 178
Query: 397 GTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQP 434
GT Y APE ++ R ++DV+S GV L ++ G P
Sbjct: 179 GTPAYIAPE--VLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 49/238 (20%), Positives = 83/238 (34%), Gaps = 39/238 (16%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
++ N +G+G V Q A K+ + D E++++ L H
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK-QEIEIMKSLDHP 66
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAIGAARG 339
+++ L + LV E G L + +V + A I
Sbjct: 67 NIIRLYETFED----NTDIYLVMELCTGGELFE----RVVHKRVFRESDAARIMKDVLSA 118
Query: 340 LEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
+ Y H+ + HRD+K N L + K+ D G+A R K M+
Sbjct: 119 VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---------MMR 166
Query: 397 ---GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
GT Y +P+ + G D +S GV++ L+ G P + I +G
Sbjct: 167 TKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 51/215 (23%), Positives = 77/215 (35%), Gaps = 36/215 (16%)
Query: 233 GQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 290
G G + V + A+K + EV++ R H+V +V
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVY 124
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT-----RVAIAIGAARGLEYLHE 345
R L+V E + G L + G T + +IG A ++YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEA--IQYLHS 179
Query: 346 AAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQ---GTF 399
I HRD+K N+L N K+TD G AK + + T
Sbjct: 180 I---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---------SLTTPCYTP 227
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
Y APE + D++S GV++ L+ G P
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 13/109 (11%)
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389
+ + A+G+E+L A+ + +HRD+ + NILL E KI D G+A+ + D
Sbjct: 196 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 390 SS---PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 434
P + + APE ++ SDV+SFGV+L E+ + G P
Sbjct: 253 GDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 25/94 (26%), Positives = 40/94 (42%), Gaps = 10/94 (10%)
Query: 230 NIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCH 282
+G+G V R VAVK K + ++E+ +L + HH +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL 316
VV L+G C++ G +++ EF GNL L
Sbjct: 88 VVNLLGACTKPGGP---LMVIVEFCKFGNLSTYL 118
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 44/220 (20%), Positives = 87/220 (39%), Gaps = 30/220 (13%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDMLSR 277
++ +G G V R VA+K+ P + E+ ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKC 117
Query: 278 LHHCHVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 335
++H +++ L+ + + + LV E M + L V+ ++ + +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----N-LCQVIQMELDHERMSYLLYQ 172
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 395
G+++LH A I+HRD+K SNI++ + KI D G+A+ + M
Sbjct: 173 MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---------M 220
Query: 396 QG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
T Y APE + D++S G ++ E++ +
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 46/221 (20%), Positives = 87/221 (39%), Gaps = 32/221 (14%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDMLSR 277
++ +G G V R VA+K+ P + E+ ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKC 80
Query: 278 LHHCHVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDC-LDGVLVEGMNWDTRVAIAI 334
++H +++ L+ + + + +V E M D L V+ ++ + +
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM------DANLCQVIQMELDHERMSYLLY 134
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
G+++LH A I+HRD+K SNI++ + KI D G+A+ +
Sbjct: 135 QMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--------- 182
Query: 395 MQG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
M T Y APE + D++S G ++ E+I G
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 59/264 (22%), Positives = 98/264 (37%), Gaps = 71/264 (26%)
Query: 219 LEHATDKFSGSNIVGQGGSSY--VYRGQLTD-GRIVAVKRFKTQGGPNADSVF-LTEVDM 274
LE ++ K+S +G G S+ V + G+ A+K+ D + E+D+
Sbjct: 2 LETSSKKYSLGKTLGTG--SFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDI 53
Query: 275 LSRLHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT---- 328
+ L H +++ L Y + + + G + +N
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 329 ------------RVAIAIGAA-----------------RGLEYLHEAAAPRILHRDIKSS 359
+V + + R + ++H I HRDIK
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQ 170
Query: 360 NILLDENLNA-KITDLGMAKRLKADGLPS----CSSSPARMQGTFGYFAPEYAMVGRASL 414
N+L++ N K+ D G AK+L PS CS R Y APE M+G A+
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICS----RF-----YRAPEL-MLG-ATE 218
Query: 415 MS---DVFSFGVVLLELITGRQPI 435
+ D++S G V ELI G +P+
Sbjct: 219 YTPSIDLWSIGCVFGELILG-KPL 241
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 36/98 (36%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
LE+LH+ I++RDIK NILLD N + +TD G++K AD GT
Sbjct: 171 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD----FCGT 223
Query: 399 FGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP 434
Y AP+ G + D +S GV++ EL+TG P
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 61/228 (26%), Positives = 90/228 (39%), Gaps = 45/228 (19%)
Query: 223 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HH 280
TD + +G G S R AVK + E+++L R H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK----SKRDPT-EEIEILLRYGQH 75
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGA-- 336
+++ L + +V E M G L D E R A A+
Sbjct: 76 PNIITLKDVYDD----GKYVYVVTELMKGGELLDKILRQKFFSE------REASAVLFTI 125
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILL-DENLNA---KITDLGMAKRLKADGLPSCSSSP 392
+ +EYLH ++HRD+K SNIL DE+ N +I D G AK+L+A+ +P
Sbjct: 126 TKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTP 180
Query: 393 ARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 434
T + APE Y A D++S GV+L ++TG P
Sbjct: 181 C---YTANFVAPEVLERQGY---DAA---CDIWSLGVLLYTMLTGYTP 219
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 52/238 (21%), Positives = 83/238 (34%), Gaps = 51/238 (21%)
Query: 221 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKR-FKTQGGPNADSVF---------LT 270
++ + G V G ++G VA+KR F T ++ L
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 271 EVDMLSRLHHCHVVPLV-----GYCSEFRGKRAMRLLVFEFMPNGNLRDC-LDGVLVEGM 324
E+ +L+ HH +++ L LV E M L V+ +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKL----YLVTELM------RTDLAQVIHDQR 128
Query: 325 NWDTRVAIA-----IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379
+ I I GL LHEA ++HRD+ NILL +N + I D +A+
Sbjct: 129 IVISPQHIQYFMYHI--LLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 380 LKADGLPSCSSSPARMQG---TFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGR 432
AD Y APE ++ D++S G V+ E+ +
Sbjct: 184 DTADA---------NKTHYVTHRWYRAPE-LVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 46/244 (18%), Positives = 84/244 (34%), Gaps = 78/244 (31%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HH 280
D + +G+G S V+ +T+ V VK K P E+ +L L
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGG 90
Query: 281 CHVVPL---VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDG------------VLVEGMN 325
+++ L V LVFE + N + + +L
Sbjct: 91 PNIITLADIVKDPVSRT-----PALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL----- 140
Query: 326 WDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADG 384
+ L+Y H I+HRD+K N+++D E+ ++ D G+A+
Sbjct: 141 ------------KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE------ 179
Query: 385 LPSCSSSPAR-MQG---TFGYFAPE---------YAMVGRASLMSDVFSFGVVLLELITG 431
P + + + PE Y++ D++S G +L +I
Sbjct: 180 ----FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFR 227
Query: 432 RQPI 435
++P
Sbjct: 228 KEPF 231
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 49/189 (25%), Positives = 77/189 (40%), Gaps = 37/189 (19%)
Query: 269 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNG----NLRDCLDGVLVEG 323
L E +L ++ +V L F+ L +V E++ G +LR G E
Sbjct: 89 LNEKRILQAVNFPFLVKLEFS---FKDNS--NLYMVMEYVAGGEMFSHLRRI--GRFSEP 141
Query: 324 MNWDTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382
R A I EYLH +++RD+K N+L+D+ ++TD G AKR+K
Sbjct: 142 H---ARFYAAQIVLT--FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP-------- 434
C GT APE + + D ++ GV++ E+ G P
Sbjct: 194 RTWTLC--------GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
Query: 435 IHRSITKGE 443
I+ I G+
Sbjct: 246 IYEKIVSGK 254
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 47/212 (22%), Positives = 82/212 (38%), Gaps = 33/212 (15%)
Query: 233 GQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 290
G+G S + + AVK + ++ E+ L H ++V L
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLEYLHEAAA 348
+ + LV E + G L + + + ++ A I + ++H+
Sbjct: 76 HD----QLHTFLVMELLNGGEL---FERIKKKK-HFSETEASYIMRKLVSAVSHMHDV-- 125
Query: 349 PRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLP---SCSSSPARMQGTFGYF 402
++HRD+K N+L ++NL KI D G A+ D P C T Y
Sbjct: 126 -GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC--------FTLHYA 176
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
APE D++S GV+L +++G+ P
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 54/233 (23%), Positives = 87/233 (37%), Gaps = 47/233 (20%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVK------RFKTQGGPNADSVFLTEV 272
E D++ +++G+G V + + VA+K F Q EV
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA--------QIEV 101
Query: 273 DMLSRL--------HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGM 324
+L + ++ V L + FR + VFE + + NL D L G+
Sbjct: 102 RLLELMNKHDTEMKYYI--VHLKRH-FMFRNHLCL---VFEML-SYNLYDLLRNTNFRGV 154
Query: 325 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA--KITDLGMAKRLKA 382
+ + A L +L I+H D+K NILL + KI D G +
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSS----- 208
Query: 383 DGLPSCSSSPAR---MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
C +Q F Y +PE + L D++S G +L+E+ TG
Sbjct: 209 -----CQLGQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 9e-12
Identities = 41/141 (29%), Positives = 65/141 (46%), Gaps = 32/141 (22%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
L +LH+ I++RD+K N+LLD + K+ D GM K +G+ + + GT
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-----FCGT 187
Query: 399 FGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEE 444
Y APE Y G A D ++ GV+L E++ G P + +I E
Sbjct: 188 PDYIAPEILQEMLY---GPA---VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE- 240
Query: 445 SLVLWVKSIITDA-SICQSFL 464
V++ + DA I +SF+
Sbjct: 241 --VVYPTWLHEDATGILKSFM 259
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 9e-12
Identities = 35/142 (24%), Positives = 60/142 (42%), Gaps = 32/142 (22%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
L +LH+ I++RD+K NI+L+ + K+TD G+ K DG + + GT
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-----FCGT 184
Query: 399 FGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEE 444
Y APE + RA D +S G ++ +++TG P I K +
Sbjct: 185 IEYMAPEILMRSGH---NRA---VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK- 237
Query: 445 SLVLWVKSIITDA-SICQSFLV 465
+ + +A + + L
Sbjct: 238 --LNLPPYLTQEARDLLKKLLK 257
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 53/218 (24%)
Query: 269 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNG----NLRDCLDGVLVEG 323
E MLS + H ++ + + + F+ + ++ ++ +++ G LR
Sbjct: 54 NDERLMLSIVTHPFIIRM--WGT-FQDAQ--QIFMIMDYIEGGELFSLLRKS--QRFPNP 106
Query: 324 MNWDTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382
+ + A + A LEYLH I++RD+K NILLD+N + KITD G AK +
Sbjct: 107 V---AKFYAAEVCLA--LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158
Query: 383 DGLPSCSSSPARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP-- 434
C GT Y APE Y ++ D +SFG+++ E++ G P
Sbjct: 159 VTYTLC--------GTPDYIAPEVVSTKPY---NKS---IDWWSFGILIYEMLAGYTPFY 204
Query: 435 ------IHRSITKGEESLVLWVKSIITDA-SICQSFLV 465
+ I E + + D + +
Sbjct: 205 DSNTMKTYEKILNAE---LRFPPFFNEDVKDLLSRLIT 239
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 52/224 (23%), Positives = 91/224 (40%), Gaps = 35/224 (15%)
Query: 221 HATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDML 275
+ VG G V G VA+K+ P +F E+ +L
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL---SRPFQSEIFAKRAYRELLLL 77
Query: 276 SRLHHCHVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
+ H +V+ L+ + R LV FM +L+ + E + +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSE----EKIQYLV 132
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+GL+Y+H A ++HRD+K N+ ++E+ KI D G+A+ A+
Sbjct: 133 YQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---------- 179
Query: 394 RMQG---TFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGR 432
M G T Y APE ++ + D++S G ++ E++TG+
Sbjct: 180 -MTGYVVTRWYRAPE-VILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 45/144 (31%), Positives = 68/144 (47%), Gaps = 38/144 (26%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-- 396
LEYLH +++RDIK N++LD++ + KITD G+ K +DG A M+
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------ATMKTF 165
Query: 397 -GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITK 441
GT Y APE Y GRA D + GVV+ E++ GR P + I
Sbjct: 166 CGTPEYLAPEVLEDNDY---GRA---VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
Query: 442 GEESLVLWVKSIITDA-SICQSFL 464
E + + +++ +A S+ L
Sbjct: 220 EE---IRFPRTLSPEAKSLLAGLL 240
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 36/119 (30%), Positives = 56/119 (47%), Gaps = 28/119 (23%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
L++LH I++RD+K NILLDE + K+TD G++K + S GT
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-----FCGT 189
Query: 399 FGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 443
Y APE + ++ +D +SFGV++ E++TG P I K +
Sbjct: 190 VEYMAPEVVNRRGH---TQS---ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 40/138 (28%), Positives = 63/138 (45%), Gaps = 26/138 (18%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR-LKADGLPS--CSSSPARM 395
GL++LH I++RD+K NILLD++ + KI D GM K + D + C
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC------- 179
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH--------RSITKGEESLV 447
GT Y APE + + + D +SFGV+L E++ G+ P H SI
Sbjct: 180 -GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN---P 235
Query: 448 LWVKSIITDA-SICQSFL 464
+ + + +A +
Sbjct: 236 FYPRWLEKEAKDLLVKLF 253
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 41/141 (29%), Positives = 65/141 (46%), Gaps = 31/141 (21%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
L+YLH +++RD+K N++LD++ + KITD G+ K DG + GT
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-----FCGT 312
Query: 399 FGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEE 444
Y APE Y GRA D + GVV+ E++ GR P + I E
Sbjct: 313 PEYLAPEVLEDNDY---GRA---VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE- 365
Query: 445 SLVLWVKSIITDA-SICQSFL 464
+ + +++ +A S+ L
Sbjct: 366 --IRFPRTLGPEAKSLLSGLL 384
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 37/144 (25%), Positives = 54/144 (37%), Gaps = 38/144 (26%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS---CSSSPARM 395
L YLH I++RD+K NILLD + +TD G+ K + C
Sbjct: 151 ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC------- 200
Query: 396 QGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITK 441
GT Y APE Y R D + G VL E++ G P ++ +I
Sbjct: 201 -GTPEYLAPEVLHKQPY---DRT---VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 253
Query: 442 GEESLVLWVKSIITDA-SICQSFL 464
+ +I A + + L
Sbjct: 254 KP---LQLKPNITNSARHLLEGLL 274
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 40/135 (29%), Positives = 65/135 (48%), Gaps = 20/135 (14%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
GL +L I++RD+K N++LD + KI D GM K DG+ + + GT
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-----FCGT 184
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWV 450
Y APE D ++FGV+L E++ G+ P + +SI + V +
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---VAYP 241
Query: 451 KSIITDA-SICQSFL 464
KS+ +A +IC+ +
Sbjct: 242 KSMSKEAVAICKGLM 256
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 26/109 (23%), Positives = 49/109 (44%), Gaps = 25/109 (22%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
R ++ LH + ++HRD+K SN+L++ N + K+ D G+A+ + + + +
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 398 TFGYF------APEYAMVGRASLMS--------DVFSFGVVLLELITGR 432
+ APE +++ DV+S G +L EL R
Sbjct: 180 V-EFVATRWYRAPEV-------MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 40/135 (29%), Positives = 65/135 (48%), Gaps = 20/135 (14%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
GL +L I++RD+K N++LD + KI D GM K DG+ + + GT
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-----FCGT 505
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWV 450
Y APE D ++FGV+L E++ G+ P + +SI + V +
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---VAYP 562
Query: 451 KSIITDA-SICQSFL 464
KS+ +A +IC+ +
Sbjct: 563 KSMSKEAVAICKGLM 577
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 26/112 (23%), Positives = 51/112 (45%), Gaps = 20/112 (17%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
+ ++YLH +LHRD+K SNILL+ + K+ D G+++ + + + +
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 398 TFGYFAPEYAMVG-------RA--SLMS--------DVFSFGVVLLELITGR 432
T + + + RA L+ D++S G +L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 38/226 (16%)
Query: 221 HATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDML 275
+ VG G V G VA+K+ P +F E+ +L
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL---YRPFQSELFAKRAYRELRLL 78
Query: 276 SRLHHCHVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDC-LDGVL-VEGMNWDTRVA 331
+ H +V+ L+ + LV FM L ++ E + D
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM------GTDLGKLMKHEKLGEDRIQF 132
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 391
+ +GL Y+H A I+HRD+K N+ ++E+ KI D G+A++ ++
Sbjct: 133 LVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-------- 181
Query: 392 PARMQG---TFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGR 432
M G T Y APE ++ R + D++S G ++ E+ITG+
Sbjct: 182 ---MTGYVVTRWYRAPE-VILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 8e-11
Identities = 36/105 (34%), Positives = 50/105 (47%), Gaps = 26/105 (24%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS---CSSSPARM 395
L YLHE I++RD+K N+LLD + K+TD GM K G + C
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC------- 171
Query: 396 QGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 434
GT Y APE Y G + D ++ GV++ E++ GR P
Sbjct: 172 -GTPNYIAPEILRGEDY---GFS---VDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 36/105 (34%), Positives = 50/105 (47%), Gaps = 26/105 (24%)
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS---CSSSPARM 395
L YLHE I++RD+K N+LLD + K+TD GM K G + C
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC------- 214
Query: 396 QGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 434
GT Y APE Y G + D ++ GV++ E++ GR P
Sbjct: 215 -GTPNYIAPEILRGEDY---GFS---VDWWALGVLMFEMMAGRSP 252
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 14/100 (14%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+Y+H A +LHRD+K SN+LL+ + KI D G+A+ D +
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD-----HDHTGFLTE 190
Query: 398 ---TFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGR 432
T Y APE M+ D++S G +L E+++ R
Sbjct: 191 YVATRWYRAPE-IMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 20/100 (20%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
RGL+Y+H A I+HRD+K SN+ ++E+ KI D G+A+ + M G
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-----------HTADEMTG 188
Query: 398 ---TFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGR 432
T Y APE M+ + D++S G ++ EL+TGR
Sbjct: 189 YVATRWYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 41/165 (24%), Positives = 61/165 (36%), Gaps = 24/165 (14%)
Query: 224 DKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHC 281
D S ++G G + V + A+K + EV++ R
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCP 71
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT-----RVAIAIGA 336
H+V +V R L+V E + G L + G T + +IG
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAK 378
A ++YLH I HRD+K N+L N K+TD G AK
Sbjct: 129 A--IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.7 bits (146), Expect = 3e-10
Identities = 37/224 (16%), Positives = 63/224 (28%), Gaps = 57/224 (25%)
Query: 200 CRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVK--RFK 257
C K + FS+ T+K +G+G V++ D VA+K +
Sbjct: 5 CSQKG------PVPFSHCL---PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIE 54
Query: 258 TQGGPNADS-----VFLTEVDML-----------------SRLHHCHVV------PLVGY 289
N L E+ + L+ H V L+
Sbjct: 55 GPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKA 114
Query: 290 CSEFRGKRAMRL------------LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 337
+ + +V EF G L+ + + + T +I
Sbjct: 115 WDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLT 171
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381
L + R HRD+ N+LL + K+ K
Sbjct: 172 ASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 54/235 (22%), Positives = 93/235 (39%), Gaps = 53/235 (22%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVK------RFKTQGGPNADSVFLTEV 272
+H ++ ++G+G V + + VA+K RF Q E+
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA--------AEEI 144
Query: 273 DMLSRL------HHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMN 325
+L L + +V+ ++ FR + + FE + + NL + + +G +
Sbjct: 145 RILEHLRKQDKDNTMNVIHMLEN-FTFRN----HICMTFELL-SMNLYELIKKNKFQGFS 198
Query: 326 WDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA--KITDLGMAKRLKAD 383
A + L+ LH+ RI+H D+K NILL + + K+ D G
Sbjct: 199 LPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG-------- 247
Query: 384 GLPSCSSSPAR------MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
SS +Q F Y APE + R + D++S G +L EL+TG
Sbjct: 248 -----SSCYEHQRVYTYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 44/224 (19%), Positives = 78/224 (34%), Gaps = 58/224 (25%)
Query: 221 HATDKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVD 273
D++ +++G G SY V + R+VA+K+ D + L E+
Sbjct: 50 QIPDRYEIRHLIGTG--SYGHVCEAYDKLEKRVVAIKKI---LRVFEDLIDCKRILREIA 104
Query: 274 MLSRLHHCHVVPLV-----GYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWD 327
+L+RL+H HVV ++ +F L +V E D
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDE-----LYVVLEIAD-----------------SD 142
Query: 328 TRVAIAIGAA--------------RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 373
+ G++Y+H A ILHRD+K +N L++++ + K+ D
Sbjct: 143 FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCD 199
Query: 374 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSD 417
G+A R S P + ++
Sbjct: 200 FGLA-RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 28/101 (27%), Positives = 52/101 (51%), Gaps = 15/101 (14%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
RGL+Y+H A +LHRD+K +N+ ++ E+L KI D G+A+ + S +
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH-----YSHKGHLS 182
Query: 397 G---TFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGR 432
T Y +P ++ + D+++ G + E++TG+
Sbjct: 183 EGLVTKWYRSPR-LLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 26/123 (21%), Positives = 50/123 (40%), Gaps = 37/123 (30%)
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
G ++HE+ I+HRD+K +N LL+++ + K+ D G+A+ + ++ + + +
Sbjct: 140 LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 398 TFG-----------------YFAPEYAMVGRASLMS---------DVFSFGVVLLELITG 431
Y APE L+ D++S G + EL+
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPE--------LILLQENYTKSIDIWSTGCIFAELLNM 248
Query: 432 RQP 434
Q
Sbjct: 249 LQS 251
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 48/227 (21%), Positives = 86/227 (37%), Gaps = 45/227 (19%)
Query: 231 IVGQGGSSYVYRGQ-LTDGRIVAVK------RFKTQGGPNADSVFLTEVDMLSRLHHC-- 281
+G G S V+ + + + VA+K + E+ +L R++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA--------EDEIKLLQRVNDADN 77
Query: 282 ---------HVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 331
H++ L+ + +G + + +VFE + NL + G+
Sbjct: 78 TKEDSMGANHILKLLDH-FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE------NLNAKITDLGMAKRLKADGL 385
I+ GL+Y+H I+H DIK N+L++ + KI DLG A
Sbjct: 136 ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
S + Y +PE + +D++S ++ ELITG
Sbjct: 194 NSIQTRE--------YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 46/214 (21%), Positives = 78/214 (36%), Gaps = 27/214 (12%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G G +Y G + VA+K + L E + L +P V +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 291 SEFRGKRAMRLLVFEFM-PN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
+ V + + P+ +L + ++ T + +A +E++H +
Sbjct: 72 GVEGDYNVL---VMDLLGPSLEDLFNFCSR----KLSLKTVLMLADQMINRVEFVHSKS- 123
Query: 349 PRILHRDIKSSNILLDENLNAK---ITDLGMAKRLK--ADGLPSCSSSPARMQGTFGYFA 403
LHRDIK N L+ A I D G+AK+ + + + GT Y A
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-A 180
Query: 404 PEYAMVGRASLMS---DVFSFGVVLLELITGRQP 434
+G S D+ S G VL+ + G P
Sbjct: 181 SVNTHLGIE--QSRRDDLESLGYVLMYFLRGSLP 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 38/158 (24%), Positives = 60/158 (37%), Gaps = 25/158 (15%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVK--RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288
+G G + G+ L VA+K K++ E +L +P V
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVY 71
Query: 289 YCSEFRGKRAMRLLVFEFM-PN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
Y AM V E + P+ +L D D + T + IAI +EY+H
Sbjct: 72 YFGPCGKYNAM---VLELLGPSLEDLFDLCDRT----FSLKTVLMIAIQLISRMEYVHSK 124
Query: 347 AAPRILHRDIKSSNILL--DENLNAK---ITDLGMAKR 379
+++RD+K N L+ N + I D +AK
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 45/212 (21%), Positives = 74/212 (34%), Gaps = 23/212 (10%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G G +Y G + G VA+K + E + + +P + +C
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVK---TKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 291 SEFRGKRAMRLLVFEFM-PN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
M V E + P+ +L + + T + +A +EY+H
Sbjct: 74 GAEGDYNVM---VMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIHSK-- 124
Query: 349 PRILHRDIKSSNILLDENLNAK---ITDLGMAKRLK--ADGLPSCSSSPARMQGTFGYFA 403
+HRD+K N L+ I D G+AK+ + + GT Y A
Sbjct: 125 -NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-A 182
Query: 404 PEYAMVGR-ASLMSDVFSFGVVLLELITGRQP 434
+G S D+ S G VL+ G P
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 41/241 (17%), Positives = 78/241 (32%), Gaps = 49/241 (20%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRG--QLTDGRIVAVK------RFKTQGGPNADSVFLTE 271
+ +++ +G+G V VA+K +++ E
Sbjct: 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA--------RLE 66
Query: 272 VDMLSRL--------HHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVE 322
+++L ++ C V + F G + + FE + N + L +
Sbjct: 67 INVLKKIKEKDKENKFLC--VLMSD-WFNFHG----HMCIAFELL-GKNTFEFLKENNFQ 118
Query: 323 GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382
+A L +LHE ++ H D+K NIL + + + + K+
Sbjct: 119 PYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175
Query: 383 DGLPSC------SSSPARMQGT------FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 430
S S++ T Y PE + + DV+S G +L E
Sbjct: 176 VKNTSIRVADFGSATFDHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYYR 234
Query: 431 G 431
G
Sbjct: 235 G 235
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 9e-08
Identities = 42/230 (18%), Positives = 81/230 (35%), Gaps = 39/230 (16%)
Query: 232 VGQGGSSYVYRGQ---------LTDGRIVAVKRFKTQGGPNADSVFLT------EVDMLS 276
+ +Y + ++K G + F +V+
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 277 RLHHCHV--VPLVGYCSEFRGKRAMRLLVFEFMPNG-NLRDCLDGVLVEGMNWDTRVAIA 333
+L+ + +P + K R LV + G +L+ LD ++ + + +A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDK--YRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVA 165
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT--DLGMAKRLKADG--LPSCS 389
LE+LHE +H ++ + NI +D +++T G A R G +
Sbjct: 166 CRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 390 SSPARMQGTFGYFAPEYAMV----GRA-SLMSDVFSFGVVLLELITGRQP 434
S + +G E+ + G S SD+ S G +L+ + G P
Sbjct: 223 GSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 46/246 (18%), Positives = 85/246 (34%), Gaps = 28/246 (11%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+G ++ G L + + VA+K + + E L C +P V Y
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRR---SDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 291 SEFRGKRAMRLLVFEFM-PN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
+ + V + + P+ +L D + T A ++ +HE +
Sbjct: 75 GQEGLHNVL---VIDLLGPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSIHEKS- 126
Query: 349 PRILHRDIKSSNILLDENLNAK-----ITDLGMAKRLK--ADGLPSCSSSPARMQGTFGY 401
+++RDIK N L+ + + D GM K + + GT Y
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 402 FAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQP---IHRSITKGEESLVLWVKSIITDA 457
+GR S D+ + G V + + G P + + K + + K
Sbjct: 185 -MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243
Query: 458 SICQSF 463
+C F
Sbjct: 244 ELCAGF 249
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 46/259 (17%), Positives = 83/259 (32%), Gaps = 71/259 (27%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G G S V+ + + VA+K K+ ++ E+ +L + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD--EIRLLKSVRNSD-------- 94
Query: 291 SEFRGKRAMRLLVFEFM---PNG------------NLRDCLDGVLVEGMNWDTRVAIAIG 335
+ + L+ +F NG +L + +G+ I
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSP 392
+GL+YLH RI+H DIK NILL ++ + + +R A + S
Sbjct: 155 VLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 393 ARMQG--------------------------------------TFGYFAPEYAMVGRA-S 413
A T Y + E ++G +
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLE-VLIGSGYN 271
Query: 414 LMSDVFSFGVVLLELITGR 432
+D++S + EL TG
Sbjct: 272 TPADIWSTACMAFELATGD 290
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 45/240 (18%), Positives = 83/240 (34%), Gaps = 47/240 (19%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQ--LTDGRIVAVK------RFKTQGGPNADSVFLTE 271
+ + ++ + +G+G V GR VAVK R+ +E
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA--------RSE 61
Query: 272 VDMLSRL--------HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG 323
+ +L L C V ++ E G + VFE + + D +
Sbjct: 62 IQVLEHLNTTDPNSTFRC--VQMLE-WFEHHGHICI---VFELL-GLSTYDFIKENGFLP 114
Query: 324 MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383
D +A + + +LH ++ H D+K NIL ++ + + + + +
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171
Query: 384 GLPSC------SSSPAR------MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG 431
P S++ + Y APE + S DV+S G +L+E G
Sbjct: 172 INPDIKVVDFGSATYDDEHHSTLVSTRH-YRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 49/250 (19%), Positives = 80/250 (32%), Gaps = 63/250 (25%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVK------RFKTQGGPNADSVFLTEV 272
+ F +G G V Q + + + AVK ++ E
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA--------KIEA 82
Query: 273 DMLSRL-------HHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGM 324
D+L ++ ++ V G + + L+FE + +L + + G
Sbjct: 83 DILKKIQNDDINNNNI--VKYHG-KFMYYD----HMCLIFEPL-GPSLYEIITRNNYNGF 134
Query: 325 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 384
+ + I + L YL + + H D+K NILLD+ K
Sbjct: 135 HIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191
Query: 385 LPSCSSSPARMQGTFG-----------------YFAPE------YAMVGRASLMSDVFSF 421
+ S FG Y APE + + SD++SF
Sbjct: 192 QIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSF 245
Query: 422 GVVLLELITG 431
G VL EL TG
Sbjct: 246 GCVLAELYTG 255
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 48/231 (20%), Positives = 76/231 (32%), Gaps = 44/231 (19%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV------- 283
+G GG +Y A K + + +E+ R+
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVE--YQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 284 -------VPLVGYCSEFRGK-RAMRLLVFEFM-PN-GNLRDC-----LDGVLVEGMNWDT 328
+PL K R+ R +V E + + + VL
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQ------- 155
Query: 329 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT--DLGMAKRLKADG-- 384
+ I LEY+HE +H DIK++N+LL ++ D G++ R +G
Sbjct: 156 ---LGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 385 LPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQP 434
+ GT F A G A S SDV G +L + G+ P
Sbjct: 210 KQYQENPRKGHNGTI-EFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 30/102 (29%), Positives = 45/102 (44%), Gaps = 13/102 (12%)
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKIT--DLGMAKRLKADG----LPSCSSSPA 393
LEY+HE +H DIK+SN+LL+ ++ D G+A R +G +
Sbjct: 165 LEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRC- 220
Query: 394 RMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQP 434
GT F A G A S D+ G +++ +TG P
Sbjct: 221 -HDGTI-EFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 2e-05
Identities = 70/464 (15%), Positives = 119/464 (25%), Gaps = 120/464 (25%)
Query: 17 WIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRS----------CDCSP--- 63
++ I + + S L D K N SR + P
Sbjct: 93 FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152
Query: 64 -----VGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKV 118
V GS GK T + A D SY C + + + V
Sbjct: 153 VLIDGVLGS--GK-TWV-ALD-----VCLSYKVQC-----KMDFKIFWLNLKNCNSPETV 198
Query: 119 VVIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKESCNSATNLISHRITSVPE 178
+ ++ L + + RS S+ K +S + + S P
Sbjct: 199 LEMLQKLLYQID---------------PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 179 TR----------VEVVSPIDLATGC-FLKTTFCRSKTWTIHGTIIRFSYSALEHATDKFS 227
+ + +L C L TT R K T + ++ +L+H + +
Sbjct: 244 ENCLLVLLNVQNAKAWNAFNL--SCKILLTT--RFKQVTDFLSAATTTHISLDHHSMTLT 299
Query: 228 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEV-DMLSRLHH-CHVVP 285
+ Y+ D R + R P S+ + D L+ + HV
Sbjct: 300 PDEVKSL-LLKYL------DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHV-- 350
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMN---------WD------- 327
C + L V E P R D V + W
Sbjct: 351 ---NCDKLTTIIESSLNVLE--PA-EYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404
Query: 328 --------TRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379
+ + ++ ++K + + L+ I D
Sbjct: 405 MVVVNKLHKYSLVEKQPKESTISIPS------IYLELK-VKLENEYALHRSIVD----HY 453
Query: 380 LKADGLPSCSSSPARMQGTF----GYFAPEYAMVGRASLMSDVF 419
S P + F G+ R +L VF
Sbjct: 454 NIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVF 497
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 466 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.98 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.03 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.68 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.68 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.54 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.45 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.39 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.35 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.06 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.06 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.03 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.83 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.64 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.63 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.51 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.44 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.42 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.38 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.22 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.18 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.12 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.96 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.77 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.04 | |
| 1z6c_A | 87 | Vitamin K-dependent protein S; EGF module, blood c | 95.71 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.33 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 95.29 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.02 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.19 | |
| 1emn_A | 82 | Fibrillin; extracellular matrix, calcium-binding, | 94.13 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 94.01 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 93.98 | |
| 2w2n_E | 107 | LDL receptor, low-density lipoprotein receptor; hy | 92.91 | |
| 1aut_L | 114 | Activated protein C; serine proteinase, plasma cal | 92.1 | |
| 2bou_A | 143 | EGF-like module containing mucin-like hormone rece | 90.78 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 89.35 | |
| 3h5c_B | 317 | Vitamin K-dependent protein Z; protein Z-protein Z | 88.87 | |
| 1z1y_A | 186 | Ookinete surface protein PVS25; four EGF-like doma | 87.69 | |
| 1nfu_B | 195 | Coagulation factor XA, light chain; hydrolase; HET | 87.18 | |
| 2bou_A | 143 | EGF-like module containing mucin-like hormone rece | 87.06 | |
| 3v65_B | 386 | Low-density lipoprotein receptor-related protein; | 86.5 | |
| 1dx5_I | 118 | Thrombomodulin; serine proteinase, EGF-like domain | 86.37 | |
| 3p5b_L | 400 | Low density lipoprotein receptor variant; B-propel | 86.2 | |
| 1yo8_A | 634 | Thrombospondin-2; EGF, Ca(2+)-binding domains, lec | 85.9 | |
| 2vj3_A | 135 | Neurogenic locus notch homolog protein 1; transcri | 85.27 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 84.63 | |
| 1yo8_A | 634 | Thrombospondin-2; EGF, Ca(2+)-binding domains, lec | 84.34 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.74 | |
| 2c4f_L | 142 | Coagulation factor VII precursor; blood coagulatio | 83.62 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 83.6 | |
| 2vh0_B | 134 | Activated factor XA light chain; serine protease, | 83.37 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 82.29 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 80.82 | |
| 2vj3_A | 135 | Neurogenic locus notch homolog protein 1; transcri | 80.66 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=382.01 Aligned_cols=203 Identities=28% Similarity=0.424 Sum_probs=174.4
Q ss_pred CCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
+...+.||+|+||.||+|.+. +++.||||+++........++|.+|+.++++++|||||+++|+|.+ ...
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~~~ 103 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK----DQP 103 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS----SSS
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE----CCE
Confidence 444578999999999999863 4678999999877666666789999999999999999999999986 345
Q ss_pred EEEEEecCCCCCHHHHhcccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 012297 300 RLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~ 365 (466)
.+|||||+++|+|.++|.... ...++|.+++.|+.|||+||+|||+.+ |+||||||+||||++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECC
Confidence 699999999999999996432 235899999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 366 ~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
++.+||+|||+++....... ........||+.|+|||++.++.++.++|||||||+||||+| |+.||...
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~---~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADY---YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGC---BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred CCCEEECCcccceeccCCCc---eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999987654322 122344679999999999999999999999999999999998 89999754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=379.34 Aligned_cols=204 Identities=31% Similarity=0.462 Sum_probs=173.8
Q ss_pred CCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
++|.+.+.||+|+||.||+|++. +++.||||+++.. .....++|.+|+++|++++|||||+++|+|.+ .
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVE----G 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee----C
Confidence 45677789999999999999864 4778999999764 33445679999999999999999999999986 4
Q ss_pred eeEEEEEecCCCCCHHHHhcccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVL-----------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~ 366 (466)
...+|||||+++|+|.++|+... ...++|.+++.++.|+|+||+|||+.+ |+||||||+||||+++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCC
Confidence 46799999999999999996532 246999999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 367 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+.+||+|||+++........ .......||+.|||||.+.+..++.++|||||||+||||+| |+.||...
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~---~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~ 234 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCE---EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcEEECCcccceecCCCCce---eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999876443221 12233568999999999999999999999999999999999 99999754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=378.42 Aligned_cols=206 Identities=31% Similarity=0.450 Sum_probs=170.2
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
|+...+++.+.+.||+|+||+||+|++.+ .||||+++... .....+.|.+|++++++++|||||+++|++.+
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----- 103 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----- 103 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-----
Confidence 34445677888999999999999998753 59999997543 33345679999999999999999999999864
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...+|||||+++|+|.++|+... ..++|.+++.|+.|+|+||+|||+.+ |+||||||+||||++++.+||+|||+|
T Consensus 104 ~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 104 DNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp SSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred CeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCc
Confidence 23589999999999999997543 45999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhccc---CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+....... ........||+.|||||++.. +.++.++|||||||+||||+||+.||...
T Consensus 180 ~~~~~~~~---~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~ 240 (307)
T 3omv_A 180 TVKSRWSG---SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI 240 (307)
T ss_dssp BC---------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eecccCCc---ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC
Confidence 87543221 112334679999999999863 46899999999999999999999999754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=379.06 Aligned_cols=204 Identities=30% Similarity=0.466 Sum_probs=168.1
Q ss_pred CCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
++|.+.+.||+|+||.||+|++. +++.||||+++.. .....++|.+|+++|++++|||||+++|+|.+ .
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTE----G 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----C
Confidence 45666789999999999999874 4789999999754 34455679999999999999999999999986 4
Q ss_pred eeEEEEEecCCCCCHHHHhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVL-------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 364 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~-------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld 364 (466)
...+|||||+++|+|.++|+... ..+++|.+++.|+.|+|+||+|||+.+ |+||||||+||||+
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEEC
Confidence 46799999999999999996532 235899999999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 365 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 365 ~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+++.+||+|||+++....... ........||+.|||||++.+..++.++|||||||+||||+| |+.||...
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~---~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~ 264 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 264 (329)
T ss_dssp TTTEEEECCCC-------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS
T ss_pred CCCcEEEcccccceeccCCCc---ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC
Confidence 999999999999987644322 112334679999999999999999999999999999999999 99999754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=378.25 Aligned_cols=203 Identities=24% Similarity=0.316 Sum_probs=172.2
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|++.+.||+|+||.||+|+.. +|+.||||++..... ....+.|.+|+++|++++|||||++++++.+ ....|
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~----~~~~y 99 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE----NGSLY 99 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE----CCEEE
Confidence 57888999999999999999875 589999999976542 2334569999999999999999999999876 45779
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
|||||+++|+|.++|.......+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++...
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 9999999999999997655556899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... ......+||+.|+|||++.+..|+.++|||||||+||||+||+.||...
T Consensus 177 ~~~-----~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 228 (350)
T 4b9d_A 177 STV-----ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228 (350)
T ss_dssp HHH-----HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCc-----ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 321 1122357999999999999999999999999999999999999999753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=372.80 Aligned_cols=199 Identities=24% Similarity=0.416 Sum_probs=176.7
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+.|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+ ....||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~----~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLV----GDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEE----TTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEEEE
Confidence 56888899999999999999875 589999999975533 334458899999999999999999999987 457899
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 149 vmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp EECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999999999975 45999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. ......+||+.|+|||++....|+.++|||||||+||||++|+.||...
T Consensus 223 ~~-----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 273 (346)
T 4fih_A 223 EV-----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 273 (346)
T ss_dssp SS-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CC-----CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 32 1234568999999999999999999999999999999999999999753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=369.20 Aligned_cols=203 Identities=27% Similarity=0.409 Sum_probs=177.9
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|++.+.||+|+||+||+|+.. +++.||||++.... .....+.+.+|+++|++++||||+++++++.+ ....
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~ 107 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD----DEKL 107 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----CCEE
Confidence 45888899999999999999875 58999999987432 23344568999999999999999999999876 4578
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
||||||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 108 yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 9999999999999999764 56999999999999999999999999 999999999999999999999999999977
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..+.. .......+||+.|+|||++.+..++.++|||||||+||||+||+.||...
T Consensus 183 ~~~~~---~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 183 SPESK---QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp CTTTT---CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCC---cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 54321 12234568999999999999999999999999999999999999999753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=362.74 Aligned_cols=200 Identities=28% Similarity=0.388 Sum_probs=170.9
Q ss_pred CcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEe
Q 012297 228 GSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 228 ~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
..+.||+|+||.||+|.+. +++.||||++.... .....+.|.+|++++++++|||||++++++.+........+||||
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE 109 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence 3467999999999999875 58899999987543 233445699999999999999999999998765555567899999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEEecCCccccccCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADG 384 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld-~~~~vkL~DfGla~~~~~~~ 384 (466)
|+++|+|.+++... ..+++..+..++.||+.||+|||+++ ++|+||||||+||||+ +++.+||+|||+|+.....
T Consensus 110 y~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 110 LMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred CCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 99999999999764 56999999999999999999999875 4599999999999997 4799999999999754321
Q ss_pred CCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 385 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 385 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.....+||+.|||||++.+ .++.++|||||||+||||+||+.||...
T Consensus 186 ------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 186 ------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp ------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 2334689999999998764 6999999999999999999999999643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=372.47 Aligned_cols=201 Identities=27% Similarity=0.336 Sum_probs=170.5
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+.|...++||+|+||.||+|++. +|+.||||+++.... +.+|+.++++++|||||++++++.+ ....+|
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~----~~~~~i 127 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVRE----GPWVNI 127 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEE----TTEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEE----CCEEEE
Confidence 45677788999999999999875 589999999976532 3579999999999999999999876 456799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRLK 381 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~-~vkL~DfGla~~~~ 381 (466)
||||+++|+|.++|+.. ..+++.++..++.|++.||+|||+++ |+||||||+||||+.++ ++||+|||+++...
T Consensus 128 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp EECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred EEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999999764 46999999999999999999999998 99999999999999987 69999999999876
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.++..........++||+.|||||++.+..++.++|||||||+||||+||+.||....
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 5443222223344689999999999999999999999999999999999999997543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=374.17 Aligned_cols=200 Identities=24% Similarity=0.414 Sum_probs=177.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.+.|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+ ....|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~----~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLV----GDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEE----CCEEE
Confidence 356899999999999999999875 589999999976543 334558999999999999999999999987 45779
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
|||||+++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 225 iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred EEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 99999999999999965 45899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...
T Consensus 299 ~~~-----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 350 (423)
T 4fie_A 299 KEV-----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 350 (423)
T ss_dssp SSC-----CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCC-----ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 432 2234568999999999999999999999999999999999999999753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=375.82 Aligned_cols=218 Identities=27% Similarity=0.410 Sum_probs=185.4
Q ss_pred eechHHHHHHhCCCCCcceecccCcEEEEEEEEcC------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCC-CCccc
Q 012297 213 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH-CHVVP 285 (466)
Q Consensus 213 ~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~ 285 (466)
.++..+|+...++|++.+.||+|+||.||+|.+.. ++.||||+++........+.|.+|+++|++++| ||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 34556777888899999999999999999998643 368999999877655566779999999999965 89999
Q ss_pred eeeeeeeccCcceeEEEEEecCCCCCHHHHhcccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012297 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351 (466)
Q Consensus 286 llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~i 351 (466)
++|+|.+. ....+|||||+++|+|.++|+... ...+++.+++.++.|||+||+|||+.+ |
T Consensus 133 l~g~~~~~---~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---i 206 (353)
T 4ase_A 133 LLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 206 (353)
T ss_dssp EEEEECCT---TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EEEEEEec---CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---e
Confidence 99998753 234689999999999999996532 234899999999999999999999998 9
Q ss_pred EecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-
Q 012297 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT- 430 (466)
Q Consensus 352 vHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt- 430 (466)
+||||||+|||+++++.+||+|||+|+....+... .......||+.|||||++.+..++.++|||||||+||||+|
T Consensus 207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~---~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~ 283 (353)
T 4ase_A 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 283 (353)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred ecCccCccceeeCCCCCEEECcchhhhhcccCCCc---eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhC
Confidence 99999999999999999999999999876543221 12234678999999999999999999999999999999998
Q ss_pred CCCCCCCCC
Q 012297 431 GRQPIHRSI 439 (466)
Q Consensus 431 G~~Pf~~~~ 439 (466)
|+.||....
T Consensus 284 G~~Pf~~~~ 292 (353)
T 4ase_A 284 GASPYPGVK 292 (353)
T ss_dssp SCCSSTTCC
T ss_pred CCCCCCCCC
Confidence 999997643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=364.84 Aligned_cols=205 Identities=27% Similarity=0.356 Sum_probs=164.6
Q ss_pred CCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
+|.+.+.||+|+||+||+|++ +|+.||||+++... .....+..|+..+.+++||||++++|+|.+........+|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 456678999999999999998 58999999986532 112223345555678899999999999987655556789999
Q ss_pred ecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-----AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~-----~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
||+++|+|.++|+. .+++|..++.++.|+++||+|||+. ..++|+||||||+|||||+++++||+|||+++.
T Consensus 81 Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999999975 4589999999999999999999986 134599999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccC------CCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVG------RASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
........ ........||+.|+|||++.+. .++.++|||||||+||||+||+.||.
T Consensus 158 ~~~~~~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 158 HDSATDTI-DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EETTTTEE-SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred ccCCCCce-eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 65432211 1223346799999999998754 36789999999999999999988764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=365.86 Aligned_cols=201 Identities=26% Similarity=0.351 Sum_probs=168.1
Q ss_pred CCCCCcceecccCcEEEEEEEEc----CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~----~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
++|++.+.||+|+||+||+|+.. .++.||||+++... .......+.+|+++|++++||||+++++++.+ ..
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~ 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT----EG 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE----TT
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE----CC
Confidence 46888899999999999999863 46899999987542 11223358899999999999999999999886 45
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred EEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccce
Confidence 779999999999999999764 56999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... ......+||+.|+|||.+.+..++.++|||||||+||||+||+.||...
T Consensus 175 ~~~~~~-----~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 175 ESIDHE-----KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp C----------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccCCC-----ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 654322 2234468999999999999999999999999999999999999999754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=351.63 Aligned_cols=199 Identities=26% Similarity=0.357 Sum_probs=161.1
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|++.+.||+|+||.||+|... +++.||||++.... .......+.+|++++++++||||+++++++.+ ....
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~~ 88 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS----KDEI 88 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE----CCEE
Confidence 57889999999999999999875 68999999997553 23334569999999999999999999999876 4577
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+ +|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||+++++++||+|||+|+..
T Consensus 89 ~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp EEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred EEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeec
Confidence 9999999 78999999754 56999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... .....+||+.|+|||.+.+..+ +.++|||||||++|||+||+.||...
T Consensus 163 ~~~~------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 163 TDGN------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp ------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCC------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 4322 2234689999999999988776 68999999999999999999999753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=351.93 Aligned_cols=208 Identities=25% Similarity=0.384 Sum_probs=164.0
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC-------
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG------- 295 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~------- 295 (466)
++|++.+.||+|+||.||+|+.. +++.||||+++........+.+.+|+++|++++|||||++++++.+...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45888899999999999999875 6899999999876555555679999999999999999999999876432
Q ss_pred -cceeEEEEEecCCCCCHHHHhccccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 012297 296 -KRAMRLLVFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 373 (466)
Q Consensus 296 -~~~~~~lV~ey~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~D 373 (466)
.....++||||+++|+|.+++..... ...++..++.++.|++.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 22346899999999999999975432 23567788999999999999999998 99999999999999999999999
Q ss_pred cCCccccccCCCCCC-------CCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 374 LGMAKRLKADGLPSC-------SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 374 fGla~~~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
||+|+....+..... .......+||+.|||||.+.+..++.++|||||||+||||++ ||..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 999987754332110 111233579999999999999999999999999999999996 7753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=347.87 Aligned_cols=208 Identities=24% Similarity=0.354 Sum_probs=173.7
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeecc--Cccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~--~~~~~ 299 (466)
++|++.+.||+|+||.||+|.+. +|+.||||+++..... ...+.+++|+++|++++|||||++++++.... .....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57899999999999999999875 6899999999765332 23356889999999999999999999876432 23456
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.||||||++ |+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence 799999995 7899999754 56999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+....... .......+||+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 208 ~~~~~~~~-~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 208 LCTSPAEH-QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp C--------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred cccCcccc-ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 64432111 1233457899999999998775 5699999999999999999999999754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=341.91 Aligned_cols=208 Identities=21% Similarity=0.332 Sum_probs=172.3
Q ss_pred HHHHHHhCCCCCcceecccCcEEEEEEEEc----CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012297 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 291 (466)
Q Consensus 217 ~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~----~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~ 291 (466)
+.+....+.|++.+.||+|+||+||+|+.+ .++.||||++.... ....+.+|+++|+.+ +||||+++++++.
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 445566788999999999999999999763 46789999986542 234578999999998 6999999999987
Q ss_pred eccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEE
Q 012297 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAK 370 (466)
Q Consensus 292 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~-~~vk 370 (466)
+ ....++||||+++|+|.+++. .+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+|
T Consensus 91 ~----~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~k 158 (361)
T 4f9c_A 91 K----NDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYA 158 (361)
T ss_dssp E----TTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEE
T ss_pred E----CCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEE
Confidence 6 457799999999999999984 4899999999999999999999999 9999999999999877 7999
Q ss_pred EEecCCccccccCCCCC-----------------------CCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHH
Q 012297 371 ITDLGMAKRLKADGLPS-----------------------CSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLL 426 (466)
Q Consensus 371 L~DfGla~~~~~~~~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~ 426 (466)
|+|||+|+......... ........+||+.|+|||++.+. .++.++||||+||++|
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ 238 (361)
T 4f9c_A 159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL 238 (361)
T ss_dssp ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence 99999998654321100 00112335799999999998775 5899999999999999
Q ss_pred HHHcCCCCCCCCC
Q 012297 427 ELITGRQPIHRSI 439 (466)
Q Consensus 427 elltG~~Pf~~~~ 439 (466)
||++|+.||....
T Consensus 239 ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 239 SLLSGRYPFYKAS 251 (361)
T ss_dssp HHHHTCSSSSCCS
T ss_pred HHHHCCCCCCCCC
Confidence 9999999997543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=357.38 Aligned_cols=202 Identities=28% Similarity=0.404 Sum_probs=171.0
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHH---HHHHHhcCCCCccceeeeeeeccCcc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTE---VDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~E---i~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
++|.+.++||+|+||.||+|+.. +|+.||||++.... .......+.+| +.+++.++|||||++++++.+ .
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~----~ 264 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----P 264 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----S
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE----C
Confidence 56889999999999999999875 58999999986431 11222234444 556667789999999999876 5
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...||||||++||+|.++|... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+|
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEeccccee
Confidence 5789999999999999999764 56999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITK 441 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~ 441 (466)
+..... .....+||+.|+|||++.. ..|+.++|||||||+||||++|++||......
T Consensus 340 ~~~~~~-------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~ 397 (689)
T 3v5w_A 340 CDFSKK-------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397 (689)
T ss_dssp EECSSC-------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC
T ss_pred eecCCC-------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 876433 2334689999999999864 57999999999999999999999999765443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=326.41 Aligned_cols=239 Identities=41% Similarity=0.752 Sum_probs=195.7
Q ss_pred ceeeeechHHHHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceee
Q 012297 209 GTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 288 (466)
Q Consensus 209 ~~~~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg 288 (466)
+....|++.+++.+.++|+..+.||+|+||.||+|.+.+++.||||++...........+.+|++++++++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34578999999999999999999999999999999988899999999987654444456899999999999999999999
Q ss_pred eeeeccCcceeEEEEEecCCCCCHHHHhccccc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 012297 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366 (466)
Q Consensus 289 ~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~ 366 (466)
++.. ....++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+...++|+||||||+|||++++
T Consensus 95 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~ 170 (326)
T 3uim_A 95 FCMT----PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170 (326)
T ss_dssp EECC----SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT
T ss_pred EEec----CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC
Confidence 9876 3455899999999999999976432 349999999999999999999999922239999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC--CCCChh
Q 012297 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS--ITKGEE 444 (466)
Q Consensus 367 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~--~~~~~~ 444 (466)
+.+||+|||+++....... .......||+.|+|||.+....++.++||||||+++|||++|+.||... ......
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 246 (326)
T 3uim_A 171 FEAVVGDFGLAKLMDYKDT----HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246 (326)
T ss_dssp CCEEECCCSSCEECCSSSS----CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCS
T ss_pred CCEEeccCccccccCcccc----cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccch
Confidence 9999999999987643321 1223345899999999998888999999999999999999999999631 122334
Q ss_pred hHHHHHHHhhc
Q 012297 445 SLVLWVKSIIT 455 (466)
Q Consensus 445 ~l~~~~~~~~~ 455 (466)
.+..|+...+.
T Consensus 247 ~~~~~~~~~~~ 257 (326)
T 3uim_A 247 MLLDWVKGLLK 257 (326)
T ss_dssp BHHHHHTTTTS
T ss_pred hHHHHHHHHhh
Confidence 45555554433
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=349.45 Aligned_cols=201 Identities=25% Similarity=0.340 Sum_probs=175.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+++|+.++||||+++++++.+ ....+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFED----DNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC----SSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE----CCEEE
Confidence 357899999999999999999875 58999999987643 2334568899999999999999999999876 55779
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC--CcEEEEecCCccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN--LNAKITDLGMAKR 379 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~--~~vkL~DfGla~~ 379 (466)
|||||+++|+|.++|.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 231 iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 9999999999999996532 45899999999999999999999999 9999999999999854 8999999999988
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 307 ~~~~~------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~ 359 (573)
T 3uto_A 307 LDPKQ------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 359 (573)
T ss_dssp CCTTS------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ccCCC------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 65432 123467999999999999999999999999999999999999999753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=322.61 Aligned_cols=230 Identities=42% Similarity=0.705 Sum_probs=193.6
Q ss_pred eeechHHHHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeee
Q 012297 212 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291 (466)
Q Consensus 212 ~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~ 291 (466)
.++.+.+++.++++|...+.||+|+||.||+|.+.+++.||||++.... ....+.+.+|++++++++||||+++++++.
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 3455667778899999999999999999999998889999999987653 345567999999999999999999999987
Q ss_pred eccCcceeEEEEEecCCCCCHHHHhccccc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 012297 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 369 (466)
Q Consensus 292 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~v 369 (466)
+ ....++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 106 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~ 178 (321)
T 2qkw_B 106 E----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVP 178 (321)
T ss_dssp C----TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCE
T ss_pred C----CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCE
Confidence 6 3456999999999999999975432 34899999999999999999999998 9999999999999999999
Q ss_pred EEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHH
Q 012297 370 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 449 (466)
Q Consensus 370 kL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~~~~~l~~~ 449 (466)
||+|||+++....... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..........+..|
T Consensus 179 kl~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~ 255 (321)
T 2qkw_B 179 KITDFGISKKGTELDQ---THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255 (321)
T ss_dssp EECCCTTCEECSSSSC---CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred EEeecccccccccccc---cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence 9999999986543221 1122335689999999999999999999999999999999999999987666555666666
Q ss_pred HHH
Q 012297 450 VKS 452 (466)
Q Consensus 450 ~~~ 452 (466)
...
T Consensus 256 ~~~ 258 (321)
T 2qkw_B 256 AVE 258 (321)
T ss_dssp THH
T ss_pred hhh
Confidence 544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=311.02 Aligned_cols=211 Identities=23% Similarity=0.378 Sum_probs=182.6
Q ss_pred eeechHHHHHHhCC----------CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCC
Q 012297 212 IRFSYSALEHATDK----------FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH 280 (466)
Q Consensus 212 ~~~~~~~l~~~t~~----------f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H 280 (466)
..|+++++..+++. |...+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCC
Confidence 35777888887765 666779999999999999986 699999999976543 344568999999999999
Q ss_pred CCccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 012297 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 360 (466)
Q Consensus 281 ~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~N 360 (466)
|||+++++++.. ....++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 102 ~niv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~N 171 (321)
T 2c30_A 102 FNVVEMYKSYLV----GEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDS 171 (321)
T ss_dssp TTBCCEEEEEEE----TTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred CCcceEEEEEEE----CCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 999999999886 3467999999999999999875 45899999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 361 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 361 ILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
||++.++.+||+|||++....... .......||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 172 Ill~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~ 244 (321)
T 2c30_A 172 ILLTLDGRVKLSDFGFCAQISKDV-----PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244 (321)
T ss_dssp EEECTTCCEEECCCTTCEECCSSS-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EEECCCCcEEEeeeeeeeecccCc-----cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999998764432 1223457899999999999999999999999999999999999999643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=307.29 Aligned_cols=200 Identities=26% Similarity=0.436 Sum_probs=175.9
Q ss_pred hCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|+..+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.++++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV----GDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEE----CCEEE
Confidence 46789999999999999999986 46899999998765433 34568999999999999999999999886 44679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 94 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999999975 35899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 168 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 219 (297)
T 3fxz_A 168 PEQS-----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (297)
T ss_dssp STTC-----CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred Cccc-----ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4321 233457899999999999999999999999999999999999999654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=330.54 Aligned_cols=213 Identities=22% Similarity=0.317 Sum_probs=180.7
Q ss_pred echHHHHHHhCCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeee
Q 012297 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290 (466)
Q Consensus 214 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~ 290 (466)
+.+.++....++|++.++||+|+||.||+|++.+ ++.||||++.... .......+.+|+.++..++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3456677778899999999999999999999865 7899999986421 111222388999999999999999999998
Q ss_pred eeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 012297 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 370 (466)
Q Consensus 291 ~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vk 370 (466)
.+ ....++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+|
T Consensus 144 ~~----~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vk 215 (437)
T 4aw2_A 144 QD----DNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIR 215 (437)
T ss_dssp EC----SSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred ee----CCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEE
Confidence 86 45679999999999999999763 245999999999999999999999998 99999999999999999999
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCcccccchhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 371 L~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|+|||+++....... .......||+.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 216 L~DFGla~~~~~~~~----~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 284 (437)
T 4aw2_A 216 LADFGSCLKLMEDGT----VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284 (437)
T ss_dssp ECCCTTCEECCTTSC----EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred EcchhhhhhcccCCC----cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence 999999987644321 1123357999999999986 466899999999999999999999999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=318.91 Aligned_cols=206 Identities=28% Similarity=0.447 Sum_probs=175.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEc--------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeec
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~--------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~ 293 (466)
.++|.+.+.||+|+||.||+|.+. ++..||||+++..........+.+|+++++++ +||||+++++++.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence 466888899999999999999863 35679999998765444556799999999999 89999999999876
Q ss_pred cCcceeEEEEEecCCCCCHHHHhccccc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 012297 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359 (466)
Q Consensus 294 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~ 359 (466)
....++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ |+||||||+
T Consensus 159 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~ 232 (370)
T 2psq_A 159 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 232 (370)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG
T ss_pred ---CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchh
Confidence 3456999999999999999975431 34899999999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 360 NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
|||+++++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCT---TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hEEECCCCCEEEccccCCcccCcccc---eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999987644321 112233457889999999999999999999999999999999 99999754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=313.03 Aligned_cols=201 Identities=26% Similarity=0.406 Sum_probs=175.0
Q ss_pred hCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
.++|.+.+.||+|+||.||+|.+ .+++.||||++.... .......+.+|+++++.++||||+++++++.. ....
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~ 89 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET----EKTL 89 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----CCEE
Confidence 35688889999999999999987 578999999987653 23344568899999999999999999999876 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 9999999999999999764 55899999999999999999999998 999999999999999999999999999866
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 165 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 165 TVGG------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp SSSC------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCC------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 4332 1234579999999999988776 48999999999999999999999754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=314.24 Aligned_cols=201 Identities=26% Similarity=0.338 Sum_probs=174.8
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|+..+.||+|+||.||+++.. +++.||+|+++... .......+.+|++++++++||||+++++++.. ....
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----~~~~ 80 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----HDRL 80 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC----SSEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe----CCEE
Confidence 46788899999999999999876 58999999987542 22334568899999999999999999999876 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 9999999999999999754 56899999999999999999999998 999999999999999999999999999864
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 208 (337)
T 1o6l_A 156 ISDG-----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp CCTT-----CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCC-----CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence 3322 1233467999999999999999999999999999999999999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=311.64 Aligned_cols=206 Identities=28% Similarity=0.368 Sum_probs=173.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|++.+.||+|+||.||+|.+. +++.||||++.........+.+.+|+.+++.++||||+++++++.+ ....+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~ 81 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE----GNIQY 81 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC----SSEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec----CCeEE
Confidence 467888999999999999999876 6899999999766544444568999999999999999999999876 45679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 999999999999999754 45899999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSIT 440 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~Pf~~~~~ 440 (466)
.... ........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....
T Consensus 157 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 157 YNNR---ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp ETTE---ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred cCCc---ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 3321 112234578999999999987775 7899999999999999999999976543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.81 Aligned_cols=211 Identities=24% Similarity=0.348 Sum_probs=175.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC------
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG------ 295 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~------ 295 (466)
.++|++.+.||+|+||.||+|++. +++.||||++.........+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 456888899999999999999986 7899999999876666667779999999999999999999999866432
Q ss_pred -----------------------------------------------cceeEEEEEecCCCCCHHHHhccccc-CCCCHH
Q 012297 296 -----------------------------------------------KRAMRLLVFEFMPNGNLRDCLDGVLV-EGMNWD 327 (466)
Q Consensus 296 -----------------------------------------------~~~~~~lV~ey~~~gsL~~~l~~~~~-~~~~~~ 327 (466)
.....++||||+++++|.+++..... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 11237999999999999999975432 236777
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCC-------CCCCCccccCcc
Q 012297 328 TRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC-------SSSPARMQGTFG 400 (466)
Q Consensus 328 ~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~-------~~~~~~~~gt~~ 400 (466)
.++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......... ........||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999998 99999999999999999999999999987654321110 112334579999
Q ss_pred cccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 401 y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999988864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=312.64 Aligned_cols=204 Identities=32% Similarity=0.418 Sum_probs=172.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
++|++.+.||+|+||.||+|++. ++.||||++.... .....+..|+.++++++||||+++++++.+........++|
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 56778899999999999999885 7899999986542 23344667888899999999999999998765545567999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEecCCCCCCEEEcCCCcEEEEe
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA----------AAPRILHRDIKSSNILLDENLNAKITD 373 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~----------~~~~ivHrDLk~~NILld~~~~vkL~D 373 (466)
|||+++|+|.++++. ..+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|
T Consensus 101 ~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECC
T ss_pred EecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEcc
Confidence 999999999999975 4589999999999999999999998 7 99999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCCccccCcccccchhcccC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 374 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-----RASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 374 fGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
||+++....... ........||+.|+|||.+.+. .++.++||||||+++|||+||+.||....
T Consensus 175 Fg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 175 FGLALKFEAGKS---AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp CTTCEEECTTSC---CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred CCcccccccccC---ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 999987654322 1223335789999999998763 45678999999999999999999997543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.06 Aligned_cols=203 Identities=30% Similarity=0.454 Sum_probs=170.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
.++|++.+.||+|+||.||+|... +++.||+|++....... ..+.|.+|+.++++++||||+++++++.+ ...
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~ 85 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE----DDC 85 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC----SSE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee----CCe
Confidence 356888899999999999999875 58899999986553332 33568999999999999999999999875 456
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 79999999999999999764 46899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 215 (294)
T 4eqm_A 161 LSETSL----TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215 (294)
T ss_dssp C-----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cccccc----cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 643321 1223456899999999999999999999999999999999999999754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=324.16 Aligned_cols=209 Identities=22% Similarity=0.340 Sum_probs=177.3
Q ss_pred hHHHHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeee
Q 012297 216 YSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 292 (466)
Q Consensus 216 ~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~ 292 (466)
+.++....++|.+.+.||+|+||.||+|+.. +++.||+|++.... .......+.+|+++++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455666788999999999999999999886 48899999986421 11122348899999999999999999999876
Q ss_pred ccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 012297 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 372 (466)
Q Consensus 293 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~ 372 (466)
....++||||+++|+|.++++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 141 ----~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~ 210 (410)
T 3v8s_A 141 ----DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLA 210 (410)
T ss_dssp ----SSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred ----CCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEe
Confidence 4567999999999999999975 35899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCcccccchhcccCC----CCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR----ASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 373 DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|||+++....... .......||+.|+|||++.... ++.++||||||+++|||++|+.||...
T Consensus 211 DFG~a~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 211 DFGTCMKMNKEGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp CCTTCEECCTTSE----EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccceeEeeccCCc----ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 9999987644321 1123457999999999987655 789999999999999999999999753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=317.37 Aligned_cols=201 Identities=25% Similarity=0.370 Sum_probs=172.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcce
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~ 298 (466)
.++|++.++||+|+||.||+|+.. +++.||||+++... .......+.+|..++.++ +||||+++++++.+ ..
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----~~ 126 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----ES 126 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC----SS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE----CC
Confidence 356888899999999999999876 47899999997542 222334578899999887 89999999999876 45
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceee
Confidence 679999999999999999764 56999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
...... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 202 ~~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 202 EGLRPG-----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CCCCTT-----CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred ecccCC-----CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 633221 223446799999999999999999999999999999999999999964
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=315.97 Aligned_cols=202 Identities=26% Similarity=0.368 Sum_probs=170.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcce
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~ 298 (466)
.++|++.+.||+|+||.||+|+.. +++.||||+++... .......+.+|.++++.+ +||||+++++++.+ ..
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----~~ 97 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT----PD 97 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe----CC
Confidence 367888899999999999999876 58999999987532 122344578899999988 69999999999876 45
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcccccee
Confidence 679999999999999999764 56999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... ......+||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 173 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 227 (353)
T 3txo_A 173 EGICNG-----VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227 (353)
T ss_dssp CSCC--------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecccCC-----ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence 543321 2234467999999999999888999999999999999999999999754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=303.58 Aligned_cols=206 Identities=25% Similarity=0.405 Sum_probs=173.9
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|...+.||+|+||.||+|.+. +++.||+|++... .......|.+|++++++++||||+++++++.+ ....++
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~l 84 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK----DKRLNF 84 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec----CCeeEE
Confidence 45777889999999999999875 5899999988553 34455669999999999999999999999986 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++|+|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 85 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 99999999999999763 356899999999999999999999998 99999999999999999999999999987644
Q ss_pred CCCCCC---------CCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSC---------SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... ........||+.|+|||.+.+..++.++||||||+++|||++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 322110 01112457999999999999999999999999999999999999998653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=308.72 Aligned_cols=209 Identities=27% Similarity=0.409 Sum_probs=171.6
Q ss_pred hCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
.++|++.+.||+|+||.||+|.+ .+++.||||++....... ....|.+|++++++++||||+++++++.........
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46788889999999999999987 568899999998654332 234688999999999999999999998875555556
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|.++++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 79999999999999999754 46899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
....... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 222 (311)
T 3ork_A 166 IADSGNS--VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccc--cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 6543221 11223356899999999999999999999999999999999999999754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=310.30 Aligned_cols=201 Identities=24% Similarity=0.362 Sum_probs=175.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCC-----hhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~ 296 (466)
.+.|.+.+.||+|+||.||++... +++.||+|.+....... ....+.+|+.++++++||||+++++++.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---- 86 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN---- 86 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe----
Confidence 466888899999999999999876 58999999997654321 24568999999999999999999999876
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEE
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKIT 372 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~----~vkL~ 372 (466)
....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++ .+||+
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEE
Confidence 45679999999999999999753 46999999999999999999999998 99999999999998877 79999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 373 DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|||++....... ......||+.|+|||.+....++.++||||||+++|||++|..||...
T Consensus 162 DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~ 221 (361)
T 2yab_A 162 DFGLAHEIEDGV------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (361)
T ss_dssp CCSSCEECCTTC------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ecCCceEcCCCC------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 999998764421 223457999999999999999999999999999999999999999754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=310.13 Aligned_cols=205 Identities=28% Similarity=0.448 Sum_probs=173.0
Q ss_pred CCCCCcceecccCcEEEEEEEEc----CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~----~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
++|.+.+.||+|+||.||+|.+. .+..||||+++..........|.+|++++++++||||+++++++.+ ...
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~ 124 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR----GRL 124 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG----GGC
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----CCc
Confidence 56777899999999999999884 3557999999876555556679999999999999999999999876 445
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred cEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 699999999999999996532 45999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
....... ........+|+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 201 ~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 201 LEDDPDA--AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp CC----C--CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cccCccc--eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 6543221 111223346778999999998999999999999999999999 99999653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=322.96 Aligned_cols=213 Identities=24% Similarity=0.324 Sum_probs=180.4
Q ss_pred echHHHHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeee
Q 012297 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290 (466)
Q Consensus 214 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~ 290 (466)
+.+.++....++|+..+.||+|+||.||+++.. +++.||||+++... .......+.+|.+++.+++|+||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 445566667789999999999999999999885 68999999986431 111223488999999999999999999998
Q ss_pred eeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 012297 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 370 (466)
Q Consensus 291 ~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vk 370 (466)
.+ ....++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++|
T Consensus 131 ~~----~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vk 202 (412)
T 2vd5_A 131 QD----ENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIR 202 (412)
T ss_dssp EC----SSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred ee----CCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEE
Confidence 76 456799999999999999997542 46899999999999999999999998 99999999999999999999
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCcccccchhcc-------cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-------VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 371 L~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|+|||+++....... .......||+.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 203 L~DFGla~~~~~~~~----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 203 LADFGSCLKLRADGT----VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp ECCCTTCEECCTTSC----EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred EeechhheeccCCCc----cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 999999987654321 1123457999999999987 356899999999999999999999999754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=300.61 Aligned_cols=217 Identities=37% Similarity=0.615 Sum_probs=185.1
Q ss_pred eeeechHHHHHHhCCCCCc------ceecccCcEEEEEEEEcCCcEEEEEEcccCC---CCChhHHHHHHHHHHHhcCCC
Q 012297 211 IIRFSYSALEHATDKFSGS------NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHC 281 (466)
Q Consensus 211 ~~~~~~~~l~~~t~~f~~~------~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~---~~~~~~~f~~Ei~~l~~l~H~ 281 (466)
...|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... .......|.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4679999999999999887 8999999999999987 68899999987543 234456799999999999999
Q ss_pred CccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 012297 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 360 (466)
Q Consensus 282 nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~N 360 (466)
||+++++++.+ ....++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 91 ~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~N 163 (307)
T 2nru_A 91 NLVELLGFSSD----GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSAN 163 (307)
T ss_dssp TBCCEEEEECS----SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred CeEEEEEEEec----CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHH
Confidence 99999999876 335699999999999999996433 345899999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 361 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 361 ILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
||+++++.+||+|||++........ ........||+.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQ---TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSS---CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred EEEcCCCcEEEeecccccccccccc---cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 9999999999999999986543221 111233568999999998764 57899999999999999999999997643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=310.29 Aligned_cols=210 Identities=30% Similarity=0.430 Sum_probs=168.6
Q ss_pred HHHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012297 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 218 ~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~ 296 (466)
+++....+|++.+.||+|+||.||+|+. +++.||||++...... .....|.+|++++++++||||+++++++.+
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---- 105 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ---- 105 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----
Confidence 3444456788889999999999999987 6888999998765432 233568999999999999999999999876
Q ss_pred ceeEEEEEecCCCCCHHHHhccccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfG 375 (466)
....++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg 184 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFG 184 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCC
Confidence 3356999999999999999975421 23899999999999999999999885 359999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 185 ~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~ 242 (309)
T 3p86_A 185 LSRLKASTF-----LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242 (309)
T ss_dssp ----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred CCccccccc-----cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 997543321 1223456899999999999999999999999999999999999999754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=308.03 Aligned_cols=201 Identities=26% Similarity=0.388 Sum_probs=165.1
Q ss_pred CCCCCcceecccCcEEEEEEEE----cCCcEEEEEEcccCCC---CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQL----TDGRIVAVKRFKTQGG---PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~----~~~~~vaVK~l~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~ 296 (466)
++|++.+.||+|+||.||+++. .+++.||+|+++.... ......+.+|++++++++||||+++++++..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---- 92 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT---- 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC----
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc----
Confidence 5678889999999999999987 4789999999976531 2233457899999999999999999999876
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGl 376 (466)
....++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCc
Confidence 44679999999999999999754 45899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
++...... .......||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 168 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 168 CKESIHDG-----TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp C---------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCC-----ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 97643322 1223457899999999999999999999999999999999999999754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=308.09 Aligned_cols=198 Identities=28% Similarity=0.358 Sum_probs=173.4
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|++.+.||+|+||.||+++.. +++.||+|+++... .......+.+|+.+++.++||||+++++++.+ ....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----~~~~ 81 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD----AQQI 81 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC----SSEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe----CCEE
Confidence 46788899999999999999875 68999999987542 12334457899999999999999999999876 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceec
Confidence 9999999999999999754 45899999999999999999999998 999999999999999999999999999865
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 206 (318)
T 1fot_A 157 PDV--------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 206 (318)
T ss_dssp SSC--------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCc--------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 321 23357899999999999999999999999999999999999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.15 Aligned_cols=204 Identities=28% Similarity=0.387 Sum_probs=174.5
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+.+.||+|+||.||++... +++.||+|++.... .......+.+|+++++.++||||+++++++.+ ....
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~ 90 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD----EEDM 90 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----CCEE
Confidence 45778899999999999999876 47899999986432 22334568899999999999999999999876 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999999999754 46999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhccc---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKG 442 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~~ 442 (466)
... .......||+.|+|||++.. ..++.++||||||+++|||++|+.||.......
T Consensus 166 ~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~ 224 (384)
T 4fr4_A 166 PRE------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS 224 (384)
T ss_dssp CTT------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC
T ss_pred cCC------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc
Confidence 432 12334679999999999864 458999999999999999999999997544433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=305.15 Aligned_cols=204 Identities=28% Similarity=0.428 Sum_probs=174.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|.+.+.||+|+||.||+|.+.. ++.||||++.........+.+.+|++++++++||||+++++++.... ....++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~~~l 86 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT--TRHKVL 86 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT--TCCEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC--CceEEE
Confidence 457778999999999999998864 89999999986654455667899999999999999999999987633 336699
Q ss_pred EEecCCCCCHHHHhccccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEEecCCc
Q 012297 303 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMA 377 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl----d~~~~vkL~DfGla 377 (466)
||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999976433 33899999999999999999999998 9999999999999 78888999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcc--------cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAM--------VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+...... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 164 RELEDDE------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp EECCTTC------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred eecCCCC------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 8764432 122356899999999886 467899999999999999999999999753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=303.37 Aligned_cols=204 Identities=29% Similarity=0.445 Sum_probs=171.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|++.+.||+|+||.||+|.+.+++.||+|++..... ......+.+|++++++++||||+++++++.+ ....+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~ 95 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS----ERCLT 95 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC----SSCEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc----CCEEE
Confidence 466888899999999999999998899999999976532 3334568999999999999999999999875 44679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 96 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 96 LVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9999997 58888886532 45899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSIT 440 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~ 440 (466)
... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 171 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (311)
T 3niz_A 171 IPV-----RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225 (311)
T ss_dssp SCC-----C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST
T ss_pred CCc-----ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh
Confidence 321 12233468999999999876 5689999999999999999999999976543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=310.47 Aligned_cols=203 Identities=25% Similarity=0.402 Sum_probs=174.6
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcc
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~ 297 (466)
..++|.+.+.||+|+||.||+|+.. +++.||||+++... .......+..|.+++..+ +||||+++++++.+ .
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~----~ 90 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----K 90 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----S
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe----C
Confidence 3567888999999999999999986 58899999997542 122344578899999887 89999999999876 4
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhh
Confidence 5679999999999999999764 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (345)
T 1xjd_A 166 KENMLGD-----AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221 (345)
T ss_dssp BCCCCTT-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhcccCC-----CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence 7643221 1234467999999999999999999999999999999999999999754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=316.93 Aligned_cols=219 Identities=27% Similarity=0.425 Sum_probs=184.3
Q ss_pred eeechHHHHHHhCCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCcc
Q 012297 212 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVV 284 (466)
Q Consensus 212 ~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv 284 (466)
..++...++...++|.+.+.||+|+||.||+|.+. +++.||||+++........+.+.+|++++.++ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 45666778888899999999999999999999742 45789999998765555556799999999999 799999
Q ss_pred ceeeeeeeccCcceeEEEEEecCCCCCHHHHhccccc-------------------------------------------
Q 012297 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV------------------------------------------- 321 (466)
Q Consensus 285 ~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~------------------------------------------- 321 (466)
++++++.+. ....++||||+++|+|.++++....
T Consensus 90 ~~~~~~~~~---~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (359)
T 3vhe_A 90 NLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG 166 (359)
T ss_dssp CEEEEECST---TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred eeeeeeecC---CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence 999998763 2346999999999999999975432
Q ss_pred ---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 322 ---------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 322 ---------------------~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 11889999999999999999999998 999999999999999999999999999866
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 439 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~~ 439 (466)
..... ........||+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 244 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 244 YKDPD---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp TSCTT---CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccccc---chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 43321 112334567889999999999999999999999999999998 999997543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=313.56 Aligned_cols=203 Identities=17% Similarity=0.185 Sum_probs=171.7
Q ss_pred HHhCCCCCcceecccCcEEEEEEE------EcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC---CCCccceeeeee
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQ------LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCS 291 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~------~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~llg~~~ 291 (466)
...++|.+.+.||+|+||.||+|. ..+++.||||++... ...++..|+++++.++ |+||+++++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 345678888999999999999994 446889999998754 2445888999998887 999999999987
Q ss_pred eccCcceeEEEEEecCCCCCHHHHhccc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---
Q 012297 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGV---LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--- 365 (466)
Q Consensus 292 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~--- 365 (466)
. ....++||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 138 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 138 F----QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp C----SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGT
T ss_pred c----CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEeccccc
Confidence 6 44669999999999999999642 2356999999999999999999999998 999999999999998
Q ss_pred --------CCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 366 --------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 366 --------~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPK---GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCT---TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred CccccccccCCEEEeeCchhhhhhccCC---CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 89999999999976543211 1122345799999999999999999999999999999999999999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=308.76 Aligned_cols=200 Identities=26% Similarity=0.369 Sum_probs=173.5
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC--ChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~ 299 (466)
++|...+.||+|+||.||+++.. +++.||+|++...... .....+.+|..++.++ +||||+++++++.+ ...
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----~~~ 84 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----ESR 84 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe----CCE
Confidence 45778899999999999999986 5889999999765322 2334588899999988 89999999999876 456
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccc
Confidence 79999999999999999754 46899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 160 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 160 GLRPG-----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp SCCTT-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccCCC-----CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 43221 123346799999999999999999999999999999999999999964
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=316.12 Aligned_cols=206 Identities=27% Similarity=0.431 Sum_probs=164.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEc----CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~----~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
..+|++.+.||+|+||.||+|++. ++..||||+++........+.|.+|+.++++++||||+++++++.+ ..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 119 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK----SK 119 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----SS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----CC
Confidence 357888999999999999999875 5778999999876555556679999999999999999999999876 34
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++|+|.++++.. ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred ceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 569999999999999999754 245899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
........ ........+++.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 196 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 196 VLEDDPEA--AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred ccccCCcc--ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 76543211 111222345778999999999999999999999999999998 99999643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=311.32 Aligned_cols=212 Identities=26% Similarity=0.448 Sum_probs=179.4
Q ss_pred HHHHHHhCCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeee
Q 012297 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290 (466)
Q Consensus 217 ~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~ 290 (466)
..++...++|...+.||+|+||.||+|.+. +++.||||+++..........|.+|++++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344556788999999999999999999875 34789999998765555566799999999999999999999998
Q ss_pred eeccCcceeEEEEEecCCCCCHHHHhcccc----------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 012297 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVL----------------------VEGMNWDTRVAIAIGAARGLEYLHEAAA 348 (466)
Q Consensus 291 ~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qia~~L~~LH~~~~ 348 (466)
.+ ....++||||+++|+|.+++.... ...+++.+++.++.|++.||.|||+.+
T Consensus 120 ~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~- 194 (343)
T 1luf_A 120 AV----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK- 194 (343)
T ss_dssp CS----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred cc----CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 76 345699999999999999997532 145899999999999999999999998
Q ss_pred CCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHH
Q 012297 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLEL 428 (466)
Q Consensus 349 ~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~el 428 (466)
|+||||||+|||+++++.+||+|||+++....... ........+|+.|+|||.+....++.++||||||+++|||
T Consensus 195 --ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 269 (343)
T 1luf_A 195 --FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY---YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269 (343)
T ss_dssp --CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC---BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred --eecCCCCcceEEECCCCeEEEeecCCCcccccCcc---ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHH
Confidence 99999999999999999999999999987643321 1122334678899999999999999999999999999999
Q ss_pred Hc-CCCCCCCC
Q 012297 429 IT-GRQPIHRS 438 (466)
Q Consensus 429 lt-G~~Pf~~~ 438 (466)
++ |+.||...
T Consensus 270 ~t~g~~p~~~~ 280 (343)
T 1luf_A 270 FSYGLQPYYGM 280 (343)
T ss_dssp HTTTCCTTTTS
T ss_pred HhcCCCcCCCC
Confidence 99 99999753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=303.46 Aligned_cols=207 Identities=19% Similarity=0.234 Sum_probs=175.8
Q ss_pred hCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~ 300 (466)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ..+.+|+++++++ +|+||+++++++.. ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~----~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYFGPC----GKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEEEEE----TTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEEEec----CCcc
Confidence 35688889999999999999986 46899999998765332 2488999999999 89999999999876 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-----EEEEecC
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-----AKITDLG 375 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~-----vkL~DfG 375 (466)
++||||+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred EEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 9999999 99999999764 356999999999999999999999998 999999999999998887 9999999
Q ss_pred CccccccCCCCC--CCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 012297 376 MAKRLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 441 (466)
Q Consensus 376 la~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~ 441 (466)
+++......... .........||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~ 223 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD 223 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc
Confidence 998764432211 111234567999999999999999999999999999999999999999875443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=302.95 Aligned_cols=203 Identities=28% Similarity=0.422 Sum_probs=161.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|+..+.||+|+||.||+|... +++.||||+++..........+.+|++++++++||||+++++++.+ ....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~ 79 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT----ENKLT 79 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC----TTEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE----CCeEE
Confidence 457888899999999999999875 5899999999876555555678999999999999999999999876 44679
Q ss_pred EEEecCCCCCHHHHhcccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 302 LVFEFMPNGNLRDCLDGVL----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
+||||++ |+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLA 155 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccc
Confidence 9999997 69999986532 235899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+...... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 156 RAFGIPV-----NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp EETTSCC-----CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eecCCCc-----ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 8764321 12234568999999999876 46899999999999999999999999754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=302.72 Aligned_cols=201 Identities=25% Similarity=0.364 Sum_probs=174.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-----ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-----~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~ 296 (466)
.+.|...+.||+|+||.||+|... +++.||+|++...... .....+.+|+.++++++||||+++++++.+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---- 85 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN---- 85 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence 345888899999999999999876 5899999998765322 134568999999999999999999999876
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEE
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKIT 372 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~----~vkL~ 372 (466)
....++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++ .+||+
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 45679999999999999999753 56899999999999999999999998 99999999999998887 89999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 373 DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|||+++...... ......||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 161 Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 220 (326)
T 2y0a_A 161 DFGLAHKIDFGN------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220 (326)
T ss_dssp CCTTCEECCTTS------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ECCCCeECCCCC------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 999998764322 123456899999999999899999999999999999999999999653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=318.90 Aligned_cols=205 Identities=29% Similarity=0.455 Sum_probs=173.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|.+.+.||+|+||.||+|.+. +++.||||+++..........|.+|++++++++||||+++++++.+ ....+
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~ 188 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ----KQPIY 188 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS----SSSCE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec----CCCcE
Confidence 456778899999999999999986 6899999999865444444568999999999999999999999876 34569
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 189 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999997532 45899999999999999999999998 9999999999999999999999999998643
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
..... .......+++.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 265 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~ 319 (377)
T 3cbl_A 265 DGVYA---ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319 (377)
T ss_dssp TSEEE---CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred CCcee---ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32111 11112235678999999998999999999999999999998 99999754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=300.79 Aligned_cols=204 Identities=27% Similarity=0.385 Sum_probs=171.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHh--cCCCCccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR--LHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
.++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++..........
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46788889999999999999988 6899999998643 34457778888777 78999999999988766656778
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH--------EAAAPRILHRDIKSSNILLDENLNAKIT 372 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH--------~~~~~~ivHrDLk~~NILld~~~~vkL~ 372 (466)
++||||+++|+|.++++. ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 999999999999999964 46899999999999999999999 776 9999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCcccccchhcccC------CCCchhHHHHHHHHHHHHHcC----------CCCCC
Q 012297 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG------RASLMSDVFSFGVVLLELITG----------RQPIH 436 (466)
Q Consensus 373 DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDv~S~Gvll~elltG----------~~Pf~ 436 (466)
|||+++......... ........||+.|+|||.+... .++.++||||||+++|||++| +.||.
T Consensus 156 Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQL-DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCTTCEEEETTTTEE-ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eCCCeeecccccccc-cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999997654432211 1112334789999999998876 455799999999999999999 88886
Q ss_pred CC
Q 012297 437 RS 438 (466)
Q Consensus 437 ~~ 438 (466)
..
T Consensus 235 ~~ 236 (301)
T 3q4u_A 235 DV 236 (301)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=310.05 Aligned_cols=198 Identities=24% Similarity=0.327 Sum_probs=174.1
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|...+.||+|+||.||+++.. +++.||||++.... .......+.+|+++++.++||||+++++++.+ ....
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~ 116 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD----NSNL 116 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc----CCEE
Confidence 56788899999999999999876 58999999986542 22334568899999999999999999999876 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 117 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceec
Confidence 9999999999999999764 45899999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 192 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 241 (350)
T 1rdq_E 192 KGR--------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp SSC--------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCC--------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence 332 23457999999999999999999999999999999999999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=310.36 Aligned_cols=202 Identities=25% Similarity=0.332 Sum_probs=174.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcce
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~ 298 (466)
.++|...+.||+|+||.||+|+... ++.||||+++... .......+..|..++..+ +||||+++++++.+ ..
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----~~ 94 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----MD 94 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC----SS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc----CC
Confidence 4678888999999999999999864 7899999987542 123345578899999988 79999999999876 45
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 679999999999999999754 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... .......||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 170 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 170 ENIWDG-----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp CCCCTT-----CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCC-----cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 643322 1233467999999999999999999999999999999999999999754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=307.62 Aligned_cols=202 Identities=24% Similarity=0.341 Sum_probs=174.8
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
..++|.+.+.||+|+||.||+|... +++.||+|++...... .....+.+|++++++++||||+++++++.+ ...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~ 102 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----ESF 102 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----CCE
Confidence 4567889999999999999999875 5899999999765432 234568899999999999999999999876 456
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEecCC
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKITDLGM 376 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~---~~vkL~DfGl 376 (466)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 79999999999999999754 45899999999999999999999998 9999999999999765 4599999999
Q ss_pred ccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 178 a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 233 (362)
T 2bdw_A 178 AIEVNDSE------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233 (362)
T ss_dssp CBCCTTCC------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceEecCCc------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 98764321 233467999999999999989999999999999999999999999753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=325.23 Aligned_cols=208 Identities=26% Similarity=0.423 Sum_probs=179.0
Q ss_pred HHHHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012297 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 217 ~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~ 296 (466)
..++...++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++..
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---- 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---- 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC----
Confidence 44556677888899999999999999999888999999998653 345679999999999999999999999752
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 376 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGl 376 (466)
...++||||+++|+|.++++......+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 255 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 255 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp -SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred -CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 24599999999999999998654446899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
++....... .......++..|+|||.+....++.++||||||++||||+| |+.||...
T Consensus 331 a~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~ 389 (454)
T 1qcf_A 331 ARVIEDNEY----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389 (454)
T ss_dssp GGGBCCHHH----HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEcCCCce----eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 987643211 11223346788999999999999999999999999999999 99999753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=309.84 Aligned_cols=209 Identities=21% Similarity=0.318 Sum_probs=177.5
Q ss_pred CCCCCcceeccc--CcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 224 DKFSGSNIVGQG--GSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G--~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
++|++.+.||+| +||.||+|+.. +++.||||++...... .....+.+|+++++.++||||+++++++.+ ...
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~ 100 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----DNE 100 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE----CCE
Confidence 457788999999 99999999986 6899999999765332 234558889999999999999999999886 446
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.+..
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence 799999999999999998765567999999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCC--CCCCCCCCccccCcccccchhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 380 LKADGL--PSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 380 ~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
....+. ...........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 543221 111122334578999999999987 678999999999999999999999997643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=297.05 Aligned_cols=201 Identities=30% Similarity=0.475 Sum_probs=174.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
++|+..+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 83 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE----QAPICLV 83 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECS----SSSEEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEec----CCceEEE
Confidence 4677789999999999999999889999999998653 234569999999999999999999999876 3457999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999997533 45899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
.. .......+|+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 160 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 160 QY----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp HH----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cc----ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 11 11223456788999999999999999999999999999999 99999753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=305.66 Aligned_cols=203 Identities=28% Similarity=0.461 Sum_probs=166.2
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCc----EEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
++|+..+.||+|+||.||+|.+. +++ .||+|.+...........|.+|+.++++++||||+++++++.+.
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 89 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-----
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----
Confidence 45777899999999999999864 333 46899887665556667799999999999999999999998752
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred CeEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCccee
Confidence 3589999999999999997643 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 166 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 223 (327)
T 3poz_A 166 LLGAEEKE---YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp HHTTTCC----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EccCCccc---ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence 76543221 12223456889999999999999999999999999999999 99999754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=303.29 Aligned_cols=200 Identities=22% Similarity=0.313 Sum_probs=174.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|.+.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.+++.++||||+++++++.+ ....+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFES----MEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE----TTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEec----CCEEE
Confidence 467888999999999999999876 5789999998754 2344568899999999999999999999876 44679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--CCcEEEEecCCccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--NLNAKITDLGMAKR 379 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~--~~~vkL~DfGla~~ 379 (466)
+||||+++|+|.+++... ...+++.++..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 78 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 78 MIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 999999999999999753 245899999999999999999999998 999999999999987 78999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 154 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 206 (321)
T 1tki_A 154 LKPGD------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp CCTTC------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCCCC------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence 64321 123356899999999999888999999999999999999999999754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=309.03 Aligned_cols=210 Identities=25% Similarity=0.311 Sum_probs=181.3
Q ss_pred eeeechHHHHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-----CCCcc
Q 012297 211 IIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-----HCHVV 284 (466)
Q Consensus 211 ~~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-----H~nIv 284 (466)
...+++.+.....++|.+.+.||+|+||.||+|... +++.||||+++.. ......+..|+++++.++ |+||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 345556666667789999999999999999999874 6889999998743 233455788999999996 99999
Q ss_pred ceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 012297 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 364 (466)
Q Consensus 285 ~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld 364 (466)
++++++.. ....++||||+ +++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 100 ~~~~~~~~----~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 171 (360)
T 3llt_A 100 KYHGKFMY----YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLD 171 (360)
T ss_dssp CEEEEEEE----TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred cccceeeE----CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEc
Confidence 99999886 34679999999 999999998765566999999999999999999999998 99999999999997
Q ss_pred C-------------------------CCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHH
Q 012297 365 E-------------------------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVF 419 (466)
Q Consensus 365 ~-------------------------~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~ 419 (466)
+ ++.+||+|||++...... .....||+.|+|||.+.+..++.++|||
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Diw 243 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--------HGSIINTRQYRAPEVILNLGWDVSSDMW 243 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--------CCSCCSCGGGCCHHHHTTCCCCTTHHHH
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--------CcCccCcccccCcHHHcCCCCCCccchH
Confidence 5 789999999999764321 2345689999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCC
Q 012297 420 SFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 420 S~Gvll~elltG~~Pf~~~ 438 (466)
|||+++|||++|+.||...
T Consensus 244 slG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 244 SFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHHHHHHSSCSCCCS
T ss_pred HHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=315.65 Aligned_cols=202 Identities=28% Similarity=0.430 Sum_probs=173.7
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 220 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 220 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
+...++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|+++|++++||||+++++++.+. ...
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~ 261 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGG 261 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECT---TSC
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcC---CCc
Confidence 344567888899999999999999985 7899999998653 345699999999999999999999998763 235
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++|+|.++++......+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 799999999999999998765445899999999999999999999998 99999999999999999999999999985
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 439 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~~ 439 (466)
.... .....++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 339 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 339 ASST--------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp CC--------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred cccc--------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 4321 112356788999999999999999999999999999998 999997543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=306.00 Aligned_cols=204 Identities=26% Similarity=0.323 Sum_probs=173.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccC----CCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ----GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~----~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
.+.|.+.+.||+|+||.||+|... +++.||||++... ......+.+.+|+.+++.++||||+++++++.+ .
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~ 98 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS----D 98 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE----T
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe----C
Confidence 356888899999999999999875 5899999998642 122234568999999999999999999999876 4
Q ss_pred eeEEEEEecCCCCCHHHHhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEE
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AKIT 372 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~---vkL~ 372 (466)
...++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEEC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEe
Confidence 56799999999999998885432 234899999999999999999999998 999999999999987655 9999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 373 DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|||++........ ......||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 176 Dfg~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 176 GFGVAIQLGESGL-----VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CCTTCEECCTTSC-----BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cCcceeEecCCCe-----eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 9999987654321 123457899999999999999999999999999999999999999753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=298.91 Aligned_cols=202 Identities=26% Similarity=0.369 Sum_probs=167.3
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-------------------------ChhHHHHHHHHHHHh
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-------------------------NADSVFLTEVDMLSR 277 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-------------------------~~~~~f~~Ei~~l~~ 277 (466)
++|.+.+.||+|+||.||+|... +++.||||++...... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 56888899999999999999875 5889999998755321 112458899999999
Q ss_pred cCCCCccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 012297 278 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 357 (466)
Q Consensus 278 l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk 357 (466)
++||||+++++++.+.. ....++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+|||||
T Consensus 93 l~h~~iv~~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPN--EDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp CCCTTBCCEEEEEECSS--SSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred CCCCCCCeEEEEEEcCC--CCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 99999999999987532 3467999999999999887643 46899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCC---CCchhHHHHHHHHHHHHHcCCCC
Q 012297 358 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQP 434 (466)
Q Consensus 358 ~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDv~S~Gvll~elltG~~P 434 (466)
|+|||++.++.+||+|||+++....... ......||+.|+|||.+.... ++.++||||||+++|||++|+.|
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-----LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC-----EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred HHHEEECCCCCEEEecCCCccccccccc-----cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 9999999999999999999987643321 122356899999999987665 37899999999999999999999
Q ss_pred CCCC
Q 012297 435 IHRS 438 (466)
Q Consensus 435 f~~~ 438 (466)
|...
T Consensus 240 f~~~ 243 (298)
T 2zv2_A 240 FMDE 243 (298)
T ss_dssp SCCS
T ss_pred CCCc
Confidence 9753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=309.18 Aligned_cols=211 Identities=19% Similarity=0.288 Sum_probs=171.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcC------CcEEEEEEcccCCCCCh----------hHHHHHHHHHHHhcCCCCccce
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNA----------DSVFLTEVDMLSRLHHCHVVPL 286 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~------~~~vaVK~l~~~~~~~~----------~~~f~~Ei~~l~~l~H~nIv~l 286 (466)
.++|.+.+.||+|+||.||+|.+.+ ++.||||++........ ...+..|+..++.++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4568888999999999999998865 47899999876532100 0113344555667789999999
Q ss_pred eeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--
Q 012297 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-- 364 (466)
Q Consensus 287 lg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld-- 364 (466)
++++..........++||||+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence 999987655556789999999 99999999763 356999999999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCCC--CCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 365 ENLNAKITDLGMAKRLKADGLPSC--SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 365 ~~~~vkL~DfGla~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.++.+||+|||+++.......... ........||+.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 889999999999987655432211 11223456999999999999999999999999999999999999999854
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=310.69 Aligned_cols=207 Identities=28% Similarity=0.429 Sum_probs=176.9
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc--------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeee
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~--------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~ 292 (466)
..++|.+.+.||+|+||.||+|.+. ++..||||+++..........+.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3467888899999999999999863 23579999998775555556799999999999 89999999999876
Q ss_pred ccCcceeEEEEEecCCCCCHHHHhccccc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 012297 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 358 (466)
Q Consensus 293 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~ 358 (466)
....++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||
T Consensus 147 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp 219 (382)
T 3tt0_A 147 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAA 219 (382)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred ----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCc
Confidence 3456999999999999999976431 34899999999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 359 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 359 ~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
+|||+++++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDY---YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCT---TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ceEEEcCCCcEEEcccCcccccccccc---cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999987644322 122333457889999999999999999999999999999999 9999975
Q ss_pred C
Q 012297 438 S 438 (466)
Q Consensus 438 ~ 438 (466)
.
T Consensus 297 ~ 297 (382)
T 3tt0_A 297 V 297 (382)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=304.93 Aligned_cols=210 Identities=27% Similarity=0.417 Sum_probs=177.2
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeec
Q 012297 220 EHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293 (466)
Q Consensus 220 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~ 293 (466)
+...++|.+.+.||+|+||.||+|... +++.||||++.........+.+.+|++++++++||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 97 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ- 97 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec-
Confidence 334567888899999999999999862 3578999999876555555679999999999999999999999876
Q ss_pred cCcceeEEEEEecCCCCCHHHHhccccc----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012297 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLV----------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351 (466)
Q Consensus 294 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~----------------------~~~~~~~~~~i~~qia~~L~~LH~~~~~~i 351 (466)
....++||||+++++|.+++..... ..+++.+++.++.|++.||+|||+.+ |
T Consensus 98 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i 171 (314)
T 2ivs_A 98 ---DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---L 171 (314)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred ---CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 3456999999999999999975432 23889999999999999999999998 9
Q ss_pred EecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-
Q 012297 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT- 430 (466)
Q Consensus 352 vHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt- 430 (466)
+||||||+|||+++++.+||+|||+++........ .......+++.|+|||.+.+..++.++||||||+++|||++
T Consensus 172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 248 (314)
T 2ivs_A 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY---VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248 (314)
T ss_dssp ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCE---ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred cccccchheEEEcCCCCEEEccccccccccccccc---eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999876433211 11233456788999999998889999999999999999999
Q ss_pred CCCCCCCCC
Q 012297 431 GRQPIHRSI 439 (466)
Q Consensus 431 G~~Pf~~~~ 439 (466)
|+.||....
T Consensus 249 g~~p~~~~~ 257 (314)
T 2ivs_A 249 GGNPYPGIP 257 (314)
T ss_dssp SCCSSTTCC
T ss_pred CCCCCCCCC
Confidence 999997543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=294.59 Aligned_cols=202 Identities=25% Similarity=0.401 Sum_probs=174.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.++|++.+.||+|+||.||+|.+.++..||||++..... ....+.+|++++++++||||+++++++.+ ....++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~l 80 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSK----EYPIYI 80 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECS----SSSEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEcc----CCceEE
Confidence 456788899999999999999999888999999976532 34568999999999999999999999865 445799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecch
Confidence 999999999999997642 45899999999999999999999998 99999999999999999999999999986644
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
.... ......+|+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 157 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 157 DQYV----SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp TCEE----ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred hhhh----cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 3211 1223446778999999998889999999999999999999 99999743
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.77 Aligned_cols=206 Identities=28% Similarity=0.396 Sum_probs=174.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~ 296 (466)
.++|.+.+.||+|+||.||+|.+. +++.||||++...........+.+|+.++++++||||+++++++.+
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---- 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 356788899999999999999853 4678999999866555556679999999999999999999999876
Q ss_pred ceeEEEEEecCCCCCHHHHhccccc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---c
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLV-----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---N 368 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~---~ 368 (466)
....++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++ .
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCce
Confidence 3345999999999999999976432 34899999999999999999999998 99999999999999554 5
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 369 vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 223 ~kL~DFG~a~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~ 290 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGY---YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290 (367)
T ss_dssp EEECCCHHHHHHHHHSS---CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEECCCccccccccccc---cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999986544322 122334567899999999999999999999999999999998 99999753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.58 Aligned_cols=207 Identities=28% Similarity=0.426 Sum_probs=178.6
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
++....+|.+.+.||+|+||.||+|.+.. +..||||+++... ...+.|.+|+++|++++||||+++++++.+ .
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~ 288 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR----E 288 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS----S
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEec----C
Confidence 44455678888999999999999999875 7899999997653 235669999999999999999999999876 3
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||+++|+|.++++......+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccc
Confidence 45699999999999999998755566999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+....... .......++..|+|||.+....++.++||||||++||||++ |+.||...
T Consensus 366 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 366 RLMTGDTY----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp ECCTTCCE----ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eeccCCce----eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 87643321 11223456788999999999999999999999999999999 99999754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=307.40 Aligned_cols=210 Identities=25% Similarity=0.429 Sum_probs=174.2
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEE------cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeee
Q 012297 220 EHATDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292 (466)
Q Consensus 220 ~~~t~~f~~~~~LG~G~fG~Vy~a~~------~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~ 292 (466)
+...++|...+.||+|+||.||+|.+ .++..||||++...........+.+|+.+++++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 34457788889999999999999986 245689999998665555566799999999999 89999999999876
Q ss_pred ccCcceeEEEEEecCCCCCHHHHhccccc---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012297 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVLV---------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351 (466)
Q Consensus 293 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~qia~~L~~LH~~~~~~i 351 (466)
....++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |
T Consensus 121 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 193 (344)
T 1rjb_A 121 ----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---C 193 (344)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred ----CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 3456999999999999999976432 23799999999999999999999998 9
Q ss_pred EecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-
Q 012297 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT- 430 (466)
Q Consensus 352 vHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt- 430 (466)
+||||||+|||++.++.+||+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|||+|
T Consensus 194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 270 (344)
T 1rjb_A 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY---VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270 (344)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred ccCCCChhhEEEcCCCcEEeCCCccCcccccCccc---eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999876543211 11233457889999999999999999999999999999998
Q ss_pred CCCCCCCCC
Q 012297 431 GRQPIHRSI 439 (466)
Q Consensus 431 G~~Pf~~~~ 439 (466)
|+.||....
T Consensus 271 g~~p~~~~~ 279 (344)
T 1rjb_A 271 GVNPYPGIP 279 (344)
T ss_dssp SCCSSTTCC
T ss_pred CCCCcccCC
Confidence 999997643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=323.06 Aligned_cols=204 Identities=28% Similarity=0.440 Sum_probs=177.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
.++|...+.||+|+||.||+|... +++.||||++.... .......+.+|++++++++||||+++++++.+ ...
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~ 258 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET----KDA 258 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee----CCE
Confidence 466888999999999999999885 68999999986531 22334558899999999999999999999876 456
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++|+|.+++.......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccccee
Confidence 799999999999999997655556999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 336 ~~~~~------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 336 VPEGQ------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp CCTTC------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred cccCc------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 64322 1223579999999999999899999999999999999999999998653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.66 Aligned_cols=202 Identities=26% Similarity=0.336 Sum_probs=165.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccC--CCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~--~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
.++|++.+.||+|+||.||+|... +++.||||++... ........+.+|+.+++.++||||+++++++.+ ...
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~~~ 222 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT----HDR 222 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE----TTE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee----CCE
Confidence 356888899999999999999875 5889999998754 223334457889999999999999999999986 446
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+++
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCce
Confidence 79999999999999999754 568999999999999999999998 87 9999999999999999999999999997
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 298 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 298 EGIKDG-----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp TTCC----------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccCCC-----cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 643322 1233467999999999999999999999999999999999999999754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=298.04 Aligned_cols=201 Identities=26% Similarity=0.429 Sum_probs=168.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|...+.||+|+||.||+|...+++.||+|++..... ......+.+|++++++++||||+++++++.+ ....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT----KKRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC----SSCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc----CCeEEE
Confidence 46788899999999999999998899999999875532 2233568899999999999999999999876 346799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 78 v~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp EEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred EEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 9999964 9999987532 45899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 153 ~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 153 PV-----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cc-----cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 11233467999999999875 45899999999999999999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=304.94 Aligned_cols=199 Identities=27% Similarity=0.353 Sum_probs=171.3
Q ss_pred CCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+.+.||+|+||.||+|.. .+++.||||++.... .......+.+|+++++.++||||+++++++.. ....
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~ 84 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT----PTDI 84 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----CCEE
Confidence 5688889999999999999987 468899999986431 12223458899999999999999999999876 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+ +|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 85 ~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp EEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 9999999 78999998754 56999999999999999999999998 999999999999999999999999999865
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... ......||+.|+|||.+.+..+ ++++||||||+++|||++|+.||...
T Consensus 159 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 159 TDGN------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp TTSB------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred cCCc------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 4332 1233568999999999987776 78999999999999999999999753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=303.89 Aligned_cols=204 Identities=25% Similarity=0.412 Sum_probs=170.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-Cc----EEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-~~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
++|...+.||+|+||.||+|.+.. ++ .|++|.+...........+.+|+.++++++||||+++++++.. .
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 87 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-----S 87 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-----S
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----C
Confidence 457778899999999999998753 43 3888888665544444558899999999999999999998853 3
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccc
Confidence 4689999999999999997542 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 439 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~~ 439 (466)
....... ........++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 164 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 164 LLPPDDK---QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp GSCCCTT---CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred ccCcccc---cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 7654322 112334567889999999999999999999999999999999 999997543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=310.15 Aligned_cols=201 Identities=24% Similarity=0.315 Sum_probs=165.4
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHH-HHhcCCCCccceeeeeeeccCccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDM-LSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~-l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
++|...+.||+|+||.||+|+.. +++.||||+++.... ......+.+|..+ ++.++||||+++++++.+ ...
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~----~~~ 113 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----ADK 113 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC----SSE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe----CCE
Confidence 45788899999999999999886 478999999976532 2233346667766 567899999999999876 457
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++.
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 79999999999999999764 45899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 189 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 242 (373)
T 2r5t_A 189 NIEHN-----STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242 (373)
T ss_dssp GBCCC-----CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccCC-----CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 43321 2234567999999999999999999999999999999999999999753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.90 Aligned_cols=204 Identities=22% Similarity=0.301 Sum_probs=174.3
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
...++|.+.+.||+|+||.||++... +++.+|+|++...... .....+.+|+++++.++||||+++++++.+ ..
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~ 83 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE----EG 83 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC----SS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE----CC
Confidence 34567889999999999999999864 6889999998765422 234458999999999999999999999876 45
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEEecC
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLG 375 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld---~~~~vkL~DfG 375 (466)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ +++.+||+|||
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 679999999999999999764 55999999999999999999999998 99999999999998 46789999999
Q ss_pred CccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
++....... .......||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 159 ~a~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~ 216 (444)
T 3soa_A 159 LAIEVEGEQ-----QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE 216 (444)
T ss_dssp SCBCCCTTC-----CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eeEEecCCC-----ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc
Confidence 997764432 1223467999999999999999999999999999999999999999653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.09 Aligned_cols=206 Identities=31% Similarity=0.474 Sum_probs=172.5
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
++...++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.+ .
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 251 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----E 251 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----C
Confidence 344556788889999999999999999888889999998653 234569999999999999999999999864 2
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR 328 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccce
Confidence 4589999999999999998655466999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
....... .......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 329 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 329 LIEDNEY----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ecCCCce----ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 7654321 11223456788999999999999999999999999999999 99999753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=295.61 Aligned_cols=202 Identities=24% Similarity=0.416 Sum_probs=171.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.++|+..+.||+|+||.||++.+.++..||||++..... ..+.+.+|++++++++|+||+++++++.+ ....++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~l 96 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTK----QRPIFI 96 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECS----SSSEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEec----CCCeEE
Confidence 456778899999999999999999888999999986532 34568999999999999999999999875 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 97 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp EECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 999999999999997633 45999999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
... .......+|+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 173 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 173 DEY----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp HHH----HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccc----ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 211 11223346788999999999999999999999999999998 99999753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=297.04 Aligned_cols=207 Identities=28% Similarity=0.423 Sum_probs=173.0
Q ss_pred HhCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCC----CChhHHHHHHHHHHHhcC---CCCccceeeeeeec
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGG----PNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEF 293 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~----~~~~~~f~~Ei~~l~~l~---H~nIv~llg~~~~~ 293 (466)
..++|++.+.||+|+||.||+|.+ .+++.||||++..... ......+.+|+++++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999986 4689999999874321 122345778888877764 99999999998764
Q ss_pred cCc-ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 012297 294 RGK-RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 372 (466)
Q Consensus 294 ~~~-~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~ 372 (466)
... ....++||||+. ++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 432 235799999996 69999998765556999999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 373 DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|||+++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 163 Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 222 (308)
T 3g33_A 163 DFGLARIYSYQ------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 222 (308)
T ss_dssp SCSCTTTSTTC------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred eCccccccCCC------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999865432 2234467899999999999999999999999999999999999999754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=290.39 Aligned_cols=206 Identities=18% Similarity=0.233 Sum_probs=174.9
Q ss_pred hCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~ 300 (466)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ..+.+|+.+++.+ +|+|++++++++.+ ....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~----~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQE----GLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEE----TTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc---HHHHHHHHHHHHHhcCCCCCeEEeecCC----Ccee
Confidence 35688889999999999999986 56899999998755332 2478999999999 79999999999875 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-----EEEEecC
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-----AKITDLG 375 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~-----vkL~DfG 375 (466)
++||||+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 82 ~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 9999999 99999999764 245999999999999999999999998 999999999999987776 9999999
Q ss_pred CccccccCCCCC--CCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 012297 376 MAKRLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 440 (466)
Q Consensus 376 la~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~ 440 (466)
+++......... .........||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 998765433211 11223456799999999999999999999999999999999999999987543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.86 Aligned_cols=203 Identities=29% Similarity=0.458 Sum_probs=176.1
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|...+.||+|+||.||+++.. +++.||+|++.... .......+.+|++++++++||||+++++++.+ ....
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~l 260 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET----KTDL 260 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee----CCEE
Confidence 56888899999999999999985 58999999986542 12334568899999999999999999999876 4567
Q ss_pred EEEEecCCCCCHHHHhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 301 LLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceee
Confidence 99999999999999997543 346999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 338 ~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 338 ELKAGQ-----TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp ECCTTC-----CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred eccCCC-----cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 764432 1123357999999999999999999999999999999999999999764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=301.58 Aligned_cols=208 Identities=25% Similarity=0.401 Sum_probs=176.8
Q ss_pred HhCCCCCcceecccCcEEEEEEEE------cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeecc
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 294 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~------~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~ 294 (466)
..++|...+.||+|+||.||+|.+ .+++.||||++.........+.+.+|+.+++++ +||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 345678889999999999999985 346789999998765545556799999999999 89999999999876
Q ss_pred CcceeEEEEEecCCCCCHHHHhccccc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 012297 295 GKRAMRLLVFEFMPNGNLRDCLDGVLV----------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 358 (466)
Q Consensus 295 ~~~~~~~lV~ey~~~gsL~~~l~~~~~----------------~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~ 358 (466)
....++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||
T Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp 173 (313)
T 1t46_A 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (313)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred --CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCcc
Confidence 3356999999999999999976432 24899999999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 359 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 359 ~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
+|||++.++.+||+|||++......... .......+|+.|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTS---EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ceEEEcCCCCEEEccccccccccccccc---eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999876543211 11233457788999999999999999999999999999999 9999975
Q ss_pred CC
Q 012297 438 SI 439 (466)
Q Consensus 438 ~~ 439 (466)
..
T Consensus 251 ~~ 252 (313)
T 1t46_A 251 MP 252 (313)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=293.52 Aligned_cols=200 Identities=24% Similarity=0.385 Sum_probs=169.8
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|+..+.||+|+||+||+|... +++.||||++..... ......+.+|++++++++||||+++++++.+ ....+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 77 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----DKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe----CCEEE
Confidence 46888899999999999999885 588999999976543 3344668899999999999999999999876 45679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 78 lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 78 LVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence 99999965 666666543 256999999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCC-CCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
... .......||+.|+|||.+.+.. ++.++||||||+++|||++|..||..
T Consensus 153 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 153 IPV-----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp SCC-----SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred Ccc-----ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 321 2233456899999999987765 79999999999999999999888654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=303.91 Aligned_cols=200 Identities=27% Similarity=0.357 Sum_probs=160.0
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
...++|.+.+.||+|+||.||+|.+. +++.||||++.... ..+.+.+|++++++++||||+++++++.+ ...
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~ 122 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFET----PTE 122 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEEC----SSE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEec----CCe
Confidence 34577888999999999999999986 47899999998653 23458899999999999999999999876 446
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCC
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGM 376 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~---~~~vkL~DfGl 376 (466)
.++||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred EEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 79999999999999999754 45899999999999999999999998 999999999999975 88999999999
Q ss_pred ccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 198 a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 253 (349)
T 2w4o_A 198 SKIVEHQV------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253 (349)
T ss_dssp ---------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred ccccCccc------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 98654321 123356899999999999999999999999999999999999999754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=307.89 Aligned_cols=200 Identities=25% Similarity=0.310 Sum_probs=164.2
Q ss_pred CCCCCc-ceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHh-cCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSR-LHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~-~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~-l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+. ++||+|+||.||++.+. +++.||||++... ..+.+|++++.+ .+|+||+++++++..........
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 445554 68999999999999875 5889999998632 347788988754 58999999999987644445678
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCCc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGMA 377 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~---~~~vkL~DfGla 377 (466)
++||||+++|+|.+++.......+++.++..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 99999999999999998755456999999999999999999999998 999999999999987 789999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+...... ......||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 212 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 212 KETTSHN------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp EECC-----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred cccCCCC------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 8654321 123457899999999999999999999999999999999999999754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=296.09 Aligned_cols=206 Identities=27% Similarity=0.452 Sum_probs=176.5
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
++...++|.+.+.||+|+||.||+|...+++.||||.+.... ...+.+.+|++++++++||||+++++++.+ .
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~ 80 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----E 80 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-----C
Confidence 344456788889999999999999999888899999987653 234569999999999999999999998763 2
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++.
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLAR 157 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccc
Confidence 3589999999999999997654446899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
....... .......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 158 LIEDNEY----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp ECSSSCE----ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccCccc----ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 7654321 11223456788999999998889999999999999999999 99999653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=298.31 Aligned_cols=205 Identities=29% Similarity=0.416 Sum_probs=168.8
Q ss_pred CCCCCcceecccCcEEEEEEEE-----cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~-----~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.|.+|++++++++||||+++++++.... ..
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~ 86 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--RR 86 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH--HT
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--CC
Confidence 5577789999999999999985 258899999987542 334456899999999999999999999986532 23
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred ceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 4689999999999999997643 34899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
........ ........++..|+|||.+.+..++.++||||||+++|||++|..||..
T Consensus 163 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 163 VLPQDKEF--FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp ---------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred cccCCcce--eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 76543211 1122234567789999999999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=299.39 Aligned_cols=197 Identities=24% Similarity=0.303 Sum_probs=164.5
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|+..++||+|+||+||+|.+. +++.||||++...... .....+..|+..+.++ +|+||+++++++.+ ....
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~----~~~~ 132 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE----GGIL 132 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe----CCEE
Confidence 56888999999999999999986 6899999998654322 2333466666666665 89999999999976 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999999 779999987643 46999999999999999999999998 999999999999999999999999998776
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
.... ......||+.|+|||++.+ .++.++||||||+++|||++|..||.
T Consensus 208 ~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 208 GTAG------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp C------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred ccCC------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 4332 1233468999999998775 78999999999999999999977765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=297.02 Aligned_cols=204 Identities=24% Similarity=0.389 Sum_probs=163.9
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcC----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~~----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
..++|.+.+.||+|+||.||+|.+.. +..||+|++.........+.|.+|+.++++++||||+++++++.+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 87 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-----
Confidence 34678888999999999999998753 457999998876555556679999999999999999999999743
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----
T ss_pred CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccc
Confidence 2458999999999999999754 245899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+....... .......+++.|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 164 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~ 221 (281)
T 1mp8_A 164 RYMEDSTY----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccCcccc----cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence 87644321 11223456788999999999999999999999999999997 99999754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=290.63 Aligned_cols=206 Identities=28% Similarity=0.368 Sum_probs=177.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|++.+.||+|+||.||+|... +++.||||++.........+.+.+|+.+++.++||||+++++++.+ ....+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 81 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE----GNIQY 81 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc----CCEEE
Confidence 456888899999999999999886 6899999999766555566779999999999999999999999876 44679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 999999999999999753 45899999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSIT 440 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~Pf~~~~~ 440 (466)
.... ........|++.|+|||.+....+ +.++||||||+++|||++|+.||.....
T Consensus 157 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 157 YNNR---ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp ETTE---ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred CCcc---hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 3321 111233568999999999987665 7899999999999999999999976543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=297.85 Aligned_cols=207 Identities=28% Similarity=0.431 Sum_probs=178.7
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
++...++|++.+.||+|+||.||+|.+.+ +..||+|.+... ....+.+.+|++++++++||||+++++++.+ .
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~ 81 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR----E 81 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECS----S
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----C
Confidence 34456678888999999999999999865 788999998754 3345679999999999999999999999875 4
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||+++++|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccc
Confidence 45799999999999999998765567999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
........ .......+++.|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 159 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~ 216 (288)
T 3kfa_A 159 RLMTGDTY----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216 (288)
T ss_dssp GTSCSSSS----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eeccCCcc----ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 87643321 12233456788999999999999999999999999999999 99999754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=295.97 Aligned_cols=201 Identities=25% Similarity=0.366 Sum_probs=175.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCC-----hhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~ 296 (466)
.++|.+.+.||+|+||.||+|... +++.||||.+....... ....+.+|++++++++||||+++++++.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 86 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN---- 86 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 355888899999999999999876 58999999997654322 34569999999999999999999999876
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEE
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKIT 372 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~----~vkL~ 372 (466)
....++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEc
Confidence 45679999999999999999753 46899999999999999999999998 99999999999999888 79999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 373 DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|||++....... ......||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 162 Dfg~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 162 DFGLAHEIEDGV------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp CCTTCEECCTTC------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred cCccceecCccc------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 999998764421 123456899999999999999999999999999999999999999753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=301.33 Aligned_cols=215 Identities=25% Similarity=0.400 Sum_probs=162.5
Q ss_pred HHHHHhCCCCCcceecccCcEEEEEEEEcCC----cEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeee
Q 012297 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDG----RIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 292 (466)
Q Consensus 218 ~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~----~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~ 292 (466)
++....++|.+.+.||+|+||.||+|.+... ..||||+++... .....+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 3444567899999999999999999987543 279999997653 23345669999999999999999999999876
Q ss_pred ccCcc--eeEEEEEecCCCCCHHHHhccccc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 012297 293 FRGKR--AMRLLVFEFMPNGNLRDCLDGVLV----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366 (466)
Q Consensus 293 ~~~~~--~~~~lV~ey~~~gsL~~~l~~~~~----~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~ 366 (466)
..... ...++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence 33221 234899999999999999964321 25899999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 367 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+.+||+|||+++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 243 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYY---RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243 (323)
T ss_dssp SCEEECCCCC--------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCEEEeeccccccccccccc---cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence 99999999999876443221 12223456788999999999999999999999999999999 99999754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=298.38 Aligned_cols=192 Identities=22% Similarity=0.327 Sum_probs=149.9
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcceeEEEEEec
Q 012297 229 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~~~lV~ey 306 (466)
.+.||+|+||.||+|.+. +++.||||++... ....+.+|+.+++.+. ||||+++++++.+ ....++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~----~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHD----QLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc----CCEEEEEEEc
Confidence 378999999999999885 5899999998643 3456889999999997 9999999999876 4567999999
Q ss_pred CCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEEecCCccccccC
Q 012297 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---NAKITDLGMAKRLKAD 383 (466)
Q Consensus 307 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~---~vkL~DfGla~~~~~~ 383 (466)
+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 88 LNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999999999764 56999999999999999999999998 99999999999997665 8999999999865433
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. ......||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 163 ~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 163 NQ-----PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp --------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CC-----cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 21 223356799999999999999999999999999999999999999753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=305.13 Aligned_cols=201 Identities=25% Similarity=0.370 Sum_probs=173.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+ ....+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFED----KYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC----SSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe----CCEEE
Confidence 457888999999999999999875 58899999987543 2234468999999999999999999999876 45679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--CCcEEEEecCCccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--NLNAKITDLGMAKR 379 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~--~~~vkL~DfGla~~ 379 (466)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 125 lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccccee
Confidence 999999999999999753 245899999999999999999999998 999999999999974 47799999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... ......||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 201 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 253 (387)
T 1kob_A 201 LNPDE------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253 (387)
T ss_dssp CCTTS------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred cCCCc------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence 64332 122346899999999999999999999999999999999999999753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=300.25 Aligned_cols=206 Identities=28% Similarity=0.451 Sum_probs=174.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEc--------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeec
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~--------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~ 293 (466)
.++|.+.+.||+|+||.||+|.+. +++.||||++...........+.+|+++++++ +||||+++++++.+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-
Confidence 456778899999999999999873 46789999998765555556799999999999 89999999999876
Q ss_pred cCcceeEEEEEecCCCCCHHHHhccccc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 012297 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359 (466)
Q Consensus 294 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~ 359 (466)
....++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+
T Consensus 113 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~ 186 (334)
T 2pvf_A 113 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186 (334)
T ss_dssp ---SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred ---CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccc
Confidence 3456999999999999999976432 24899999999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 360 NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
|||++.++.+||+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSS---EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eEEEcCCCCEEEcccccccccccccc---ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 99999999999999999987644321 111233456788999999998889999999999999999999 99999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=301.87 Aligned_cols=213 Identities=26% Similarity=0.292 Sum_probs=172.6
Q ss_pred HHHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccC----CCCChhHHHHHHHHHHHhcCCCCccceeeeeee
Q 012297 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ----GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 292 (466)
Q Consensus 218 ~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~----~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~ 292 (466)
++....++|.+.+.||+|+||.||+|... +++.||+|++... ........+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 45667788999999999999999999874 5789999998643 134555679999999999999999999999876
Q ss_pred ccCcceeEEEEEecCCCCCHHHHhccccc--------------------------------------CCCCHHHHHHHHH
Q 012297 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------------------------------EGMNWDTRVAIAI 334 (466)
Q Consensus 293 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~--------------------------------------~~~~~~~~~~i~~ 334 (466)
....++||||+++|+|.+++..... ..+++..+..++.
T Consensus 100 ----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 100 ----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp ----SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred ----CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 4567999999999999999852111 1135777889999
Q ss_pred HHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC--cEEEEecCCccccccCCCCCCCCCCCccccCcccccchhccc--C
Q 012297 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENL--NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--G 410 (466)
Q Consensus 335 qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~--~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~ 410 (466)
|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++......... ........||+.|+|||.+.. .
T Consensus 176 qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 176 QIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE-YYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccc-cccccccCCCccccCchhhccCCC
Confidence 9999999999998 99999999999998776 89999999998764422111 112334568999999999865 6
Q ss_pred CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 411 RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 411 ~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.++.++||||||+++|||++|+.||...
T Consensus 252 ~~~~~~DiwslG~il~el~~g~~pf~~~ 279 (345)
T 3hko_A 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGV 279 (345)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 7899999999999999999999999654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=303.07 Aligned_cols=200 Identities=24% Similarity=0.306 Sum_probs=163.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|.+.+.||+|+||.||+++.. +++.||||++..... ....+.+|+.+++.++||||+++++++.+ ....+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~ 92 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILT----PTHLA 92 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEee----CCEEE
Confidence 456888899999999999999886 689999999976533 23458899999999999999999999876 45679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--EEEEecCCccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN--AKITDLGMAKR 379 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~--vkL~DfGla~~ 379 (466)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 93 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 93 IIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 999999999999999754 45999999999999999999999998 999999999999987765 99999999975
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLM-SDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
..... ......||+.|+|||.+.+..++.+ +||||||+++|||++|+.||....
T Consensus 168 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 168 SVLHS------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp -------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred ccccC------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 43221 2234568999999999988887655 899999999999999999997543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=303.73 Aligned_cols=212 Identities=28% Similarity=0.428 Sum_probs=178.5
Q ss_pred HHHHHHhCCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeee
Q 012297 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290 (466)
Q Consensus 217 ~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~ 290 (466)
++++...++|.+.+.||+|+||.||+|.+. +++.||||.+...........|.+|++++++++|+||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 345556678889999999999999999764 36789999998665545556699999999999999999999998
Q ss_pred eeccCcceeEEEEEecCCCCCHHHHhcccc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 012297 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNIL 362 (466)
Q Consensus 291 ~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NIL 362 (466)
.+ ....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||
T Consensus 98 ~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIl 170 (322)
T 1p4o_A 98 SQ----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 170 (322)
T ss_dssp CS----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred cc----CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEE
Confidence 76 335699999999999999996532 135799999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 363 LDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 363 ld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
++.++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCE---EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred EcCCCeEEECcCcccccccccccc---ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 999999999999999865433211 11122356788999999999999999999999999999999 89999653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=289.32 Aligned_cols=201 Identities=35% Similarity=0.512 Sum_probs=163.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCC---ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP---NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
.++|+..+.||+|+||.||+|.+. ++.||||++...... ...+.+.+|+++++.++||||+++++++.+ ...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 80 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK----EPN 80 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC----C--
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec----CCc
Confidence 356788899999999999999985 889999998765322 234568999999999999999999999876 345
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--------CCcEEE
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--------NLNAKI 371 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~--------~~~vkL 371 (466)
.++||||+++++|.+++.. ..+++..++.++.|++.||+|||+.+..+|+||||||+|||+++ ++.+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 6999999999999999964 46899999999999999999999988666899999999999986 678999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 372 ~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+|||++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 158 ~Dfg~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 158 TDFGLAREWHRTT-------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp CCCCC--------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred ccCCccccccccc-------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999998654321 22346899999999999999999999999999999999999999753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=293.95 Aligned_cols=202 Identities=24% Similarity=0.353 Sum_probs=168.4
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|++.+.||+|+||.||+|.+. +++.||||++...... .....+.+|++++++++||||+++++++.+ ....+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~ 78 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR----KRRLH 78 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec----CCeEE
Confidence 57888899999999999999886 4899999998765432 224558899999999999999999999876 44679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 79 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp EEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 999999999999988653 55899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
... .......||..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 154 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 154 GPS-----DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp -----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred Ccc-----cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 322 12233568899999999876 668999999999999999999999997643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=290.84 Aligned_cols=200 Identities=25% Similarity=0.392 Sum_probs=176.7
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+.|...+.||+|+||.||+|... +++.||||++...........+.+|+.++++++||||+++++++.+ ....++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 97 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK----DTKLWI 97 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec----CCeEEE
Confidence 45777899999999999999875 5889999999877656666779999999999999999999999876 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 98 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999999999964 45899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... ......|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 172 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 222 (303)
T 3a7i_A 172 TQI-----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222 (303)
T ss_dssp TBC-----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccc-----ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence 321 123456899999999999999999999999999999999999999753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=300.41 Aligned_cols=214 Identities=24% Similarity=0.298 Sum_probs=175.3
Q ss_pred echHHHHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCC----------hhHHHHHHHHHHHhcCCCCc
Q 012297 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN----------ADSVFLTEVDMLSRLHHCHV 283 (466)
Q Consensus 214 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~----------~~~~f~~Ei~~l~~l~H~nI 283 (466)
....++....++|.+.+.||+|+||.||+|...+++.||||++....... ..+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 44578899999999999999999999999999889999999986543221 12568999999999999999
Q ss_pred cceeeeeeecc-CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 012297 284 VPLVGYCSEFR-GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNIL 362 (466)
Q Consensus 284 v~llg~~~~~~-~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NIL 362 (466)
+++++++.... ......++||||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 99999986544 23446799999996 6898888753 246899999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 363 LDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 363 ld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
++.++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp ECTTCCEEECCTTC---------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EcCCCCEEEEecCccccccccc------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 9999999999999997543321 2233568899999998876 67899999999999999999999999754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=289.18 Aligned_cols=202 Identities=24% Similarity=0.342 Sum_probs=174.4
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
..++|++.+.||+|+||.||+|... +++.||+|++..... ......+.+|++++++++||||+++++++.+ ...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 79 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----ESF 79 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc----CCE
Confidence 3577889999999999999999875 588999999876532 2334568899999999999999999999875 456
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEEecCC
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AKITDLGM 376 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~---vkL~DfGl 376 (466)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 79999999999999998754 55899999999999999999999998 999999999999987655 99999999
Q ss_pred ccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 210 (284)
T 3kk8_A 155 AIEVNDSE------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210 (284)
T ss_dssp CEECCSSC------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eEEcccCc------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence 97654322 123356899999999999999999999999999999999999999653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=292.10 Aligned_cols=201 Identities=23% Similarity=0.328 Sum_probs=169.3
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|.+.+.||+|+||.||++... ++..+|+|++.........+.+.+|++++++++||||+++++++.+ ....++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~l 97 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED----YHNMYI 97 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec----CCeEEE
Confidence 45777899999999999999875 5889999999876655556779999999999999999999999876 456799
Q ss_pred EEecCCCCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCCc
Q 012297 303 VFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMA 377 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl---d~~~~vkL~DfGla 377 (466)
||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 99999999999998543 2356999999999999999999999998 9999999999999 45678999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
....... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||...
T Consensus 175 ~~~~~~~------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~ 228 (285)
T 3is5_A 175 ELFKSDE------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228 (285)
T ss_dssp CC----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCcc------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence 7654322 123456899999999875 56899999999999999999999999754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=301.33 Aligned_cols=202 Identities=26% Similarity=0.412 Sum_probs=164.5
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|...+.||+|+||.||+|... +++.||||++...........+.+|++++++++||||+++++++.. ....++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 77 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT----EKSLTL 77 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC----SSCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee----CCEEEE
Confidence 46888899999999999999886 6889999999765443333346689999999999999999999876 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||++ |+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 78 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp EEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred Eecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 999996 6999998764 245899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.. .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 153 ~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 153 PT-----KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205 (324)
T ss_dssp ---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred Cc-----cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 12233467999999999876 568999999999999999999999997643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=300.08 Aligned_cols=218 Identities=27% Similarity=0.427 Sum_probs=182.7
Q ss_pred eechHHHHHHhCCCCCcceecccCcEEEEEEEE------cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccc
Q 012297 213 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 285 (466)
Q Consensus 213 ~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~------~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~ 285 (466)
.+....++...++|.+.+.||+|+||.||+|.+ .+++.||||++...........+.+|++++.++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 455566677778899999999999999999975 346899999998765555556799999999999 7999999
Q ss_pred eeeeeeeccCcceeEEEEEecCCCCCHHHHhccccc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012297 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRI 351 (466)
Q Consensus 286 llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qia~~L~~LH~~~~~~i 351 (466)
+++++... ....++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |
T Consensus 96 ~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i 169 (316)
T 2xir_A 96 LLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 169 (316)
T ss_dssp EEEEECCT---TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EEEEEecC---CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 99998753 2346999999999999999976432 12789999999999999999999998 9
Q ss_pred EecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-
Q 012297 352 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT- 430 (466)
Q Consensus 352 vHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt- 430 (466)
+||||||+|||++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~ 246 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPD---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT---SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccccCccceEEECCCCCEEECCCccccccccCcc---ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999986643321 111223457889999999999999999999999999999998
Q ss_pred CCCCCCCCC
Q 012297 431 GRQPIHRSI 439 (466)
Q Consensus 431 G~~Pf~~~~ 439 (466)
|+.||....
T Consensus 247 g~~p~~~~~ 255 (316)
T 2xir_A 247 GASPYPGVK 255 (316)
T ss_dssp SCCSSTTCC
T ss_pred CCCCCcccc
Confidence 999997543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.59 Aligned_cols=205 Identities=27% Similarity=0.456 Sum_probs=161.5
Q ss_pred CCCcceecccCcEEEEEEEEcC----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~~----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
|...+.||+|+||.||+|.+.+ +..||||.++........+.|.+|+.++++++||||+++++++.+. ....+
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~---~~~~~ 167 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---EGSPL 167 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC---SSCCE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC---CCCeE
Confidence 4556789999999999998642 2468999998765555667799999999999999999999987642 23458
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++|+|.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 168 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999999753 245899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
...... ........+|+.|+|||.+....++.++||||||+++|||+| |.+||...
T Consensus 244 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 244 DKEFDS-VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred cccccc-ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 432111 112233457889999999999999999999999999999999 77777654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=287.55 Aligned_cols=200 Identities=25% Similarity=0.389 Sum_probs=171.6
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-----ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-----~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
++|.+.+.||+|+||.||++... +++.||+|.++..... ...+.+.+|+.++++++||||+++++++.+ .
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~ 80 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN----K 80 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----S
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC----C
Confidence 45788899999999999999886 5899999998765322 235669999999999999999999999876 4
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEEe
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKITD 373 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~----~vkL~D 373 (466)
...++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++ .+||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred CeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEe
Confidence 4679999999999999999753 56899999999999999999999998 99999999999998877 899999
Q ss_pred cCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 374 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 374 fGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
||++....... ......|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 156 fg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 214 (283)
T 3bhy_A 156 FGIAHKIEAGN------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 214 (283)
T ss_dssp CTTCEECC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccceeccCCC------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence 99998764322 123346889999999999999999999999999999999999999754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.84 Aligned_cols=204 Identities=28% Similarity=0.427 Sum_probs=174.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|.+.+.||+|+||.||+|.+.. ++.||||++.........+.+.+|++++++++||||+++++++.+.. ....++
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~~~l 86 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT--TRHKVL 86 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT--TCCEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC--CCeeEE
Confidence 457778999999999999998864 89999999986554455567889999999999999999999987633 336699
Q ss_pred EEecCCCCCHHHHhccccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEEecCCc
Q 012297 303 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMA 377 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl----d~~~~vkL~DfGla 377 (466)
||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999976432 33899999999999999999999998 9999999999999 77888999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhccc--------CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--------GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+...... ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 164 RELEDDE------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp EECCCGG------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred eEccCCC------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 8764432 1223568999999998865 56788999999999999999999999753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=299.64 Aligned_cols=199 Identities=26% Similarity=0.338 Sum_probs=169.6
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccee
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~ 299 (466)
..++|++.+.||+|+||.||++... +++.||||++...... +.+|++++.++ +||||+++++++.+ ...
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~----~~~ 90 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDD----GKY 90 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEEC----SSE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEc----CCE
Confidence 4567888999999999999999876 5889999999765322 45788888888 79999999999876 456
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----CcEEEEecC
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN----LNAKITDLG 375 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~----~~vkL~DfG 375 (466)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+.++ +.+||+|||
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 79999999999999999754 45899999999999999999999998 9999999999998443 359999999
Q ss_pred CccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 166 ~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 224 (342)
T 2qr7_A 166 FAKQLRAENG-----LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224 (342)
T ss_dssp TCEECBCTTC-----CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST
T ss_pred CcccCcCCCC-----ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC
Confidence 9987644321 1233568999999999988889999999999999999999999997643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=294.74 Aligned_cols=204 Identities=28% Similarity=0.432 Sum_probs=170.8
Q ss_pred CCCCcceecccCcEEEEEEEE-----cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 225 KFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~-----~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
.|+..+.||+|+||.||+|.+ .+++.||||++...........+.+|++++++++||||+++++++.+.. ...
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~ 99 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG--GNG 99 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----CC
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--Cce
Confidence 366778999999999999984 3688999999987665556677999999999999999999999987632 245
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 789999999999999996543 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
....... ........+|..|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 176 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 176 IETDKEY--YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CCTTCCE--EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ccCCCcc--eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 6543211 112333567888999999999999999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=303.47 Aligned_cols=195 Identities=26% Similarity=0.376 Sum_probs=164.2
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEecC
Q 012297 229 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 307 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~ 307 (466)
.+.||+|+||.||+|... +++.||+|+++... ....+.|.+|++++++++||||+++++++.+ ....++||||+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~E~~ 168 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFES----KNDIVLVMEYV 168 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEEEEEEECC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE----CCEEEEEEeCC
Confidence 467999999999999875 58999999998653 2344569999999999999999999999876 44679999999
Q ss_pred CCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE--cCCCcEEEEecCCccccccCCC
Q 012297 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 308 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl--d~~~~vkL~DfGla~~~~~~~~ 385 (466)
++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++......
T Consensus 169 ~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 169 DGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp TTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 9999999986532 35899999999999999999999998 9999999999999 667899999999998764432
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
......||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 244 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 291 (373)
T 2x4f_A 244 -----KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291 (373)
T ss_dssp -----BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred -----ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 122346899999999999889999999999999999999999999754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=299.69 Aligned_cols=197 Identities=28% Similarity=0.426 Sum_probs=169.5
Q ss_pred CCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
+.|...+.||+|+||.||+|.. .+++.||||++...... .....+.+|++++++++||||+++++++.+ ....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~ 129 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----EHTA 129 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----CCeE
Confidence 4578889999999999999986 46899999999765322 223468999999999999999999999876 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||++ |+|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 130 ~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 130 WLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 99999996 78888886432 56899999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... ....||+.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 205 ~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 205 APA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp SSB---------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCC---------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 332 2346899999999884 567899999999999999999999999653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=289.51 Aligned_cols=201 Identities=26% Similarity=0.461 Sum_probs=174.3
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc------
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR------ 294 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~------ 294 (466)
...+|+..+.||+|+||.||+|.+. +++.||+|++.... ..+.+|++++++++||||+++++++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 3456888899999999999999986 68999999997643 23779999999999999999999876421
Q ss_pred ------CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 012297 295 ------GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 368 (466)
Q Consensus 295 ------~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~ 368 (466)
......++||||+++++|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 12345799999999999999997665567999999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 369 vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
+||+|||++....... ......|++.|+|||.+....++.++||||||+++|||++|..||.
T Consensus 161 ~kl~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EEECCCTTCEESSCCS------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred EEECcchhheeccccc------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 9999999998765432 1223468999999999999999999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=290.50 Aligned_cols=203 Identities=26% Similarity=0.417 Sum_probs=170.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcC----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
.++|.+.+.||+|+||.||+|.+.+ +..||||.+.........+.|.+|++++++++||||+++++++.+ .
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~ 85 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-----E 85 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----S
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----C
Confidence 4567788999999999999998643 346999999876555556679999999999999999999999754 2
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence 348999999999999999764 245899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
....... .......+++.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 162 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 162 YIEDEDY----YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp CC-------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccccccc----cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 7644321 11233456788999999998999999999999999999998 99999743
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=324.34 Aligned_cols=207 Identities=31% Similarity=0.475 Sum_probs=177.6
Q ss_pred HHHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 218 ~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
.++...++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++|+||+++++++.+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----- 333 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----- 333 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-----
Confidence 3444566788889999999999999999888889999998653 234569999999999999999999999864
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...+|||||+++|+|.++|.......+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 24589999999999999998654456899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+....... .......++..|+|||.+....++.++||||||++||||++ |+.||...
T Consensus 411 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 411 RLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp TTCCCHHH----HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred eecCCCce----ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 86543211 11223346788999999999999999999999999999999 99999753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=301.90 Aligned_cols=209 Identities=23% Similarity=0.339 Sum_probs=164.6
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcc
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~ 297 (466)
...++|++.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.+++++. |+||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--~ 83 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN--D 83 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT--S
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC--C
Confidence 45678999999999999999999875 58999999986542 2333455889999999997 999999999987532 3
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 46799999996 699999875 46899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCC----------------CCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLP----------------SCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~----------------~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+........ ..........||+.|+|||.+.+ ..++.++||||||+++|||++|++||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 865431110 00112234579999999999876 67899999999999999999999999754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=290.92 Aligned_cols=204 Identities=27% Similarity=0.418 Sum_probs=172.5
Q ss_pred CCCCCcc-eecccCcEEEEEEEEc---CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 224 DKFSGSN-IVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~-~LG~G~fG~Vy~a~~~---~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
++|.+.+ .||+|+||.||+|.+. ++..||||+++........+.+.+|++++++++||||+++++++.. ..
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 83 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----EA 83 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----SS
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-----CC
Confidence 3444445 8999999999999864 5788999999876555556679999999999999999999999842 34
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred cEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceee
Confidence 69999999999999999753 345899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
....... ........+|+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 217 (287)
T 1u59_A 160 LGADDSY--YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217 (287)
T ss_dssp CTTCSCE--ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eccCcce--eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 6433211 112233456889999999988889999999999999999998 99999754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=325.53 Aligned_cols=203 Identities=25% Similarity=0.330 Sum_probs=175.1
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcc
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~ 297 (466)
..++|.+.+.||+|+||.||+|... +++.||||+++... .......+..|.+++..+ +|+||+++++++.+ .
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~----~ 414 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----M 414 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC----S
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe----C
Confidence 3467889999999999999999876 57889999987531 223344578899999988 69999999998875 4
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...+|||||+++|+|.++++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||++
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred CEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeeccee
Confidence 5679999999999999999864 45999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+...... .......||+.|+|||++....++.++||||||++||||++|+.||...
T Consensus 490 ~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 490 KENIWDG-----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp EECCCTT-----CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccccCC-----cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 8643332 1234567999999999999999999999999999999999999999754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=290.48 Aligned_cols=202 Identities=31% Similarity=0.479 Sum_probs=153.9
Q ss_pred CCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+.+.||+|+||.||+|.. .+++.||||++.... .......+.+|++++++++||||+++++++.+ ....
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 86 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED----SNYV 86 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC----SSEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc----CCeE
Confidence 4678889999999999999987 468999999986432 12234568999999999999999999999876 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 9999999999999999753 246899999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 163 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 215 (278)
T 3cok_A 163 KMPHE-----KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215 (278)
T ss_dssp C---------------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred cCCCC-----cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence 43211 122356889999999999888999999999999999999999999753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=296.93 Aligned_cols=203 Identities=28% Similarity=0.461 Sum_probs=167.2
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCc----EEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
++|.+.+.||+|+||.||+|.+. +++ .|++|.+...........+.+|+.++++++||||+++++++...
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----- 89 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 89 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-----
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-----
Confidence 56888899999999999999864 343 46888887666666677899999999999999999999998752
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++|+||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 90 TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp SEEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred CceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 3589999999999999997643 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 166 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 223 (327)
T 3lzb_A 166 LLGAEEKE---YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp -----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EccCcccc---ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 76443211 12223456788999999999999999999999999999999 99999754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=299.42 Aligned_cols=201 Identities=24% Similarity=0.350 Sum_probs=165.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCC--CCccceeeeeeeccCccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H--~nIv~llg~~~~~~~~~~~ 299 (466)
.++|++.+.||+|+||.||++...+++.||||++..... ......+.+|++++++++| +||+++++++.+ ...
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----~~~ 83 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----DQY 83 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee----CCE
Confidence 345788899999999999999998899999999876543 2333568999999999976 999999999876 457
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++|||+ .+++|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence 7999995 588999999764 56899999999999999999999998 99999999999997 57899999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhccc-----------CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-----------GRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
...... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||..
T Consensus 157 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 157 MQPDTT---SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp C---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCcccc---cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 654321 112234578999999999865 6789999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=288.59 Aligned_cols=201 Identities=29% Similarity=0.458 Sum_probs=173.5
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
++|...+.||+|+||.||++...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 81 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLE----QAPICLV 81 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECS----SSSCEEE
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcc----CCCeEEE
Confidence 46777889999999999999998899999999986532 33568999999999999999999999876 3456999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp ECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999997542 45899999999999999999999998 999999999999999999999999999865332
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
.. .......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 158 QY----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp HH----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cc----cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 11 11223456788999999998999999999999999999999 89999753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=286.50 Aligned_cols=200 Identities=21% Similarity=0.262 Sum_probs=172.5
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
..++|.+.+.||+|+||.||+|.... +..+|+|++..... ...+.+.+|++++++++||||+++++++.+ ....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~ 81 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFED----NTDI 81 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEec----CCeE
Confidence 34568888999999999999998764 67899999876543 334568999999999999999999999876 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCCc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMA 377 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl---d~~~~vkL~DfGla 377 (466)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 82 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 9999999999999998754 55899999999999999999999998 9999999999999 78899999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
....... ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (277)
T 3f3z_A 157 ARFKPGK------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP 210 (277)
T ss_dssp EECCTTS------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeccCcc------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC
Confidence 8764332 22334689999999987654 899999999999999999999999754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=298.79 Aligned_cols=208 Identities=22% Similarity=0.239 Sum_probs=168.3
Q ss_pred CCCCCcceecccCcEEEEEEEEc----CCcEEEEEEcccCCCCC----------hhHHHHHHHHHHHhcCCCCccceeee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPN----------ADSVFLTEVDMLSRLHHCHVVPLVGY 289 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~----~~~~vaVK~l~~~~~~~----------~~~~f~~Ei~~l~~l~H~nIv~llg~ 289 (466)
++|.+.+.||+|+||.||+|.+. ++..+|||++....... ....+.+|+..++.++|+||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56778899999999999999986 56789999987653211 11236678888999999999999999
Q ss_pred eeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC--
Q 012297 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-- 367 (466)
Q Consensus 290 ~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~-- 367 (466)
+..........++||||+ +++|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence 987555566789999999 999999998653 6899999999999999999999998 99999999999999887
Q ss_pred cEEEEecCCccccccCCCCCCC--CCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 368 NAKITDLGMAKRLKADGLPSCS--SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 368 ~vkL~DfGla~~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.+||+|||+++........... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999999999876543321111 112345789999999999999999999999999999999999999964
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=304.06 Aligned_cols=202 Identities=26% Similarity=0.356 Sum_probs=169.9
Q ss_pred CCCCCcceecccCcEEEEEEEE----cCCcEEEEEEcccCC---CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccC
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQL----TDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRG 295 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~----~~~~~vaVK~l~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~ 295 (466)
++|.+.+.||+|+||.||+++. .+++.||||+++... .......+.+|+++++++ +|+||+++++++..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 130 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--- 130 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee---
Confidence 5688889999999999999987 368999999987532 122334477899999999 69999999999876
Q ss_pred cceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 012297 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (466)
Q Consensus 296 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfG 375 (466)
....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 131 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 131 -ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp -TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred -CceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCC
Confidence 44679999999999999999764 46899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCccccCcccccchhccc--CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+++....... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 205 ~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 205 LSKEFVADET----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp EEEECCGGGG----GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred CCeecccCCC----CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 9986543221 11234578999999999885 34789999999999999999999999754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=289.12 Aligned_cols=201 Identities=25% Similarity=0.408 Sum_probs=174.0
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|...+.||+|+||.||++.+. +++.+|+|++..... ....+.+.+|+.++++++|+||+++++++.+ ....
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 90 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED----NDFV 90 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc----CCEE
Confidence 45777889999999999999886 478999999875532 2334568899999999999999999999876 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999999998754 46899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 218 (294)
T 2rku_A 166 EYDGE-----RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218 (294)
T ss_dssp CSTTC-----CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccCcc-----ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 43321 123356899999999999888999999999999999999999999754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=310.92 Aligned_cols=202 Identities=21% Similarity=0.274 Sum_probs=166.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeecc--Ccce
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRA 298 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~--~~~~ 298 (466)
.++|++.+.||+|+||.||+|... +++.||||++.... .......+.+|+.+++.++||||+++++++.... ....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467888999999999999999875 58899999997542 2233456889999999999999999999987543 2234
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++ +|.+.+.. .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 67999999965 57666643 4899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 213 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 213 TAGTS------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp ----C------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCC------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 76432 1233467899999999999999999999999999999999999999754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=296.86 Aligned_cols=215 Identities=27% Similarity=0.437 Sum_probs=173.6
Q ss_pred echHHHHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012297 214 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 291 (466)
Q Consensus 214 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~ 291 (466)
+++.++....++|.+.+.||+|+||.||+|.+. +++.||||++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 444555667788999999999999999999874 68999999987553 2345689999999999 7999999999987
Q ss_pred eccC--cceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 012297 292 EFRG--KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 369 (466)
Q Consensus 292 ~~~~--~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~v 369 (466)
.... .....++||||+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 6331 1346799999999999999998655567999999999999999999999998 9999999999999999999
Q ss_pred EEEecCCccccccCCCCCCCCCCCccccCcccccchhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 370 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 370 kL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
||+|||++....... .......|++.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 169 kl~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp EECCCTTTC------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EEeeCcCceecCcCc-----cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 999999998654321 1123356899999999986 566899999999999999999999999643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=300.81 Aligned_cols=210 Identities=24% Similarity=0.377 Sum_probs=177.0
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEcC------CcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeee
Q 012297 220 EHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 292 (466)
Q Consensus 220 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~~------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~ 292 (466)
+...++|...+.||+|+||.||+|.... ...||+|.+...........+.+|+.+++++ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3345678888999999999999998743 2479999998765555566799999999999 89999999999876
Q ss_pred ccCcceeEEEEEecCCCCCHHHHhcccc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 012297 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVL------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 360 (466)
Q Consensus 293 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~N 360 (466)
....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 122 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 194 (333)
T 2i1m_A 122 ----GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARN 194 (333)
T ss_dssp ----SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ----CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccce
Confidence 335699999999999999996532 245899999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 012297 361 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 439 (466)
Q Consensus 361 ILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~~ 439 (466)
||++.++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||+| |..||....
T Consensus 195 Il~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 195 VLLTNGHVAKIGDFGLARDIMNDSNY---IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp CEEEGGGEEEBCCCGGGCCGGGCTTS---EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred EEECCCCeEEECccccccccccccce---eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 99999999999999999876543211 11233456789999999999999999999999999999998 999997543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=289.20 Aligned_cols=201 Identities=23% Similarity=0.349 Sum_probs=170.5
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|...+.||+|+||.||+|++. ++.||||++..... ....+.|.+|++++++++||||+++++++.+.. ....++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~~~l 86 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP--APHPTL 86 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT--SSSCEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC--CCCeEe
Confidence 46778899999999999999985 88899999986642 233456999999999999999999999987632 245699
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++|+|.+++.......+++..++.++.|++.||.|||+.+ ++++||||||+|||+++++.++|.|||+.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 999999999999998765456999999999999999999999875 459999999999999999999999998875432
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCC---CchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRA---SLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 165 ---------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 165 ---------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp ---------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred ---------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 123467899999999886554 34899999999999999999999753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=302.39 Aligned_cols=199 Identities=27% Similarity=0.415 Sum_probs=174.7
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|.+.+.||+|+||.||+|.+. +++.||+|++...........+.+|+.++++++||||+++++++.+ ....++
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 108 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS----DGEISI 108 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE----TTEEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE----CCEEEE
Confidence 56788899999999999999886 5889999999876555556679999999999999999999999886 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~-~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
||||+++++|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++....
T Consensus 109 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999999999764 4589999999999999999999985 7 9999999999999999999999999997654
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 184 ~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 184 DSM-------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp HHC-----------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ccc-------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 321 22346899999999999999999999999999999999999999754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=309.00 Aligned_cols=202 Identities=23% Similarity=0.322 Sum_probs=156.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeecc-Cccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR-GKRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~-~~~~~ 299 (466)
.++|.+.+.||+|+||.||+|.+. +++.||||++..... ....+.+.+|++++++++|+||+++++++.... .....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367888999999999999999875 688999999875432 233456899999999999999999999986533 23356
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+ +++|.+++... ..+++.++..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 79999998 67999999753 56999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCC----------------------CCCCCccccCcccccchhc-ccCCCCchhHHHHHHHHHHHHHc
Q 012297 380 LKADGLPSC----------------------SSSPARMQGTFGYFAPEYA-MVGRASLMSDVFSFGVVLLELIT 430 (466)
Q Consensus 380 ~~~~~~~~~----------------------~~~~~~~~gt~~y~aPE~~-~~~~~s~~sDv~S~Gvll~ellt 430 (466)
......... .......+||+.|+|||++ ....++.++|||||||+||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 643221100 0123345789999999976 56679999999999999999999
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=290.81 Aligned_cols=205 Identities=28% Similarity=0.451 Sum_probs=169.0
Q ss_pred CCCCcceecccCcEEEEEEEEcC----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
+|...+.||+|+||.||+|.+.+ ...+|+|.+...........+.+|++++++++||||+++++++.+. ....
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 102 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---EGSP 102 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS---SSCC
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC---CCce
Confidence 46667899999999999998643 2368999988765555566799999999999999999999987653 2356
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 103 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 8999999999999999753 355899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |.+||..
T Consensus 179 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 235 (298)
T 3f66_A 179 YDKEYYS-VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235 (298)
T ss_dssp SCGGGCB-C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cccchhc-cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 4432111 122334567889999999999999999999999999999999 5556554
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=299.59 Aligned_cols=201 Identities=25% Similarity=0.343 Sum_probs=173.3
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCC-------hhHHHHHHHHHHHhcCCCCccceeeeeeec
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~-------~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~ 293 (466)
..++|.+.+.||+|+||.||+|... +++.||||++....... ....+.+|++++++++||||+++++++.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~- 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN- 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 4567889999999999999999864 68899999998653211 22347889999999999999999999876
Q ss_pred cCcceeEEEEEecCCCC-CHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 012297 294 RGKRAMRLLVFEFMPNG-NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 372 (466)
Q Consensus 294 ~~~~~~~~lV~ey~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~ 372 (466)
....++||||+.+| +|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 101 ---~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 101 ---QGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp ---SSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEEC
T ss_pred ---CCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEe
Confidence 45679999999777 999999754 45999999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCcccccchhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 373 DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
|||++....... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..
T Consensus 173 Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 173 DFGSAAYLERGK------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp CCTTCEECCTTC------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ecccceECCCCC------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 999998764432 2234568999999999988776 8899999999999999999999964
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=321.25 Aligned_cols=204 Identities=26% Similarity=0.403 Sum_probs=168.6
Q ss_pred CCCCcc-eecccCcEEEEEEEEc---CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 225 KFSGSN-IVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 225 ~f~~~~-~LG~G~fG~Vy~a~~~---~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++.+.+ .||+|+||.||+|.+. ++..||||+++........+.|.+|+++|++++||||+++++++.. ...
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~~~ 410 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----EAL 410 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----SSE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----CCe
Confidence 333334 7999999999999874 4667999999877655566789999999999999999999999864 246
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 411 ~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 9999999999999999754 355999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 439 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~~ 439 (466)
...... ........+++.|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 487 ~~~~~~--~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 487 GADDSY--YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp C----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCCCce--eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 433211 111222345688999999999999999999999999999998 999997543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=294.86 Aligned_cols=202 Identities=31% Similarity=0.443 Sum_probs=172.7
Q ss_pred CCcceecccCcEEEEEEEEc-----CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 227 SGSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 227 ~~~~~LG~G~fG~Vy~a~~~-----~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++.+.||+|+||.||++.+. +++.||||++...........+.+|++++++++||||+++++++.+.. ....+
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~~~ 111 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG--AASLQ 111 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--TTEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC--CceEE
Confidence 66789999999999998653 588999999987755555667999999999999999999999988643 34679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 112 lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999999975 34899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... ........+|..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 186 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 186 EGHEY--YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp TTCSE--EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred ccccc--cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 43211 11223345788899999999989999999999999999999999999753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=311.37 Aligned_cols=200 Identities=26% Similarity=0.371 Sum_probs=173.3
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~ 91 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST----PSDI 91 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEE
Confidence 46778899999999999999876 68999999986542 12334568999999999999999999999876 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 ~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 9999999999999999753 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 167 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 219 (476)
T 2y94_A 167 SDGE------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219 (476)
T ss_dssp CTTC------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccc------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence 4322 1233568999999999988765 78999999999999999999999754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=296.81 Aligned_cols=205 Identities=27% Similarity=0.441 Sum_probs=166.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcC-----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~-----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
.++|...+.||+|+||.||+|.+.. +..||||++...........|.+|++++++++||||+++++++.+ .
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~ 118 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK----Y 118 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----S
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec----C
Confidence 3456677899999999999998653 246999999876554555679999999999999999999999875 4
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcc
Confidence 4679999999999999999753 246899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 437 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~ 437 (466)
+........ ........+|+.|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 195 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 195 RVLEDDPEA--TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp ------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hhhcccccc--ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 876543211 111222346788999999999999999999999999999999 9999964
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=295.31 Aligned_cols=201 Identities=25% Similarity=0.416 Sum_probs=174.6
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
.+|.+.+.||+|+||.||++.+.+ ++.+|+|++..... ....+.+.+|+.++++++|+||+++++++.+ ....
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 116 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED----NDFV 116 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----CCeE
Confidence 567778999999999999998864 78999999875432 2344568899999999999999999999876 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 117 ~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 9999999999999998754 56899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 192 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 192 EYDGE-----RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp CSTTC-----CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccCcc-----cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 43321 223356899999999999888999999999999999999999999754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=287.29 Aligned_cols=200 Identities=29% Similarity=0.512 Sum_probs=168.3
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChh------HHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNAD------SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~------~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~ 296 (466)
++|...+.||+|+||.||+|.+. +++.||||++......... +.+.+|++++++++||||+++++++.+.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 95 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--- 95 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT---
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC---
Confidence 56777889999999999999874 6899999998765433221 5689999999999999999999988642
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-----EEE
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-----AKI 371 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~-----vkL 371 (466)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++. +||
T Consensus 96 ---~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 96 ---PRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp ---TEEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred ---CeEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEe
Confidence 169999999999999886543 46999999999999999999999885 34999999999999988776 999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCcccccchhcc--cCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM--VGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 372 ~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
+|||+++.... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 171 ~Dfg~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 171 ADFGLSQQSVH--------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp CCCTTCBCCSS--------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCCccccccc--------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 99999975432 123356899999999983 4557899999999999999999999997543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=306.36 Aligned_cols=203 Identities=26% Similarity=0.373 Sum_probs=164.2
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-------CCChhHHHHHHHHHHHhcCCCCccceeeeee
Q 012297 220 EHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-------GPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291 (466)
Q Consensus 220 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-------~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~ 291 (466)
....++|.+.+.||+|+||.||+|... +++.||||++.... .......+.+|++++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 355788999999999999999999875 47899999987532 1112224889999999999999999999975
Q ss_pred eccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---Cc
Q 012297 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LN 368 (466)
Q Consensus 292 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~---~~ 368 (466)
. ...++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.+ ..
T Consensus 211 ~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 280 (419)
T 3i6u_A 211 A-----EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCL 280 (419)
T ss_dssp S-----SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCC
T ss_pred c-----CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcce
Confidence 3 2468999999999999998754 56999999999999999999999998 9999999999999654 45
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCcccccchhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 369 vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+||+|||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 281 ~kl~DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 281 IKITDFGHSKILGETS------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp EEECCSSTTTSCC-----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred EEEeecccceecCCCc------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 9999999998764321 223457899999999885 366889999999999999999999999754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=297.05 Aligned_cols=208 Identities=27% Similarity=0.453 Sum_probs=177.4
Q ss_pred hHHHHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCC-------hhHHHHHHHHHHHhc-CCCCccce
Q 012297 216 YSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-------ADSVFLTEVDMLSRL-HHCHVVPL 286 (466)
Q Consensus 216 ~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~-------~~~~f~~Ei~~l~~l-~H~nIv~l 286 (466)
........++|.+.+.||+|+||.||+|.+. +|+.||||++....... ..+.+.+|+++++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3445666788999999999999999999986 69999999987653221 134578999999999 79999999
Q ss_pred eeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 012297 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366 (466)
Q Consensus 287 lg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~ 366 (466)
++++.. ....++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++++
T Consensus 166 ~~~~~~----~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~ 236 (365)
T 2y7j_A 166 IDSYES----SSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDN 236 (365)
T ss_dssp EEEEEB----SSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred EEEEee----CCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 999876 45679999999999999999754 46899999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhccc------CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV------GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 367 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 237 ~~ikl~DfG~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 237 MQIRLSDFGFSCHLEPGE------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp CCEEECCCTTCEECCTTC------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCEEEEecCcccccCCCc------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 999999999998765432 1234578999999998863 35788999999999999999999999653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=290.11 Aligned_cols=200 Identities=25% Similarity=0.406 Sum_probs=170.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
.++|.+.+.||+|+||.||+|... +++.||||++.... .......+.+|++++++++||||+++++++.+ ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 83 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD----ATR 83 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec----CCE
Confidence 456888899999999999999876 46789999986432 12234558899999999999999999999876 446
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++..
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecccccc
Confidence 79999999999999999764 45899999999999999999999998 99999999999999999999999998865
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 210 (279)
T 3fdn_A 159 APSS-------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210 (279)
T ss_dssp C---------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCcc-------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence 4332 123356899999999999999999999999999999999999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=292.50 Aligned_cols=206 Identities=27% Similarity=0.367 Sum_probs=166.0
Q ss_pred CCCCCc-ceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~-~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~ 300 (466)
+.|.+. +.||+|+||.||+|... +++.||||++.... ......+.+|++++.++ +||||+++++++.+ ....
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~----~~~~ 86 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE----EDRF 86 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee----CCEE
Confidence 456663 78999999999999864 68999999997653 33455689999999985 79999999999876 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEEecCCc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AKITDLGMA 377 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~---vkL~DfGla 377 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 9999999999999999764 46899999999999999999999998 999999999999988776 999999999
Q ss_pred cccccCCCCC--CCCCCCccccCcccccchhccc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 378 KRLKADGLPS--CSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 378 ~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.......... .........||+.|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 8664322111 1112223568999999999865 557889999999999999999999997543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=295.23 Aligned_cols=210 Identities=24% Similarity=0.346 Sum_probs=172.7
Q ss_pred CCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccC----cc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG----KR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~----~~ 297 (466)
++|.+.+.||+|+||.||+|.. .+++.||||++..... ......+.+|+++++.++||||+++++++..... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4678889999999999999988 4689999999866543 2334568899999999999999999999876332 13
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||++ ++|.+.+.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 45799999996 58888776533 45999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
+......... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 172 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 172 RAFSLAKNSQ-PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp EECCCCSSSS-CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccc-ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8765332211 122344578999999998876 557999999999999999999999997643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=293.34 Aligned_cols=197 Identities=28% Similarity=0.480 Sum_probs=162.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
++|++.+.||+|+||.||+|... ++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN------PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT------TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC------CcEEE
Confidence 45777889999999999999985 788999998643 345679999999999999999999998763 24899
Q ss_pred EecCCCCCHHHHhccccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-EEEEecCCccccc
Q 012297 304 FEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-AKITDLGMAKRLK 381 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~-vkL~DfGla~~~~ 381 (466)
|||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999999999975432 24789999999999999999999932223999999999999998886 7999999997653
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 158 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 158 TH--------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred cc--------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 22 12345899999999999999999999999999999999999999754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.85 Aligned_cols=212 Identities=26% Similarity=0.407 Sum_probs=156.2
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 220 EHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 220 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
....++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+.++++++||||+++++++.. ..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~ 86 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV----KD 86 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES----SS
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee----cC
Confidence 344578889999999999999999864 6889999998766544455668899999999999999999999876 34
Q ss_pred eEEEEEecCCCCCHHHHhccc------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 012297 299 MRLLVFEFMPNGNLRDCLDGV------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 372 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~------~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~ 372 (466)
..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEE
Confidence 579999999999999999642 2245899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 373 DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|||++...................||+.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 9999976644322111122334578999999998875 56899999999999999999999999754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=297.66 Aligned_cols=208 Identities=23% Similarity=0.320 Sum_probs=174.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc-CcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR-GKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~-~~~~~~ 300 (466)
.++|++.+.||+|+||.||+|... +++.||||++...........+.+|++++++++||||+++++++.... ......
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 356888899999999999999875 578899999986554445567999999999999999999999987533 223467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999996 699999865 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
...... ........||+.|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 179 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 179 DPDHDH--TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp CGGGCB--CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCCc--cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 543211 11223457899999999865 4558999999999999999999999997643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=286.29 Aligned_cols=202 Identities=27% Similarity=0.389 Sum_probs=171.5
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
|.+.+.||+|+||.||+|.+. ++..||+|.+.... .......+.+|++++++++||||+++++++..........++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 455678999999999999875 57889999987653 2334456899999999999999999999988765556778999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEEecCCcccccc
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld-~~~~vkL~DfGla~~~~~ 382 (466)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||||+|||++ +++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999764 55899999999999999999999875 3599999999999997 789999999999975432
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
. ......||+.|+|||.+. +.++.++||||||+++|||++|+.||...
T Consensus 185 ~-------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 185 S-------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp T-------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred c-------ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 2 123356899999999776 45899999999999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=284.81 Aligned_cols=199 Identities=25% Similarity=0.328 Sum_probs=169.3
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcce
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~ 298 (466)
..++|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|+..+..+ +||||+++++++.+ ..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~----~~ 84 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE----DD 84 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE----TT
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec----CC
Confidence 3467888899999999999999886 689999999986533 33455688999999999 89999999999876 44
Q ss_pred eEEEEEecCCCCCHHHHhccccc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----------
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---------- 366 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~---------- 366 (466)
..++||||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccc
Confidence 67999999999999999975432 55899999999999999999999998 9999999999999844
Q ss_pred ---------CcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 367 ---------LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 367 ---------~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
..+||+|||++...... ....||+.|+|||.+.+. .++.++||||||+++|||++|.+|+.
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSP---------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp --------CCCEEECCCTTCEETTCS---------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred ccccccCCceEEEEcccccccccCCc---------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 47999999999876432 223488999999998766 56789999999999999999998764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.34 Aligned_cols=201 Identities=25% Similarity=0.346 Sum_probs=166.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--cce
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 298 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~--~~~ 298 (466)
.++|...+.||+|+||.||+|.+. +|+.||||++..... ......+.+|++++++++||||+++++++..... ...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 356888899999999999999874 689999999865432 2234568899999999999999999999876322 123
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 459999999 8899999975 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... .....+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 177 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 177 QADSE--------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp ECCSS--------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccc--------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 75322 234568999999999877 67899999999999999999999999754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=283.85 Aligned_cols=207 Identities=20% Similarity=0.288 Sum_probs=170.9
Q ss_pred HhCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
..++|.+.+.||+|+||.||+|.. .+++.||||++....... .+.+|+++++.++|++++..++.+... ....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~e~~~l~~l~~~~~i~~~~~~~~~---~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP---QLHIESKIYKMMQGGVGIPTIRWCGAE---GDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CC---CHHHHHHHHHHHTTSTTCCCEEEEEEE---TTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccch---HHHHHHHHHHHhcCCCCCCeeeeecCC---CCce
Confidence 457899999999999999999987 568899999876553322 378999999999999988888777542 3466
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCCc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMA 377 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl---d~~~~vkL~DfGla 377 (466)
++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 9999999 999999997532 45999999999999999999999998 9999999999999 78999999999999
Q ss_pred cccccCCCCC--CCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 378 KRLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 378 ~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
+......... .........||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 8765543211 1122345678999999999999999999999999999999999999998643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=301.58 Aligned_cols=201 Identities=23% Similarity=0.343 Sum_probs=166.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcC--CCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLH--HCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~--H~nIv~llg~~~~~~~~~~~~ 300 (466)
.+|.+.+.||+|+||.||++...+++.||||++..... ......+.+|++++++++ |+||+++++++.. ....
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~----~~~~ 131 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----DQYI 131 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec----CCEE
Confidence 34778899999999999999988899999999976532 233456899999999996 5999999999876 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||| +.+++|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||+++..
T Consensus 132 ~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 99999 5689999999764 46899999999999999999999998 99999999999996 578999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhccc-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-----------GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 205 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 205 QPDTT---SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp ------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cCCCc---cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 44321 111234579999999999864 46899999999999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=294.10 Aligned_cols=210 Identities=22% Similarity=0.331 Sum_probs=176.1
Q ss_pred hHHHHHHhCCCCCc-ceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcC-CCCccceeeeee
Q 012297 216 YSALEHATDKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLH-HCHVVPLVGYCS 291 (466)
Q Consensus 216 ~~~l~~~t~~f~~~-~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~ 291 (466)
+...+...+.|.+. +.||+|+||.||+|... +++.||||++..... ......+.+|+.++..+. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34456667777777 88999999999999876 589999999876532 233456899999999995 799999999987
Q ss_pred eccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCc
Q 012297 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLN 368 (466)
Q Consensus 292 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~---~~~ 368 (466)
+ ....++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.
T Consensus 100 ~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 100 N----TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp C----SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred e----CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 6 456799999999999999997655567999999999999999999999998 999999999999987 789
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 369 vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+||+|||+++...... ......||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 173 ~kL~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHAC------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp EEECCGGGCEEC---------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEeeCccccccCCcc------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999998764332 123356899999999999999999999999999999999999999653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=291.85 Aligned_cols=203 Identities=26% Similarity=0.351 Sum_probs=164.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
.++|.+.+.||+|+||.||+|... +++.||||++...... .....+.+|+.++++++||||+++++++.. ...
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~ 108 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI----DGQ 108 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee----CCe
Confidence 467888899999999999999875 6889999998765322 223568999999999999999999999876 446
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 79999999999999999764 45899999999999999999999998 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 184 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 184 TTDEKL----TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred cccccc----ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 544321 1223356899999999999989999999999999999999999999743
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=282.59 Aligned_cols=206 Identities=20% Similarity=0.291 Sum_probs=173.9
Q ss_pred hCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ..+.+|+++++.++|+++++.++++... ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~---~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAE---GDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEE---TTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCC---CCceE
Confidence 46788899999999999999987 57899999998765432 3488999999999999988887776542 34669
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCCcc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAK 378 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl---d~~~~vkL~DfGla~ 378 (466)
+||||+ +++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||++.
T Consensus 82 lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 999999 999999997432 56999999999999999999999998 9999999999999 588999999999998
Q ss_pred ccccCCCCC--CCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 379 RLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 379 ~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
......... .........||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 765543211 1112345679999999999999999999999999999999999999998643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=287.87 Aligned_cols=203 Identities=26% Similarity=0.399 Sum_probs=168.9
Q ss_pred CCCcceecccCcEEEEEEEEcC-C---cEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLTD-G---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~~-~---~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
|...++||+|+||.||+|.+.+ + ..+|+|.+.........+.|.+|+.++++++||||+++++++.+.. ...+
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~ 99 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE---GLPH 99 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS---SCCE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC---CCcE
Confidence 4455789999999999998643 2 3799999987655555567999999999999999999999987532 2348
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+.+|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 100 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999999763 356899999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
...... ........+++.|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 176 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~ 229 (298)
T 3pls_A 176 DREYYS-VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229 (298)
T ss_dssp TGGGGC-SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred CCcccc-cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC
Confidence 332111 122334567889999999999999999999999999999999666554
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=293.94 Aligned_cols=202 Identities=28% Similarity=0.448 Sum_probs=167.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCC-hhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|.+.+.||+|+||.||+|.... ++.||||++....... ....+.+|++++++++||||+++++++.+ ....+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 100 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK----KKRWY 100 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec----CCEEE
Confidence 467888999999999999998864 8999999987654332 34458899999999999999999999876 45679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 101 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp EEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 999999999998887543 45899999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.... ......|++.|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 176 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 176 APGE-----VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp -------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCcc-----ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3321 12334688999999998775 68999999999999999999999997543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=286.82 Aligned_cols=199 Identities=25% Similarity=0.390 Sum_probs=172.4
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+.+.||+|+||.||+|... +++.||||++.... .......+.+|++++++++||||+++++++.+ ....
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 89 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD----RKRI 89 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc----CCEE
Confidence 45778899999999999999876 57889999986432 12234568999999999999999999999876 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999999999764 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 165 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 165 PSL-------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp SSS-------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccc-------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 332 122356899999999999989999999999999999999999999754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=289.20 Aligned_cols=202 Identities=30% Similarity=0.488 Sum_probs=160.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|++.+.||+|+||.||+|.+. ..||||+++.... ....+.|.+|++++++++|+||+++++++.. ...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 95 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-----PQLA 95 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----SSCE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC-----CccE
Confidence 466888899999999999999864 3599999976543 2334569999999999999999999997643 2458
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 96 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999996543 55899999999999999999999998 9999999999999999999999999997654
Q ss_pred cCCCCCCCCCCCccccCcccccchhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... ........||+.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 172 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 172 RWSG---SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccc---cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 3211 11223456899999999886 667899999999999999999999999754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=291.59 Aligned_cols=207 Identities=27% Similarity=0.417 Sum_probs=168.4
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhc--CCCCccceeeeeeeccCc
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL--HHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l--~H~nIv~llg~~~~~~~~ 296 (466)
-....++|++.+.||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +|+||+++++++.+....
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3445578999999999999999999985 899999998643 233456667766655 899999999998875544
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeEecCCCCCCEEEcCCCc
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA--------AAPRILHRDIKSSNILLDENLN 368 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~--------~~~~ivHrDLk~~NILld~~~~ 368 (466)
....++||||+++|+|.++++. ..+++..++.++.|++.||+|||+. + |+||||||+|||++.++.
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSC
T ss_pred CCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCC
Confidence 4678999999999999999965 3589999999999999999999988 6 999999999999999999
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCch------hHHHHHHHHHHHHHcC----------C
Q 012297 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLM------SDVFSFGVVLLELITG----------R 432 (466)
Q Consensus 369 vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~------sDv~S~Gvll~elltG----------~ 432 (466)
+||+|||+++......... ........||+.|+|||.+.....+.+ +||||||+++|||+|| +
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEV-DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp EEECCCTTCEECC----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EEEEeCCCceeeccccccc-cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 9999999997764432211 111234578999999999987766554 9999999999999999 7
Q ss_pred CCCCC
Q 012297 433 QPIHR 437 (466)
Q Consensus 433 ~Pf~~ 437 (466)
.||..
T Consensus 260 ~p~~~ 264 (337)
T 3mdy_A 260 LPYHD 264 (337)
T ss_dssp CTTTT
T ss_pred ccHhh
Confidence 77764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=297.93 Aligned_cols=205 Identities=24% Similarity=0.341 Sum_probs=167.1
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc---
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--- 294 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~--- 294 (466)
++...++|.+.+.||+|+||.||+|.+ .+++.||||++...... ..+|+++++.++|+||+++++++....
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 345677899999999999999999987 46899999998765322 347999999999999999999986532
Q ss_pred -------------------------------CcceeEEEEEecCCCCCHHHHhcc--cccCCCCHHHHHHHHHHHHHHHH
Q 012297 295 -------------------------------GKRAMRLLVFEFMPNGNLRDCLDG--VLVEGMNWDTRVAIAIGAARGLE 341 (466)
Q Consensus 295 -------------------------------~~~~~~~lV~ey~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qia~~L~ 341 (466)
......++||||++ |+|.+.+.. .....+++..+..++.|+++||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 22334789999997 688887754 22356999999999999999999
Q ss_pred HHHhCCCCCeEecCCCCCCEEEc-CCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHH
Q 012297 342 YLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVF 419 (466)
Q Consensus 342 ~LH~~~~~~ivHrDLk~~NILld-~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~ 419 (466)
|||+.+ |+||||||+|||++ +++.+||+|||+++...... ......+|..|+|||.+.+. .++.++|||
T Consensus 156 ~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 156 FIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE------PSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC------CCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 999998 99999999999998 68899999999998764432 12334678999999988765 489999999
Q ss_pred HHHHHHHHHHcCCCCCCCC
Q 012297 420 SFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 420 S~Gvll~elltG~~Pf~~~ 438 (466)
|||+++|||++|+.||...
T Consensus 227 slG~il~ell~g~~pf~~~ 245 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGE 245 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCS
T ss_pred hHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=298.29 Aligned_cols=203 Identities=25% Similarity=0.257 Sum_probs=173.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC--------CCCccceeeeeeec
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH--------HCHVVPLVGYCSEF 293 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~--------H~nIv~llg~~~~~ 293 (466)
.++|.+.+.||+|+||.||+|... +++.||||++... ......+.+|+++++.++ |+||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 367888999999999999999864 5889999998743 234456889999999985 78899999998755
Q ss_pred cCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCC-----
Q 012297 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENL----- 367 (466)
Q Consensus 294 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~-~~~~ivHrDLk~~NILld~~~----- 367 (466)
.......++||||+ +++|.+++.......+++..++.++.|++.||+|||+. + |+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 44566789999999 67777777655446699999999999999999999998 8 99999999999998775
Q ss_pred --------------------------------------------cEEEEecCCccccccCCCCCCCCCCCccccCccccc
Q 012297 368 --------------------------------------------NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403 (466)
Q Consensus 368 --------------------------------------------~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~a 403 (466)
.+||+|||+++..... .....||+.|+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--------~~~~~gt~~y~a 261 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--------FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--------SCSCCSCGGGCC
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--------CccCCCCCcccC
Confidence 7999999999876432 233468999999
Q ss_pred chhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 404 PE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
||.+.+..++.++||||||+++|||++|+.||....
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 999999999999999999999999999999997544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=293.61 Aligned_cols=202 Identities=29% Similarity=0.492 Sum_probs=167.4
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcE--EEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRI--VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~--vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~ 299 (466)
++|...+.||+|+||.||+|.+. ++.. ++||.+...........+.+|+++++++ +||||+++++++.+ ...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----~~~ 100 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGY 100 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----TTE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee----CCc
Confidence 46778899999999999999865 4554 5999988665555556799999999999 89999999999876 446
Q ss_pred EEEEEecCCCCCHHHHhcccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 012297 300 RLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~ 365 (466)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 177 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcC
Confidence 799999999999999997542 246899999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 366 ~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
++.+||+|||+++...... ......+++.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 245 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYV------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245 (327)
T ss_dssp GGCEEECCTTCEESSCEEC------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCeEEEcccCcCccccccc------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999987543221 1223356788999999988889999999999999999998 99999643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=297.81 Aligned_cols=203 Identities=18% Similarity=0.270 Sum_probs=170.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcC---------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccc---------
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD---------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP--------- 285 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~---------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~--------- 285 (466)
++|.+.+.||+|+||.||+|.... ++.||||++... ..+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 567788999999999999998764 789999998754 23889999999999999988
Q ss_pred ------eeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 012297 286 ------LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359 (466)
Q Consensus 286 ------llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~ 359 (466)
+++++.. .....++||||+ +++|.+++.......+++.+++.++.|++.||+|||+.+ |+||||||+
T Consensus 116 ~~~i~~~~~~~~~---~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~ 188 (352)
T 2jii_A 116 LLAIPTCMGFGVH---QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAE 188 (352)
T ss_dssp TCSCCCCCEEEEE---TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGG
T ss_pred ccCccchhhcccc---CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHH
Confidence 4555543 134679999999 999999998654467999999999999999999999998 999999999
Q ss_pred CEEEcCCC--cEEEEecCCccccccCCCCC--CCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 012297 360 NILLDENL--NAKITDLGMAKRLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435 (466)
Q Consensus 360 NILld~~~--~vkL~DfGla~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf 435 (466)
|||++.++ .+||+|||+++......... .........||+.|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 89999999998765433211 111223457899999999999999999999999999999999999999
Q ss_pred CCCC
Q 012297 436 HRSI 439 (466)
Q Consensus 436 ~~~~ 439 (466)
....
T Consensus 269 ~~~~ 272 (352)
T 2jii_A 269 TNCL 272 (352)
T ss_dssp GGGT
T ss_pred ccCC
Confidence 8654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=291.57 Aligned_cols=216 Identities=24% Similarity=0.370 Sum_probs=166.4
Q ss_pred HHHHHHhCCCCCcceecccCcEEEEEEEEcC----CcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeee
Q 012297 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291 (466)
Q Consensus 217 ~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~----~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~ 291 (466)
.++....++|.+.+.||+|+||.||+|.+.. ++.||||++..... ....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3444556778888999999999999997642 45899999976543 233456899999999999999999999987
Q ss_pred eccCc-ceeEEEEEecCCCCCHHHHhccc----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 012297 292 EFRGK-RAMRLLVFEFMPNGNLRDCLDGV----LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366 (466)
Q Consensus 292 ~~~~~-~~~~~lV~ey~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~ 366 (466)
+.... ....++||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++++
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 64322 12459999999999999998432 2345899999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 367 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+.+||+|||+++........ .......+++.|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 253 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYY---RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253 (313)
T ss_dssp SCEEECSCSCC-------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CcEEEeecCcceeccccccc---CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 99999999999876443211 12233456789999999999999999999999999999999 89998754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=288.00 Aligned_cols=198 Identities=29% Similarity=0.446 Sum_probs=164.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.++|+..+.||+|+||.||++... ++.||||+++... ..+.|.+|++++++++||||+++++++.+. ....++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC-----CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC---CCceEE
Confidence 356788899999999999999884 8899999987543 345689999999999999999999987652 235699
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 999999999999997654344899999999999999999999998 99999999999999999999999999876533
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
. .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 170 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 218 (278)
T 1byg_A 170 T--------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218 (278)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred c--------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 122356788999999999999999999999999999998 99999754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=287.45 Aligned_cols=202 Identities=26% Similarity=0.406 Sum_probs=169.6
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
...++|++.+.||+|+||.||+|... +++.||||.+.... ....+.+|++++++++||||+++++++.. ...
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 98 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFK----NTD 98 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEe----CCE
Confidence 44567888999999999999999886 48999999997653 23458999999999999999999999876 446
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 79999999999999999743 356899999999999999999999998 99999999999999999999999999977
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... .......|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 175 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 175 LTDTM-----AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp CBTTB-----SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred hhhhc-----cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 64321 1123346889999999999989999999999999999999999999753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=288.50 Aligned_cols=209 Identities=22% Similarity=0.333 Sum_probs=171.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
.++|++.+.||+|+||.||++... +++.||+|.+..... ....+.+.+|++++++++||||+++++++.+.. ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT--NTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG--GTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC--CceE
Confidence 356788899999999999999875 689999999976543 234456899999999999999999999886532 3467
Q ss_pred EEEEecCCCCCHHHHhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 012297 301 LLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAA--APRILHRDIKSSNILLDENLNAKITDLGM 376 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~~L~~LH~~~--~~~ivHrDLk~~NILld~~~~vkL~DfGl 376 (466)
++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999999999999997532 234899999999999999999999976 23499999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
++...... .......|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 163 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 163 ARILNHDT-----SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp HHHC---C-----HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred heeecccc-----ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 97654321 0112346889999999999989999999999999999999999999754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=287.54 Aligned_cols=203 Identities=25% Similarity=0.364 Sum_probs=162.2
Q ss_pred CCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+.+.||+|+||.||+|.. .+++.||||++.... .......+.+|++++++++|+||+++++++.+ ....
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~ 107 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE----DNEL 107 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCcE
Confidence 4578889999999999999987 468999999997643 23344568999999999999999999999886 4467
Q ss_pred EEEEecCCCCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 301 LLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 9999999999999999642 2345899999999999999999999998 9999999999999999999999999988
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... .......|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 185 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 185 FFSSKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp -------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred eecCCC-----ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 654322 1123356889999999999999999999999999999999999999653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=294.28 Aligned_cols=204 Identities=29% Similarity=0.467 Sum_probs=162.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHH--HhcCCCCccceeeeeeecc-Cccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDML--SRLHHCHVVPLVGYCSEFR-GKRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l--~~l~H~nIv~llg~~~~~~-~~~~~ 299 (466)
.++|.+.+.||+|+||.||+|+. +++.||||++... ....+..|.+++ ..++|+||+++++.+.... .....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 35678889999999999999987 6899999998743 233455555554 4579999999998765422 23446
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEecCCCCCCEEEcCCCcEE
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA---------AAPRILHRDIKSSNILLDENLNAK 370 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~---------~~~~ivHrDLk~~NILld~~~~vk 370 (466)
.++||||+++|+|.+++... ..++..++.++.|++.||+|||+. + |+||||||+|||++.++.+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 68999999999999999653 458999999999999999999998 7 99999999999999999999
Q ss_pred EEecCCccccccCCCCC---CCCCCCccccCcccccchhccc-------CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 371 ITDLGMAKRLKADGLPS---CSSSPARMQGTFGYFAPEYAMV-------GRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 371 L~DfGla~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
|+|||+++......... .........||+.|+|||.+.+ ..++.++||||||+++|||++|..||..
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 99999998765432211 1112234569999999999876 3567789999999999999999877653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=294.23 Aligned_cols=204 Identities=27% Similarity=0.390 Sum_probs=165.1
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCC----hhHHHHHHHHHHHhcCCCCccceeeeeeeccC
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 295 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~----~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~ 295 (466)
...++|...+.||+|+||.||+|.+. +++.||||++....... ....+.+|++++++++||||+++++++.+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 83 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--- 83 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC---
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee---
Confidence 34577899999999999999999875 58999999997543221 22458899999999999999999999875
Q ss_pred cceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 012297 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (466)
Q Consensus 296 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfG 375 (466)
....++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 84 -~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 84 -KSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp -TTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCG
T ss_pred -CCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecc
Confidence 3456999999975 8999887532 45889999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+++...... .......||+.|+|||.+.+. .++.++||||||+++|||++|.+||...
T Consensus 158 ~a~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 158 LAKSFGSPN-----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp GGSTTTSCC-----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cceeccCCc-----ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 998764322 123345689999999998754 5899999999999999999999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=287.85 Aligned_cols=199 Identities=27% Similarity=0.382 Sum_probs=170.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|.+.+.||+|+||.||++... +++.||+|.+..... .....+.+|++++++++||||+++++++.+ ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYES----TTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEEC----SSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhccc----CCEEE
Confidence 456788899999999999999875 689999999986532 233458899999999999999999999876 44679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCCcc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAK 378 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl---d~~~~vkL~DfGla~ 378 (466)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ ++++.+||+|||++.
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 83 LVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp EEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 999999999999999754 45899999999999999999999998 9999999999999 788999999999987
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 158 MEQNG-------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp CCCCB-------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ecCCC-------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 54321 123356899999999999999999999999999999999999999653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=294.27 Aligned_cols=206 Identities=27% Similarity=0.389 Sum_probs=169.6
Q ss_pred hCCCCCcceecccCcEEEEEEEE------cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~------~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~ 296 (466)
.++|.+.+.||+|+||.||+|.+ .+++.||||++...........+.+|+.++++++||||+++++++.+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC----
Confidence 45688889999999999999984 24678999999766555556679999999999999999999999876
Q ss_pred ceeEEEEEecCCCCCHHHHhccccc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCc
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLV-----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLN 368 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~---~~~ 368 (466)
....++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++. +..
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcce
Confidence 3345999999999999999976432 34899999999999999999999998 999999999999984 456
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 369 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 369 vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+||+|||++........ ........+++.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 182 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASY---YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp EEECCCHHHHHHHC---------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEECccccccccccccc---cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 99999999986543321 112234567889999999999999999999999999999998 99999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=301.18 Aligned_cols=208 Identities=22% Similarity=0.289 Sum_probs=167.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccC-ccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~-~~~~ 299 (466)
.++|.+.+.||+|+||.||+|.+. +++.||||++..... ....+.+.+|++++++++|+||+++++++..... ....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467888899999999999999875 478999999976432 2334568999999999999999999999875321 1246
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||++ ++|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 799999985 6999999753 56999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCC-----------------CCCCCCccccCcccccchhc-ccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 380 LKADGLPS-----------------CSSSPARMQGTFGYFAPEYA-MVGRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 380 ~~~~~~~~-----------------~~~~~~~~~gt~~y~aPE~~-~~~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
........ .........||+.|+|||.+ ....++.++||||||+++|||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 65432110 00122456789999999986 56679999999999999999998666554
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=301.05 Aligned_cols=199 Identities=22% Similarity=0.286 Sum_probs=171.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc------CCCCccceeeeeeeccC
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL------HHCHVVPLVGYCSEFRG 295 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l------~H~nIv~llg~~~~~~~ 295 (466)
..+|.+.+.||+|+||.||+|... +++.||||++... ......+.+|+++++.+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE---
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc---
Confidence 456888899999999999999876 4889999999754 23345578899888887 57799999999876
Q ss_pred cceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--EEEEe
Q 012297 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN--AKITD 373 (466)
Q Consensus 296 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~--vkL~D 373 (466)
....++||||++ ++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 171 -~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 171 -RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp -TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECC
T ss_pred -CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEee
Confidence 456799999995 79999998766567999999999999999999999998 999999999999999987 99999
Q ss_pred cCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 374 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 374 fGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 246 FG~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 246 FGSSCYEHQR--------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CTTCEETTCC--------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccceecCCc--------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999764322 223568999999999999999999999999999999999999997643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=283.92 Aligned_cols=200 Identities=25% Similarity=0.353 Sum_probs=165.4
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.+++.++||||+++++++.+ ....
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 86 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST----PTDF 86 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec----CCeE
Confidence 56788899999999999999986 68999999986542 22334568999999999999999999999876 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++...
T Consensus 87 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999999754 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 162 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 162 SDGE------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp CC-------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCc------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 4322 1223468899999999987765 68999999999999999999999753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=294.12 Aligned_cols=201 Identities=22% Similarity=0.336 Sum_probs=162.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
.++|.+.+.||+|+||.||+|... +++.||||++...... .....+.+|++++++++||||+++++++.+ ....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 108 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH----NHRL 108 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE----TTEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec----CCEE
Confidence 456888899999999999999865 6889999999765432 233457899999999999999999999876 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-----cCCCcEEEEecC
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL-----DENLNAKITDLG 375 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl-----d~~~~vkL~DfG 375 (466)
++||||++ |+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||
T Consensus 109 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99999996 5999999764 45899999999999999999999998 9999999999999 455569999999
Q ss_pred CccccccCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+++...... .......||+.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 183 ~a~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 183 LARAFGIPI-----RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp HHHHHC----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CccccCCcc-----cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 998764321 122334679999999998774 4899999999999999999999999754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=289.37 Aligned_cols=208 Identities=28% Similarity=0.433 Sum_probs=174.1
Q ss_pred HHhCCCCCcceecccCcEEEEEEEE--cCCcEEEEEEcccCCC-CChhHHHHHHHHHHHhc---CCCCccceeeeeeecc
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQL--TDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFR 294 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~--~~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l---~H~nIv~llg~~~~~~ 294 (466)
.+.++|.+.+.||+|+||.||+|.. .+++.||||++..... ......+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457889999999999999999998 4688999999875432 12223467888887776 8999999999986322
Q ss_pred -CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 012297 295 -GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 373 (466)
Q Consensus 295 -~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~D 373 (466)
......++||||++ |+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 23557799999997 69999998765556999999999999999999999998 99999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 374 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 374 fGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
||+++...... ......||..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 164 fg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 164 FGLARIYSFQM------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp CCSCCCCCGGG------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CcccccccCCC------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99997654321 122356889999999999999999999999999999999999999754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=293.85 Aligned_cols=205 Identities=30% Similarity=0.400 Sum_probs=173.8
Q ss_pred CCCCCcceecccCcEEEEEEEE-----cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~-----~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
++|+..+.||+|+||.||++++ .+++.||||++.... ....+.+.+|++++++++|+||+++++++.... ..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~ 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG--RQ 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--SC
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC--Cc
Confidence 4577788999999999999984 358899999987652 334456899999999999999999999886422 44
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred eEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 6799999999999999997643 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
........ ........+|..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 176 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 176 LLPLDKDY--YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp ECCTTCSE--EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ecccCCcc--ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 76433211 1122334578889999999998999999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=289.71 Aligned_cols=204 Identities=26% Similarity=0.415 Sum_probs=167.7
Q ss_pred hCCCCCcc-eecccCcEEEEEEEEc---CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 223 TDKFSGSN-IVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 223 t~~f~~~~-~LG~G~fG~Vy~a~~~---~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
.++|.+.+ .||+|+||.||+|.+. +++.||||++...... ...+.+.+|+++++.++||||+++++++. .
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 89 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----A 89 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----S
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-----C
Confidence 34566666 8999999999999653 3678999999865433 23566999999999999999999999983 2
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 3568999999999999999764 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
......... ........+++.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 165 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 224 (291)
T 1xbb_A 165 KALRADENY--YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224 (291)
T ss_dssp EECCTTCSE--EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred eeeccCCCc--ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 876443211 111222346788999999988889999999999999999999 99999753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=292.40 Aligned_cols=209 Identities=23% Similarity=0.350 Sum_probs=172.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc-CcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR-GKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~-~~~~~~ 300 (466)
.++|.+.+.||+|+||.||+|... +++.||||++...........+.+|++++++++||||+++++++.... ......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888899999999999999876 588999999976544445566889999999999999999999876521 223567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999996 699999875 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCC-----CCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSC-----SSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
........ ........||+.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 54321110 011223578999999998764 77899999999999999999999999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=305.46 Aligned_cols=201 Identities=26% Similarity=0.340 Sum_probs=169.9
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC------------ChhHHHHHHHHHHHhcCCCCccceee
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP------------NADSVFLTEVDMLSRLHHCHVVPLVG 288 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~------------~~~~~f~~Ei~~l~~l~H~nIv~llg 288 (466)
..++|.+.+.||+|+||.||+|... +++.||||++...... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3567888999999999999999876 4789999998765321 33456899999999999999999999
Q ss_pred eeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-
Q 012297 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL- 367 (466)
Q Consensus 289 ~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~- 367 (466)
++.+ ....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 114 ~~~~----~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 114 VFED----KKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNS 184 (504)
T ss_dssp EEEC----SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTC
T ss_pred EEEc----CCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCC
Confidence 9876 45679999999999999999754 56999999999999999999999998 99999999999998776
Q ss_pred --cEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 368 --NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 368 --~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.+||+|||++....... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||...
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 250 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDY------KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ 250 (504)
T ss_dssp CSSEEECCCTTCEECCTTS------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CccEEEEECCCCEEcCCCC------ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 69999999998764432 123356899999999876 56899999999999999999999999754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=292.88 Aligned_cols=211 Identities=28% Similarity=0.381 Sum_probs=171.7
Q ss_pred hCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|.+.+.||+|+||.||++.. .+++.||||++... .......+.+|++++++++||||+++++++..........+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 35678889999999999999987 56899999998654 23345568999999999999999999999986555566789
Q ss_pred EEEecCCCCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 302 LVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
+||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999999753 2355899999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCCCCC----CCCCCccccCcccccchhcccCC---CCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 380 LKADGLPSC----SSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 380 ~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
......... ........||+.|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 432110000 00011234689999999987554 68899999999999999999999964
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=288.53 Aligned_cols=195 Identities=25% Similarity=0.378 Sum_probs=165.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-C-------cEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-G-------RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 295 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-~-------~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~ 295 (466)
++|...+.||+|+||.||+|.+.. + ..||+|++.... ....+.|.+|++++++++||||+++++++.+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 83 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVC--- 83 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC---
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe---
Confidence 467778999999999999997653 2 579999986543 3445669999999999999999999999876
Q ss_pred cceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-------
Q 012297 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN------- 368 (466)
Q Consensus 296 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~------- 368 (466)
....++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 84 -~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 84 -GDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp -TTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred -CCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccc
Confidence 335589999999999999997642 34899999999999999999999998 999999999999998887
Q ss_pred -EEEEecCCccccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 369 -AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 369 -vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
+||+|||++..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|..|+.
T Consensus 159 ~~kl~Dfg~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~ 219 (289)
T 4fvq_A 159 FIKLSDPGISITVLP---------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219 (289)
T ss_dssp EEEECCCCSCTTTSC---------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eeeeccCcccccccC---------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence 99999999865422 123457889999999887 778999999999999999999655543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=295.43 Aligned_cols=202 Identities=20% Similarity=0.327 Sum_probs=173.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCCh----------------hHHHHHHHHHHHhcCCCCccce
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA----------------DSVFLTEVDMLSRLHHCHVVPL 286 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~----------------~~~f~~Ei~~l~~l~H~nIv~l 286 (466)
.++|.+.+.||+|+||.||+|.. +++.||||++........ ...|.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46788889999999999999999 899999999875422111 1679999999999999999999
Q ss_pred eeeeeeccCcceeEEEEEecCCCCCHHHH------hcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCC
Q 012297 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDC------LDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSS 359 (466)
Q Consensus 287 lg~~~~~~~~~~~~~lV~ey~~~gsL~~~------l~~~~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivHrDLk~~ 359 (466)
++++.+ ....++||||+++++|.++ +.......+++..++.++.|++.||.|||+ .+ ++||||||+
T Consensus 109 ~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~ 181 (348)
T 2pml_X 109 EGIITN----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPS 181 (348)
T ss_dssp SEEEES----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGG
T ss_pred EEEEee----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChH
Confidence 999876 4467999999999999999 655435679999999999999999999999 88 999999999
Q ss_pred CEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccC-CCCc-hhHHHHHHHHHHHHHcCCCCCCC
Q 012297 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASL-MSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 360 NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
|||++.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||..
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK-------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT-------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hEEEcCCCcEEEeccccccccccc-------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999875432 12334688999999999877 5666 99999999999999999999975
Q ss_pred CC
Q 012297 438 SI 439 (466)
Q Consensus 438 ~~ 439 (466)
..
T Consensus 255 ~~ 256 (348)
T 2pml_X 255 KI 256 (348)
T ss_dssp SS
T ss_pred CC
Confidence 43
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=282.58 Aligned_cols=201 Identities=27% Similarity=0.426 Sum_probs=167.5
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
+|....+||+|+||.||+|... +++.||||.+.... ......+.+|+.+++.++||||+++++++.+ ....++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE----NGFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEE----TTEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe----CCcEEEE
Confidence 3555668999999999999874 57899999987653 3344568999999999999999999999876 4467999
Q ss_pred EecCCCCCHHHHhcccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEEecCCccccc
Q 012297 304 FEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRLK 381 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~-~~~vkL~DfGla~~~~ 381 (466)
|||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+|||++. ++.+||+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 99999999999997642 234678999999999999999999998 999999999999987 8999999999998754
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCC--CCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .......|++.|+|||.+.... ++.++||||||+++|||++|+.||...
T Consensus 175 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 175 GIN-----PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp C----------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred CCC-----CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 321 1123456899999999987643 899999999999999999999999743
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=299.57 Aligned_cols=199 Identities=26% Similarity=0.373 Sum_probs=164.0
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--cceeEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAMRL 301 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~--~~~~~~ 301 (466)
+|...+.||+|+||.||+|++. +++.||||++...... +.+|++++++++|+||+++++++..... .....+
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-----HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4677789999999999999985 5899999998754321 3479999999999999999999865332 234467
Q ss_pred EEEecCCCCCHHHHhcc--cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEEecCCcc
Q 012297 302 LVFEFMPNGNLRDCLDG--VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAK 378 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~-~~vkL~DfGla~ 378 (466)
+||||+++ +|.+.+.. .....+++..+..++.|+++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 67666643 22356999999999999999999999998 9999999999999965 568999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 206 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 206 QLVRGE------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp ECCTTC------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hcccCC------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 764322 12335689999999998764 7899999999999999999999999754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=305.86 Aligned_cols=200 Identities=26% Similarity=0.370 Sum_probs=167.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
.+.|...+.||+|+||.||+|... ++..||||++.... .......+.+|+++++.++||||+++++++.+ ....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~ 111 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED----KRNY 111 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----CCEE
Confidence 456888899999999999999886 58899999987653 23335568999999999999999999999876 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEecCCc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKITDLGMA 377 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~---~~vkL~DfGla 377 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||++
T Consensus 112 ~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999999998754 55899999999999999999999998 9999999999999764 55999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
....... ......||+.|+|||++. ..++.++||||||+++|||++|+.||...
T Consensus 187 ~~~~~~~------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 240 (494)
T 3lij_A 187 AVFENQK------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ 240 (494)
T ss_dssp EECBTTB------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eECCCCc------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 8764321 123356899999999876 56899999999999999999999999754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=307.73 Aligned_cols=200 Identities=27% Similarity=0.419 Sum_probs=173.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
.++|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++.+ ...
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~ 100 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED----KGY 100 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----CCE
Confidence 456888899999999999999886 689999999865532 3445669999999999999999999999876 457
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCC
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGM 376 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl---d~~~~vkL~DfGl 376 (466)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 79999999999999999754 56899999999999999999999998 9999999999999 5678999999999
Q ss_pred ccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
++...... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...
T Consensus 176 a~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 230 (484)
T 3nyv_A 176 STHFEASK------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA 230 (484)
T ss_dssp HHHBCCCC------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eEEccccc------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC
Confidence 98764321 1233568999999998865 6899999999999999999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=293.95 Aligned_cols=202 Identities=21% Similarity=0.278 Sum_probs=163.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeecc--Ccce
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRA 298 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~--~~~~ 298 (466)
.++|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|+.+++.++||||+++++++.... ....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367888899999999999999875 588999999976432 233456889999999999999999999987533 1223
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||++ ++|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 6799999996 58888885 34899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 176 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 176 TAGTSF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp --------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccc------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 654321 123357899999999999999999999999999999999999999754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=306.31 Aligned_cols=200 Identities=26% Similarity=0.376 Sum_probs=170.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
.++|.+.+.||+|+||.||+|... +++.||||++.... .......+.+|++++++++||||+++++++.+ ....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~ 96 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED----SSSF 96 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc----CCEE
Confidence 356888899999999999999875 68999999986432 22334568999999999999999999999876 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEEecCCc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMA 377 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld---~~~~vkL~DfGla 377 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||++
T Consensus 97 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999999998754 46899999999999999999999998 99999999999995 5567999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+...... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||...
T Consensus 172 ~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 225 (486)
T 3mwu_A 172 TCFQQNT------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (486)
T ss_dssp TTBCCC----------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eECCCCC------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 8654321 1233568999999998865 5999999999999999999999999754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=285.25 Aligned_cols=195 Identities=21% Similarity=0.311 Sum_probs=168.4
Q ss_pred CCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|++.+.||+|+||.||+|.. .+++.||||+++.. ....+.+|++++++++ |+||+++++++.+.. ....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~--~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPV--SRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT--TCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC--CCceE
Confidence 5678889999999999999986 46899999998743 2456899999999997 999999999987632 34679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRL 380 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~-~vkL~DfGla~~~ 380 (466)
+||||+++++|.+++.. +++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 110 lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999998853 789999999999999999999998 99999999999999776 8999999999866
Q ss_pred ccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 182 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 182 HPGQ------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp CTTC------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCCC------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 4432 1233468899999999877 67899999999999999999999999654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=305.37 Aligned_cols=204 Identities=17% Similarity=0.210 Sum_probs=161.8
Q ss_pred HhCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCC--CCChhHHHHHHHH---HHHhcCCCCcccee-------e
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQG--GPNADSVFLTEVD---MLSRLHHCHVVPLV-------G 288 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~--~~~~~~~f~~Ei~---~l~~l~H~nIv~ll-------g 288 (466)
..++|.+.+.||+|+||.||+|.+ .+++.||||++.... .....+.|.+|++ .+++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 345677889999999999999986 468999999997542 3345567899994 55566899999998 4
Q ss_pred eeeeccC--------cc-----eeEEEEEecCCCCCHHHHhcccccC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 012297 289 YCSEFRG--------KR-----AMRLLVFEFMPNGNLRDCLDGVLVE-----GMNWDTRVAIAIGAARGLEYLHEAAAPR 350 (466)
Q Consensus 289 ~~~~~~~--------~~-----~~~~lV~ey~~~gsL~~~l~~~~~~-----~~~~~~~~~i~~qia~~L~~LH~~~~~~ 350 (466)
++.+... .. ...++||||+ +|+|.+++.....- .+++..++.++.|++.||+|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4443211 00 1368999999 68999999754211 1335888899999999999999998
Q ss_pred eEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccC-----------CCCchhHHH
Q 012297 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-----------RASLMSDVF 419 (466)
Q Consensus 351 ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDv~ 419 (466)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||.+... .++.++|||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC--------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC--------cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 99999999999999999999999999986322 1223456 899999999877 899999999
Q ss_pred HHHHHHHHHHcCCCCCCCC
Q 012297 420 SFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 420 S~Gvll~elltG~~Pf~~~ 438 (466)
|||+++|||++|+.||...
T Consensus 298 SlG~il~elltg~~Pf~~~ 316 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKD 316 (377)
T ss_dssp HHHHHHHHHHHSSCCC---
T ss_pred HHHHHHHHHHHCCCCCccc
Confidence 9999999999999999653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=316.61 Aligned_cols=197 Identities=28% Similarity=0.447 Sum_probs=164.1
Q ss_pred ceecccCcEEEEEEEEc---CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~---~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|+||.||+|.+. .++.||||+++.... ....+.|.+|++++++++||||+++++++.. ...++|||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~~~lv~E 449 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----ESWMLVME 449 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-----SSEEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCEEEEEE
Confidence 47999999999999663 457899999976532 3345679999999999999999999999853 23689999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 450 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 450 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred ccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 99999999999753 56899999999999999999999998 99999999999999999999999999987654321
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
. ........+|+.|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 525 ~--~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 576 (635)
T 4fl3_A 525 Y--YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred c--cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 112223456788999999999999999999999999999998 99999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=287.46 Aligned_cols=199 Identities=23% Similarity=0.295 Sum_probs=170.7
Q ss_pred hCCCCCcceecccCcEEEEEEEE--cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCC------ccceeeeeeecc
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL--TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH------VVPLVGYCSEFR 294 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~--~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~llg~~~~~~ 294 (466)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.. ......+.+|+++++.++|+| ++++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~-- 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH-- 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE--
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc--
Confidence 35788889999999999999987 36889999998753 233456889999999987654 8999998876
Q ss_pred CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---------
Q 012297 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--------- 365 (466)
Q Consensus 295 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~--------- 365 (466)
....++||||+ +++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 89 --~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 89 --HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC-
T ss_pred --CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCC
Confidence 44779999999 899999998765557899999999999999999999998 999999999999987
Q ss_pred ----------CCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 012297 366 ----------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435 (466)
Q Consensus 366 ----------~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf 435 (466)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH--------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC--------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccCCCceEeeCcccccCccc--------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 668999999999764321 23456899999999999999999999999999999999999999
Q ss_pred CCCC
Q 012297 436 HRSI 439 (466)
Q Consensus 436 ~~~~ 439 (466)
....
T Consensus 235 ~~~~ 238 (339)
T 1z57_A 235 PTHD 238 (339)
T ss_dssp CCSC
T ss_pred CCCC
Confidence 7543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=283.07 Aligned_cols=208 Identities=27% Similarity=0.353 Sum_probs=171.7
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC---CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
..++|.+.+.||+|+||.||++... +++.||+|++.... .......+.+|++++++++|+||+++++++.... .
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~ 80 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE--K 80 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC----
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC--C
Confidence 3478999999999999999999875 57899999987542 2345567999999999999999999999985422 3
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||++++ |.+++.......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence 4679999999766 888887655567999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCC--CchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
......... .......|++.|+|||.+.+... +.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 157 EALHPFAAD---DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp EECCTTCSS---CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCccccc---cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 876432211 11223468999999999876443 78999999999999999999999753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=289.41 Aligned_cols=209 Identities=27% Similarity=0.401 Sum_probs=174.1
Q ss_pred HHHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHh--cCCCCccceeeeeeeccC
Q 012297 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR--LHHCHVVPLVGYCSEFRG 295 (466)
Q Consensus 218 ~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~llg~~~~~~~ 295 (466)
.-....++|.+.+.||+|+||.||+|+. +++.||||++... ....+.+|++++.. ++||||+++++++.....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 3455667899999999999999999998 5899999998643 34568889999988 689999999999887554
Q ss_pred cceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCEEEcCCC
Q 012297 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH--------EAAAPRILHRDIKSSNILLDENL 367 (466)
Q Consensus 296 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH--------~~~~~~ivHrDLk~~NILld~~~ 367 (466)
.....++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNG 184 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTS
T ss_pred ccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCC
Confidence 44478999999999999999975 35899999999999999999999 676 99999999999999999
Q ss_pred cEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCC------CCchhHHHHHHHHHHHHHcC----------
Q 012297 368 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR------ASLMSDVFSFGVVLLELITG---------- 431 (466)
Q Consensus 368 ~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~sDv~S~Gvll~elltG---------- 431 (466)
.+||+|||++.......... ........||+.|+|||.+.... ++.++||||||+++|||+||
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTI-DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp CEEECCCTTCEEEETTTTEE-EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CEEEEECCCceecccccccc-ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 99999999998765432110 01223456899999999987653 34789999999999999999
Q ss_pred CCCCCCC
Q 012297 432 RQPIHRS 438 (466)
Q Consensus 432 ~~Pf~~~ 438 (466)
+.||...
T Consensus 264 ~~p~~~~ 270 (342)
T 1b6c_B 264 QLPYYDL 270 (342)
T ss_dssp CCTTTTT
T ss_pred ccCcccc
Confidence 7888754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=280.98 Aligned_cols=202 Identities=29% Similarity=0.425 Sum_probs=172.7
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC--------ChhHHHHHHHHHHHhcC-CCCccceeeeee
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--------NADSVFLTEVDMLSRLH-HCHVVPLVGYCS 291 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~--------~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~ 291 (466)
..++|.+.+.||+|+||.||+|... +++.||||++...... ...+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3567888899999999999999885 5889999999765321 12345889999999995 999999999987
Q ss_pred eccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 012297 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 371 (466)
Q Consensus 292 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL 371 (466)
. ....++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||
T Consensus 95 ~----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 95 T----NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp C----SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred c----CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEE
Confidence 5 45679999999999999999754 46899999999999999999999998 999999999999999999999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCcccccchhcc------cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 372 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM------VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 372 ~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+|||++....... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 166 ~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 166 TDFGFSCQLDPGE------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp CCCTTCEECCTTC------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecccchhhcCCCc------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 9999998764322 123356889999999875 456789999999999999999999999643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=286.86 Aligned_cols=202 Identities=21% Similarity=0.367 Sum_probs=167.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+++++.++||||+++++++.. ....+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 92 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYH----DGKLW 92 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----C-CEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee----CCeEE
Confidence 466888899999999999999986 48899999987653 3345568999999999999999999999876 34679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 93 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp EEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999998753 255899999999999999999999998 9999999999999999999999999876432
Q ss_pred cCCCCCCCCCCCccccCcccccchhc-----ccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYA-----MVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .......|++.|+|||.+ ....++.++||||||+++|||++|+.||...
T Consensus 169 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 225 (302)
T 2j7t_A 169 KTL-----QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225 (302)
T ss_dssp HHH-----HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccc-----cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 211 112234688999999988 3667899999999999999999999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.26 Aligned_cols=202 Identities=11% Similarity=0.026 Sum_probs=153.1
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC--ChhHHHHHHHHHHHhc--CCCCcccee-------eeee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRL--HHCHVVPLV-------GYCS 291 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l--~H~nIv~ll-------g~~~ 291 (466)
.+|...+.||+|+||.||+|.+. +++.||||++...... .....+.+|+++++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 34777889999999999999975 6899999999876432 2334577885555544 699988755 3333
Q ss_pred eccC-------------cceeEEEEEecCCCCCHHHHhcccccCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeE
Q 012297 292 EFRG-------------KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR------VAIAIGAARGLEYLHEAAAPRIL 352 (466)
Q Consensus 292 ~~~~-------------~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~------~~i~~qia~~L~~LH~~~~~~iv 352 (466)
.... .....++||||++ |+|.+++.... ..+.+..+ +.++.|++.||+|||+.+ |+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 2111 0145799999998 89999997642 23455666 788899999999999998 99
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhccc--CCCCchhHHHHHHHHHHHHHc
Q 012297 353 HRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELIT 430 (466)
Q Consensus 353 HrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~S~Gvll~ellt 430 (466)
||||||+|||++.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE--------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC--------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 9999999999999999999999999865321 113456799999999987 678999999999999999999
Q ss_pred CCCCCCCC
Q 012297 431 GRQPIHRS 438 (466)
Q Consensus 431 G~~Pf~~~ 438 (466)
|+.||...
T Consensus 289 g~~Pf~~~ 296 (371)
T 3q60_A 289 LFLPFGLV 296 (371)
T ss_dssp SSCSTTBC
T ss_pred CCCCCCCc
Confidence 99999765
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=296.79 Aligned_cols=208 Identities=22% Similarity=0.293 Sum_probs=171.6
Q ss_pred hCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|.+.++||+|+||.||+|.+ .+++.||||++....... .+.+|+++++.++|.+.+..+.++... ....+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~E~~il~~L~~~~~i~~i~~~~~~---~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLLYESKIYRILQGGTGIPNVRWFGVE---GDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC---CHHHHHHHHHHTTTSTTCCCEEEEEEE---TTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH---HHHHHHHHHHHhcCCCCCCeEEEEEee---CCEEE
Confidence 46788999999999999999987 468999999887654322 378999999999876555554444321 44669
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEEecCCcc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAK 378 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl---d~~~~vkL~DfGla~ 378 (466)
|||||+ +++|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++
T Consensus 80 lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 999999 99999999753 256999999999999999999999998 9999999999999 688999999999998
Q ss_pred ccccCCCCC--CCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 012297 379 RLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 441 (466)
Q Consensus 379 ~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~ 441 (466)
......... .........||+.|+|||.+.+..++.++||||||++||||++|+.||......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~ 219 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch
Confidence 765543211 112233567999999999999999999999999999999999999999875443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=292.56 Aligned_cols=202 Identities=23% Similarity=0.292 Sum_probs=171.3
Q ss_pred CCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-----------CCCccceeeeee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-----------HCHVVPLVGYCS 291 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~llg~~~ 291 (466)
.+|.+.+.||+|+||.||+|.. .+++.||||++... ......+.+|++++++++ |+||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 5688889999999999999987 46889999998743 233456889999999886 899999999988
Q ss_pred eccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEc------
Q 012297 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLD------ 364 (466)
Q Consensus 292 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~-~~~~ivHrDLk~~NILld------ 364 (466)
.........++||||+ +++|.+++.......+++..+..++.|++.||+|||+. + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 7555556789999999 99999999876556699999999999999999999998 8 99999999999994
Q ss_pred CCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 365 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 365 ~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.++.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH--------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TEEEEEECCCTTCEETTBC--------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CcceEEEcccccccccCCC--------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4457999999999876432 223468999999999999999999999999999999999999997543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=284.96 Aligned_cols=207 Identities=23% Similarity=0.366 Sum_probs=164.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc-------
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR------- 294 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~------- 294 (466)
.++|.+.+.||+|+||.||+|...+ ++.||||++... .....+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3568888999999999999999864 899999998754 2334556899999999999999999999875321
Q ss_pred ---CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEE
Q 012297 295 ---GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAK 370 (466)
Q Consensus 295 ---~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld-~~~~vk 370 (466)
......++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 22356799999997 699999964 45899999999999999999999998 99999999999997 567999
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 371 L~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
|+|||+++........ ........++..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 162 l~Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSH--KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp ECCCTTCBCC----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EccCccccccCCCccc--ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999876432111 112334567899999998765 678999999999999999999999997543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=294.04 Aligned_cols=200 Identities=26% Similarity=0.340 Sum_probs=164.1
Q ss_pred CCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--cceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~--~~~~~~l 302 (466)
+|...+.||+|+||.||+|++.++..+|+|++...... ..+|+++++.++||||+++++++..... .....++
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 47778999999999999999987777999988654322 2379999999999999999999876442 2344689
Q ss_pred EEecCCCCCHHHHhc-ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEEecCCcccc
Q 012297 303 VFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRL 380 (466)
Q Consensus 303 V~ey~~~gsL~~~l~-~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld-~~~~vkL~DfGla~~~ 380 (466)
||||++++.+..... ......+++..+..++.|+++||+|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999997654433332 112356999999999999999999999998 99999999999999 7999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... ......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 193 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 245 (394)
T 4e7w_A 193 IAGE------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245 (394)
T ss_dssp CTTC------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCC------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4332 12345689999999998764 5899999999999999999999999764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=288.42 Aligned_cols=202 Identities=26% Similarity=0.369 Sum_probs=166.7
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-------CChhHHHHHHHHHHHhcCCCCccceeeeeeec
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-------PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 293 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-------~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~ 293 (466)
..++|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence 3467888999999999999999875 478999999875421 1122348899999999999999999999764
Q ss_pred cCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EE
Q 012297 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AK 370 (466)
Q Consensus 294 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~---vk 370 (466)
. ..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ---~-~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 ---E-DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp ---S-SEEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEE
T ss_pred ---C-ceEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEE
Confidence 1 369999999999999999754 56899999999999999999999998 999999999999987664 99
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCcccccchhcc---cCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 371 L~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
|+|||++....... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 158 l~Dfg~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 158 ITDFGHSKILGETS------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp ECCCTTCEECCCCH------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred EccCccceeccccc------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99999998653221 112346899999999874 5678999999999999999999999997543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=295.20 Aligned_cols=201 Identities=26% Similarity=0.367 Sum_probs=154.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--cce
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 298 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~--~~~ 298 (466)
.++|...+.||+|+||.||+|.+. +++.||||++..... ......+.+|+++++.++||||+++++++..... ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 367888899999999999999864 588999999876432 2334568899999999999999999999865321 124
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 569999999 7899998865 46899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 181 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 233 (367)
T 2fst_X 181 HTADE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccc--------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 65322 233578999999999876 67899999999999999999999999754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=283.68 Aligned_cols=201 Identities=24% Similarity=0.322 Sum_probs=155.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHH-HHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVF-LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f-~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
.++|++.+.||+|+||.||+|... +++.||||++...........+ .++...++.++||||+++++++.+ ....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~----~~~~ 81 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR----EGDV 81 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSSE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec----cCCE
Confidence 466888899999999999999874 6899999999766443333333 444445778899999999999876 4467
Q ss_pred EEEEecCCCCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 301 LLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~~-~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
++||||++ |+|.+++... ....+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGIS 157 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCc
Confidence 99999996 5998887542 235699999999999999999999997 8 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhc----ccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYA----MVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
....... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 158 GYLVDDV------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred ccccccc------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 8764432 12234688999999996 566789999999999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=296.40 Aligned_cols=202 Identities=25% Similarity=0.345 Sum_probs=154.2
Q ss_pred CCC-cceecccCcEEEEEEEEc---CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 226 FSG-SNIVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 226 f~~-~~~LG~G~fG~Vy~a~~~---~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
|.. .++||+|+||.||+|... +++.||||++..... ...+.+|++++++++||||+++++++.... ....+
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~~~ 96 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHA--DRKVW 96 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETT--TTEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCC--CCeEE
Confidence 444 458999999999999975 478899999975432 235889999999999999999999986533 34679
Q ss_pred EEEecCCCCCHHHHhcccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEE
Q 012297 302 LVFEFMPNGNLRDCLDGVL-------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAK 370 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl----d~~~~vk 370 (466)
+||||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999995 68888875321 124899999999999999999999998 9999999999999 7789999
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 371 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 371 L~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|+|||+++.......+ ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 173 l~Dfg~a~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 173 IADMGFARLFNSPLKP--LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp ECCTTCCC------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEECCCceecCCCCcc--cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 9999999876432211 112334678999999999887 45899999999999999999999999754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=288.82 Aligned_cols=205 Identities=29% Similarity=0.419 Sum_probs=171.7
Q ss_pred CCCCCcceecccCcEEEEEEEE-----cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~-----~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
++|.+.+.||+|+||.||++++ .+++.||||++... .....+.+.+|++++++++|+||+++++++.... ..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~ 117 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--RR 117 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC--CC
Confidence 4577789999999999999984 36889999998764 3344566999999999999999999999886532 23
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 5689999999999999997642 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
........ ........++..|+|||.+.+..++.++||||||+++|||+||..||..
T Consensus 194 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 194 VLPQDKEY--YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp ECCSSCSE--EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hccccccc--cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 76543211 0112234567789999999988899999999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=286.03 Aligned_cols=211 Identities=24% Similarity=0.320 Sum_probs=162.0
Q ss_pred HHHHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC
Q 012297 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 295 (466)
Q Consensus 217 ~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~ 295 (466)
.......++|.+.+.||+|+||.||+|.+. +++.||||++..... ....+.++++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 455677789999999999999999999885 589999999865532 22346788889999999999999999876432
Q ss_pred ---cceeEEEEEecCCCCCHHHHhcc--cccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCCEEEcC-CC
Q 012297 296 ---KRAMRLLVFEFMPNGNLRDCLDG--VLVEGMNWDTRVAIAIGAARGLEYLH--EAAAPRILHRDIKSSNILLDE-NL 367 (466)
Q Consensus 296 ---~~~~~~lV~ey~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qia~~L~~LH--~~~~~~ivHrDLk~~NILld~-~~ 367 (466)
.....++||||+++ +|.+.+.. .....+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence 22346899999975 55554432 12355899999999999999999999 887 999999999999997 89
Q ss_pred cEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 368 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 368 ~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.+||+|||+++...... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||....
T Consensus 170 ~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp EEEECCCTTCBCCCTTS------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cEEEeeCCCceecCCCC------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 99999999998765432 223456899999999986654 8999999999999999999999997643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=287.53 Aligned_cols=200 Identities=23% Similarity=0.292 Sum_probs=149.8
Q ss_pred hCCCCCc-ceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHH-HHHHhcCCCCccceeeeeeeccCccee
Q 012297 223 TDKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEV-DMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 223 t~~f~~~-~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei-~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
.++|.+. ++||+|+||.||+|.+. +++.||||++... . ...+|+ ..++.++|+||+++++++.........
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~-~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----P-KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----H-HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----H-HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 3556664 46999999999999886 5899999998653 1 133333 346677999999999998876555667
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCC
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGM 376 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~---~~~vkL~DfGl 376 (466)
.++||||+++|+|.+++.......+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 899999999999999998765567999999999999999999999998 999999999999976 45599999999
Q ss_pred ccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
++...... .....||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 178 ~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 178 AKETTQNA-------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp CEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ceeccccc-------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 98654321 22346789999999998888999999999999999999999999643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=289.67 Aligned_cols=211 Identities=23% Similarity=0.307 Sum_probs=168.8
Q ss_pred HHHHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccC
Q 012297 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 295 (466)
Q Consensus 217 ~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~ 295 (466)
++++...++|++.+.||+|+||.||+|.+.+ .+|+|+++.... ....+.|.+|+.++++++|+||+++++++.+
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 100 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--- 100 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC---
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec---
Confidence 4455556788999999999999999998854 499999875532 2233457889999999999999999999886
Q ss_pred cceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 012297 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (466)
Q Consensus 296 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfG 375 (466)
....++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++ ++.+||+|||
T Consensus 101 -~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 101 -PPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp -SSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCS
T ss_pred -CCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecC
Confidence 345799999999999999997642 45899999999999999999999998 99999999999998 6799999999
Q ss_pred CccccccCCCCCCCCCCCccccCcccccchhccc---------CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV---------GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+++..................|++.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 246 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9876543221111223334568999999998864 45799999999999999999999999753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=286.05 Aligned_cols=212 Identities=24% Similarity=0.328 Sum_probs=157.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeec----cCc
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEF----RGK 296 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~----~~~ 296 (466)
..+|.+.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.++.++. ||||+++++++... ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 346777899999999999999875 68999999986542 334456899999999996 99999999998532 123
Q ss_pred ceeEEEEEecCCCCCHHHHhcccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfG 375 (466)
....++||||+. |+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 456799999994 89999986522 245999999999999999999999875 359999999999999999999999999
Q ss_pred CccccccCCCCCC-------CCCCCccccCcccccchhc---ccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 376 MAKRLKADGLPSC-------SSSPARMQGTFGYFAPEYA---MVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 376 la~~~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~---~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
++........... ........||+.|+|||.+ ....++.++||||||+++|||++|+.||..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 9987654321100 0111234589999999988 566789999999999999999999999964
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=288.90 Aligned_cols=200 Identities=24% Similarity=0.351 Sum_probs=166.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc--e
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR--A 298 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~--~ 298 (466)
.++|...+.||+|+||.||+|.+. +++.||||++...... .....+.+|+.+++.++||||+++++++....... .
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888899999999999999875 5899999999765332 23456889999999999999999999987643221 1
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||++ ++|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 2489999996 68988874 34899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 193 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 193 HADAE--------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp ---------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccC--------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 65332 223467999999999877 67899999999999999999999999754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=284.28 Aligned_cols=201 Identities=28% Similarity=0.395 Sum_probs=150.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHH-HHHhcCCCCccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~-~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
.++|...+.||+|+||.||+|... +++.||||++...........+..|+. +++.++||||+++++++.+ ....
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~----~~~~ 96 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR----EGDC 96 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC----SSEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe----CCce
Confidence 366788899999999999999885 689999999987654444455666766 6677899999999999876 3467
Q ss_pred EEEEecCCCCCHHHHhcc---cccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCC
Q 012297 301 LLVFEFMPNGNLRDCLDG---VLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGM 376 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~---~~~~~~~~~~~~~i~~qia~~L~~LH~~-~~~~ivHrDLk~~NILld~~~~vkL~DfGl 376 (466)
++||||++ ++|.+++.. .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 97 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 97 WICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp EEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred EEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCC
Confidence 99999997 588888753 1235689999999999999999999998 8 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCcccccchhc----ccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYA----MVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
++...... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||..
T Consensus 173 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 173 SGQLVDSI------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp SCC------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred ceeccccc------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 98764321 12234689999999998 456789999999999999999999999964
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=282.69 Aligned_cols=204 Identities=29% Similarity=0.386 Sum_probs=161.3
Q ss_pred CCCCCcceecccCcEEEEEEEEc--CCc--EEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT--DGR--IVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~--~~~--~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
++|++.+.||+|+||.||+|.+. +++ .||||+++... .....+.+.+|++++++++||||+++++++...
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 93 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---- 93 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC----
Confidence 45777899999999999999863 233 68999987653 233456699999999999999999999998752
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 94 -~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 94 -PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred -CceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccc
Confidence 2589999999999999997642 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
......... ........+|..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 169 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 169 RALPQNDDH--YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp EECCC-CCE--EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccccc--hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 876443211 111223457788999999998889999999999999999999 99999643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=277.41 Aligned_cols=202 Identities=25% Similarity=0.364 Sum_probs=171.9
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
...++|.+.+.||+|+||.||+|... +++.||||++.... .......+.+|++++++++||||+++++++.+ ..
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~ 94 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED----SS 94 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SS
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC----CC
Confidence 34567888999999999999999886 68899999986543 23345668999999999999999999999876 44
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEEecC
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKITDLG 375 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~---~~vkL~DfG 375 (466)
..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.+ +.+||+|||
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred eEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccC
Confidence 679999999999999998754 45899999999999999999999998 9999999999999754 469999999
Q ss_pred CccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
++....... ......+++.|+|||.+.+ .++.++||||||+++|||++|+.||...
T Consensus 170 ~~~~~~~~~------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (287)
T 2wei_A 170 LSTCFQQNT------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (287)
T ss_dssp GGGTBCCCS------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cceeecCCC------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence 998654321 1233458899999998765 4899999999999999999999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=308.40 Aligned_cols=207 Identities=24% Similarity=0.384 Sum_probs=172.6
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcC----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 294 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~ 294 (466)
++...++|.+.+.||+|+||.||+|.+.. +..||||++.........+.|.+|+.++++++||||+++++++.+
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-- 462 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-- 462 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence 33445678888999999999999998743 467999998876555555679999999999999999999999853
Q ss_pred CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEec
Q 012297 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 374 (466)
Q Consensus 295 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~Df 374 (466)
...++||||+++|+|.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 463 ---~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 463 ---NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCC
T ss_pred ---CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEec
Confidence 2358999999999999999753 245899999999999999999999998 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 375 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 375 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
|+++....... .......+|+.|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 536 G~a~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 536 GLSRYMEDSTY----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp CCCCSCCC--------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCeecCCCcc----eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99987643321 11223456789999999999999999999999999999997 99999753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=279.29 Aligned_cols=203 Identities=29% Similarity=0.397 Sum_probs=162.7
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc------
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR------ 294 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~------ 294 (466)
..++|++.+.||+|+||.||+|... +++.||||++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 3456888899999999999999875 6899999998643 233456899999999999999999999886532
Q ss_pred ---CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 012297 295 ---GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 371 (466)
Q Consensus 295 ---~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL 371 (466)
......++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 22457799999999999999997532 35788999999999999999999998 999999999999999999999
Q ss_pred EecCCccccccCCC---------CCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHc
Q 012297 372 TDLGMAKRLKADGL---------PSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELIT 430 (466)
Q Consensus 372 ~DfGla~~~~~~~~---------~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~ellt 430 (466)
+|||++........ +..........|++.|+|||.+.+. .++.++||||||+++|||++
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 99999986543210 0011223345689999999998764 68999999999999999998
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=288.81 Aligned_cols=200 Identities=26% Similarity=0.302 Sum_probs=169.2
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCC-----ccceeeeeeec
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCH-----VVPLVGYCSEF 293 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~n-----Iv~llg~~~~~ 293 (466)
...++|.+.+.||+|+||.||+|... +++.||||+++.. ......+..|+.+++.++ |+| |+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~- 127 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF- 127 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-
Confidence 34578899999999999999999876 5789999999743 223455778999988885 554 8999998876
Q ss_pred cCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEecCCCCCCEEEc--CCCcE
Q 012297 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE--AAAPRILHRDIKSSNILLD--ENLNA 369 (466)
Q Consensus 294 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~--~~~~~ivHrDLk~~NILld--~~~~v 369 (466)
....++||||++ ++|.+++.......+++..+..++.|++.||.|||. .+ |+||||||+|||++ .++.+
T Consensus 128 ---~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~ 200 (382)
T 2vx3_A 128 ---RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAI 200 (382)
T ss_dssp ---TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCE
T ss_pred ---CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcE
Confidence 456799999995 699999987655669999999999999999999994 45 99999999999994 57889
Q ss_pred EEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 370 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 370 kL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 201 kL~DFG~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 201 KIVDFGSSCQLGQR--------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EECCCTTCEETTCC--------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEeccCceecccc--------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999876322 23356899999999999999999999999999999999999999854
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=284.34 Aligned_cols=206 Identities=23% Similarity=0.338 Sum_probs=167.1
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcC--CCCccceeeeeeeccC
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLH--HCHVVPLVGYCSEFRG 295 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~--H~nIv~llg~~~~~~~ 295 (466)
+....++|.+.+.||+|+||.||++...+++.||||++..... ......+.+|++++++++ |+||+++++++..
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--- 99 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--- 99 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC---
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec---
Confidence 3344566888899999999999999998899999999976532 233456899999999997 5999999999876
Q ss_pred cceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 012297 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (466)
Q Consensus 296 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfG 375 (466)
....++||| +.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++ +.+||+|||
T Consensus 100 -~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 100 -DQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp -SSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred -CCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 446799999 5689999999764 46899999999999999999999998 999999999999965 899999999
Q ss_pred CccccccCCCCCCCCCCCccccCcccccchhccc-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-----------GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
++........ ........|++.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 172 ~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 172 IANQMQPDTT---SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp SSCC-----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccCccc---cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 9987644321 111233568999999999865 46889999999999999999999999753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=282.54 Aligned_cols=199 Identities=20% Similarity=0.246 Sum_probs=168.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-C-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCC------ccceeeeeeecc
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-D-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH------VVPLVGYCSEFR 294 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~llg~~~~~~ 294 (466)
.++|.+.+.||+|+||.||+|... + ++.||||+++.. ......+.+|++++++++|++ ++.+.+++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~-- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF-- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE--
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee--
Confidence 367888899999999999999875 3 368999998743 234456889999999997665 8888888776
Q ss_pred CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-----------
Q 012297 295 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----------- 363 (466)
Q Consensus 295 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILl----------- 363 (466)
....++||||+ +++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 94 --~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 94 --HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECC
T ss_pred --CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccc
Confidence 44679999999 778888887655457999999999999999999999998 9999999999999
Q ss_pred --------cCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 012297 364 --------DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435 (466)
Q Consensus 364 --------d~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf 435 (466)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH--------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC--------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccCCCcEEEeecCcccccccc--------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 67889999999999764322 23356899999999999999999999999999999999999999
Q ss_pred CCCC
Q 012297 436 HRSI 439 (466)
Q Consensus 436 ~~~~ 439 (466)
....
T Consensus 240 ~~~~ 243 (355)
T 2eu9_A 240 QTHE 243 (355)
T ss_dssp CCSS
T ss_pred CCCC
Confidence 7543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=284.94 Aligned_cols=200 Identities=23% Similarity=0.336 Sum_probs=166.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc--ce
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK--RA 298 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~--~~ 298 (466)
.++|...+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.++++++||||+++++++...... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 356888899999999999999875 5899999999765322 2345688999999999999999999998764321 12
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||++ ++|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 3599999996 68888775 34899999999999999999999998 9999999999999999999999999997
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 175 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 175 HADAE--------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp C----------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred CCCCC--------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 65322 223467899999998876 67899999999999999999999999754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=283.72 Aligned_cols=204 Identities=24% Similarity=0.352 Sum_probs=170.9
Q ss_pred HHHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCC-----hhHHHHHHHHHHHhcC--CCCccceeee
Q 012297 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRLH--HCHVVPLVGY 289 (466)
Q Consensus 218 ~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~-----~~~~f~~Ei~~l~~l~--H~nIv~llg~ 289 (466)
+.+...++|.+.+.||+|+||.||+|... +++.||||++....... ....+.+|++++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 44555678999999999999999999864 68899999987653221 2234778999999996 5999999999
Q ss_pred eeeccCcceeEEEEEecCCC-CCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCC
Q 012297 290 CSEFRGKRAMRLLVFEFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENL 367 (466)
Q Consensus 290 ~~~~~~~~~~~~lV~ey~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld-~~~ 367 (466)
+.. ....++|||++.+ ++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++ +++
T Consensus 117 ~~~----~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 117 FER----PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEC----SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTT
T ss_pred Eec----CCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCC
Confidence 876 4467999999976 8999999764 56899999999999999999999998 99999999999999 789
Q ss_pred cEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 368 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 368 ~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.+||+|||+++...... .....||+.|+|||.+....+ +.++||||||+++|||++|+.||..
T Consensus 188 ~~kL~Dfg~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 188 ELKLIDFGSGALLKDTV-------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp EEEECCCTTCEECCSSC-------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred CEEEeeCcccccccccc-------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 99999999998764321 223468999999999887665 7889999999999999999999964
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=310.61 Aligned_cols=197 Identities=22% Similarity=0.408 Sum_probs=167.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEc--CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc-ee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT--DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR-AM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~--~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~-~~ 299 (466)
.++|.+.+.||+|+||.||+|.+. +++.||||++...........|.+|++++++++||||+++++++....... ..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 467889999999999999999986 589999999876554455567899999999999999999999998754322 23
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.+|||||+++++|.+++.. .+++.+++.++.|++.||.|||+.+ |+||||||+|||++++ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 6999999999999987753 5899999999999999999999998 9999999999999986 899999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.... ....||+.|+|||++.+.. +.++||||||+++|||++|..||..
T Consensus 231 ~~~~---------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 231 INSF---------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp TTCC---------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred cccC---------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 5432 3356899999999887654 8999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=281.09 Aligned_cols=203 Identities=25% Similarity=0.361 Sum_probs=163.9
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCC-----hhHHHHHHHHHHHhc----CCCCccceee
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRL----HHCHVVPLVG 288 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~-----~~~~f~~Ei~~l~~l----~H~nIv~llg 288 (466)
.+...++|.+.+.||+|+||.||+|... +++.||||++....... ....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 4455678999999999999999999864 68899999997653221 222366799999998 8999999999
Q ss_pred eeeeccCcceeEEEEEec-CCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CC
Q 012297 289 YCSEFRGKRAMRLLVFEF-MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-EN 366 (466)
Q Consensus 289 ~~~~~~~~~~~~~lV~ey-~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld-~~ 366 (466)
++.. ....++|||| +++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++ ++
T Consensus 106 ~~~~----~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 106 WFET----QEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR 176 (312)
T ss_dssp EC---------CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTT
T ss_pred EEec----CCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCC
Confidence 9876 3456899999 7899999999764 45899999999999999999999998 99999999999999 88
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 367 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
+.+||+|||++....... .....|+..|+|||.+....+ +.++||||||+++|||++|+.||..
T Consensus 177 ~~~kl~dfg~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP-------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp TEEEECCCSSCEECCSSC-------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred CeEEEEEcchhhhcccCc-------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 999999999998764332 223468899999999887766 4589999999999999999999964
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=276.57 Aligned_cols=200 Identities=25% Similarity=0.397 Sum_probs=149.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHH-HHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~-f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
.++|...+.||+|+||.||+|.+. +++.||||++........... +.++..+++.++||||+++++++.+ ....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----~~~~ 99 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT----NTDV 99 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec----CCcE
Confidence 456788899999999999999885 689999999986644333333 4444456788899999999999876 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~-~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
++||||+ ++.+..+... ....+++..+..++.|++.||.|||+. + ++||||||+|||++.++.+||+|||++..
T Consensus 100 ~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 9999999 5555555443 335689999999999999999999985 7 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
..... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 175 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 175 LVDDK------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp ------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccCCc------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 54322 122346889999999984 55688999999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=289.22 Aligned_cols=200 Identities=27% Similarity=0.383 Sum_probs=154.3
Q ss_pred CCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeEEEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+ ....++||
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----~~~~~lv~ 88 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETT----DRFLYIAL 88 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC----SSEEEEEE
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEec----CCeEEEEE
Confidence 3445789999999998777778999999998653 234578999999987 89999999998765 45679999
Q ss_pred ecCCCCCHHHHhcccccCC-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-------------
Q 012297 305 EFMPNGNLRDCLDGVLVEG-----MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN------------- 366 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~-----~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~------------- 366 (466)
||++ |+|.+++....... .++..++.++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCc
Confidence 9995 79999997543211 133356789999999999999998 9999999999999654
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhccc-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-------GRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 367 ~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+.+||+|||+++......... ........||+.|+|||.+.+ ..++.++||||||+++|||++ |+.||...
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSF-RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp CEEEECCCTTCEECCC---------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred eEEEEcccccceecCCCCccc-eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 489999999998765432110 111234579999999999865 668999999999999999999 99999653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=302.83 Aligned_cols=205 Identities=29% Similarity=0.464 Sum_probs=173.3
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc--CcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~--~~~~~~ 300 (466)
++|.+.+.||+|+||.||+|.+. +++.||||++...........|.+|++++++++||||+++++++.... ......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 57899999999999999999874 588999999987655555667999999999999999999999875422 113456
Q ss_pred EEEEecCCCCCHHHHhcccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEEecCC
Q 012297 301 LLVFEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AKITDLGM 376 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~---vkL~DfGl 376 (466)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 235899999999999999999999998 999999999999987665 99999999
Q ss_pred ccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 377 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 377 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 171 a~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 171 AKELDQGE------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCBTTSCC------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccc------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 98764432 12345789999999999999999999999999999999999999953
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=287.92 Aligned_cols=200 Identities=27% Similarity=0.387 Sum_probs=156.5
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.+|...++||+|+||+||.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+ ....++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~----~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKD----RQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEE----TTEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEec----CCEEEE
Confidence 34667789999999997666666899999999875432 2257899999999 79999999998876 456799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-----CCcEEEEecCCc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-----NLNAKITDLGMA 377 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~-----~~~vkL~DfGla 377 (466)
||||++ |+|.+++.... ..+.+..++.++.|++.||+|||+.+ |+||||||+|||++. ...+||+|||++
T Consensus 96 v~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 999995 69999997643 23455567789999999999999998 999999999999943 346889999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcc---cCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+........ ........||+.|+|||.+. ...++.++||||||+++|||++ |..||...
T Consensus 171 ~~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 171 KKLAVGRHS--FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp ECC--------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred eeccCCCcc--eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 876533211 11233457999999999987 4567889999999999999999 99999643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=278.85 Aligned_cols=196 Identities=16% Similarity=0.111 Sum_probs=161.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCC-------CChhHHHHHHHHHHHhcC---------CCCccce
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-------PNADSVFLTEVDMLSRLH---------HCHVVPL 286 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~-------~~~~~~f~~Ei~~l~~l~---------H~nIv~l 286 (466)
.++|.+.+.||+|+||.||+|+. +++.||||++..... ....+.+.+|+.+++.++ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35577889999999999999998 689999999986532 223366899999999886 8888877
Q ss_pred eeeeeecc--------------------------CcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHH
Q 012297 287 VGYCSEFR--------------------------GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 340 (466)
Q Consensus 287 lg~~~~~~--------------------------~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L 340 (466)
.+++.... ......++||||+++|++.+.+.+ ..+++..+..++.|++.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 77643210 014567999999999977766643 4589999999999999999
Q ss_pred HHHH-hCCCCCeEecCCCCCCEEEcCCC--------------------cEEEEecCCccccccCCCCCCCCCCCccccCc
Q 012297 341 EYLH-EAAAPRILHRDIKSSNILLDENL--------------------NAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399 (466)
Q Consensus 341 ~~LH-~~~~~~ivHrDLk~~NILld~~~--------------------~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~ 399 (466)
+||| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----------~~~gt~ 241 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----------IVVFCD 241 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----------EEECCC
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----------cEEEee
Confidence 9999 898 99999999999999887 8999999999876431 347899
Q ss_pred ccccchhcccCCCCchhHHHHHHHH-HHHHHcCCCCCC
Q 012297 400 GYFAPEYAMVGRASLMSDVFSFGVV-LLELITGRQPIH 436 (466)
Q Consensus 400 ~y~aPE~~~~~~~s~~sDv~S~Gvl-l~elltG~~Pf~ 436 (466)
.|+|||.+.+.. +.++|||||+.+ .+++++|..||.
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 999999998666 899999998776 778889999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-32 Score=265.57 Aligned_cols=172 Identities=18% Similarity=0.153 Sum_probs=148.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+.+.||+|+||.||+|.+.. ++.||||++....... ....|.+|+.++++++|+||+++++++.+ ....
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~~ 106 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT----RAGG 106 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE----CCcE
Confidence 567888999999999999999864 8999999998764432 23569999999999999999999999876 4467
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++++|.++++.. ....++..++.|++.||+|||+.+ |+||||||+|||+++++.+||++++
T Consensus 107 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----
Confidence 9999999999999999642 466678999999999999999998 9999999999999999999998543
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|++ .++.++||||||+++|||+||+.||...
T Consensus 175 --------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~ 205 (286)
T 3uqc_A 175 --------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEA 205 (286)
T ss_dssp --------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCC
T ss_pred --------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 333 3688999999999999999999999754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.9e-32 Score=263.03 Aligned_cols=178 Identities=24% Similarity=0.332 Sum_probs=152.8
Q ss_pred CCCCCc-ceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHH-HhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDML-SRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~-~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l-~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+. +.||+|+||.||++... +++.||+|++... ..+.+|++++ +..+||||+++++++..........
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 445555 67999999999999874 6889999998642 3477899988 5568999999999987655556678
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCCc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGMA 377 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~---~~~vkL~DfGla 377 (466)
++||||+++|+|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999998765557999999999999999999999998 999999999999998 788999999998
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.... +..++.++||||||+++|||++|+.||..
T Consensus 168 ~~~~---------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~ 200 (299)
T 3m2w_A 168 KETT---------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYS 200 (299)
T ss_dssp EECT---------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccc---------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 6532 13457789999999999999999999954
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=280.68 Aligned_cols=204 Identities=17% Similarity=0.163 Sum_probs=154.8
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC--ChhHHHHHHHHHHHhcCC-CCcccee---------e
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHH-CHVVPLV---------G 288 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H-~nIv~ll---------g 288 (466)
.+.+|...++||+|+||.||+|.+. +++.||||++...... ...+.|.+|+.+++.++| +|...+. .
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3445667789999999999999864 6899999998844322 234568999999999987 3222111 1
Q ss_pred ee------------eec-cCcceeEEEEEecCCCCCHHHHhcc-----cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 012297 289 YC------------SEF-RGKRAMRLLVFEFMPNGNLRDCLDG-----VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350 (466)
Q Consensus 289 ~~------------~~~-~~~~~~~~lV~ey~~~gsL~~~l~~-----~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ 350 (466)
.. ... .......+++|+++ +++|.++++. .....+++..++.++.|+++||+|||+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 11 000 00122357777765 7899999852 22234788899999999999999999998
Q ss_pred eEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhc----------ccCCCCchhHHHH
Q 012297 351 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA----------MVGRASLMSDVFS 420 (466)
Q Consensus 351 ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~sDv~S 420 (466)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE--------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc--------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 999999999999999999999999998865432 223456 899999998 5556889999999
Q ss_pred HHHHHHHHHcCCCCCCCC
Q 012297 421 FGVVLLELITGRQPIHRS 438 (466)
Q Consensus 421 ~Gvll~elltG~~Pf~~~ 438 (466)
||+++|||++|+.||...
T Consensus 303 lGvil~elltg~~Pf~~~ 320 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDD 320 (413)
T ss_dssp HHHHHHHHHHSSCCCCTT
T ss_pred HHHHHHHHHHCCCCCCCc
Confidence 999999999999999754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-30 Score=270.58 Aligned_cols=186 Identities=19% Similarity=0.155 Sum_probs=128.1
Q ss_pred ecccCcEEEEEEE-EcCCcEEEEEEcccCCCC---------ChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeE
Q 012297 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGP---------NADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 232 LG~G~fG~Vy~a~-~~~~~~vaVK~l~~~~~~---------~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~ 300 (466)
...|++|.+..++ ..-|+.++||++...... ...++|.+|+++|+++ .|+||+++++++.+ ....
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed----~~~~ 317 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN----AQSG 317 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC----SSEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE----CCEE
Confidence 4556666666543 334788999999765211 1234599999999999 69999999999876 5578
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
||||||++|++|.++|... .+++.. +|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+++..
T Consensus 318 yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 9999999999999999764 446654 47899999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf 435 (466)
..+. ......+||+.|+|||.+.+ .+..++|+||+|+++++|.++..|+
T Consensus 390 ~~~~-----~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 390 PQDC-----SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp C--------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCC-----ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 5432 22345689999999998865 4566899999999988776654443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=244.95 Aligned_cols=190 Identities=15% Similarity=0.172 Sum_probs=143.3
Q ss_pred CCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCCh-------hHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 227 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA-------DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 227 ~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~-------~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
...++||+|+||.||+|.. .++.+++|+......... .+.|.+|++++++++||||+++..++... ..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~----~~ 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL----DN 413 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET----TT
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC----Cc
Confidence 3457899999999999954 577889998655432211 23479999999999999999666555542 23
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|.+++.. +..++.|+++||+|||+.+ |+||||||+|||+++ .+||+|||+++.
T Consensus 414 ~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred cEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEE
Confidence 4999999999999999975 5689999999999999998 999999999999999 999999999987
Q ss_pred cccCCCCCC--CCCCCccccCcccccchhccc--CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 380 LKADGLPSC--SSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 380 ~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
......... ........||+.|+|||++.. ..|+...|+||..+-.++-+.++.+|.
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 643210000 000124679999999999976 667888999999999999888887764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=9.6e-24 Score=204.38 Aligned_cols=152 Identities=14% Similarity=0.056 Sum_probs=120.8
Q ss_pred HHHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCC-----------------ChhHHHHHHHHHHHhcCC
Q 012297 218 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-----------------NADSVFLTEVDMLSRLHH 280 (466)
Q Consensus 218 ~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~-----------------~~~~~f~~Ei~~l~~l~H 280 (466)
.+......|.+.+.||+|+||.||+|.+.+++.||||.++..... .....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 344455667777999999999999999977999999999754211 12345899999999999
Q ss_pred CCccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 012297 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 360 (466)
Q Consensus 281 ~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~N 360 (466)
| +++.+++.. ...++||||+++++|.+ +.. .....++.|++.||+|||+.+ |+||||||+|
T Consensus 163 -~-~~v~~~~~~-----~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N 223 (282)
T 1zar_A 163 -G-LAVPKVYAW-----EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN 223 (282)
T ss_dssp -T-SSSCCEEEE-----ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred -C-CCcCeEEec-----cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence 5 677765533 23499999999999998 432 124469999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcc
Q 012297 361 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 408 (466)
Q Consensus 361 ILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 408 (466)
||++ ++.+||+|||+++.. ..++|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~~~------------------~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVEV------------------GEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCEET------------------TSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeEC------------------CCCCHHHHHH
Confidence 9999 999999999999743 3478899764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.4e-19 Score=170.05 Aligned_cols=137 Identities=20% Similarity=0.231 Sum_probs=105.7
Q ss_pred CCCcceecccCcEEEEEEEE-cCCcE--EEEEEcccCCCCC-----------------------hhHHHHHHHHHHHhcC
Q 012297 226 FSGSNIVGQGGSSYVYRGQL-TDGRI--VAVKRFKTQGGPN-----------------------ADSVFLTEVDMLSRLH 279 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~-~~~~~--vaVK~l~~~~~~~-----------------------~~~~f~~Ei~~l~~l~ 279 (466)
|.+.+.||+|+||.||+|.+ .+|+. ||||+++...... ....+.+|+.++..++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55678999999999999988 68888 9999876542110 0125789999999998
Q ss_pred CCCc--cceeeeeeeccCcceeEEEEEecCCC-C----CHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCe
Q 012297 280 HCHV--VPLVGYCSEFRGKRAMRLLVFEFMPN-G----NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH-EAAAPRI 351 (466)
Q Consensus 280 H~nI--v~llg~~~~~~~~~~~~~lV~ey~~~-g----sL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH-~~~~~~i 351 (466)
|+++ ..++++ ...+|||||+.+ | +|.++... .++..+..++.|++.+|.||| +.+ |
T Consensus 129 ~~~i~~p~~~~~--------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---i 192 (258)
T 1zth_A 129 EAGVSVPQPYTY--------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---L 192 (258)
T ss_dssp HTTCCCCCEEEE--------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---E
T ss_pred hCCCCCCeEEEc--------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 8864 334432 133899999942 4 67766532 234457789999999999999 888 9
Q ss_pred EecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 352 LHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 352 vHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
+||||||+|||+++ .++|+|||++...
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.3e-17 Score=164.83 Aligned_cols=145 Identities=14% Similarity=0.133 Sum_probs=101.4
Q ss_pred HHHHHhCC---CCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCC-------------ChhHHH--------HHHHH
Q 012297 218 ALEHATDK---FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-------------NADSVF--------LTEVD 273 (466)
Q Consensus 218 ~l~~~t~~---f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~-------------~~~~~f--------~~Ei~ 273 (466)
.|....++ |.+...||+|++|.||+|...+|+.||||+++..... ...... .+|..
T Consensus 86 AL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~ 165 (397)
T 4gyi_A 86 ALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA 165 (397)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence 34444444 8889999999999999999999999999997643110 001112 24555
Q ss_pred HHHhcCCCCccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 012297 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILH 353 (466)
Q Consensus 274 ~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH 353 (466)
.|.++.+.++.-..-+... ..+|||||+++++|.++... .....++.|++.+|.+||+.+ |||
T Consensus 166 nL~rL~~~gv~vp~p~~~~------~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g---IVH 228 (397)
T 4gyi_A 166 FMKALYEEGFPVPEPIAQS------RHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG---LIH 228 (397)
T ss_dssp HHHHHHHTTCSCCCEEEEE------TTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHhcCCCCCeeeecc------CceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC---CcC
Confidence 5666644433211111111 12799999999888765431 123567899999999999998 999
Q ss_pred cCCCCCCEEEcCCC----------cEEEEecCCccc
Q 012297 354 RDIKSSNILLDENL----------NAKITDLGMAKR 379 (466)
Q Consensus 354 rDLk~~NILld~~~----------~vkL~DfGla~~ 379 (466)
|||||.|||+++++ .+.|+||+.+-.
T Consensus 229 rDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 229 GDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99999999998876 389999997653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=2.7e-11 Score=114.94 Aligned_cols=147 Identities=15% Similarity=0.093 Sum_probs=110.3
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcc
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~ 297 (466)
+......|.....++.|+.+.||++... ++.+++|+....... ....+.+|+++++.+. +.++.+++++... .
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~-~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~----~ 82 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERH----D 82 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEE----T
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC-CHHHHHHHHHHHHHHhcCCCCCeEEEEEec----C
Confidence 3344566777778888889999999754 688999998753111 1224889999999995 6677889988765 3
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA------------------------------ 347 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~------------------------------ 347 (466)
...++||||++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 83 ~~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 83 GWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp TEEEEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred CceEEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 456999999999999876421 1123467889999999999821
Q ss_pred --------------------------CCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 348 --------------------------APRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 348 --------------------------~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
.+.++|+|+++.|||++++..+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876566799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=2.2e-11 Score=114.92 Aligned_cols=130 Identities=17% Similarity=0.125 Sum_probs=95.2
Q ss_pred ecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCc--cceeeeeeeccCcceeEEEEEecCCC
Q 012297 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV--VPLVGYCSEFRGKRAMRLLVFEFMPN 309 (466)
Q Consensus 232 LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~llg~~~~~~~~~~~~~lV~ey~~~ 309 (466)
.+.|..+.||++...+|+.+++|...... ...+.+|+++++.+.+.++ .+++++... ....++||||++|
T Consensus 28 ~~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~----~~~~~~v~e~i~G 99 (264)
T 1nd4_A 28 TIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTE----AGRDWLLLGEVPG 99 (264)
T ss_dssp SCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC----SSCEEEEEECCSS
T ss_pred ccCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccC----CCCCEEEEEecCC
Confidence 34566799999988778889999876541 1237899999999965554 457776554 2346999999999
Q ss_pred CCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 012297 310 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA------------------------------------------ 347 (466)
Q Consensus 310 gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~------------------------------------------ 347 (466)
.+|. ... .+ ...++.++++.|..||+..
T Consensus 100 ~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T 1nd4_A 100 QDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 169 (264)
T ss_dssp EETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred cccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence 8884 221 12 2356778888888888643
Q ss_pred -------------CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 348 -------------APRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 348 -------------~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.+.++|+|++|.|||++++..+.|+||+.+..
T Consensus 170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998876677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=2.3e-10 Score=113.84 Aligned_cols=145 Identities=15% Similarity=0.181 Sum_probs=106.1
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEcc--cCCCCChhHHHHHHHHHHHhcC--CCCccceeeeeeeccCcceeEEEEE
Q 012297 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFK--TQGGPNADSVFLTEVDMLSRLH--HCHVVPLVGYCSEFRGKRAMRLLVF 304 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~--~~~~~~~~~~f~~Ei~~l~~l~--H~nIv~llg~~~~~~~~~~~~~lV~ 304 (466)
.+.|+.|.++.||+....+ ..+++|+.. ..........+.+|..+++.+. +.++.++++++.+... ....++||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~-~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV-IGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT-TSSCEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc-cCCeEEEE
Confidence 4578899999999998754 578888776 3322222335889999999997 4567788888765321 13458999
Q ss_pred ecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 012297 305 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA------------------------------------- 347 (466)
Q Consensus 305 ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~------------------------------------- 347 (466)
||++|..+.+.. ...++..++..++.++++.|..||...
T Consensus 121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999998875421 134678888999999999999999831
Q ss_pred ------------------CCCeEecCCCCCCEEEcCCCc--EEEEecCCccc
Q 012297 348 ------------------APRILHRDIKSSNILLDENLN--AKITDLGMAKR 379 (466)
Q Consensus 348 ------------------~~~ivHrDLk~~NILld~~~~--vkL~DfGla~~ 379 (466)
.+.++|+|+++.|||+++++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997754 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.03 E-value=2.2e-10 Score=111.34 Aligned_cols=187 Identities=21% Similarity=0.236 Sum_probs=122.1
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCC--ccceeeeeeeccCcceeEEEEEe
Q 012297 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCH--VVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~n--Iv~llg~~~~~~~~~~~~~lV~e 305 (466)
.+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++..... .......|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~-~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP-SETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC-CSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC-CCCCCcceEEEc
Confidence 3568899999999864 45888875432 23456889999999884 333 2344443222 111124488999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA-------------------------------------- 347 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~-------------------------------------- 347 (466)
+++|.+|.+... ..++..++..++.++++.+..||+..
T Consensus 97 ~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 97 KIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred ccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 999988865332 23677788888889999998888621
Q ss_pred -----------------CCCeEecCCCCCCEEEcC--CCcEEEEecCCccccccCCCCCCCCCCCccccCccc---ccch
Q 012297 348 -----------------APRILHRDIKSSNILLDE--NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY---FAPE 405 (466)
Q Consensus 348 -----------------~~~ivHrDLk~~NILld~--~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y---~aPE 405 (466)
.+.++|+|+++.||++++ +..+.|+||+.+....... .+.....+ ..|+
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---------Dl~~~~~~~~~~~~~ 243 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---------DFISLMEDDEEYGME 243 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---------HHHTTCCTTTSCCHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---------HHHHHHhhccccCHH
Confidence 135899999999999998 4567899999987542210 00000001 2222
Q ss_pred hcc----c-CCC---------CchhHHHHHHHHHHHHHcCCCCCC
Q 012297 406 YAM----V-GRA---------SLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 406 ~~~----~-~~~---------s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
... . +.. ....+.|+++.++|.+.+|..||.
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 111 0 111 123689999999999999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=5.7e-07 Score=87.25 Aligned_cols=137 Identities=17% Similarity=0.171 Sum_probs=93.3
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCC---CccceeeeeeeccCcceeEEEEEec
Q 012297 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC---HVVPLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~llg~~~~~~~~~~~~~lV~ey 306 (466)
+.++.|....||+. +..+++|+... ......+.+|.++|+.+.+. .+.+++.+... .....++||||
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~---~~g~~~~v~e~ 94 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR---SDGNPFVGYRK 94 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC---TTSCEEEEEEC
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc---CCCceEEEEec
Confidence 46788888999988 46688887432 22345688999999999753 24455555432 13345899999
Q ss_pred CCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 012297 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA---------------------------------------- 346 (466)
Q Consensus 307 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~---------------------------------------- 346 (466)
++|.+|.+..- ..++..+...++.++++.|..||+.
T Consensus 95 i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 95 VQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred cCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 99988876321 1234555555566666666666543
Q ss_pred -----------------CCCCeEecCCCCCCEEEcC---CCc-EEEEecCCcccc
Q 012297 347 -----------------AAPRILHRDIKSSNILLDE---NLN-AKITDLGMAKRL 380 (466)
Q Consensus 347 -----------------~~~~ivHrDLk~~NILld~---~~~-vkL~DfGla~~~ 380 (466)
..+.++|+|+++.|||+++ ++. +.|+||+.+...
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2234799999999999987 455 489999987653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.1e-06 Score=83.09 Aligned_cols=135 Identities=19% Similarity=0.132 Sum_probs=93.5
Q ss_pred eecccCcE-EEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcceeEEEEEecC
Q 012297 231 IVGQGGSS-YVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEFM 307 (466)
Q Consensus 231 ~LG~G~fG-~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~~~lV~ey~ 307 (466)
.+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +-.+.++++++.+ ....++|||++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~----~~~~~lvme~l 102 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRT----PDDAWLLTTAI 102 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE----TTEEEEEEECC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEE----CCeEEEEEEee
Confidence 34445554 68988764 4567899976532 3345888999999885 3346677887765 33569999999
Q ss_pred CCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 012297 308 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA---------------------------------------- 347 (466)
Q Consensus 308 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~---------------------------------------- 347 (466)
++.++.+..... ......+..+++..|..||...
T Consensus 103 ~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 103 PGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred CCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 998887765321 1123345666667777777431
Q ss_pred ---------------CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 348 ---------------APRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 348 ---------------~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999887778999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=9.1e-07 Score=87.45 Aligned_cols=84 Identities=7% Similarity=-0.084 Sum_probs=55.2
Q ss_pred cee-cccCcEEEEEEEEc-------CCcEEEEEEcccCCC--CChhHHHHHHHHHHHhcC-C--CCccceeeeeeeccCc
Q 012297 230 NIV-GQGGSSYVYRGQLT-------DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLH-H--CHVVPLVGYCSEFRGK 296 (466)
Q Consensus 230 ~~L-G~G~fG~Vy~a~~~-------~~~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~-H--~nIv~llg~~~~~~~~ 296 (466)
+.| +.|....+|+.... +++.+++|+...... ......+.+|+.+++.+. + -.+.++++++.+...
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~- 104 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV- 104 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT-
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc-
Confidence 467 78889999998764 267789998654320 101124788999988885 3 356677877654221
Q ss_pred ceeEEEEEecCCCCCHHH
Q 012297 297 RAMRLLVFEFMPNGNLRD 314 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~ 314 (466)
....++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 124589999999876643
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.06 E-value=1.8e-05 Score=75.78 Aligned_cols=78 Identities=24% Similarity=0.325 Sum_probs=56.1
Q ss_pred CCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCC---CccceeeeeeeccCcceeEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC---HVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~llg~~~~~~~~~~~~~l 302 (466)
....+.+|.|..+.||+.++.||+.++||+..... ......|..|.+.|+.|... .+.+++++.. .++
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~--------~~l 87 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD--------RTL 87 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET--------TEE
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEeccC--------ceE
Confidence 33446789999999999999999999999866443 23334588999999988532 3445554321 278
Q ss_pred EEecCCCCCH
Q 012297 303 VFEFMPNGNL 312 (466)
Q Consensus 303 V~ey~~~gsL 312 (466)
||||++++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.06 E-value=1.3e-05 Score=78.10 Aligned_cols=141 Identities=17% Similarity=0.258 Sum_probs=79.4
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCC--CCccceeee-----eeeccCcceeEEE
Q 012297 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH--CHVVPLVGY-----CSEFRGKRAMRLL 302 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~llg~-----~~~~~~~~~~~~l 302 (466)
+.|+.|..+.||+....++ .+++|+.... ...+..|.++++.+.. -.+.+++.. +.. .....++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~---~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSK---HGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEE---ETTEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEE---ECCEEEE
Confidence 3466677899999987655 4889988752 1234455666665531 123334321 111 1235689
Q ss_pred EEecCCCCCHH-----------H---Hhccccc------------CCCCHHHHH--------------------------
Q 012297 303 VFEFMPNGNLR-----------D---CLDGVLV------------EGMNWDTRV-------------------------- 330 (466)
Q Consensus 303 V~ey~~~gsL~-----------~---~l~~~~~------------~~~~~~~~~-------------------------- 330 (466)
+|||++|.++. . .++.... ....|....
T Consensus 109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 188 (346)
T 2q83_A 109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY 188 (346)
T ss_dssp EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence 99999986542 1 1111100 001332211
Q ss_pred -----HHHHHHHHHHHHHHh----------CCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 331 -----AIAIGAARGLEYLHE----------AAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 331 -----~i~~qia~~L~~LH~----------~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.+..++.+++++|+. ...+.++|+|+++.|||++.++.+.|+||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111224446667763 1234699999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=2.1e-05 Score=78.89 Aligned_cols=76 Identities=20% Similarity=0.185 Sum_probs=48.0
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEcccCCC------CChhHHHHHHHHHHHhcCC--CCcc-ceeeeeeeccCcce
Q 012297 229 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG------PNADSVFLTEVDMLSRLHH--CHVV-PLVGYCSEFRGKRA 298 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~------~~~~~~f~~Ei~~l~~l~H--~nIv-~llg~~~~~~~~~~ 298 (466)
.+.||.|..+.||++... +++.++||....... ......+..|.++++.+.. +..+ +++.+ +. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~----~ 108 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT----E 108 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET----T
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC----C
Confidence 357899999999999764 467899998653211 1123346789999988742 3334 45543 21 1
Q ss_pred eEEEEEecCCCC
Q 012297 299 MRLLVFEFMPNG 310 (466)
Q Consensus 299 ~~~lV~ey~~~g 310 (466)
..++||||+++.
T Consensus 109 ~~~lvmE~l~g~ 120 (397)
T 2olc_A 109 MAVTVMEDLSHL 120 (397)
T ss_dssp TTEEEECCCTTS
T ss_pred ccEEEEEeCCCc
Confidence 238999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00011 Score=71.23 Aligned_cols=137 Identities=17% Similarity=0.181 Sum_probs=88.5
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC---CCCccceeeeeeeccCcceeEEEEEe
Q 012297 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
.+.|+.|....+|+... ++..+++|+.... ....|..|.+.|+.+. ...+.+++++... ....++|||
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~----~g~~~lvme 111 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS----QGHSFLLLE 111 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC----SSEEEEEEE
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec----CCceEEEEE
Confidence 35688999999999986 4677889986542 2456889999998884 2556778877654 245699999
Q ss_pred cCCCCCHH--------HH---hccccc-C-------------------CCCHHHHH---HHHH----------------H
Q 012297 306 FMPNGNLR--------DC---LDGVLV-E-------------------GMNWDTRV---AIAI----------------G 335 (466)
Q Consensus 306 y~~~gsL~--------~~---l~~~~~-~-------------------~~~~~~~~---~i~~----------------q 335 (466)
|+++..+. +. |+.... . .-+|.+.. ++.. .
T Consensus 112 ~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~ 191 (312)
T 3jr1_A 112 ALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDL 191 (312)
T ss_dssp CCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHH
T ss_pred eccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHH
Confidence 99987642 11 222111 0 02454322 1111 1
Q ss_pred HH-HHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 012297 336 AA-RGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLG 375 (466)
Q Consensus 336 ia-~~L~~LH~-~~~~~ivHrDLk~~NILld~~~~vkL~DfG 375 (466)
+. +....|.. ...|.++|+|+.+.|++++.++ +.|+|+.
T Consensus 192 l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 192 IVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 11223422 2346799999999999999887 8999984
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00024 Score=68.28 Aligned_cols=71 Identities=8% Similarity=-0.014 Sum_probs=44.5
Q ss_pred cceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCc-cceeeeeeeccCcceeEEEEEecC
Q 012297 229 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAMRLLVFEFM 307 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~llg~~~~~~~~~~~~~lV~ey~ 307 (466)
.+.|+.|....+|+. +.+++|+........ ....+|..+++.+....+ .+++++..+ .-++++||+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~--~~r~~E~~~l~~l~~~g~~P~~~~~~~~------~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY--INRANEAVAAREAAKAGVSPEVLHVDPA------TGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C--CCHHHHHHHHHHHHHTTSSCCEEEECTT------TCCEEEECC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce--eCHHHHHHHHHHHHHcCCCCceEEEECC------CCEEEEeec
Confidence 567888999999998 458889876542211 113568888887753344 355554321 127899999
Q ss_pred -CCCCH
Q 012297 308 -PNGNL 312 (466)
Q Consensus 308 -~~gsL 312 (466)
++.+|
T Consensus 90 ~~g~~l 95 (301)
T 3dxq_A 90 AGAQTM 95 (301)
T ss_dssp TTCEEC
T ss_pred CCCccC
Confidence 65444
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00019 Score=72.54 Aligned_cols=77 Identities=10% Similarity=0.094 Sum_probs=45.6
Q ss_pred CCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccc--cCcccccchhcccC---CCCchhHHHHHH
Q 012297 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ--GTFGYFAPEYAMVG---RASLMSDVFSFG 422 (466)
Q Consensus 348 ~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~s~~sDv~S~G 422 (466)
.+.++|+|+++.|||+++++ ++|+||+.+....+... ..... -...|.+|+..... ......++....
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D------la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD------IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTI 303 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH------HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH------HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHH
Confidence 45699999999999998876 99999998875321100 00000 01234555544311 112235556777
Q ss_pred HHHHHHHcC
Q 012297 423 VVLLELITG 431 (466)
Q Consensus 423 vll~elltG 431 (466)
..+|+.+++
T Consensus 304 ~~~~~~y~~ 312 (420)
T 2pyw_A 304 EQTWNLFNK 312 (420)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 777777664
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00051 Score=66.41 Aligned_cols=161 Identities=9% Similarity=0.099 Sum_probs=88.0
Q ss_pred echHHHHHHhCCCCCc-----ceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCC--ccce
Q 012297 214 FSYSALEHATDKFSGS-----NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPL 286 (466)
Q Consensus 214 ~~~~~l~~~t~~f~~~-----~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l 286 (466)
++.+++......|... +.|+.|....+|+....++ .+++|+....... ..+..|+.++..+.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~---~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH---HHHHHHHHHHHHHHHCCCCCCcc
Confidence 3445555555556542 3466788899999987666 5788988753111 23567888887774322 2333
Q ss_pred eeeeeecc---CcceeEEEEEecCCCCCHHH-----------H---hccc----ccC---C---CCHHHHHH--------
Q 012297 287 VGYCSEFR---GKRAMRLLVFEFMPNGNLRD-----------C---LDGV----LVE---G---MNWDTRVA-------- 331 (466)
Q Consensus 287 lg~~~~~~---~~~~~~~lV~ey~~~gsL~~-----------~---l~~~----~~~---~---~~~~~~~~-------- 331 (466)
+... +.. ......+++|+|++|..+.. . ++.. ... . ..|.....
T Consensus 83 ~~~~-~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 83 LPRK-DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp CCBT-TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cCCC-CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3210 000 01234589999998865311 0 1111 000 0 11322111
Q ss_pred ----HHHHHHHHHHHHHhC----CCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 332 ----IAIGAARGLEYLHEA----AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 332 ----i~~qia~~L~~LH~~----~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
+...+...++.|... ..+.++|+|+++.|||++++..+.|+||+.+..
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244456666532 123599999999999999876568999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00085 Score=68.52 Aligned_cols=74 Identities=11% Similarity=0.058 Sum_probs=48.3
Q ss_pred cceecccCcEEEEEEEEcC-CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCcc-ceeeeeeeccCcceeEEEEEec
Q 012297 229 SNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~llg~~~~~~~~~~~~~lV~ey 306 (466)
.+.|+.|-...+|+....+ +..+++|+......... ...+|..+++.+...++. ++++++.. .+||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i--dR~~E~~vl~~L~~~gl~P~ll~~~~~--------G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII--NREREKKISCILYNKNIAKKIYVFFTN--------GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS--CHHHHHHHHHHHTTSSSBCCEEEEETT--------EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc--CHHHHHHHHHHHHhcCCCCCEEEEeCC--------eEEEEe
Confidence 3467778889999998865 47888998754321111 125889999999766564 66666521 359999
Q ss_pred CCCCCH
Q 012297 307 MPNGNL 312 (466)
Q Consensus 307 ~~~gsL 312 (466)
+++.+|
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00072 Score=65.80 Aligned_cols=141 Identities=15% Similarity=0.124 Sum_probs=73.6
Q ss_pred ceecccCcEE-EEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCC--CccceeeeeeeccCcceeEEEEEec
Q 012297 230 NIVGQGGSSY-VYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--HVVPLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 230 ~~LG~G~fG~-Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~llg~~~~~~~~~~~~~lV~ey 306 (466)
+.|+.|.... +|+....++..+++|....... ..+..|+.+++.+... .+.+++.+..+ .. +++||+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~----~g--~ll~e~ 93 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHA----RG--LLLIED 93 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETT----TT--EEEECC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCC----CC--EEEEee
Confidence 3455555444 6677654467777776543321 1245677777777422 34456655321 12 689999
Q ss_pred CCCCCHHHHhccccc------------------------CCCCHHHHH-------H-------------HHHHHHHHHHH
Q 012297 307 MPNGNLRDCLDGVLV------------------------EGMNWDTRV-------A-------------IAIGAARGLEY 342 (466)
Q Consensus 307 ~~~gsL~~~l~~~~~------------------------~~~~~~~~~-------~-------------i~~qia~~L~~ 342 (466)
+.+..+.+++..... ..++..... . ....+...++.
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 977777554432100 012211100 0 00112222333
Q ss_pred HHh---CCCCCeEecCCCCCCEEEcCC----CcEEEEecCCcccc
Q 012297 343 LHE---AAAPRILHRDIKSSNILLDEN----LNAKITDLGMAKRL 380 (466)
Q Consensus 343 LH~---~~~~~ivHrDLk~~NILld~~----~~vkL~DfGla~~~ 380 (466)
|.+ ...+.++|||+.+.|||++++ ..+.|+||+.+...
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 311 123469999999999999875 67999999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00048 Score=69.81 Aligned_cols=72 Identities=19% Similarity=0.295 Sum_probs=49.7
Q ss_pred ceecccCcEEEEEEEEcC--------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCc-cceeeeeeeccCcceeE
Q 012297 230 NIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~--------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~llg~~~~~~~~~~~~ 300 (466)
+.|+.|....+|+....+ ++.+++|+.... .....+.+|..+++.+...++ .++++.+.+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~-------- 147 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG-------- 147 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--------
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC--------
Confidence 467788899999998753 578999988432 111346689999998864444 466665432
Q ss_pred EEEEecCCCCCH
Q 012297 301 LLVFEFMPNGNL 312 (466)
Q Consensus 301 ~lV~ey~~~gsL 312 (466)
.+|+||++|.+|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 389999986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0012 Score=65.66 Aligned_cols=140 Identities=19% Similarity=0.219 Sum_probs=82.3
Q ss_pred ceecccCcEEEEEEEEc--------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCc-cceeeeeeeccCcceeE
Q 012297 230 NIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~--------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~llg~~~~~~~~~~~~ 300 (466)
+.|..|-...+|+.... +++.+++|+.-.. ......+.+|..+++.+...++ .++++++.+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-------- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE-------- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--------
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--------
Confidence 45666888899999875 2478999986332 1223446789999988853333 466665432
Q ss_pred EEEEecCCCCCHHHH-----------------hcccc---cCCCC--HHHHHHHHHHHHH-------------------H
Q 012297 301 LLVFEFMPNGNLRDC-----------------LDGVL---VEGMN--WDTRVAIAIGAAR-------------------G 339 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~-----------------l~~~~---~~~~~--~~~~~~i~~qia~-------------------~ 339 (466)
.+||||++|.+|..- |+... .+... |.++.++..++.. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 289999988655311 11111 11122 3444444433321 2
Q ss_pred HHHH----HhCC-CCCeEecCCCCCCEEEcCC----CcEEEEecCCccc
Q 012297 340 LEYL----HEAA-APRILHRDIKSSNILLDEN----LNAKITDLGMAKR 379 (466)
Q Consensus 340 L~~L----H~~~-~~~ivHrDLk~~NILld~~----~~vkL~DfGla~~ 379 (466)
++.| .... ...++|+|+.+.|||++++ +.+.|+||..+..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3333 2222 2359999999999999876 7899999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0029 Score=61.14 Aligned_cols=143 Identities=16% Similarity=0.158 Sum_probs=81.7
Q ss_pred ceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCC--ccceeeeeeecc---CcceeEEEEE
Q 012297 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSEFR---GKRAMRLLVF 304 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~llg~~~~~~---~~~~~~~lV~ 304 (466)
..++ |....||+....+|+.+++|+...... ....+..|..+++.+.... +.+++.. +.. ...+..+++|
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEE
Confidence 3466 888899998877787899999874321 2334677888888875322 3444432 110 0123558899
Q ss_pred ecCCCCCHH-----HH---------hcccc-------cCCCCHHHH----HHH---------------HHHHHHHHHHHH
Q 012297 305 EFMPNGNLR-----DC---------LDGVL-------VEGMNWDTR----VAI---------------AIGAARGLEYLH 344 (466)
Q Consensus 305 ey~~~gsL~-----~~---------l~~~~-------~~~~~~~~~----~~i---------------~~qia~~L~~LH 344 (466)
||++|..+. .+ ++... ....++... ..+ ...+...++.+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 999875431 11 11100 011222211 001 111112233332
Q ss_pred hC----CCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 345 EA----AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 345 ~~----~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.. ..+.++|+|+++.|||++ + .+.|+||+.+..
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 21 234589999999999999 4 899999988764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0009 Score=66.15 Aligned_cols=73 Identities=10% Similarity=0.122 Sum_probs=44.0
Q ss_pred ceecccCcEEEEEEEEcC---------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCcc-ceeeeeeeccCccee
Q 012297 230 NIVGQGGSSYVYRGQLTD---------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAM 299 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~---------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~llg~~~~~~~~~~~ 299 (466)
..|+.|....+|+....+ ++.+++|+...... .......|.++++.+...+++ ++++...
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~~-------- 108 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTFN-------- 108 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEET--------
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEecC--------
Confidence 457778889999998754 26788888754321 111246788888888544443 5665431
Q ss_pred EEEEEecCCCCCH
Q 012297 300 RLLVFEFMPNGNL 312 (466)
Q Consensus 300 ~~lV~ey~~~gsL 312 (466)
-++||||++|..+
T Consensus 109 ~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 GGRIEEWLYGDPL 121 (369)
T ss_dssp TEEEEECCCSEEC
T ss_pred CcEEEEEecCCcC
Confidence 1689999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.003 Score=61.69 Aligned_cols=32 Identities=22% Similarity=0.248 Sum_probs=28.2
Q ss_pred CCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 349 PRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 349 ~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
+.++|+|+.+.||++++++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998888999999887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.04 E-value=0.029 Score=56.45 Aligned_cols=73 Identities=11% Similarity=0.130 Sum_probs=48.5
Q ss_pred ceecccCcEEEEEEEEcC--------CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCc-cceeeeeeeccCcceeE
Q 012297 230 NIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~--------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~llg~~~~~~~~~~~~ 300 (466)
+.+..|-...+|+....+ ++.+++|+........ .+..+|..+++.+...++ .++++.+. -
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~--idR~~E~~~l~~L~~~gi~P~l~~~~~--------~ 145 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF--YDSKVELDVFRYLSNINIAPNIIADFP--------E 145 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC--CCHHHHHHHHHHHHHTTSSCCEEEEET--------T
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh--cCHHHHHHHHHHHHhcCCCCCEEEEcC--------C
Confidence 456678889999998763 5789999865432211 124578888888854444 45555332 1
Q ss_pred EEEEecCCCCCH
Q 012297 301 LLVFEFMPNGNL 312 (466)
Q Consensus 301 ~lV~ey~~~gsL 312 (466)
++||||++|.+|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 789999998664
|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.71 E-value=0.0024 Score=49.20 Aligned_cols=48 Identities=21% Similarity=0.495 Sum_probs=31.9
Q ss_pred CcccceEEeccCCCCCchhhcccCCcccccccCC-----CCCCCCeeeeeecCCCCCc
Q 012297 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSPV-----GGSSEGKWTCICAADGLPK 83 (466)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~-----~~~~~~~~~c~~~~~g~~~ 83 (466)
...+|+|.|..||+||+ +- ..|.+..+|.+. =....|+|+|.|. |+++
T Consensus 21 ~~g~y~C~C~~G~~~~~-~g--~~C~dideC~~~~C~~~C~n~~g~y~C~C~--g~~G 73 (87)
T 1z6c_A 21 IPGDFECECPEGYRYNL-KS--KSCEDIDECSENMCAQLCVNYPGGYTCYCD--GKKG 73 (87)
T ss_dssp BTTBCCCSSSTTCEEET-TT--TEEECCCHHHHSCCSSEECCCSSSCCEECC--SSSC
T ss_pred CCCCEEEECCCCceECC-CC--CcCCCcCeeCCCCCCCEEEccCCCEEEECC--CCcC
Confidence 34689999999999876 32 256655554321 1346788999995 5554
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.33 E-value=0.047 Score=54.44 Aligned_cols=29 Identities=28% Similarity=0.416 Sum_probs=25.1
Q ss_pred eEecCCCCCCEEE------cCCCcEEEEecCCccc
Q 012297 351 ILHRDIKSSNILL------DENLNAKITDLGMAKR 379 (466)
Q Consensus 351 ivHrDLk~~NILl------d~~~~vkL~DfGla~~ 379 (466)
++|+|+.+.|||+ +++..+.++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999998864
|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
Probab=95.29 E-value=0.0028 Score=48.69 Aligned_cols=50 Identities=20% Similarity=0.564 Sum_probs=34.3
Q ss_pred CcccceEEeccCCCCCchhhcccCCcccccccCCC--------CCCCCeeeeeecCCCCCc
Q 012297 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSPVG--------GSSEGKWTCICAADGLPK 83 (466)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~--------~~~~~~~~c~~~~~g~~~ 83 (466)
..++|+|.|..||+|++ +.. .+|.+..+|.... ....|+|+|.| ..|+..
T Consensus 21 ~~g~y~C~C~~Gy~~~~-~~g-~~C~dideC~~~~~~C~~~~C~n~~g~y~C~C-~~G~~~ 78 (86)
T 1lmj_A 21 TPGDFECKCDEGYESGF-MMM-KNCMDIDECQRDPLLCRGGVCHNTEGSYRCEC-PPGHQL 78 (86)
T ss_dssp ETTEEEECCCSSEEECT-TTS-SSEEECCHHHHCSSTTTTSEEEEETTEEEEES-CTTSCC
T ss_pred CCCCEEeeCCCCcCccC-CCC-CccCCcccccCCCCcCCCCEeEcCCCCEEEEC-cCCccc
Confidence 34689999999999876 333 4777666664321 23578899999 666654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.02 E-value=0.078 Score=48.00 Aligned_cols=103 Identities=13% Similarity=0.089 Sum_probs=67.8
Q ss_pred CCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCC
Q 012297 310 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389 (466)
Q Consensus 310 gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~ 389 (466)
-+|.+.|+.. ..++++.+++.++.|.+..|.-+-....+ ..+=+-|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence 4789999864 47799999999999999998776321111 1223346899999999988764 1110
Q ss_pred CCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCC
Q 012297 390 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434 (466)
Q Consensus 390 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~P 434 (466)
.....+.|||... ...+.+.=|||||+++|.-+--..|
T Consensus 98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0112367888653 4557889999999999999975554
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.19 E-value=0.043 Score=36.00 Aligned_cols=19 Identities=16% Similarity=0.223 Sum_probs=7.9
Q ss_pred HHHHHHHHHHHHHHhhcCC
Q 012297 129 LTTIAFLMLVLCYVYRKGK 147 (466)
Q Consensus 129 ~~~l~~l~~~~~~~~rr~k 147 (466)
++++++++++++++.||++
T Consensus 21 v~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 21 LLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHHHhhhhH
Confidence 3333444444444444443
|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A | Back alignment and structure |
|---|
Probab=94.13 E-value=0.014 Score=44.18 Aligned_cols=47 Identities=19% Similarity=0.532 Sum_probs=29.0
Q ss_pred CcccceEEeccCCCCCchhhcccCCccccccc------CCC-CCCCCeeeeeecCCCCCc
Q 012297 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCS------PVG-GSSEGKWTCICAADGLPK 83 (466)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~------~~~-~~~~~~~~c~~~~~g~~~ 83 (466)
...+|+|.|..||.|+- .+|.+..+|. ... ....|+|+|.| ..||.+
T Consensus 22 ~~g~y~C~C~~Gy~~~g-----~~C~dideC~~~~~C~~~~C~n~~g~y~C~C-~~G~~g 75 (82)
T 1emn_A 22 TDGSYRCECPFGYILAG-----NECVDTDECSVGNPCGNGTCKNVIGGFECTC-EEGFEP 75 (82)
T ss_dssp CSSCCCEECCTTEEEET-----TEEEECCGGGTCCTTSSSCEEECSSSEEECC-SSSSCC
T ss_pred cCCCEEEECCCCeECCC-----CccCCcccccCCCCCCCCEeECCCCCEEeEC-CCCeEe
Confidence 34689999999997522 2344433333 110 23578899998 667665
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=94.01 E-value=0.034 Score=36.34 Aligned_cols=10 Identities=10% Similarity=0.129 Sum_probs=4.3
Q ss_pred HHHHHHhhcC
Q 012297 137 LVLCYVYRKG 146 (466)
Q Consensus 137 ~~~~~~~rr~ 146 (466)
.+++|++||+
T Consensus 30 ~~~~~~RRR~ 39 (44)
T 2jwa_A 30 VFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHC
T ss_pred HHHhheehhh
Confidence 3344444444
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.98 E-value=0.034 Score=36.41 Aligned_cols=19 Identities=16% Similarity=0.230 Sum_probs=7.9
Q ss_pred HHHHHHHHHHHHHHhhcCC
Q 012297 129 LTTIAFLMLVLCYVYRKGK 147 (466)
Q Consensus 129 ~~~l~~l~~~~~~~~rr~k 147 (466)
+++++++++.++++.||++
T Consensus 20 v~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 20 LFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHhhhhh
Confidence 3333344444444444443
|
| >2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A | Back alignment and structure |
|---|
Probab=92.91 E-value=0.02 Score=45.84 Aligned_cols=48 Identities=21% Similarity=0.551 Sum_probs=17.2
Q ss_pred CcccceEEeccCCCCCchhhcccCCcccccccC------CCCCCCCeeeeeecCCCCCc
Q 012297 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSP------VGGSSEGKWTCICAADGLPK 83 (466)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~------~~~~~~~~~~c~~~~~g~~~ 83 (466)
..++|+|.|..||+|+. ...|++..+|.. .=....|+|+|.| ..|+..
T Consensus 46 ~~g~y~C~C~~Gy~g~~----g~~C~dideC~~~~~C~~~C~n~~gsy~C~C-~~Gy~~ 99 (107)
T 2w2n_E 46 LKIGYECLCPDGFQLVA----QRRCEDIDECQDPDTCSQLCVNLEGGYKCQC-EEGFQL 99 (107)
T ss_dssp CSBSCEEECCTTCEEET----TTEEEC--------------------------------
T ss_pred CCCCeEEECCCCccccC----CCccccccccCCCCCcCCeeecCCCCEEEEC-CCCceE
Confidence 34689999999999953 146666666642 1134578899988 556654
|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* | Back alignment and structure |
|---|
Probab=92.10 E-value=0.067 Score=43.17 Aligned_cols=58 Identities=28% Similarity=0.521 Sum_probs=32.5
Q ss_pred hhhhccccccccCcccceEEeccCCCCCchhhcc---cCCcc-cccccCCCCCCCCeeeeeecCCCCCc
Q 012297 19 QRSICDKLSERSGQKNWKCTCSSSLQGDQSNILK---LNCSR-SCDCSPVGGSSEGKWTCICAADGLPK 83 (466)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~c~~-~~~~~~~~~~~~~~~~c~~~~~g~~~ 83 (466)
.++.|.+ ..++|+|.|..||.|+. =... +.|.. .+.|..+=....|+|+|.| ..|+.+
T Consensus 24 ~~g~C~~-----~~~~y~C~C~~G~~G~~-C~~~~~~~~C~~~~~~C~~~C~n~~g~y~C~C-~~G~~~ 85 (114)
T 1aut_L 24 GHGTCID-----GIGSFSCDCRSGWEGRF-CQREVSFLNCSLDNGGCTHYCLEEVGWRRCSC-APGYKL 85 (114)
T ss_dssp TSEEECC-----CSSCCCEEECTTEESTT-SCEECCSSSSSSGGGGCSSEEEECSSSEEEEC-CTTEEE
T ss_pred CcCCCCC-----CCCCcEeeCCCCCcCCC-cCcCCcCCcCcCCCCCCCCEeECCCCCEEeEC-CCCeeE
Confidence 4455654 34789999999998853 1110 01321 1112111123578999999 667654
|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A | Back alignment and structure |
|---|
Probab=90.78 E-value=0.064 Score=45.10 Aligned_cols=59 Identities=20% Similarity=0.452 Sum_probs=37.2
Q ss_pred hhhhccccccccCcccceEEeccCCCCCchhh------cccCCcccccccC-------CC--CCCCCeeeeeecCCCCCc
Q 012297 19 QRSICDKLSERSGQKNWKCTCSSSLQGDQSNI------LKLNCSRSCDCSP-------VG--GSSEGKWTCICAADGLPK 83 (466)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~c~~~~~~~~-------~~--~~~~~~~~c~~~~~g~~~ 83 (466)
.++.|.+ ...+|+|.|..||.|++ +. ....|.+..+|.. .+ ....|+|+|.| ..|+.+
T Consensus 57 ~~~~C~n-----~~g~y~C~C~~Gy~g~~-~~~~~~~~~~~~C~dideC~~~~~~C~~~~~C~n~~g~y~C~C-~~Gy~g 129 (143)
T 2bou_A 57 KFSDCWN-----TEGSYDCVCSPGYEPVS-GAKTFKNESENTCQDVDECSSGQHQCDSSTVCFNTVGSYSCRC-RPGWKP 129 (143)
T ss_dssp TTEEEEE-----CSSCEEEEECTTEEETT-CCSCBSSGGGCCEEECCHHHHTCCCCCTTSEEEECSSCEEEEC-CSSSCB
T ss_pred CCCEEEc-----CCCCeEeECCCCcccCc-CccccccCCCCCcCCccCccCcCCCCCCCCEEECCCCCEEeeC-CCCccc
Confidence 3455644 33589999999999974 21 0136665555542 11 24678999999 667765
Q ss_pred c
Q 012297 84 V 84 (466)
Q Consensus 84 ~ 84 (466)
.
T Consensus 130 ~ 130 (143)
T 2bou_A 130 R 130 (143)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* | Back alignment and structure |
|---|
Probab=89.35 E-value=0.15 Score=43.19 Aligned_cols=60 Identities=18% Similarity=0.497 Sum_probs=33.3
Q ss_pred CcccceEEeccCCCCCchhhcccCCccc-ccccCCC-CCCCCeeeeeecCCCCCccccccCCccccc
Q 012297 31 GQKNWKCTCSSSLQGDQSNILKLNCSRS-CDCSPVG-GSSEGKWTCICAADGLPKVAANSYDTTCFA 95 (466)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~c~~~-~~~~~~~-~~~~~~~~c~~~~~g~~~~~~~~~~~~c~~ 95 (466)
..++|+|.|..||.|.. =...+-|... +.|...= ....|+|+|.| .+|+-.. ..+..|..
T Consensus 65 ~~~~y~C~C~~G~~G~~-C~~~deC~~~~~~C~~~C~~n~~g~y~C~C-~~Gy~l~---~dG~~C~~ 126 (146)
T 1x7a_L 65 DINSYECWCQVGFEGKN-CELDATCNIKNGRCKQFCKTGADSKVLCSC-TTGYRLA---PDQKSCKP 126 (146)
T ss_dssp CSSCEEEECCSSEESTT-TCEECCTTSGGGSCSSBCCCCSSSCCCCBC-CTTEEEC---TTSSSEEE
T ss_pred CCCCEEEecCCCCcCCc-CCCCccccCCCCCCcCCCCCCCCCCEEeEc-CCCcEeC---CCCCcCCC
Confidence 34689999999998842 1111223321 1222221 34578999999 6676532 22456654
|
| >3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.87 E-value=0.46 Score=45.44 Aligned_cols=53 Identities=28% Similarity=0.680 Sum_probs=34.0
Q ss_pred cccceEEeccCCCCCchhhcccCCc-ccccccC--------CCCCCCCeeeeeecCCCCCccccccCCccccc
Q 012297 32 QKNWKCTCSSSLQGDQSNILKLNCS-RSCDCSP--------VGGSSEGKWTCICAADGLPKVAANSYDTTCFA 95 (466)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~~~~c~-~~~~~~~--------~~~~~~~~~~c~~~~~g~~~~~~~~~~~~c~~ 95 (466)
.++|+|.|..||.|+ +|+ +..+|.+ .=....|+|+|.| ..|+-+. .....|..
T Consensus 23 ~~~~~C~C~~g~~g~-------~C~~~~~eC~~~~~~~C~~~C~~~~g~~~C~C-~~g~~~~---~~~~~C~~ 84 (317)
T 3h5c_B 23 IWGYTCTCSPGYEGS-------NCELAKNECHPERTDGCQHFCLPGQESYTCSC-AQGYRLG---EDHKQCVP 84 (317)
T ss_dssp SSSCCCCCSSSCCSS-------SSCCCSSSCCTTCTTSCSSEEECCSSSCEEEC-CTTEECC---TTSSCCEE
T ss_pred CCCeEEECCCCCcCC-------ccccCcccCCCCCCCCCcCccccCCCeeEEec-ccccccc---cccccccc
Confidence 468999999999986 343 3334433 1124578999999 6676542 22456755
|
| >1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A | Back alignment and structure |
|---|
Probab=87.69 E-value=0.13 Score=45.28 Aligned_cols=49 Identities=18% Similarity=0.506 Sum_probs=31.0
Q ss_pred CcccceEEeccCCCCCchhhcccCCccccccc---------CCC--CCCC-----CeeeeeecCCCCCcc
Q 012297 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCS---------PVG--GSSE-----GKWTCICAADGLPKV 84 (466)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~---------~~~--~~~~-----~~~~c~~~~~g~~~~ 84 (466)
..++|+|.|..||.|+. ...|.+..+|. ..+ .... |+|+|.| ..||-+.
T Consensus 21 ~~g~~~C~C~~G~~g~~----~~~C~~id~C~~~~~~~~C~~~~~C~~~~~~~~~g~y~C~C-~~G~~g~ 85 (186)
T 1z1y_A 21 MSNHFXCMCNEGLVHLS----ENTCEEXNECXXETLGXACGEFGQCIENPDPAQVNMYXCGC-IEGYTLX 85 (186)
T ss_dssp CSSCEEEEECTTEEEEE----TTEEEECCCCSGGGTTSEEETTEEEEECSSTTSSCSEEEEE-CTTEEEE
T ss_pred CCCCeEeECCCCCccCC----CCccCCCCcccCCCCCCCCCCCCEeecCCCCcCCCCEECCC-CCCCccC
Confidence 34689999999999863 12454443333 221 1223 8999999 7777653
|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* | Back alignment and structure |
|---|
Probab=87.18 E-value=0.14 Score=45.50 Aligned_cols=59 Identities=24% Similarity=0.620 Sum_probs=14.4
Q ss_pred hhhhhccccccccCcccceEEeccCCCCCchhhcc-cCCccc-ccccCCCCCCCCeeeeeecCCCCC
Q 012297 18 IQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILK-LNCSRS-CDCSPVGGSSEGKWTCICAADGLP 82 (466)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~c~~~-~~~~~~~~~~~~~~~c~~~~~g~~ 82 (466)
..++.|.+ ..++|+|.|..||.|..=-... +-|... +.|...=....|+|+|.| ..|+-
T Consensus 51 ~ngg~C~n-----~~g~y~C~C~~Gf~G~~Ce~~i~deC~~~~~~C~~~C~n~~gsy~C~C-~~Gy~ 111 (195)
T 1nfu_B 51 QNQGKCKD-----GLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSC-ARGYT 111 (195)
T ss_dssp -----------------------------------CCGGGTGGGGCSSEEEEETTEEEEEC-CTTEE
T ss_pred CCCCEeEC-----CCCCeeEeCCCCceeccccccccccccCCCCCCCCEeECCCCCeEEEC-CCCce
Confidence 34456654 3468999999999984310000 113321 222221123578999999 56665
|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A | Back alignment and structure |
|---|
Probab=87.06 E-value=0.25 Score=41.37 Aligned_cols=48 Identities=21% Similarity=0.647 Sum_probs=31.7
Q ss_pred cceEEeccCCCCCchhhc---ccCCcccccccCC--------C--CCCCCeeeeeecCCCCCc
Q 012297 34 NWKCTCSSSLQGDQSNIL---KLNCSRSCDCSPV--------G--GSSEGKWTCICAADGLPK 83 (466)
Q Consensus 34 ~~~~~~~~~~~~~~~~~~---~~~c~~~~~~~~~--------~--~~~~~~~~c~~~~~g~~~ 83 (466)
.|+|.|..||+|++ ++. ...|.+..+|... + ....|+|+|.| ..||.+
T Consensus 18 ~~~C~C~~G~~g~~-~~~~~~~~~C~dideC~~~~~~~C~~~~~C~n~~g~y~C~C-~~Gy~g 78 (143)
T 2bou_A 18 ATACRCNPGFSSFS-EIITTPMETCDDINECATLSKVSCGKFSDCWNTEGSYDCVC-SPGYEP 78 (143)
T ss_dssp SSCEEECTTEECSS-SSBCSTTCCCEECCGGGC----CCCTTEEEEECSSCEEEEE-CTTEEE
T ss_pred CCEEeCCCCCcCcc-ccccCCCCcCCccccccCCCCCCCCCCCEEEcCCCCeEeEC-CCCccc
Confidence 48999999999985 321 1356655555432 1 23568999999 667665
|
| >3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=86.50 E-value=0.16 Score=50.22 Aligned_cols=48 Identities=23% Similarity=0.538 Sum_probs=8.6
Q ss_pred CcccceEEeccCCCCCchhhcccCCccccccc------CCCCCCCCeeeeeecCCCCC
Q 012297 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCS------PVGGSSEGKWTCICAADGLP 82 (466)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~------~~~~~~~~~~~c~~~~~g~~ 82 (466)
..++|+|.|..||+.++ +- ..|.+..+|. +.=....|+|+|.| ..|+.
T Consensus 20 ~~g~~~C~C~~G~~l~~-~~--~~C~d~~eC~~~~~C~~~C~~~~g~~~C~C-~~g~~ 73 (386)
T 3v65_B 20 IRGAVQCTCHTGYRLTE-DG--RTCQDVNECAEEGYCSQGCTNSEGAFQCWC-EAGYE 73 (386)
T ss_dssp -----------------------------------CCTTEEC-----CCEEC-CTTEE
T ss_pred CCCCcEeECCCCceECC-CC--CccCccceeCCcCcccCcCCCCCCCCeEEE-CCCce
Confidence 33569999999998665 22 3676665564 11134678999999 66664
|
| >1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A | Back alignment and structure |
|---|
Probab=86.37 E-value=0.16 Score=41.23 Aligned_cols=48 Identities=17% Similarity=0.450 Sum_probs=26.4
Q ss_pred cccceEEeccCCCCCchhhcccCCcc---cccccCCCCCCCCeeeeeecCCCCCc
Q 012297 32 QKNWKCTCSSSLQGDQSNILKLNCSR---SCDCSPVGGSSEGKWTCICAADGLPK 83 (466)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~~~~c~~---~~~~~~~~~~~~~~~~c~~~~~g~~~ 83 (466)
.++|+|.|..||+|+..-+ +.|.. ...|..+=.. .|.|+|.| ..|+..
T Consensus 21 ~g~y~C~C~~Gy~g~~~~~--~~C~~~C~~~~C~~~C~~-~~~y~C~C-~~Gy~~ 71 (118)
T 1dx5_I 21 QTSYLCVCAEGFAPIPHEP--HRCQMFCNQTACPADCDP-NTQASCEC-PEGYIL 71 (118)
T ss_dssp SSCEEEECCTTEEEETTEE--EEEEECCCSSEEECEECT-TSTTCEEC-CTTEEE
T ss_pred CCCEEeECCCCccccCCCC--CccccccCCCCCCCcccC-CCCeEeEC-CCCccC
Confidence 3678899998888864211 23332 1112210011 37788888 667763
|
| >3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L | Back alignment and structure |
|---|
Probab=86.20 E-value=0.43 Score=47.32 Aligned_cols=48 Identities=21% Similarity=0.555 Sum_probs=32.4
Q ss_pred CcccceEEeccCCCCCchhhcccCCccccccc------CCCCCCCCeeeeeecCCCCCc
Q 012297 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCS------PVGGSSEGKWTCICAADGLPK 83 (466)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~------~~~~~~~~~~~c~~~~~g~~~ 83 (466)
..++|+|.|..||+++. ..+|.+..+|. +.=....|+|+|.| ..|+..
T Consensus 17 ~~~~y~C~C~~G~~~~~----~~~C~dideC~~~~~C~~~C~n~~g~~~C~C-~~g~~~ 70 (400)
T 3p5b_L 17 LKIGYECLCPDGFQLVA----QRRCEDIDECQDPDTCSQLCVNLEGGYKCQC-EEGFQL 70 (400)
T ss_dssp CSSSEEEECCTTEEECS----SSCEEECCCCSTTSSCSSCCBCCSSSCBCCC-CTTCCC
T ss_pred CCCCeEEECCCCCCcCC----CCcccCchhhhccCCCCCccCCCccceeeec-cccccc
Confidence 34689999999998621 14566655554 22234678999999 667654
|
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* | Back alignment and structure |
|---|
Probab=85.90 E-value=0.2 Score=52.60 Aligned_cols=51 Identities=25% Similarity=0.623 Sum_probs=31.8
Q ss_pred CcccceEE-eccCCCCCchhh---------cccCCcccccccC-------------CCCCCCCeeeeeecCCCCCc
Q 012297 31 GQKNWKCT-CSSSLQGDQSNI---------LKLNCSRSCDCSP-------------VGGSSEGKWTCICAADGLPK 83 (466)
Q Consensus 31 ~~~~~~~~-~~~~~~~~~~~~---------~~~~c~~~~~~~~-------------~~~~~~~~~~c~~~~~g~~~ 83 (466)
...+|+|. |..||.|+. +. ....|.....|.. ......|+|+|.| ..|+.+
T Consensus 66 t~gsY~C~~C~~Gy~G~~-c~g~g~~~~~~dg~~C~dideC~~~~~pC~~~~~Cvnt~~~~~GsY~C~C-~~Gy~G 139 (634)
T 1yo8_A 66 TQPGFHCLPCPPRYRGNQ-PVGVGLEAAKTEKQVCEPENPCKDKTHNCHKHAECIYLGHFSDPMYKCEC-QTGYAG 139 (634)
T ss_dssp CSSSEEECCCCTTEEECC-CEESSSHHHHSCCCCEEECCTTTTTCCCCCTTEEEEECCTTCSSSEEEEE-CTTEEE
T ss_pred ccCceecccCCCCcccCc-cccccccccccCCCcccccccccCCCcccccCccccccccccccceeeec-cCCccc
Confidence 34689999 999999986 32 0112444434432 2112348999999 777765
|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* | Back alignment and structure |
|---|
Probab=85.27 E-value=0.35 Score=40.08 Aligned_cols=58 Identities=22% Similarity=0.516 Sum_probs=33.3
Q ss_pred hhhhccccccccCcccceEEeccCCCCCchhhcccCCcccccccCCC--CCCCCeeeeeecCCCCCc
Q 012297 19 QRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSPVG--GSSEGKWTCICAADGLPK 83 (466)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~--~~~~~~~~c~~~~~g~~~ 83 (466)
+++.|.+ ...+|+|.|..||.|+.--...+-|. +..|...+ ....|.|+|.| ..|+.+
T Consensus 17 ~~g~C~~-----~~g~~~C~C~~Gy~G~~C~~~~~~C~-~~~C~~~~~C~~~~g~~~C~C-~~G~~G 76 (135)
T 2vj3_A 17 HAGKCIN-----TLGSFECQCLQGYTGPRCEIDVNECV-SNPCQNDATCLDQIGEFQCIC-MPGYEG 76 (135)
T ss_dssp TTCEEEE-----CSSSEEEECCTTEESTTSCEECCTTT-TCCCCSSCEEEECSSCEEEEC-CTTEES
T ss_pred CCCEeEC-----CCCCEEEECCCCCcCCcccccCccCC-CCCCCCCCEEeCCCCCceeeC-CCCCcC
Confidence 3455654 34679999999999964111112332 12233222 13468899999 667654
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=84.63 E-value=0.59 Score=29.53 Aligned_cols=11 Identities=27% Similarity=0.549 Sum_probs=4.7
Q ss_pred HHHHHHHHhhc
Q 012297 135 LMLVLCYVYRK 145 (466)
Q Consensus 135 l~~~~~~~~rr 145 (466)
++.+.++++||
T Consensus 27 i~~l~~~~~rr 37 (38)
T 2k1k_A 27 LLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHCC
T ss_pred HHHHHHHHeec
Confidence 33333444444
|
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* | Back alignment and structure |
|---|
Probab=84.34 E-value=0.37 Score=50.67 Aligned_cols=45 Identities=18% Similarity=0.650 Sum_probs=30.7
Q ss_pred cceE-EeccCCCCCchhhcccCCccccccc-------CCC-----CCCCCeeeee-ecCCCCCcc
Q 012297 34 NWKC-TCSSSLQGDQSNILKLNCSRSCDCS-------PVG-----GSSEGKWTCI-CAADGLPKV 84 (466)
Q Consensus 34 ~~~~-~~~~~~~~~~~~~~~~~c~~~~~~~-------~~~-----~~~~~~~~c~-~~~~g~~~~ 84 (466)
.|+| .|..||.||. ..|+...+|. ..+ ....|+|+|. | ..|+.+.
T Consensus 24 sy~C~~C~~GytGdg-----~~CeDiDEC~~~p~~C~~gg~~~~CvNt~gsY~C~~C-~~Gy~G~ 82 (634)
T 1yo8_A 24 SWSCGFCPVGFLGNG-----THCEDLDECALVPDICFSTSKVPRCVNTQPGFHCLPC-PPRYRGN 82 (634)
T ss_dssp CEEECCCCTTBCSCS-----SSCCBCCTTTTSCCCSCCCSSSCCEEECSSSEEECCC-CTTEEEC
T ss_pred CeECCcCCCccCCCC-----CCccccccccCCCCcccCCccccceeeccCceecccC-CCCcccC
Confidence 3999 9999999986 3565444443 221 1357889998 9 6777654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.74 E-value=2.9 Score=37.48 Aligned_cols=117 Identities=8% Similarity=0.068 Sum_probs=76.2
Q ss_pred CCCCccceeeeeeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 012297 279 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 358 (466)
Q Consensus 279 ~H~nIv~llg~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~ 358 (466)
.||++++.- +-.+ .....+.|+. ..+...|-. .+.++...+++++.+++...++++. -+|--|+|
T Consensus 43 ~~~~Fl~~~-I~e~----eD~v~~~y~~--~~~~~~f~~---ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P 107 (215)
T 4ann_A 43 HSPYFIDAE-LTEL----RDSFQIHYDI--NDNHTPFDN---IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP 107 (215)
T ss_dssp CCTTBCCEE-EEEC----SSEEEEEECC--CTTSEEGGG---GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred cCCcccceE-EEEc----ccEEEEEEEc--CcccCCHHH---HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence 578887652 2222 2243444443 333333322 1447889999999999998866653 37888999
Q ss_pred CCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 359 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 359 ~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
+||+++.++.+++.-.|+-..+ +|. ..+...=.-.+=+++..+++++..|+.
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~l----------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNVV----------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp GGEEECTTSCEEESCCEETTTB----------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred ceEEEcCCCCEEEEEccCccCC----------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999999999876654322 221 223334445677788889999888864
|
| >2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... | Back alignment and structure |
|---|
Probab=83.62 E-value=0.31 Score=40.90 Aligned_cols=49 Identities=22% Similarity=0.521 Sum_probs=26.5
Q ss_pred cccceEEeccCCCCCchhhcccCCcccccccCCC-----CCCCC-eeeeeecCCCCC
Q 012297 32 QKNWKCTCSSSLQGDQSNILKLNCSRSCDCSPVG-----GSSEG-KWTCICAADGLP 82 (466)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~-----~~~~~-~~~c~~~~~g~~ 82 (466)
.++|+|.|..||.|..=-...+.|. +|.|...+ ....| +|+|.| ..|+.
T Consensus 65 ~g~y~C~C~~G~~G~~C~~~~~~c~-~c~~~~~~C~~~C~~~~g~~y~C~C-~~Gy~ 119 (142)
T 2c4f_L 65 LQSYICFCLPAFEGRNCETHKDDQL-ICVNENGGCEQYCSDHTGTKRSCRC-HEGYS 119 (142)
T ss_dssp TTEEEEECCTTEESTTSCEEGGGCC-STTTGGGGCSSEEECCTTSCCEEEC-CTTEE
T ss_pred CCCEEeeCCCCccCCccccCccccc-cccCCCCCccCEeECCCCCCEEEEC-CCCce
Confidence 3689999999998843100001110 11121111 13456 899999 56665
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.60 E-value=0.29 Score=31.47 Aligned_cols=8 Identities=25% Similarity=0.484 Sum_probs=3.4
Q ss_pred HHHHHhhc
Q 012297 138 VLCYVYRK 145 (466)
Q Consensus 138 ~~~~~~rr 145 (466)
++++++||
T Consensus 32 ~~~~~~rR 39 (41)
T 2k9y_A 32 VGFFIHRR 39 (41)
T ss_dssp HHHSSSSS
T ss_pred HheeEeee
Confidence 33444444
|
| >2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... | Back alignment and structure |
|---|
Probab=83.37 E-value=0.28 Score=40.68 Aligned_cols=57 Identities=25% Similarity=0.585 Sum_probs=14.5
Q ss_pred hhhhccccccccCcccceEEeccCCCCCch-h-hcccCCccc-ccccCCCCCCCCeeeeeecCCCCC
Q 012297 19 QRSICDKLSERSGQKNWKCTCSSSLQGDQS-N-ILKLNCSRS-CDCSPVGGSSEGKWTCICAADGLP 82 (466)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~c~~~-~~~~~~~~~~~~~~~c~~~~~g~~ 82 (466)
.++.|.+ ..++|+|.|..||.|+.= . +. +-|... +.|...=....|+|+|.| ..|+-
T Consensus 52 n~g~C~~-----~~~~y~C~C~~G~~G~~C~~~i~-d~C~~~~~~C~~~C~~~~g~y~C~C-~~Gy~ 111 (134)
T 2vh0_B 52 NQGKCKD-----GLGEYTCTCLEGFEGKNCELFTR-KLCSLDNGDCDQFCHEEQNSVVCSC-ARGYT 111 (134)
T ss_dssp ----------------------------------C-CGGGTGGGGCSSEEEEETTEEEEEC-CTTEE
T ss_pred CcCCccc-----CCCCEEeeCCCCccCCccccCCC-CccccCCCCCCCEeECCCCCEEEEC-CCCcE
Confidence 4456654 346899999999998520 0 10 113321 122221123568999999 56665
|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* | Back alignment and structure |
|---|
Probab=82.29 E-value=0.83 Score=45.73 Aligned_cols=49 Identities=18% Similarity=0.421 Sum_probs=28.2
Q ss_pred ccceEEeccCCCCCc-------hhhcccCCcccccccCC----CCCCCCeeeeeecCCCCCc
Q 012297 33 KNWKCTCSSSLQGDQ-------SNILKLNCSRSCDCSPV----GGSSEGKWTCICAADGLPK 83 (466)
Q Consensus 33 ~~~~~~~~~~~~~~~-------~~~~~~~c~~~~~~~~~----~~~~~~~~~c~~~~~g~~~ 83 (466)
..++|.|..||.|.. .|.- ..|...|.|+.. +.=..+.++|.| ..|+-+
T Consensus 214 ~~g~C~C~~G~~G~~Ce~~C~~g~~g-~~C~~~C~~~~~C~~~g~C~~~~~~C~C-~~G~~G 273 (423)
T 2gy5_A 214 DTGECICPPGFMGRTCEKACELHTFG-RTCKERCSGQEGCKSYVFCLPDPYGCSC-ATGWKG 273 (423)
T ss_dssp TTCCEECCTTEESTTSCEECCTTEES-TTSCEECCSTTTTTTCCEEETTTTEEEC-CBTCBS
T ss_pred CCCcEeCCCCccCCCcccccCCCCCC-CCcCccCCCCCCCCCCCEECCCCCeEEe-CCCccc
Confidence 357999999998832 1211 245444443321 111356889999 566654
|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.82 E-value=0.81 Score=38.01 Aligned_cols=27 Identities=15% Similarity=0.409 Sum_probs=16.7
Q ss_pred hhhhhccccccccCcccceEEeccCCCCCc
Q 012297 18 IQRSICDKLSERSGQKNWKCTCSSSLQGDQ 47 (466)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 47 (466)
..+..|.+.. +..+|+|.|..||.|..
T Consensus 9 ~~~g~C~~~~---~~g~~~C~C~~G~~G~~ 35 (143)
T 4d90_A 9 ENGGICLPGL---ADGSFSCECPDGFTDPN 35 (143)
T ss_dssp GGGCEEEC--------CCEEECCTTCCTTT
T ss_pred CCCCEeeCCC---CCCCEEeECCCCCCCCC
Confidence 3456675411 11479999999999843
|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* | Back alignment and structure |
|---|
Probab=80.66 E-value=0.59 Score=38.62 Aligned_cols=50 Identities=20% Similarity=0.556 Sum_probs=28.7
Q ss_pred cccceEEeccCCCCCchhhcccCCcccccccCCC--CCCCCeeeeeecCCCCCc
Q 012297 32 QKNWKCTCSSSLQGDQSNILKLNCSRSCDCSPVG--GSSEGKWTCICAADGLPK 83 (466)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~--~~~~~~~~c~~~~~g~~~ 83 (466)
..+|+|.|..||.|..--...+-|. +..|...+ ....|.|+|.| ..|+-+
T Consensus 63 ~g~~~C~C~~G~~G~~C~~~~~~C~-~~~C~~~g~C~~~~g~~~C~C-~~G~~G 114 (135)
T 2vj3_A 63 IGEFQCICMPGYEGVHCEVNTDECA-SSPCLHNGRCLDKINEFQCEC-PTGFTG 114 (135)
T ss_dssp SSCEEEECCTTEESSSSCEECCTTT-TCCSTTTCEEEECSSCEEEEC-CTTEES
T ss_pred CCCceeeCCCCCcCCcceecCCccc-CCCcCCCCEeECCCCCeEEEC-CCCCcC
Confidence 4679999999999853111112332 12233222 12468899999 566653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 466 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-57 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-45 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-42 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-37 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-16 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 6e-57
Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 16/219 (7%)
Query: 219 LEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 277
+E D F + +G G V++ G ++A K + P + + E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 278 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 337
+ ++V G + E M G+L L + ++I
Sbjct: 61 CNSPYIVGFYGAFYS----DGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVI 114
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
+GL YL E +I+HRD+K SNIL++ K+ D G++ +L S G
Sbjct: 115 KGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------DSMANSFVG 165
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
T Y +PE S+ SD++S G+ L+E+ GR PI
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-54
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 18/217 (8%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFK-TQGGPNADSVFLTEVDMLSRLHHCH 282
+ + +G G VY+G+ VAVK T P F EV +L + H +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
++ +GY + +V ++ +L L + + IA A+G++Y
Sbjct: 66 ILLFMGYSTAP-----QLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDY 119
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
LH I+HRD+KS+NI L E+L KI D G+A S S ++ G+ +
Sbjct: 120 LHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW---SGSHQFEQLSGSILWM 173
Query: 403 APEYAMV---GRASLMSDVFSFGVVLLELITGRQPIH 436
APE + S SDV++FG+VL EL+TG+ P
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (442), Expect = 1e-51
Identities = 57/243 (23%), Positives = 108/243 (44%), Gaps = 21/243 (8%)
Query: 214 FSYSALEHATDKFSGS---------NIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG 260
F++ A +F+ ++G G V G L VA+K K+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 261 GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL 320
FL+E ++ + H +V+ L G ++ +++ EFM NG+L D
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK----STPVMIITEFMENGSL-DSFLRQN 121
Query: 321 VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380
V + G A G++YL + +HRD+ + NIL++ NL K++D G+++ L
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
Query: 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 440
+ D +S + + APE + + SDV+S+G+V+ E+++ + + +T
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238
Query: 441 KGE 443
+
Sbjct: 239 NQD 241
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-51
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+ +G G V+ G VAVK K G + FL E +++ +L H +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRL 70
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
V L ++ ++ E+M NG+L D L + + + +A A G+ ++
Sbjct: 71 VRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
E +HRD++++NIL+ + L+ KI D G+A+ ++ + + + + A
Sbjct: 126 EE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK----FPIKWTA 178
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
PE G ++ SDV+SFG++L E++T + + +T E
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-49
Identities = 48/217 (22%), Positives = 87/217 (40%), Gaps = 13/217 (5%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHC 281
+ + +G G + + +DG+I+ K + ++EV++L L H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARG 339
++V + +V E+ G+L + E ++ + + +
Sbjct: 64 NIVRYYDRIIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 340 LEYLHE--AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
L+ H +LHRD+K +N+ LD N K+ D G+A+ L D +S G
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-----TSFAKAFVG 176
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
T Y +PE + SD++S G +L EL P
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-49
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+ +G+G V G G VAVK K A FL E ++++L H ++
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNL 62
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
V L+G E +G +V E+M G+L D L + D + ++ +EYL
Sbjct: 63 VQLLGVIVEEKGGL---YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
+HRD+ + N+L+ E+ AK++D G+ K SS+ + + A
Sbjct: 120 EG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--------SSTQDTGKLPVKWTA 168
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
PE + S SDV+SFG++L E+ + +
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRV 199
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-49
Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+ +GQG V+ G VA+K K G + FL E ++ +L H +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKL 74
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
V L SE +V E+M G+L D L G + + V +A A G+ Y+
Sbjct: 75 VQLYAVVSEEP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
+HRD++++NIL+ ENL K+ D G+A+ ++ + + + + A
Sbjct: 130 ER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG----AKFPIKWTA 182
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
PE A+ GR ++ SDV+SFG++L EL T + + + E
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 222
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 3e-49
Identities = 54/220 (24%), Positives = 86/220 (39%), Gaps = 24/220 (10%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLH 279
FS +G G VY + + + +VA+K+ G + + + EV L +L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339
H + + G LV E+ V + + A+ GA +G
Sbjct: 74 HPNTIQYRGCYLR----EHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQG 127
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L YLH ++HRD+K+ NILL E K+ D G A + GT
Sbjct: 128 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---------SFVGTP 175
Query: 400 GYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIH 436
+ APE + G+ DV+S G+ +EL + P+
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-49
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 12/216 (5%)
Query: 229 SNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 284
+ ++G+G VY G L D AVK S FLTE ++ H +V+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH 344
L+G C G L+V +M +G+LR+ + + A+G+++L
Sbjct: 92 SLLGICLRSEGSP---LVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 404
+ +HRD+ + N +LDE K+ D G+A+ + S + + A
Sbjct: 148 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK-LPVKWMAL 203
Query: 405 EYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 440
E + + SDV+SFGV+L EL+T P + +
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 239
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 6e-49
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 18/214 (8%)
Query: 232 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 291
+G+G V+RG+ G VAVK F ++ E+ L H +++ + +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 292 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA--- 348
+ G LV ++ +G+L D L+ + + + +A+ A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 349 --PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
P I HRD+KS NIL+ +N I DLG+A R + + +P GT Y APE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT-DTIDIAPNHRVGTKRYMAPEV 183
Query: 407 ------AMVGRASLMSDVFSFGVVLLELITGRQP 434
+ +D+++ G+V E+
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 3e-48
Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 14/217 (6%)
Query: 230 NIVGQGGSSYVYRGQLTD-GRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 287
+G+G VY+G T+ VA + + F E +ML L H ++V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 288 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 347
+ +LV E M +G L+ L + M + +GL++LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT-R 131
Query: 348 APRILHRDIKSSNILL-DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
P I+HRD+K NI + + KI DLG+A + +S + GT + APE
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-------ASFAKAVIGTPEFMAPEM 184
Query: 407 AMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
+ DV++FG+ +LE+ T P +
Sbjct: 185 YE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 220
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 4e-48
Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 14/220 (6%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 283
+ + +G G V+ G + VA+K + G ++ F+ E +++ +L H +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKL 62
Query: 284 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 343
V L G C E +A LVFEFM +G L D +T + + + G+ YL
Sbjct: 63 VQLYGVCLE----QAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 344 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 403
E ++HRD+ + N L+ EN K++D GM + + D S + + + +
Sbjct: 118 EE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG----TKFPVKWAS 170
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
PE R S SDV+SFGV++ E+ + + + + + E
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-47
Identities = 53/214 (24%), Positives = 80/214 (37%), Gaps = 19/214 (8%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 280
+ F +G+G VY + I+A+K A EV++ S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 340
+++ L GY + L+ E+ P G + L + + A L
Sbjct: 66 PNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANAL 119
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
Y H R++HRDIK N+LL KI D G + SS + GT
Sbjct: 120 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-------SSRRTTLCGTLD 169
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
Y PE D++S GV+ E + G+ P
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 203
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 4e-47
Identities = 55/266 (20%), Positives = 109/266 (40%), Gaps = 40/266 (15%)
Query: 215 SYSALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVF 268
+LE+ + +G+G V++ + +VAVK K + + + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 269 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL------------ 316
E +++ + ++V L+G C+ L+FE+M G+L + L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAV----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 317 ----------DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 366
++ ++ IA A G+ YL E + +HRD+ + N L+ EN
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGEN 176
Query: 367 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLL 426
+ KI D G+++ + + + A + PE R + SDV+++GVVL
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDA---IPIRWMPPESIFYNRYTTESDVWAYGVVLW 233
Query: 427 ELITGRQPIHRSITKGEESLVLWVKS 452
E+ + + + E ++ +V+
Sbjct: 234 EIFSYGLQPYYGMA--HEEVIYYVRD 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-46
Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 15/220 (6%)
Query: 219 LEHATDKFSGSNIV-GQGGSSYVYRGQL---TDGRIVAVKRFKTQGGPNADSVFLTEVDM 274
L D ++I G G V +G VA+K K + E +
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 275 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 334
+ +L + ++V L+G C +LV E G L L G E + +
Sbjct: 63 MHQLDNPYIVRLIGVCQAEA-----LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLH 116
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 394
+ G++YL E +HRD+ + N+LL AKI+D G++K L AD + S
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--A 171
Query: 395 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+ ++APE + S SDV+S+GV + E ++ Q
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-46
Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 20/220 (9%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
D + +G G VY+ Q + + A K T+ + ++ E+D+L+ H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-YMVEIDILASCDHP 69
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
++V L+ ++ EF G + + L + + L
Sbjct: 70 NIVKLLDAFYY----ENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALN 124
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
YLH+ +I+HRD+K+ NIL + + K+ D G++ + S GT +
Sbjct: 125 YLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-----FIGTPYW 176
Query: 402 FAPEYAMVGRA-----SLMSDVFSFGVVLLELITGRQPIH 436
APE M + +DV+S G+ L+E+ P H
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 216
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (404), Expect = 4e-46
Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 14/232 (6%)
Query: 213 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTE 271
+Y E + + +G G VY G VAVK K + FL E
Sbjct: 6 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKE 63
Query: 272 VDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 331
++ + H ++V L+G C+ ++ EFM GNL D L + ++ +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTR----EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 119
Query: 332 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 391
+A + +EYL + +HRD+ + N L+ EN K+ D G+++ + D + + +
Sbjct: 120 MATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 176
Query: 392 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
+ APE + S+ SDV++FGV+L E+ T + I +
Sbjct: 177 K----FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 224
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 1e-45
Identities = 56/215 (26%), Positives = 85/215 (39%), Gaps = 14/215 (6%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+ + +G+G V VAVK + + E+ + L+H +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
VV G+ + ++ L E+ G L D ++ GM G+ Y
Sbjct: 65 VVKFYGHRR----EGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVY 118
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
LH I HRDIK N+LLDE N KI+D G+A + + + M GT Y
Sbjct: 119 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK---MCGTLPYV 172
Query: 403 APEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIH 436
APE + DV+S G+VL ++ G P
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-45
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 16/218 (7%)
Query: 230 NIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVP 285
+G G V +G + VAVK K + P L E +++ +L + ++V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
++G C +LV E G L L + + + + G++YL E
Sbjct: 73 MIGICEAES-----WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE 125
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 405
+HRD+ + N+LL AKI+D G++K L+AD + + + ++APE
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD--ENYYKAQTHGKWPVKWYAPE 180
Query: 406 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
+ S SDV+SFGV++ E + Q +R + E
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-45
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
K++ +GQG S VY + G+ VA+++ Q P + + E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
++V + +V E++ G+L D + M+ A+ + LE
Sbjct: 78 NIVNYLDSYLVGD----ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALE 130
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
+LH +++HRDIKS NILL + + K+TD G ++ + S + M GT +
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-----SKRSTMVGTPYW 182
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
APE D++S G++ +E+I G P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-45
Identities = 49/214 (22%), Positives = 93/214 (43%), Gaps = 14/214 (6%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289
+G G V G+ VA+K K G ++ F+ E ++ L H +V L G
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 349
C++ + ++ E+M NG L + L + + + +EYL
Sbjct: 68 CTK----QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLES---K 119
Query: 350 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 409
+ LHRD+ + N L+++ K++D G+++ + D S + + PE M
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG----SKFPVRWSPPEVLMY 175
Query: 410 GRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
+ S SD+++FGV++ E+ + + + T E
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-45
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 15/225 (6%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDG-----RIVAVKRFKTQGGPNADSVFLTEVDMLSRL 278
+ ++G G VY+G L VA+K K FL E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 279 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 338
H +++ L G S+++ +++ E+M NG L L + V + G A
Sbjct: 67 SHHNIIRLEGVISKYKP----MMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAA 121
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
G++YL +HRD+ + NIL++ NL K++D G+++ L+ D P + + + +
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD--PEATYTTSGGKIP 176
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
+ APE + + SDV+SFG+V+ E++T + + ++ E
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-44
Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 17/225 (7%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 278
+F ++G G VY+G VA+K + P A+ L E +++ +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 279 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 338
+ HV L+G C + L+ + MP G L D + + + + + A+
Sbjct: 69 DNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 122
Query: 339 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 398
G+ YL + R++HRD+ + N+L+ + KITD G+AK L A+ + +
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG---GKVP 176
Query: 399 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
+ A E + + SDV+S+GV + EL+T + I E
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (389), Expect = 4e-44
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 10/217 (4%)
Query: 221 HATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSR 277
H +D++ I+G GG S V+ + L R VAVK + + F E +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 278 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 337
L+H +V + + +V E++ LRD + M + + A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADAC 121
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
+ L + H+ I+HRD+K +NI++ K+ D G+A+ + G + + A + G
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG--NSVTQTAAVIG 176
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
T Y +PE A SDV+S G VL E++TG P
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 5e-44
Identities = 51/249 (20%), Positives = 99/249 (39%), Gaps = 38/249 (15%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSR 277
+ ++G G V VAVK K + + ++E+ M+++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 278 L-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-------------------- 316
L H ++V L+G C+ L+FE+ G+L + L
Sbjct: 97 LGSHENIVNLLGACTL----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 317 -DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375
+ + + ++ + A A+G+E+L +HRD+ + N+L+ KI D G
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435
+A+ + +D S + + APE G ++ SDV+S+G++L E+ +
Sbjct: 210 LARDIMSD---SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266
Query: 436 HRSITKGEE 444
+ I
Sbjct: 267 YPGIPVDAN 275
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-43
Identities = 56/238 (23%), Positives = 101/238 (42%), Gaps = 31/238 (13%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRL-H 279
+ +++G+G V + ++ A+KR K + F E+++L +L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMN 325
H +++ L+G C R L E+ P+GNL D L ++
Sbjct: 70 HPNIINLLGACE----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 326 WDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385
+ A ARG++YL + + +HRD+ + NIL+ EN AKI D G+++
Sbjct: 126 SQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR------G 176
Query: 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
+ + A E + SDV+S+GV+L E+++ + +T E
Sbjct: 177 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-43
Identities = 52/244 (21%), Positives = 94/244 (38%), Gaps = 33/244 (13%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 277
++ S +G G V VAVK K ++E+ +LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 278 L-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVE-------------- 322
L +H ++V L+G C+ L++ E+ G+L + L
Sbjct: 83 LGNHMNIVNLLGACTI----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 323 --GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380
++ + ++ + A+G+ +L +HRD+ + NILL KI D G+A+ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 440
K D S + + APE + SDV+S+G+ L EL + + +
Sbjct: 196 KND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 441 KGEE 444
+
Sbjct: 253 VDSK 256
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-43
Identities = 61/234 (26%), Positives = 96/234 (41%), Gaps = 23/234 (9%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 280
+ F I+G+G S V + L R A+K + + + V E D++SRL H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 340
V L + + NG L + + + L
Sbjct: 68 PFFVKLYFTFQD----DEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSAL 121
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
EYLH I+HRD+K NILL+E+++ +ITD G AK L + + ++S GT
Sbjct: 122 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS---FVGTAQ 175
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESL 446
Y +PE A SD+++ G ++ +L+ G P I + I K E
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 229
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-42
Identities = 49/224 (21%), Positives = 90/224 (40%), Gaps = 17/224 (7%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH 279
++ +G+G V++G VA+K K + FL E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339
H H+V L+G +E ++ E G LR V ++ + + A +
Sbjct: 67 HPHIVKLIGVITEN-----PVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTA 120
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L YL R +HRDI + N+L+ N K+ D G+++ ++ S + +
Sbjct: 121 LAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS----KGKLPI 173
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
+ APE R + SDV+ FGV + E++ + + +
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 150 bits (381), Expect = 3e-42
Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 18/214 (8%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
D + +G G V+R GR+ K T P E+ ++++LHH
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPK 87
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
++ L + + +L+ EF+ G L D + M+ + A GL++
Sbjct: 88 LINLHDAFED----KYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKH 142
Query: 343 LHEAAAPRILHRDIKSSNILLD--ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
+HE I+H DIK NI+ + + + KI D G+A +L D + T
Sbjct: 143 MHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV------TTATAE 193
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+ APE +D+++ GV+ L++G P
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 227
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 150 bits (379), Expect = 6e-42
Identities = 51/218 (23%), Positives = 85/218 (38%), Gaps = 18/218 (8%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 278
+H D + +G G V+R G A K T + ++ E+ +S L
Sbjct: 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET-VRKEIQTMSVL 80
Query: 279 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 338
H +V L + ++++EFM G L + + M+ D V +
Sbjct: 81 RHPTLVNLHDAFED----DNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCK 135
Query: 339 GLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
GL ++HE +H D+K NI+ + K+ D G+ L S
Sbjct: 136 GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK------QSVKVTT 186
Query: 397 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
GT + APE A +D++S GV+ L++G P
Sbjct: 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 148 bits (375), Expect = 3e-41
Identities = 61/233 (26%), Positives = 98/233 (42%), Gaps = 23/233 (9%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLH- 279
+ FS I+G+GG VY + D G++ A+K + +++ L E MLS +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 280 --HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 337
+V + + + M G+L L + A
Sbjct: 64 GDCPFIVCMSYAFHT----PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEII 117
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
GLE++H +++RD+K +NILLDE+ + +I+DLG+A P G
Sbjct: 118 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS-------KKKPHASVG 167
Query: 398 TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 449
T GY APE G A +D FS G +L +L+ G P + TK + +
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-40
Identities = 56/209 (26%), Positives = 82/209 (39%), Gaps = 17/209 (8%)
Query: 232 VGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVP 285
+G G V RG+ VAVK K +++ F+ EV+ + L H +++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 286 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 345
L G +V E P G+L D L T A+ A G+ YL
Sbjct: 76 LYGVVLTPP-----MKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 346 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 405
R +HRD+ + N+LL KI D G+ + L + + F + APE
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPE 184
Query: 406 YAMVGRASLMSDVFSFGVVLLELITGRQP 434
S SD + FGV L E+ T Q
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQE 213
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 141 bits (357), Expect = 1e-39
Identities = 59/227 (25%), Positives = 91/227 (40%), Gaps = 31/227 (13%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--------FLTEVDM 274
+ + I+G+G SS V R + AVK GG + + L EVD+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 275 LSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
L ++ H +++ L LVF+ M G L D L ++ I
Sbjct: 63 LRKVSGHPNIIQLKDTYET----NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIM 116
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 393
+ LH+ I+HRD+K NILLD+++N K+TD G + +L
Sbjct: 117 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG------EKLR 167
Query: 394 RMQGTFGYFAPEYAMVGRA------SLMSDVFSFGVVLLELITGRQP 434
+ GT Y APE D++S GV++ L+ G P
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-39
Identities = 55/234 (23%), Positives = 97/234 (41%), Gaps = 24/234 (10%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 277
+K + S +GQG VY G VA+K FL E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 278 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------DGVLVEGMNWDTR 329
+ HVV L+G S + L++ E M G+L+ L + ++ +
Sbjct: 80 FNCHHVVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 330 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 389
+ +A A G+ YL+ + +HRD+ + N ++ E+ KI D GM + +
Sbjct: 136 IQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 390 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 443
+ + +PE G + SDV+SFGVVL E+ T + ++ ++ +
Sbjct: 193 G---KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-39
Identities = 47/216 (21%), Positives = 89/216 (41%), Gaps = 10/216 (4%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 281
+++ + +G+G V + VA+K+ L E+ +L R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
+++ + ++ + + + +L L + ++ D RGL+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLK 123
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
Y+H A +LHRD+K SN+LL+ + KI D G+A+ D + T Y
Sbjct: 124 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH--DHTGFLTEYVATRWY 178
Query: 402 FAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIH 436
APE + + S D++S G +L E+++ R
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 214
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 141 bits (356), Expect = 6e-39
Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 20/210 (9%)
Query: 230 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL 286
+G G V+ + +GR A+K K + V E MLS + H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 287 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 346
G + ++ +++ G L L + A LEYLH
Sbjct: 70 WGTFQD----AQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHS- 122
Query: 347 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 406
I++RD+K NILLD+N + KITD G AK + + GT Y APE
Sbjct: 123 --KDIIYRDLKPENILLDKNGHIKITDFGFAKYV--------PDVTYTLCGTPDYIAPEV 172
Query: 407 AMVGRASLMSDVFSFGVVLLELITGRQPIH 436
+ D +SFG+++ E++ G P +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFY 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 6e-39
Identities = 48/211 (22%), Positives = 76/211 (36%), Gaps = 20/211 (9%)
Query: 231 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVG 288
++G G + V + A+K + EV++ R H+V +V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVD 72
Query: 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 348
R L+V E + G L + + I ++YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 130
Query: 349 PRILHRDIKSSNILLD---ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 405
I HRD+K N+L N K+TD G AK + +S T Y APE
Sbjct: 131 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH------NSLTTPCYTPYYVAPE 183
Query: 406 YAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
+ D++S GV++ L+ G P +
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 214
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 7e-39
Identities = 58/242 (23%), Positives = 101/242 (41%), Gaps = 30/242 (12%)
Query: 224 DKFSGSNIVGQGGSSYVYRG------QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 277
D+ +G+G V + R VAVK K + ++E+ +L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 278 -LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVE 322
HH +VV L+G C++ G +++ EF GNL L + + +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPL---MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 323 GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382
+ + + + A+G+E+L + +HRD+ + NILL E KI D G+A+ +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKG 442
D + + APE ++ SDV+SFGV+L E+ + + +
Sbjct: 187 DPDYVRKGD---ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 443 EE 444
EE
Sbjct: 244 EE 245
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (352), Expect = 2e-38
Identities = 50/225 (22%), Positives = 87/225 (38%), Gaps = 19/225 (8%)
Query: 216 YSALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDM 274
+ E D + +++G G S V + ++VA+K + + E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 275 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 334
L ++ H ++V L L+ + + G L D + +
Sbjct: 61 LHKIKHPNIVALDDIYES----GGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIF 114
Query: 335 GAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSS 391
++YLH+ I+HRD+K N+L DE+ I+D G++K + S
Sbjct: 115 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--- 168
Query: 392 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436
GT GY APE S D +S GV+ L+ G P +
Sbjct: 169 ---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 210
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-38
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 230 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV----FLTEVDMLSRLHHCHVV 284
+ +G+G + VY+ + +IVA+K+ K A L E+ +L L H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 285 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH 344
L+ ++ LVF+FM D L + A + +GLEYLH
Sbjct: 64 GLLDAFGH----KSNISLVFDFMETDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLH 117
Query: 345 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 404
+ ILHRD+K +N+LLDEN K+ D G+AK + + + T Y AP
Sbjct: 118 Q---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-----NRAYTHQVVTRWYRAP 169
Query: 405 EYAMVGRA-SLMSDVFSFGVVLLELITGRQP 434
E R + D+++ G +L EL+
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 3e-38
Identities = 56/243 (23%), Positives = 102/243 (41%), Gaps = 33/243 (13%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDML 275
D+ +G+G V + VAVK K+ S ++E++M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 276 SRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVL 320
+ H +++ L+G C++ ++ E+ GNLR+ L
Sbjct: 73 KMIGKHKNIINLLGACTQ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 321 VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380
E ++ V+ A ARG+EYL + +HRD+ + N+L+ E+ KI D G+A+ +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 440
+++ + + APE + SDV+SFGV+L E+ T + +
Sbjct: 186 HHIDYYKKTTN---GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242
Query: 441 KGE 443
E
Sbjct: 243 VEE 245
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 4e-38
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 15/219 (6%)
Query: 222 ATDKFSGSNIVGQGGSSYVYRGQ--LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRL 278
A ++ +G+G V++ + GR VA+KR + Q G + + EV +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 279 ---HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 335
H +VV L C+ R R +L + + +L LD V G+ +T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 336 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 395
RGL++LH R++HRD+K NIL+ + K+ D G+A+ + S + +
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR------IYSFQMALTSV 175
Query: 396 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
T Y APE + + D++S G + E+ +
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-37
Identities = 52/215 (24%), Positives = 87/215 (40%), Gaps = 18/215 (8%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV--FLTEVDMLSR-LH 279
+ F ++G+G V+ + + A+K K D V + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 280 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339
H + + + V E++ G+L + + A G
Sbjct: 62 HPFLTHMFCTFQT----KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILG 115
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L++LH I++RD+K NILLD++ + KI D GM K + GT
Sbjct: 116 LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-----AKTNTFCGTP 167
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
Y APE + + + D +SFGV+L E++ G+ P
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-37
Identities = 44/214 (20%), Positives = 89/214 (41%), Gaps = 19/214 (8%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+K+ + +G+G V+R + + K K +G + E+ +L+ H +
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRN 62
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
++ L +++FEF+ ++ + ++ E +N V+ L++
Sbjct: 63 ILHLHESFES----MEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQF 117
Query: 343 LHEAAAPRILHRDIKSSNILLD--ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
LH I H DI+ NI+ + KI + G A++LK + +
Sbjct: 118 LHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK------PGDNFRLLFTAPE 168
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
Y+APE S +D++S G ++ L++G P
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 6e-37
Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 20/215 (9%)
Query: 226 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 284
++ + ++G G VY+ +L D G +VA+K+ E+ ++ +L HC++V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIV 76
Query: 285 PLVGYCSEF--RGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLE 341
L + + LV +++P R + + R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 342 YLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
Y+H I HRDIK N+LLD + K+ D G AK+L +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSYICSRY 187
Query: 401 YFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQP 434
Y APE + DV+S G VL EL+ G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 9e-37
Identities = 47/214 (21%), Positives = 87/214 (40%), Gaps = 16/214 (7%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHC 281
+ F +G+G VY+ + G +VA+K+ + S + E+ +L L+H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
++V L+ +L + + +L+ +D + G+ + +GL
Sbjct: 62 NIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
+ H R+LHRD+K N+L++ K+ D G+A+ T Y
Sbjct: 117 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWY 168
Query: 402 FAPE-YAMVGRASLMSDVFSFGVVLLELITGRQP 434
APE S D++S G + E++T R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (334), Expect = 4e-36
Identities = 39/215 (18%), Positives = 71/215 (33%), Gaps = 17/215 (7%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 282
+++ +G G +Y G + G VA+K + E + +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK---TKHPQLHIESKIYKMMQGGV 63
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
+P + +C ++V E + + T + +A +EY
Sbjct: 64 GIPTIRWCGAEGD---YNVMVMELLGPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEY 118
Query: 343 LHEAAAPRILHRDIKSSNIL---LDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQG 397
+H +HRD+K N L + I D G+AK+ + + G
Sbjct: 119 IHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 398 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 432
T Y + + S D+ S G VL+ G
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 210
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-35
Identities = 54/214 (25%), Positives = 81/214 (37%), Gaps = 17/214 (7%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 280
+ F ++G+G V + GR A+K + + D V +TE +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 340
+ L V E+ G L L + L
Sbjct: 65 PFLTALKYAFQT----HDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSAL 118
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
EYLH +++RDIK N++LD++ + KITD G+ K +DG GT
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-----TFCGTPE 170
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
Y APE D + GVV+ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 4e-35
Identities = 51/225 (22%), Positives = 87/225 (38%), Gaps = 25/225 (11%)
Query: 220 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-----FLTEVD 273
E+ D + +G G + V + + + G A K K + ++ EV
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 274 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 333
+L + H +V+ L + +L+ E + G L D L E + +
Sbjct: 66 ILKEIQHPNVITLHEVYEN----KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFL 119
Query: 334 IGAARGLEYLHEAAAPRILHRDIKSSNILLDEN----LNAKITDLGMAKRLKADGLPSCS 389
G+ YLH +I H D+K NI+L + KI D G+A ++
Sbjct: 120 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN- 175
Query: 390 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+ GT + APE L +D++S GV+ L++G P
Sbjct: 176 -----IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 129 bits (326), Expect = 5e-35
Identities = 40/211 (18%), Positives = 74/211 (35%), Gaps = 19/211 (9%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 290
+G+G ++ G L + + VA+K + + E L C +P V Y
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRR---SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 291 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 350
+ +LV + + G + L + + T A ++ +HE
Sbjct: 70 GQEGL---HNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---S 121
Query: 351 ILHRDIKSSNILLDENLN-----AKITDLGMAKRLKAD--GLPSCSSSPARMQGTFGYFA 403
+++RDIK N L+ + + D GM K + + GT Y +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 404 PEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+ S D+ + G V + + G P
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLP 212
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 6e-35
Identities = 49/220 (22%), Positives = 92/220 (41%), Gaps = 13/220 (5%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHC 281
K+ +GQG V++ + G+ VA+K+ + + L E+ +L L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 282 HVVPLVGYC----SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 337
+VV L+ C S + + LVF+F + + ++ ++ RV +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 338 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 397
L L+ +ILHRD+K++N+L+ + K+ D G+A+ S +
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK-NSQPNRYTNRVV 183
Query: 398 TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIH 436
T Y PE + R D++ G ++ E+ T +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 127 bits (320), Expect = 3e-34
Identities = 47/212 (22%), Positives = 86/212 (40%), Gaps = 14/212 (6%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCH 282
+K+ G +G+G VY+ Q G A+K+ + + S + E+ +L L H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
+V L RL++ + +L+ LD V G+ T + + G+ Y
Sbjct: 62 IVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAY 115
Query: 343 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 402
H+ R+LHRD+K N+L++ KI D G+A+ + +
Sbjct: 116 CHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH----EIVTLWYRA 168
Query: 403 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
+ S D++S G + E++ G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (313), Expect = 1e-32
Identities = 46/214 (21%), Positives = 79/214 (36%), Gaps = 20/214 (9%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 280
D+F +G G V + G A+K Q + L E +L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 340
+V L + +V E++ G + L + + A
Sbjct: 101 PFLVKLEFSFKDNS----NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTF 154
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
EYLH +++RD+K N+L+D+ ++TD G AKR + GT
Sbjct: 155 EYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR--------VKGRTWTLCGTPE 203
Query: 401 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
APE + + D ++ GV++ E+ G P
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 7e-32
Identities = 46/214 (21%), Positives = 78/214 (36%), Gaps = 25/214 (11%)
Query: 231 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-----FLTEVDMLSRLHHCH-- 282
++G GG VY G ++D VA+K + + + EV +L ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 283 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 342
V+ L+ + +L+ E + + + + +
Sbjct: 71 VIRLLDWFER----PDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 125
Query: 343 LHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
H +LHRDIK NIL+D N K+ D G LK GT Y
Sbjct: 126 CHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 175
Query: 402 FAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQP 434
PE+ R + V+S G++L +++ G P
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-31
Identities = 44/214 (20%), Positives = 79/214 (36%), Gaps = 15/214 (7%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHC 281
K+ +G+G V++ + IVA+KR + S L E+ +L L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
++V L LVFEF + ++ + + +GL
Sbjct: 62 NIVRLHDVLHS----DKKLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLG 115
Query: 342 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 401
+ H +LHRD+K N+L++ N K+ + G+A+ A + +
Sbjct: 116 FCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV----RCYSAEVVTLWYR 168
Query: 402 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 435
S D++S G + EL +P+
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-30
Identities = 49/216 (22%), Positives = 80/216 (37%), Gaps = 20/216 (9%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHC 281
+ VG G V G VA+K+ E+ +L + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 282 HVVPLVGYC--SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339
+V+ L+ E LV FM + + D + +G
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE----KLGEDRIQFLVYQMLKG 133
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L Y+H I+HRD+K N+ ++E+ KI D G+A++ S T
Sbjct: 134 LRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA--------DSEMTGYVVTR 182
Query: 400 GYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQP 434
Y APE + R + D++S G ++ E+ITG+
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 115 bits (288), Expect = 2e-29
Identities = 43/219 (19%), Positives = 83/219 (37%), Gaps = 24/219 (10%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHC 281
D + +G+G S V+ +T+ V VK K P E+ +L L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGGP 90
Query: 282 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 341
+++ L + + LVFE + N + + L + + + L+
Sbjct: 91 NIITLADIVKDPVSRTPA--LVFEHVNNTDFKQ-----LYQTLTDYDIRFYMYEILKALD 143
Query: 342 YLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
Y H I+HRD+K N+++D E+ ++ D G+A+ + +
Sbjct: 144 YCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV------RVASRY 194
Query: 401 YFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRS 438
+ PE + D++S G +L +I ++P
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-27
Identities = 40/215 (18%), Positives = 84/215 (39%), Gaps = 18/215 (8%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHC 281
++ +G G V R VA+K+ + E+ ++ ++H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 282 HVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339
+++ L+ + + + LV E M + V+ ++ + + G
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCG 131
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
+++LH I+HRD+K SNI++ + KI D G+A+ + + T
Sbjct: 132 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP------YVVTR 182
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 434
Y APE + D++S G ++ E++ +
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-27
Identities = 50/215 (23%), Positives = 85/215 (39%), Gaps = 16/215 (7%)
Query: 223 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHH 280
+++ + VG G V G VAVK+ + E+ +L + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 281 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 340
+V+ L+ + R + G D + V + + D + RGL
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMG--ADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 341 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 400
+Y+H I+HRD+K SN+ ++E+ KI D G+A+ T
Sbjct: 135 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH--------TDDEMTGYVATRW 183
Query: 401 YFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQP 434
Y APE + + D++S G ++ EL+TGR
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 7e-27
Identities = 52/220 (23%), Positives = 84/220 (38%), Gaps = 21/220 (9%)
Query: 224 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSV---FLTEVDMLS 276
+ F ++G G V+ + G++ A+K K TE +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 277 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA 336
+ + + Y + K + L +++ G L L T + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLIL---DYINGGELFTHL-----SQRERFTEHEVQIYV 135
Query: 337 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 396
+ L I++RDIK NILLD N + +TD G++K AD +
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD----ETERAYDFC 191
Query: 397 GTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP 434
GT Y AP+ G + D +S GV++ EL+TG P
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (257), Expect = 5e-25
Identities = 44/235 (18%), Positives = 82/235 (34%), Gaps = 19/235 (8%)
Query: 232 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--------- 281
+G G S V+ + + + VA+K + E+ +L R++
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 282 --HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 339
H++ L+ + + ++VFE + L G+ I+ G
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLG 137
Query: 340 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 399
L+Y+H I+H DIK N+L++ + + +L K T
Sbjct: 138 LDYMHRR--CGIIHTDIKPENVLMEIVDSPE--NLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 400 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWVKSII 454
Y +PE + +D++S ++ ELITG + II
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 75.2 bits (184), Expect = 2e-16
Identities = 22/168 (13%), Positives = 43/168 (25%), Gaps = 38/168 (22%)
Query: 230 NIVGQGGSSYVYRGQLTDGRIVAVKRFKT---------QGGPNADSVFLTE--------V 272
++G+G S V+ VK K + D F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 273 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 332
L +L V + + ++ E + L + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNA--------VLMELIDAKELYRV---------RVENPDEV 108
Query: 333 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380
+ + I+H D+ N+L+ E I D + +
Sbjct: 109 LDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 466 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.54 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.24 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.97 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.22 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.11 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.82 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 93.49 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 84.4 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 83.95 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 82.91 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.96 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 80.65 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=359.26 Aligned_cols=205 Identities=28% Similarity=0.370 Sum_probs=174.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|++.+.||+|+||+||+|+.. +++.||||++.........+.+.+|++++++++||||+++++++.+ ....+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~----~~~~~ 79 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE----GNIQY 79 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE----TTEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc----CceeE
Confidence 356888899999999999999875 6899999999766544445569999999999999999999999987 45779
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 80 ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeec
Confidence 999999999999999753 46999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.... .......+||+.|+|||.+.+..+ +.++|||||||+||||+||+.||....
T Consensus 155 ~~~~---~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 155 YNNR---ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp ETTE---ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred cCCc---cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 4321 122334679999999999988776 678999999999999999999997654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-46 Score=363.59 Aligned_cols=206 Identities=27% Similarity=0.429 Sum_probs=163.4
Q ss_pred CCCCcceecccCcEEEEEEEEcC-C---cEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTD-G---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~-~---~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
+|++.++||+|+||+||+|.+.. + ..||||++.........+.|.+|+++|++++||||++++|++.+ ....
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----~~~~ 102 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK----STPV 102 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----SSSC
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee----CCEE
Confidence 34556899999999999998753 2 36899998876666666779999999999999999999999976 3456
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++.... ..+++.+++.++.|+|+||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEc
Confidence 99999999999999987543 45899999999999999999999998 999999999999999999999999999877
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
................||+.|+|||.+....++.++|||||||+||||+| |+.||...
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 55432221222333568899999999999999999999999999999998 89999754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=358.01 Aligned_cols=205 Identities=30% Similarity=0.482 Sum_probs=170.3
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 220 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 220 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
+...++|++.+.||+|+||+||+|+++ ..||||+++... .....+.|.+|++++++++||||++++|++.+ .
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-----~ 76 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-----P 76 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-----c
Confidence 334578899999999999999999864 359999997553 34556679999999999999999999998754 2
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++|+|.+++.... ..+++..++.++.|+|+||+|||+.+ |+||||||+||||++++.+||+|||+++
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred EEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEcccccee
Confidence 4589999999999999997543 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhccc---CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
....... ........||+.|+|||++.. ..++.++|||||||+||||+||+.||...
T Consensus 153 ~~~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~ 212 (276)
T d1uwha_ 153 VKSRWSG---SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212 (276)
T ss_dssp C---------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eccccCC---cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC
Confidence 7643221 122344679999999999864 45899999999999999999999999754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=357.38 Aligned_cols=204 Identities=26% Similarity=0.422 Sum_probs=176.0
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
|+...++|++.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|++++++++||||++++|++.+ .
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~ 80 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----E 80 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-----C
Confidence 344456788889999999999999999888999999997643 334569999999999999999999998764 2
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+++|+|.+++.......+++..++.++.||++||.|||+.+ |+||||||+||||++++.+||+|||+++
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceE
Confidence 3589999999999999987665567999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
....... .......||+.|+|||.+....++.++|||||||++|||+||..|+.
T Consensus 158 ~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 158 LIEDNEY----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp ECSSSCE----ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred EccCCcc----ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 7654321 12334568899999999999999999999999999999999655554
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=353.01 Aligned_cols=199 Identities=27% Similarity=0.444 Sum_probs=176.3
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|+..+.||+|+||+||+|... +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+ ....++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV----GDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEE----CCEEEE
Confidence 56999999999999999999864 6899999998765433 34569999999999999999999999887 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++|+|.+++.. ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 95 vmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp EEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999999998865 45899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus 169 ~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 219 (293)
T d1yhwa1 169 EQ-----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (293)
T ss_dssp TT-----CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cc-----ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC
Confidence 32 1233457999999999999999999999999999999999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-46 Score=364.80 Aligned_cols=202 Identities=26% Similarity=0.402 Sum_probs=179.1
Q ss_pred HhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
..++|++.+.||+|+||+||+|+.. +|+.||+|+++..........+.+|+.+|++++||||+++++++.+ ....
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~ 79 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS----DGEI 79 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC----SSEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEE
Confidence 3567889999999999999999875 6899999999877666666779999999999999999999999986 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~-~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
++||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+. + |+||||||+||||++++.+||+|||+|+.
T Consensus 80 ~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 9999999999999999764 4599999999999999999999974 7 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~-------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 155 LIDSM-------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HHHHT-------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred cCCCc-------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 65432 234689999999999999999999999999999999999999997543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=349.26 Aligned_cols=199 Identities=25% Similarity=0.410 Sum_probs=175.2
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|++.+.||+|+||.||+|+.. +++.||+|++.... .......+.+|++++++++||||+++++++.+ ....
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~ 81 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD----ATRV 81 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE----CCEE
Confidence 45888899999999999999885 58899999986431 23345568999999999999999999999886 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 82 ~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred EEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeec
Confidence 9999999999999999754 56999999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... ......||+.|+|||.+.+..++.++|||||||+||||++|+.||...
T Consensus 157 ~~~-------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 157 PSS-------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp CCC-------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCC-------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 432 233467999999999999999999999999999999999999999753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.6e-46 Score=358.13 Aligned_cols=206 Identities=27% Similarity=0.395 Sum_probs=177.8
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
|+...++|++.+.||+|+||+||+|.+. +++.||||+++... ...+.|.+|+++|++++||||++++|++.+ .
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~ 85 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR----E 85 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS----S
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEee----C
Confidence 4444567888899999999999999886 48899999987653 344569999999999999999999999976 3
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||||++++.+||+|||++
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccce
Confidence 45699999999999999998766677999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
+....+.. .......|++.|+|||.+.+..++.++||||||+++|||++|..||..
T Consensus 163 ~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~ 218 (287)
T d1opja_ 163 RLMTGDTY----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218 (287)
T ss_dssp TTCCSSSS----EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eecCCCCc----eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 87654321 122334688999999999999999999999999999999998777653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=349.67 Aligned_cols=199 Identities=30% Similarity=0.467 Sum_probs=163.6
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
++|+..+.||+|+||.||+|.+.+++.||||+++... ...++|.+|++++++++||||++++|++.+ ....++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE----QAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceecc----CCceEEE
Confidence 4677788999999999999999989999999997643 345679999999999999999999999976 3456999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++|+|.+++.... ..+++..++.++.|+|.||+|||+.+ |+||||||+|||+|+++.+||+|||+++.....
T Consensus 79 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred EEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCC
Confidence 99999999999987543 55899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcC-CCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG-RQPIH 436 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG-~~Pf~ 436 (466)
.. .......||+.|+|||.+.+..++.++||||||+++|||+|+ ++||.
T Consensus 155 ~~----~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~ 204 (263)
T d1sm2a_ 155 QY----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred Cc----eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC
Confidence 22 122335689999999999999999999999999999999995 55554
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=352.13 Aligned_cols=208 Identities=23% Similarity=0.331 Sum_probs=165.7
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|++.+.||+|+||.||+|+.. +|+.||||++..... ....+.|.+|++++++++||||+++++++.+.. ....+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT--NTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC------CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC--CCEEE
Confidence 46888899999999999999875 689999999976643 233456899999999999999999999986522 33569
Q ss_pred EEEecCCCCCHHHHhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 302 LVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAA--APRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~~L~~LH~~~--~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
+||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+||||+.++.+||+|||++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 999999999999999643 2356999999999999999999999865 235999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+....+. .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus 162 ~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~ 217 (269)
T d2java1 162 RILNHDT-----SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217 (269)
T ss_dssp HHC----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eecccCC-----CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC
Confidence 8765432 1233467899999999999999999999999999999999999999753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-45 Score=350.67 Aligned_cols=204 Identities=27% Similarity=0.429 Sum_probs=173.9
Q ss_pred CCCCCcce-ecccCcEEEEEEEEc---CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 224 DKFSGSNI-VGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~~-LG~G~fG~Vy~a~~~---~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
++|...+. ||+|+||.||+|.+. ++..||||+++........+.|.+|+++|++++||||++++|++.. ..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----~~ 82 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----EA 82 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----SS
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Ce
Confidence 34555564 999999999999764 3557999999876655566779999999999999999999999864 24
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhc
Confidence 689999999999999986532 46999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
....... ........||+.|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus 159 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~ 216 (285)
T d1u59a_ 159 LGADDSY--YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216 (285)
T ss_dssp CTTCSCE--ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccc--cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC
Confidence 7543321 122334568999999999999999999999999999999998 99999754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=344.47 Aligned_cols=199 Identities=28% Similarity=0.398 Sum_probs=170.4
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEcccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEec
Q 012297 229 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 306 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~ey 306 (466)
.+.||+|+||+||+|.+. +++.||+|++.... .....+.|.+|+++|++++||||+++++++.+........++||||
T Consensus 14 ~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~ 93 (270)
T d1t4ha_ 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 93 (270)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeC
Confidence 457999999999999876 57899999987653 2334456999999999999999999999987755556678999999
Q ss_pred CCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEEecCCccccccCCC
Q 012297 307 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 307 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld-~~~~vkL~DfGla~~~~~~~~ 385 (466)
+++|+|.+++... ..+++..+..++.|+++||+|||+++ ++|+||||||+|||++ +++.+||+|||+++.....
T Consensus 94 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-- 168 (270)
T d1t4ha_ 94 MTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 168 (270)
T ss_dssp CCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred CCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC--
Confidence 9999999999764 56899999999999999999999875 4599999999999996 5789999999999754322
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
......||+.|+|||.+.+ .++.++|||||||++|||++|+.||...
T Consensus 169 -----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 169 -----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp -----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred -----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 2234679999999998865 5999999999999999999999999743
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=350.44 Aligned_cols=203 Identities=27% Similarity=0.409 Sum_probs=173.7
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|++.+.||+|+||+||+|... +++.||||++.... .....+.+.+|++++++++||||+++++++.+ ....
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~ 83 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD----DEKL 83 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC----SSEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE----CCEE
Confidence 45888899999999999999875 68999999986432 23334568999999999999999999999876 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 84 ~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceec
Confidence 9999999999999998764 56999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... ........||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 159 ~~~~~---~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 159 SPESK---QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp C-------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCc---ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 54321 11223457999999999999999999999999999999999999999753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=340.05 Aligned_cols=202 Identities=24% Similarity=0.417 Sum_probs=177.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
++|+..+.||+|+||+||+|++++++.||||+++... ...++|++|++++++++||||++++|++.+ ....++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~----~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK----QRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECC----SSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEee----CCceEEE
Confidence 5788899999999999999999889999999998653 334579999999999999999999999976 3467999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 99999999999986543 45899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 439 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~~ 439 (466)
.. .......||+.|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 154 ~~----~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~ 206 (258)
T d1k2pa_ 154 EY----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206 (258)
T ss_dssp SC----CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred Cc----eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC
Confidence 22 22334568999999999999999999999999999999998 899997654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=350.21 Aligned_cols=201 Identities=23% Similarity=0.354 Sum_probs=173.1
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
+.|++.+.||+|+||.||+|++. +++.||||++.... ....+.|.+|+++|++++||||+++++++.+ ....++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYY----ENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE----TTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----CCeEEE
Confidence 45788899999999999999875 58899999997653 3444568999999999999999999999887 456799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++|+|.+++... ...+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 vmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred EEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999999999998653 256999999999999999999999998 99999999999999999999999999976533
Q ss_pred CCCCCCCCCCCccccCcccccchhcc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.. .......||+.|+|||++. ...++.++|||||||++|||+||+.||...
T Consensus 163 ~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 163 TI-----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp HH-----HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred Cc-----ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence 21 0122356899999999884 456799999999999999999999999754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-44 Score=349.71 Aligned_cols=201 Identities=23% Similarity=0.347 Sum_probs=160.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.+.|++.+.||+|+||+||+|+.. +++.||||++...........+.+|+++|++++||||+++++++.+ ....+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~ 83 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES----GGHLY 83 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC----SSEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEEE
Confidence 466888999999999999999875 5899999999866544445568899999999999999999999876 45679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEEecCCcc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAK 378 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld---~~~~vkL~DfGla~ 378 (466)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+. +++.+||+|||+++
T Consensus 84 lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp EEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeE
Confidence 999999999999999754 56999999999999999999999998 99999999999994 57899999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
...... ......||+.|+|||.+.+..++.++|||||||+||||++|+.||...
T Consensus 159 ~~~~~~------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 212 (307)
T d1a06a_ 159 MEDPGS------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212 (307)
T ss_dssp --------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EccCCC------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence 654332 223457999999999999999999999999999999999999999743
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=353.28 Aligned_cols=209 Identities=24% Similarity=0.429 Sum_probs=173.2
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEcC------CcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeec
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~~------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~ 293 (466)
...++|++.+.||+|+||+||+|++.. ...||||++...........|.+|+.++.++ +|||||++++++.+
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~- 112 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL- 112 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee-
Confidence 344678888999999999999998753 2369999997766666667799999999998 89999999999986
Q ss_pred cCcceeEEEEEecCCCCCHHHHhccccc---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 012297 294 RGKRAMRLLVFEFMPNGNLRDCLDGVLV---------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRIL 352 (466)
Q Consensus 294 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~qia~~L~~LH~~~~~~iv 352 (466)
....++||||+++|+|.++|+.... ..+++..++.++.|+++||+|||+.+ |+
T Consensus 113 ---~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---Ii 186 (325)
T d1rjba_ 113 ---SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CV 186 (325)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ---CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 3456999999999999999965421 24899999999999999999999998 99
Q ss_pred ecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-C
Q 012297 353 HRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-G 431 (466)
Q Consensus 353 HrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G 431 (466)
||||||+|||++.++.+||+|||+++........ .......||+.|+|||.+.+..++.++|||||||+||||+| |
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g 263 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY---VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred eccCchhccccccCCeEEEeeccccccccCCCce---eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence 9999999999999999999999999876543221 11233568999999999999999999999999999999998 8
Q ss_pred CCCCCCCC
Q 012297 432 RQPIHRSI 439 (466)
Q Consensus 432 ~~Pf~~~~ 439 (466)
+.||....
T Consensus 264 ~~Pf~~~~ 271 (325)
T d1rjba_ 264 VNPYPGIP 271 (325)
T ss_dssp CCSSTTCC
T ss_pred CCCCCCCC
Confidence 99997543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=345.65 Aligned_cols=203 Identities=27% Similarity=0.406 Sum_probs=166.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCC-----cEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDG-----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~-----~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
+.|+..++||+|+||.||+|.+++. ..||||++...........|++|++++++++||||++++|++.+ ..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~----~~ 82 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK----YK 82 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----SS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec----CC
Confidence 4577788999999999999987642 47999999876655556679999999999999999999999976 34
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+.+++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhh
Confidence 5699999999999999886533 56999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
........ ........||+.|+|||.+....++.++||||||+++|||++|..|+.
T Consensus 159 ~~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 159 VLEDDPEA--TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cccCCCcc--ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence 76543211 112333568999999999999999999999999999999999766654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-44 Score=342.87 Aligned_cols=197 Identities=28% Similarity=0.447 Sum_probs=165.4
Q ss_pred ceecccCcEEEEEEEEcC---CcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~---~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
+.||+|+||.||+|.+.+ ++.||||+++.... ....+.|.+|+++|++++||||++++|+|.. ...+||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-----~~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----ESWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----SSEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-----CCEEEEEE
Confidence 469999999999998753 46899999976533 3345679999999999999999999999853 23589999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++|+|.++++.. ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 88 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 88 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred cCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999999999754 56999999999999999999999998 99999999999999999999999999987654322
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
. ........||+.|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus 163 ~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~ 214 (277)
T d1xbba_ 163 Y--YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214 (277)
T ss_dssp E--EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred c--cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC
Confidence 1 112233568999999999999999999999999999999998 89999754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=345.76 Aligned_cols=201 Identities=30% Similarity=0.448 Sum_probs=169.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.++|++.+.||+|+||.||+|++++++.||||+++... ...+.|.+|+.++++++|+|||+++|++.+ ...++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-----~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec-----CCeEE
Confidence 35688889999999999999999988899999997553 334669999999999999999999999854 23589
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
||||+++|+|..++.......++|.+++.++.||+.||+|||+.+ |+||||||+|||||+++++||+|||+++....
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccC
Confidence 999999999999998766667999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
... .......||+.|+|||++....++.++||||||+++|||++|..||..
T Consensus 166 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 166 NEY----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCc----eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 322 123335689999999999999999999999999999999997666543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=348.48 Aligned_cols=201 Identities=26% Similarity=0.338 Sum_probs=177.0
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|++.+.||+|+||.||+|+.. +++.||||+++... .......+.+|+++|++++||||+++++++.+ ....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~ 80 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----HDRL 80 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC----SSEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc----cccc
Confidence 46888899999999999999874 68999999987432 23344568899999999999999999999987 5577
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred ccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccc
Confidence 9999999999999999764 56899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~-----~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~ 208 (337)
T d1o6la_ 156 ISDG-----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp CCTT-----CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCC-----cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc
Confidence 4332 1234468999999999999999999999999999999999999999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-43 Score=338.26 Aligned_cols=201 Identities=25% Similarity=0.362 Sum_probs=175.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-----CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-----PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 296 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~ 296 (466)
.+.|++.+.||+|+||+||+|+.. +|+.||||+++.... ....+.|.+|+++|++++||||+++++++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---- 84 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN---- 84 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----
Confidence 357888999999999999999974 689999999865422 2235669999999999999999999999876
Q ss_pred ceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEE
Q 012297 297 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKIT 372 (466)
Q Consensus 297 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~----~vkL~ 372 (466)
....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred CCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEec
Confidence 45779999999999999999764 46999999999999999999999998 99999999999998776 49999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 373 DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|||++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 160 DfG~a~~~~~~~------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 219 (293)
T d1jksa_ 160 DFGLAHKIDFGN------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219 (293)
T ss_dssp CCTTCEECTTSC------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred chhhhhhcCCCc------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence 999998764432 223456899999999999999999999999999999999999999754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-43 Score=344.80 Aligned_cols=198 Identities=28% Similarity=0.358 Sum_probs=174.5
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|++.+.||+|+||+||+|+.. +|+.||||+++... .....+.+.+|+.++++++||||+++++++.+ ....
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~ 79 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD----AQQI 79 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC----SSEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee----CCee
Confidence 45888899999999999999974 58999999986431 23344568999999999999999999999876 4577
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|..++... ..+++..+..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 80 ~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred eeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEe
Confidence 9999999999999998764 45789999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .....||+.|+|||.+.+..++.++|||||||+||||+||+.||...
T Consensus 155 ~~~--------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 204 (316)
T d1fota_ 155 PDV--------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 204 (316)
T ss_dssp SSC--------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccc--------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc
Confidence 432 23457999999999999999999999999999999999999999753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-43 Score=344.45 Aligned_cols=197 Identities=27% Similarity=0.388 Sum_probs=170.5
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
..|+..+.||+|+||.||+|+.. +++.||||++...... ...+.|.+|+++|++++||||+++++++.+ ....
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~~ 90 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----EHTA 90 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE----CCEE
Confidence 34788899999999999999875 6889999999765432 223458999999999999999999999886 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+++|+|..++... ..+++.++..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 91 ~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (309)
T ss_dssp EEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccccccc
Confidence 9999999999998776543 56999999999999999999999998 999999999999999999999999999865
Q ss_pred ccCCCCCCCCCCCccccCcccccchhccc---CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 166 ~~~---------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~ 217 (309)
T d1u5ra_ 166 APA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (309)
T ss_dssp SSB---------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCC---------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC
Confidence 332 23569999999999853 45899999999999999999999999753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-42 Score=333.82 Aligned_cols=209 Identities=27% Similarity=0.391 Sum_probs=173.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
.++|++.+.||+|+||.||+|... +++.||||+++..... .....|.+|+++++.++||||+++++++.........
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 466888999999999999999874 6899999999765433 2345699999999999999999999998876655567
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++..+|+|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence 89999999999999998764 56999999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
....... ........||+.|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 217 (277)
T d1o6ya_ 161 IADSGNS--VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 217 (277)
T ss_dssp CC------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hcccccc--ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc
Confidence 5433211 12234467999999999999999999999999999999999999999753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.6e-43 Score=345.56 Aligned_cols=200 Identities=25% Similarity=0.345 Sum_probs=174.7
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+ ....++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFED----DNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE----TTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEEEE
Confidence 47888999999999999999875 68999999997543 2344568999999999999999999999887 456799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCcEEEEecCCcccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD--ENLNAKITDLGMAKRL 380 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld--~~~~vkL~DfGla~~~ 380 (466)
||||+++|+|.+++.... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 101 vmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 999999999999996532 45999999999999999999999999 99999999999995 4678999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 177 ~~~~------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 228 (350)
T d1koaa2 177 DPKQ------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 228 (350)
T ss_dssp CTTS------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccc------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence 4332 223467899999999999999999999999999999999999999754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-43 Score=343.12 Aligned_cols=213 Identities=25% Similarity=0.432 Sum_probs=179.7
Q ss_pred hHHHHHHhCCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeee
Q 012297 216 YSALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 289 (466)
Q Consensus 216 ~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~ 289 (466)
+.+|+..+++|++.+.||+|+||+||+|++. +++.||||+++........+.|.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3456777889999999999999999999864 3578999999876555556779999999999999999999999
Q ss_pred eeeccCcceeEEEEEecCCCCCHHHHhcccc----------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 012297 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL----------------------VEGMNWDTRVAIAIGAARGLEYLHEAA 347 (466)
Q Consensus 290 ~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qia~~L~~LH~~~ 347 (466)
+.+ ....++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+
T Consensus 85 ~~~----~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ 160 (301)
T d1lufa_ 85 CAV----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 160 (301)
T ss_dssp ECS----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ecc----CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC
Confidence 976 345699999999999999996421 124889999999999999999999998
Q ss_pred CCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHH
Q 012297 348 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 427 (466)
Q Consensus 348 ~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~e 427 (466)
|+||||||+|||||.++.+||+|||+++....... ........|++.|+|||.+....++.++|||||||++||
T Consensus 161 ---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~e 234 (301)
T d1lufa_ 161 ---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY---YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234 (301)
T ss_dssp ---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC---BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ---eEeeEEcccceEECCCCcEEEccchhheeccCCcc---ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHH
Confidence 99999999999999999999999999986644321 112234568899999999999999999999999999999
Q ss_pred HHcCC-CCCCCC
Q 012297 428 LITGR-QPIHRS 438 (466)
Q Consensus 428 lltG~-~Pf~~~ 438 (466)
|++|. +||...
T Consensus 235 ll~~~~~p~~~~ 246 (301)
T d1lufa_ 235 IFSYGLQPYYGM 246 (301)
T ss_dssp HHTTTCCTTTTS
T ss_pred HHccCCCCCCCC
Confidence 99986 566644
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-43 Score=341.73 Aligned_cols=204 Identities=27% Similarity=0.457 Sum_probs=169.2
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCc----EEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcce
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 298 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~ 298 (466)
.+|+..++||+|+||+||+|.+. +|+ .||||+++........+.|.+|++++++++||||++++|+|.+.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 35888899999999999999875 333 69999998766666777899999999999999999999999752
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++++||+.+|+|.+++... ...+++..++.++.|||.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred CeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccce
Confidence 347889999999999988764 356999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 439 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~~ 439 (466)
....... ........||+.|+|||.+.++.++.++||||||++||||+| |++||....
T Consensus 160 ~~~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 160 LLGAEEK---EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp HTTTTCC-----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred ecccccc---cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence 7654322 112233568999999999999999999999999999999998 888987543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2e-42 Score=343.44 Aligned_cols=200 Identities=26% Similarity=0.377 Sum_probs=174.6
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|++.+.||+|+||.||+|... +|+.||||+++... ......+.+|+++|++++||||+++++++.+ ....++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFED----KYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC----SSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEEEE
Confidence 46888899999999999999874 69999999987653 2334568899999999999999999999876 457799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCcEEEEecCCcccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD--ENLNAKITDLGMAKRL 380 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld--~~~~vkL~DfGla~~~ 380 (466)
||||+++|+|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||++...
T Consensus 104 vmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceec
Confidence 99999999999988653 245999999999999999999999998 99999999999997 6789999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... ......||+.|+|||++.+..++.++|||||||+||||+||+.||...
T Consensus 180 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 231 (352)
T d1koba_ 180 NPDE------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 231 (352)
T ss_dssp CTTS------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCCC------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 5432 223457899999999999999999999999999999999999999743
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-42 Score=344.14 Aligned_cols=198 Identities=24% Similarity=0.327 Sum_probs=174.9
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|++.+.||+|+||.||+|++. +|+.||||++.... .....+.+.+|+++|+.++||||+++++++.+ ....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~ 116 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD----NSNL 116 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc----cccc
Confidence 46888899999999999999875 68999999986431 22334568999999999999999999999876 4567
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 380 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~ 380 (466)
++||||+.+|+|.+++... ..+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 117 ~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 9999999999999999764 46999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .....||+.|+|||++.+..++.++|||||||+||||+||+.||...
T Consensus 192 ~~~--------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 192 KGR--------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp SSC--------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccc--------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence 432 23457999999999999999999999999999999999999999753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-43 Score=336.13 Aligned_cols=205 Identities=24% Similarity=0.384 Sum_probs=165.4
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcC----CcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 222 ATDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 222 ~t~~f~~~~~LG~G~fG~Vy~a~~~~----~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
..++|++.+.||+|+||.||+|++.. +..||||.++..........|.+|++++++++||||++++|++.+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 79 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 79 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence 34678888999999999999998753 356899998766555556679999999999999999999999853
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----
T ss_pred CeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhh
Confidence 2459999999999999988653 356899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 439 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~~ 439 (466)
+....... .......||+.|+|||.+....++.++|||||||++|||+| |.+||....
T Consensus 156 ~~~~~~~~----~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 156 RYMEDSTY----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred eeccCCcc----eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence 87644321 12234568899999999999999999999999999999998 899997543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-42 Score=335.86 Aligned_cols=201 Identities=25% Similarity=0.412 Sum_probs=172.8
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHHHHHHH-hcCCCCccceeeeeeeccCccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLS-RLHHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~-~l~H~nIv~llg~~~~~~~~~~~ 299 (466)
++|.+.+.||+|+||+||+|+.. +++.||||+++... .....+.+..|+.++. .++||||+++++++.+ +..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~----~~~ 77 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----KEN 77 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----SSE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc----CCc
Confidence 46888899999999999999875 58999999996432 1223344667777665 6899999999999887 456
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++.
T Consensus 78 ~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred eeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhh
Confidence 79999999999999999754 55899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~ 206 (320)
T d1xjda_ 153 NMLGD-----AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 206 (320)
T ss_dssp CCCTT-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccc-----ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC
Confidence 54332 2233457999999999999999999999999999999999999999753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.3e-42 Score=340.32 Aligned_cols=202 Identities=28% Similarity=0.402 Sum_probs=169.9
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCC--CCChhHHHHHH---HHHHHhcCCCCccceeeeeeeccCcc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTE---VDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~--~~~~~~~f~~E---i~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
++|++.++||+|+||.||+|+.. +|+.||||++.... .......+.+| +.+++.++||||+++++++.+ .
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~----~ 79 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----P 79 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----S
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE----C
Confidence 56888999999999999999875 58999999986431 11222334454 556667789999999999876 4
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred CEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeecee
Confidence 5679999999999999999764 56899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITK 441 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~ 441 (466)
+...... .....||+.|+|||.+.. ..++.++|||||||+||||+||+.||......
T Consensus 155 ~~~~~~~-------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 212 (364)
T d1omwa3 155 CDFSKKK-------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212 (364)
T ss_dssp EECSSSC-------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred eecCCCc-------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH
Confidence 8765432 234579999999999865 56899999999999999999999999765443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-41 Score=326.17 Aligned_cols=201 Identities=29% Similarity=0.434 Sum_probs=173.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCC--------hhHHHHHHHHHHHhcC-CCCccceeeeeee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--------ADSVFLTEVDMLSRLH-HCHVVPLVGYCSE 292 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~--------~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~ 292 (466)
.++|++.+.||+|+||+||+|+.. +++.||||++....... ..+.+.+|++++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 367888999999999999999874 68999999987654221 1235889999999997 9999999999986
Q ss_pred ccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 012297 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 372 (466)
Q Consensus 293 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~ 372 (466)
....++||||+++|+|.++++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 82 ----~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~ 152 (277)
T d1phka_ 82 ----NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 152 (277)
T ss_dssp ----SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred ----CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEc
Confidence 55779999999999999999764 46999999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCcccccchhccc------CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV------GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 373 DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
|||+++...... ......||+.|+|||.+.. ..++.++||||+|++||||++|+.||...
T Consensus 153 DFG~a~~~~~~~------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~ 218 (277)
T d1phka_ 153 DFGFSCQLDPGE------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218 (277)
T ss_dssp CCTTCEECCTTC------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cchheeEccCCC------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC
Confidence 999998765432 2234579999999998852 34688999999999999999999999754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-42 Score=339.11 Aligned_cols=200 Identities=25% Similarity=0.311 Sum_probs=172.3
Q ss_pred CCCCCc-ceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcceeE
Q 012297 224 DKFSGS-NIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 300 (466)
Q Consensus 224 ~~f~~~-~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~~ 300 (466)
++|.+. +.||+|+||+||+|++ .+++.||||+++.. ..+.+|++++.++ +||||+++++++.+........
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 467765 4699999999999987 46899999998642 3478899987655 8999999999987655556678
Q ss_pred EEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEEecCCc
Q 012297 301 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGMA 377 (466)
Q Consensus 301 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~---~~~vkL~DfGla 377 (466)
++||||+++|+|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+|||+++ ++.+||+|||++
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 99999999999999998655567999999999999999999999999 999999999999975 467999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+...... ......||+.|+|||++.+..++.++|||||||+||||+||+.||...
T Consensus 162 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~ 216 (335)
T d2ozaa1 162 KETTSHN------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216 (335)
T ss_dssp EECCCCC------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred eeccCCC------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence 8765432 233457999999999999999999999999999999999999999643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-42 Score=333.89 Aligned_cols=214 Identities=27% Similarity=0.409 Sum_probs=169.3
Q ss_pred hHHHHHHhCCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceee
Q 012297 216 YSALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVG 288 (466)
Q Consensus 216 ~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg 288 (466)
...|+...++|++.+.||+|+||.||+|.+. +++.||||+++........+.+.+|+..+.++ +|+||+++++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 3455556678999999999999999999864 24689999998766555666788999988887 6899999999
Q ss_pred eeeeccCcceeEEEEEecCCCCCHHHHhcccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 012297 289 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHR 354 (466)
Q Consensus 289 ~~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHr 354 (466)
++.+. ....++||||+++|+|.++++... ...+++.+++.++.|+++||.|||+.+ |+||
T Consensus 85 ~~~~~---~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHr 158 (299)
T d1ywna1 85 ACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 158 (299)
T ss_dssp EECST---TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred eeccC---CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCC
Confidence 87653 235699999999999999996532 134889999999999999999999998 9999
Q ss_pred CCCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCC-C
Q 012297 355 DIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR-Q 433 (466)
Q Consensus 355 DLk~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~-~ 433 (466)
||||+||||++++++||+|||+++....... ........||+.|+|||.+.+..++.++|||||||++|||+||. +
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~ 235 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPD---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTT---SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCccceeECCCCcEEEccCcchhhcccccc---ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCC
Confidence 9999999999999999999999987644322 12233467999999999999999999999999999999999964 5
Q ss_pred CCCCC
Q 012297 434 PIHRS 438 (466)
Q Consensus 434 Pf~~~ 438 (466)
||...
T Consensus 236 p~~~~ 240 (299)
T d1ywna1 236 PYPGV 240 (299)
T ss_dssp SSTTC
T ss_pred CCCCC
Confidence 67543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=331.07 Aligned_cols=197 Identities=29% Similarity=0.449 Sum_probs=164.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
++|+..+.||+|+||.||+|.+ .|+.||||+++... ..+.|.+|++++++++||||++++|++.+. ....++|
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~~~~lv 79 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGGLYIV 79 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC-----CCEEE
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEec---CCcEEEE
Confidence 4567778999999999999998 47889999997543 345699999999999999999999998652 2345999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||+++|+|.++|.......++|..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC
Confidence 99999999999997654456899999999999999999999998 999999999999999999999999999865332
Q ss_pred CCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
.....+|..|+|||.+.+..+++++||||||+++|||+| |++||...
T Consensus 157 --------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~ 204 (262)
T d1byga_ 157 --------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204 (262)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred --------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC
Confidence 223457889999999999999999999999999999998 78888654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-41 Score=330.47 Aligned_cols=200 Identities=28% Similarity=0.459 Sum_probs=171.6
Q ss_pred ceecccCcEEEEEEEEcCC----cEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEEEe
Q 012297 230 NIVGQGGSSYVYRGQLTDG----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 305 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~~----~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV~e 305 (466)
++||+|+||+||+|++.++ ..||||+++........++|.+|+++|++++||||++++|++.+. +...++|||
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~~~~lv~E 109 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---EGSPLVVLP 109 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET---TTEEEEEEE
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec---CCceEEEEE
Confidence 6799999999999987542 368999998665566667799999999999999999999998753 235799999
Q ss_pred cCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012297 306 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 385 (466)
Q Consensus 306 y~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~~~ 385 (466)
|+++|+|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999998754 345789999999999999999999998 99999999999999999999999999987755433
Q ss_pred CCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 386 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 386 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
.. ........||+.|+|||.+....++.++||||||+++|||+||+.||..
T Consensus 186 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 186 DS-VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp CC-TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred cc-ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 22 2223345789999999999999999999999999999999998888764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-42 Score=332.32 Aligned_cols=203 Identities=27% Similarity=0.384 Sum_probs=165.0
Q ss_pred CCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHH--HHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD--MLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~--~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
.|...+.||+|+||.||+|++ +|+.||||+++.. ....+..|.+ .+.+++||||++++|++.+........++
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 456678899999999999997 5889999998643 2233444544 45678999999999999986665667899
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA-----APRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~-----~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
||||+++|+|.++|++ ..++|..++.++.|+|.||+|||+.. .++|+||||||+||||++++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999975 35899999999999999999999741 235999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCC------CCchhHHHHHHHHHHHHHcCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR------ASLMSDVFSFGVVLLELITGRQPIH 436 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~sDv~S~Gvll~elltG~~Pf~ 436 (466)
+........ .........||+.|+|||++.... ++.++||||||++||||+||..||.
T Consensus 156 ~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 156 VRHDSATDT-IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EEEETTTTE-ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred ccccCCCcc-eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 877543321 112334467999999999987543 5779999999999999999998874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-41 Score=330.28 Aligned_cols=200 Identities=22% Similarity=0.324 Sum_probs=174.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
.++|.+.+.||+|+||+||+|... +++.||||+++... .....+.+|+++|+.++||||+++++++.+ ....+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFES----MEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE----TTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE----CCEEE
Confidence 467889999999999999999875 58899999997652 334458899999999999999999999876 45689
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC--CcEEEEecCCccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN--LNAKITDLGMAKR 379 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~--~~vkL~DfGla~~ 379 (466)
+||||+++|+|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++.
T Consensus 78 lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhc
Confidence 9999999999999997542 35899999999999999999999998 9999999999999854 5899999999987
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~ 206 (321)
T d1tkia_ 154 LKPGD------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp CCTTC------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccCC------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC
Confidence 64321 123356899999999999999999999999999999999999999754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-42 Score=328.12 Aligned_cols=204 Identities=29% Similarity=0.377 Sum_probs=162.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcC--C--cEEEEEEcccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD--G--RIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~--~--~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~ 297 (466)
++|++.+.||+|+||.||+|++.. + ..||||+++... ..+..+.|.+|+++|++++||||++++|++.+.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---- 83 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---- 83 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec----
Confidence 457778899999999999998642 2 378999987653 233445799999999999999999999999652
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
..++||||+++|+|.+++.... ..+++..++.++.|+|.||.|||+.+ |+||||||+|||++.++++||+|||++
T Consensus 84 -~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 84 -PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred -chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhh
Confidence 3489999999999999887543 45999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
+........ ........|+..|+|||.+....++.++||||||+++|||+| |+.||...
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 159 RALPQNDDH--YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp EECCC-CCE--EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred hhcccCCCc--ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence 976544321 112334567889999999999999999999999999999998 89999743
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=329.24 Aligned_cols=201 Identities=28% Similarity=0.469 Sum_probs=167.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcC-Cc--EEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTD-GR--IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~-~~--~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~~~~~~~ 299 (466)
++|++.+.||+|+||.||+|++.+ +. .||||+++........+.|.+|+++|+++ +||||++++|++.+ ...
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----~~~ 85 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGY 85 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----TTE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec----CCe
Confidence 567778999999999999998754 33 57889887665555566799999999999 79999999999987 456
Q ss_pred EEEEEecCCCCCHHHHhccc--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 012297 300 RLLVFEFMPNGNLRDCLDGV--------------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 365 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~ 365 (466)
.++||||+++|+|.++|+.. ....+++..++.++.|+|.||.|||+.+ |+||||||+|||++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECG
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcC
Confidence 79999999999999999643 2356999999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCC-CCCC
Q 012297 366 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQ-PIHR 437 (466)
Q Consensus 366 ~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~-Pf~~ 437 (466)
++.+||+|||+++...... ......||..|+|||.+....++.++||||||+++|||++|.. ||..
T Consensus 163 ~~~~kl~DfG~a~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~ 229 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYV------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229 (309)
T ss_dssp GGCEEECCTTCEESSCEEC------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCceEEccccccccccccc------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC
Confidence 9999999999998654332 1233468899999999999999999999999999999999765 5653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-41 Score=328.07 Aligned_cols=206 Identities=28% Similarity=0.429 Sum_probs=171.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcC--------CcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeec
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~~--------~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~ 293 (466)
.++|.+.+.||+|+||.||+|+... +..||||+++.........++.+|...+.++ +||||++++++|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~- 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence 4567778999999999999997632 3479999998776655667799999999888 79999999999986
Q ss_pred cCcceeEEEEEecCCCCCHHHHhcccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 012297 294 RGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 359 (466)
Q Consensus 294 ~~~~~~~~lV~ey~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~ 359 (466)
+...++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+
T Consensus 91 ---~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~ 164 (299)
T d1fgka_ 91 ---DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 164 (299)
T ss_dssp ---SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred ---CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccc
Confidence 345699999999999999996543 234899999999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 012297 360 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 438 (466)
Q Consensus 360 NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~ellt-G~~Pf~~~ 438 (466)
|||++.++.+||+|||+++........ .......+|+.|+|||.+.++.++.++||||||+++|||++ |++||...
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTT---CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceeecCCCCeEeccchhhccccccccc---cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 999999999999999999887654332 22344668999999999999999999999999999999998 78888643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-41 Score=326.76 Aligned_cols=196 Identities=28% Similarity=0.370 Sum_probs=162.7
Q ss_pred cceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCC----hhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEEE
Q 012297 229 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 303 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~----~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~lV 303 (466)
.++||+|+||+||+|++. +|+.||||+++...... ....+.+|++++++++||||+++++++.+ ....++|
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~----~~~~~iv 78 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH----KSNISLV 78 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC----TTCCEEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc----CCceeeh
Confidence 468999999999999875 58999999987553221 23458999999999999999999999876 3456999
Q ss_pred EecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccccC
Q 012297 304 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 383 (466)
Q Consensus 304 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~~ 383 (466)
|||++++++..+.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 79 mE~~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp EECCSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred hhhhcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC
Confidence 9999888777666532 55899999999999999999999998 999999999999999999999999999876443
Q ss_pred CCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 384 GLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 384 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
. .......||+.|+|||.+.. ..++.++|||||||++|||+||++||...
T Consensus 154 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 154 N-----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp C-----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c-----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 2 12334578999999998865 45799999999999999999999999653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-41 Score=325.06 Aligned_cols=202 Identities=25% Similarity=0.432 Sum_probs=169.6
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|++.+.||+|+||+||+|++. +++.||||+++.... ......+.+|++++++++||||+++++++.+ ....+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~----~~~~~ 77 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT----ENKLY 77 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc----cccee
Confidence 57888999999999999999874 689999999975532 2234568999999999999999999999987 45779
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+||||+. +++.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 78 iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 78 LVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp EEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred EEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceecc
Confidence 9999995 56666665545567999999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCC-CCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... .......||+.|+|||.+.... ++.++|||||||++|||++|+.||...
T Consensus 154 ~~~-----~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 154 VPV-----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp CCS-----BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCc-----ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 432 2233457899999999877655 588999999999999999999999743
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=328.97 Aligned_cols=208 Identities=25% Similarity=0.386 Sum_probs=175.7
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeec
Q 012297 221 HATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 293 (466)
Q Consensus 221 ~~t~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~llg~~~~~ 293 (466)
...++|++.+.||+|+||.||+|++. +++.||||+++..........|.+|+.+++++ +||||++++|++.+
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~- 98 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI- 98 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee-
Confidence 34467778899999999999999862 46789999998776666666799999999999 69999999999976
Q ss_pred cCcceeEEEEEecCCCCCHHHHhcccc----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 012297 294 RGKRAMRLLVFEFMPNGNLRDCLDGVL----------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 357 (466)
Q Consensus 294 ~~~~~~~~lV~ey~~~gsL~~~l~~~~----------------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk 357 (466)
....++||||+++|+|.++++... ...+++..++.++.||++||+|||+++ ++|||||
T Consensus 99 ---~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLK 172 (311)
T d1t46a_ 99 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA 172 (311)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred ---CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccc
Confidence 345699999999999999996532 124899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcC-CCCCC
Q 012297 358 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG-RQPIH 436 (466)
Q Consensus 358 ~~NILld~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG-~~Pf~ 436 (466)
|+|||++.++.+||+|||+++........ .......||+.|+|||.+....++.++||||||+++|||+|+ .+||.
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTS---EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccccccccCcccccccchheeccCCCcc---eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 99999999999999999999876543221 123346789999999999999999999999999999999995 55554
Q ss_pred CC
Q 012297 437 RS 438 (466)
Q Consensus 437 ~~ 438 (466)
..
T Consensus 250 ~~ 251 (311)
T d1t46a_ 250 GM 251 (311)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=331.60 Aligned_cols=209 Identities=28% Similarity=0.427 Sum_probs=175.7
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEc------CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeee
Q 012297 219 LEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 292 (466)
Q Consensus 219 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~------~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~ 292 (466)
|+...++|++.+.||+|+||.||+|.+. +++.||||+++..........|.+|++++++++||||++++|++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3344567788899999999999999863 3578999999866555555679999999999999999999999976
Q ss_pred ccCcceeEEEEEecCCCCCHHHHhcccc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 012297 293 FRGKRAMRLLVFEFMPNGNLRDCLDGVL--------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 364 (466)
Q Consensus 293 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld 364 (466)
....++||||+++|+|.+++.... ...+++..+..++.|+|+||.|||+.+ |+||||||+|||+|
T Consensus 95 ----~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld 167 (308)
T d1p4oa_ 95 ----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA 167 (308)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred ----CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeec
Confidence 345699999999999999985421 134789999999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCC-CCCCC
Q 012297 365 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR-QPIHR 437 (466)
Q Consensus 365 ~~~~vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~-~Pf~~ 437 (466)
+++++||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||+||. +||..
T Consensus 168 ~~~~~Kl~DFGla~~~~~~~~~---~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~ 238 (308)
T d1p4oa_ 168 EDFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 238 (308)
T ss_dssp TTCCEEECCTTCCCGGGGGGCE---EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred CCceEEEeecccceeccCCcce---eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC
Confidence 9999999999999876544321 1123346899999999999999999999999999999999985 66654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-40 Score=319.71 Aligned_cols=201 Identities=24% Similarity=0.380 Sum_probs=169.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|++.+.||+|+||+||+|++++++.||||+++.... ......|.+|+.+|++++||||+++++++.. ....++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT----KKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC----SSCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc----CCceeE
Confidence 57888899999999999999999999999999976532 2334569999999999999999999999886 446799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcccccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 382 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~~ 382 (466)
+|||+.++.+..+.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 78 ~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (286)
T ss_dssp EEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred EEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceeccc
Confidence 99999877766665533 56999999999999999999999998 99999999999999999999999999987644
Q ss_pred CCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 383 DGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 383 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
... ......+++.|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 153 ~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 153 PVR-----KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred Ccc-----ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 321 22334688999999988754 5699999999999999999999999754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-40 Score=325.35 Aligned_cols=209 Identities=22% Similarity=0.311 Sum_probs=171.1
Q ss_pred hCCCCCcceecccCcEEEEEEEE-cCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~-~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
+++|.+.+.||+|+||+||+|.. .+|+.||||++.........+.+++|+++|++++||||+++++++..........+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45688899999999999999986 47999999999766555555678999999999999999999999876433222334
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 55566779999999964 46999999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCcccccchhcc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
..... ........||+.|+|||.+. ...++.++||||+|+++|||++|+.||....
T Consensus 161 ~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 161 PDHDH--TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp GGGCB--CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCCcc--ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 43221 12234467899999999884 4567999999999999999999999997543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=318.69 Aligned_cols=199 Identities=24% Similarity=0.361 Sum_probs=167.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-----ChhHHHHHHHHHHHhcC--CCCccceeeeeeecc
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-----NADSVFLTEVDMLSRLH--HCHVVPLVGYCSEFR 294 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-----~~~~~f~~Ei~~l~~l~--H~nIv~llg~~~~~~ 294 (466)
.++|++.+.||+|+||.||+|+.. +++.||||++...... .....+.+|+.++++++ ||||+++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence 357888999999999999999875 6899999998754211 11223678999999996 8999999999876
Q ss_pred CcceeEEEEEecCCC-CCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEE
Q 012297 295 GKRAMRLLVFEFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKIT 372 (466)
Q Consensus 295 ~~~~~~~lV~ey~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~-~~vkL~ 372 (466)
....++||||+.+ +++.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.+ +.+||+
T Consensus 81 --~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~ 153 (273)
T d1xwsa_ 81 --PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 153 (273)
T ss_dssp --SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEEC
T ss_pred --CCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEEC
Confidence 4567999999975 6888888654 56999999999999999999999998 9999999999999854 799999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCcccccchhcccCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q 012297 373 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHR 437 (466)
Q Consensus 373 DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDv~S~Gvll~elltG~~Pf~~ 437 (466)
|||+++..... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||..
T Consensus 154 DFG~a~~~~~~-------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 154 DFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp CCTTCEECCSS-------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ccccceecccc-------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 99999865432 1234579999999999987765 6779999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-40 Score=319.50 Aligned_cols=206 Identities=26% Similarity=0.395 Sum_probs=170.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-C-CcEEEEEEcccCCC-CChhHHHHHHHHHHHhc---CCCCccceeeeeeecc-C
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-D-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFR-G 295 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~-~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l---~H~nIv~llg~~~~~~-~ 295 (466)
.++|++.+.||+|+||+||+|++. + ++.||||+++.... ......+.+|+++++.+ +||||+++++++.... .
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 467899999999999999999874 3 67899999865422 22233467888887766 7999999999986532 2
Q ss_pred cceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 012297 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (466)
Q Consensus 296 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfG 375 (466)
.....+++|||++++++..... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 3457799999998776654443 33466899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~~~~------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 162 LARIYSFQM------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp SCCCCCGGG------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hhhhhcccc------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 987654321 233457999999999999999999999999999999999999999754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-38 Score=308.20 Aligned_cols=206 Identities=18% Similarity=0.228 Sum_probs=173.0
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCC-CCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH-CHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|++.+.||+|+||+||+|++. +++.||||++...... ..+.+|++.++.++| +|++.+++++.+ ....+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~----~~~~~ 77 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQE----GLHNV 77 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEE----TTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeec----CCccE
Confidence 57888999999999999999875 5889999988655332 237889999999975 899999988876 45679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-----CCcEEEEecCC
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-----NLNAKITDLGM 376 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~-----~~~vkL~DfGl 376 (466)
+||||+ +++|.++++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 78 ~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccce
Confidence 999999 78999998653 356999999999999999999999998 999999999999974 57899999999
Q ss_pred ccccccCCCC--CCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 012297 377 AKRLKADGLP--SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 441 (466)
Q Consensus 377 a~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~~~ 441 (466)
++........ ..........||+.|+|||.+.+..++.++||||||+++|||+||+.||......
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~ 219 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch
Confidence 9876543221 1223344578999999999999999999999999999999999999999765443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-39 Score=314.29 Aligned_cols=209 Identities=22% Similarity=0.305 Sum_probs=167.8
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeecc----Ccc
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR----GKR 297 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~----~~~ 297 (466)
++|++.+.||+|+||+||+|++. +|+.||||++..... ......+.+|+++|++++|+||+++++++.... ...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 56888899999999999999974 689999999865532 334456899999999999999999999886532 123
Q ss_pred eeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCc
Q 012297 298 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 377 (466)
Q Consensus 298 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla 377 (466)
...++||||++++.+..+... ...++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence 457999999987777655543 256899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 378 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
+......... ........||+.|+|||.+... .++.++|||||||++|||++|+.||...
T Consensus 165 ~~~~~~~~~~-~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~ 225 (318)
T d3blha1 165 RAFSLAKNSQ-PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225 (318)
T ss_dssp EECCC------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eecccccccc-cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence 8765433211 1223345799999999998755 6899999999999999999999999753
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-38 Score=305.95 Aligned_cols=205 Identities=20% Similarity=0.294 Sum_probs=168.4
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 302 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~l 302 (466)
++|++.+.||+|+||.||+|++. +++.||||++...... ..+..|+++++.++|+|++..++.+... ....++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~---~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAE---GDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEE---TTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEec---CCEEEE
Confidence 46888899999999999999874 5899999998765332 2378999999999988877776665542 346799
Q ss_pred EEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEEecCCccc
Q 012297 303 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAKR 379 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld---~~~~vkL~DfGla~~ 379 (466)
||||+ +++|.+.+... ...+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+++.
T Consensus 81 vme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCccee
Confidence 99999 66777766543 356999999999999999999999999 99999999999985 456799999999998
Q ss_pred cccCCCCC--CCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 380 LKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 380 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
........ .........||+.|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 75543221 1223345679999999999999999999999999999999999999997643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-38 Score=313.75 Aligned_cols=199 Identities=26% Similarity=0.363 Sum_probs=162.9
Q ss_pred CCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc--CcceeEEE
Q 012297 226 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRAMRLL 302 (466)
Q Consensus 226 f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~--~~~~~~~l 302 (466)
|+..++||+|+||+||+|++. +++.||||++...... +.+|+++|++++|+||+++++++.... .+....++
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 556689999999999999985 5899999999765322 347999999999999999999986543 23345789
Q ss_pred EEecCCCCCHHHHhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccc
Q 012297 303 VFEFMPNGNLRDCLDG-VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRL 380 (466)
Q Consensus 303 V~ey~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~-~vkL~DfGla~~~ 380 (466)
||||++++.+..+.+. .....+++.++..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999976644443321 22356999999999999999999999998 99999999999999775 8999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 174 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 174 VRGE------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp CTTS------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred cCCc------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence 4432 2233578999999998765 56899999999999999999999999754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-38 Score=313.64 Aligned_cols=201 Identities=25% Similarity=0.348 Sum_probs=165.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--cce
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 298 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~--~~~ 298 (466)
.++|++.+.||+|+||+||+|.+. +|+.||||+++..... ...+.+.+|+++|++++||||+++++++..... ...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467888899999999999999875 5899999999765332 234568899999999999999999999876432 233
Q ss_pred eEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 299 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 299 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
..++||||+ +.+|..+++. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence 569999999 6678877754 46999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCcccccchhccc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 379 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 170 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 170 QADSE--------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp ECCSS--------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCc--------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 75432 234578999999998876 45689999999999999999999999754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-38 Score=302.97 Aligned_cols=201 Identities=23% Similarity=0.335 Sum_probs=172.6
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|++.+.||+|+||+||+|++. +++.||||+++.... ......+.+|+.+++.++||||+++++++.+ ....+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----~~~~~ 77 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----DKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc----cccee
Confidence 46888999999999999999874 688999999976543 3445678999999999999999999999887 45679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 381 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~~~ 381 (466)
+|+|++.+++|..+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++...
T Consensus 78 iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhccc
Confidence 999999999988887643 56899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCcccccchhcccCC-CCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 382 ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 382 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... ......++..|+|||.+.... ++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 205 (292)
T d1unla_ 153 IPVR-----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp SCCS-----CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred CCCc-----cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC
Confidence 4322 223345678899999887655 699999999999999999999998643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=312.01 Aligned_cols=203 Identities=27% Similarity=0.358 Sum_probs=169.7
Q ss_pred CCCCCcceecccCcEEEEEEEEc----CCcEEEEEEcccCC---CCChhHHHHHHHHHHHhcCC-CCccceeeeeeeccC
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHH-CHVVPLVGYCSEFRG 295 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~----~~~~vaVK~l~~~~---~~~~~~~f~~Ei~~l~~l~H-~nIv~llg~~~~~~~ 295 (466)
++|++.+.||+|+||+||+|... +|+.||||.++... .....+.+.+|++++++++| |||+++++++.+
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--- 100 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--- 100 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc---
Confidence 45888899999999999999762 47899999986432 12234458899999999976 899999999877
Q ss_pred cceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecC
Q 012297 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 375 (466)
Q Consensus 296 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfG 375 (466)
....++||||+.+|+|.++++.. ..++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 101 -~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG 174 (322)
T d1vzoa_ 101 -ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 174 (322)
T ss_dssp -TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred -CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeecc
Confidence 45679999999999999999765 45788999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCccccCcccccchhcccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 376 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 376 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
+++....... .......|++.|++||.+... .++.++|||||||+||||++|+.||....
T Consensus 175 ~a~~~~~~~~----~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~ 236 (322)
T d1vzoa_ 175 LSKEFVADET----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236 (322)
T ss_dssp EEEECCGGGG----GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred chhhhccccc----ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 9987643221 122345789999999998754 46889999999999999999999997653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-37 Score=305.24 Aligned_cols=196 Identities=20% Similarity=0.296 Sum_probs=167.5
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcceeEE
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRL 301 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~~~~~~~ 301 (466)
++|++.++||+|+||+||+|+.. +++.||||+++.. ..+.+.+|+++|++++ ||||+++++++.... ....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~--~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPV--SRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT--TCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecC--CCcee
Confidence 47889999999999999999874 6899999998743 2456889999999995 999999999987532 34679
Q ss_pred EEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEEecCCcccc
Q 012297 302 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRL 380 (466)
Q Consensus 302 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~-~vkL~DfGla~~~ 380 (466)
+||||+++++|..+. +.+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 109 ~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceec
Confidence 999999999998764 45899999999999999999999999 99999999999998655 6999999999876
Q ss_pred ccCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 012297 381 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 439 (466)
Q Consensus 381 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~~ 439 (466)
.... ......+|+.|+|||.+.+. .++.++||||+|+++|||++|+.||....
T Consensus 181 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 181 HPGQ------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp CTTC------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cCCC------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 5432 23345689999999998765 47999999999999999999999997644
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-37 Score=304.97 Aligned_cols=201 Identities=20% Similarity=0.271 Sum_probs=161.0
Q ss_pred CCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--ccee
Q 012297 224 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAM 299 (466)
Q Consensus 224 ~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~--~~~~ 299 (466)
++|.+.++||+|+||+||+|.+. +|+.||||++...... .....+.+|+.++++++||||+++++++..... ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56888899999999999999976 5999999999765432 333458899999999999999999999865322 3467
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.++||||+.++ +.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhc
Confidence 89999999655 444443 35899999999999999999999999 99999999999999999999999999876
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... .......+|+.|+|||.+.+..+++++||||+||++|||++|+.||...
T Consensus 169 ~~~~------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 169 AGTS------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccc------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 5432 2234457899999999999999999999999999999999999999744
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-37 Score=305.48 Aligned_cols=202 Identities=25% Similarity=0.364 Sum_probs=166.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccC-ccee
Q 012297 223 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAM 299 (466)
Q Consensus 223 t~~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~llg~~~~~~~-~~~~ 299 (466)
.++|++.+.||+|+||+||+|++. +|+.||||++...... ...+.+.+|+++|++++|+||+++++++..... ....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467889999999999999999864 6999999999865322 233468899999999999999999998864322 1223
Q ss_pred EEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 300 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 300 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
.+++++|+.+|+|.+++.. +.+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence 3566777889999999964 45999999999999999999999999 99999999999999999999999999876
Q ss_pred cccCCCCCCCCCCCccccCcccccchhcccC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 380 LKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 380 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
.... .....|++.|+|||..... .++.++||||||+++|||++|+.||...
T Consensus 171 ~~~~--------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 171 TDDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp CTGG--------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCcc--------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 5332 2335688999999987665 4689999999999999999999999643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7e-33 Score=275.53 Aligned_cols=199 Identities=24% Similarity=0.264 Sum_probs=157.4
Q ss_pred CCCCcceecccCcEEEEEEEEc-CCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-----------CCCccceeeeeee
Q 012297 225 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-----------HCHVVPLVGYCSE 292 (466)
Q Consensus 225 ~f~~~~~LG~G~fG~Vy~a~~~-~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~llg~~~~ 292 (466)
+|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4888899999999999999874 68999999997542 23345788999888875 5789999988865
Q ss_pred ccCcceeEEEEEecCCCC-CHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCc--
Q 012297 293 FRGKRAMRLLVFEFMPNG-NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLN-- 368 (466)
Q Consensus 293 ~~~~~~~~~lV~ey~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivHrDLk~~NILld~~~~-- 368 (466)
.... ..++++++...+ +............+++..+..++.|++.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 92 KGPN--GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EETT--EEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred cccc--ceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccc
Confidence 3332 335555554443 34444444444668999999999999999999998 76 999999999999986653
Q ss_pred ----EEEEecCCccccccCCCCCCCCCCCccccCcccccchhcccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 012297 369 ----AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 438 (466)
Q Consensus 369 ----vkL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDv~S~Gvll~elltG~~Pf~~~ 438 (466)
++++|||.+...... .....||+.|+|||.+....++.++||||+|++++||++|+.||...
T Consensus 167 ~~~~~kl~dfg~s~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH--------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp TEEEEEECCCTTCEETTBC--------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ccceeeEeecccccccccc--------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 999999998765332 23456899999999999999999999999999999999999999754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=3.1e-24 Score=193.45 Aligned_cols=164 Identities=16% Similarity=0.139 Sum_probs=118.7
Q ss_pred CCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCC-------------C----hhHHHHHHHHHHHhcCCCCccceeee
Q 012297 227 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-------------N----ADSVFLTEVDMLSRLHHCHVVPLVGY 289 (466)
Q Consensus 227 ~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~-------------~----~~~~f~~Ei~~l~~l~H~nIv~llg~ 289 (466)
.+.+.||+|+||+||+|.+.+|+.||||+++..... . ....+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356799999999999999999999999987643110 0 01224567888999999999988765
Q ss_pred eeeccCcceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 012297 290 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 369 (466)
Q Consensus 290 ~~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivHrDLk~~NILld~~~~v 369 (466)
.. .+++|||+++..+.+ ++......++.|++.+|.|||+.+ |+||||||+|||++++ .+
T Consensus 83 ~~--------~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 83 EG--------NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp ET--------TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EE
T ss_pred cC--------CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CE
Confidence 32 179999998765543 333445678999999999999998 9999999999999965 58
Q ss_pred EEEecCCccccccCCCCCCCCCCCccccCcccccc------hhcccCCCCchhHHHHHHHHH
Q 012297 370 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP------EYAMVGRASLMSDVFSFGVVL 425 (466)
Q Consensus 370 kL~DfGla~~~~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~s~~sDv~S~Gvll 425 (466)
+|+|||++....... ...|... |. ..+.|+.++|+||..--+
T Consensus 142 ~liDFG~a~~~~~~~-------------~~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 142 WIIDFPQSVEVGEEG-------------WREILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EECCCTTCEETTSTT-------------HHHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred EEEECCCcccCCCCC-------------cHHHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 999999987643210 0112211 11 235677889999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.54 E-value=2.5e-07 Score=84.96 Aligned_cols=150 Identities=15% Similarity=0.106 Sum_probs=99.4
Q ss_pred HHHHHHhCCCCCcceecccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccC
Q 012297 217 SALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRG 295 (466)
Q Consensus 217 ~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~llg~~~~~~~ 295 (466)
.++...-++|...+..+.++...||+... +++.+++|+........ ...+.+|...+..+. +-.+.+++.+...
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~-~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--- 81 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERH--- 81 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEE---
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc-hhhHHHHHHHHHHHhccCCCCcEEEEEec---
Confidence 35666667777665555455678999875 45667888876543222 123678888888774 4345677776554
Q ss_pred cceeEEEEEecCCCCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCC---------------------------
Q 012297 296 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA--------------------------- 348 (466)
Q Consensus 296 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~--------------------------- 348 (466)
....++||+++++.++.+..... .. ...++.++++.+..||+...
T Consensus 82 -~~~~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 82 -DGWSNLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp -TTEEEEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred -CCceEEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 34569999999998886644211 11 22345566666666664320
Q ss_pred -----------------------------CCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 349 -----------------------------PRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 349 -----------------------------~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
+.++|+|+.|.|||++++....|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 2379999999999999876677999997753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.24 E-value=9.6e-07 Score=80.48 Aligned_cols=129 Identities=17% Similarity=0.130 Sum_probs=82.2
Q ss_pred ecccC-cEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCC--CccceeeeeeeccCcceeEEEEEecCC
Q 012297 232 VGQGG-SSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--HVVPLVGYCSEFRGKRAMRLLVFEFMP 308 (466)
Q Consensus 232 LG~G~-fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~llg~~~~~~~~~~~~~lV~ey~~ 308 (466)
+..|. ...||+...+++..+++|........ .+..|.+.++.+... .+.+++++..+ ....++||+|++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~----~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN----ELQDEAARLSWLATTGVPCAAVLDVVTE----AGRDWLLLGEVP 89 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS----CHHHHHHHHHHHHTTTCCBCCEEEEEEC----SSCEEEEEECCS
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh----HHHHHHHHHHHHHhcCCCCCceeeeccc----ccceEEEEEeee
Confidence 34444 36899999888888999986654322 367888888877533 34566766554 345699999998
Q ss_pred CCCHHHHhcccccCCCCHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 012297 309 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH-------------------------------------------- 344 (466)
Q Consensus 309 ~gsL~~~l~~~~~~~~~~~~~~~i~~qia~~L~~LH-------------------------------------------- 344 (466)
|.++.+.. ... ..++.++++.|.-||
T Consensus 90 G~~~~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 90 GQDLLSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp SEETTTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cccccccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 86653310 110 111222333333333
Q ss_pred -------hCC----CCCeEecCCCCCCEEEcCCCcEEEEecCCcc
Q 012297 345 -------EAA----APRILHRDIKSSNILLDENLNAKITDLGMAK 378 (466)
Q Consensus 345 -------~~~----~~~ivHrDLk~~NILld~~~~vkL~DfGla~ 378 (466)
... .+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 211 1237999999999999987667899998765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.97 E-value=1.3e-05 Score=78.14 Aligned_cols=76 Identities=21% Similarity=0.188 Sum_probs=46.9
Q ss_pred ceecccCcEEEEEEEEcC-CcEEEEEEccc------CCCCChhHHHHHHHHHHHhcC-C--CCccceeeeeeeccCccee
Q 012297 230 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKT------QGGPNADSVFLTEVDMLSRLH-H--CHVVPLVGYCSEFRGKRAM 299 (466)
Q Consensus 230 ~~LG~G~fG~Vy~a~~~~-~~~vaVK~l~~------~~~~~~~~~f~~Ei~~l~~l~-H--~nIv~llg~~~~~~~~~~~ 299 (466)
+.||.|....||+....+ ++.++||.-.. ...+....+...|.+.|+.+. + ..+.+++.+..+ .
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~------~ 105 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE------M 105 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT------T
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC------C
Confidence 468999999999998765 67899996432 111222233556888887763 2 334556654322 3
Q ss_pred EEEEEecCCCCC
Q 012297 300 RLLVFEFMPNGN 311 (466)
Q Consensus 300 ~~lV~ey~~~gs 311 (466)
.++|||++++..
T Consensus 106 ~~lvmE~L~~~~ 117 (392)
T d2pula1 106 AVTVMEDLSHLK 117 (392)
T ss_dssp TEEEECCCTTSE
T ss_pred CEEEEeccCCcc
Confidence 389999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.22 E-value=0.00065 Score=63.75 Aligned_cols=141 Identities=18% Similarity=0.200 Sum_probs=78.0
Q ss_pred cCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCc--cceeeeee-eccCcceeEEEEEecCCCCC
Q 012297 235 GGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV--VPLVGYCS-EFRGKRAMRLLVFEFMPNGN 311 (466)
Q Consensus 235 G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~llg~~~-~~~~~~~~~~lV~ey~~~gs 311 (466)
+-.-.||++++.+|+.+++|+.+.... ..+++..|...+..|....+ +..+.... .........+.++++++|..
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 334689999999999999999876532 23457889988888853332 11111000 00011345688999997643
Q ss_pred H-----HHH------h---c----ccc---cCCCCHHH-------------------HHHHHHHHHHHHHHHHh----CC
Q 012297 312 L-----RDC------L---D----GVL---VEGMNWDT-------------------RVAIAIGAARGLEYLHE----AA 347 (466)
Q Consensus 312 L-----~~~------l---~----~~~---~~~~~~~~-------------------~~~i~~qia~~L~~LH~----~~ 347 (466)
+ ..+ + + ... ....++.. +..+...+.+.++.+.. ..
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 2 111 0 1 000 01111111 11122222333333332 22
Q ss_pred CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 348 APRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 348 ~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
...++|+|+.+.|||++++ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 3358999999999999754 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.11 E-value=0.00083 Score=64.78 Aligned_cols=73 Identities=19% Similarity=0.256 Sum_probs=50.0
Q ss_pred cceecccCcEEEEEEEEcCC--------cEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCcc-ceeeeeeeccCccee
Q 012297 229 SNIVGQGGSSYVYRGQLTDG--------RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAM 299 (466)
Q Consensus 229 ~~~LG~G~fG~Vy~a~~~~~--------~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~llg~~~~~~~~~~~ 299 (466)
.+.|+.|-.-.+|+....++ +.|++++.- .. .. .....+|..+++.+.-.++. ++++++..
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~------- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ET-ESHLVAESVIFTLLSERHLGPKLYGIFSG------- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT-------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-ch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-------
Confidence 35678799999999987643 456766654 22 22 23456899999988644554 77777643
Q ss_pred EEEEEecCCCCCH
Q 012297 300 RLLVFEFMPNGNL 312 (466)
Q Consensus 300 ~~lV~ey~~~gsL 312 (466)
.+|+||+++.+|
T Consensus 117 -g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -GRLEEYIPSRPL 128 (395)
T ss_dssp -EEEECCCCEEEC
T ss_pred -ceEEEEeccccC
Confidence 689999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.82 E-value=0.0051 Score=56.82 Aligned_cols=160 Identities=9% Similarity=0.047 Sum_probs=83.0
Q ss_pred echHHHHHHhCCCCCccee-----cccCcEEEEEEEEcCCcEEEEEEcccCCCCChhHHHHHHHHHHHhcCCCCc--cce
Q 012297 214 FSYSALEHATDKFSGSNIV-----GQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV--VPL 286 (466)
Q Consensus 214 ~~~~~l~~~t~~f~~~~~L-----G~G~fG~Vy~a~~~~~~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l 286 (466)
.+.++++....+|.+.++. ..|---+.|+.+.++|+ +++|++....... +...|++++..+...++ ...
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~~---~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEKN---DLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---CC---HHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCHH---HHHHHHHHHHhhhhcccccccc
Confidence 3557888888888775543 35666889999887765 8889886543222 34556777777643222 111
Q ss_pred e----eeeeeccCcceeEEEEEecCCCCCHHH-----------H---hcc----cc---cCCCCH---------------
Q 012297 287 V----GYCSEFRGKRAMRLLVFEFMPNGNLRD-----------C---LDG----VL---VEGMNW--------------- 326 (466)
Q Consensus 287 l----g~~~~~~~~~~~~~lV~ey~~~gsL~~-----------~---l~~----~~---~~~~~~--------------- 326 (466)
+ |..... .......++.+..+..... . ++. .. ......
T Consensus 79 i~~~~g~~~~~--~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (316)
T d2ppqa1 79 LPRKDGELLGE--LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 156 (316)
T ss_dssp CCBTTCCSCEE--ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred ceecCCCccee--eecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence 1 111100 1223466677766543210 0 000 00 000000
Q ss_pred ---HHHHHHHHHHHHHHHHHHhCC-CCCeEecCCCCCCEEEcCCCcEEEEecCCccc
Q 012297 327 ---DTRVAIAIGAARGLEYLHEAA-APRILHRDIKSSNILLDENLNAKITDLGMAKR 379 (466)
Q Consensus 327 ---~~~~~i~~qia~~L~~LH~~~-~~~ivHrDLk~~NILld~~~~vkL~DfGla~~ 379 (466)
......+......+.-.+... +..++|+|+.++||+++.+...-|+||+.+..
T Consensus 157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 001112222222222222211 23599999999999999887778999999864
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=93.49 E-value=0.0065 Score=37.64 Aligned_cols=26 Identities=15% Similarity=0.451 Sum_probs=19.6
Q ss_pred HhhhhhccccccccCcccceEEeccCCCCCc
Q 012297 17 WIQRSICDKLSERSGQKNWKCTCSSSLQGDQ 47 (466)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 47 (466)
+..++.|.+ ...+|+|+|..||.||-
T Consensus 9 C~~~A~C~N-----t~Gsy~C~C~~Gy~GdG 34 (40)
T d1gl4a2 9 CSVHAECRD-----YATGFCCRCVANYTGNG 34 (40)
T ss_dssp SCTTEEEEE-----CSSCEEEEECTTEEECS
T ss_pred CCCCCEeec-----CCCCeEeECCCCCcCCC
Confidence 345667765 34689999999999985
|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.40 E-value=0.14 Score=32.74 Aligned_cols=15 Identities=33% Similarity=0.915 Sum_probs=12.5
Q ss_pred CcccceEEeccCCCC
Q 012297 31 GQKNWKCTCSSSLQG 45 (466)
Q Consensus 31 ~~~~~~~~~~~~~~~ 45 (466)
..++|+|.|..||.|
T Consensus 24 ~~~~y~C~C~~G~~G 38 (48)
T d1autl1 24 GIGSFSCDCRSGWEG 38 (48)
T ss_dssp CSSCCCEEECTTEES
T ss_pred CCCCCeEeCCCCCcC
Confidence 457899999999877
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.95 E-value=0.074 Score=33.38 Aligned_cols=23 Identities=17% Similarity=0.595 Sum_probs=17.3
Q ss_pred hhhccccccccCcccceEEeccCCCCCc
Q 012297 20 RSICDKLSERSGQKNWKCTCSSSLQGDQ 47 (466)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 47 (466)
++.|.| -..+|+|.|..||+|+.
T Consensus 15 ~~~C~N-----t~Gsy~C~C~~Gy~~~~ 37 (44)
T d1lmja1 15 RGQCVN-----TPGDFECKCDEGYESGF 37 (44)
T ss_dssp TSCEEE-----ETTEEEECCCSSEEECT
T ss_pred CCEeEc-----CCCCeEEeCCCCCccCC
Confidence 456765 45689999999998874
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.91 E-value=0.16 Score=31.44 Aligned_cols=23 Identities=17% Similarity=0.533 Sum_probs=16.8
Q ss_pred hhhhccccccccCcccceEEeccCCCCC
Q 012297 19 QRSICDKLSERSGQKNWKCTCSSSLQGD 46 (466)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 46 (466)
.++.|.+ ..++|+|.|..||.|.
T Consensus 15 n~g~C~n-----~~g~y~C~C~~G~~G~ 37 (42)
T d2vj3a1 15 HAGKCIN-----TLGSFECQCLQGYTGP 37 (42)
T ss_dssp TTCEEEE-----CSSSEEEECCTTEEST
T ss_pred CCcEeEC-----CCCCEEeECCCCCcCC
Confidence 4455644 5578999999998875
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.96 E-value=0.12 Score=32.14 Aligned_cols=17 Identities=12% Similarity=0.388 Sum_probs=10.8
Q ss_pred CcccceEEeccCCCCCc
Q 012297 31 GQKNWKCTCSSSLQGDQ 47 (466)
Q Consensus 31 ~~~~~~~~~~~~~~~~~ 47 (466)
...+|.|.|..||.++.
T Consensus 22 t~Gsy~C~C~~Gy~~~g 38 (43)
T d1emoa1 22 TDGSYRCECPFGYILAG 38 (43)
T ss_dssp CSSCCCCCCCTTEEESS
T ss_pred CCCCeEeECCCCcccCC
Confidence 44567777777766543
|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.65 E-value=0.18 Score=30.58 Aligned_cols=16 Identities=25% Similarity=0.729 Sum_probs=12.9
Q ss_pred CcccceEEeccCCCCC
Q 012297 31 GQKNWKCTCSSSLQGD 46 (466)
Q Consensus 31 ~~~~~~~~~~~~~~~~ 46 (466)
..++|+|.|..||.|.
T Consensus 18 ~~~~~~C~C~~g~~G~ 33 (39)
T d1g1ta2 18 TINNYTCKCDPGFSGL 33 (39)
T ss_dssp ETTEEEEEECTTEEST
T ss_pred CCCCEEEeCCCCCcCc
Confidence 3478999999998874
|